Citrus Sinensis ID: 039258

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230----
Protein Sequence
SCFILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHccccccccEEcccccEEEEEEEccccEEEEEEEEEcccccccHHHHHHHHHHHcccccccccEEEEEcccccccccEEEEEEcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccccccccccEEEcccccccccccccccccccccccccEEcccEEEccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHcccccccccccccccEEcHHHHHHHHccccHHccccccccccEEcEEccccccEEEEEEEEccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEcccccccccEEEEEEEcccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEcccccHHHEEEcccccEEEccccccEEcccccccccccccEEEEEEEEcEccccc
Coil and Loop (DISEMBL)
scfilssclTIVYVRrrgsvrkpidtlpmekqfpmvsYAELSKATcefsqsnmigqgsygsvykgilgeDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLhhncqppmvhgdikpsnvlldndmvahvgdfglskflssdhldtasetpsssigikgtvgyvap
Flexible Loop (DISEMBL)
scfilsscltivyvrrrgsvrkpidtlpmekqFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTasetpsssigikgtvgyvap
Low Complexity Region (SEG)
SCFILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP
Disordered region (IsUnstruct)
*CFILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL***************************
Disordered Region (DISOPRED)
SCFILSSCLTIVYV*******************PMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS*************IGIKGTVGYVAP
Disordered Region (DISEMBL)
SCFILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL**********IGIKGTVGYVAP
Disordered Region (DISPRO)
SCFILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
SCFILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	234	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.987	0.228	0.464	2e-59
C0LGT6	1031	LRR receptor-like serine/	no	no	0.982	0.223	0.465	8e-58
Q9SD62	1025	Putative receptor-like pr	no	no	0.871	0.199	0.528	2e-57
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.820	0.153	0.417	5e-36
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.837	0.2	0.440	1e-35
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.820	0.153	0.396	4e-35
Q9FL28	1173	LRR receptor-like serine/	no	no	0.782	0.156	0.421	2e-33
P47735	999	Receptor-like protein kin	no	no	0.935	0.219	0.380	1e-32
Q9LJF3	1164	Receptor-like protein kin	no	no	0.846	0.170	0.393	2e-32
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.841	0.164	0.388	2e-32

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  229 bits (583), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 110/237 (46%), Positives = 168/237 (70%), Gaps = 6/237 (2%)

Query: 3   FILSSCLTIVYVRRRGSVRKPIDTLP--MEKQFPMVSYAELSKATCEFSQSNMIGQGSYG 60
            +  + +T++++R+R   ++  +  P  +E     +SY +L  AT  FS SNM+G GS+G
Sbjct: 655 LLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFG 714

Query: 61  SVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA 120
           +VYK +L  ++ VVAVKV+N++++GA +SF+AECE+L++IRHRNL K++T CSSID +G 
Sbjct: 715 TVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGN 774

Query: 121 DFKALVFEYMENGSLEDWLHQ---TNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP 177
           +F+AL++E+M NGSL+ WLH       H     L+L++R+NIAIDVAS ++YLH +C  P
Sbjct: 775 EFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEP 834

Query: 178 MVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + H D+KPSNVLLD+D+ AHV DFGL++ L     ++     SS+ G++GT+GY AP
Sbjct: 835 IAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSA-GVRGTIGYAAP 890

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  223 bits (568), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 116/249 (46%), Positives = 163/249 (65%), Gaps = 19/249 (7%)

Query: 2   CFILSSCLTIVYV-----------RRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQ 50
           C  ++S L I+ V           +   S   P D+  +      VSY EL  AT  FS 
Sbjct: 655 CIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSS 714

Query: 51  SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +N+IG G++G+V+KG+LG +  +VAVKV+NL + GA +SF+AECE  + IRHRNL K+IT
Sbjct: 715 TNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLIT 774

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLH-----QTNDHLEVFKLSLIQRVNIAIDVAS 165
           +CSS+DS+G DF+ALV+E+M  GSL+ WL      + NDH     L+  +++NIAIDVAS
Sbjct: 775 VCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSR--SLTPAEKLNIAIDVAS 832

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           A+EYLH +C  P+ H DIKPSN+LLD+D+ AHV DFGL++ L     ++     SS+ G+
Sbjct: 833 ALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSA-GV 891

Query: 226 KGTVGYVAP 234
           +GT+GY AP
Sbjct: 892 RGTIGYAAP 900

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  222 bits (566), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 112/212 (52%), Positives = 146/212 (68%), Gaps = 8/212 (3%)

Query: 28  PMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF 87
           P++  +  +SY EL K T  FS SN+IG G++G+V+KG LG     VA+KV+NL ++GA 
Sbjct: 699 PVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAA 758

Query: 88  RSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE 147
           +SF+AECEAL  IRHRNL K++TICSS D +G DF+ALV+E+M NG+L+ WLH   D +E
Sbjct: 759 KSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP--DEIE 816

Query: 148 -----VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG 202
                   L L  R+NIAIDVASA+ YLH  C  P+ H DIKPSN+LLD D+ AHV DFG
Sbjct: 817 ETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFG 876

Query: 203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           L++ L     DT      SS G++GT+GY AP
Sbjct: 877 LAQLLLKFDRDTF-HIQFSSAGVRGTIGYAAP 907

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  151 bits (381), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 84/201 (41%), Positives = 121/201 (60%), Gaps = 9/201 (4%)

Query: 36   VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECE 95
            + + ++ +AT   S+  MIG G  G VYK  L   E V   K++      + +SF  E +
Sbjct: 939  IRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVK 998

Query: 96   ALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK--LSL 153
             L  IRHR+L K++  CSS   K      L++EYM+NGS+ DWLH+    LE  K  L  
Sbjct: 999  TLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055

Query: 154  IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
              R+ IA+ +A  +EYLHH+C PP+VH DIK SNVLLD++M AH+GDFGL+K L +++ D
Sbjct: 1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVL-TENCD 1114

Query: 214  TASETPSSSIGIKGTVGYVAP 234
            T ++   S+     + GY+AP
Sbjct: 1115 TNTD---SNTWFACSYGYIAP 1132

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  149 bits (377), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/211 (44%), Positives = 122/211 (57%), Gaps = 15/211 (7%)

Query: 30  EKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR- 88
           + ++P +SY +L  AT  F+ S++IG G +G VYKG+L  +   VAVKV++ K    F  
Sbjct: 643 DPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSG 701

Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEV 148
           SF  EC+ L+  RHRNL +IIT CS        F ALV   M NGSLE  L+        
Sbjct: 702 SFKRECQILKRTRHRNLIRIITTCSK-----PGFNALVLPLMPNGSLERHLYP--GEYSS 754

Query: 149 FKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
             L LIQ VNI  DVA  I YLHH     +VH D+KPSN+LLD++M A V DFG+S+ + 
Sbjct: 755 KNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQ 814

Query: 209 SDHLDTASETPSSSIG-----IKGTVGYVAP 234
               +T S   S S G     + G+VGY+AP
Sbjct: 815 GVE-ETVSTDDSVSFGSTDGLLCGSVGYIAP 844

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  147 bits (372), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 79/199 (39%), Positives = 119/199 (59%), Gaps = 7/199 (3%)

Query: 36   VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECE 95
            + + ++ +AT   ++  MIG G  G VYK  L   E +   K++      + +SF  E +
Sbjct: 936  IKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVK 995

Query: 96   ALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQ 155
             L  IRHR+L K++  CSS   K      L++EYM NGS+ DWLH   +  +   L    
Sbjct: 996  TLGTIRHRHLVKLMGYCSS---KADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWET 1052

Query: 156  RVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTA 215
            R+ IA+ +A  +EYLH++C PP+VH DIK SNVLLD+++ AH+GDFGL+K L+ ++ DT 
Sbjct: 1053 RLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNY-DTN 1111

Query: 216  SETPSSSIGIKGTVGYVAP 234
            +E   S+    G+ GY+AP
Sbjct: 1112 TE---SNTMFAGSYGYIAP 1127

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  142 bits (359), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 83/197 (42%), Positives = 123/197 (62%), Gaps = 14/197 (7%)

Query: 40   ELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEAL 97
            EL +AT  F+ +N+IG  S  +VYKG L ED  V+AVKV+NLK+  A   + F  E + L
Sbjct: 862  ELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWFYTEAKTL 920

Query: 98   RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
              ++HRNL KI+        +    KALV  +MENG+LED +H +   +     SL++++
Sbjct: 921  SQLKHRNLVKILGFAW----ESGKTKALVLPFMENGNLEDTIHGSAAPIG----SLLEKI 972

Query: 158  NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            ++ + +AS I+YLH     P+VH D+KP+N+LLD+D VAHV DFG ++ L     +  S 
Sbjct: 973  DLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILG--FREDGST 1030

Query: 218  TPSSSIGIKGTVGYVAP 234
            T S+S   +GT+GY+AP
Sbjct: 1031 TASTS-AFEGTIGYLAP 1046

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1

 Score =  139 bits (351), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 92/242 (38%), Positives = 129/242 (53%), Gaps = 23/242 (9%)

Query: 3   FILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSV 62
           F++   + I   R+  +++         + F  + ++E   A C   + N+IG GS G V
Sbjct: 639 FVVGIVMFIAKCRKLRALKSSTLAASKWRSFHKLHFSEHEIADC-LDEKNVIGFGSSGKV 697

Query: 63  YKGILGEDEMVVAVKVINLKQKGA---FRS-------FVAECEALRNIRHRNLTKIITIC 112
           YK  L   E VVAVK +N   KG    + S       F AE E L  IRH+++ ++   C
Sbjct: 698 YKVELRGGE-VVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCC 756

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           SS      D K LV+EYM NGSL D LH   D      L   +R+ IA+D A  + YLHH
Sbjct: 757 SS-----GDCKLLVYEYMPNGSLADVLH--GDRKGGVVLGWPERLRIALDAAEGLSYLHH 809

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
           +C PP+VH D+K SN+LLD+D  A V DFG++K        + S+TP +  GI G+ GY+
Sbjct: 810 DCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQM----SGSKTPEAMSGIAGSCGYI 865

Query: 233 AP 234
           AP
Sbjct: 866 AP 867

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  139 bits (350), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/211 (39%), Positives = 119/211 (56%), Gaps = 13/211 (6%)

Query: 24   IDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ 83
            I+    EK    +++A L +AT  FS  +MIG G +G VYK  L +  +V   K+I +  
Sbjct: 834  INVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTG 893

Query: 84   KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN 143
            +G  R F+AE E +  I+HRNL  ++  C     K  + + LV+EYM+ GSLE  LH+  
Sbjct: 894  QGD-REFMAEMETIGKIKHRNLVPLLGYC-----KIGEERLLVYEYMKYGSLETVLHEKT 947

Query: 144  DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
                +F L    R  IAI  A  + +LHH+C P ++H D+K SNVLLD D VA V DFG+
Sbjct: 948  KKGGIF-LDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGM 1006

Query: 204  SKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            ++ +S+  LDT     +    + GT GYV P
Sbjct: 1007 ARLVSA--LDTHLSVST----LAGTPGYVPP 1031

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  139 bits (350), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/211 (38%), Positives = 119/211 (56%), Gaps = 14/211 (6%)

Query: 24   IDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ 83
            I+    EK    +++A+L +AT  F   ++IG G +G VYK IL +   V   K+I++  
Sbjct: 859  INLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSG 918

Query: 84   KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN 143
            +G  R F+AE E +  I+HRNL  ++  C     K  D + LV+E+M+ GSLED LH   
Sbjct: 919  QGD-REFMAEMETIGKIKHRNLVPLLGYC-----KVGDERLLVYEFMKYGSLEDVLHDPK 972

Query: 144  DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
                  KL+   R  IAI  A  + +LHHNC P ++H D+K SNVLLD ++ A V DFG+
Sbjct: 973  K--AGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGM 1030

Query: 204  SKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            ++ +S      A +T  S   + GT GYV P
Sbjct: 1031 ARLMS------AMDTHLSVSTLAGTPGYVPP 1055

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	234
224117950	1018	predicted protein [Populus trichocarpa]	0.982	0.225	0.573	6e-71
359482058	1040	PREDICTED: probable LRR receptor-like se	0.944	0.212	0.597	3e-70
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.944	0.116	0.593	2e-69
449483698	1099	PREDICTED: probable LRR receptor-like se	0.974	0.207	0.543	4e-67
218190319	868	hypothetical protein OsI_06373 [Oryza sa	0.961	0.259	0.556	6e-67
224127492	1022	predicted protein [Populus trichocarpa]	0.884	0.202	0.585	8e-67
224119022	1021	predicted protein [Populus trichocarpa]	0.957	0.219	0.567	1e-66
255574413	468	ATP binding protein, putative [Ricinus c	0.957	0.478	0.548	2e-66
444737622	1032	Putative LRR receptor-like serine/threon	0.876	0.198	0.608	2e-66
356523290	1001	PREDICTED: probable LRR receptor-like se	0.952	0.222	0.548	3e-66

>gi|224117950|ref|XP_002317696.1| predicted protein [Populus trichocarpa] gi|222858369|gb|EEE95916.1| predicted protein [Populus trichocarpa]

 Score =  273 bits (697), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 133/232 (57%), Positives = 176/232 (75%), Gaps = 2/232 (0%)

Query: 4   ILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVY 63
           +L +C+  V  R+  + RKP+    MEK+F +VSY +L++AT  FS +NMIG G YGSVY
Sbjct: 663 LLLACIFAVGYRKLSANRKPLSASTMEKKFQIVSYQDLARATDGFSSANMIGDGGYGSVY 722

Query: 64  KGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK 123
           KGILG D   VA+KV+  +Q+GA R+FVAECE LR IRHRNL KI+T CSSID KG DFK
Sbjct: 723 KGILGPDGQTVAIKVLKPEQRGANRTFVAECETLRRIRHRNLVKIVTACSSIDFKGNDFK 782

Query: 124 ALVFEYMENGSLEDWLHQTN-DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD 182
           ALVF++M  GSLE WLH +  +     +LSL+QR+++ IDVASA++YLH++C   +VH D
Sbjct: 783 ALVFDFMPGGSLESWLHPSAVESQNSKRLSLLQRISMLIDVASALDYLHNHCDEQIVHCD 842

Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +KPSN+LLDND+ AHVGDFGL++ LS+   +T S T +SS+G++GTVGYVAP
Sbjct: 843 LKPSNILLDNDLTAHVGDFGLARILSAATGETPS-TSTSSLGVRGTVGYVAP 893

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  270 bits (691), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 138/231 (59%), Positives = 171/231 (74%), Gaps = 10/231 (4%)

Query: 11  IVYVRRRGSVRKPIDTLPMEKQFPM-VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGE 69
           +V  R R   R+P  T    K   + VSY  L KAT  FS +N+IG G +GSVYKGILG+
Sbjct: 675 LVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQ 734

Query: 70  DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEY 129
           DE VVAVKVI L Q+GA +SF AECEALRNIRHRNL K++T CSS+D +G DFKALV+E+
Sbjct: 735 DETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEF 794

Query: 130 MENGSLEDWLH------QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDI 183
           M NGSLE+WLH      + ND L +  LSL QR+NIAIDVASA++YLHH+C  P+VH D+
Sbjct: 795 MPNGSLENWLHPVPTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDL 852

Query: 184 KPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           KPSN+LLDNDM AHVGDFGL++F+  +    +  + SSSIG+KGT+GY AP
Sbjct: 853 KPSNILLDNDMTAHVGDFGLARFI-PEAAGRSHPSQSSSIGLKGTIGYAAP 902

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  268 bits (684), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 137/231 (59%), Positives = 170/231 (73%), Gaps = 10/231 (4%)

Query: 11  IVYVRRRGSVRKPIDTLPMEKQFPM-VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGE 69
           +V  R R   R+P  T    K   + VSY  L KAT  FS +N+IG G +GSVYKG LG+
Sbjct: 706 LVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQ 765

Query: 70  DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEY 129
           DE VVAVKVI L Q+GA +SF AECEALRNIRHRNL K++T CSS+D +G DFKALV+E+
Sbjct: 766 DETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEF 825

Query: 130 MENGSLEDWLH------QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDI 183
           M NGSLE+WLH      + ND L +  LSL QR+NIAIDVASA++YLHH+C  P+VH D+
Sbjct: 826 MPNGSLENWLHPVPTPDEINDVLRI--LSLPQRLNIAIDVASALDYLHHHCHKPIVHCDL 883

Query: 184 KPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           KPSN+LLDNDM AHVGDFGL++F+  +    +  + SSSIG+KGT+GY AP
Sbjct: 884 KPSNILLDNDMTAHVGDFGLARFI-PEAAGRSHPSQSSSIGLKGTIGYAAP 933

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449483698|ref|XP_004156663.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  260 bits (664), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 126/232 (54%), Positives = 169/232 (72%), Gaps = 4/232 (1%)

Query: 3   FILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSV 62
           FIL  C  +   R+  S     ++L  ++  P +SY ELSK+T  FS  N+IG GS+GSV
Sbjct: 716 FILV-CFVLRKSRKDAST---TNSLSAKEFIPQISYLELSKSTSGFSTENLIGSGSFGSV 771

Query: 63  YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF 122
           YKG+L  D  VVAVKV+NL+Q+GA +SFV EC AL NIRHRNL KIIT CSSID +G +F
Sbjct: 772 YKGVLSNDGSVVAVKVLNLQQQGASKSFVDECNALSNIRHRNLLKIITSCSSIDGQGNEF 831

Query: 123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD 182
           KALVF +M NG+L+ WLH  N    + +LSLIQR+NIAID+A  ++YLH +C+ P++H D
Sbjct: 832 KALVFNFMSNGNLDCWLHPKNQGTNLRRLSLIQRLNIAIDIACGLDYLHTHCETPIIHCD 891

Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           IKPSN+LLD+DMVAHVGDFGL++F+  +  D  S + + S+ +KG++GY+ P
Sbjct: 892 IKPSNILLDDDMVAHVGDFGLARFMLEESNDQISFSQTMSLALKGSIGYIPP 943

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|218190319|gb|EEC72746.1| hypothetical protein OsI_06373 [Oryza sativa Indica Group]

 Score =  259 bits (662), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 133/239 (55%), Positives = 178/239 (74%), Gaps = 14/239 (5%)

Query: 3   FILSSCLTIVYVRRRGSVRKPIDTLPM-EKQFPMVSYAELSKATCEFSQSNMIGQGSYGS 61
            IL +C  +   RRR  +R+    +P+ ++Q   VSYA+LSKAT  F+  N+IG GS+G+
Sbjct: 511 LILFTCFAL---RRRTKLRRANPKIPLSDEQHMRVSYAQLSKATNRFASENLIGVGSFGA 567

Query: 62  VYKGILG--EDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG 119
           VYKG +G  + +MVVAVKV+NL+Q GA+RSF AECEALR IRHRNL KI+T+CS ID +G
Sbjct: 568 VYKGRIGISDQQMVVAVKVLNLQQAGAYRSFDAECEALRCIRHRNLVKILTVCSGIDFQG 627

Query: 120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFK----LSLIQRVNIAIDVASAIEYLHHNCQ 175
           +DFKALVFE++ NG+L+ WLH+   HLE       L+L++R+ IAIDVASA+EYLH +  
Sbjct: 628 SDFKALVFEFLPNGNLDQWLHK---HLEEEGEPKVLNLVERLQIAIDVASALEYLHQHKP 684

Query: 176 PPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            P+VH D+KPSN+LLDNDMVAHVGDFGL++FL  +H   +S+  +    I+GT+GYVAP
Sbjct: 685 CPIVHCDLKPSNILLDNDMVAHVGDFGLARFLHQEH-SNSSDKSTGWNAIRGTIGYVAP 742

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  259 bits (661), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 127/217 (58%), Positives = 171/217 (78%), Gaps = 10/217 (4%)

Query: 22  KPIDTLP-MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN 80
           KP  + P +E  FP V+Y +L  AT  FS +N+IG+GS+GSV+KGILG D++VVAVKV+N
Sbjct: 682 KPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVLN 741

Query: 81  LKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           L +KGA +SF+AECEAL++IRHRNL K++T CSSID +G DFKALV+E+M NG+LE+WLH
Sbjct: 742 LLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWLH 801

Query: 141 --QTNDHLEVFK-LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
             QT+D     K L L+ R+NIAI +ASA+ YLHH+CQ P++H D+KPSN+LLD +M AH
Sbjct: 802 PVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTAH 861

Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           VGDFGL++F    H + +++T  SS+G+KGT+GY AP
Sbjct: 862 VGDFGLARF----HSEASNQT--SSVGLKGTIGYAAP 892

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa]

 Score =  258 bits (659), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 130/229 (56%), Positives = 168/229 (73%), Gaps = 5/229 (2%)

Query: 7   SCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI 66
           +CL +   RR+   R+ I    M  +   VSY  L KAT  FS SN++G GS+GSVYKG+
Sbjct: 661 TCLFLCSSRRK---RREIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGSFGSVYKGM 717

Query: 67  LGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALV 126
           L ++ MV+AVKV+NL ++GA RSF+AECEALRNIRHRNL K++T CSSID  G DFKA+V
Sbjct: 718 LDQNGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFKAIV 777

Query: 127 FEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP 185
           +E+M NGSLEDWLH           L+L+QR+NIAIDVA A+EYLHH+C+ P+ H D+KP
Sbjct: 778 YEFMANGSLEDWLHPTGTGGGTTLTLNLLQRLNIAIDVACALEYLHHHCEMPIAHCDLKP 837

Query: 186 SNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           SNVLLD+++  HVGDFGL+KFLS   LD  +   S+SIG++GT+GY  P
Sbjct: 838 SNVLLDDELTGHVGDFGLAKFLSGASLDYPTNE-STSIGVRGTIGYAPP 885

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255574413|ref|XP_002528120.1| ATP binding protein, putative [Ricinus communis] gi|223532509|gb|EEF34299.1| ATP binding protein, putative [Ricinus communis]

 Score =  258 bits (658), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 130/237 (54%), Positives = 172/237 (72%), Gaps = 13/237 (5%)

Query: 4   ILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVY 63
           I++SC+  ++   R S RK     P E Q   +SY EL+K+T  FS  N+IG GS+GSVY
Sbjct: 93  IVASCIVAIFCMARNS-RKKHSAAPEEWQVG-ISYTELAKSTDGFSAENLIGLGSFGSVY 150

Query: 64  KGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK 123
           KG+L  +  +VAVKV+NL+Q+GA +SF+ EC ALR+IRHRNL +IIT CSSID +G DFK
Sbjct: 151 KGVLSGNGEIVAVKVLNLQQQGASKSFIDECNALRSIRHRNLIRIITTCSSIDHQGNDFK 210

Query: 124 ALVFEYMENGSLEDWLHQTNDHLE-VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD 182
           ALVFE+M N SL+DWLH   D  +   +LS I+R+NIAID+ASA++YLHH C+ P+VH D
Sbjct: 211 ALVFEFMANRSLDDWLHPKADEQDRTMRLSFIKRLNIAIDIASALDYLHHYCETPIVHCD 270

Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP-----SSSIGIKGTVGYVAP 234
           +KPSNVLLD +M AHVGDFGL++FL       ASETP     + S+ +KG++GY+ P
Sbjct: 271 LKPSNVLLDKNMTAHVGDFGLARFLLE-----ASETPFKRTEAMSVSLKGSIGYIPP 322

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|444737622|emb|CCM07279.1| Putative LRR receptor-like serine/threonine-protein kinase FLS2 [Musa balbisiana]

 Score =  257 bits (657), Expect = 2e-66,   Method: Compositional matrix adjust.
 Identities = 126/207 (60%), Positives = 158/207 (76%), Gaps = 2/207 (0%)

Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
           +E+QF  +SY EL +AT EFS SN+IG GS+GSVYKG +  D   VAVKV+NL++ GA +
Sbjct: 690 IEEQFKRISYNELLRATDEFSASNLIGMGSFGSVYKGAMDADGTTVAVKVLNLERHGASQ 749

Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEV 148
           SF++ECEALRNIRHRNL KI+TIC S+D++G DFKALV  YM NGSLE+WLH        
Sbjct: 750 SFISECEALRNIRHRNLVKILTICLSVDNRGNDFKALVLNYMSNGSLENWLHPKESEAST 809

Query: 149 -FKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
             KL+L QR++IAIDV+SA++YLHH+   P+VH D+KPSNVLLD +M AHVGDFGL++FL
Sbjct: 810 RRKLTLPQRLSIAIDVSSALDYLHHHGPMPIVHCDLKPSNVLLDQEMCAHVGDFGLARFL 869

Query: 208 SSDHLDTASETPSSSIGIKGTVGYVAP 234
               LDT     + S GIKGT+GYVAP
Sbjct: 870 QGTMLDT-DRNRTISTGIKGTIGYVAP 895

Source: Musa balbisiana

Species: Musa balbisiana

Genus: Musa

Family: Musaceae

Order: Zingiberales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523290|ref|XP_003530273.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Glycine max]

 Score =  257 bits (656), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 131/239 (54%), Positives = 170/239 (71%), Gaps = 16/239 (6%)

Query: 1   SCFILSSCLTIVYVRRRGSVRKPIDT----LPMEKQFPMVSYAELSKATCEFSQSNMIGQ 56
           SCF     LT+  + +R   + P  T    L +E     +SY+E++K T  FSQ N+IG 
Sbjct: 631 SCF-----LTLFPIVKRAKRKTPTSTTGNALDLE-----ISYSEITKCTGGFSQDNLIGS 680

Query: 57  GSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSID 116
           GS+GSVYKG L  D  +VAVKV+NL+Q+GA RSF+ EC  LR+IRHRNL KIIT  S +D
Sbjct: 681 GSFGSVYKGTLSGDGSIVAVKVLNLQQRGASRSFIDECHVLRSIRHRNLLKIITAISGVD 740

Query: 117 SKGADFKALVFEYMENGSLEDWLHQTND-HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQ 175
            +G DFKALVFEYM NGSLEDWLH  N+   +  KL+ IQR+NIAIDVA A+EYLHH C+
Sbjct: 741 HQGNDFKALVFEYMPNGSLEDWLHPVNNVQTQTKKLTFIQRLNIAIDVACALEYLHHFCE 800

Query: 176 PPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            P+VH DIKPSNVLLDND+VAHVGDFGL+ FL  +    ++++  S+  ++G++GY+ P
Sbjct: 801 TPIVHCDIKPSNVLLDNDLVAHVGDFGLATFLFEESSKFSTQSVISA-SLRGSIGYIPP 858

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	234
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.965	0.220	0.530	5.2e-56
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.978	0.226	0.472	4.6e-55
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.863	0.402	0.528	7e-54
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.927	0.210	0.493	2.1e-53
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.871	0.199	0.528	5.6e-53
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.982	0.227	0.444	1.8e-52
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.970	0.224	0.424	1.6e-50
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.820	0.153	0.422	6.8e-34
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.649	0.186	0.521	9.6e-34
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.837	0.2	0.440	1.2e-33

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 585 (211.0 bits), Expect = 5.2e-56, P = 5.2e-56
 Identities = 123/232 (53%), Positives = 164/232 (70%)

Query:     4 ILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVY 63
             ILSS   ++   +R     P  T    K  P+VSY++L KAT  F+ +N++G GS+GSVY
Sbjct:   666 ILSSLYLLITWHKRTKKGAPSRT--SMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVY 723

Query:    64 KGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK 123
             KG L   + V AVKV+ L+   A +SF AECEALRN+RHRNL KI+TICSSID++G DFK
Sbjct:   724 KGKLNIQDHV-AVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFK 782

Query:   124 ALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD 182
             A+V+++M NGSLEDW+H +TND  +   L+L +RV I +DVA A++YLH +   P+VH D
Sbjct:   783 AIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCD 842

Query:   183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             IK SNVLLD+DMVAHVGDFGL++ L  D      ++ +SS+G  GT+GY AP
Sbjct:   843 IKSSNVLLDSDMVAHVGDFGLARILV-DGTSLIQQS-TSSMGFIGTIGYAAP 892

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 576 (207.8 bits), Expect = 4.6e-55, P = 4.6e-55
 Identities = 112/237 (47%), Positives = 169/237 (71%)

Query:     4 ILSSCLTIVYVRRRGSVRKPIDTLP--MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGS 61
             +  + +T++++R+R   ++  +  P  +E     +SY +L  AT  FS SNM+G GS+G+
Sbjct:   656 LFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGT 715

Query:    62 VYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD 121
             VYK +L  ++ VVAVKV+N++++GA +SF+AECE+L++IRHRNL K++T CSSID +G +
Sbjct:   716 VYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNE 775

Query:   122 FKALVFEYMENGSLEDWLH--QTND-HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPM 178
             F+AL++E+M NGSL+ WLH  +  + H     L+L++R+NIAIDVAS ++YLH +C  P+
Sbjct:   776 FRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPI 835

Query:   179 VHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE-TPSSSIGIKGTVGYVAP 234
              H D+KPSNVLLD+D+ AHV DFGL++ L     D  S     SS G++GT+GY AP
Sbjct:   836 AHCDLKPSNVLLDDDLTAHVSDFGLARLLLK--FDEESFFNQLSSAGVRGTIGYAAP 890

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 557 (201.1 bits), Expect = 7.0e-54, P = 7.0e-54
 Identities = 111/210 (52%), Positives = 150/210 (71%)

Query:    30 EKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS 89
             +K+   +SY EL  AT  FS SN+IG G++  V+KG+LG +E +VAVKV+NL + GA +S
Sbjct:   191 KKKNDKISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKS 250

Query:    90 FVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH-----QTND 144
             F+AECE+ + IRHRNL K+IT+CSS+DS+G DF+ALV+E+M  GSL+ WL        N+
Sbjct:   251 FIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANN 310

Query:   145 HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
             H     L+  ++VNIAIDVASA+EYLH  C  P+ H DIKPSNVLLD+D+ AHV DFGL+
Sbjct:   311 HSR--SLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLA 368

Query:   205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + L +    T     SS+ G++GT+GY AP
Sbjct:   369 RLLYNFDEKTFLNQFSSA-GVRGTIGYAAP 397

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 2.1e-53, P = 2.1e-53
 Identities = 111/225 (49%), Positives = 155/225 (68%)

Query:    15 RRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVV 74
             +   S   P D+  +      VSY EL  AT  FS +N+IG G++G+V+KG+LG +  +V
Sbjct:   679 KNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLV 738

Query:    75 AVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGS 134
             AVKV+NL + GA +SF+AECE  + IRHRNL K+IT+CSS+DS+G DF+ALV+E+M  GS
Sbjct:   739 AVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGS 798

Query:   135 LEDWLH-----QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVL 189
             L+ WL      + NDH     L+  +++NIAIDVASA+EYLH +C  P+ H DIKPSN+L
Sbjct:   799 LDMWLQLEDLERVNDHSR--SLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNIL 856

Query:   190 LDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             LD+D+ AHV DFGL++ L     ++     SS+ G++GT+GY AP
Sbjct:   857 LDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSA-GVRGTIGYAAP 900

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 557 (201.1 bits), Expect = 5.6e-53, P = 5.6e-53
 Identities = 112/212 (52%), Positives = 146/212 (68%)

Query:    28 PMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF 87
             P++  +  +SY EL K T  FS SN+IG G++G+V+KG LG     VA+KV+NL ++GA 
Sbjct:   699 PVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAA 758

Query:    88 RSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE 147
             +SF+AECEAL  IRHRNL K++TICSS D +G DF+ALV+E+M NG+L+ WLH   D +E
Sbjct:   759 KSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP--DEIE 816

Query:   148 VF-----KLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG 202
                     L L  R+NIAIDVASA+ YLH  C  P+ H DIKPSN+LLD D+ AHV DFG
Sbjct:   817 ETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFG 876

Query:   203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             L++ L     DT      SS G++GT+GY AP
Sbjct:   877 LAQLLLKFDRDTF-HIQFSSAGVRGTIGYAAP 907

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 552 (199.4 bits), Expect = 1.8e-52, P = 1.8e-52
 Identities = 105/236 (44%), Positives = 169/236 (71%)

Query:     4 ILSSCLTIVYVRRRGSVRKPIDTLP--MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGS 61
             +L   +++ + ++R + +K  ++ P  +E     +SY +L  AT  FS SN++G GS+G+
Sbjct:   655 LLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGT 714

Query:    62 VYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD 121
             V+K +L  +  +VAVKV+N++++GA +SF+AECE+L++IRHRNL K++T C+SID +G +
Sbjct:   715 VFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNE 774

Query:   122 FKALVFEYMENGSLEDWLH--QTND-HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPM 178
             F+AL++E+M NGSL+ WLH  +  + H     L+L++R+NIAIDVAS ++YLH +C  P+
Sbjct:   775 FRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPI 834

Query:   179 VHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
              H D+KPSN+LLD+D+ AHV DFGL++ L     ++     SS+ G++GT+GY AP
Sbjct:   835 AHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSA-GVRGTIGYAAP 889

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 534 (193.0 bits), Expect = 1.6e-50, P = 1.6e-50
 Identities = 101/238 (42%), Positives = 167/238 (70%)

Query:     4 ILSSCLTIVYVRRRGSVRKPIDTLPMEKQF--PMVSYAELSKATCEFSQSNMIGQGSYGS 61
             +++S + + + R+R   ++  + +P + +     +SY +L  AT  FS SNM+G GS+G+
Sbjct:   658 VIAS-MVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGT 716

Query:    62 VYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD 121
             V+K +L  +  +VAVKV+N++++GA +SF+AECE+L++ RHRNL K++T C+S D +G +
Sbjct:   717 VFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNE 776

Query:   122 FKALVFEYMENGSLEDWLHQTNDHLEVFK-----LSLIQRVNIAIDVASAIEYLHHNCQP 176
             F+AL++EY+ NGS++ WLH   + +E  +     L+L++R+NI IDVAS ++YLH +C  
Sbjct:   777 FRALIYEYLPNGSVDMWLHP--EEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHE 834

Query:   177 PMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             P+ H D+KPSNVLL++D+ AHV DFGL++ L     ++     SS+ G++GT+GY AP
Sbjct:   835 PIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSA-GVRGTIGYAAP 891

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 381 (139.2 bits), Expect = 6.8e-34, P = 6.8e-34
 Identities = 85/201 (42%), Positives = 124/201 (61%)

Query:    36 VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECE 95
             + + ++ +AT   S+  MIG G  G VYK  L   E V   K++      + +SF  E +
Sbjct:   939 IRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVK 998

Query:    96 ALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK--LSL 153
              L  IRHR+L K++  CSS  S+G +   L++EYM+NGS+ DWLH+    LE  K  L  
Sbjct:   999 TLGRIRHRHLVKLMGYCSS-KSEGLNL--LIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055

Query:   154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
               R+ IA+ +A  +EYLHH+C PP+VH DIK SNVLLD++M AH+GDFGL+K L+ ++ D
Sbjct:  1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLT-ENCD 1114

Query:   214 TASETPSSSIGIKGTVGYVAP 234
             T ++   S+     + GY+AP
Sbjct:  1115 TNTD---SNTWFACSYGYIAP 1132

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 376 (137.4 bits), Expect = 9.6e-34, P = 9.6e-34
 Identities = 84/161 (52%), Positives = 109/161 (67%)

Query:     3 FILSSCLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSV 62
             F L   L   + RR+  V  P  T  M+   PM++Y +L KAT  FS S+++G GS+GSV
Sbjct:   643 FSLLYMLLTCHKRRKKEV--PATT-SMQGH-PMITYKQLVKATDGFSSSHLLGSGSFGSV 698

Query:    63 YKGIL----GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK 118
             YKG      GE   +VAV+V+ L+   A +SF AECE LRN RHRNL KI+TICSSID++
Sbjct:   699 YKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNR 758

Query:   119 GADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVN 158
             G DFKA+V+++M NGSLEDWLH +TND  E   L+L QRV+
Sbjct:   759 GNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 377 (137.8 bits), Expect = 1.2e-33, P = 1.2e-33
 Identities = 93/211 (44%), Positives = 123/211 (58%)

Query:    30 EKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR- 88
             + ++P +SY +L  AT  F+ S++IG G +G VYKG+L  +   VAVKV++ K    F  
Sbjct:   643 DPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSG 701

Query:    89 SFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEV 148
             SF  EC+ L+  RHRNL +IIT CS        F ALV   M NGSLE  L+      + 
Sbjct:   702 SFKRECQILKRTRHRNLIRIITTCSK-----PGFNALVLPLMPNGSLERHLYPGEYSSK- 755

Query:   149 FKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
               L LIQ VNI  DVA  I YLHH     +VH D+KPSN+LLD++M A V DFG+S+ + 
Sbjct:   756 -NLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQ 814

Query:   209 SDHLDTASETPSSSIG-----IKGTVGYVAP 234
                 +T S   S S G     + G+VGY+AP
Sbjct:   815 GVE-ETVSTDDSVSFGSTDGLLCGSVGYIAP 844

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	234
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-37
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-33
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-33
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-26
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-12
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-10
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-06
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-05
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
COG2334	331	COG2334, COG2334, Putative homoserine kinase type	2e-04
COG3173	321	COG3173, COG3173, Predicted aminoglycoside phospho	3e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-04
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	6e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-04
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.001
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.001
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	0.001
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.001
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	0.001
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	0.002
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.002
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	0.002
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	0.002
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	0.002
cd05155	235	cd05155, APH_ChoK_like_1, Uncharacterized bacteria	0.003
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	0.003
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.003
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.003
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.003
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.003
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (345), Expect = 5e-40
 Identities = 58/183 (31%), Positives = 90/183 (49%), Gaps = 23/183 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLTKIITIC 112
           +G+G +G+VY     +    VA+K+I  +   +     + E E L+ + H N+ K+  + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                   +   LV EY E GSL+D L +        KLS  + + I + +   +EYLH 
Sbjct: 61  EDE-----NHLYLVMEYCEGGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHS 110

Query: 173 NCQPPMVHGDIKPSNVLLDND-MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
           N    ++H D+KP N+LLD+D     + DFGLSK L+SD     +        I GT  Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--------IVGTPAY 159

Query: 232 VAP 234
           +AP
Sbjct: 160 MAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  129 bits (328), Expect = 5e-37
 Identities = 56/182 (30%), Positives = 84/182 (46%), Gaps = 24/182 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+GS+G VY     +   +VA+KVI   K K      + E + L+ ++H N   I+ + 
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPN---IVRLY 63

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
              + +   +  LV EY E G L D L +        +LS  +       + SA+EYLH 
Sbjct: 64  DVFEDEDKLY--LVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQILSALEYLHS 115

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                +VH D+KP N+LLD D    + DFGL++ L      T            GT  Y+
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT---------TFVGTPEYM 163

Query: 233 AP 234
           AP
Sbjct: 164 AP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  121 bits (306), Expect = 1e-33
 Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 24/183 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           +G GS+G+VYK        +VAVK++  +       ++   E   LR + H N   I+ +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPN---IVRL 63

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             + + K  D   LV EY E G L D+L +         LS  +   IA+ +   +EYLH
Sbjct: 64  IDAFEDK--DHLYLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEYLH 115

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
            N    ++H D+KP N+LLD + V  + DFGL+K L        S + ++     GT  Y
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS-----SSSLTT---FVGTPWY 164

Query: 232 VAP 234
           +AP
Sbjct: 165 MAP 167

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  120 bits (304), Expect = 2e-33
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 18/162 (11%)

Query: 54  IGQGSYGSVYKGIL----GEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G++G VYKG L       E  VAVK +     +     F+ E   ++ + H N+ ++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           + +C+    +G     +V EYM  G L D+L +  +     KL+L   + +A+ +A  +E
Sbjct: 67  LGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGE-----KLTLKDLLQMALQIAKGME 116

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           YL        VH D+   N L+  ++V  + DFGLS+ +  D
Sbjct: 117 YLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  120 bits (303), Expect = 3e-33
 Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 15/166 (9%)

Query: 52  NMIGQGSYGSVYKGIL---GEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTK 107
             +G+G++G VYKG L         VAVK +     +   + F+ E   ++ + H N+ +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK---LSLIQRVNIAIDVA 164
           ++ +C+  +        LV EYME G L D+L ++       +   LSL   ++ AI +A
Sbjct: 61  LLGVCTEEEPL-----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
             +EYL        VH D+   N L+  D+V  + DFGLS+ +  D
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  119 bits (302), Expect = 4e-33
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 17/169 (10%)

Query: 53  MIGQGSYGSVYKGIL----GEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTK 107
            +G+G++G VYKG L       E+ VAVK +     +     F+ E   +R + H N+ K
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           ++ +C+  +        +V EYM  G L D+L +        +LSL   ++ A+ +A  +
Sbjct: 66  LLGVCTEEEPL-----MIVMEYMPGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGM 116

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           EYL        +H D+   N L+  ++V  + DFGLS+ L  D      
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK 162

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  119 bits (301), Expect = 5e-33
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 18/163 (11%)

Query: 53  MIGQGSYGSVYKGIL----GEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTK 107
            +G+G++G VYKG L    G+ ++ VAVK +     +     F+ E   +R + H N+ K
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           ++ +C+  +        +V EYME G L  +L +        KLSL   ++ A+ +A  +
Sbjct: 66  LLGVCTEEEPL-----YIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGM 115

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           EYL        +H D+   N L+  ++V  + DFGLS+ L  D
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  104 bits (263), Expect = 2e-27
 Identities = 48/190 (25%), Positives = 88/190 (46%), Gaps = 20/190 (10%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRN 104
           E+++  ++G+GS+GSVY  +  +   ++AVK + L         +   E   L +++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           + +        +    +   +  EY+  GSL   L +           +I++      + 
Sbjct: 61  IVRYYGSERDEEKNTLN---IFLEYVSGGSLSSLLKK----FGKLPEPVIRKY--TRQIL 111

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
             + YLH N    +VH DIK +N+L+D+D V  + DFG +K L         ET   +  
Sbjct: 112 EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD------IETGEGTGS 162

Query: 225 IKGTVGYVAP 234
           ++GT  ++AP
Sbjct: 163 VRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 7e-26
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 14/160 (8%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+G+YG VYK    +   +VA+K I ++ +  G   + + E + L+ +RH N+ ++  I
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +S   KG+ +  +VFEYM++  L   L          K +  Q       +   ++YLH
Sbjct: 67  VTS-KGKGSIY--MVFEYMDH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLH 117

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
            N    ++H DIK SN+L++ND V  + DFGL++  +  +
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 99.2 bits (248), Expect = 3e-25
 Identities = 57/189 (30%), Positives = 88/189 (46%), Gaps = 24/189 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
            F     IG+G +G VYK         VA+KVI L+ K      + E + L+  +H N+ 
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           K      S   K  D   +V E+   GSL+D L  TN   +    S I    +  ++   
Sbjct: 61  KYYG---SYLKK--DELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAY--VCKELLKG 110

Query: 167 IEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           +EYLH +     ++H DIK +N+LL +D    + DFGLS  LS       ++  ++ +  
Sbjct: 111 LEYLHSNG----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD------TKARNTMV-- 158

Query: 226 KGTVGYVAP 234
            GT  ++AP
Sbjct: 159 -GTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 94.8 bits (236), Expect = 2e-23
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 18/167 (10%)

Query: 51  SNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRN 104
              +G+G +G V             E V AVK +N   +   RS F  E E LR + H N
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQV-AVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           + K   +C   +  G     L+ EY+ +GSL D+L +  D     +++L + +  +  + 
Sbjct: 68  IVKYKGVC---EKPGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQIC 119

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++YL        +H D+   N+L++++ +  + DFGL+K L  D 
Sbjct: 120 KGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 5e-23
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 17/166 (10%)

Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRN 99
            ++    +   +  IG+G +G V  G     +  VAVK +      A ++F+AE   +  
Sbjct: 2   AINSKELKLGAT--IGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAA-QAFLAEASVMTT 56

Query: 100 IRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           +RH NL +++ +   +         +V EYM  GSL D+L      +        Q++  
Sbjct: 57  LRHPNLVQLLGVV--LQGNPL---YIVTEYMAKGSLVDYLRSRGRAVITLA----QQLGF 107

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           A+DV   +EYL        VH D+   NVL+  D+VA V DFGL+K
Sbjct: 108 ALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 92.6 bits (231), Expect = 1e-22
 Identities = 48/161 (29%), Positives = 76/161 (47%), Gaps = 12/161 (7%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINL-KQKGAFRSFV-AECEALRNIRHRNLTKII 109
             IG+GS+G VY      D  +  +K I+L       R     E + L+ + H N   II
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN---II 62

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
               S + KG     +V EY + G L   + +     + F    I  ++  + +  A++Y
Sbjct: 63  KYYESFEEKGKLC--IVMEYADGGDLSQKIKKQKKEGKPFPEEQI--LDWFVQLCLALKY 118

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           LH      ++H DIKP N+ L ++ +  +GDFG+SK LSS 
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 92.7 bits (231), Expect = 1e-22
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 30/186 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLTKIITIC 112
           +GQGS G VYK        + A+K I++     FR   + E + LR+     +       
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV------- 61

Query: 113 SSIDSKGADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
             +   GA +K    ++V EYM+ GSL D L +     E   L+ I     A  +   ++
Sbjct: 62  --VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPV-LAYI-----ARQILKGLD 113

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           YLH      ++H DIKPSN+L+++     + DFG+SK      L+   +  ++ +   GT
Sbjct: 114 YLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISK-----VLENTLDQCNTFV---GT 163

Query: 229 VGYVAP 234
           V Y++P
Sbjct: 164 VTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 91.9 bits (229), Expect = 2e-22
 Identities = 60/193 (31%), Positives = 99/193 (51%), Gaps = 30/193 (15%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRHRN 104
            +   ++IG+G++G VYKG+  E    VA+K I+L   ++ A +S + E + L+N++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           + K I    SI++   D   ++ EY ENGSL   + +       F  SL     +A+ V 
Sbjct: 61  IVKYIG---SIETS--DSLYIILEYAENGSLRQIIKKFGP----FPESL-----VAVYVY 106

Query: 165 ---SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
                + YLH   +  ++H DIK +N+L   D V  + DFG++  L+    D AS     
Sbjct: 107 QVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS----- 158

Query: 222 SIGIKGTVGYVAP 234
              + GT  ++AP
Sbjct: 159 ---VVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 2e-21
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 16/164 (9%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNL 105
           + +   +G+G+YG VYK    +   +VA+K I L  +  G   + + E   L+ ++H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            K++ +  +          LVFEY +   L+ +L +    L     +LI+   I   +  
Sbjct: 61  VKLLDVIHTERKL-----YLVFEYCDM-DLKKYLDKRPGPLS---PNLIKS--IMYQLLR 109

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
            + Y H +    ++H D+KP N+L++ D V  + DFGL++    
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 89.8 bits (223), Expect = 2e-21
 Identities = 54/170 (31%), Positives = 83/170 (48%), Gaps = 30/170 (17%)

Query: 54  IGQGSYGSVYKG-----ILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 105
           +G+G++G V+ G         D+ +VAVK   LK+     A + F  E E L N +H N+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL--------EVFKLSLIQRV 157
            K   +C+  D        +VFEYME+G L  +L                + +L+L Q +
Sbjct: 71  VKFYGVCTEGDPP-----IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 158 NIAIDVASAIEYL--HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            IA+ +AS + YL   H      VH D+   N L+  D+V  +GDFG+S+
Sbjct: 126 QIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 91.0 bits (224), Expect = 2e-21
 Identities = 61/185 (32%), Positives = 94/185 (50%), Gaps = 19/185 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G+GS+G VY   L  D  +VA+KV+  K   +      F+ E + L ++ H     I+ 
Sbjct: 8   LGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN--IVK 62

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +      +G+ +  LV EY++ GSLED L +         LS  + + I   + SA+EYL
Sbjct: 63  LYDFFQDEGSLY--LVMEYVDGGSLEDLLKKIGRKG---PLSESEALFILAQILSALEYL 117

Query: 171 HHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           H      ++H DIKP N+LLD +  V  + DFGL+K L      ++     S+    GT 
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST--SVGTP 172

Query: 230 GYVAP 234
           GY+AP
Sbjct: 173 GYMAP 177

Length = 384

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 88.9 bits (221), Expect = 3e-21
 Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 22/188 (11%)

Query: 50  QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTK 107
           + N IG G++G VY  +  +   ++AVK I ++       +    E + L  ++H NL K
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 108 IITICSSIDSKGADFKALVF-EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
              +      +    K  +F EY   G+LE+ L     H  +    +I+     + +   
Sbjct: 64  YYGV------EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRV--YTLQLLEG 111

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           + YLH +    +VH DIKP+N+ LD++ V  +GDFG +  L +      +        + 
Sbjct: 112 LAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN----NTTTMGEEVQSLA 164

Query: 227 GTVGYVAP 234
           GT  Y+AP
Sbjct: 165 GTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 84.5 bits (209), Expect = 1e-19
 Identities = 50/189 (26%), Positives = 95/189 (50%), Gaps = 22/189 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNL 105
           + +  + +G G YG VY+G+  +  + VAVK   LK+       F+ E   ++ I+H NL
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNL 64

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            +++ +C+    +   F  ++ E+M  G+L D+L + N       ++ +  + +A  ++S
Sbjct: 65  VQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQE----VNAVVLLYMATQISS 115

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           A+EYL        +H D+   N L+  + +  V DFGLS+ ++ D       T ++  G 
Sbjct: 116 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGA 165

Query: 226 KGTVGYVAP 234
           K  + + AP
Sbjct: 166 KFPIKWTAP 174

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 83.5 bits (207), Expect = 3e-19
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 23/183 (12%)

Query: 52  NMIGQGSYGSVYKGIL---GEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNL 105
            +IG G +G V +G L   G+ E+ VA+K   LK          F+ E   +    H N+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            ++  + +   S+      ++ EYMENGSL+ +L + +      K ++ Q V +   +AS
Sbjct: 68  IRLEGVVTK--SRPV---MIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIAS 117

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
            ++YL        VH D+   N+L+++++V  V DFGLS+ L     +    T    I I
Sbjct: 118 GMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED--SEATYTTKGGKIPI 172

Query: 226 KGT 228
           + T
Sbjct: 173 RWT 175

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 83.5 bits (207), Expect = 3e-19
 Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 27/189 (14%)

Query: 54  IGQGSYGSVY---KGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTK 107
           I +G+YG V+   K   G+   + A+KVI    + +K      + E    R+I  +  + 
Sbjct: 1   ISKGAYGRVFLAKKKSTGD---IYAIKVIKKADMIRKNQVDQVLTE----RDILSQAQSP 53

Query: 108 -IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ +  S   K   +  LV EY+  G L   L     ++      +  R+ IA ++  A
Sbjct: 54  YVVKLYYSFQGKKNLY--LVMEYLPGGDLASLLE----NVGSLDEDVA-RIYIA-EIVLA 105

Query: 167 IEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           +EYLH +      +H D+KP N+L+D++    + DFGLSK          ++       I
Sbjct: 106 LEYLHSNGI----IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 226 KGTVGYVAP 234
            GT  Y+AP
Sbjct: 162 VGTPDYIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.1 bits (200), Expect = 3e-18
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 34/193 (17%)

Query: 53  MIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQKGAF-----RSFVAECEALRNIRHRN 104
           +IG G +G V +G L   G+ E+ VA+K +    K  +     R F++E   +    H N
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTL----KSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 105 ---LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
              L  ++T    +         ++ E+MENG+L+ +L Q ND     + ++IQ V +  
Sbjct: 67  IIHLEGVVTKSRPV--------MIITEFMENGALDSFLRQ-NDG----QFTVIQLVGMLR 113

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
            +A+ ++YL    +   VH D+   N+L+++++V  V DFGLS+FL     DT+  T +S
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTYTS 167

Query: 222 SIGIKGTVGYVAP 234
           S+G K  + + AP
Sbjct: 168 SLGGKIPIRWTAP 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.4 bits (198), Expect = 3e-18
 Identities = 59/170 (34%), Positives = 85/170 (50%), Gaps = 18/170 (10%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV-VAVKVINLKQKGAFRSFVAECEALRNIRHRNL 105
           E      IG+G +G V   +LG+     VAVK I  K     ++F+AE   +  +RH NL
Sbjct: 7   ELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNL 61

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            +++ +   ++ KG  +  +V EYM  GSL D+L      +    L     +  ++DV  
Sbjct: 62  VQLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCE 113

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTA 215
           A+EYL  N     VH D+   NVL+  D VA V DFGL+K  SS   DT 
Sbjct: 114 AMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTG 159

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 80.2 bits (198), Expect = 4e-18
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 13/164 (7%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           EF+    +G G +G V++G L ++ + VA+K++        + F  E +AL+ +RH++L 
Sbjct: 7   EFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            +  +CS       +   ++ E ME GSL  +L       E   L +   +++A  VA  
Sbjct: 66  SLFAVCS-----VGEPVYIITELMEKGSLLAFLRSP----EGQVLPVASLIDMACQVAEG 116

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           + YL        +H D+   N+L+  D+V  V DFGL++ +  D
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.5 bits (196), Expect = 9e-18
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 9/164 (5%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVINLK--QKGAFRSFVAECEALRNIRH 102
                ++G+G +GSV +G L +D+     VAVK + L          F++E   +++  H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 103 RNLTKIITICSSIDSKGADFKALV-FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
            N+ K+I +C    S     K +V   +M++G L  +L  +       KL L   +   +
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           D+A  +EYL +      +H D+   N +L  DM   V DFGLSK
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 1e-17
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 21/160 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG G+YG VYK        +VA+KVI L+    F     E   L+  RH N+        
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF---- 66

Query: 114 SIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
                G+  +     +V EY   GSL+D    T   L   +++ + R     +    + Y
Sbjct: 67  -----GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAY 116

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           LH   +   +H DIK +N+LL  D    + DFG+S  L++
Sbjct: 117 LHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 78.1 bits (193), Expect = 3e-17
 Identities = 48/183 (26%), Positives = 72/183 (39%), Gaps = 41/183 (22%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLTKI 108
           IG+GS+G+V K     D  ++  K I+      K+K      V+E   LR ++H N   I
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRELKHPN---I 61

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR------------ 156
           +     I  +      +V EY E G L                 LIQ+            
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEYCEGGDLA---------------QLIQKCKKERKYIEEEF 106

Query: 157 -VNIAIDVASAIEYLHHNCQPPMV--HGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
              I   +  A+   H+   P     H D+KP+N+ LD +    +GDFGL+K L  D   
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166

Query: 214 TAS 216
             +
Sbjct: 167 AKT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 4e-17
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 26/165 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR------HRNLTK 107
           IG+G+YG VYK        +VA+K I L+    F S      ALR I+      H N+ K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLR----FESEGIPKTALREIKLLKELNHPNIIK 62

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           ++ +      KG D   LVFE+M+     D      D       SLI+  +    +   +
Sbjct: 63  LLDV---FRHKG-DL-YLVFEFMD----TDLYKLIKDRQRGLPESLIK--SYLYQLLQGL 111

Query: 168 EYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
            + H H      +H D+KP N+L++ + V  + DFGL++   S  
Sbjct: 112 AFCHSHGI----LHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 77.6 bits (192), Expect = 5e-17
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 16/160 (10%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITIC 112
            IG+G+ G VYK         VA+K + L+++      + E   +++ +H N      I 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPN------IV 78

Query: 113 SSIDS-KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
              DS    D   +V EYM+ GSL D + Q        +++  Q   +  +V   +EYLH
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLH 133

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
                 ++H DIK  N+LL  D    + DFG +  L+ + 
Sbjct: 134 SQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 6e-17
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 27/159 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVK------VINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           IG+G++G VYKG+L +    VAVK        +LK+K     F+ E E L+   H N+ K
Sbjct: 3   IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +I +C            +V E +  GSL  +L +  + L V KL     + +++D A+ +
Sbjct: 57  LIGVCVQKQP-----IYIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGM 106

Query: 168 EYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           EYL   NC    +H D+   N L+  + V  + DFG+S+
Sbjct: 107 EYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 6e-17
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 27/185 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G+GS+G V      +   + A+KV+    + ++      + E   L  I H  + K+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
              +  ++   +  LV EY   G L   L +       F     +    A ++  A+EYL
Sbjct: 60  --YAFQTEEKLY--LVLEYAPGGELFSHLSK----EGRFSEERARF--YAAEIVLALEYL 109

Query: 171 H-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           H       +++ D+KP N+LLD D    + DFGL+K LSS+         ++     GT 
Sbjct: 110 HSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSE-----GSRTNTFC---GTP 157

Query: 230 GYVAP 234
            Y+AP
Sbjct: 158 EYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 76.6 bits (189), Expect = 1e-16
 Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 23/178 (12%)

Query: 54  IGQGSYGSVYKGI-LGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIIT 110
           +G G +G V+ G   G  +  VAVK   LK  G     +F+ E + ++ +RH  L ++  
Sbjct: 14  LGAGQFGEVWMGTWNGTTK--VAVKT--LKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +CS       +   +V EYM  GSL D+L          KL L Q V++A  +A  + YL
Sbjct: 69  VCS-----EEEPIYIVTEYMSKGSLLDFLKSGEGK----KLRLPQLVDMAAQIAEGMAYL 119

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
                   +H D+   N+L+  ++V  + DFGL++ +  D   TA E   +   IK T
Sbjct: 120 E---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TARE--GAKFPIKWT 171

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.6 bits (191), Expect = 1e-16
 Identities = 59/193 (30%), Positives = 95/193 (49%), Gaps = 27/193 (13%)

Query: 43  KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-ECEALRNIR 101
           K+  E  + N IG G+ G+VYK I      + A+KVI    +   R  +  E E LR++ 
Sbjct: 71  KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN 130

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+ K    C  +     + + L+ E+M+ GSLE       D   +         ++A 
Sbjct: 131 HPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADEQFL--------ADVAR 175

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
            + S I YLH      +VH DIKPSN+L+++     + DFG+S+ L+   +D      +S
Sbjct: 176 QILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPC----NS 227

Query: 222 SIGIKGTVGYVAP 234
           S+   GT+ Y++P
Sbjct: 228 SV---GTIAYMSP 237

Length = 353

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 76.1 bits (188), Expect = 1e-16
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 38/201 (18%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINL-------KQKGAFRSFVAECEAL-RNIRHRNL 105
           IG+GS+ +V      E     A+K+++        K K        E E L R   H  +
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI----EKEVLTRLNGHPGI 64

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            K+    +  D +   F   V EY  NG L  ++ +         L        A ++  
Sbjct: 65  IKLY--YTFQDEENLYF---VLEYAPNGELLQYIRK------YGSLDEKCTRFYAAEILL 113

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           A+EYLH      ++H D+KP N+LLD DM   + DFG +K L  +    +++  +++I  
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 226 K------------GTVGYVAP 234
           +            GT  YV+P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSP 191

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 75.0 bits (185), Expect = 3e-16
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 23/155 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G+GSYGSVYK I  E   VVA+KV+ +  +   +  + E   L+      + K      
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKY----- 63

Query: 114 SIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
                G+ FK     +V EY   GS+ D +  TN  L   +++ I            +EY
Sbjct: 64  ----YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY-----QTLKGLEY 114

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           LH N     +H DIK  N+LL+ +  A + DFG+S
Sbjct: 115 LHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 75.0 bits (184), Expect = 4e-16
 Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 32/195 (16%)

Query: 49  SQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL----KQKGAFRSFVAECEALRNIR 101
           ++  +IG G +G V++GIL   G  E+ VA+K +      KQ+   + F++E   +    
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMGQFS 64

Query: 102 HRNLTKIITICSSIDSKGADFK--ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           H N+ ++  + +        FK   ++ EYMENG+L+ +L   +     ++L     V +
Sbjct: 65  HHNIIRLEGVVTK-------FKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGM 112

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
              +A+ ++YL        VH D+   N+L+++++   V DFGLS+ L  D      E  
Sbjct: 113 LRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD-----PEGT 164

Query: 220 SSSIGIKGTVGYVAP 234
            ++ G K  + + AP
Sbjct: 165 YTTSGGKIPIRWTAP 179

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 74.6 bits (183), Expect = 5e-16
 Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 19/153 (12%)

Query: 54  IGQGSYGSVYKG-ILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           IG+G +G+V +G   G+    VAVK  N+K     ++F+ E   +  + H+NL +++ + 
Sbjct: 14  IGEGEFGAVLQGEYTGQK---VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV- 67

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
             I   G     +V E M  G+L ++L           +S+IQ +  ++DVA  +EYL  
Sbjct: 68  --ILHNGL---YIVMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLES 118

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
                +VH D+   N+L+  D VA V DFGL++
Sbjct: 119 K---KLVHRDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.3 bits (186), Expect = 6e-16
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 42/175 (24%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLTK 107
           IG G+YG V   +       VA+K I+      +  K   R    E + LR++RH N+  
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENIIG 63

Query: 108 IITICSSIDSKGADFKAL--VFEYMENGSLEDWLHQ--------TNDHLEVFKLSLIQRV 157
           ++ I         DF  +  V E ME     D LH+        T+DH++ F   L Q  
Sbjct: 64  LLDI--LRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQYF---LYQ-- 111

Query: 158 NIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
                +   ++YLH  N     +H D+KPSN+L++++    + DFGL++ +  D 
Sbjct: 112 -----ILRGLKYLHSANV----IHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 73.8 bits (181), Expect = 7e-16
 Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 32/193 (16%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRN 104
           E +    IG G +G V+ G   E   V A+K I   ++GA     F+ E + +  + H  
Sbjct: 5   ELTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTI---REGAMSEEDFIEEAQVMMKLSHPK 60

Query: 105 LTKIITIC---SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           L ++  +C   S I         LVFE+ME+G L D+L          K S    + + +
Sbjct: 61  LVQLYGVCTERSPI--------CLVFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCL 107

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
           DV   + YL  +    ++H D+   N L+  + V  V DFG+++F+  D         +S
Sbjct: 108 DVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-------TS 157

Query: 222 SIGIKGTVGYVAP 234
           S G K  V + +P
Sbjct: 158 STGTKFPVKWSSP 170

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 74.1 bits (183), Expect = 8e-16
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 19/163 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G+Y  VYK    E   +VA+K I L      + G   + + E + L+ ++H N   I
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN---I 64

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           I +      K      LVFE+ME   LE  +   +    V   + I+  +  +     +E
Sbjct: 65  IGLLDVFGHK--SNINLVFEFME-TDLEKVIKDKS---IVLTPADIK--SYMLMTLRGLE 116

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           YLH N    ++H D+KP+N+L+ +D V  + DFGL++   S +
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.8 bits (181), Expect = 1e-15
 Identities = 58/186 (31%), Positives = 90/186 (48%), Gaps = 30/186 (16%)

Query: 53  MIGQGSYGSVYKGIL---GEDEMVVAVKVINL----KQKGAFRSFVAECEALRNIRHRN- 104
           +IG G +G V  G L   G+ E+ VA+K +      KQ+   R F++E   +    H N 
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFDHPNI 67

Query: 105 --LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
             L  ++T    +         +V EYMENGSL+ +L + +    V     IQ V +   
Sbjct: 68  IHLEGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQFTV-----IQLVGMLRG 114

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           +AS ++YL        VH D+   N+L+++++V  V DFGLS+ L  D  + A  T    
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTRGGK 170

Query: 223 IGIKGT 228
           I I+ T
Sbjct: 171 IPIRWT 176

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 73.3 bits (180), Expect = 1e-15
 Identities = 52/184 (28%), Positives = 87/184 (47%), Gaps = 28/184 (15%)

Query: 54  IGQGSYGSVYKGI-LGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIIT 110
           +G G +G V+ G   G+ +  VA+K+I    +GA     F+ E + +  + H NL ++  
Sbjct: 12  LGSGQFGVVHLGKWRGKID--VAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C+    +   F  +V EYM NG L ++L +            +  +++  DV  A+EYL
Sbjct: 67  VCTK---QRPIF--IVTEYMANGCLLNYLRE---RKGKLGTEWL--LDMCSDVCEAMEYL 116

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
             N     +H D+   N L+  D V  V DFGL++++  D         +SS G K  V 
Sbjct: 117 ESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-------TSSQGTKFPVK 166

Query: 231 YVAP 234
           +  P
Sbjct: 167 WAPP 170

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 73.5 bits (180), Expect = 1e-15
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 23/180 (12%)

Query: 54  IGQGSYGSVY----KGILGE-DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G++G V+      +L E D+M+VAVK +    + A + F  E E L  ++H+++ + 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWL--HQTNDHL-------EVFKLSLIQRVNI 159
             +C+           +VFEYM +G L  +L  H  +  +          +L+L Q + I
Sbjct: 73  YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDTASET 218
           A  +AS + YL        VH D+   N L+   +V  +GDFG+S+   S+D+      T
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 73.5 bits (180), Expect = 1e-15
 Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 30/184 (16%)

Query: 54  IGQGSYGSVYKGILGE--------DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 105
           +G+G++G V+   L E        D+M+VAVK +      A + F  E E L N++H ++
Sbjct: 13  LGEGAFGKVF---LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF----------KLSLIQ 155
            K   +C        D   +VFEYM++G L  +L        +           +L L Q
Sbjct: 70  VKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 156 RVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDT 214
            ++IA  +AS + YL        VH D+   N L+  +++  +GDFG+S+   S+D+   
Sbjct: 125 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181

Query: 215 ASET 218
              T
Sbjct: 182 GGHT 185

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 2e-15
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 16/158 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G +G V++G L  +   VAVK +        + F+AE + ++ +RH  L ++  +C+
Sbjct: 14  LGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH-H 172
             +        +V E M+ GSL ++L           L L Q +++A  VAS + YL   
Sbjct: 72  LEEPI-----YIVTELMKYGSLLEYLQ----GGAGRALKLPQLIDMAAQVASGMAYLEAQ 122

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           N     +H D+   NVL+  + +  V DFGL++ +  D
Sbjct: 123 N----YIHRDLAARNVLVGENNICKVADFGLARVIKED 156

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.1 bits (180), Expect = 2e-15
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 16/159 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+G++G V+K    E    VA+K + L++   G     + E +AL+  +H  + K++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
              +   G+ F  LV EYM    L + L       E   L   Q  +    +   + Y+H
Sbjct: 66  --DVFPHGSGF-VLVMEYMP-SDLSEVLRD-----EERPLPEAQVKSYMRMLLKGVAYMH 116

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            N    ++H D+KP+N+L+  D V  + DFGL++  S +
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 72.8 bits (179), Expect = 3e-15
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 18/170 (10%)

Query: 53  MIGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLTKI 108
            IG+G +G VY+G+      +++ VAVK        + R  F+ E   +R   H ++ K+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           I + +       +   +V E    G L  +L      L++  L L      +  +++A+ 
Sbjct: 73  IGVITE------NPVWIVMELAPLGELRSYLQVNKYSLDLASLILY-----SYQLSTALA 121

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASET 218
           YL        VH DI   NVL+ +     +GDFGLS++L  +    AS+ 
Sbjct: 122 YLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG 168

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 72.5 bits (178), Expect = 3e-15
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 31/199 (15%)

Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQK--GAFRS-FVAE 93
           E+  +   F +   +G+G++G VYKG L    E     +V +  LK+      +  F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF---- 149
            E + +++H N+  ++ +C+           ++FEY+ +G L ++L + + H +V     
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPT-----CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 150 ------KLSLIQRVNIAIDVASAIEYL--HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF 201
                  L     ++IAI +A+ +EYL  HH      VH D+   N L+   +   + DF
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDF 168

Query: 202 GLSKFL-SSDHLDTASETP 219
           GLS+ + S+D+    S++ 
Sbjct: 169 GLSRDIYSADYYRVQSKSL 187

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 5e-15
 Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 23/171 (13%)

Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV---VAVKVINLKQ-KGAFRSFVAECEALRNIR 101
           E  +  ++G G++G+VYKG+ + E E V   VA+KV+  +    A +  + E   + ++ 
Sbjct: 8   ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H ++ +++ IC S          L+ + M  G L D++    D++    L     +N  +
Sbjct: 68  HPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYL-----LNWCV 116

Query: 162 DVASAIEYL--HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            +A  + YL         +VH D+   NVL+       + DFGL+K L  D
Sbjct: 117 QIAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 71.6 bits (176), Expect = 6e-15
 Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 18/161 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLTKIITIC 112
           IG G+   VY  I   +   VA+K I+L++       +  E +A+    H N+ K     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--YYT 66

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI---DVASAIEY 169
           S +     D   LV  Y+  GSL D +  +      +    +    IA    +V   +EY
Sbjct: 67  SFVVG---DELWLVMPYLSGGSLLDIMKSS------YPRGGLDEAIIATVLKEVLKGLEY 117

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           LH N Q   +H DIK  N+LL  D    + DFG+S  L+  
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADG 155

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 72.0 bits (177), Expect = 6e-15
 Identities = 49/167 (29%), Positives = 87/167 (52%), Gaps = 16/167 (9%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVK-VINLKQKGAFRSFVA--ECEALRNIRHRN 104
           + +   IGQG++G V+K    + + +VA+K V+   +K  F    A  E + L+ ++H N
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF-PITALREIKILQLLKHEN 72

Query: 105 LTKIITICSSIDSKGADFKA---LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           +  +I IC +  +    +K    LVFE+ E+  L   L   N     F LS I++V    
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK---FTLSEIKKV--MK 126

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
            + + + Y+H N    ++H D+K +N+L+  D +  + DFGL++  S
Sbjct: 127 MLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFS 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 71.4 bits (175), Expect = 8e-15
 Identities = 53/179 (29%), Positives = 86/179 (48%), Gaps = 32/179 (17%)

Query: 52  NMIGQGSYGSVYKGIL------GEDEMVVAVKVINLKQKGA----FRSFVAECEALRNIR 101
           N +G G++G VY+G        G   + VAVK +   +KGA     + F+ E   + N  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK---LSLIQRVN 158
           H N+ K++ +C   +      + ++ E ME G L  +L      +E F    L+L + ++
Sbjct: 58  HPNIVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDAR--VERFGPPLLTLKELLD 110

Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL-----DNDMVAHVGDFGLSKFL-SSDH 211
           I +DVA    YL    Q   +H D+   N L+     D D V  +GDFGL++ +  SD+
Sbjct: 111 ICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.7 bits (176), Expect = 8e-15
 Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 26/176 (14%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFR-SFVAECEALRNIRHRN 104
           +F     IG+G+YG VYK    +   +VA+K + L  +K  F  + + E + LR + HRN
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67

Query: 105 LTKIITICSSIDSKGADFKA------LVFEYMEN---GSLEDWL-HQTNDHLEVFKLSLI 154
           +  +  I +       DFK       LVFEYM++   G LE  L H + DH++ F   L+
Sbjct: 68  IVNLKEIVTD-KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           +           + Y H   +   +H DIK SN+LL+N     + DFGL++  +S+
Sbjct: 127 E----------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 71.0 bits (174), Expect = 1e-14
 Identities = 54/191 (28%), Positives = 97/191 (50%), Gaps = 25/191 (13%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINL---------KQKGAFRSFVAECEALRNIRHR 103
           +IG GS+GSVY G+      ++AVK + L         +++    +   E   L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+ + +   SS+D   AD   +  EY+  GS+   L+        F+ +L++  N    +
Sbjct: 67  NIVQYLG--SSLD---ADHLNIFLEYVPGGSVAALLNNYG----AFEETLVR--NFVRQI 115

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
              + YLH+     ++H DIK +N+L+DN     + DFG+SK L ++ L T +     S 
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS- 171

Query: 224 GIKGTVGYVAP 234
            ++G+V ++AP
Sbjct: 172 -LQGSVFWMAP 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.1 bits (174), Expect = 1e-14
 Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 26/168 (15%)

Query: 54  IGQGSYGSVYKGIL--------GEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRN 104
           +G+G +G V    L        G  EMV AVK +  +      S +  E   L+ + H N
Sbjct: 12  LGEGHFGKV---SLYCYDPANDGTGEMV-AVKTLKRECGQQNTSGWKKEINILKTLYHEN 67

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           + K    CS    KG     L+ EY+  GSL D+L +         L+L Q +  A  + 
Sbjct: 68  IVKYKGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQIC 117

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
             + YLH       +H D+   NVLLDND +  +GDFGL+K +   H 
Sbjct: 118 EGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 70.4 bits (172), Expect = 2e-14
 Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 8/157 (5%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS----FVAECEALRNIRHRNLTKII 109
           +G+G +GSV +G L +D+ ++ V V  +K     RS    F++E   ++   H N+ ++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 110 TIC-SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
            +C  +++S+G     ++  +M++G L  +L  +        L     V    D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           YL        +H D+   N +L+ +M   V DFGLSK
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 70.1 bits (172), Expect = 2e-14
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 30/188 (15%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF-RSFVAECEA----LRNIRHRNLTK 107
           ++G GS+GSVY+G+  +D    AVK ++L   G   +  V + E     L  ++H N   
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN--- 63

Query: 108 IITICSSIDSKGADFKALVF-EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
              I   + ++  +    +F E +  GSL   L +       F   +I+       +   
Sbjct: 64  ---IVQYLGTEREEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIR--LYTRQILLG 114

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +EYLH       VH DIK +N+L+D + V  + DFG++K      +   S   S     K
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKS----FK 162

Query: 227 GTVGYVAP 234
           G+  ++AP
Sbjct: 163 GSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 18/163 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRN 104
           EF + N IG+G+YG VY+        +VA+K + +  +  G   S + E   L N+RH N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 105 LTKIITICSSIDSKGADFKALVFEYMEN--GSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
              I+ +   +  K  D   LV EY E    SL D +            S  Q   + + 
Sbjct: 68  ---IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--------FSESQVKCLMLQ 116

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   ++YLH N    ++H D+K SN+LL +     + DFGL++
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (173), Expect = 2e-14
 Identities = 52/177 (29%), Positives = 75/177 (42%), Gaps = 42/177 (23%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
            F+    IG+GS+G VYK I      VVA+KVI+L+            EA   I   ++ 
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE------------EAEDEI--EDIQ 47

Query: 107 KIITICSSIDS-----------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQ 155
           + I   S   S           KG+    ++ EY   GS  D L          K   + 
Sbjct: 48  QEIQFLSQCRSPYITKYYGSFLKGSKL-WIIMEYCGGGSCLDLL----------KPGKLD 96

Query: 156 RVNIAI---DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
              IA    +V   +EYLH   +   +H DIK +N+LL  +    + DFG+S  L+S
Sbjct: 97  ETYIAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTS 150

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 69.9 bits (172), Expect = 2e-14
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 25/159 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-------HRNLT 106
           +G G++GSVY     E   +VA+K    K K  F S+  EC  LR ++       H N+ 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSW-EECMNLREVKSLRKLNEHPNIV 61

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           K+  +    ++    F   VFEYME       L+Q     +    S     +I   +   
Sbjct: 62  KLKEVF--RENDELYF---VFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           + ++H +      H D+KP N+L+    V  + DFGL++
Sbjct: 112 LAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 3e-14
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 28/165 (16%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF------RSFVAECEALRNIRHRNLT 106
           ++G+G+YG V K        +VA+K    K K +       ++ + E + LR +RH N+ 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL--EVFKLSLIQRVNIAIDVA 164
            +         KG  +  LVFEY+E   LE  L  +   L  +  +  + Q +       
Sbjct: 64  NLKEAFRR---KGRLY--LVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQ------ 111

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
            AI Y H +    ++H DIKP N+L+    V  + DFG ++ L +
Sbjct: 112 -AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.8 bits (168), Expect = 6e-14
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 9/168 (5%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDE---MVVAVKVI--NLKQKGAFRSFVAECEALRNIRH 102
           F+   M+G+G +GSV +  L  ++     VAVK++  ++        F+ E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 103 RNLTKIITICSSIDSKGA-DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
            N+ K+I +     +KG      ++  +M++G L  +L  +    E F L L   V   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           D+AS +EYL        +H D+   N +L+ +M   V DFGLSK + S
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 68.3 bits (167), Expect = 8e-14
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 28/193 (14%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRN 104
           ++ +  ++G+G++G V+      D+ +V +K I ++Q  K    +   EC+ L+ + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 105 LTKIITICSSIDSKGADFKAL--VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
                 I    ++   D KAL  V EY   G+L +++ +  + L      L   V I + 
Sbjct: 61  ------IIEYYENFLED-KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA 113

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
                  LHH     ++H D+K  N+LLD + MV  +GDFG+SK LSS          S 
Sbjct: 114 -------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---------SK 157

Query: 222 SIGIKGTVGYVAP 234
           +  + GT  Y++P
Sbjct: 158 AYTVVGTPCYISP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 68.1 bits (167), Expect = 8e-14
 Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 28/191 (14%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK----GAFRSFVAECEALRNIRHR 103
           F    +IG+G++G V      + + + A+K +N KQK    G+ R+ + E   L+ + H 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHP 60

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            L  +     S   +  +   LV + +  G L   L         F    ++      ++
Sbjct: 61  FLVNL---WYSFQDE--ENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKF--WICEI 109

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+EYLH      ++H DIKP N+LLD     H+ DF ++  ++ D L T         
Sbjct: 110 VLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT--------- 157

Query: 224 GIKGTVGYVAP 234
              GT GY+AP
Sbjct: 158 STSGTPGYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.4 bits (168), Expect = 1e-13
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVK--VINLKQKGAFRSFVAECEALRNIR---H 102
           + +   IG+G+YG+VYK         VA+K   + L ++G   S + E   L+ +    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ +++ +C    +       LVFE+++    +D L           L      ++   
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQ 115

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           +   +++LH +    +VH D+KP N+L+ +D    + DFGL++  S +
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 1e-13
 Identities = 49/163 (30%), Positives = 72/163 (44%), Gaps = 23/163 (14%)

Query: 54  IGQGSYGSVYKGIL---GEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTK 107
           +G G++GSV KG+       E+ VAVK   LKQ       + F+ E   +  + H  + +
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKT--LKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +I +C     KG     LV E    G L  +L +    + V  L       +A  VA  +
Sbjct: 61  LIGVC-----KGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDL-----KELAHQVAMGM 108

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            YL        VH D+   NVLL N   A + DFG+S+ L + 
Sbjct: 109 AYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 54/169 (31%), Positives = 87/169 (51%), Gaps = 37/169 (21%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR----------HR 103
           +G+G+YG V+K I    + VVA+K    K   AFR+     +A R  R          H 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALK----KIFDAFRN---ATDAQRTFREIMFLQELGDHP 67

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN---IA 160
           N+ K++ +  + + K  D   LVFEYME     D LH       V + ++++ V+   I 
Sbjct: 68  NIVKLLNVIKAENDK--DI-YLVFEYMET----D-LHA------VIRANILEDVHKRYIM 113

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
             +  A++Y+H      ++H D+KPSN+LL++D    + DFGL++ LS 
Sbjct: 114 YQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 67.3 bits (165), Expect = 2e-13
 Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 23/182 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLTKIITIC 112
           +G G+ G V K +      ++AVK I L+   A  +  + E + L          I+   
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY---IVGFY 65

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
            +  + G     +  EYM+ GSL+  L +    +    L       IA+ V   + YLH 
Sbjct: 66  GAFYNNGDIS--ICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
             +  ++H D+KPSN+L+++     + DFG+S  L +    T            GT  Y+
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----------GTSSYM 166

Query: 233 AP 234
           AP
Sbjct: 167 AP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.9 bits (163), Expect = 3e-13
 Identities = 46/171 (26%), Positives = 84/171 (49%), Gaps = 19/171 (11%)

Query: 45  TCEFSQSNMIGQGSYGSVYKGI-LGEDEMV---VAVKVI-NLKQKGAFRSFVAECEALRN 99
             E  +  ++G G +G+V+KGI + E + +   VA+K I +   +  F+       A+ +
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 100 IRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           + H  + +++ IC      GA  + LV +    GSL D + Q  D L+  +L     +N 
Sbjct: 66  LDHAYIVRLLGICP-----GASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRL-----LNW 114

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            + +A  + YL  +    MVH ++   N+LL +D +  + DFG++  L  D
Sbjct: 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.0 bits (163), Expect = 3e-13
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 21/178 (11%)

Query: 54  IGQGSYGSV-----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G++G V     Y     +D+++VAVK +      A + F  E E L N++H ++ K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF-------KLSLIQRVNIAI 161
             +C        D   +VFEYM++G L  +L        +        +L+  Q ++IA 
Sbjct: 73  YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDTASET 218
            +A+ + YL        VH D+   N L+  +++  +GDFG+S+   S+D+      T
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.7 bits (163), Expect = 4e-13
 Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 15/162 (9%)

Query: 53  MIGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
            +G+G++GSV    Y  +      VVAVK +        R F  E E L++++H N+ K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
             +C S   +      LV EY+  GSL D+L +  + L+  KL L      A  +   +E
Sbjct: 71  KGVCYSAGRRNL---RLVMEYLPYGSLRDYLQKHRERLDHRKLLLY-----ASQICKGME 122

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           YL        VH D+   N+L++++    +GDFGL+K L  D
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 68.0 bits (166), Expect = 4e-13
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 18/149 (12%)

Query: 50  QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           + N+I +G  G+ YKG   ++ M   VK IN        S +A+   +  ++H N+ K+I
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLI 749

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   KGA    L+ EY+E  +L + L           LS  +R  IAI +A A+ +
Sbjct: 750 GLCRS--EKGA---YLIHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRF 795

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           LH  C P +V G++ P  +++D     H+
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 66.3 bits (162), Expect = 4e-13
 Identities = 41/159 (25%), Positives = 81/159 (50%), Gaps = 13/159 (8%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLT 106
           F Q   +G+G+Y +VYKG       +VA+K I+L  ++G   + + E   ++ ++H N  
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHEN-- 59

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+ +   I ++  +   LVFEYM+   L+ ++  T+        + ++  +    +   
Sbjct: 60  -IVRLHDVIHTE--NKLMLVFEYMDK-DLKKYM-DTHGVRGALDPNTVK--SFTYQLLKG 112

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           I + H N    ++H D+KP N+L++      + DFGL++
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 66.3 bits (162), Expect = 5e-13
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 28/165 (16%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLT 106
           ++G+GSYG V K    E   +VA+K         + +K A R    E   L+ +RH NL 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR----EIRMLKQLRHENLV 63

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTND-HLEVFKLSLIQRVNIAIDVAS 165
            +I +      +      LVFE++++  L+D     N       +  L Q       +  
Sbjct: 64  NLIEVF-----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQ-------ILR 111

Query: 166 AIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
            IE+ H HN    ++H DIKP N+L+    V  + DFG ++ L++
Sbjct: 112 GIEFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 65.8 bits (160), Expect = 6e-13
 Identities = 51/184 (27%), Positives = 91/184 (49%), Gaps = 28/184 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIITI 111
           +GQG +G V+ G       V A+K +   + G     +F+ E + ++ +RH  L ++  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRV-AIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
            S       +   +V EYM  GSL D+L  +   +L      L Q V++A  +AS + Y+
Sbjct: 70  VSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLR-----LPQLVDMAAQIASGMAYV 118

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
               +   VH D++ +N+L+  ++V  V DFGL++ +  D+  TA +      G K  + 
Sbjct: 119 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQ------GAKFPIK 168

Query: 231 YVAP 234
           + AP
Sbjct: 169 WTAP 172

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.8 bits (160), Expect = 9e-13
 Identities = 44/168 (26%), Positives = 86/168 (51%), Gaps = 22/168 (13%)

Query: 52  NMIGQGSYGSVYKGILGED--EMVVAVKVIN-LKQKGAFRSFVAECEALRNI-RHRNLTK 107
           ++IG+G++G V + ++ +D  +M  A+K++     +   R F  E E L  +  H N+  
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQT----------NDHLEVFKLSLIQRV 157
           ++  C   +++G  + A+  EY   G+L D+L ++           +H     L+  Q +
Sbjct: 68  LLGAC---ENRGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             A DVA+ ++YL    +   +H D+   NVL+  ++ + + DFGLS+
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.7 bits (160), Expect = 1e-12
 Identities = 41/138 (29%), Positives = 73/138 (52%), Gaps = 12/138 (8%)

Query: 74  VAVKVINLKQKGA-FRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMEN 132
           VAVK +  +  G        E E LRN+ H N+ K   IC+  +  G   K L+ E++ +
Sbjct: 36  VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT--EDGGNGIK-LIMEFLPS 92

Query: 133 GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN 192
           GSL+++L +  + +     +L Q++  A+ +   ++YL        VH D+   NVL+++
Sbjct: 93  GSLKEYLPRNKNKI-----NLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVES 144

Query: 193 DMVAHVGDFGLSKFLSSD 210
           +    +GDFGL+K + +D
Sbjct: 145 EHQVKIGDFGLTKAIETD 162

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.1 bits (159), Expect = 1e-12
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 17/158 (10%)

Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G GS+G V +G     G   + VAVK + + K       F+ E   + ++ H NL ++ 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +  +          +V E    GSL D L +  D L  F +S +   + A+ +A+ + Y
Sbjct: 63  GVVLTHPLM------MVTELAPLGSLLDRLRK--DALGHFLISTL--CDYAVQIANGMRY 112

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
           L        +H D+   N+LL +D    +GDFGL + L
Sbjct: 113 LE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.0 bits (158), Expect = 1e-12
 Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 19/156 (12%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVI--NLKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           ++G+G++G V+KG L +D+  VAVK    +L Q+   + F++E   L+   H N+ K+I 
Sbjct: 2   LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C+           +V E +  G    +L +  D L+  +L     V  A+D A+ + YL
Sbjct: 60  VCTQRQP-----IYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYL 109

Query: 171 H-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
              NC    +H D+   N L+  + V  + DFG+S+
Sbjct: 110 ESKNC----IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 65.6 bits (160), Expect = 1e-12
 Identities = 48/159 (30%), Positives = 68/159 (42%), Gaps = 31/159 (19%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA---FRSFVAECEALRNIRHRNLTKIIT 110
           IG GS+G+VY         VVA+K ++   K +   ++  + E   L+ +RH N      
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN------ 76

Query: 111 ICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI---DV 163
              +I+ KG   +     LV EY         L   +D LEV K  L Q V IA      
Sbjct: 77  ---TIEYKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPL-QEVEIAAICHGA 124

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG 202
              + YLH +     +H DIK  N+LL       + DFG
Sbjct: 125 LQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFG 160

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 64.8 bits (158), Expect = 2e-12
 Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 18/164 (10%)

Query: 52  NMIGQGSYGSVYKG-ILGED----EMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRNL 105
             +G G++G VY+G   G D    E+ VAVK +         S F+ E   +    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE-VFKLSLIQRVNIAIDVA 164
            ++I +           + ++ E M  G L+ +L +     E    L++   +  A DVA
Sbjct: 72  VRLIGVSFERLP-----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSK 205
              +YL  N     +H DI   N LL       VA + DFG+++
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 20/163 (12%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLTK 107
           +GQGS+G VY+G+      GE E  VA+K +N       R  F+ E   ++     ++ +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 108 IITICSSIDSKGADFKALV-FEYMENGSLEDWLHQT---NDHLEVFK-LSLIQRVNIAID 162
           ++ +     S G     LV  E M  G L+ +L       ++       +L + + +A +
Sbjct: 74  LLGVV----STGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +A  + YL        VH D+   N ++  D+   +GDFG+++
Sbjct: 128 IADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 63.7 bits (155), Expect = 3e-12
 Identities = 46/183 (25%), Positives = 83/183 (45%), Gaps = 26/183 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIITI 111
           +G G +G V  G     +  VA+K+I   ++G+     F+ E + +  + H  L ++  +
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
           C+    +   +  +V EYM NG L ++L +     +  +L     + +  DV   + YL 
Sbjct: 68  CTK---QRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLE 117

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
                  +H D+   N L+D+     V DFGLS+++  D         +SS+G K  V +
Sbjct: 118 SK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRW 167

Query: 232 VAP 234
             P
Sbjct: 168 SPP 170

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 63.3 bits (154), Expect = 5e-12
 Identities = 56/190 (29%), Positives = 81/190 (42%), Gaps = 22/190 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAEC--EALRNIRHRN 104
           +F   N IG+GS+G V+K +   D+ V A+K I+L      R    E   EA R +   +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL--SKMNRREREEAIDEA-RVLAKLD 57

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            + II    S   KG     +V EY ENG L   L           L   Q     I + 
Sbjct: 58  SSYIIRYYESFLDKGK--LNIVMEYAENGDLHKLLKMQRGR----PLPEDQVWRFFIQIL 111

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
             + +LH      ++H DIK  N+ LD      +GD G++K LS +     +        
Sbjct: 112 LGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-------- 160

Query: 225 IKGTVGYVAP 234
           I GT  Y++P
Sbjct: 161 IVGTPYYLSP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.9 bits (156), Expect = 5e-12
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 43/173 (24%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF-------RSFVAECEALRNIRHRNLT 106
           IG G+YG V   I       VA+K    K   AF       R+   E + LR+ +H N  
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTL-RELKILRHFKHDN-- 65

Query: 107 KIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ--------TNDHLEVFKLSLIQR 156
            II I   +   GADFK   +V + ME+      LH         T +H+  F   L++ 
Sbjct: 66  -IIAIRDILRPPGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYFLYQLLR- 118

Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
                     ++Y+H      ++H D+KPSN+L++ D    +GDFG+++ LSS
Sbjct: 119 ---------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.4 bits (154), Expect = 6e-12
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 20/176 (11%)

Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
           +EK   +VS  +  K    F +   IGQG+ G+VY  I       VA+K +NL+Q+    
Sbjct: 5   LEKLRTIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE 61

Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQTNDHLE 147
             + E   +R  +H N      I + +DS    D   +V EY+  GSL D + +T   ++
Sbjct: 62  LIINEILVMRENKHPN------IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMD 113

Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
             +++ + R     +   A+E+LH N    ++H DIK  N+LL  D    + DFG 
Sbjct: 114 EGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 62.8 bits (153), Expect = 6e-12
 Identities = 47/174 (27%), Positives = 77/174 (44%), Gaps = 24/174 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+GSYGSVYK     D    A+K ++L     K++      V E   L ++ H N+   
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER---EDAVNEIRILASVNHPNI--- 61

Query: 109 ITIC---SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
             I    + +D        +V EY   G L   + +     ++     I R  I I +  
Sbjct: 62  --ISYKEAFLDGNKL---CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQLLR 114

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
            ++ LH      ++H D+K +N+LL  + +  +GD G+SK L  +   T   TP
Sbjct: 115 GLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP 165

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.2 bits (154), Expect = 7e-12
 Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 48/173 (27%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVK---------VINLKQKGAFRSFVAECEALRNIRHRN 104
           IG+GSYG V+K    E   +VA+K         VI   +K A R    E   L+ ++H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI---KKIALR----EIRMLKQLKHPN 61

Query: 105 LTKIITICSSIDSKGADFKA-----LVFEYMEN---GSLEDWLHQTNDHLEVFKLSLIQR 156
           L  +I +          F+      LVFEY ++     LE       +H           
Sbjct: 62  LVNLIEV----------FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH---------LI 102

Query: 157 VNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
             I      A+ + H HNC    +H D+KP N+L+       + DFG ++ L+
Sbjct: 103 KKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILT 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.9 bits (153), Expect = 7e-12
 Identities = 46/183 (25%), Positives = 91/183 (49%), Gaps = 26/183 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIITI 111
           +G G +G V+ G        VA+K  +LKQ G+    +F+AE   ++ ++H  L ++  +
Sbjct: 14  LGAGQFGEVWMGYY-NGHTKVAIK--SLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +       +   ++ EYMENGSL D+L          KL++ + +++A  +A  + ++ 
Sbjct: 70  VTQ------EPIYIITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIE 119

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
              +   +H D++ +N+L+   +   + DFGL++ +  +   TA E      G K  + +
Sbjct: 120 ---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TARE------GAKFPIKW 169

Query: 232 VAP 234
            AP
Sbjct: 170 TAP 172

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.0 bits (154), Expect = 8e-12
 Identities = 42/167 (25%), Positives = 79/167 (47%), Gaps = 26/167 (15%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG------AFRSFVAECEALRNI 100
           E+ + N I +G+YG VY+    +   +VA+K + ++++       + R    E   L  +
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINILLKL 61

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK--LSLIQRVN 158
           +H N   I+T+   +     D   +V EY+E        H     +E  K      +   
Sbjct: 62  QHPN---IVTVKEVVVGSNLDKIYMVMEYVE--------HDLKSLMETMKQPFLQSEVKC 110

Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           + + + S + +LH N    ++H D+K SN+LL+N  +  + DFGL++
Sbjct: 111 LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 62.9 bits (153), Expect = 8e-12
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 34/176 (19%)

Query: 54  IGQGSYGSVYK----GIL-GEDEMVVAVKVINLKQKGAF---RSFVAECEALRNIRHRNL 105
           IGQG++G V++    G+L  E   +VAVK+  LK++ +      F  E   +    H N+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLED--------WLHQ-TNDHLEVFK------ 150
            K++ +C+           L+FEYM  G L +             ++      K      
Sbjct: 71  VKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 151 -LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            LS  +++ IA  VA+ + YL        VH D+   N L+  +MV  + DFGLS+
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 1e-11
 Identities = 52/188 (27%), Positives = 82/188 (43%), Gaps = 26/188 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITIC 112
           IG+G+YG VYK    +   +VA+K++++  +        E   LR    H N+       
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 113 SSIDSKGADFKA-LVFEYMENGSLEDW---LHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
              +  G D +  LV E    GS+ D    L +    L+   ++ I R     +    + 
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGLA 127

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG--DFGLSKFLSSDHLDTASETPSSSIGIK 226
           YLH N    ++H DIK  N+LL  +  A V   DFG+S       LD+     ++ I   
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFGVSA-----QLDSTLGRRNTFI--- 174

Query: 227 GTVGYVAP 234
           GT  ++AP
Sbjct: 175 GTPYWMAP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 49/183 (26%), Positives = 88/183 (48%), Gaps = 26/183 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIITI 111
           +G G +G V+ G    +  V AVK +   + G     SF+ E + ++ +RH  L ++  +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKV-AVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            S       +   +V EYM  GSL D+L           L L   V++A  VA+ + Y+ 
Sbjct: 70  VSE------EPIYIVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIE 119

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
              +   +H D++ +N+L+ + +V  + DFGL++ +  D+  TA +      G K  + +
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQ------GAKFPIKW 169

Query: 232 VAP 234
            AP
Sbjct: 170 TAP 172

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.4 bits (151), Expect = 2e-11
 Identities = 48/169 (28%), Positives = 87/169 (51%), Gaps = 19/169 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV---VAVKVIN-LKQKGAFRSFVAECEALRNIR 101
           E  +  ++G G++G+VYKGI + E E V   VA+K++N      A   F+ E   + ++ 
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H +L +++ +C S   +      LV + M +G L D++H+  D++    L     +N  +
Sbjct: 68  HPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCV 116

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            +A  + YL    +  +VH D+   NVL+ +     + DFGL++ L  D
Sbjct: 117 QIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.9 bits (150), Expect = 2e-11
 Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 22/168 (13%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLTK 107
           ++IG+G++G V K  + +D + +   +  +K+   K   R F  E E L  +  H N+  
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLIQRV 157
           ++  C   + +G  +  L  EY  +G+L D+L ++            +     LS  Q +
Sbjct: 73  LLGAC---EHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           + A DVA  ++YL    Q   +H D+   N+L+  + VA + DFGLS+
Sbjct: 128 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 20/167 (11%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA---FRSFVAECEALRNIRHRNLTKI 108
           ++IG+G++G V K  + +D + +   +  +K+  +    R F  E E L  + H     I
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH--PNI 58

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLIQRVN 158
           I +  + + +G  + A+  EY  +G+L D+L ++            +     LS  Q ++
Sbjct: 59  INLLGACEHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            A DVA  ++YL    Q   +H D+   N+L+  + VA + DFGLS+
Sbjct: 117 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 61.2 bits (148), Expect = 3e-11
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 24/158 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLTK 107
           IG+G++G V+ G L  D   VAVK        +LK K     F+ E   L+   H N+ +
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +I +C+    K   +  +V E ++ G    +L      L+V +L     + +  + A+ +
Sbjct: 58  LIGVCT---QKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKEL-----IQMVENAAAGM 107

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           EYL        +H D+   N L+    V  + DFG+S+
Sbjct: 108 EYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 60.9 bits (148), Expect = 3e-11
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 19/162 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           IG+G +  VYK I   D  VVA+K +    +    A +  + E + L+ + H N+ K + 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI---AIDVASAI 167
             S I++   +   +V E  + G L   +          +  LI    I    + + SA+
Sbjct: 70  --SFIENNELN---IVLELADAGDLSRMIKHFKK-----QKRLIPERTIWKYFVQLCSAL 119

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           E++H      ++H DIKP+NV +    V  +GD GL +F SS
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.9 bits (148), Expect = 4e-11
 Identities = 41/169 (24%), Positives = 80/169 (47%), Gaps = 14/169 (8%)

Query: 46  CEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRSFVAECEALRNI 100
              + S+++ +G++G ++ GIL     G++E V    V +   +      + E   L  +
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK--LSLIQRVN 158
            H+N+  I+ +C        +   +++ YM  G+L+ +L Q           LS  Q V+
Sbjct: 66  SHQNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121

Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
           +AI +A  + YLH   +  ++H DI   N ++D ++   + D  LS+ L
Sbjct: 122 MAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 6e-11
 Identities = 49/190 (25%), Positives = 82/190 (43%), Gaps = 24/190 (12%)

Query: 50  QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRN 104
           +  ++GQG++G VY     +    +AVK +         K    +   E + L+N++H  
Sbjct: 6   RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           + +    C   D   + F     EYM  GS++D L       E    ++ ++    I   
Sbjct: 66  IVQYYG-CLRDDETLSIF----MEYMPGGSVKDQLKAYGALTE----TVTRKYTRQI--L 114

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
             +EYLH N    +VH DIK +N+L D+     +GDFG SK L +               
Sbjct: 115 EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS----- 166

Query: 225 IKGTVGYVAP 234
           + GT  +++P
Sbjct: 167 VTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 60.2 bits (146), Expect = 6e-11
 Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 22/172 (12%)

Query: 48  FSQSNM-----IGQGSYGSVYKG-----ILGEDEMVVAVKVIN-LKQKGAFRSFVAECEA 96
           F +SN+     +G+G +G V+            E +V VK +   K +     F  E + 
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK---LSL 153
            R + H+N+ +++ +C     + A+   ++ EY + G L+ +L  T    E  K   LS 
Sbjct: 62  FRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            Q+V +   +A  +++L +      VH D+   N L+ +     V    LSK
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.1 bits (145), Expect = 7e-11
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 34/175 (19%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F++   IG+GS+G VYKGI    + VVA+K+I+L++        AE E        ++ +
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDEI------EDIQQ 51

Query: 108 IITICSSIDSK------GADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            IT+ S  DS       G+  K     ++ EY+  GS  D L      LE   ++ I R 
Sbjct: 52  EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILR- 108

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
               ++   ++YLH   +   +H DIK +NVLL       + DFG++  L+   +
Sbjct: 109 ----EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.0 bits (146), Expect = 8e-11
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 26/163 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVK-VINLKQK-----GAFRSFVAECEALRNIRHRNLTK 107
           +G+G++G VYK    +   VVA+K ++   +K      A R    E + L+ ++H N+  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71

Query: 108 IITICSSIDSKGADFKA---LVFEYMENGSLEDWLHQTNDHLEV--FKLSLIQRVNIAID 162
           +I +      K    +    +V  YM++  L   L   +  L     K  ++Q       
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQ------- 123

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   I YLH N    ++H DIK +N+L+DN  +  + DFGL++
Sbjct: 124 LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 9e-11
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 26/192 (13%)

Query: 54  IGQGSYGSVYKGIL--GEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           IG+G+YG VYK     G+D    A+K       +  G  +S   E   LR ++H N+  +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV--NIAIDVASA 166
           + +      K      L+F+Y E+    D       H +  ++S+   +  ++   + + 
Sbjct: 68  VEVFLEHADKSV---YLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH----VGDFGLSKFLSSDHLDTASETPSSS 222
           + YLH N    ++H D+KP+N+L+  +        +GD GL++  ++       +  +  
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA-----PLKPLADL 172

Query: 223 IGIKGTVGYVAP 234
             +  T+ Y AP
Sbjct: 173 DPVVVTIWYRAP 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.2 bits (146), Expect = 9e-11
 Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 27/171 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G GS G V+  +  + +  VAVK I L    + +  + E + +R + H N+ K+  +  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 114 SIDSK-GADFKAL--------VFEYMENGSLEDWLHQ---TNDHLEVFKLSLIQRVNIAI 161
              S    D  +L        V EYME   L + L Q   + +H  +F   L++      
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLR------ 125

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDH 211
                ++Y+H      ++H D+KP+NV ++  D+V  +GDFGL++ +   +
Sbjct: 126 ----GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 9e-11
 Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 19/166 (11%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLT 106
           + +  +IG+G+YG+VY+G       VVA+K+INL       S +  E   L  +R     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI---DV 163
            I     S   KG     ++ EY E GS+            + K   I    I++   +V
Sbjct: 63  NITKYYGSY-LKGPRL-WIIMEYAEGGSV----------RTLMKAGPIAEKYISVIIREV 110

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
             A++Y+H      ++H DIK +N+L+ N     + DFG++  L+ 
Sbjct: 111 LVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 59.7 bits (144), Expect = 1e-10
 Identities = 47/183 (25%), Positives = 90/183 (49%), Gaps = 26/183 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIITI 111
           +GQG +G V+ G        VA+K +   + G     +F+ E + ++ +RH  L  +  +
Sbjct: 14  LGQGCFGEVWMGTW-NGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            S       +   +V E+M  GSL D+L + +       L L Q V++A  +A  + Y+ 
Sbjct: 70  VSE------EPIYIVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYIE 119

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
              +   +H D++ +N+L+ +++V  + DFGL++ +  D+  TA +      G K  + +
Sbjct: 120 ---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQ------GAKFPIKW 169

Query: 232 VAP 234
            AP
Sbjct: 170 TAP 172

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 59.5 bits (145), Expect = 1e-10
 Identities = 45/169 (26%), Positives = 67/169 (39%), Gaps = 39/169 (23%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVK------VINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           +G GS+G V            A+K      ++ LKQ       + E   L++IRH  L  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ---VEHVLNEKRILQSIRHPFLVN 65

Query: 108 IITICSSIDSKGA--DFKAL--VFEYMENGSLEDWLHQ----TNDHLEVFKLSLIQRVNI 159
           +          G+  D   L  V EY+  G L   L +           +          
Sbjct: 66  LY---------GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY---------- 106

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           A  V  A+EYLH      +V+ D+KP N+LLD+D    + DFG +K + 
Sbjct: 107 AAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 59.4 bits (144), Expect = 1e-10
 Identities = 47/192 (24%), Positives = 88/192 (45%), Gaps = 30/192 (15%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINL----------KQKGAFRSFVAECEALRNIRH 102
           +IG+G+YG VY  +      ++AVK + L          +QK   ++  +E E L+++ H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ + +           ++ ++  EY+  GS+   L       E       ++V     
Sbjct: 68  LNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV----- 117

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
               + YLH      ++H D+K  N+L+D D +  + DFG+SK   SD +    +  S  
Sbjct: 118 -LEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMS-- 169

Query: 223 IGIKGTVGYVAP 234
             ++G+V ++AP
Sbjct: 170 --MQGSVFWMAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 59.2 bits (143), Expect = 2e-10
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 13/160 (8%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIR---HRNLTKI 108
           IG G+YG+VYK         VA+K + ++  + G   S V E   L+ +    H N+ ++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           + +C++  +       LVFE+++   L  +L    D +    L      ++       ++
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           +LH NC   +VH D+KP N+L+ +     + DFGL++  S
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 34/175 (19%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F++   IG+GS+G V+KGI    + VVA+K+I+L++        AE E        ++ +
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDEI------EDIQQ 51

Query: 108 IITICSSIDSK------GADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            IT+ S  DS       G+  K     ++ EY+  GS  D        LE   L   Q  
Sbjct: 52  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-------LEPGPLDETQIA 104

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
            I  ++   ++YLH   +   +H DIK +NVLL       + DFG++  L+   +
Sbjct: 105 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 41/153 (26%), Positives = 81/153 (52%), Gaps = 15/153 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+Y +V+KG     E +VA+K I L+ ++GA  + + E   L+N++H N   I+T+ 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN---IVTLH 69

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
             I ++      LVFEY+++  L+ +L    + + +  + +         +   + Y H 
Sbjct: 70  DIIHTERC--LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM-----FQLLRGLSYCHK 121

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
                ++H D+KP N+L++      + DFGL++
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.8 bits (142), Expect = 2e-10
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 30/180 (16%)

Query: 54  IGQGSYGSVY----KGI---LGEDE-------MVVAVKVINLK-QKGAFRSFVAECEALR 98
           +G+G +G V+    +G+   LGE         ++VAVK++     K A   F+ E + + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 99  NIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN 158
            +++ N+ +++ +C S D        ++ EYMENG L  +L Q          + I  V+
Sbjct: 73  RLKNPNIIRLLGVCVSDDPL-----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 159 I------AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL-SSDH 211
           I      A+ +AS ++YL        VH D+   N L+ N     + DFG+S+ L S D+
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.9 bits (142), Expect = 3e-10
 Identities = 42/169 (24%), Positives = 84/169 (49%), Gaps = 19/169 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL---GED-EMVVAVKVI-NLKQKGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+    GE  ++ VA+K +       A +  + E   + ++ 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 68  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 116

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            +A  + YL    +  +VH D+   NVL+       + DFGL+K L +D
Sbjct: 117 QIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 31/196 (15%)

Query: 47  EFSQSN---MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHR 103
           E+ ++    ++G+G+YG VY       ++ +A+K I  +     +    E      ++HR
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQT----NDHLEVFKLSLIQRVNI 159
           N+ + +      DS+   FK +  E +  GSL   L        D+ +       Q    
Sbjct: 66  NIVQYL----GSDSENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ---- 116

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDFGLSKFLSSDHLDTASET 218
              +   ++YLH N    +VH DIK  NVL++    V  + DFG SK L+   ++  +ET
Sbjct: 117 ---ILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTET 168

Query: 219 PSSSIGIKGTVGYVAP 234
                   GT+ Y+AP
Sbjct: 169 ------FTGTLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 15/154 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR---SFVAECEALRNIRHRNLTKIIT 110
           IG G +G V    +  D  V  V V  LK   + +    F+ + +  R ++H N+ + + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
            C       A    LVFEY E G L+ +L Q   H    +L L+QR  +A ++A+ + ++
Sbjct: 63  QCVE-----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHM 115

Query: 171 H-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
           H HN     +H D+   N  L +D+   VGD+G+
Sbjct: 116 HKHN----FLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.5 bits (141), Expect = 3e-10
 Identities = 44/155 (28%), Positives = 83/155 (53%), Gaps = 19/155 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+Y +VYKG     + +VA+K I L+ ++GA  + + E   L++++H N   I+T+ 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN---IVTLH 70

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTND--HLEVFKLSLIQRVNIAIDVASAIEYL 170
             I ++ +    LVFEY++   L+ +L    +  ++   KL L Q       +   + Y 
Sbjct: 71  DIIHTEKS--LTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ-------LLRGLNYC 120

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           H      ++H D+KP N+L++      + DFGL++
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 58.1 bits (140), Expect = 4e-10
 Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 36/184 (19%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F++   IG+GS+G V+KGI    + VVA+K+I+L++        AE E        ++ +
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDEI------EDIQQ 51

Query: 108 IITICSSIDSK------GADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            IT+ S  DS       G+  K     ++ EY+  GS  D L       + F+++ + + 
Sbjct: 52  EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLK- 108

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL--DTA 215
               ++   ++YLH   +   +H DIK +NVLL       + DFG++  L+   +  +T 
Sbjct: 109 ----EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161

Query: 216 SETP 219
             TP
Sbjct: 162 VGTP 165

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 57.8 bits (140), Expect = 4e-10
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 16/170 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA--ECEALRNIRHRNLTKIITI 111
           +G+G++G        ED+ +V  K +NL +        A  E   L  ++H N   II  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN---IIAY 64

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +           +  EY   G+L D + +    L  F+  ++  +     + SA+ Y+H
Sbjct: 65  YNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQL--FEEEMV--LWYLFQIVSAVSYIH 118

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD--HLDTASETP 219
                 ++H DIK  N+ L    +  +GDFG+SK L S+    +T   TP
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTP 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.9 bits (140), Expect = 5e-10
 Identities = 42/160 (26%), Positives = 82/160 (51%), Gaps = 15/160 (9%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRHRNL 105
           F +   IG+G+YG VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            K++ +   I ++   +  LVFE++ +  L+ ++  +   L    L LI+  +    +  
Sbjct: 62  VKLLDV---IHTENKLY--LVFEFL-HQDLKKFMDASP--LSGIPLPLIK--SYLFQLLQ 111

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.6 bits (139), Expect = 5e-10
 Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 34/187 (18%)

Query: 54  IGQGSYGSVYKGILGE--DEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKII 109
           +G G +G V+   LG+   ++ VA+K IN   +GA     F+ E + +  + H  L ++ 
Sbjct: 12  LGSGQFGVVH---LGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLY 65

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL--EVFKLSLIQRVNIAIDVASAI 167
            +C     K      +V E+MENG L ++L Q    L  ++  LS+ Q      DV   +
Sbjct: 66  GVC--TQQKPL---YIVTEFMENGCLLNYLRQRQGKLSKDML-LSMCQ------DVCEGM 113

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           EYL  N     +H D+   N L+ +  V  V DFG+++++  D         +SS G K 
Sbjct: 114 EYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKF 163

Query: 228 TVGYVAP 234
            V +  P
Sbjct: 164 PVKWSPP 170

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 29/160 (18%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+GSY +VYKGI   +  +VA+KVI++K ++G   + + E   L+ ++H N+  +  I 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 113 SSIDSKGADFKALVFEYMENGSLEDW-------LHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            + ++        VFEYM    L  +       LH  N  L +F+L              
Sbjct: 73  HTKET-----LTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQL------------LR 114

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            + Y+H      ++H D+KP N+L+       + DFGL++
Sbjct: 115 GLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 57.8 bits (140), Expect = 5e-10
 Identities = 48/172 (27%), Positives = 71/172 (41%), Gaps = 35/172 (20%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-----QKGAFRSFVAECEALRNIR 101
           +  + + +G+G+ GSV K  L    M+ A+K I        QK   R    E E  ++ +
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSCK 57

Query: 102 HRNLTKIITIC-----SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI-- 154
              + K          SSI         +  EY E GSL+          +V K      
Sbjct: 58  SPYIVKYYGAFLDESSSSI--------GIAMEYCEGGSLDSIYK------KVKKRGGRIG 103

Query: 155 QRV--NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           ++V   IA  V   + YLH      ++H DIKPSN+LL       + DFG+S
Sbjct: 104 EKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 57.7 bits (139), Expect = 6e-10
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 21/162 (12%)

Query: 54  IGQGSYGSVYKGILG--EDEMVVAVKVI-NLKQKGAFR-SFVAECEALRNIRHRNLTKII 109
           +G G++G+V KG+    + E  VAVK++ N     A +   + E   ++ + +  + ++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLS-LIQRVNIAIDVASAIE 168
            IC       A+   LV E  E G L  +L Q N H+    ++ L+ +V++ +      +
Sbjct: 63  GICE------AESWMLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGM------K 109

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           YL        VH D+   NVLL     A + DFGLSK L +D
Sbjct: 110 YLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.8 bits (139), Expect = 6e-10
 Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 19/161 (11%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLT 106
           + +   +G+GSY +VYKG    +  +VA+KVI L+ ++G   + + E   L+ ++H N+ 
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWL--HQTNDHLEVFKLSLIQRVNIAIDVA 164
            +  I  + ++       LVFEY+    L  ++  H    H E  KL L Q       + 
Sbjct: 67  LLHDIIHTKET-----LTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQ-------LL 113

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             + Y+H   Q  ++H D+KP N+L+ +     + DFGL++
Sbjct: 114 RGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 8e-10
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 19/155 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+GSY +VYKG       +VA+K I L+  +GA  + + E   L++++H N   I+T+ 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN---IVTLH 69

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTND--HLEVFKLSLIQRVNIAIDVASAIEYL 170
             I +K      LVFEY++   L+ ++        +   +L L Q       +   + Y 
Sbjct: 70  DIIHTKKT--LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ-------LLRGLAYC 119

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           H      ++H D+KP N+L+       + DFGL++
Sbjct: 120 HQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 21/170 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF---RSFVAECEALRNIRHRNLTKIIT 110
           IG G +G V  G +        V V  L+   +      F+ E +  R+++H NL + + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            C+ +         LV E+   G L+ +L       L     + +QR  +A ++A  + +
Sbjct: 63  QCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLH 115

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-------FLSSDHL 212
           LH N     +H D+   N LL  D+   +GD+GLS        +++ D L
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 16/158 (10%)

Query: 52  NMIGQGSYGSVYKGILGED---EMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLTK 107
            +IG+G +G VY G L +    ++  AVK +N +        F+ E   +++  H N+  
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  +
Sbjct: 61  LLGIC--LPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           EYL        VH D+   N +LD      V DFGL++
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.1 bits (135), Expect = 2e-09
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 17/160 (10%)

Query: 54  IGQGSYGSVYKGI--LGEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLTKIIT 110
           +G G++G V KG+  + + ++ VA+KV+  + + + R   + E E +  + +  + ++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C       A+   LV E    G L  +L    D + V  +     V +   V+  ++YL
Sbjct: 63  VCE------AEALMLVMEMASGGPLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYL 111

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
                   VH D+   NVLL N   A + DFGLSK L +D
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 29/172 (16%)

Query: 53  MIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGA---FRSFVAECEALRNI-RHR 103
            +G+G++G V K          +   VAVK+  LK           V+E E ++ I +H+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ----------TNDHLEVFKLSL 153
           N+  ++ +C+    +G  +  +V EY  +G+L D+L             +       L+ 
Sbjct: 77  NIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
              V+ A  VA  +E+L        +H D+   NVL+  D V  + DFGL++
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 33/172 (19%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 104
           FS    IG GS+G+VY      +  VVA+K ++   K +   ++  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 105 LTKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
                    +I  +G   +     LV EY         L   +D LEV K  L Q V IA
Sbjct: 77  ---------TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 118

Query: 161 IDVASAIE---YLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
                A++   YLH HN    M+H D+K  N+LL    +  +GDFG +  ++
Sbjct: 119 AVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 44/165 (26%), Positives = 84/165 (50%), Gaps = 22/165 (13%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRN 104
           ++++   IG+G+YG VYKG   +   +VA+K I L+  ++G   + + E   L+ ++H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQT--NDHL--EVFKLSLIQRVNIA 160
           +  +  +    +S+      L+FE++    L+ +L       ++  E+ K  L Q     
Sbjct: 61  IVCLQDVLMQ-ESR----LYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQ----- 109

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             +   I + H      ++H D+KP N+L+DN  V  + DFGL++
Sbjct: 110 --ILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 52/165 (31%), Positives = 73/165 (44%), Gaps = 31/165 (18%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA---FRSFVAECEALRNIRHRNLTKIIT 110
           IG GS+G+VY         VVAVK ++   K     ++  + E + L+ ++H N      
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN------ 82

Query: 111 ICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
              +I+ KG   K     LV EY         L   +D LEV K  L Q V IA     A
Sbjct: 83  ---TIEYKGCYLKEHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIAAITHGA 130

Query: 167 IE---YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           ++   YLH +    M+H DIK  N+LL       + DFG +   S
Sbjct: 131 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS 172

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 14/163 (8%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F     IG G+YG VYK        + A+KVI L+    F     E   +++ +H N  
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN-- 67

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    S   +  D   +  E+   GSL+D  H T        LS  Q   ++ +    
Sbjct: 68  -IVAYFGSYLRR--DKLWICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQG 118

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           + YLH   +   +H DIK +N+LL ++    + DFG+S  +++
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA 158

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 55.7 bits (134), Expect = 2e-09
 Identities = 50/196 (25%), Positives = 97/196 (49%), Gaps = 27/196 (13%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA------FRSFVAECEALRNI 100
           E+++  ++G+G+YG+VY G+  + ++ +AVK + L           +     E + L+++
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE-VFKLSLIQRVNI 159
           +H N+ + +  C   ++      ++  E++  GS+   L++     E VF     Q    
Sbjct: 60  KHVNIVQYLGTCLDDNT-----ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ---- 110

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD-TASET 218
              +   + YLH+NC   +VH DIK +NV+L  + +  + DFG ++ L+   L  T S  
Sbjct: 111 ---ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM 164

Query: 219 PSSSIGIKGTVGYVAP 234
             S   + GT  ++AP
Sbjct: 165 LKS---MHGTPYWMAP 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 55.5 bits (133), Expect = 3e-09
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 20/176 (11%)

Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
           +EK   +VS  +  K    F +   IGQG+ G+VY  +       VA++ +NL+Q+    
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62

Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQTNDHLE 147
             + E   +R  ++ N      I + +DS    D   +V EY+  GSL D + +T   ++
Sbjct: 63  LIINEILVMRENKNPN------IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MD 114

Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
             +++ + R     +   A+E+LH N    ++H DIK  N+LL  D    + DFG 
Sbjct: 115 EGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.5 bits (134), Expect = 3e-09
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 28/160 (17%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+G+YG+V+K    E   +VA+K + L    +G   S + E   L+ ++H+N+ ++  +
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE-----VFKLSLIQRVNIAIDVASA 166
             S D K      LVFEY +   L+ +    N  ++      F   L++           
Sbjct: 68  LHS-DKK----LTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLK----------G 111

Query: 167 IEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           + + H HN    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LAFCHSHN----VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 55.6 bits (134), Expect = 4e-09
 Identities = 55/186 (29%), Positives = 81/186 (43%), Gaps = 28/186 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+GS+G V       D    AVKV+     LK+K   +  +AE    RN+  +N+    
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-KHIMAE----RNVLLKNVKHPF 57

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVASAIE 168
            +      + AD    V +Y+  G L   L +     E        R    A ++ASA+ 
Sbjct: 58  LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-------RARFYAAEIASALG 110

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           YLH      +++ D+KP N+LLD+     + DFGL K    +H  T S          GT
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTST-------FCGT 159

Query: 229 VGYVAP 234
             Y+AP
Sbjct: 160 PEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 42/181 (23%), Positives = 86/181 (47%), Gaps = 21/181 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G +G V+ G    +   VAVK +      + ++F+ E   ++ ++H  L ++  + +
Sbjct: 14  LGAGQFGEVWMGYY-NNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             +        ++ EYM  GSL D+L       E  K+ L + ++ +  +A  + Y+   
Sbjct: 72  KEEPI-----YIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE-- 120

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
            +   +H D++ +NVL+   ++  + DFGL++ +  +   TA E      G K  + + A
Sbjct: 121 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TARE------GAKFPIKWTA 172

Query: 234 P 234
           P
Sbjct: 173 P 173

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 55.7 bits (134), Expect = 4e-09
 Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 29/168 (17%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHR 103
           EF     I +G++G VY G    +  + AVKV+   ++  K       AE +AL      
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA----- 59

Query: 104 NLTK---IITICSSIDSKGADFKALVFEYMENGSLEDWLH---QTNDHLEVFKLSLIQRV 157
            L+K   I+ +  S+ S  A+   LV EY+  G ++  LH     ++ + V  +S     
Sbjct: 60  -LSKSPFIVHLYYSLQS--ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----- 111

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
               +VA A++YLH   +  ++H D+KP N+L+ N+    + DFGLSK
Sbjct: 112 ----EVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.1 bits (132), Expect = 4e-09
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 20/176 (11%)

Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
           +EK   +VS  +  K    F +   IGQG+ G+VY  I       VA+K +NL+Q+    
Sbjct: 5   LEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE 61

Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQTNDHLE 147
             + E   +R  ++ N      I + +DS    D   +V EY+  GSL D + +T   ++
Sbjct: 62  LIINEILVMRENKNPN------IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MD 113

Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
             +++ + R     +   A+++LH N    ++H DIK  N+LL  D    + DFG 
Sbjct: 114 EGQIAAVCR-----ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 4e-09
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 19/156 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+G+YG VYK        +VA+K I L+   +G   + + E   L+ + H N+ +++ +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKL--SLIQRVNIAIDVASAIEY 169
             S ++K      LVFE+     L+  L +  D   +  L   LI+     +     I Y
Sbjct: 67  VHS-ENK----LYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQL--LQGIAY 114

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            H +    ++H D+KP N+L+D +    + DFGL++
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 54.7 bits (131), Expect = 6e-09
 Identities = 42/171 (24%), Positives = 80/171 (46%), Gaps = 22/171 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FVAECEALR 98
           + + S  +GQGS+G VY+GI       E E  VA+K +N  +  + R    F+ E   ++
Sbjct: 7   KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMK 64

Query: 99  NIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKL----SLI 154
                ++ +++ + S           ++ E M  G L+ +L      +E   +    SL 
Sbjct: 65  EFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 120 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 54.7 bits (132), Expect = 6e-09
 Identities = 37/152 (24%), Positives = 70/152 (46%), Gaps = 15/152 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G VYK    E  +  A K+I ++ +     F+ E + L   +H N+  +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA-Y 71

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE-VFKLSLIQRVNIAIDVASAIEYLHH 172
             ++K      ++ E+ + G+L+  +      LE       I+ V     +  A+ +LH 
Sbjct: 72  FYENK----LWILIEFCDGGALDSIM----LELERGLTEPQIRYV--CRQMLEALNFLHS 121

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           +    ++H D+K  N+LL  D    + DFG+S
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.5 bits (131), Expect = 6e-09
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 30/178 (16%)

Query: 54  IGQGSYGSVY----KGIL------------GEDEMVVAVKVINLK-QKGAFRSFVAECEA 96
           +G+G +G V+    +G+             G   ++VAVK++     K A   F+ E + 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL--HQTNDHL---EVFKL 151
           +  ++  N+ +++ +C  I S   D   ++ EYMENG L  +L  H+  +     +V  +
Sbjct: 73  MSRLKDPNIIRLLAVC--ITS---DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           S    + +A  +AS ++YL        VH D+   N L+  +    + DFG+S+ L S
Sbjct: 128 SYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.7 bits (131), Expect = 7e-09
 Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 26/179 (14%)

Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKG 85
           MEK   +VS  +  K   ++++   IGQG+ G+V+  I    G++   VA+K INL+++ 
Sbjct: 5   MEKLRTIVSIGDPKK---KYTRYEKIGQGASGTVFTAIDVATGQE---VAIKQINLQKQP 58

Query: 86  AFRSFVAECEALRNIRHRNLTKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQTND 144
                + E   ++ +++ N      I + +DS    D   +V EY+  GSL D + +T  
Sbjct: 59  KKELIINEILVMKELKNPN------IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC- 111

Query: 145 HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
                 +   Q   +  +   A+E+LH N    ++H DIK  NVLL  D    + DFG 
Sbjct: 112 ------MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 8e-09
 Identities = 52/207 (25%), Positives = 83/207 (40%), Gaps = 42/207 (20%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           IG+G++G V+     +   V A+KV+    + ++       AE + L +     + K+  
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
             S  D    +   LV EYM  G L + L       +VF      R  IA ++  A++ +
Sbjct: 68  -YSFQDE---EHLYLVMEYMPGGDLMNLL----IRKDVFPEETA-RFYIA-ELVLALDSV 117

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSK----------FLSSDHLDTASET 218
           H   +   +H DIKP N+L+D D   H+   DFGL K          +L+  H     + 
Sbjct: 118 H---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 219 PSSSIGIK-----------GTVGYVAP 234
                              GT  Y+AP
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAP 199

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.3 bits (130), Expect = 8e-09
 Identities = 55/172 (31%), Positives = 77/172 (44%), Gaps = 33/172 (19%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 104
           F+    IG GS+G+VY         VVA+K ++   K +   ++  + E + L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 105 LTKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
                    SI+ KG   +     LV EY         L   +D LEV K  L Q V IA
Sbjct: 87  ---------SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 128

Query: 161 IDVASAIE---YLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
                A++   YLH HN    M+H DIK  N+LL       + DFG +   S
Sbjct: 129 AITHGALQGLAYLHSHN----MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 32/170 (18%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVIN--LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +IG+GSYG V   I       VA+K IN   +        + E + LR +RH ++ +I  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 111 ICSSIDSKGADFKAL--VFEYMENGSLEDWLHQ--------TNDHLEVFKLSLIQRVNIA 160
           I      +  +FK +  VFE ME+      LHQ        T +H + F   L++     
Sbjct: 67  IMLPPSRR--EFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQLLR----- 114

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
                A++Y+H      + H D+KP N+L + D    + DFGL++   +D
Sbjct: 115 -----ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND 156

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 25/192 (13%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVK---VINLKQKGAFRSFVAECEALRNIRHRN 104
           F     IG+G +  VY+     D + VA+K   + +L    A    + E + L+ + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV--NIAID 162
           + K     S I+    +   +V E  + G L     +   H +  K  + ++      + 
Sbjct: 64  VIKYYA--SFIEDNELN---IVLELADAGDLS----RMIKHFKKQKRLIPEKTVWKYFVQ 114

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           + SA+E++H      ++H DIKP+NV +    V  +GD GL +F SS    TA+ +    
Sbjct: 115 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHS---- 165

Query: 223 IGIKGTVGYVAP 234
             + GT  Y++P
Sbjct: 166 --LVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 24/168 (14%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG--AFRSFVAECEALRNIRHRN 104
           +F    ++G+G+YG V K    E + +VA+K     ++      + + E + LR ++  N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----DHLEVFKLSLIQRVNIA 160
              I+ +  +   +G  +  LVFEY+E   LE      N    + +  +   LI+     
Sbjct: 62  ---IVELKEAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK----- 111

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
                AI + H N    +VH DIKP N+L+ ++ V  + DFG ++ LS
Sbjct: 112 -----AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLS 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 41/155 (26%), Positives = 80/155 (51%), Gaps = 19/155 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+Y +V+KG     E +VA+K I L+ ++GA  + + E   L++++H N+  +  I 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEV--FKLSLIQRVNIAIDVASAIEYL 170
            +  S       LVFEY++   L+ ++    + + +   K+ L Q       +   + Y 
Sbjct: 74  HTDKSL-----TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ-------ILRGLAYC 120

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           H      ++H D+KP N+L++      + DFGL++
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 27/194 (13%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVK---VINLKQKGAFRSFVAECEALRNIRHR 103
            F     IG+G +  VY+     D   VA+K   +  +    A +  V E + L+ + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 104 NLTKIITICSSIDSKGADFKA-LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV--NIA 160
           N+ K +      DS   D +  +V E  + G L     Q   + +  K  + +R      
Sbjct: 63  NVIKYL------DSFIEDNELNIVLELADAGDLS----QMIKYFKKQKRLIPERTVWKYF 112

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPS 220
           + + SA+E++H      ++H DIKP+NV +    V  +GD GL +F SS    TA+ +  
Sbjct: 113 VQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHS-- 165

Query: 221 SSIGIKGTVGYVAP 234
               + GT  Y++P
Sbjct: 166 ----LVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.0 bits (127), Expect = 2e-08
 Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 22/164 (13%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +GQGS+G VY+G       GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----VFKLSLIQRVNIAI 161
            +++ + S    KG     +V E M +G L+ +L       E        +L + + +A 
Sbjct: 72  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           ++A  + YL+       VH D+   N ++ +D    +GDFG+++
Sbjct: 127 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 52.7 bits (126), Expect = 2e-08
 Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 14/151 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G+YG VYK        + AVK+I L+    F     E   ++  +H N   I+    
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN---IVAYFG 73

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
           S  S+   +  +  EY   GSL+D  H T        LS +Q   +  +    + YLH  
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK 125

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
            +   +H DIK +N+LL ++    + DFG++
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 36/172 (20%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFV------AECEALRNIRHRNLTK 107
           IG+G+YG V      E    VA+K I      AF + +       E + LR++ H N+  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA----NAFDNRIDAKRTLREIKLLRHLDHENVIA 68

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQ--------TNDHLEVFKLSLIQRVNI 159
           I  I      +  +   +V+E M+       LHQ        ++DH + F   L++    
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLR---- 119

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
                  ++Y+H      ++H D+KPSN+LL+ +    + DFGL++  S   
Sbjct: 120 ------GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 21/170 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGED----EMVVAVKVI--NLKQKGAFRSFVAECEALRNI 100
           E  +  ++G G++G+VYKGI   D    ++ VA+KV+  N   K A +  + E   +  +
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGV 66

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
               + +++ IC +   +      LV + M  G L D++ +  D +    L     +N  
Sbjct: 67  GSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNWC 115

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           + +A  + YL    +  +VH D+   NVL+ +     + DFGL++ L  D
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 32/171 (18%), Positives = 68/171 (39%), Gaps = 35/171 (20%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINL----KQKGAFRSFVAEC----------EAL 97
             +G+G+YG V K        +VA+K + +          R  V  C          + +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENG---SLEDWLHQTNDHLEVFKLSLI 154
             I+H N+  ++ +         DF  LV + M +     ++  +  T   ++   L ++
Sbjct: 75  NEIKHENIMGLVDVYVE-----GDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQIL 129

Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             +N+            H      +H D+ P+N+ +++  +  + DFGL++
Sbjct: 130 NGLNVL-----------HKWY--FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 52.4 bits (126), Expect = 3e-08
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 15/157 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V           VAVK ++L+++        E   +R+ +H N   I+ + S
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN---IVEMYS 83

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
           S      D   +V E++E G+L D +  T  + E       Q   + + V  A+ +LH  
Sbjct: 84  SYLV--GDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLAVLKALSFLHAQ 134

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               ++H DIK  ++LL +D    + DFG    +S +
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 23/184 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA--LRNIRHRNLTKIITI 111
           +G+GSYG V       D     +K +NL+         AE EA  L  ++H N   I+  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN---IVAY 64

Query: 112 CSSIDSKGAD-FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
             S +  G D    +V  + E G L   L +    L    L   Q V   + +A A++YL
Sbjct: 65  RESWE--GEDGLLYIVMGFCEGGDLYHKLKEQKGKL----LPENQVVEWFVQIAMALQYL 118

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H   +  ++H D+K  NV L    +  VGD G+++ L +   D AS        + GT  
Sbjct: 119 H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMAST-------LIGTPY 167

Query: 231 YVAP 234
           Y++P
Sbjct: 168 YMSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 4e-08
 Identities = 55/193 (28%), Positives = 83/193 (43%), Gaps = 40/193 (20%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+G++G VY+    +   + A+KV++ K+       VA+ E    I  RN    I + +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE------IVAKKEVAHTIGERN----ILVRT 50

Query: 114 SIDSK----GADFK-------ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI- 161
            +D      G  F         LV +YM  G L  W  Q              R    I 
Sbjct: 51  LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSE------DRAKFYIA 103

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
           ++  A+E+LH      +V+ D+KP N+LLD      + DFGLSK   +D+  T +     
Sbjct: 104 ELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT----- 155

Query: 222 SIGIKGTVGYVAP 234
                GT  Y+AP
Sbjct: 156 ---FCGTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.1 bits (125), Expect = 5e-08
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 22/158 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+G+YG VYK         +A+K I L+Q  +G   + + E   L+ ++H N+ ++  +
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTND---HLEVFKLSLIQRVNIAIDVASAIE 168
             S + +      LVFEY++   L+  +  + D   +  + K  L Q       +   I 
Sbjct: 70  VHS-EKR----LYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQ-------ILRGIA 116

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVA-HVGDFGLSK 205
           Y H +    ++H D+KP N+L+D    A  + DFGL++
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.6 bits (123), Expect = 8e-08
 Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 26/186 (13%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKII 109
           +IG+GS+G V       +E   AVKV+  K   +K   +  ++E    RN+  +N+    
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE----RNVLLKNVKHPF 57

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVASAIE 168
            +      + AD    V +Y+  G L         HL+  +  L  R    A ++ASA+ 
Sbjct: 58  LVGLHFSFQTADKLYFVLDYINGGEL-------FYHLQRERCFLEPRARFYAAEIASALG 110

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           YLH      +V+ D+KP N+LLD+     + DFGL K    ++++    T +      GT
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTST----FCGT 159

Query: 229 VGYVAP 234
             Y+AP
Sbjct: 160 PEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 30/182 (16%)

Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS-FVAE 93
           E++ +T  F +   +G+  +G VYKG L     GE    VA+K +  K +G  R  F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEV----- 148
                 ++H N+  ++ + +          +++F Y  +  L ++L   + H +V     
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPL-----SMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 149 -----FKLSLIQRVNIAIDVASAIEYL--HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF 201
                  L     V+I   +A+ +E+L  HH     +VH D+   NVL+ + +   + D 
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDL 168

Query: 202 GL 203
           GL
Sbjct: 169 GL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 50.5 bits (120), Expect = 1e-07
 Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 17/167 (10%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS---FVAECEA--LRNIRH 102
           + +  ++GQG++G VY     +    +A K +    +    S      ECE   L+N++H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
               +I+     +  +      +  EYM  GS++D L       E       +++     
Sbjct: 64  E---RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI----- 115

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
               + YLH N    +VH DIK +N+L D+     +GDFG SK L +
Sbjct: 116 -LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 22/181 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G +G V+     +    VAVK +      +  +F+AE   ++ ++H  L K+  + +
Sbjct: 14  LGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 72  K------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 119

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
            Q   +H D++ +N+L+   +V  + DFGL++ +  D+  TA E      G K  + + A
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTARE------GAKFPIKWTA 171

Query: 234 P 234
           P
Sbjct: 172 P 172

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 33/200 (16%)

Query: 54  IGQGSYGSVYKG-ILGEDE----MVVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 104
           +G+G +G V     +G D+     V  V V  LK           ++E E ++ I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L                +   +LS  
Sbjct: 86  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDT 214
             V+ A  VA  +EYL        +H D+   NVL+  D V  + DFGL++ +   H+D 
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDY 195

Query: 215 ASETPSSSIGIKGTVGYVAP 234
             +T +  + +K    ++AP
Sbjct: 196 YKKTTNGRLPVK----WMAP 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 29/189 (15%)

Query: 54  IGQGSYGSVY--KGILGEDE-MVVAVKVIN-----LKQKGAFRSFVAECEALRNIRHRNL 105
           +G G+YG V+  + + G D   + A+KV+       K K A  +   E + L  +R    
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLEAVRRCPF 66

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
              +      D+K      L+ +Y+  G L   L+Q     E F  S + RV IA ++  
Sbjct: 67  LVTLHYAFQTDTK----LHLILDYVNGGELFTHLYQR----EHFTESEV-RVYIA-EIVL 116

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           A+++LH   Q  +++ DIK  N+LLD++    + DFGLSK   ++  + A          
Sbjct: 117 ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-------F 166

Query: 226 KGTVGYVAP 234
            GT+ Y+AP
Sbjct: 167 CGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 40/197 (20%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVK------VINLKQKGAFRSFVAECEALRNI 100
           +  +   +G G++G V+       E   A+K      VI LKQ+    +   E   L+ +
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEV 58

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQT---NDHLEVFKLSLIQRV 157
            H  + ++    +  D +   F  ++ EY+  G L  +L  +   ++   +F        
Sbjct: 59  SHPFIIRLF--WTEHDQR---FLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-------- 105

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             A ++  A+EYLH      +V+ D+KP N+LLD +    + DFG +K L  D   T   
Sbjct: 106 -YASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWTLCG 160

Query: 218 TPSSSIGIKGTVGYVAP 234
           TP           Y+AP
Sbjct: 161 TPE----------YLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 49.9 bits (119), Expect = 2e-07
 Identities = 37/157 (23%), Positives = 68/157 (43%), Gaps = 18/157 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS------FVAECEALRNIRHRNLTK 107
           IG G +G V   +LGE    ++   + +K+  A  +      F+ E +  R + H N+ +
Sbjct: 3   IGNGWFGKV---LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
            +  C            LV E+   G L+++L      +       + +  +A +VAS +
Sbjct: 60  CLGQCIESIPY-----LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ-RMACEVASGL 113

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
            +LH       +H D+   N  L  D+   +GD+GL+
Sbjct: 114 LWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 17/173 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-----RHRNLTKI 108
           IG+G+YG V+K +  ++    AVK+++            E EA  NI      H N+ K 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
             +    D K  D   LV E    GS+ D +       E  +  +I    I  +    ++
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII--AYILHEALMGLQ 138

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL--DTASETP 219
           +LH N     +H D+K +N+LL  +    + DFG+S  L+S  L  +T+  TP
Sbjct: 139 HLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 49.8 bits (119), Expect = 2e-07
 Identities = 42/164 (25%), Positives = 65/164 (39%), Gaps = 34/164 (20%)

Query: 54  IGQGSYGSVY---KGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           I +G++GSVY   K   G+   +  +K  ++  K    +  AE   +             
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV--AK 61

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV---------NIAI 161
           +  S  SK  D+  LV EY+  G                  SLI+ +             
Sbjct: 62  LYYSFQSK--DYLYLVMEYLNGGDCA---------------SLIKTLGGLPEDWAKQYIA 104

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +V   +E LH   Q  ++H DIKP N+L+D      + DFGLS+
Sbjct: 105 EVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR 145

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 34/181 (18%)

Query: 47  EFSQSNM-----IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRSFVAECEALR 98
           EF ++N+     +G G++G V +     L + + V+ V V  LK   A  S   E EAL 
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSS---EREALM 86

Query: 99  NI--------RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK 150
           +          H N+  ++  C+     G     ++ EY   G L ++L +  +      
Sbjct: 87  SELKIMSHLGNHENIVNLLGACT----IGGPI-LVITEYCCYGDLLNFLRRKRESF---- 137

Query: 151 LSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           L+L   ++ +  VA  + +L   NC    +H D+   NVLL +  +  + DFGL++ + +
Sbjct: 138 LTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMN 193

Query: 210 D 210
           D
Sbjct: 194 D 194

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 41/179 (22%), Positives = 77/179 (43%), Gaps = 38/179 (21%)

Query: 54  IGQGSYGSVYKGILGEDE-----MVVAVKVINLKQKGA----FRSFVAECEALRNIRHRN 104
           +G+G +G V K      +       VAVK++   ++ A     R  ++E   L+ + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN------------------DHL 146
           + K+   CS     G     L+ EY + GSL  +L ++                   D+ 
Sbjct: 65  VIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 147 EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   L++   ++ A  ++  ++YL    +  +VH D+   NVL+       + DFGLS+
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 49.9 bits (120), Expect = 2e-07
 Identities = 48/184 (26%), Positives = 75/184 (40%), Gaps = 26/184 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G G +G V    +       A+K +  +   + G      +E E L    H  + K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
             +  D K   +  ++ EY   G L   L       +        R  IA  V  A EYL
Sbjct: 60  -RTFKDKK---YIYMLMEYCLGGELWTILRD-RGLFD----EYTARFYIAC-VVLAFEYL 109

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H+     +++ D+KP N+LLD++    + DFG +K L S       +T +      GT  
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-----GQKTWT----FCGTPE 157

Query: 231 YVAP 234
           YVAP
Sbjct: 158 YVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 42/164 (25%), Positives = 80/164 (48%), Gaps = 20/164 (12%)

Query: 54  IGQGSYGSVYKGI-LGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIR---HRNLTK 107
           IG+G+YG V+K   L      VA+K + ++  ++G   S + E   LR++    H N+ +
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDH---LEVFKLSLIQRVNIAIDVA 164
           +  +C+   +       LVFE+++   L  +L +  +     E  K  + Q       + 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ-------LL 120

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
             +++LH +    +VH D+KP N+L+ +     + DFGL++  S
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.5 bits (118), Expect = 3e-07
 Identities = 33/144 (22%), Positives = 69/144 (47%), Gaps = 20/144 (13%)

Query: 54  IGQGSYGSVYKGI---LGED----EMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +GQG++  ++KGI   +G+     +  V +KV++   +    SF      +  + H++L 
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
               +C        D   +V EY++ GSL+ +L +  +      +++  ++ +A  +A A
Sbjct: 63  LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWA 112

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLL 190
           + +L       + HG++   NVLL
Sbjct: 113 LHFLEDK---GLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 31/189 (16%)

Query: 50  QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEA--LRNIRHRN 104
              ++G+G++G VY     +    +AVK +      Q+ +      ECE   L+N+RH  
Sbjct: 6   LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65

Query: 105 LTKIITICSSIDSKGADFKALVF-EYMENGSLEDWLHQTNDHLEVFKLSLIQRVN--IAI 161
           + +        + K    K  +F EYM  GS++D L            +L + V      
Sbjct: 66  IVQYYGCLRDPEEK----KLSIFVEYMPGGSIKDQLKAYG--------ALTENVTRRYTR 113

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
            +   + YLH N    +VH DIK +N+L D+     +GDFG SK + +  +        S
Sbjct: 114 QILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM--------S 162

Query: 222 SIGIKGTVG 230
             GIK   G
Sbjct: 163 GTGIKSVTG 171

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 23/174 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLTKI 108
           IG+GS+G +Y      D     +K I+L     K+K A +    E   L  ++H N   I
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPN---I 61

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           +T  +S    G  F  +V EY + G   D + + N    V   S  Q ++  + ++  ++
Sbjct: 62  VTFFASFQENGRLF--IVMEYCDGG---DLMKRINRQRGVL-FSEDQILSWFVQISLGLK 115

Query: 169 YLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFL--SSDHLDTASETP 219
           ++H      ++H DIK  N+ L  N MVA +GDFG+++ L  S +   T   TP
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 49.5 bits (118), Expect = 3e-07
 Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 23/158 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YGSVYK +     + +A+K I L+  +  F   + E + L    H+ ++  I   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYI--- 61

Query: 113 SSIDSKGADF-KALVF---EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
             +D  GA F +  V+   EYM+ GSL D L+      E     +++R  I   V   ++
Sbjct: 62  --VDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLK 116

Query: 169 YL--HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           +L   HN    ++H D+KP+NVL++ +    + DFG+S
Sbjct: 117 FLKEEHN----IIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 25/182 (13%)

Query: 54  IGQGSYGSVYKGIL----GEDEMVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+ ++G +YKG L     +   +VA+K + ++     +  F  E   +  + H N+  +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEV---------FKLSLIQR--V 157
           + + +           ++FEY+  G L ++L   + H +V          K SL     +
Sbjct: 73  LGVVTQEQPV-----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDTAS 216
           +IAI +A+ +EYL  +     VH D+   N+L+   +   + D GLS+   S+D+     
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 217 ET 218
           ++
Sbjct: 185 KS 186

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 44/215 (20%)

Query: 47  EFSQSNMI-----GQGSYGSVYK----GILGE--DEMV-VAVKVINLKQKGA---FRSFV 91
           EF +  ++     G+G +G V +    GI     D+ V VAVK+  LK           +
Sbjct: 8   EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLI 65

Query: 92  AECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ--------T 142
           +E E ++ I +H+N+  ++ +C+    +G  +  ++ EY   G+L ++L          T
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYT 120

Query: 143 NDHLEVFK--LSLIQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVG 199
            D  +V +  LS    V+ A  VA  +EYL    C    +H D+   NVL+  D V  + 
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIA 176

Query: 200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           DFGL++      +D   +T +  + +K    ++AP
Sbjct: 177 DFGLAR--GVHDIDYYKKTSNGRLPVK----WMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 4e-07
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 36/178 (20%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRHRN 104
            +   + IG+G+YG V         + VA+K I+    Q    R+ + E + LR  +H N
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHEN 64

Query: 105 LTKI--ITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------TNDHLEVFKLSL 153
           +  I  I    S +S    F    +V E ME       L++       +NDH++ F L  
Sbjct: 65  IIGILDIIRPPSFES----FNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYF-LYQ 114

Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           I R          ++Y+H      ++H D+KPSN+LL+ +    + DFGL++    +H
Sbjct: 115 ILR---------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 49.2 bits (117), Expect = 4e-07
 Identities = 35/151 (23%), Positives = 72/151 (47%), Gaps = 13/151 (8%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G VYK    E  ++ A KVI+ K +     ++ E + L +  H N+ K++    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             ++       ++ E+   G+++  + +    L   ++ ++ +  +      A+ YLH N
Sbjct: 73  YENNLW-----ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLHEN 122

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
               ++H D+K  N+L   D    + DFG+S
Sbjct: 123 ---KIIHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 48.9 bits (116), Expect = 5e-07
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 21/155 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G VYK    E   + A KVI  K +     ++ E E L    H  + K++    
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---- 75

Query: 114 SIDSKGADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
                GA +      ++ E+   G+++  + + +  L   ++ +I R      +  A++Y
Sbjct: 76  -----GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR-----QMLEALQY 125

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           LH      ++H D+K  NVLL  D    + DFG+S
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.8 bits (116), Expect = 7e-07
 Identities = 55/186 (29%), Positives = 81/186 (43%), Gaps = 26/186 (13%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKII 109
           +IG+GS+G V       D    AVKV+  K   +K      +AE    RN+  +NL    
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAE----RNVLLKNLKHPF 57

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVASAIE 168
            +      + A+    V +Y+  G L         HL+  +  L  R    A +VASAI 
Sbjct: 58  LVGLHYSFQTAEKLYFVLDYVNGGEL-------FFHLQRERCFLEPRARFYAAEVASAIG 110

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           YLH      +++ D+KP N+LLD+     + DFGL K           E   ++    GT
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGVEPEETTSTFCGT 159

Query: 229 VGYVAP 234
             Y+AP
Sbjct: 160 PEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 48.5 bits (116), Expect = 9e-07
 Identities = 36/131 (27%), Positives = 54/131 (41%), Gaps = 14/131 (10%)

Query: 73  VVAVKVINL--KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM 130
           +VAVK INL    K   +    E    R ++H N+   +T    +DS+      +V   M
Sbjct: 27  LVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT-SFIVDSE----LYVVSPLM 81

Query: 131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
             GS ED L       E      I    I  DV +A++Y+H       +H  +K S++LL
Sbjct: 82  AYGSCEDLL--KTHFPEGLPELAI--AFILKDVLNALDYIHSK---GFIHRSVKASHILL 134

Query: 191 DNDMVAHVGDF 201
             D    +   
Sbjct: 135 SGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.0 bits (114), Expect = 1e-06
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 38/205 (18%)

Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVI----NLKQKGAFRSFVA 92
           EL   + +  +   +G G +G + +G L    + E+ VA+  +    + KQ+   R F+A
Sbjct: 1   ELDNKSIKIERI--LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR---RGFLA 55

Query: 93  ECEALRNIRHRNLTK---IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF 149
           E   L    H N+ +   +IT  +++         +V EYM NG+L+ +L +        
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEG----- 102

Query: 150 KLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           +L   Q + +   +AS ++YL    +   VH  +    VL+++D+V  +  F     L  
Sbjct: 103 QLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQE 156

Query: 210 DHLDTASETPSSSIGIKGTVGYVAP 234
           D     SE   +++  K  V + AP
Sbjct: 157 DK----SEAIYTTMSGKSPVLWAAP 177

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 27/197 (13%)

Query: 35  MVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAEC 94
           M+    L   T  +     IG+G+YG VYK    +D  + AVK+++            E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEI 65

Query: 95  EALRNI-----RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF 149
           EA  NI      H N+ K   +    D        LV E    GS+           E+ 
Sbjct: 66  EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVT----------ELV 115

Query: 150 KLSLI--QRVN---IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           K  LI  QR++   I+  +  A+  L H     ++H D+K +N+LL  +    + DFG+S
Sbjct: 116 KGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175

Query: 205 KFLSSDHL--DTASETP 219
             L+S  L  +T+  TP
Sbjct: 176 AQLTSTRLRRNTSVGTP 192

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 10/159 (6%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLT 106
           F    ++G G+YG VYKG   +   + A+KV+++ +         E   L+    HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76

Query: 107 KIITICSSIDSKGADFKA-LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
                       G D +  LV E+   GS+ D +  T  +    K   I    I  ++  
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN--ALKEDWI--AYICREILR 132

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
            + +LH +    ++H DIK  NVLL  +    + DFG+S
Sbjct: 133 GLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 47.5 bits (113), Expect = 1e-06
 Identities = 46/184 (25%), Positives = 80/184 (43%), Gaps = 24/184 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G+G +G V    +     + A K ++   LK++   +  + E + L  +  R    I++
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF---IVS 57

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +  + ++K  D   LV   M  G L+   H  N     F  +  + +  A  +   +E+L
Sbjct: 58  LAYAFETK--DDLCLVMTLMNGGDLK--YHIYNVGEPGFPEA--RAIFYAAQIICGLEHL 111

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H   Q  +V+ D+KP NVLLD+     + D GL+  L         +         GT G
Sbjct: 112 H---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK------GGKKIKGRA---GTPG 159

Query: 231 YVAP 234
           Y+AP
Sbjct: 160 YMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 29/195 (14%)

Query: 48  FSQSNMIGQGSYGSVY--KGILGEDE-----MVVAVKVINLKQKGAFRSFVAECEALRNI 100
           F    ++G G+YG V+  + + G D      M V  K   +++         E + L +I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
           R       +      D+K      L+ +Y+  G L   L Q     E       Q V I 
Sbjct: 62  RQSPFLVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRERFKE-------QEVQIY 110

Query: 161 I-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
             ++  A+E+LH   +  +++ DIK  N+LLD++    + DFGLSK    D ++ A    
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-- 165

Query: 220 SSSIGIKGTVGYVAP 234
                  GT+ Y+AP
Sbjct: 166 -----FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLT 106
           F    ++G G+YG VYKG   +   + A+KV+++           E   L+    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 107 KIITICSSIDSKGADFKA-LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
                    +  G D +  LV E+   GS+ D +  T       K + ++   IA     
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-------KGNTLKEEWIAYICRE 119

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
            +  L H  Q  ++H DIK  NVLL  +    + DFG+S
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 22/150 (14%)

Query: 72  MVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM 130
           ++VAVK++     K A   F+ E + L  ++  N+ +++ +C   D        ++ EYM
Sbjct: 47  LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL-----CMITEYM 101

Query: 131 ENGSLEDWL--HQTNDHLE-----------VFKLSLIQRVNIAIDVASAIEYLHHNCQPP 177
           ENG L  +L  H  +D  E           +  +S    +++A+ +AS ++YL       
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLN 158

Query: 178 MVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
            VH D+   N L+  ++   + DFG+S+ L
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 21/184 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G+G +G V    +     + A K +N   LK++  +   + E   L  +  R    I++
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF---IVS 57

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +  +  +K  D   LV   M  G L    H  N   E       +       + S +E+L
Sbjct: 58  LAYAFQTK-TDL-CLVMTIMNGGDLR--YHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H   Q  +++ D+KP NVLLDND    + D GL+  L     D  S+T     G  GT G
Sbjct: 114 H---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL----KDGQSKTK----GYAGTPG 162

Query: 231 YVAP 234
           ++AP
Sbjct: 163 FMAP 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 15/157 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V           VAVK ++L+++        E   +R+  H N+  +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN--- 86

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  D   +V E++E G+L D +  T  + E       Q   + + V  A+ YLH+ 
Sbjct: 87  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 137

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               ++H DIK  ++LL +D    + DFG    +S +
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 47.0 bits (111), Expect = 2e-06
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 26/189 (13%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS---FVAECEA--LRNIRHRNLTK 107
           ++GQG++G VY     +    +AVK +    +    S      ECE   L+N+ H    +
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE---R 65

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN--IAIDVAS 165
           I+     +        ++  E+M  GS++D L            +L + V       +  
Sbjct: 66  IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--------ALTENVTRKYTRQILE 117

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
            + YLH N    +VH DIK +N+L D+     +GDFG SK      L T   + +    +
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK-----RLQTICLSGTGMKSV 169

Query: 226 KGTVGYVAP 234
            GT  +++P
Sbjct: 170 TGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 17/146 (11%)

Query: 74  VAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMEN 132
           VAVKV+       A   F+ E + L  +   N+ +++ +C+           ++ EYMEN
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL-----CMIMEYMEN 103

Query: 133 GSLEDWLHQ----TNDHLEVFK-LSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPS 186
           G L  +L +    T+      K LS    + +A  +AS + YL   N     VH D+   
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATR 159

Query: 187 NVLLDNDMVAHVGDFGLSKFL-SSDH 211
           N L+  +    + DFG+S+ L SSD+
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDY 185

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 19/189 (10%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F   +++G+G +G V          + A+KV+      A +  V+  E  R+I   + +
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA-QETVSFFEEERDILSISNS 60

Query: 107 K-IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
             I  +  +   K  D   LV EY   G   D L   N + + F   + Q       +A 
Sbjct: 61  PWIPQLQYAFQDK--DNLYLVMEYQPGG---DLLSLLNRYEDQFDEDMAQ-----FYLAE 110

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
            +  +H   Q   VH DIKP NVL+D      + DFG +  L+++ +   S+ P      
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPV----- 164

Query: 226 KGTVGYVAP 234
            GT  Y+AP
Sbjct: 165 -GTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 19/161 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G+G  G V+   L     + A+KV++ K   ++   +  + E E L  + H     + T
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH---PFLPT 65

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           + +S  +    +  LV +Y   G L   L +           + +    A +V  A+EYL
Sbjct: 66  LYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGK--CLSEEVARF--YAAEVLLALEYL 119

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSS 209
           H      +V+ D+KP N+LL      H+   DF LSK    
Sbjct: 120 HLL---GIVYRDLKPENILLHES--GHIMLSDFDLSKQSDV 155

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 15/157 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N+ ++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 84

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  D   +V E++E G+L D +  T  + E       Q   + + V  A+  LH  
Sbjct: 85  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLKALSVLHAQ 135

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               ++H DIK  ++LL +D    + DFG    +S +
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 44/215 (20%)

Query: 47  EFSQSNM-----IGQGSYGSVYKG-ILGEDE------MVVAVKVINLKQKGA---FRSFV 91
           E S++ +     +G+G +G V     +G D+      + VAVK+  LK           V
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLV 65

Query: 92  AECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTND------ 144
           +E E ++ I +H+N+  ++  C+    +      LV EY   G+L ++L           
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYS 120

Query: 145 ----HLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVG 199
                L   +L+    V+ A  VA  +EYL    C    +H D+   NVL+  D V  + 
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIA 176

Query: 200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           DFGL++     ++D   +T +  + +K    ++AP
Sbjct: 177 DFGLAR--DVHNIDYYKKTTNGRLPVK----WMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 39/149 (26%), Positives = 75/149 (50%), Gaps = 29/149 (19%)

Query: 54  IGQGSYGSVYKGIL-----------GEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIR 101
           +GQG++ ++YKG+L           G++  VV +KV  L        +F      +  + 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVV-LKV--LGSDHRDSLAFFETASLMSQLS 59

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H++L K+  +C        D   +V EY++ G L+ +LH+  ++     +SL  ++++A 
Sbjct: 60  HKHLVKLYGVCV------RDENIMVEEYVKFGPLDVFLHREKNN-----VSLHWKLDVAK 108

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
            +ASA+ YL       +VHG++   N+L+
Sbjct: 109 QLASALHYLEDK---KLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 27/193 (13%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 103
           +F    +IG+G++G V    L   + V A+K++N   + ++     F  E + L N  ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL--EVFKLSLIQRVNIAI 161
            +T   T+  +   +   +  LV +Y   G L   L +  D L  ++ +  L + V IAI
Sbjct: 62  WIT---TLHYAFQDENNLY--LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAI 115

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
           D   ++  LH+      VH DIKP N+L+D +    + DFG    L  D       T  S
Sbjct: 116 D---SVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG------TVQS 160

Query: 222 SIGIKGTVGYVAP 234
           S+ + GT  Y++P
Sbjct: 161 SVAV-GTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 46.6 bits (110), Expect = 4e-06
 Identities = 49/188 (26%), Positives = 92/188 (48%), Gaps = 22/188 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V K       +++A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 63

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 64  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKRIPE----EILGKVSIA--VLRG 115

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           + YL    Q  ++H D+KPSN+L+++     + DFG+S  L    +D+ + +        
Sbjct: 116 LAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS------FV 163

Query: 227 GTVGYVAP 234
           GT  Y++P
Sbjct: 164 GTRSYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 15/157 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V           VAVK+++L+++        E   +R+ +H+N+ ++    S
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK--S 86

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
            +   G +   L+ E+++ G+L D + QT       +L+  Q   +   V  A+ YLH  
Sbjct: 87  YL--VGEELWVLM-EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ 136

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               ++H DIK  ++LL  D    + DFG    +S D
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 42/158 (26%), Positives = 81/158 (51%), Gaps = 12/158 (7%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V+K       +++A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 63

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 64  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 115

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 116 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 151

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 45.6 bits (108), Expect = 7e-06
 Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 21/164 (12%)

Query: 54  IGQGSYGSVYK-GILGEDEMVVAVKVINLKQ----KGA------FRSFVAECEALR-NIR 101
           +G G++G VYK       + ++A+K IN+      K            V+E   ++  +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+ +             D   +V + +E   L +  +   +  + F    I   NI +
Sbjct: 68  HPNIVRYYKTFLE-----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW--NIFV 120

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            +  A+ YLH   +  +VH D+ P+N++L  D    + DFGL+K
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 45.5 bits (108), Expect = 7e-06
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 16/158 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITIC- 112
           +G+G+YG V K        ++AVK I        R+ V   E  R +   +++     C 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI--------RATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 113 SSIDSKGADFK-ALVFEYME--NGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            ++   GA F+   V+  ME  + SL+ +  +  D        ++ +  IA+ +  A+EY
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEY 118

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
           LH      ++H D+KPSNVL++ +    + DFG+S +L
Sbjct: 119 LHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL 154

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.4 bits (108), Expect = 8e-06
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 19/160 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+G++G+V K +      ++AVK I        RS V E E  R +   ++    + C 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI--------RSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 114 SI-DSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEV-FKLSLIQRVNIAIDVASAI 167
            I    GA F+     +  E M+  SL+ +     + L+      ++ ++ +A     A+
Sbjct: 64  YIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVA--TVKAL 120

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
            YL    +  ++H D+KPSN+LLD +    + DFG+S  L
Sbjct: 121 NYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 19/189 (10%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F    +IG+G++G V    +   E + A+K++N K +   R+  A     RN+      
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGDC 60

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVAS 165
           + IT       +  ++  LV +Y   G L   L +  D L E      I  + +AI    
Sbjct: 61  QWITTLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH--- 116

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           +I  LH+      VH DIKP NVLLD +    + DFG    ++ D       T  SS+ +
Sbjct: 117 SIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG------TVQSSVAV 164

Query: 226 KGTVGYVAP 234
            GT  Y++P
Sbjct: 165 -GTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 9e-06
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 31/195 (15%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 103
           +F    +IG+G++G V    +     V A+K++N   + ++     F  E + L N   R
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL--EVFKLSLIQRVNIAI 161
            +T +         +  +   LV +Y   G L   L +  D L  ++ +  L + V +AI
Sbjct: 62  WITNL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-LAI 115

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETP 219
           D    + Y         VH DIKP NVLL  D   H+   DFG    L +D       T 
Sbjct: 116 DSVHQLGY---------VHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADG------TV 158

Query: 220 SSSIGIKGTVGYVAP 234
            S++ + GT  Y++P
Sbjct: 159 QSNVAV-GTPDYISP 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 43/172 (25%), Positives = 67/172 (38%), Gaps = 30/172 (17%)

Query: 74  VAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS--KGADFKAL 125
           VA+K++         Q+  FR   A C  L    H N+  ++      DS          
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVALL------DSGEAPPGLLFA 56

Query: 126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP 185
           VFEY+   +L + L    D      L   +   + + V  A+   H+     +VH D+KP
Sbjct: 57  VFEYVPGRTLREVL--AADGA----LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKP 107

Query: 186 SNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            N+++        A V DFG+   L     D    T + +  + GT  Y AP
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVR-DADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 37/192 (19%)

Query: 53  MIGQGSYGSVY--KGILGEDE-MVVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLT 106
           ++GQGS+G V+  + I G D   + A+KV+    LK +   R+ + E + L  + H    
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNH---P 58

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ----TNDHLEVFKLSLIQRVNIAID 162
            I+ +  +  ++G  +  L+ +++  G L   L +    T + ++ +   L         
Sbjct: 59  FIVKLHYAFQTEGKLY--LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL--------- 107

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
            A A+++LH      +++ D+KP N+LLD +    + DFGLSK    + +D   +  S  
Sbjct: 108 -ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYS-- 157

Query: 223 IGIKGTVGYVAP 234
               GTV Y+AP
Sbjct: 158 --FCGTVEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 44.4 bits (105), Expect = 2e-05
 Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 33/191 (17%)

Query: 53  MIGQGSYGSVY--KGILGED-EMVVAVKVINLKQKGAFRSF--VAECEALRNIRHRNLTK 107
           ++G+G YG V+  + + G D   + A+KV  LK+    R+    A  +A RNI      K
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEA--VK 58

Query: 108 IITICSSIDSKGADFKA-LVFEYMENGSLEDWLHQTNDHLE---VFKLSLIQRVNIAIDV 163
              I   I +     K  L+ EY+  G L   L +    +E    F LS         ++
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS---------EI 109

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
           + A+E+LH      +++ D+KP N+LLD      + DFGL K   S H  T + T     
Sbjct: 110 SLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHT----- 159

Query: 224 GIKGTVGYVAP 234
              GT+ Y+AP
Sbjct: 160 -FCGTIEYMAP 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 32/198 (16%)

Query: 29  MEKQFPMVSYAELSKATCE-FSQSNMIGQGSYG---SVYKGILGEDEMVVAVKVI----- 79
            + QF  V  A+ +    + + Q   IG G+ G   + +  +LG   + VAVK +     
Sbjct: 3   EDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLG---INVAVKKLSRPFQ 59

Query: 80  -NLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA--LVFEYMENGSLE 136
                K A+R  V     L+ + H+N+  ++ + +   S   +F+   LV E M+  +L 
Sbjct: 60  NQTHAKRAYRELVL----LKCVNHKNIISLLNVFTPQKSL-EEFQDVYLVMELMD-ANLC 113

Query: 137 DWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVA 196
             +H   DH E     L Q       +   I++LH      ++H D+KPSN+++ +D   
Sbjct: 114 QVIHMELDH-ERMSYLLYQ-------MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 162

Query: 197 HVGDFGLSKFLSSDHLDT 214
            + DFGL++   ++ + T
Sbjct: 163 KILDFGLARTACTNFMMT 180

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 44.1 bits (104), Expect = 2e-05
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 26/164 (15%)

Query: 54  IGQGSYGSVYKGIL---GEDEMVVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNL 105
           IG+GS+G   K IL    ED     +K IN+     K++   R    E   L N++H N 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPN- 60

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
             I+    S +  G  +  +V +Y E G L   ++     L        Q ++  + +  
Sbjct: 61  --IVQYQESFEENGNLY--IVMDYCEGGDLYKKINAQRGVL----FPEDQILDWFVQICL 112

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           A++++H      ++H DIK  N+ L  D    +GDFG+++ L+S
Sbjct: 113 ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 36/171 (21%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN------LKQKGAFRSFVAECEALRNIRHRN--- 104
           +G G+YG V      +    VA+K ++      +  K  +R    E   L+++ H N   
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHENVIG 78

Query: 105 LTKIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ---TNDHLEVFKLSLIQRVNI 159
           L  + T  SS++    DF+   LV   M    L + +     ++DH++ F +  I R   
Sbjct: 79  LLDVFTPASSLE----DFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQ-FLVYQILR--- 129

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
                  ++Y+H      ++H D+KPSN+ ++ D    + DFGL++    +
Sbjct: 130 ------GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 25/160 (15%)

Query: 53  MIGQGSYGSVYKGILGEDE---MVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++G+G++G V   IL  ++      A+K++    +  K      V E   L+N RH  LT
Sbjct: 2   LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVAS 165
            +         +  D    V EY   G L  + H + +   VF     +R      ++ S
Sbjct: 59  AL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFTE---ERARFYGAEIVS 106

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           A+EYLH      +V+ DIK  N++LD D    + DFGL K
Sbjct: 107 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 25/67 (37%), Positives = 36/67 (53%), Gaps = 10/67 (14%)

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG--IKG 227
           +HH     M+H DIK +N+LL ++ +  +GDFG SK  ++        T S  +G    G
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA--------TVSDDVGRTFCG 207

Query: 228 TVGYVAP 234
           T  YVAP
Sbjct: 208 TPYYVAP 214

Length = 496

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 44.0 bits (104), Expect = 3e-05
 Identities = 48/198 (24%), Positives = 78/198 (39%), Gaps = 42/198 (21%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVK------VINLKQKGAFRSFVAECEALRNI 100
           +F     +G GS+G V            A+K      ++ +KQ    +    E   L  +
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ---VQHVAQEKSILMEL 75

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQT----NDHLEVFKLSLIQR 156
            H  +  ++  CS  D     F   + E++  G L   L +     ND  + +   L+  
Sbjct: 76  SHPFIVNMM--CSFQDENRVYF---LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL- 129

Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
                    A EYLH +    +++ D+KP N+LLDN     V DFG +K           
Sbjct: 130 ---------AFEYLH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----------- 166

Query: 217 ETPSSSIGIKGTVGYVAP 234
           + P  +  + GT  Y+AP
Sbjct: 167 KVPDRTFTLCGTPEYLAP 184

Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 43.8 bits (103), Expect = 3e-05
 Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 29/196 (14%)

Query: 47  EFSQSNMIGQGSYGSVY--KGILGEDE-----MVVAVKVINLKQKGAFRSFVAECEALRN 99
            F    ++G G+YG V+  + + G D      M V  K   +++         E   L +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 100 IRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           +R       +      ++K      L+ +Y+  G +   L+Q  D+   F    + R   
Sbjct: 61  VRQSPFLVTLHYAFQTEAK----LHLILDYVSGGEMFTHLYQ-RDN---FSEDEV-RFYS 111

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDTASET 218
             ++  A+E+LH   +  +V+ DIK  N+LLD++    + DFGLSK FLS +   T S  
Sbjct: 112 G-EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-- 165

Query: 219 PSSSIGIKGTVGYVAP 234
                   GT+ Y+AP
Sbjct: 166 ------FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.4 bits (103), Expect = 4e-05
 Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 29/158 (18%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-------HRNLT 106
           IG+G++  V K    +     A+K      K  F+S + +   LR I+       H N  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKS-LEQVNNLREIQALRRLSPHPN-- 59

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL--EVFKLSLIQRVNIAIDVA 164
            I+ +   +  +     ALVFE M+  +L + +      L  +  K  + Q +       
Sbjct: 60  -ILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLL------- 110

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG 202
            +++++H N    + H DIKP N+L+ +D++  + DFG
Sbjct: 111 KSLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 43/168 (25%)

Query: 54  IGQGSYGSVY---KGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTK 107
           +GQG YG V+   K   GE   +VA+K +    L +    R  + E + L   +   L K
Sbjct: 9   VGQGGYGQVFLAKKKDTGE---IVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65

Query: 108 IITICSSIDSK----------GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
           ++   +  D +          G DF+ L+      G L +      DH   +        
Sbjct: 66  LLY--AFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSE------DHARFY-------- 106

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
               ++  A++ LH   +   +H D+KP N L+D      + DFGLSK
Sbjct: 107 --MAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.2 bits (102), Expect = 5e-05
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 21/164 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F    +I  G+YG+VY     E     A+K IN KQ    R+ + +    R+I    LT
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-KQNLILRNQIQQVFVERDI----LT 56

Query: 107 K-----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
                 ++++  S ++K      +V EY+E G     L     ++    + +  R+  A 
Sbjct: 57  FAENPFVVSMFCSFETK--RHLCMVMEYVEGGDCATLL----KNIGALPVDMA-RMYFAE 109

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            V  A+EYLH+     +VH D+KP N+L+ +     + DFGLSK
Sbjct: 110 TVL-ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 43.1 bits (101), Expect = 5e-05
 Identities = 45/190 (23%), Positives = 83/190 (43%), Gaps = 24/190 (12%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRN 104
           F Q  ++G+G +G V    +     + A K +    +K++      + E + L  +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
              ++++  + ++K  D   LV   M  G L+  ++    H+        + V  A ++ 
Sbjct: 62  ---VVSLAYAYETK--DALCLVLTLMNGGDLKFHIY----HMGEAGFEEGRAVFYAAEIC 112

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
             +E LH   Q  +V+ D+KP N+LLD+     + D GL+  +             +  G
Sbjct: 113 CGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---------TIKG 160

Query: 225 IKGTVGYVAP 234
             GTVGY+AP
Sbjct: 161 RVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.0 bits (101), Expect = 5e-05
 Identities = 36/152 (23%), Positives = 72/152 (47%), Gaps = 25/152 (16%)

Query: 54  IGQGSYGSVYKGILG------------EDEMVVAVKVINLKQKGAFRSFVAECEALRNIR 101
           +G+G+   +Y GIL             E E+ V +KV++   +    +F      +R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H+++  +  +C   D +      +V E++E G L+ ++H+ +D      L+   +  +A 
Sbjct: 63  HKHIVLLYGVCVR-DVE----NIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAK 112

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDND 193
            +ASA+ YL       +VHG++   N+LL  +
Sbjct: 113 QLASALSYLEDK---DLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.1 bits (101), Expect = 5e-05
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 50/218 (22%)

Query: 47  EFSQSNM-----IGQGSYGSVYKG-ILGEDE------MVVAVKVI--NLKQKGAFRSFVA 92
           EFS+  +     +G+G +G V     LG D+      + VAVK++  +  +K      V+
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVS 69

Query: 93  ECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH----------- 140
           E E ++ I +H+N+  ++  C+    +      +V EY   G+L ++L            
Sbjct: 70  EMEMMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSY 124

Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVA 196
              +  D    FK      V+    VA  +EYL    C    +H D+   NVL+  + V 
Sbjct: 125 DIARVPDEQMTFK----DLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVM 176

Query: 197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            + DFGL++    +++D   +T +  + +K    ++AP
Sbjct: 177 KIADFGLAR--DVNNIDYYKKTTNGRLPVK----WMAP 208

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.0 bits (101), Expect = 5e-05
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 20/174 (11%)

Query: 54  IGQGSYGSVY-----KGILGEDEMVVA-VKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           +G+GS+G+VY     K +  E   V+  + V  L      ++   E + L  + H     
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLSKLDH---PA 63

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           I+   +S   +  D   ++ EY E   L+  L +     +   LS  Q     I +   +
Sbjct: 64  IVKFHASFLER--DAFCIITEYCEGRDLDCKLEELKHTGK--TLSENQVCEWFIQLLLGV 119

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL--SSDHLDTASETP 219
            Y+H   Q  ++H D+K  N+ L N+++  +GDFG+S+ L  S D   T + TP
Sbjct: 120 HYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFTGTP 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.5 bits (100), Expect = 7e-05
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 13/161 (8%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRN-LTKIIT 110
           IG+G+YG VYK        +VA+K   L+  ++G   + + E   L+ +     + +++ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWL--HQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           +    +  G     LVFEY+++  L+ ++  +       +     I+  +    +   + 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPA-KTIK--SFMYQLLKGVA 124

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDND-MVAHVGDFGLSKFLS 208
           + H +    ++H D+KP N+L+D    +  + D GL +  S
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 11/76 (14%)

Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASET 218
           + + +  A+ YL       ++H D+KPSN+LLD      + DFG+S  L    +D+ ++T
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL----VDSKAKT 172

Query: 219 PSSSIGIKGTVGYVAP 234
            S      G   Y+AP
Sbjct: 173 RS-----AGCAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 9/78 (11%)

Query: 126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP 185
           V +Y+  G +   L +    L +F+  L  R  IA ++  AIE +H   +   +H DIKP
Sbjct: 79  VMDYIPGGDMMSLLIR----LGIFEEDL-ARFYIA-ELTCAIESVH---KMGFIHRDIKP 129

Query: 186 SNVLLDNDMVAHVGDFGL 203
            N+L+D D    + DFGL
Sbjct: 130 DNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.9 bits (96), Expect = 1e-04
 Identities = 31/143 (21%), Positives = 66/143 (46%), Gaps = 22/143 (15%)

Query: 66  ILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT--KIITICSSIDSKGADFK 123
           +LG  +    +K+   ++KGA R    E   L+ +  + L   K++      +S G  + 
Sbjct: 16  LLGTKDEDYVLKINPSREKGADR--EREVAILQLLARKGLPVPKVLASG---ESDGWSY- 69

Query: 124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDI 183
            L+ E++E  +L+             ++S  ++ +IA  +A  +  LH      + HGD+
Sbjct: 70  -LLMEWIEGETLD-------------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDL 115

Query: 184 KPSNVLLDNDMVAHVGDFGLSKF 206
            P N+L+D+  +  + D+  + +
Sbjct: 116 HPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.0 bits (98), Expect = 1e-04
 Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 52/190 (27%)

Query: 40  ELSKATCEFSQS----NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFV---- 91
           EL+K   E  +       +G G+YGSV           VAVK    K    F+S +    
Sbjct: 5   ELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARR 60

Query: 92  --AECEALRNIRHRN---LTKIITICSSIDS----------KGADFKALV-FEYMENGSL 135
              E   L++++H N   L  + T  +SI++           GAD   +V  + +     
Sbjct: 61  TYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKL----- 115

Query: 136 EDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
                 +++H++     L++           ++Y+H      ++H D+KPSNV ++ D  
Sbjct: 116 ------SDEHVQFLIYQLLR----------GLKYIH---SAGIIHRDLKPSNVAVNEDCE 156

Query: 196 AHVGDFGLSK 205
             + DFGL++
Sbjct: 157 LRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 42.0 bits (98), Expect = 1e-04
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 17/156 (10%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKII 109
           ++G+G++G V            A+K++    +  K      + E   L+N RH  LT   
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT--- 58

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
           ++  S  +K  D    V EY+  G L  + H + + +     S  +      ++ SA++Y
Sbjct: 59  SLKYSFQTK--DRLCFVMEYVNGGEL--FFHLSRERV----FSEDRTRFYGAEIVSALDY 110

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           LH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 111 LHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 36/166 (21%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI------RHRNLTK 107
           IG G++G V+      D   VA+K    K    F++ V+     R +      +H N+  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALK----KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQ--------TNDHLEVFKLSLIQRVNI 159
            + I         +   +V E M++      LH+        ++DH++VF L  I R   
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQSD-----LHKIIVSPQPLSSDHVKVF-LYQILR--- 114

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
                  ++YLH      ++H DIKP N+L++++ V  + DFGL++
Sbjct: 115 ------GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.0 bits (98), Expect = 1e-04
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 30/171 (17%)

Query: 54  IGQGSYGSVYKGIL--GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITI 111
           +G+G+YG VYK     G+DE   A+K I  +  G   S   E   LR ++H N+  +  +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 112 CSSIDSKGADFKA-LVFEYMENGSLEDWLH--------QTNDHLEVFKLSLIQRVNIAID 162
             S     +D K  L+F+Y E+    D  H        + N        S+++  ++   
Sbjct: 67  FLS----HSDRKVWLLFDYAEH----DLWHIIKFHRASKANKKPMQLPRSMVK--SLLYQ 116

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV----AHVGDFGLSKFLSS 209
           +   I YLH N    ++H D+KP+N+L+  +        + D G ++  +S
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 18/47 (38%), Positives = 24/47 (51%), Gaps = 3/47 (6%)

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
           AI+ +H   +   +H DIKP N+LLD      + DFGL   L   H 
Sbjct: 113 AIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 38/206 (18%)

Query: 53  MIGQGSYGSVYKGILGEDEMV---VAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLT 106
           +IG+G  G VY   L  D +    VA+K I  +L +    +  F+ E +   ++ H  + 
Sbjct: 9   LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 107 KIITICSSIDS--------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN 158
            + +ICS  D         +G   K+L+    +  SL   L +        K S+   ++
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE--------KTSVGAFLS 117

Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS-- 216
           I   + + IEY+H      ++H D+KP N+LL       + D+G + F   +  D     
Sbjct: 118 IFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 217 ----ETPSSSIGIK----GTVGYVAP 234
                   SS+ I     GT  Y+AP
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAP 200

Length = 932

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 45/189 (23%), Positives = 84/189 (44%), Gaps = 32/189 (16%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIIT-- 110
           +IG+G +G VY     +   + A+K ++ K     R  + + E L  +  R +  +++  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54

Query: 111 -----ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
                +C +      D    + + M  G L   L Q      VF    ++    A ++  
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----VFSEKEMRFY--ATEIIL 108

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
            +E++H+     +V+ D+KP+N+LLD      + D GL+        D + + P +S+  
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV-- 156

Query: 226 KGTVGYVAP 234
            GT GY+AP
Sbjct: 157 -GTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 28/192 (14%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRN 104
           F Q  ++G+G +G V    +     + A K +    +K++      + E + L  +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
              ++ +  + ++K  D   LV   M  G L+   H  N     F+      +  A ++ 
Sbjct: 62  ---VVNLAYAYETK--DALCLVLTIMNGGDLK--FHIYNMGNPGFEEERA--LFYAAEIL 112

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI- 223
             +E LH   +   V+ D+KP N+LLD+     + D GL           A + P     
Sbjct: 113 CGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGL-----------AVKIPEGESI 158

Query: 224 -GIKGTVGYVAP 234
            G  GTVGY+AP
Sbjct: 159 RGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 38/161 (23%), Positives = 74/161 (45%), Gaps = 26/161 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFV------AECEALRNIRHRNLTK 107
           +G G+YGSV      +  + VAVK    K    F+S +       E   L++++H N+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLH---QTNDHLEVFKLSLIQRVNIAIDVA 164
           ++ + +   S        +  ++    L + +     T+DH++ F +  I R        
Sbjct: 81  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ-FLIYQILR-------- 131

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             ++Y+H      ++H D+KPSN+ ++ D    + DFGL++
Sbjct: 132 -GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 24/119 (20%), Positives = 44/119 (36%), Gaps = 23/119 (19%)

Query: 115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH--- 171
           +      F    FE        +W       L   +L L++  ++   + +A++ L    
Sbjct: 134 LHLALRGFP---FERPNALRRLEWDILEPRAL--LRLDLVEPEDLRAALLAALDRLLARL 188

Query: 172 ----HNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFG----------LSKFLSSDHLDTA 215
                     ++HGD+ P NVL D +  V+   DF           L+  L++ + D A
Sbjct: 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGYGWFIYDLAIALNAWNGDEA 247

Length = 331

>gnl|CDD|225714 COG3173, COG3173, Predicted aminoglycoside phosphotransferase [General function prediction only]

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 24/99 (24%), Positives = 37/99 (37%), Gaps = 15/99 (15%)

Query: 114 SIDS-KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           SID+    D             L  W  +        K  L  R+ +A      I++L  
Sbjct: 139 SIDAAGLPDPGKPNAY--RGRQLARWDDE----YRRAKKELGGRIPLA---DRLIKWLEA 189

Query: 173 NC-----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF 206
           N       P +VHGD +P N+++D      V D+ L+  
Sbjct: 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228

Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 20/173 (11%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKII 109
           +IG+GS+G V       D    AVKV+  K    +   +  +AE    RN+  +N+    
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAE----RNVLLKNVKHPF 57

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVASAIE 168
            +      +  +    V +++  G L   L +     E        R    A ++ASA+ 
Sbjct: 58  LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE-------PRARFYAAEIASALG 110

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK--FLSSDHLDTASETP 219
           YLH      +V+ D+KP N+LLD+     + DFGL K     SD   T   TP
Sbjct: 111 YLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 3e-04
 Identities = 29/84 (34%), Positives = 41/84 (48%), Gaps = 9/84 (10%)

Query: 151 LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           L L Q   +A  + SAI+Y+H   +  ++H DIK  NVL++      +GDFG + F    
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDICLGDFGAACFAR-- 311

Query: 211 HLDTASETPSSSIGIKGTVGYVAP 234
                S +     GI GTV   AP
Sbjct: 312 ----GSWSTPFHYGIAGTVDTNAP 331

Length = 461

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 40.6 bits (95), Expect = 3e-04
 Identities = 43/166 (25%), Positives = 74/166 (44%), Gaps = 36/166 (21%)

Query: 53  MIGQGSYGSVYKGIL-GEDEMVVAVKVINLKQKGAFRSFVAECEAL-RNI-----RHRNL 105
           ++G+GS+G V    L G DE V A+KV  LK+    +    +C    + I     +H  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDE-VYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFL 58

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN------I 159
           T    +     +K   F   V EY+  G L            +F++   ++ +       
Sbjct: 59  T---ALHCCFQTKDRLF--FVMEYVNGGDL------------MFQIQRSRKFDEPRSRFY 101

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           A +V  A+ +LH +    +++ D+K  N+LLD +    + DFG+ K
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 40.2 bits (94), Expect = 4e-04
 Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 43/191 (22%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF-RSFVAECEALRNIRHRNLTKIIT 110
            ++G G+ G+VYK        ++AVKVI L       +  ++E E            I+ 
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE------------ILY 54

Query: 111 ICSS---IDSKGADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            C S   I   GA F     ++  E+M+ GSL D   +  +H+       + R  IA+ V
Sbjct: 55  KCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIPEHV-------LGR--IAVAV 104

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
              + YL       ++H D+KPSN+L++      + DFG+S  L +          S + 
Sbjct: 105 VKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----------SIAK 151

Query: 224 GIKGTVGYVAP 234
              GT  Y+AP
Sbjct: 152 TYVGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 26/169 (15%)

Query: 54  IGQGSYGSVYKGIL--GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITI 111
           +G+G+YG VYK     G+D+   A+K I  +  G   S   E   LR ++H N+  +  +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 112 CSSIDSKGADFKA-LVFEYMENGSLEDWLHQTNDHL------EVFKLSLIQRVNIAIDVA 164
             S     AD K  L+F+Y E+    D  H    H       +  +L      ++   + 
Sbjct: 67  FLS----HADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV----AHVGDFGLSKFLSS 209
             I YLH N    ++H D+KP+N+L+  +        + D G ++  +S
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 40.5 bits (95), Expect = 4e-04
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 40/175 (22%)

Query: 54  IGQGSYGSV--YKGILGEDEMVVAVKVIN------LKQKGAFRSFVAECEALRNIR-HRN 104
           +GQG+YG V   +     +E  VA+K I       +  K A R    E + LR+ R H+N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ--------TNDHLEVFKLSLIQR 156
           +T +  +   +     +   L  E ME       LHQ        T+ H + F   ++  
Sbjct: 64  ITCLYDM-DIVFPGNFNELYLYEELMEAD-----LHQIIRSGQPLTDAHFQSFIYQIL-- 115

Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
                     ++Y+H      ++H D+KP N+L++ D    + DFGL++  S + 
Sbjct: 116 --------CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 39/156 (25%), Positives = 62/156 (39%), Gaps = 22/156 (14%)

Query: 61  SVYKGILGEDEMVVAVKVINLKQKGA---FRSFVAECEALRNIRHRNLTKI----ITICS 113
           S+YKGI    E  V ++      KG          E + LR I   N+ KI    I I  
Sbjct: 35  SIYKGIFNNKE--VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
            +        +L+ EY   G L + L +  D      LS   ++++AID    +  L+  
Sbjct: 93  DLPRL-----SLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKGLYNLYKY 141

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
              P  + ++   + L+  +    +   GL K LSS
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSS 175

Length = 283

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 40.3 bits (94), Expect = 4e-04
 Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 32/189 (16%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIIT-- 110
           +IG+G +G VY     +   + A+K ++ K     R  + + E L  +  R +  +++  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54

Query: 111 -----ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
                +C S      D  + + + M  G L   L Q      VF  S  +    A ++  
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VF--SEAEMRFYAAEIIL 108

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
            +E++H+     +V+ D+KP+N+LLD      + D GL+        D + + P +S+  
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV-- 156

Query: 226 KGTVGYVAP 234
            GT GY+AP
Sbjct: 157 -GTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 39.7 bits (93), Expect = 6e-04
 Identities = 28/80 (35%), Positives = 39/80 (48%), Gaps = 10/80 (12%)

Query: 126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP 185
           V EY   G L   +H      +VF  S  + V  A  V   ++YLH N    +V+ D+K 
Sbjct: 80  VMEYAAGGDLMMHIHT-----DVF--SEPRAVFYAACVVLGLQYLHEN---KIVYRDLKL 129

Query: 186 SNVLLDNDMVAHVGDFGLSK 205
            N+LLD +    + DFGL K
Sbjct: 130 DNLLLDTEGFVKIADFGLCK 149

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.9 bits (94), Expect = 6e-04
 Identities = 39/174 (22%), Positives = 69/174 (39%), Gaps = 41/174 (23%)

Query: 50  QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAEC-EALRNIRHRNLTKI 108
             ++IG+G+   + KG     + V+  +V        +R    E  E LR  R R   ++
Sbjct: 337 PDHLIGKGAEADIKKGEYLGRDAVIKERV-----PKGYR--HPELDERLRTERTRAEARL 389

Query: 109 ITIC----------SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN 158
           ++              +D +    K +V EY+    L+D L    + +            
Sbjct: 390 LSEARRAGVPTPVIYDVDPEE---KTIVMEYIGGKDLKDVLEGNPELVR----------- 435

Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
               V   +  LH      +VHGD+  SN ++ +D +  + DFGL K+  SD +
Sbjct: 436 ---KVGEIVAKLHKA---GIVHGDLTTSNFIVRDDRLYLI-DFGLGKY--SDLI 480

Length = 535

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.0 bits (93), Expect = 7e-04
 Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 23/178 (12%)

Query: 46  CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 105
             F +   +G G++G V      + + + A+K +  K+    R+ VA  +A R+I     
Sbjct: 1   SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR-KKDVLLRNQVAHVKAERDILAEAD 59

Query: 106 TK-IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            + ++ +  S   K  D    V +Y+  G +   L +    + +F   L  R  IA ++ 
Sbjct: 60  NEWVVRLYYSFQDK--DNLYFVMDYIPGGDMMSLLIR----MGIFPEDL-ARFYIA-ELT 111

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL---------SKFLSS-DHL 212
            A+E +H   +   +H DIKP N+L+D D    + DFGL         SK+  S DH+
Sbjct: 112 CAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 39.6 bits (92), Expect = 8e-04
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 22/159 (13%)

Query: 53  MIGQGSYGSVYKGILGEDEMV---VAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++G+G++G V   IL +++      A+K++    +  K      + E   L+N RH  LT
Sbjct: 2   LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            +         +  D    V EY   G L  + H + + +     S  +      ++ SA
Sbjct: 59  AL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAEIVSA 107

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           ++YLH   +  +V+ D+K  N++LD D    + DFGL K
Sbjct: 108 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 39.7 bits (93), Expect = 8e-04
 Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 24/160 (15%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECE-------ALRNIRHRNL 105
           ++G+GS+G V    L   + + AVKV  LK+    +    EC        AL   +H  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
           T++    S   +K   F   V EY+  G L   + +       F     +    A ++  
Sbjct: 59  TQLH---SCFQTKDRLF--FVMEYVNGGDLMFHIQR----SGRFDEP--RARFYAAEIVL 107

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            +++LH   +  +++ D+K  NVLLD++    + DFG+ K
Sbjct: 108 GLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.5 bits (92), Expect = 8e-04
 Identities = 16/50 (32%), Positives = 31/50 (62%), Gaps = 3/50 (6%)

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
           NI  D+ + +EY+H +    + HGDIKP N+++D +   ++ D+G++   
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHF 176

Length = 294

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 39.1 bits (92), Expect = 8e-04
 Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 12/83 (14%)

Query: 125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH-HNCQPPMVHGDI 183
           L+ +Y+++G L D L +    L   ++       I   +  A+  LH HN    ++H DI
Sbjct: 86  LIMDYIKDGDLFDLL-KKEGKLSEAEVK-----KIIRQLVEALNDLHKHN----IIHNDI 135

Query: 184 KPSNVLLDNDMV-AHVGDFGLSK 205
           K  NVL D      ++ D+GL K
Sbjct: 136 KLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 39.2 bits (91), Expect = 9e-04
 Identities = 38/158 (24%), Positives = 69/158 (43%), Gaps = 13/158 (8%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTKIITI 111
           ++G+GS+G          +   A+K I L K   A      E   L  ++H N   I+  
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN---IVAF 63

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             S ++ G  +  +V EY + G L   +      L  F    I  +   + +   ++++H
Sbjct: 64  KESFEADGHLY--IVMEYCDGGDLMQKIKLQRGKL--FPEDTI--LQWFVQMCLGVQHIH 117

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
              +  ++H DIK  N+ L  +    +GDFG ++ L+S
Sbjct: 118 ---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.1 bits (91), Expect = 0.001
 Identities = 35/161 (21%), Positives = 70/161 (43%), Gaps = 37/161 (22%)

Query: 54  IGQGSYGSVYKGIL-------GED-----------------EMVVAVKVINLKQKGAFRS 89
           +GQG+  ++Y G L        E+                 E+ V +KV++   +    +
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 90  FVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF 149
           F      +  + H +L  +  +C     +G++   +V E++E+G L+  L +    + V 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCV----RGSE-NIMVEEFVEHGPLDVCLRKEKGRVPV- 116

Query: 150 KLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
                 ++ +A  +ASA+ YL       +VHG++   N+LL
Sbjct: 117 ----AWKITVAQQLASALSYLEDK---NLVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 39.0 bits (91), Expect = 0.001
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 26/158 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G+ G V K +     +++A K+I+L+ K           A+RN   R L K++  C+
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIK----------PAIRNQIIREL-KVLHECN 57

Query: 114 S---IDSKGADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           S   +   GA +     ++  E+M+ GSL+  L +     E    +++ +++IA  V   
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----NILGKISIA--VLRG 111

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 147

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 38.7 bits (90), Expect = 0.001
 Identities = 42/195 (21%), Positives = 85/195 (43%), Gaps = 25/195 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL------KQKGAFRSFVAECEALRNI 100
           E+ +   +G G++ S Y+    +   ++AVK +        +Q+    +   E   +  +
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            H ++ +          + + F   V E+M  GS+   L +       FK ++I  +N  
Sbjct: 61  NHPHIIR----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYG----AFKEAVI--INYT 109

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND-MVAHVGDFGLSKFLSSDHLDTASETP 219
             +   + YLH N    ++H D+K +N+L+D+      + DFG +  L++     A E  
Sbjct: 110 EQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK-GTGAGEFQ 165

Query: 220 SSSIGIKGTVGYVAP 234
              +   GT+ ++AP
Sbjct: 166 GQLL---GTIAFMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 39.0 bits (91), Expect = 0.001
 Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 19/178 (10%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNL 105
           +F    +IG+G++G V        + V A+K+++ K +   RS  A     R+I  H N 
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERDIMAHANS 102

Query: 106 TKIITICSSI-DSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
             I+ +  +  D K   +  +V EYM  G L + L    D  E +       V +A+D  
Sbjct: 103 EWIVQLHYAFQDDK---YLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAI 158

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD---HLDTASETP 219
            ++ +         +H D+KP N+LLD      + DFG    + ++     DTA  TP
Sbjct: 159 HSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTP 207

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 38.8 bits (90), Expect = 0.001
 Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 22/159 (13%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRN------IRHRNLT 106
           M+G+GS+G V+   L       A+K   LK+         EC  +          H  LT
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            +     +  +K   F   V EY+  G L    H  + H    K  L +    A ++   
Sbjct: 60  HLYC---TFQTKENLF--FVMEYLNGGDL--MFHIQSCH----KFDLPRATFYAAEIICG 108

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +++LH      +V+ D+K  N+LLD D    + DFG+ K
Sbjct: 109 LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 47/192 (24%), Positives = 80/192 (41%), Gaps = 38/192 (19%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIR-HRNLTKI 108
           ++G+GS+G V    L E   + AVKV+    + Q       + E   L   R H  LT++
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN------IAID 162
                + D         V E++  G L            +F +   +R +       A +
Sbjct: 62  YCCFQTPDRL-----FFVMEFVNGGDL------------MFHIQKSRRFDEARARFYAAE 104

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           + SA+ +LH      +++ D+K  NVLLD++    + DFG+ K    +   T++      
Sbjct: 105 ITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST------ 155

Query: 223 IGIKGTVGYVAP 234
               GT  Y+AP
Sbjct: 156 --FCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 38.2 bits (89), Expect = 0.002
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 31/163 (19%)

Query: 54  IGQGSYGSV---YKGILGEDEMVVAVKVIN------LKQKGAFRSFVAECEALRNIRHRN 104
           IG G+ G V   Y  + G++   VA+K ++         K A+R  V     ++ + H+N
Sbjct: 24  IGSGAQGIVCAAYDTVTGQN---VAIKKLSRPFQNVTHAKRAYRELVL----MKLVNHKN 76

Query: 105 LTKIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
           +  ++    +      +F+   LV E M+  +L   +    DH E     L Q       
Sbjct: 77  IIGLLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDH-ERMSYLLYQ------- 126

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   I++LH      ++H D+KPSN+++ +D    + DFGL++
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 25/160 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLTK 107
           +G G+YGSV   I       VA+K ++      +  K A+R    E   L++++H N+  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVIG 78

Query: 108 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
           ++ + +S  S G +F+   LV  YM+       L +   H     LS  +   +   +  
Sbjct: 79  LLDVFTSAVS-GDEFQDFYLVMPYMQTD-----LQKIMGH----PLSEDKVQYLVYQMLC 128

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            ++Y+H      ++H D+KP N+ ++ D    + DFGL++
Sbjct: 129 GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 38.5 bits (89), Expect = 0.002
 Identities = 36/123 (29%), Positives = 56/123 (45%), Gaps = 19/123 (15%)

Query: 116 DSKGADFKALVFEYMENGSLEDWLHQT-NDHL--EVFKLSLIQRVNIAIDVASAIEYLHH 172
           D K  D   L+ EY   G L   + Q   +HL  + +++ L+        +  A++ +H 
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL-----FYQIVLALDEVHS 187

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDTASETPSSSIGIKGTVGY 231
                M+H D+K +N+ L    +  +GDFG SK +  S  LD AS          GT  Y
Sbjct: 188 RK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS-------FCGTPYY 237

Query: 232 VAP 234
           +AP
Sbjct: 238 LAP 240

Length = 478

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 38.0 bits (88), Expect = 0.002
 Identities = 45/184 (24%), Positives = 79/184 (42%), Gaps = 24/184 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G+G +G V    +     + A K ++   LK+K   +  + E E L  +   N   I+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +  + +SK      LV   M  G L+  ++    ++    L + + ++ +  +   I +L
Sbjct: 58  LAYAFESK--THLCLVMSLMNGGDLKYHIY----NVGERGLEMERVIHYSAQITCGILHL 111

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H      +V+ D+KP NVLLD+     + D GL+  L      T            GT G
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---------AGTNG 159

Query: 231 YVAP 234
           Y+AP
Sbjct: 160 YMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|240176 cd05155, APH_ChoK_like_1, Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

 Score = 37.7 bits (88), Expect = 0.003
 Identities = 16/50 (32%), Positives = 23/50 (46%), Gaps = 6/50 (12%)

Query: 161 IDVASAIEY----LHHNCQPP--MVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           IDV +A       L      P    HGD+ P N+L+ +  ++ V DFG  
Sbjct: 143 IDVDAARALWEAALRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCL 192

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 235

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 38.0 bits (88), Expect = 0.003
 Identities = 41/168 (24%), Positives = 76/168 (45%), Gaps = 30/168 (17%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVI------NLKQKGAFRSFVAECEALRNIRHRN--- 104
           +G G+YG+V   +       VA+K +       L  K A+R    E   L++++H N   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78

Query: 105 LTKIITICSSIDSKGADFKALVFEYM--ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
           L  + T   S+D +  DF  LV  +M  + G L      + D ++     +++       
Sbjct: 79  LLDVFTPDLSLD-RFHDF-YLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK------- 129

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               ++Y+H      ++H D+KP N+ ++ D    + DFGL++   S+
Sbjct: 130 ---GLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 20/163 (12%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI--- 108
           N+IG GS+G VY+ I  +    VA+K   + Q   +++   E   ++N+ H N+  +   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN--RELLIMKNLNHINIIFLKDY 127

Query: 109 -ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVAS 165
             T C   + K   F  +V E++     +   H  + N  L +F + L      +  +  
Sbjct: 128 YYTECFKKNEKNI-FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-----YSYQLCR 181

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFL 207
           A+ Y+H      + H D+KP N+L+D N     + DFG +K L
Sbjct: 182 ALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Length = 440

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 37.3 bits (87), Expect = 0.003
 Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 24/119 (20%)

Query: 95  EALRNIRHRNLTKIITICSSIDSKG-------ADFKALVFEYMENGSLEDWLHQTNDHLE 147
           E LR  R R   +I+                  D   +V EY+E   L+D L    +   
Sbjct: 39  EKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---EEA-- 93

Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF 206
                   R ++  +V   +  LH      +VHGD+  SN++L    + +  DFGL +F
Sbjct: 94  --------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGRI-YFIDFGLGEF 140

Length = 204

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 37.6 bits (87), Expect = 0.003
 Identities = 52/184 (28%), Positives = 79/184 (42%), Gaps = 25/184 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHR-NLTKIITIC 112
           IG+GS+G V +    + + + A+K I  K     RS V    A R +  + N   I+ + 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
            S  S    +  LV  ++  G L   L +       F LS   R   A ++  A+E LH 
Sbjct: 60  FSFQSPEKLY--LVLAFINGGELFHHLQREGR----FDLSR-ARFYTA-ELLCALENLH- 110

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF--LSSDHLDTASETPSSSIGIKGTVG 230
             +  +++ D+KP N+LLD      + DFGL K      D  +T   TP           
Sbjct: 111 --KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE---------- 158

Query: 231 YVAP 234
           Y+AP
Sbjct: 159 YLAP 162

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 37.7 bits (87), Expect = 0.003
 Identities = 46/190 (24%), Positives = 84/190 (44%), Gaps = 22/190 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEAL--RNIRHRN 104
           +F+   ++G+GS+G V        + + A+K+  LK+    +    EC  +  R +  ++
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
               +T   S   +  D    V EY+  G L   + Q      V K    Q V  A +++
Sbjct: 59  KPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEIS 111

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
             + +LH   +  +++ D+K  NV+LD++    + DFG+ K    D + T +        
Sbjct: 112 VGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-------- 160

Query: 225 IKGTVGYVAP 234
             GT  Y+AP
Sbjct: 161 FCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 37.4 bits (86), Expect = 0.004
 Identities = 32/115 (27%), Positives = 50/115 (43%), Gaps = 20/115 (17%)

Query: 93  ECEALRNIRHRNLTKIITICSSID-----SKGADFKALVFEYMENGSLEDWLHQTNDHLE 147
           E  AL  + H N+ KI  I  S       ++  DF   ++ +M + +  DW  +      
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAF-DWKDRP----- 264

Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG 202
                L Q   I   +  A+EY+H      ++H DIK  N+ L+ D    +GDFG
Sbjct: 265 ----LLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFG 312

Length = 501

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	234
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	99.98
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.98
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.98
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.98
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.98
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.96
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.96
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.96
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.96
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.96
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.96
PHA03212	391	serine/threonine kinase US3; Provisional	99.96
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.96
KOG0584	632	consensus Serine/threonine protein kinase [General	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
PTZ00036	440	glycogen synthase kinase; Provisional	99.96
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.96
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.95
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.95
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
PHA03209	357	serine/threonine kinase US3; Provisional	99.95
PHA02988	283	hypothetical protein; Provisional	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.95
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.95
PTZ00284	467	protein kinase; Provisional	99.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.95
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.95
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.95
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.95
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
PHA03207	392	serine/threonine kinase US3; Provisional	99.95
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.95
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.95
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.95
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.95
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.95
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.95
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.95
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.94
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.94
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.94
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.94
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.94
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.94
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.94
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.94
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.94
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.94
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.94
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.94
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.94
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.94
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.94
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.94
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.94
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.94
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.94
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.94
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.94
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.94
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.94
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.94
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.94
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.94
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.94
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.94
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.94
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.94
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.94
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.94
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.94
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.94
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.94
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.94
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.94
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.94
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.94
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.94
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.94
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.94
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.94
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.94
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.94
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.94
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.94
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.94
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.94
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.94
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.94
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.94
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.94
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.94
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.94
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.94
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.93
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.93
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.93
PHA03210	501	serine/threonine kinase US3; Provisional	99.93
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.93
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.93
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.93
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.93
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.93
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.93
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.93
PLN00009	294	cyclin-dependent kinase A; Provisional	99.93
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.93
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.93
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.93
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.93
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
PHA02882	294	putative serine/threonine kinase; Provisional	99.93
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.93
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.93
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.93
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.93
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.93
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.93
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.93
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.93
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.93
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.93
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.93
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.93
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.93
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.93
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.93
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.93
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.93
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.93
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.92
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.92
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.92
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.92
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.92
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.92
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.92
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.92
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.92
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.92
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.92
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.92
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.92
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.92
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.92
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.91
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.91
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.91
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.9
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.9
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.9
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.9
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.89
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.88
PRK10345	210	hypothetical protein; Provisional	99.88
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.87
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.86
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.86
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.86
smart00090	237	RIO RIO-like kinase.	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.81
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.64
PLN00181	793	protein SPA1-RELATED; Provisional	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.56
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
KOG3087	229	consensus Serine/threonine protein kinase [General	99.38
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.36
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.35
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.34
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.21
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.2
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.18
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.13
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.11
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.03
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.01
KOG1243	690	consensus Protein kinase [General function predict	98.95
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.89
PRK09902	216	hypothetical protein; Provisional	98.88
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.8
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.79
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.61
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.58
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.47
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.45
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.37
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.35
PF01636	239	APH: Phosphotransferase enzyme family This family	98.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.08
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.02
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.0
PLN02876	822	acyl-CoA dehydrogenase	97.98
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.96
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.9
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.74
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.73
PRK10593	297	hypothetical protein; Provisional	97.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	97.61
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.6
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.47
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.32
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.27
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.23
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.21
PRK05231	319	homoserine kinase; Provisional	97.12
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.89
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.81
PRK12396	409	5-methylribose kinase; Reviewed	96.75
KOG2270	520	consensus Serine/threonine protein kinase involved	96.66
PLN02756	418	S-methyl-5-thioribose kinase	96.56
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.55
PLN02236	344	choline kinase	96.5
COG4248	637	Uncharacterized protein with protein kinase and he	96.47
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.44
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.31
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.91
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.22
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	94.58
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	93.83
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.7
PTZ00296	442	choline kinase; Provisional	93.69
PTZ00384	383	choline kinase; Provisional	93.57
PRK10271	188	thiK thiamine kinase; Provisional	93.47
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.85
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	91.9
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.84
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	91.58
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	90.7
PRK06148	1013	hypothetical protein; Provisional	90.64

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-41  Score=271.82  Aligned_cols=168  Identities=31%  Similarity=0.582  Sum_probs=148.2

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ...+|...+.||.|+||+||+|+++.++..||||.+...  .+...+.+..|+.+|+.++|||||.+++++..     .+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-----~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-----DD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-----CC
Confidence            346788888999999999999999999999999999755  45556778999999999999999999999854     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC------Cc
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND------MV  195 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~------~~  195 (234)
                      ++|+|||||+||||.+|+...+      .+++..+..++.|++.|+++||++   +||||||||.|||++..      -.
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~  153 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPV  153 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCce
Confidence            5899999999999999999987      789999999999999999999999   99999999999999654      35


Q ss_pred             eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+|||+|+.+.+.....         ++||++-||||
T Consensus       154 LKIADFGfAR~L~~~~~a~---------tlcGSplYMAP  183 (429)
T KOG0595|consen  154 LKIADFGFARFLQPGSMAE---------TLCGSPLYMAP  183 (429)
T ss_pred             EEecccchhhhCCchhHHH---------HhhCCccccCH
Confidence            8999999999988543221         38999999998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=252.45  Aligned_cols=168  Identities=30%  Similarity=0.418  Sum_probs=147.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|+++++||+|+||+|++++.+.|++.+|+|+++.+   .....+....|..+|..++||.|+.+...|     ++..
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence            45799999999999999999999999999999999743   233457889999999999999999998776     4566


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+|+|+||+.||+|...+.+.+      .+++..+..++.+|+.||.|||++   +||||||||+|||+|.+|+++++||
T Consensus        99 kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF  169 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF  169 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence            6899999999999999999877      788999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|+.........        .++|||+.||||
T Consensus       170 gL~k~~~~~~~~t--------~tfcGT~eYmAP  194 (357)
T KOG0598|consen  170 GLCKEDLKDGDAT--------RTFCGTPEYMAP  194 (357)
T ss_pred             ccchhcccCCCcc--------ccccCCccccCh
Confidence            9999654432221        138999999999

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-38  Score=254.13  Aligned_cols=168  Identities=31%  Similarity=0.453  Sum_probs=141.4

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-------chhhHHHHHHHHHHHhcCCCCceeEEEEeeecC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-------KGAFRSFVAECEALRNIRHRNLTKIITICSSID  116 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~  116 (234)
                      ....|.+.+.||+|+||.|-+|..+.|++.||||+++...       ........+|+++|.+++|||||++.+++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4556788999999999999999999999999999996321       112234579999999999999999999986554


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC---
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND---  193 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~---  193 (234)
                      .     .|+||||++||+|++.+..+.      .+.+.....++.|++.|+.|||++   ||+||||||+|||+..+   
T Consensus       250 s-----~YmVlE~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~  315 (475)
T KOG0615|consen  250 S-----SYMVLEYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED  315 (475)
T ss_pred             c-----eEEEEEEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence            4     699999999999999998776      344555688999999999999999   99999999999999765   


Q ss_pred             CceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          194 MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       194 ~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..+||+|||+|+..+....         ..++||||.|.||
T Consensus       316 ~llKItDFGlAK~~g~~sf---------m~TlCGTpsYvAP  347 (475)
T KOG0615|consen  316 CLLKITDFGLAKVSGEGSF---------MKTLCGTPSYVAP  347 (475)
T ss_pred             eEEEecccchhhcccccee---------hhhhcCCccccCh
Confidence            7899999999998764211         1138999999999

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=248.64  Aligned_cols=165  Identities=28%  Similarity=0.444  Sum_probs=146.5

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      +.+..+.||+|..|+||+++|+.|++.+|+|++... ++...+++.+|+++++..+||+||.++|.|+....    .+.|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~isI  155 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EISI  155 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEEe
Confidence            566688999999999999999999999999999644 45566889999999999999999999999865432    3789


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||++|+|.+++...+      ++++...-.++.++++||.|||+ .   .||||||||+|+|++..|+|||||||.+
T Consensus       156 ~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             ehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecccccc
Confidence            999999999999998875      68888999999999999999996 6   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.+.+....          +++||..||||
T Consensus       227 ~~lvnS~a~----------tfvGT~~YMsP  246 (364)
T KOG0581|consen  227 GILVNSIAN----------TFVGTSAYMSP  246 (364)
T ss_pred             HHhhhhhcc----------cccccccccCh
Confidence            987765222          28899999998

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-37  Score=259.36  Aligned_cols=167  Identities=26%  Similarity=0.439  Sum_probs=150.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..|...+.||+|+|+.||++++..+|+.||+|+++.+   +....+...+|+++.+.++|||||+++++|++     ..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-----s~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-----SNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-----CCc
Confidence            5699999999999999999999999999999999743   44556789999999999999999999999854     445


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +|||+|+|+.++|..+++.+.      .+++.++..+..||+.||.|||+.   +|+|||||..|++++.+.+|||+|||
T Consensus        93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence            899999999999999998655      799999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|..+..++...        .+.||||-|+||
T Consensus       164 LAt~le~~~Erk--------~TlCGTPNYIAP  187 (592)
T KOG0575|consen  164 LATQLEYDGERK--------KTLCGTPNYIAP  187 (592)
T ss_pred             eeeeecCccccc--------ceecCCCcccCh
Confidence            999887654332        248999999998

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-36  Score=249.72  Aligned_cols=185  Identities=45%  Similarity=0.754  Sum_probs=155.7

Q ss_pred             cCCCcChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEE
Q 039258           32 QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITI  111 (234)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~  111 (234)
                      ....+++.++..++++|.....||+|+||.||+|...++ ..||||.+..........|..|++++.+++|||+++|+|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            456689999999999999999999999999999998655 8899998865433213559999999999999999999999


Q ss_pred             eeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                      |...+.    ..+||+||+++|+|.+.+......    .++|..++.|+.+++.||+|||..+.++|||||||++|||+|
T Consensus       140 C~e~~~----~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD  211 (361)
T KOG1187|consen  140 CLEGGE----HRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD  211 (361)
T ss_pred             EecCCc----eEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence            964432    358999999999999999875432    579999999999999999999998877899999999999999


Q ss_pred             CCCceEEccCccccccCC-CccCCCCCCCCccccc-cccccccCC
Q 039258          192 NDMVAHVGDFGLSKFLSS-DHLDTASETPSSSIGI-KGTVGYVAP  234 (234)
Q Consensus       192 ~~~~vki~dfG~a~~~~~-~~~~~~~~~~~~~~~~-~gt~~y~aP  234 (234)
                      .++++||+|||+|+.... .....         .. .||.+|+||
T Consensus       212 ~~~~aKlsDFGLa~~~~~~~~~~~---------~~~~gt~gY~~P  247 (361)
T KOG1187|consen  212 EDFNAKLSDFGLAKLGPEGDTSVS---------TTVMGTFGYLAP  247 (361)
T ss_pred             CCCCEEccCccCcccCCcccccee---------eecCCCCccCCh
Confidence            999999999999965443 11110         01 599999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=233.83  Aligned_cols=165  Identities=27%  Similarity=0.394  Sum_probs=146.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|+..+.||.|+||.|.+++++.++..+|+|+++...   ....+....|..+|..+.||.++++.+.+.     +..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-----d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-----DNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-----cCC
Confidence            346888999999999999999999999999999997442   223466788999999999999999998874     445


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ++++||||++||.|++++++.+      ++++..+..++.||+.|++|||++   +|++|||||+|||+|.+|.+||+||
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence            5899999999999999999987      789999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|+.+.....           +.||||.|+||
T Consensus       189 GFAK~v~~rT~-----------TlCGTPeYLAP  210 (355)
T KOG0616|consen  189 GFAKRVSGRTW-----------TLCGTPEYLAP  210 (355)
T ss_pred             cceEEecCcEE-----------EecCCccccCh
Confidence            99998766421           28999999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-36  Score=246.17  Aligned_cols=167  Identities=26%  Similarity=0.445  Sum_probs=149.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeec---ccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|.||+|-+|+....|+.||||.++.   .+++..-.+.+|+++|+.++||||+.++.+|+     +.+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-----Nkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-----NKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-----CCc
Confidence            4578889999999999999999999999999999963   35666778999999999999999999999974     455


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+.|||||..+|.|++|+.+++      .+++.++..+++||..|+.|+|.+   +++|||||.+|||+|.++++||+||
T Consensus       127 KIvivMEYaS~GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF  197 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISERG------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF  197 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence            5899999999999999999988      799999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++-.+.+.....         ++||+|.|.+|
T Consensus       198 GLSNly~~~kfLq---------TFCGSPLYASP  221 (668)
T KOG0611|consen  198 GLSNLYADKKFLQ---------TFCGSPLYASP  221 (668)
T ss_pred             chhhhhccccHHH---------HhcCCcccCCc
Confidence            9998876654322         38999999988

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-35  Score=245.73  Aligned_cols=173  Identities=31%  Similarity=0.446  Sum_probs=148.5

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .....|+.++.||+|+||.||+|++..+++.||+|.+....  +.......+|+.+|++++||||++|.+......   .
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~  190 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---S  190 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---C
Confidence            33446888899999999999999999999999999997653  556677899999999999999999999876542   3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ..+|+|+|||+. ||.-++...+-     .|++.++..++.|++.||+|+|++   +++|||||.+|||+|++|.+||+|
T Consensus       191 ~siYlVFeYMdh-DL~GLl~~p~v-----kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaD  261 (560)
T KOG0600|consen  191 GSIYLVFEYMDH-DLSGLLSSPGV-----KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIAD  261 (560)
T ss_pred             ceEEEEEecccc-hhhhhhcCCCc-----ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecc
Confidence            447999999976 99998876543     789999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|+++.........       ..+.|.+|.||
T Consensus       262 FGLAr~y~~~~~~~~T-------~rVvTLWYRpP  288 (560)
T KOG0600|consen  262 FGLARFYTPSGSAPYT-------SRVVTLWYRPP  288 (560)
T ss_pred             ccceeeccCCCCcccc-------cceEEeeccCh
Confidence            9999988776543321       15689999988

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=247.79  Aligned_cols=179  Identities=28%  Similarity=0.450  Sum_probs=151.9

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCC
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDS  117 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~  117 (234)
                      .+...+|..++.||+|+|++|++|+.+.++++||||++...   .+...+-..+|-+.|..| .||.|++|+-.|.+.  
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--
Confidence            45567899999999999999999999999999999999633   233445677888899999 799999999887443  


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                         ..+|.|+||+++|+|.++|...+      .+.+.++..++.||+.|++|||++   |||||||||+|||+|.+++++
T Consensus       147 ---~sLYFvLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  147 ---ESLYFVLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             ---cceEEEEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence               34899999999999999999987      789999999999999999999999   999999999999999999999


Q ss_pred             EccCccccccCCCccC-----CCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLD-----TASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~-----~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||.|+.+.+....     ........+..++||..|.+|
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP  256 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSP  256 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCH
Confidence            9999999998765433     111122222459999999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=241.92  Aligned_cols=169  Identities=28%  Similarity=0.429  Sum_probs=144.7

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc----cc-hhhHHHHHHHHHHHhcC-CCCceeEEEEeeecC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK----QK-GAFRSFVAECEALRNIR-HRNLTKIITICSSID  116 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~  116 (234)
                      .....|.+.+.||+|+||+|+.|.+..++..||+|+++..    .. ...+.+.+|+.+++.++ ||||+++++++..  
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--   91 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--   91 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--
Confidence            3456799999999999999999999999999999987643    11 23356678999999998 9999999999743  


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC-Cc
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND-MV  195 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~-~~  195 (234)
                         ...+++||||+.+|+|++++.+.+      ++.+..+..++.|++.|++|+|++   +|+||||||+|+|++.+ ++
T Consensus        92 ---~~~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~  159 (370)
T KOG0583|consen   92 ---PTKIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN  159 (370)
T ss_pred             ---CCeEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence               333899999999999999999865      788899999999999999999999   99999999999999988 99


Q ss_pred             eEEccCccccccC-CCccCCCCCCCCccccccccccccCC
Q 039258          196 AHVGDFGLSKFLS-SDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 vki~dfG~a~~~~-~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+|||++.... .+....         ..|||+.|+||
T Consensus       160 ~Kl~DFG~s~~~~~~~~~l~---------t~cGsp~Y~aP  190 (370)
T KOG0583|consen  160 LKLSDFGLSAISPGEDGLLK---------TFCGSPAYAAP  190 (370)
T ss_pred             EEEeccccccccCCCCCccc---------CCCCCcccCCH
Confidence            9999999999873 222111         27999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-36  Score=235.70  Aligned_cols=176  Identities=26%  Similarity=0.400  Sum_probs=146.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++++.||.|.||.||++....+|..+|.|-++..  +....+.+..|+.+|+.++||||+++++....   +.+.-+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence            4578889999999999999999999999999998743  34456789999999999999999999874321   233446


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCC-CCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQ-PPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~-~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +||||+|+.|+|.+.++......  ..+++..++.++.|++.||.++|++-+ ..++||||||.||+++.+|.+|+.|||
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qk--r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQK--RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhcc--ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            89999999999999987543221  268999999999999999999998311 138999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++.+....+...        .++|||.||||
T Consensus       174 L~r~l~s~~tfA~--------S~VGTPyYMSP  197 (375)
T KOG0591|consen  174 LGRFLSSKTTFAH--------SLVGTPYYMSP  197 (375)
T ss_pred             hHhHhcchhHHHH--------hhcCCCcccCH
Confidence            9999877654332        38999999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6e-34  Score=236.85  Aligned_cols=167  Identities=35%  Similarity=0.567  Sum_probs=137.2

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      ....+.+|+|+||+||+|.++.+. .||+|.+.....  ...++|.+|+.+|.+++||||++++|+|.....    .++|
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~i  117 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLCI  117 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceEE
Confidence            344556999999999999996552 399999974322  225689999999999999999999999964431    3689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC-eeecCCCCCCeeeCCCC-ceEEccCcc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP-MVHGDIKPSNVLLDNDM-VAHVGDFGL  203 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~-ivH~dlk~~nil~~~~~-~vki~dfG~  203 (234)
                      ||||+++|+|.+++....    ...+++..++.++.||+.||.|||++   + ||||||||+|+|++.++ ++||+|||+
T Consensus       118 VtEy~~~GsL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             EEEeCCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            999999999999998741    11788999999999999999999999   7 99999999999999997 999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.........        ....||+.||||
T Consensus       191 sr~~~~~~~~~--------~~~~GT~~wMAP  213 (362)
T KOG0192|consen  191 SREKVISKTSM--------TSVAGTYRWMAP  213 (362)
T ss_pred             ceeeccccccc--------cCCCCCccccCh
Confidence            98765432111        014699999999

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.4e-35  Score=230.33  Aligned_cols=165  Identities=27%  Similarity=0.393  Sum_probs=138.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .|+.+..+|+|+||+|++|+++.||+.||||.+..+  ++...+-.++|+.+|+.++|+|+|.++.+|..     ...++
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-----krklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-----KRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-----cceeE
Confidence            477788899999999999999999999999998543  23344678999999999999999999998743     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +|+|||+. ++.+-+.....     .++...+..+..|++.|+.|+|++   ++|||||||+|||++.++.+|+||||+|
T Consensus        78 LVFE~~dh-TvL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFA  148 (396)
T KOG0593|consen   78 LVFEYCDH-TVLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFA  148 (396)
T ss_pred             EEeeecch-HHHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhh
Confidence            99999976 66666655443     678888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCC-CccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSS-DHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~-~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.+.. ......         .+.|.+|.||
T Consensus       149 R~L~~pgd~YTD---------YVATRWYRaP  170 (396)
T KOG0593|consen  149 RTLSAPGDNYTD---------YVATRWYRAP  170 (396)
T ss_pred             HhhcCCcchhhh---------hhhhhhccCh
Confidence            98874 222211         6788888887

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-34  Score=220.50  Aligned_cols=167  Identities=29%  Similarity=0.446  Sum_probs=142.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|...+.+|+|.||+||+|++..|++.||||.++...  +......++|+..|..++|+||+.++++|.+.     +.+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----Cce
Confidence            35777889999999999999999999999999998552  23346789999999999999999999998543     336


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      .||+||++. +|+..++....     .++..++..++.+++.|++|+|++   .|+||||||.|+|++.+|.+||+|||+
T Consensus        77 ~lVfEfm~t-dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             EEEEEeccc-cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence            899999975 99999987654     688899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+.+.........        .+.|.+|.||
T Consensus       148 Ar~f~~p~~~~~~--------~V~TRWYRAP  170 (318)
T KOG0659|consen  148 ARFFGSPNRIQTH--------QVVTRWYRAP  170 (318)
T ss_pred             hhccCCCCccccc--------ceeeeeccCh
Confidence            9988764322211        2577888887

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=242.44  Aligned_cols=169  Identities=27%  Similarity=0.386  Sum_probs=144.9

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhh-HHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF-RSFVAECEALRNIR-HRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ...+|...+.||.|+||.||+|+...++..||||.++.+-..+. ..-++|+.-|++++ ||||+++.+++...+.    
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~----   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR----   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc----
Confidence            34578889999999999999999999999999999975543332 34589999999998 9999999998754332    


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+++|||||+ .+|+++++.+++     .+++..+..|+.||++||+|+|.+   |+.|||+||||||+..+..+||+||
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence            5899999995 599999998854     799999999999999999999999   9999999999999998899999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|+......-..         ..+.|.+|.||
T Consensus       155 GLARev~SkpPYT---------eYVSTRWYRAP  178 (538)
T KOG0661|consen  155 GLAREVRSKPPYT---------EYVSTRWYRAP  178 (538)
T ss_pred             ccccccccCCCcc---------hhhhcccccch
Confidence            9999866543222         16789999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-33  Score=224.71  Aligned_cols=174  Identities=31%  Similarity=0.495  Sum_probs=144.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|...+.||+|+||.||++.+..++...|||.+...+....+.+.+|+.+|+.++|||||+.+|.....+.   ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence            3457778899999999999999998899999999976533335778999999999999999999996432221   3578


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-CCceEEccCcc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDFGL  203 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-~~~vki~dfG~  203 (234)
                      +.|||+++|+|.+++...+.     .+++..+..+..||+.||.|||++   ++||+||||+|||++. ++.+||+|||+
T Consensus        93 i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence            99999999999999998763     588999999999999999999999   9999999999999998 79999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++........     ......+.||+.||||
T Consensus       165 a~~~~~~~~~-----~~~~~~~~Gtp~~maP  190 (313)
T KOG0198|consen  165 AKKLESKGTK-----SDSELSVQGTPNYMAP  190 (313)
T ss_pred             cccccccccc-----ccccccccCCccccCc
Confidence            9876641111     0111126799999999

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.1e-33  Score=232.17  Aligned_cols=150  Identities=25%  Similarity=0.373  Sum_probs=136.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|+.+++||+|+||.||+|+.+.||..+|+|+++.+   .....+..+.|-.+|.....|+||+++..|     ++..
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~~  214 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDKE  214 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCCC
Confidence            45899999999999999999999999999999999754   344557788999999999999999999886     4556


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ++||||||++|||+..+|...+      .+++.++..++.+++.|++.+|..   |+|||||||+|+|+|..|++|++||
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccc
Confidence            7999999999999999998877      789999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccC
Q 039258          202 GLSKFLS  208 (234)
Q Consensus       202 G~a~~~~  208 (234)
                      |++.-+.
T Consensus       286 GLs~gl~  292 (550)
T KOG0605|consen  286 GLSTGLD  292 (550)
T ss_pred             cccchhh
Confidence            9997543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-33  Score=223.01  Aligned_cols=170  Identities=25%  Similarity=0.395  Sum_probs=144.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|+.+..|++|+||.||+|+++.|++.||+|.++...  .+..-.-++|+.+|.+++||||+.+-.+....   +.+-
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDK  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccce
Confidence            346788899999999999999999999999999998553  33345678999999999999999998877542   3344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +|+|||||+. ||.+.+.+-..     ++...++..++.|++.|+.|||.+   .|+|||||++|+|+++.|.+||+|||
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG  222 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG  222 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence            7999999975 99999887542     788899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+.+......-.        ..+.|.+|.||
T Consensus       223 LAR~ygsp~k~~T--------~lVVTLWYRaP  246 (419)
T KOG0663|consen  223 LAREYGSPLKPYT--------PLVVTLWYRAP  246 (419)
T ss_pred             hhhhhcCCcccCc--------ceEEEeeecCH
Confidence            9998877532111        16789999987

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-33  Score=238.24  Aligned_cols=168  Identities=26%  Similarity=0.381  Sum_probs=144.1

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~  119 (234)
                      ...+|...++||+|+||+|+++..+.+++.+|||+++..   .....+....|..++... +||.++.++.++     ++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence            345789999999999999999999999999999999743   455667888899988877 499999999886     66


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      ..+++.||||+.||++..+....       .+++..+..++..++.||.|||++   +||+||||.+|||+|..|.+||+
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA  510 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA  510 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence            77799999999999954444322       789999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++........        ..++||||.||||
T Consensus       511 DFGlcKe~m~~g~~--------TsTfCGTpey~aP  537 (694)
T KOG0694|consen  511 DFGLCKEGMGQGDR--------TSTFCGTPEFLAP  537 (694)
T ss_pred             ccccccccCCCCCc--------cccccCChhhcCh
Confidence            99999975533221        2249999999998

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=227.44  Aligned_cols=177  Identities=28%  Similarity=0.399  Sum_probs=140.8

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc----------c----hhhHHHHHHHHHHHhcCCCCceeE
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ----------K----GAFRSFVAECEALRNIRHRNLTKI  108 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~----~~~~~~~~e~~~l~~l~h~~i~~l  108 (234)
                      +..+.|++.+.||+|.||+|-+|++..+++.||||++....          .    ...+...+|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            44568999999999999999999999999999999996321          0    123578999999999999999999


Q ss_pred             EEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCe
Q 039258          109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV  188 (234)
Q Consensus       109 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~ni  188 (234)
                      +.+..++   ..+.+|+|+|||..|.+...-....      .+++.++..++.+++.||+|||.+   +||||||||+|+
T Consensus       174 iEvLDDP---~s~~~YlVley~s~G~v~w~p~d~~------els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL  241 (576)
T KOG0585|consen  174 IEVLDDP---ESDKLYLVLEYCSKGEVKWCPPDKP------ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL  241 (576)
T ss_pred             EEeecCc---ccCceEEEEEeccCCccccCCCCcc------cccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence            9987544   3456899999998877654322211      278889999999999999999999   999999999999


Q ss_pred             eeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       189 l~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++.+|++||+|||.+...........+.   .-...+|||.||||
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~---~L~~tvGTPAF~AP  284 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDD---QLSRTVGTPAFFAP  284 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHH---HHhhcCCCccccch
Confidence            99999999999999988653321111100   00125799999998

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-33  Score=236.48  Aligned_cols=166  Identities=24%  Similarity=0.381  Sum_probs=145.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      +-|+.++.||.|+.|.|.+|++..||+.+|||++..+.   ......+.+|+-+|+.+.|||+++++++++     ++.+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe-----~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE-----NKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec-----cCce
Confidence            45788999999999999999999999999999997552   223356788999999999999999999974     4556


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +|+|+||+++|.|++++...+      ++++.++..++.||+.|+.|+|..   +|+||||||+|+|+|..+++||+|||
T Consensus        87 lylvlEyv~gGELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFG  157 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFG  157 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccc
Confidence            899999999999999999888      788899999999999999999998   99999999999999988889999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|..-.++..-.         +.||+|.|.||
T Consensus       158 MAsLe~~gklLe---------TSCGSPHYA~P  180 (786)
T KOG0588|consen  158 MASLEVPGKLLE---------TSCGSPHYAAP  180 (786)
T ss_pred             eeecccCCcccc---------ccCCCcccCCc
Confidence            999755543322         27999999998

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.3e-33  Score=234.69  Aligned_cols=166  Identities=34%  Similarity=0.510  Sum_probs=144.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ++|.+.++||+|+||+||+|+.+.+.+.||+|.+....  +...+.+.+|+++++.++||||+.++++|+     +...+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-----t~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-----TSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-----ccceE
Confidence            46788889999999999999999999999999997543  345678999999999999999999999974     34458


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      |+|+||+.| +|..++...+      .+++..+..++.+++.||.|||+.   +|.|||+||.|||++..+++|+||||+
T Consensus        77 ~vVte~a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             EEEehhhhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence            999999976 9999998876      789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+.......        -.....|||.||||
T Consensus       147 Ar~m~~~t~--------vltsikGtPlYmAP  169 (808)
T KOG0597|consen  147 ARAMSTNTS--------VLTSIKGTPLYMAP  169 (808)
T ss_pred             hhhcccCce--------eeeeccCcccccCH
Confidence            997655321        11126799999998

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=230.50  Aligned_cols=166  Identities=28%  Similarity=0.436  Sum_probs=146.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      ..|+.-..||+|+.|.||.|....++..||||.+........+-++.|+.+|+..+|+|||.+++.|...     +.+|+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEE
Confidence            3577778899999999999999999999999999877666668889999999999999999999876433     34799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++|+|.+.+...       .+++.++..++.+++.||.|||.+   +|+|||||..|||++.+|.+||+|||+|.
T Consensus       348 VMEym~ggsLTDvVt~~-------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT-------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             EEeecCCCchhhhhhcc-------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence            99999999999998765       588899999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+.......        .+.+|||.||||
T Consensus       418 qi~~~~~KR--------~TmVGTPYWMAP  438 (550)
T KOG0578|consen  418 QISEEQSKR--------STMVGTPYWMAP  438 (550)
T ss_pred             ccccccCcc--------ccccCCCCccch
Confidence            877654332        237899999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.9e-32  Score=228.94  Aligned_cols=155  Identities=30%  Similarity=0.551  Sum_probs=132.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ...++..+.||+|.||.|+.|.+..+ ..||+|.++.... ..+.|++|+++|.+++|+|||+++++|...+     .++
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piy  277 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIY  277 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceE
Confidence            33456678899999999999999654 4699999975432 3378999999999999999999999996433     479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      |||||++.|+|.++++.....    .+...+.+.++.|||+||+||+++   ++|||||..+||||+.+..+||+|||+|
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~----~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGG----LLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCC----ccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccc
Confidence            999999999999999984322    677788999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccC
Q 039258          205 KFLSSDHLD  213 (234)
Q Consensus       205 ~~~~~~~~~  213 (234)
                      +...++.+.
T Consensus       351 r~~~d~~Y~  359 (468)
T KOG0197|consen  351 RLIGDDEYT  359 (468)
T ss_pred             cccCCCcee
Confidence            965555443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=6.7e-33  Score=210.86  Aligned_cols=168  Identities=25%  Similarity=0.386  Sum_probs=144.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++++.||+|.||.||.|+.+.++-.||+|++..++   .+...++.+|+++-+.++||||.+++++|.+.     .
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-----~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-----K   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-----c
Confidence            356888999999999999999999999999999996442   33446889999999999999999999998543     3


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+|+++||.+.|+++..+......    .+++.....++.|++.|+.|+|.+   +++|||+||+|+|++..+.+||+||
T Consensus        96 riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCC
Confidence            479999999999999999865433    677888899999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..-.          +..+.++|||.-|.+|
T Consensus       169 GwsV~~p----------~~kR~tlcgt~dyl~p  191 (281)
T KOG0580|consen  169 GWSVHAP----------SNKRKTLCGTLDYLPP  191 (281)
T ss_pred             CceeecC----------CCCceeeecccccCCH
Confidence            9987532          1122348999999987

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.98  E-value=1.1e-32  Score=213.75  Aligned_cols=170  Identities=29%  Similarity=0.462  Sum_probs=146.9

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-----c---hhhHHHHHHHHHHHhc-CCCCceeEEEEe
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-----K---GAFRSFVAECEALRNI-RHRNLTKIITIC  112 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~---~~~~~~~~e~~~l~~l-~h~~i~~l~~~~  112 (234)
                      ......|...+.||+|..++|.+|.++.++..+|+|++....     +   ...+...+|+++|+.+ -||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            345567888889999999999999999999999999997421     1   1235678899999998 599999999997


Q ss_pred             eecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC
Q 039258          113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN  192 (234)
Q Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~  192 (234)
                      .+     ..+.++|+|.|+.|.|++++.+.-      .+++.....+++|+..|+.|+|.+   +||||||||+|||++.
T Consensus        93 es-----~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd  158 (411)
T KOG0599|consen   93 ES-----DAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD  158 (411)
T ss_pred             cC-----cchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence            54     455799999999999999998754      789999999999999999999999   9999999999999999


Q ss_pred             CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.++||+|||+|..+.+.+.-.         .+||||+|.||
T Consensus       159 n~~i~isDFGFa~~l~~GekLr---------elCGTPgYLAP  191 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGEKLR---------ELCGTPGYLAP  191 (411)
T ss_pred             ccceEEeccceeeccCCchhHH---------HhcCCCcccCh
Confidence            9999999999999877654322         28999999998

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.98  E-value=1.5e-31  Score=214.33  Aligned_cols=173  Identities=25%  Similarity=0.433  Sum_probs=142.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCC-ceeEEEEeeecCC-CCCCc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRN-LTKIITICSSIDS-KGADF  122 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~-i~~l~~~~~~~~~-~~~~~  122 (234)
                      .|+..+.||+|+||+||+|+.+.+|..||+|.+....  +.......+|+.+++.++|+| |+.+.+++..... +....
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            4666778999999999999999999999999998653  345677899999999999999 9999999876542 22345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +++|+||++. +|..++.......  ...+...+..++.|++.||+|||++   +|+||||||.|+|++.+|.+||+|||
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence            7899999965 9999998765321  2456678899999999999999999   99999999999999999999999999


Q ss_pred             cccccCCC-ccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSD-HLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~-~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+...-+ ....         .-++|..|.||
T Consensus       166 lAra~~ip~~~yt---------~evvTlWYRaP  189 (323)
T KOG0594|consen  166 LARAFSIPMRTYT---------PEVVTLWYRAP  189 (323)
T ss_pred             hHHHhcCCccccc---------ccEEEeeccCH
Confidence            99965522 2111         14588888887

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=2.7e-31  Score=223.80  Aligned_cols=149  Identities=24%  Similarity=0.336  Sum_probs=130.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|+..+.||+|+||+||+|.+..++..||+|+++...   ......+..|+.++..++|+||+++++.+..     ...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence            36888999999999999999999999999999996432   2233567889999999999999999998743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence            799999999999999998654      678889999999999999999999   99999999999999999999999999


Q ss_pred             cccccC
Q 039258          203 LSKFLS  208 (234)
Q Consensus       203 ~a~~~~  208 (234)
                      +++...
T Consensus       147 la~~~~  152 (363)
T cd05628         147 LCTGLK  152 (363)
T ss_pred             Cccccc
Confidence            998654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=3.2e-32  Score=218.43  Aligned_cols=170  Identities=27%  Similarity=0.424  Sum_probs=137.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      -.|...+++|.|+||.||+|....++..||||.+-...+-    -.+|+++|.++.||||+++.-+|......+..++.+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3477788999999999999999999999999987433221    137999999999999999988887655444567889


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-CCceEEccCccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDFGLS  204 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-~~~vki~dfG~a  204 (234)
                      ||||++. +|++.++.....  ...++...+.-+..||+.|+.|||+.   +|+||||||.|+|+|. +|.+||||||.|
T Consensus       100 VleymP~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            9999965 999999853111  11567778888999999999999998   9999999999999995 489999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.+...+.+.         ...-|..|.||
T Consensus       174 K~L~~~epni---------SYicSRyYRaP  194 (364)
T KOG0658|consen  174 KVLVKGEPNI---------SYICSRYYRAP  194 (364)
T ss_pred             eeeccCCCce---------eEEEeccccCH
Confidence            9887754332         25567788887

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-31  Score=224.05  Aligned_cols=149  Identities=23%  Similarity=0.354  Sum_probs=131.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|+..+.||+|+||.||+|++..+++.||||++...   .......+.+|++++..++||||+++++++..     .++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence            3688899999999999999999999999999999743   22334567889999999999999999998743     445


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++...+      .+++..+..++.|++.||.|||++   +++||||||+|||++.++.++|+|||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence            799999999999999987654      578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccC
Q 039258          203 LSKFLS  208 (234)
Q Consensus       203 ~a~~~~  208 (234)
                      ++..+.
T Consensus       147 ~~~~~~  152 (364)
T cd05599         147 LCTGLK  152 (364)
T ss_pred             cceecc
Confidence            987653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=3.1e-31  Score=223.91  Aligned_cols=171  Identities=20%  Similarity=0.317  Sum_probs=142.1

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      .....+|+..+.||+|+||.||++.+..++..+|+|++...   .......+.+|+.++..++||||+++++++..    
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~----  114 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD----  114 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc----
Confidence            34456799999999999999999999999999999999632   22233567889999999999999999998743    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                       ....++||||+++++|.+++...       .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||
T Consensus       115 -~~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL  183 (370)
T cd05621         115 -DKYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKL  183 (370)
T ss_pred             -CCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEE
Confidence             34579999999999999998653       467788899999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||++..........       ....+||+.|+||
T Consensus       184 ~DFG~a~~~~~~~~~~-------~~~~~gt~~Y~aP  212 (370)
T cd05621         184 ADFGTCMKMDETGMVR-------CDTAVGTPDYISP  212 (370)
T ss_pred             EecccceecccCCcee-------cccCCCCcccCCH
Confidence            9999998754322111       0125799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=7.4e-31  Score=222.50  Aligned_cols=147  Identities=23%  Similarity=0.344  Sum_probs=129.7

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .|+..+.||+|+||+||+|.+..++..||+|++...   .......+.+|++++..++|+||+++++.+..     .+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence            588899999999999999999999999999999643   22334678899999999999999999998753     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++....      .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence            99999999999999987654      577888889999999999999999   999999999999999999999999999


Q ss_pred             cccc
Q 039258          204 SKFL  207 (234)
Q Consensus       204 a~~~  207 (234)
                      ++..
T Consensus       148 ~~~~  151 (381)
T cd05626         148 CTGF  151 (381)
T ss_pred             Cccc
Confidence            8644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=7.7e-31  Score=217.72  Aligned_cols=161  Identities=29%  Similarity=0.360  Sum_probs=135.2

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      +.||+|+||.||+|.+..++..||+|+++..   .......+.+|+.++..++||||+++.+.+..     .+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence            3699999999999999999999999999743   22334567889999999999999999988743     345799999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      |+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            999999999987654      678888999999999999999999   99999999999999999999999999987533


Q ss_pred             CCccCCCCCCCCccccccccccccCC
Q 039258          209 SDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ...+||+.|+||
T Consensus       147 ~~~~~~--------~~~~gt~~y~aP  164 (323)
T cd05571         147 SDGATM--------KTFCGTPEYLAP  164 (323)
T ss_pred             cCCCcc--------cceecCccccCh
Confidence            221111        125799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=4.3e-31  Score=219.78  Aligned_cols=164  Identities=23%  Similarity=0.381  Sum_probs=140.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||.||+|.+..+++.||+|+++...   ....+.+.+|+.++..++||||+++++.+..     .+.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----ENR   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CCE
Confidence            56888999999999999999999999999999996432   2234678899999999999999999998743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence            799999999999999998754      577788888999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++.......           ..+||+.|+||
T Consensus       164 ~~~~~~~~~~-----------~~~gt~~y~aP  184 (329)
T PTZ00263        164 FAKKVPDRTF-----------TLCGTPEYLAP  184 (329)
T ss_pred             CceEcCCCcc-----------eecCChhhcCH
Confidence            9986543211           15699999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=216.35  Aligned_cols=178  Identities=26%  Similarity=0.349  Sum_probs=151.5

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      .+.....|+...+||.|..++||+|+...++..||||+++...- .....+++|+..|+.++||||+.++..|....   
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~---   97 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS---   97 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc---
Confidence            34445679999999999999999999999999999999986532 33588999999999999999999998876543   


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                        .+|+||.||.+|++.+++...-..    .+.+..+..+.++++.||.|||.+   |-||||+|+.|||++.+|.|||+
T Consensus        98 --~LWvVmpfMa~GS~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLa  168 (516)
T KOG0582|consen   98 --ELWVVMPFMAGGSLLDIIKTYYPD----GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLA  168 (516)
T ss_pred             --eeEEeehhhcCCcHHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEc
Confidence              389999999999999999887544    688999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||....+.+.....    ..+...++||+.||||
T Consensus       169 dFgvsa~l~~~G~R~----~~rf~tfvgtp~wmAP  199 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQ----VTRFNTFVGTPCWMAP  199 (516)
T ss_pred             CceeeeeecccCcee----eEeeccccCcccccCh
Confidence            999887766644221    1111347899999998

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=226.82  Aligned_cols=173  Identities=29%  Similarity=0.533  Sum_probs=143.6

Q ss_pred             HHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecC
Q 039258           39 AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSID  116 (234)
Q Consensus        39 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~  116 (234)
                      ++......+..++..||+|.||+||+|++-++   ||||+++...  +...+.|..|+..+++-+|.||+-+.|+|..+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            44444555667788999999999999998654   9999998653  446688999999999999999999999985432


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCce
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~v  196 (234)
                            +.||+.+|+|-+|+.++....-     .|.......|+.||++||.|||++   +|||+|||..||+++++++|
T Consensus       462 ------~AIiTqwCeGsSLY~hlHv~et-----kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  462 ------LAIITQWCEGSSLYTHLHVQET-----KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             ------eeeeehhccCchhhhhccchhh-----hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcE
Confidence                  3899999999999999976542     577778899999999999999999   99999999999999999999


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||.|||++............++      -.|...||||
T Consensus       528 kIgDFGLatvk~~w~g~~q~~q------p~gsilwmAP  559 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQ------PHGSLLWMAP  559 (678)
T ss_pred             EEecccceeeeeeeccccccCC------CccchhhhcH
Confidence            9999999987665533333222      2377889998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-31  Score=215.98  Aligned_cols=163  Identities=26%  Similarity=0.421  Sum_probs=139.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +|+..+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|++++..++||||+++++++.     +....
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCeE
Confidence            6888999999999999999999999999999996432   223456788999999999999999988763     33457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++...+      .+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+||+|||+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~  147 (291)
T cd05612          77 YMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGF  147 (291)
T ss_pred             EEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCc
Confidence            99999999999999997754      577888899999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.......           ..+||+.|+||
T Consensus       148 ~~~~~~~~~-----------~~~gt~~y~aP  167 (291)
T cd05612         148 AKKLRDRTW-----------TLCGTPEYLAP  167 (291)
T ss_pred             chhccCCcc-----------cccCChhhcCH
Confidence            886543211           14689999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=1e-30  Score=221.72  Aligned_cols=146  Identities=22%  Similarity=0.333  Sum_probs=128.8

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .|+..+.||+|+||.||+|.+..++..+|+|++....   ......+.+|++++..++|+||+++++.+..     .+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCEE
Confidence            5888999999999999999999999999999996432   2334578889999999999999999998753     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++...+      .+++..+..++.|++.||.|+|++   +|+||||||+|||++.++.+||+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence            99999999999999987654      577888889999999999999999   999999999999999999999999999


Q ss_pred             ccc
Q 039258          204 SKF  206 (234)
Q Consensus       204 a~~  206 (234)
                      +..
T Consensus       148 a~~  150 (382)
T cd05625         148 CTG  150 (382)
T ss_pred             Ccc
Confidence            864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=1.5e-30  Score=220.29  Aligned_cols=148  Identities=23%  Similarity=0.313  Sum_probs=129.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....   ......+.+|++++..++|+||+++++.+.     +.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCE
Confidence            36889999999999999999999999999999986321   223456788999999999999999998874     3445


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +++||||+++++|.+++...+      .+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            799999999999999997654      577788888999999999999999   99999999999999999999999999


Q ss_pred             ccccc
Q 039258          203 LSKFL  207 (234)
Q Consensus       203 ~a~~~  207 (234)
                      +|..+
T Consensus       147 ~a~~~  151 (376)
T cd05598         147 LCTGF  151 (376)
T ss_pred             CCccc
Confidence            98643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-30  Score=220.11  Aligned_cols=148  Identities=24%  Similarity=0.339  Sum_probs=129.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||.||+|.+..+++.||||++...   .......+.+|++++..++||||+++++++..     ..+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence            3688899999999999999999999999999998633   22334667889999999999999999998743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|++|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence            799999999999999987654      577888889999999999999999   99999999999999999999999999


Q ss_pred             ccccc
Q 039258          203 LSKFL  207 (234)
Q Consensus       203 ~a~~~  207 (234)
                      +++.+
T Consensus       147 la~~~  151 (377)
T cd05629         147 LSTGF  151 (377)
T ss_pred             ccccc
Confidence            99643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-30  Score=216.75  Aligned_cols=164  Identities=26%  Similarity=0.400  Sum_probs=140.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++...   ......+..|++++..++||||+++++++..     .+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCE
Confidence            36888999999999999999999999999999997432   2334678889999999999999999998743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence            799999999999999997654      577888899999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.......           ...+||+.|+||
T Consensus       147 ~a~~~~~~~-----------~~~~gt~~y~aP  167 (333)
T cd05600         147 LSKGIVTYA-----------NSVVGSPDYMAP  167 (333)
T ss_pred             CCccccccc-----------CCcccCccccCh
Confidence            998654311           125699999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=1.4e-30  Score=220.11  Aligned_cols=174  Identities=20%  Similarity=0.318  Sum_probs=143.8

Q ss_pred             HHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeec
Q 039258           39 AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSI  115 (234)
Q Consensus        39 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~  115 (234)
                      .+......+|++.+.||+|+||.||+|.+..+++.+|+|++...   .......+.+|..++..++||||+++++.+.. 
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-  114 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-  114 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-
Confidence            34445557899999999999999999999999999999998632   22233557789999999999999999988743 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV  195 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~  195 (234)
                          ..+.++||||+++++|.+++...       .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.
T Consensus       115 ----~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~  180 (371)
T cd05622         115 ----DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH  180 (371)
T ss_pred             ----CCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCC
Confidence                34579999999999999998653       467788889999999999999999   9999999999999999999


Q ss_pred             eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+|||++..........       ....+||+.||||
T Consensus       181 ikL~DfG~a~~~~~~~~~~-------~~~~~gt~~y~aP  212 (371)
T cd05622         181 LKLADFGTCMKMNKEGMVR-------CDTAVGTPDYISP  212 (371)
T ss_pred             EEEEeCCceeEcCcCCccc-------ccCcccCccccCH
Confidence            9999999998754322111       0125799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=2e-30  Score=215.22  Aligned_cols=161  Identities=30%  Similarity=0.381  Sum_probs=134.6

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      +.||+|+||.||++.+..++..||+|++...   .......+.+|+.++..++|||++++++++..     .+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence            4699999999999999999999999999743   22334567889999999999999999988743     345799999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      |+++++|..++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++...
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            999999998887654      578889999999999999999999   99999999999999999999999999987533


Q ss_pred             CCccCCCCCCCCccccccccccccCC
Q 039258          209 SDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....||+.|+||
T Consensus       147 ~~~~~~--------~~~~gt~~y~aP  164 (323)
T cd05595         147 SDGATM--------KTFCGTPEYLAP  164 (323)
T ss_pred             CCCCcc--------ccccCCcCcCCc
Confidence            221111        125699999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=219.02  Aligned_cols=168  Identities=29%  Similarity=0.394  Sum_probs=143.7

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK---GAFRSFVAECEALRNIR-HRNLTKIITICSSIDSK  118 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~  118 (234)
                      .....|++.+.||+|.||+||+|..+.+|+.+|+|+++....   .....+.+|+.+|..+. |||++.+.++++...  
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--  109 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--  109 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--
Confidence            344568888999999999999999999999999999974432   23468899999999998 999999999986543  


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC----CC
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN----DM  194 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~----~~  194 (234)
                         .+++|||++.||+|++.+...       .+++..+..++.|++.++.|+|+.   +++||||||+|+|+..    ++
T Consensus       110 ---~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~  176 (382)
T KOG0032|consen  110 ---SVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSG  176 (382)
T ss_pred             ---eEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCC
Confidence               479999999999999999875       288999999999999999999998   9999999999999952    35


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+|++|||++.........         ...+||+.|+||
T Consensus       177 ~ik~~DFGla~~~~~~~~~---------~~~~Gtp~y~AP  207 (382)
T KOG0032|consen  177 RIKLIDFGLAKFIKPGERL---------HTIVGTPEYVAP  207 (382)
T ss_pred             cEEEeeCCCceEccCCceE---------eeecCCccccCc
Confidence            7999999999987762111         127899999998

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=1.4e-30  Score=217.52  Aligned_cols=165  Identities=24%  Similarity=0.390  Sum_probs=139.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCC-eEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDE-MVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|.+..++ ..||+|.+...   .....+.+.+|+.++..++||||+++++++..     .
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-----E  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----C
Confidence            346888999999999999999876554 78999998633   22334568889999999999999999998743     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D  174 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD  174 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence            45799999999999999997654      578888899999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++.......           ...+||+.||||
T Consensus       175 FG~a~~~~~~~-----------~~~~gt~~y~aP  197 (340)
T PTZ00426        175 FGFAKVVDTRT-----------YTLCGTPEYIAP  197 (340)
T ss_pred             CCCCeecCCCc-----------ceecCChhhcCH
Confidence            99998654321           125799999998

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-31  Score=211.66  Aligned_cols=174  Identities=26%  Similarity=0.381  Sum_probs=146.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEee--cccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN--LKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ...|...+.||+|+||.|+.+.++.++..||||.+.  .......++.++|+.+|+.++|+||+.+.+++.......-.-
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345666788999999999999999999999999886  455666788999999999999999999999886533333444


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +|+|+|+|+ .+|.+.++.+.      .++...+..++.|++.|+.|+|+.   +++||||||.|++++.++.+||+|||
T Consensus       101 vYiV~elMe-tDL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence            699999994 59999998775      588899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+..... ....     .-...+.|.+|.||
T Consensus       171 LAR~~~~~-~~~~-----~mTeYVaTRWYRAP  196 (359)
T KOG0660|consen  171 LARYLDKF-FEDG-----FMTEYVATRWYRAP  196 (359)
T ss_pred             ceeecccc-Cccc-----chhcceeeeeecCH
Confidence            99988654 1111     11136789999998

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=3.7e-30  Score=209.98  Aligned_cols=167  Identities=23%  Similarity=0.373  Sum_probs=138.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .|+..+.||+|+||.||+|.+..++..||+|.+....   ......+.+|+.++..++|+|++.+.+.+..     .+..
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeE
Confidence            3677889999999999999999999999999986432   2223467889999999999999999988743     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++......    .+++..+..++.|++.|+.|||++   +++||||||+||+++.++.++|+|||+
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~  148 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNP----GFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL  148 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence            9999999999999887654321    578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........         ...||+.|+||
T Consensus       149 ~~~~~~~~~~~---------~~~g~~~y~aP  170 (285)
T cd05631         149 AVQIPEGETVR---------GRVGTVGYMAP  170 (285)
T ss_pred             cEEcCCCCeec---------CCCCCCCccCH
Confidence            98654322111         14689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=3.4e-30  Score=214.32  Aligned_cols=161  Identities=28%  Similarity=0.385  Sum_probs=134.8

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      +.||+|+||.||++.+..++..||+|++...   .......+.+|+.++..++||||+++.+.+..     .+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence            3699999999999999999999999999643   22344678889999999999999999988743     345799999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      |+++++|..++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            999999998887654      578889999999999999999999   99999999999999999999999999987533


Q ss_pred             CCccCCCCCCCCccccccccccccCC
Q 039258          209 SDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ...+||+.|+||
T Consensus       147 ~~~~~~--------~~~~gt~~y~aP  164 (328)
T cd05593         147 TDAATM--------KTFCGTPEYLAP  164 (328)
T ss_pred             Cccccc--------ccccCCcCccCh
Confidence            221111        125799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.2e-30  Score=214.71  Aligned_cols=169  Identities=28%  Similarity=0.351  Sum_probs=140.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||.||++.+..++..||+|++...   .....+.+.+|..++..++|+||+.+++++..     .++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence            3688899999999999999999999999999999632   22334567889999999999999999998743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++.....     .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence            7999999999999999976432     578888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++...........       ....||+.||||
T Consensus       148 ~~~~~~~~~~~~~-------~~~~gt~~y~aP  172 (331)
T cd05597         148 SCLRLLADGTVQS-------NVAVGTPDYISP  172 (331)
T ss_pred             ceeecCCCCCccc-------cceeccccccCH
Confidence            9876543221110       114689999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=5.7e-30  Score=212.65  Aligned_cols=161  Identities=28%  Similarity=0.362  Sum_probs=133.7

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      +.||+|+||.||++.+..++..||+|+++..   .......+..|+.++..++||||+++.+++..     .+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence            3699999999999999999999999999743   22334567889999999999999999988743     345799999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      |+++++|..++....      .+++..+..++.|++.||.|||+ +   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            999999999887654      57888999999999999999997 6   9999999999999999999999999998753


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......        ....||+.|+||
T Consensus       147 ~~~~~~~--------~~~~gt~~y~aP  165 (325)
T cd05594         147 IKDGATM--------KTFCGTPEYLAP  165 (325)
T ss_pred             CCCCccc--------ccccCCcccCCH
Confidence            3221111        125699999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=1.5e-30  Score=219.78  Aligned_cols=168  Identities=21%  Similarity=0.337  Sum_probs=139.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|+++..   .......+..|+.++..++||||+++++++.     +..
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~~~  116 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----DDK  116 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            45788999999999999999999999999999999632   2223345778999999999999999998874     344


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      +.++||||+++++|.+++...       .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~Df  186 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEec
Confidence            579999999999999988653       467788888999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........       ....+||+.|+||
T Consensus       187 G~~~~~~~~~~~~-------~~~~~gt~~y~aP  212 (370)
T cd05596         187 GTCMKMDANGMVR-------CDTAVGTPDYISP  212 (370)
T ss_pred             cceeeccCCCccc-------CCCCCCCcCeECH
Confidence            9998654322111       0125699999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=3.7e-30  Score=214.47  Aligned_cols=173  Identities=27%  Similarity=0.369  Sum_probs=141.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|++.+.||+|+||.||+|.+..++..||||.+...  .......+.+|+.++..++||||+++++++......+....+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478889999999999999999999999999998632  223345688999999999999999999987654444444579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+. ++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence            9999995 69999887654      578889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........     .....||+.|+||
T Consensus       151 ~~~~~~~~~~~~-----~~~~~~t~~y~aP  175 (338)
T cd07859         151 RVAFNDTPTAIF-----WTDYVATRWYRAP  175 (338)
T ss_pred             cccccccCcccc-----ccCCCCCCCcCCH
Confidence            864332211110     0125689999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-30  Score=213.06  Aligned_cols=159  Identities=26%  Similarity=0.373  Sum_probs=133.9

Q ss_pred             eecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           54 IGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        54 lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      ||+|+||.||+|.+..++..||+|+++..   .......+.+|+.++..++||||+++++++..     .+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence            69999999999999999999999999643   23344677889999999999999999988743     34579999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~  210 (234)
                      ++++|.+++...+      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            9999999997654      578888999999999999999999   9999999999999999999999999998854322


Q ss_pred             ccCCCCCCCCccccccccccccCC
Q 039258          211 HLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       211 ~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...        ....+||+.|+||
T Consensus       147 ~~~--------~~~~~gt~~y~aP  162 (312)
T cd05585         147 DDK--------TNTFCGTPEYLAP  162 (312)
T ss_pred             CCc--------cccccCCcccCCH
Confidence            111        1125799999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.2e-30  Score=221.04  Aligned_cols=170  Identities=26%  Similarity=0.427  Sum_probs=147.6

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ..-...|.+.+.||+|.|++|.++++..++..||||+++...  ....+.+.+|+++|..++||||++++++.+.     
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-----  126 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-----  126 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-----
Confidence            344567899999999999999999999999999999997542  2334558899999999999999999999754     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      ...+|+||||+.+|.+++++.+++      +..+..+..++.|+..|++|+|++   .|+|||||.+|++++.+.++||+
T Consensus       127 ~~~lylV~eya~~ge~~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIa  197 (596)
T KOG0586|consen  127 EATLYLVMEYASGGELFDYLVKHG------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIA  197 (596)
T ss_pred             cceeEEEEEeccCchhHHHHHhcc------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeee
Confidence            445899999999999999999887      455678889999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++..+.......         .+||++.|.||
T Consensus       198 DfgfS~~~~~~~~lq---------t~cgsppyAaP  223 (596)
T KOG0586|consen  198 DFGFSTFFDYGLMLQ---------TFCGSPPYAAP  223 (596)
T ss_pred             ccccceeeccccccc---------ccCCCCCccCh
Confidence            999999877533221         27999999998

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=5.2e-30  Score=215.77  Aligned_cols=148  Identities=24%  Similarity=0.349  Sum_probs=130.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +|+..+.||+|+||.||+|.+..++..||+|+++..   .......+..|+.++..++|+|++++++.+.     +....
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCEE
Confidence            688899999999999999999999999999999643   2233467788999999999999999998874     33457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~  147 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGL  147 (360)
T ss_pred             EEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccC
Confidence            99999999999999997654      578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccC
Q 039258          204 SKFLS  208 (234)
Q Consensus       204 a~~~~  208 (234)
                      +....
T Consensus       148 ~~~~~  152 (360)
T cd05627         148 CTGLK  152 (360)
T ss_pred             Ccccc
Confidence            87553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=6.5e-30  Score=208.81  Aligned_cols=167  Identities=26%  Similarity=0.462  Sum_probs=137.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+|+..+.||+|+||.||+|.+..++..||+|.++... ......+.+|+.++..++||||+++++++..     ....+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----ERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeEE
Confidence            46888999999999999999999999999999997442 2233567899999999999999999998743     34478


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++ +|.+++...+.     .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcce
Confidence            99999975 99998876542     467788899999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.........        ....||+.|+||
T Consensus       151 ~~~~~~~~~~--------~~~~~~~~y~aP  172 (288)
T cd07871         151 RAKSVPTKTY--------SNEVVTLWYRPP  172 (288)
T ss_pred             eeccCCCccc--------cCceecccccCh
Confidence            7643321111        114578889988

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=4.3e-30  Score=213.95  Aligned_cols=169  Identities=27%  Similarity=0.355  Sum_probs=140.3

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++|++.+.||+|+||.||++++..+++.||+|++...   .......+.+|..++..++|+||+.+++++..     .++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-----~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-----ENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence            3688899999999999999999999999999998642   22233557889999999999999999998743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++.....     .+++..+..++.|++.||.|+|++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence            7999999999999999976432     577888889999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++...........       ...+||+.|+||
T Consensus       148 ~a~~~~~~~~~~~-------~~~~gt~~y~aP  172 (331)
T cd05624         148 SCLKMNQDGTVQS-------SVAVGTPDYISP  172 (331)
T ss_pred             ceeeccCCCceee-------ccccCCcccCCH
Confidence            9986544321110       114699999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-31  Score=225.53  Aligned_cols=172  Identities=30%  Similarity=0.490  Sum_probs=140.4

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCCccee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGADFKAL  125 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~~~~l  125 (234)
                      |...+.||+|+||.||+|+++.+|+.||||.++.. .....+..-+|+++|++++|+|||+++++-+.... .-.....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            44556799999999999999999999999999743 33445677899999999999999999987432220 00234579


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC--CCC--ceEEccC
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD--NDM--VAHVGDF  201 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~--~~~--~vki~df  201 (234)
                      |||||++|||...+....+   .+++++...+.+..+++.|+.|||++   +|+||||||.||++.  .+|  --||+||
T Consensus        95 vmEyC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             EEeecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            9999999999999986543   23799999999999999999999999   999999999999983  323  4689999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |.|+.++++....         .++||+.|.+|
T Consensus       169 G~Arel~d~s~~~---------S~vGT~~YLhP  192 (732)
T KOG4250|consen  169 GAARELDDNSLFT---------SLVGTEEYLHP  192 (732)
T ss_pred             cccccCCCCCeee---------eecCchhhcCh
Confidence            9999888765222         27899999998

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=209.44  Aligned_cols=167  Identities=25%  Similarity=0.447  Sum_probs=141.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ...|++-++||+|.|++|++|.++.+|+.+|+|+++.+  .....+.+.+|+.++..++||||+++.+.+.     ...+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-----~~~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-----ccce
Confidence            34577788999999999999999999999999999743  2235578899999999999999999988752     3456


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC---CCCceEEc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVG  199 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~---~~~~vki~  199 (234)
                      .++|+|+++|++|..-+..+.      -+++..+-.++.||+++|.|+|.+   +|||||+||+|+++.   ...-+|++
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             eEEEEecccchHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeec
Confidence            799999999999988776653      678889999999999999999999   999999999999994   34568999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+|..+.+.         ..+-+++|||+||||
T Consensus       156 ~FGvAi~l~~g---------~~~~G~~GtP~fmaP  181 (355)
T KOG0033|consen  156 DFGLAIEVNDG---------EAWHGFAGTPGYLSP  181 (355)
T ss_pred             ccceEEEeCCc---------cccccccCCCcccCH
Confidence            99999987732         122247899999998

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=3.9e-30  Score=214.61  Aligned_cols=177  Identities=20%  Similarity=0.365  Sum_probs=137.1

Q ss_pred             hcCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~  117 (234)
                      ..+|++.+.||+|+||.||+|.+.     .++..||+|+++... ......+.+|+.++..+ +||||++++++|...  
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP--   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence            457889999999999999999752     345789999986432 23346789999999999 899999999987432  


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCc---------------------------------------------------
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHL---------------------------------------------------  146 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------------------------------------------  146 (234)
                        ...++++|||+++|+|.+++.......                                                   
T Consensus        84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence              334689999999999999987532110                                                   


Q ss_pred             -----cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCc
Q 039258          147 -----EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS  221 (234)
Q Consensus       147 -----~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~  221 (234)
                           ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..........      
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~------  232 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR------  232 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhc------
Confidence                 012367778889999999999999999   999999999999999999999999999986543221111      


Q ss_pred             cccccccccccCC
Q 039258          222 SIGIKGTVGYVAP  234 (234)
Q Consensus       222 ~~~~~gt~~y~aP  234 (234)
                      .....+++.|+||
T Consensus       233 ~~~~~~~~~y~aP  245 (338)
T cd05102         233 KGSARLPLKWMAP  245 (338)
T ss_pred             ccCCCCCccccCc
Confidence            0113466789988

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=8.8e-30  Score=211.85  Aligned_cols=169  Identities=25%  Similarity=0.324  Sum_probs=141.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++|.+.+.||+|+||.||+|.+..++..||+|+++...   ....+.+.+|+.++..++|+|++++++++..     .+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence            36888999999999999999999999999999997432   2234567889999999999999999988743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++.....     .+++..+..++.|++.||.|+|+.   +++||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence            7999999999999999987532     578888899999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++...........       ....||+.|+||
T Consensus       148 ~a~~~~~~~~~~~-------~~~~gt~~y~aP  172 (330)
T cd05601         148 SAARLTANKMVNS-------KLPVGTPDYIAP  172 (330)
T ss_pred             CCeECCCCCceee-------ecccCCccccCH
Confidence            9987654321110       113589999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=216.84  Aligned_cols=169  Identities=32%  Similarity=0.487  Sum_probs=137.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHh--cCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+...++|+|.||.||+|..  +++.||||++....+   +.+..|-++.+.  ++|+||+++++.-...... ..-++
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCcc-cccee
Confidence            455677899999999999988  448999999975433   567778777775  5799999999885444322 33469


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC------CCCeeecCCCCCCeeeCCCCceEE
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC------QPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~------~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                      ||+||.+.|+|.+|+..+       ..+|.....++..++.||+|||+-.      .++|+|||||++|||+.++.+.-|
T Consensus       285 LVt~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            999999999999999876       6888999999999999999999742      346999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+|..+.+.....      ...+-+||.+||||
T Consensus       358 aDFGLAl~~~p~~~~~------d~~~qVGT~RYMAP  387 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQG------DTHGQVGTRRYMAP  387 (534)
T ss_pred             eccceeEEecCCCCCc------chhhhhhhhhhcCH
Confidence            9999999877543222      22235799999998

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=9.7e-30  Score=211.16  Aligned_cols=166  Identities=25%  Similarity=0.344  Sum_probs=136.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCC-CceeEEEEeeecCCCCCCc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHR-NLTKIITICSSIDSKGADF  122 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~i~~l~~~~~~~~~~~~~~  122 (234)
                      +|++.+.||+|+||.||+|.+..++..||+|++...   .....+.+..|..++..+.|+ +++.+++++..     .+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence            478889999999999999999999999999999643   233446778899999999765 57777777643     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence            799999999999999987654      577888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.........        ....+||+.|+||
T Consensus       147 ~~~~~~~~~~~--------~~~~~gt~~y~aP  170 (324)
T cd05587         147 MCKENIFGGKT--------TRTFCGTPDYIAP  170 (324)
T ss_pred             cceecCCCCCc--------eeeecCCccccCh
Confidence            98753221111        1125799999998

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=1.2e-29  Score=211.12  Aligned_cols=161  Identities=24%  Similarity=0.323  Sum_probs=134.1

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+..++..||+|+++..   .......+..|..++..+ +||||+++++++..     ....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence            4699999999999999999999999999743   223345678899999888 79999999998743     34579999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            9999999999887654      688899999999999999999999   9999999999999999999999999998743


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....+||+.|+||
T Consensus       147 ~~~~~~--------~~~~~gt~~y~aP  165 (329)
T cd05588         147 IRPGDT--------TSTFCGTPNYIAP  165 (329)
T ss_pred             ccCCCc--------cccccCCccccCH
Confidence            221111        1125799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=229.10  Aligned_cols=187  Identities=22%  Similarity=0.304  Sum_probs=149.9

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecC-CCC-
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSID-SKG-  119 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~-~~~-  119 (234)
                      ....+.++.+.|.+|||+.||+|.....+..||+|.+-..++...+.+.+|+++|+.|+ |+|||.+++...... ..+ 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            33456778899999999999999998888999999998778888899999999999997 999999999432222 222 


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      .--.+|.||||++|.|-+++..+...    +|++.+++.|+.|+++||.+||.. +.+|||||||.||+|++.+++.|||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence            23356889999999999999876543    699999999999999999999987 5679999999999999999999999


Q ss_pred             cCccccccCCCcc-CCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHL-DTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~-~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||.|........ .......+..+....|+.|.||
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsP  224 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSP  224 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccCh
Confidence            9999876443321 1111112223335678999988

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=1.7e-29  Score=207.77  Aligned_cols=168  Identities=26%  Similarity=0.436  Sum_probs=137.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++..     ....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-----CCeE
Confidence            3578999999999999999999999999999999974422 223467889999999999999999998743     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||++ ++|.+++.....     .+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~  149 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL  149 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence            99999995 588888765432     467788899999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........        ...||+.|+||
T Consensus       150 ~~~~~~~~~~~~--------~~~~~~~y~aP  172 (303)
T cd07869         150 ARAKSVPSHTYS--------NEVVTLWYRPP  172 (303)
T ss_pred             ceeccCCCccCC--------CCcccCCCCCh
Confidence            875432211110        14588899998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=211.29  Aligned_cols=169  Identities=28%  Similarity=0.349  Sum_probs=145.1

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..++|+.+++||+|.||+|.+|+.+.+++.+|+|+++..   .+......+.|-.+|...+||.+..+--.|     +++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence            346788999999999999999999999999999999733   344556678899999999999988775443     667


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      +.+|.||||..||.|+-.+....      .+++.....+..+|+.||.|||++   +||.||||.+|.|+|.+|++||+|
T Consensus       241 drlCFVMeyanGGeLf~HLsrer------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitD  311 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRER------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITD  311 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhhh------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeee
Confidence            88999999999999998887655      788889999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++.-........        .+||||.|.||
T Consensus       312 FGLCKE~I~~g~t~k--------TFCGTPEYLAP  337 (516)
T KOG0690|consen  312 FGLCKEEIKYGDTTK--------TFCGTPEYLAP  337 (516)
T ss_pred             cccchhcccccceec--------cccCChhhcCc
Confidence            999986443322221        38999999998

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.6e-30  Score=213.68  Aligned_cols=151  Identities=25%  Similarity=0.382  Sum_probs=132.4

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|+++..   .......+..|++++..++|+|++++++++.     ..++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence            3688899999999999999999999999999999743   2234467888999999999999999998764     3345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence            799999999999999998764      678889999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCC
Q 039258          203 LSKFLSSD  210 (234)
Q Consensus       203 ~a~~~~~~  210 (234)
                      ++......
T Consensus       147 ~~~~~~~~  154 (350)
T cd05573         147 LCKKMNKA  154 (350)
T ss_pred             CCccCccc
Confidence            99876543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.4e-30  Score=216.03  Aligned_cols=151  Identities=29%  Similarity=0.524  Sum_probs=129.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCC----eEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDE----MVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      ..+-...++||+|+||.||+|..+..+    ..||+|..+.+   .+.....+.+|+++|+.++||||++++|++.... 
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-  234 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-  234 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-
Confidence            344455689999999999999976432    23899999752   3455678999999999999999999999985443 


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                          .++||||+|+||+|.+++.....     .++..+.+.++.+.+.||+|||++   ++|||||..+|+|++.++.+|
T Consensus       235 ----Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  235 ----PLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             ----ccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence                37999999999999999998764     478889999999999999999999   999999999999999999999


Q ss_pred             EccCccccccC
Q 039258          198 VGDFGLSKFLS  208 (234)
Q Consensus       198 i~dfG~a~~~~  208 (234)
                      |+|||+++.-.
T Consensus       303 ISDFGLs~~~~  313 (474)
T KOG0194|consen  303 ISDFGLSRAGS  313 (474)
T ss_pred             eCccccccCCc
Confidence            99999988644

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=1.5e-29  Score=209.36  Aligned_cols=161  Identities=24%  Similarity=0.390  Sum_probs=131.6

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+..++..||+|+++..   .....+.+..|..++... +||||+++++++..     ....++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence            3699999999999999999999999999743   222334556677777654 89999999988743     34579999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            9999999999987654      578888899999999999999999   9999999999999999999999999999864


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....+||+.|+||
T Consensus       147 ~~~~~~--------~~~~~gt~~y~aP  165 (316)
T cd05592         147 MNGEGK--------ASTFCGTPDYIAP  165 (316)
T ss_pred             CCCCCc--------cccccCCccccCH
Confidence            332211        1125799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=1.7e-29  Score=210.42  Aligned_cols=168  Identities=27%  Similarity=0.359  Sum_probs=139.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +|++.+.||+|+||.||++.+..++..+|+|++...   .......+..|..++..++|+|++.+++++..     .+..
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCEE
Confidence            688899999999999999999999999999998632   22233457889999999999999999988743     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++.....     .+++..+..++.|++.|+.|+|++   +++||||||+||+++.++.+||+|||+
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~  148 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS  148 (332)
T ss_pred             EEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecch
Confidence            999999999999999976432     577888889999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........       ....+||+.|+||
T Consensus       149 a~~~~~~~~~~-------~~~~~gt~~y~aP  172 (332)
T cd05623         149 CLKLMEDGTVQ-------SSVAVGTPDYISP  172 (332)
T ss_pred             heecccCCcce-------ecccccCccccCH
Confidence            87654322111       0114699999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=1.5e-29  Score=210.04  Aligned_cols=166  Identities=26%  Similarity=0.376  Sum_probs=136.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      +|+..+.||+|+||.||+|.+..++..||+|++...   .....+.+..|..++..+. |++++++.+++..     .+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence            467788999999999999999999999999999743   2233456778888888886 5677778877643     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence            799999999999999987654      578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++.........        ....||+.|+||
T Consensus       147 ~~~~~~~~~~~~--------~~~~gt~~y~aP  170 (323)
T cd05615         147 MCKEHMVDGVTT--------RTFCGTPDYIAP  170 (323)
T ss_pred             cccccCCCCccc--------cCccCCccccCH
Confidence            987543322111        125699999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=1.9e-29  Score=210.07  Aligned_cols=167  Identities=25%  Similarity=0.350  Sum_probs=136.8

Q ss_pred             CCCCCceeecccceEEEEEEEC---CCCeEEEEEEeecc----cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILG---EDEMVVAVKVINLK----QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSK  118 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~  118 (234)
                      +|++.+.||+|+||.||++++.   .++..||+|++...    .....+.+..|+.++..+ +|+||+.+++++..    
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----   76 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT----   76 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence            4788899999999999999864   46889999999632    122345678899999999 58999999888642    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                       .+..++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||
T Consensus        77 -~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl  146 (332)
T cd05614          77 -EAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL  146 (332)
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence             345789999999999999987654      578888999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++.........       ....+||+.|+||
T Consensus       147 ~DfG~~~~~~~~~~~~-------~~~~~gt~~y~aP  175 (332)
T cd05614         147 TDFGLSKEFLSEEKER-------TYSFCGTIEYMAP  175 (332)
T ss_pred             eeCcCCccccccCCCc-------cccccCCccccCH
Confidence            9999988654322111       1125799999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=2.1e-29  Score=209.12  Aligned_cols=166  Identities=25%  Similarity=0.359  Sum_probs=136.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      +|...+.||+|+||.||+|.+..++..||+|++....   ......+..|..++..+ +|++++.+++++..     .+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence            5788899999999999999999999999999997431   22334567788888777 57888888888743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence            799999999999999987654      577888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++.........        ...+||+.|+||
T Consensus       147 ~~~~~~~~~~~~--------~~~~gt~~y~aP  170 (323)
T cd05616         147 MCKENMWDGVTT--------KTFCGTPDYIAP  170 (323)
T ss_pred             CceecCCCCCcc--------ccCCCChhhcCH
Confidence            987543221111        125699999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=3.1e-29  Score=208.78  Aligned_cols=167  Identities=23%  Similarity=0.356  Sum_probs=141.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|+..+.||+|+||.||++.+..++..+|+|++.... ......+.+|++++..++|||++++++++...     +..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence            357899999999999999999999999999999997542 33446789999999999999999999987543     347


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++....      .+++..+..++.|++.|+.|+|++.  +++|+||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence            89999999999999997654      5778888999999999999999851  599999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.........          ...||+.|+||
T Consensus       151 ~~~~~~~~~~----------~~~g~~~y~aP  171 (331)
T cd06649         151 SGQLIDSMAN----------SFVGTRSYMSP  171 (331)
T ss_pred             cccccccccc----------cCCCCcCcCCH
Confidence            8765432111          14689999998

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=1.6e-29  Score=209.58  Aligned_cols=161  Identities=27%  Similarity=0.386  Sum_probs=133.2

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|++..+++.||+|++...   .....+.+..|.+++..+ +||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence            3689999999999999999999999999643   223345677888888866 79999999998753     34479999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|..++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...
T Consensus        76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999887654      577888899999999999999999   9999999999999999999999999998754


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......        ...+||+.|+||
T Consensus       147 ~~~~~~~--------~~~~gt~~y~aP  165 (321)
T cd05591         147 ILNGVTT--------TTFCGTPDYIAP  165 (321)
T ss_pred             ccCCccc--------cccccCccccCH
Confidence            3221111        125699999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.9e-30  Score=216.06  Aligned_cols=170  Identities=25%  Similarity=0.438  Sum_probs=146.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|..++++|+|+||.++.++++..+..+++|.+....  ....+...+|+.++++++||||+.+.+.++    .++.++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            46888999999999999999999999999999997553  333456789999999999999999999874    233447


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      +|||+||+||++.+.+......    -+++..+..++.|++.|+.|||++   .|+|||||+.||+++.++.||+.|||+
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~----~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl  152 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGV----LFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL  152 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence            9999999999999999876522    688999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+.+.+....        ....+||+.||+|
T Consensus       153 aK~l~~~~~~--------a~tvvGTp~YmcP  175 (426)
T KOG0589|consen  153 AKILNPEDSL--------ASTVVGTPYYMCP  175 (426)
T ss_pred             hhhcCCchhh--------hheecCCCcccCH
Confidence            9988775421        1237899999998

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=2.5e-29  Score=209.17  Aligned_cols=161  Identities=25%  Similarity=0.343  Sum_probs=133.1

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+..+++.+|+|+++..   .......+..|+.++..+ +||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence            4699999999999999999999999999743   223345677888888776 79999999998743     34479999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|..++....      .+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            9999999998887654      578889999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....+||+.|+||
T Consensus       147 ~~~~~~--------~~~~~gt~~y~aP  165 (329)
T cd05618         147 LRPGDT--------TSTFCGTPNYIAP  165 (329)
T ss_pred             cCCCCc--------cccccCCccccCH
Confidence            221111        1125799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=2.1e-29  Score=209.13  Aligned_cols=164  Identities=26%  Similarity=0.379  Sum_probs=133.0

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHH---HhcCCCCceeEEEEeeecCCCCCC
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEAL---RNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      |++.+.||+|+||.||+|.+..++..||||+++...   ....+.+.+|..++   ..++||||+++++++..     .+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence            567889999999999999999999999999997431   22334566666555   46679999999998743     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|..++...       .+++..+..++.|++.|+.|||++   +++||||||+||+++.++.+||+||
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence            579999999999998887542       578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++........        ....+||+.|+||
T Consensus       146 g~~~~~~~~~~~--------~~~~~g~~~y~aP  170 (324)
T cd05589         146 GLCKEGMGFGDR--------TSTFCGTPEFLAP  170 (324)
T ss_pred             cCCccCCCCCCc--------ccccccCccccCH
Confidence            998753322111        1126799999998

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=6.2e-29  Score=202.88  Aligned_cols=171  Identities=25%  Similarity=0.445  Sum_probs=136.3

Q ss_pred             CCCCCceeecccceEEEEEEECC-CCeEEEEEEeeccc--chhhHHHHHHHHHHHhc---CCCCceeEEEEeeecCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGE-DEMVVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~l~~~~~~~~~~~~  120 (234)
                      +|++.+.||+|+||.||+|.+.. ++..||+|.++...  ......+.+|+.++..+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68889999999999999999854 56889999986432  22234566777777665   69999999998865444445


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||++ ++|.+++......    .+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+||+|
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence            56799999996 5999998764322    478888999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++........         ....||+.|+||
T Consensus       154 fg~~~~~~~~~~~---------~~~~~~~~y~aP  178 (290)
T cd07862         154 FGLARIYSFQMAL---------TSVVVTLWYRAP  178 (290)
T ss_pred             ccceEeccCCccc---------ccccccccccCh
Confidence            9999865432111         125689999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=2.6e-29  Score=208.32  Aligned_cols=161  Identities=27%  Similarity=0.393  Sum_probs=133.1

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+..++..||+|++...   .....+.+..|..++..+ +||||+++++++..     .+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence            3699999999999999999999999999643   223345677888888776 69999999998743     34579999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            9999999999887654      578888999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......        ....||+.|+||
T Consensus       147 ~~~~~~~--------~~~~gt~~y~aP  165 (320)
T cd05590         147 IFNGKTT--------STFCGTPDYIAP  165 (320)
T ss_pred             CcCCCcc--------cccccCccccCH
Confidence            3221111        125699999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=2.2e-29  Score=205.24  Aligned_cols=168  Identities=27%  Similarity=0.382  Sum_probs=136.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ++|++.+.||+|+||.||+|++..++..+|+|.++...  ....+.+.+|+.++..++||||+++++++..     .+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence            36888999999999999999999999999999997432  2334678899999999999999999988743     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||++++.+..+.....      .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMPN------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence            99999998866654433222      578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........       ....||+.|+||
T Consensus       147 ~~~~~~~~~~~~-------~~~~~~~~y~aP  170 (287)
T cd07848         147 ARNLSEGSNANY-------TEYVATRWYRSP  170 (287)
T ss_pred             cccccccccccc-------cccccccccCCc
Confidence            987543221111       114689999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.1e-29  Score=206.54  Aligned_cols=150  Identities=27%  Similarity=0.361  Sum_probs=134.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..|+.++.||.|.-|+||+|+.+.++..+|+|+++..   .+....+...|-++|..++||.++.|+..+.     +..+
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-----t~~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE-----TDKY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee-----ccce
Confidence            3577789999999999999999999999999999743   3455677888999999999999999999874     4566


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .+++||||+||+|..+.+.+...    .+++..+..++.+++.||+|||-.   |||.|||||+|||+..+|+|.++||.
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD  224 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD  224 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence            89999999999999999887654    789999999999999999999999   99999999999999999999999999


Q ss_pred             ccccc
Q 039258          203 LSKFL  207 (234)
Q Consensus       203 ~a~~~  207 (234)
                      ++...
T Consensus       225 LS~~~  229 (459)
T KOG0610|consen  225 LSLRC  229 (459)
T ss_pred             ccccC
Confidence            87654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=3.6e-29  Score=207.68  Aligned_cols=161  Identities=25%  Similarity=0.373  Sum_probs=131.7

Q ss_pred             ceeecccceEEEEEEEC---CCCeEEEEEEeecc----cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           52 NMIGQGSYGSVYKGILG---EDEMVVAVKVINLK----QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +.||+|+||.||++++.   .+++.||+|+++..    .......+..|++++..++||||+++++++..     .+..+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeEE
Confidence            57999999999999864   46789999999642    12233567789999999999999999988743     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++...+      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        77 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  147 (323)
T cd05584          77 LILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC  147 (323)
T ss_pred             EEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence            9999999999999987654      567778888999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.........        ...+||+.|+||
T Consensus       148 ~~~~~~~~~~--------~~~~gt~~y~aP  169 (323)
T cd05584         148 KESIHEGTVT--------HTFCGTIEYMAP  169 (323)
T ss_pred             eecccCCCcc--------cccCCCccccCh
Confidence            7533221111        125699999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=2.9e-29  Score=218.50  Aligned_cols=172  Identities=22%  Similarity=0.300  Sum_probs=140.9

Q ss_pred             CCCCCceeecccceEEEEEEECCC-CeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGED-EMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .|.+.+.||+|+||.||+|....+ +..||+|.+..........+..|+.++..++||||+++++.+..     .+..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEEEE
Confidence            488899999999999999998777 78899998765544444667889999999999999999998754     345799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++......  ...+++..+..++.|++.||.|+|++   +|+||||||+||+++.++.+||+|||+++
T Consensus       143 v~E~~~gg~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~  217 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKE--HLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK  217 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence            99999999999988653211  11577888899999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........      .....+||+.|+||
T Consensus       218 ~~~~~~~~~------~~~~~~gt~~y~aP  240 (478)
T PTZ00267        218 QYSDSVSLD------VASSFCGTPYYLAP  240 (478)
T ss_pred             ecCCccccc------cccccCCCccccCH
Confidence            765432111      11126799999998

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.96  E-value=3.2e-29  Score=208.15  Aligned_cols=161  Identities=29%  Similarity=0.400  Sum_probs=130.2

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHH-HHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECE-ALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||+||+|.+..++..+|+|++...   .......+..|.. ++..++||||+++++.+..     .+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence            4699999999999999999999999999643   1222344555554 4677899999999988743     34479999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|..++....      .+++..+..++.||+.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            9999999998887654      678889999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....+||+.|+||
T Consensus       147 ~~~~~~--------~~~~~gt~~y~aP  165 (325)
T cd05604         147 IAQSDT--------TTTFCGTPEYLAP  165 (325)
T ss_pred             CCCCCC--------cccccCChhhCCH
Confidence            221111        1125799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5e-29  Score=203.27  Aligned_cols=167  Identities=25%  Similarity=0.379  Sum_probs=138.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +|+..+.||+|+||.||++.+..++..||+|.+....   ......+.+|+.++..++|+|++.+++.+..     .++.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence            4778899999999999999999899999999986432   2223457789999999999999999988743     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++......    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNP----GFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence            9999999999999888654321    578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........         ...|++.|+||
T Consensus       149 ~~~~~~~~~~~---------~~~~~~~y~aP  170 (285)
T cd05605         149 AVEIPEGETIR---------GRVGTVGYMAP  170 (285)
T ss_pred             ceecCCCCccc---------cccCCCCccCc
Confidence            88654322111         14688899988

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=4.7e-29  Score=205.12  Aligned_cols=176  Identities=23%  Similarity=0.399  Sum_probs=136.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECC----------------CCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCcee
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGE----------------DEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTK  107 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~  107 (234)
                      ..+|.+.+.||+|+||.||+|.+..                ++..||+|++.... ......+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3568888999999999999998532                34579999986442 333467899999999999999999


Q ss_pred             EEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCC-------------ccccccCHHHHHHHHHHHHHHHHHHHhCC
Q 039258          108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDH-------------LEVFKLSLIQRVNIAIDVASAIEYLHHNC  174 (234)
Q Consensus       108 l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~  174 (234)
                      +++++...     +..++||||+++++|.+++......             .....+++..+..++.|++.|+.|||+. 
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-  157 (304)
T cd05096          84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-  157 (304)
T ss_pred             EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence            99988543     3469999999999999998653211             0112456778889999999999999999 


Q ss_pred             CCCeeecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          175 QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       175 ~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                        +++||||||+||+++.++.+||+|||+++...........      ....++..||||
T Consensus       158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~------~~~~~~~~y~aP  209 (304)
T cd05096         158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ------GRAVLPIRWMAW  209 (304)
T ss_pred             --CccccCcchhheEEcCCccEEECCCccceecccCceeEec------CcCCCCccccCH
Confidence              9999999999999999999999999999865433211110      013456778887

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.96  E-value=3.7e-29  Score=207.07  Aligned_cols=161  Identities=23%  Similarity=0.368  Sum_probs=132.0

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|++..++..||+|+++...   .........|..++... +|||++++++++..     .++.++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence            46999999999999999999999999997431   22345567788888754 89999999998743     34579999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++....      .+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||+++..
T Consensus        76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            9999999999987654      577888999999999999999999   9999999999999999999999999998743


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....+||+.|+||
T Consensus       147 ~~~~~~--------~~~~~gt~~y~aP  165 (316)
T cd05620         147 VFGDNR--------ASTFCGTPDYIAP  165 (316)
T ss_pred             ccCCCc--------eeccCCCcCccCH
Confidence            221110        1126799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.96  E-value=4.6e-29  Score=207.19  Aligned_cols=161  Identities=31%  Similarity=0.409  Sum_probs=129.0

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHH-HHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|++..++..+|+|++....   ......+..|.. ++..++|+||+++++.+..     .+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence            36999999999999999999999999996432   122233444444 4677899999999988743     34479999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++....      .+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            9999999999987654      567788888999999999999999   9999999999999999999999999998754


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....+||+.|+||
T Consensus       147 ~~~~~~--------~~~~~gt~~y~aP  165 (325)
T cd05602         147 IEHNGT--------TSTFCGTPEYLAP  165 (325)
T ss_pred             ccCCCC--------cccccCCccccCH
Confidence            322111        1125799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.96  E-value=5.2e-29  Score=206.74  Aligned_cols=161  Identities=31%  Similarity=0.416  Sum_probs=129.9

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHH-HHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||+||+|.+..+++.||+|++....   ......+..|.. ++..++||||+++++.+..     .+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence            46999999999999999999999999996432   222234555544 4577899999999988743     34479999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|..++....      .+++..+..++.||+.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            9999999999987654      577888899999999999999999   9999999999999999999999999998753


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....+||+.|+||
T Consensus       147 ~~~~~~--------~~~~~gt~~y~aP  165 (323)
T cd05575         147 IEHSKT--------TSTFCGTPEYLAP  165 (323)
T ss_pred             ccCCCc--------cccccCChhhcCh
Confidence            221111        1125799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.96  E-value=5.1e-29  Score=206.23  Aligned_cols=161  Identities=25%  Similarity=0.406  Sum_probs=131.9

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||+||+|.+..++..||+|+++...   .........|..++... +||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence            46999999999999999999999999997431   22335566788888764 89999999998743     34579999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            9999999999987654      577888899999999999999999   9999999999999999999999999998753


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        .....||+.|+||
T Consensus       147 ~~~~~~--------~~~~~gt~~y~aP  165 (316)
T cd05619         147 MLGDAK--------TCTFCGTPDYIAP  165 (316)
T ss_pred             CCCCCc--------eeeecCCccccCH
Confidence            221111        1125699999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.7e-31  Score=213.95  Aligned_cols=167  Identities=28%  Similarity=0.428  Sum_probs=145.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..|+..+.||+|+||.||+|.+..+++.||+|+++.. .+...+.+.+|+.++..++++||.++++.+...     ..++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccHH
Confidence            4577788999999999999999999999999999865 345568899999999999999999999987443     3479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||+.||++.+.+...+      .+.+..+..++++++.|+.|+|..   +.+|||||+.||++..+|.+|++|||.+
T Consensus        88 iiMey~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa  158 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA  158 (467)
T ss_pred             HHHHHhcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence            9999999999999998765      446667777889999999999999   9999999999999998899999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .++........        .++|||.||||
T Consensus       159 ~ql~~~~~rr~--------tfvGTPfwMAP  180 (467)
T KOG0201|consen  159 GQLTNTVKRRK--------TFVGTPFWMAP  180 (467)
T ss_pred             eeeechhhccc--------cccccccccch
Confidence            98776544432        38999999999

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.96  E-value=5.6e-29  Score=206.30  Aligned_cols=161  Identities=32%  Similarity=0.398  Sum_probs=129.5

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHH-HHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECE-ALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|++..++..||+|++....   ......+..|.. ++..++||||+++++.+..     .+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence            36999999999999999999999999996431   222344555554 5778899999999988743     34479999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|...+....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            9999999998887544      577788889999999999999999   9999999999999999999999999998753


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....+||+.|+||
T Consensus       147 ~~~~~~--------~~~~~gt~~y~aP  165 (321)
T cd05603         147 VEPEET--------TSTFCGTPEYLAP  165 (321)
T ss_pred             CCCCCc--------cccccCCcccCCH
Confidence            222111        1125799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=4.3e-29  Score=212.19  Aligned_cols=161  Identities=24%  Similarity=0.359  Sum_probs=135.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      ..|++.+.||+|+||.||+|.+..+++.||+|...      ...+.+|++++..++||||+++++++..     ....++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEE
Confidence            57999999999999999999999999999999653      1346789999999999999999998753     334689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      |||++. ++|..++....      .+++..++.++.|++.||.|+|++   +|+||||||+||+++.++.+||+|||+++
T Consensus       161 v~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~  230 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC  230 (391)
T ss_pred             EEecCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence            999995 68988887654      577888999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........       ....+||+.|+||
T Consensus       231 ~~~~~~~~~-------~~~~~gt~~y~aP  252 (391)
T PHA03212        231 FPVDINANK-------YYGWAGTIATNAP  252 (391)
T ss_pred             ccccccccc-------cccccCccCCCCh
Confidence            543321111       1125799999998

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.96  E-value=4.8e-29  Score=206.44  Aligned_cols=161  Identities=25%  Similarity=0.341  Sum_probs=132.9

Q ss_pred             ceeecccceEEEEEEE---CCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceee
Q 039258           52 NMIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      +.||+|+||.||++++   ..++..+|+|+++...  ......+..|++++..++||||+++++++..     .+..++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence            5799999999999886   3578999999997432  1223456789999999999999999998743     3457999


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      |||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus        77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence            99999999999987654      578889999999999999999999   999999999999999999999999999886


Q ss_pred             cCCCccCCCCCCCCccccccccccccCC
Q 039258          207 LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......        .....||+.|+||
T Consensus       148 ~~~~~~~--------~~~~~g~~~y~aP  167 (318)
T cd05582         148 SIDHEKK--------AYSFCGTVEYMAP  167 (318)
T ss_pred             cCCCCCc--------eecccCChhhcCH
Confidence            5432111        1125689999998

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-30  Score=218.67  Aligned_cols=161  Identities=29%  Similarity=0.446  Sum_probs=140.4

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      |..++.||.|+||.||-|++..+...||||.+....+   ..+.++++|+..|..++|||.+.+-|+|-.     ...-|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchHH
Confidence            6667889999999999999999999999999976544   356889999999999999999999998732     33469


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||| -|+-.+++..+..     ++.+..+.-|..+.+.||.|||+.   +.||||||..|||+...|.||++|||.|
T Consensus       103 LVMEYC-lGSAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA  173 (948)
T KOG0577|consen  103 LVMEYC-LGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA  173 (948)
T ss_pred             HHHHHH-hccHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence            999999 5688888876654     677888889999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+..+..            .|+|||.||||
T Consensus       174 si~~PAn------------sFvGTPywMAP  191 (948)
T KOG0577|consen  174 SIMAPAN------------SFVGTPYWMAP  191 (948)
T ss_pred             hhcCchh------------cccCCccccch
Confidence            9766532            28899999999

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=7.6e-29  Score=206.60  Aligned_cols=167  Identities=23%  Similarity=0.378  Sum_probs=140.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|+..+.||+|+||.||++.+..++..+|+|++... .......+.+|++++..++|+||+++++++...     +..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence            46789999999999999999999999999999998754 233446788999999999999999999998542     347


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++....      .+++..+..++.|++.|+.|+|++.  +++|+||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence            99999999999999997654      5677888899999999999999741  699999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.........          ...||..|+||
T Consensus       151 ~~~~~~~~~~----------~~~~~~~y~aP  171 (333)
T cd06650         151 SGQLIDSMAN----------SFVGTRSYMSP  171 (333)
T ss_pred             chhhhhhccc----------cCCCCccccCH
Confidence            8765432111          14688899988

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.96  E-value=6e-29  Score=206.73  Aligned_cols=161  Identities=25%  Similarity=0.341  Sum_probs=133.6

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+..++..+|+|+++..   .....+.+..|..++..+ +||||+.+++++..     ...+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence            3699999999999999999999999999743   223345678899999888 69999999998743     34479999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|..++....      .+++..+..++.|++.|+.|||++   +++||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            9999999999887654      688899999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....+||+.|+||
T Consensus       147 ~~~~~~--------~~~~~gt~~y~aP  165 (327)
T cd05617         147 LGPGDT--------TSTFCGTPNYIAP  165 (327)
T ss_pred             cCCCCc--------eecccCCcccCCH
Confidence            221111        1126799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=2.9e-30  Score=219.16  Aligned_cols=166  Identities=22%  Similarity=0.485  Sum_probs=144.0

Q ss_pred             CCCceeecccceEEEEEEECCCCeEEEEEEeec----ccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           49 SQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL----KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +...+||+|+|-+||+|.+..+|.+||.-.++.    ..+...++|..|+++|+.|+|+||+++++.+.+...   ..+.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            445689999999999999999999999777653    234456889999999999999999999998876543   4567


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC-CCCceEEccCcc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGL  203 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~-~~~~vki~dfG~  203 (234)
                      +|+|.+..|+|..|+++.+      +.....+..+++||+.||.|||++ .++|||||||..||+++ +.|.|||.|+|+
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             eeeecccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence            8999999999999999887      677788999999999999999998 66899999999999997 679999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |..+.......          ..|||.||||
T Consensus       193 Atl~r~s~aks----------vIGTPEFMAP  213 (632)
T KOG0584|consen  193 ATLLRKSHAKS----------VIGTPEFMAP  213 (632)
T ss_pred             HHHhhccccce----------eccCccccCh
Confidence            99877765432          6799999998

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=7.8e-29  Score=209.49  Aligned_cols=171  Identities=23%  Similarity=0.303  Sum_probs=139.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.||+|.+..++..||+|.+...  .....+.+.+|++++..++|+||+++++++...+.......+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999989999999998632  223346788999999999999999999988654422233578


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+. ++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence            9999996 58888876543      678889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........       ...||+.|+||
T Consensus       151 ~~~~~~~~~~~~-------~~~~~~~y~aP  173 (372)
T cd07853         151 RVEEPDESKHMT-------QEVVTQYYRAP  173 (372)
T ss_pred             eecccCccccCC-------CCCcCCCcCCH
Confidence            865433211110       13578888887

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.96  E-value=4.2e-29  Score=209.70  Aligned_cols=163  Identities=32%  Similarity=0.473  Sum_probs=133.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+|+..+.||+|+||.||+|.+..+++.||||++.... ......+.+|++++..++|+||+++++++..     .+.++
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----NGEIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----CCeEE
Confidence            45777889999999999999999999999999996442 2334678899999999999999999998743     34478


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+..          ...+..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus       149 lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        149 VLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             EEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999886432          344567788999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.........        ....||..|+||
T Consensus       216 ~~~~~~~~~~--------~~~~gt~~y~aP  237 (353)
T PLN00034        216 RILAQTMDPC--------NSSVGTIAYMSP  237 (353)
T ss_pred             eecccccccc--------cccccCccccCc
Confidence            8654321110        014689999988

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=7.8e-29  Score=216.33  Aligned_cols=180  Identities=26%  Similarity=0.328  Sum_probs=144.3

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC---
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK---  118 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~---  118 (234)
                      ...+|++.+.||+|+||.||+|.+..++..||||++...  .......+.+|+..+..++|+|++++.+.+...+..   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346899999999999999999999999999999999644  233446788899999999999999988766433221   


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                      ....+++||||+++++|.+++.......  ..+++..+..++.|++.||.|+|++   +|+||||||+||+++.++.+||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~--~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTN--RTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence            1224679999999999999987643211  2578888999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++.+........      ....+||+.|+||
T Consensus       185 ~DFGls~~~~~~~~~~~------~~~~~Gt~~Y~aP  214 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDV------GRTFCGTPYYVAP  214 (496)
T ss_pred             EecccCeeccccccccc------cccccCCcceeCH
Confidence            99999987654321111      1125799999998

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=1.7e-28  Score=200.02  Aligned_cols=171  Identities=27%  Similarity=0.460  Sum_probs=137.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhc---CCCCceeEEEEeeecCCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      +|+..+.||+|+||.||+|.+..++..||+|.++...  ........+|++++..+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999999999999999987432  22234556677777655   699999999988654444456


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..+++||++++ +|.+++......    .+++..+..++.|++.||.|+|++   +++|+||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPP----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            67899999974 898888764321    478889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........         ...||..|+||
T Consensus       153 g~~~~~~~~~~~~---------~~~~~~~y~aP  176 (288)
T cd07863         153 GLARIYSCQMALT---------PVVVTLWYRAP  176 (288)
T ss_pred             CccccccCcccCC---------CccccccccCc
Confidence            9998654322111         14588889998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.96  E-value=1.2e-28  Score=200.47  Aligned_cols=163  Identities=25%  Similarity=0.392  Sum_probs=132.4

Q ss_pred             eecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           54 IGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        54 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      ||+|+||+||+|.+..++..+|+|.+....   ....+.+..|+.++..++|+|++++.+++..     ....++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence            699999999999999999999999986432   2233567889999999999999999888643     34479999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~  210 (234)
                      ++++|.+++......  ...+++..+..++.|++.||.|+|++   +++||||||+||+++.++.++|+|||++......
T Consensus        76 ~~g~L~~~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          76 NGGDLRYHIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            999999887543211  11578889999999999999999999   9999999999999999999999999998765432


Q ss_pred             ccCCCCCCCCccccccccccccCC
Q 039258          211 HLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       211 ~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ....        ....||+.|+||
T Consensus       151 ~~~~--------~~~~g~~~y~aP  166 (280)
T cd05608         151 QSKT--------KGYAGTPGFMAP  166 (280)
T ss_pred             Cccc--------cccCCCcCccCH
Confidence            2111        125689999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=232.07  Aligned_cols=173  Identities=26%  Similarity=0.338  Sum_probs=149.7

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      +.-...+|.++++||+|+||.|.+++++.+++.||+|+++.+   .+.....|..|-++|..-+.+.|+.++-.|     
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----  144 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----  144 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----
Confidence            334456899999999999999999999999999999999753   345557789999999999999999998765     


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                      .+..++|+||||++||+|..++.+..      .+++.++.++...|+.|+.-+|+.   |.|||||||.|||+|..|++|
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEe
Confidence            56677999999999999999998765      689999999999999999999999   999999999999999999999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++|||.|-.+..++.-       .+...+|||-|+||
T Consensus       216 LADFGsClkm~~dG~V-------~s~~aVGTPDYISP  245 (1317)
T KOG0612|consen  216 LADFGSCLKMDADGTV-------RSSVAVGTPDYISP  245 (1317)
T ss_pred             eccchhHHhcCCCCcE-------EeccccCCCCccCH
Confidence            9999988766654322       12236799999998

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.2e-28  Score=205.14  Aligned_cols=159  Identities=29%  Similarity=0.364  Sum_probs=128.4

Q ss_pred             eecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhc---CCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           54 IGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNI---RHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        54 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      ||+|+||+||+|++..++..||+|++....   .........|..++...   +||||+.+++.+..     ....++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence            699999999999999999999999996331   12223455566666554   69999999988743     34479999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+||+++.++.++|+|||++...
T Consensus        76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            9999999999887654      578889999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......        ...+||+.|+||
T Consensus       147 ~~~~~~~--------~~~~gt~~y~aP  165 (330)
T cd05586         147 LTDNKTT--------NTFCGTTEYLAP  165 (330)
T ss_pred             CCCCCCc--------cCccCCccccCH
Confidence            3221111        125799999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.1e-30  Score=209.46  Aligned_cols=171  Identities=23%  Similarity=0.344  Sum_probs=146.4

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ...+.|..-++||+|+||.||-|+.+.||+.+|+|.+..+   .+......+.|-.+|.+++.+.||.+-.+|     ++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eT  256 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ET  256 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cC
Confidence            3445788889999999999999999999999999988532   333445678899999999999999997776     45


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      .+.+++||..|.||+|.-.|.+.++.    .+++..++.++.+|+.||++||..   +||.|||||+|||+|..|+++|+
T Consensus       257 kd~LClVLtlMNGGDLkfHiyn~g~~----gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRIS  329 (591)
T KOG0986|consen  257 KDALCLVLTLMNGGDLKFHIYNHGNP----GFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRIS  329 (591)
T ss_pred             CCceEEEEEeecCCceeEEeeccCCC----CCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEee
Confidence            56699999999999999988877653    789999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|+|..+.....-.         +.+||.+||||
T Consensus       330 DLGLAvei~~g~~~~---------~rvGT~GYMAP  355 (591)
T KOG0986|consen  330 DLGLAVEIPEGKPIR---------GRVGTVGYMAP  355 (591)
T ss_pred             ccceEEecCCCCccc---------cccCcccccCH
Confidence            999998765532111         14799999998

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=2.6e-28  Score=196.86  Aligned_cols=168  Identities=27%  Similarity=0.407  Sum_probs=140.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+..++..+|+|++..........+.+|+.++..++|||++++++.+..     ....+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEE
Confidence            3469999999999999999999999999999999975544444667889999999999999999998753     23478


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++....      .+++..+..++.|++.|+.|+|+.   +++|+|++|+||+++.++.++++|||++
T Consensus        83 iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~  153 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA  153 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence            9999999999999887544      578888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....|++.|+||
T Consensus       154 ~~~~~~~~~~--------~~~~~~~~y~~P  175 (267)
T cd06646         154 AKITATIAKR--------KSFIGTPYWMAP  175 (267)
T ss_pred             eeeccccccc--------CccccCccccCH
Confidence            8654321111        114577888887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=1.4e-28  Score=203.73  Aligned_cols=161  Identities=25%  Similarity=0.393  Sum_probs=133.4

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+..++..||+|+++..   .......+..|..++..+ +||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence            4699999999999999999999999999743   223345677888888877 69999999998743     34579999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|..++....      .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            9999999999887654      578889999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......        ....+||+.|+||
T Consensus       147 ~~~~~~--------~~~~~g~~~y~aP  165 (318)
T cd05570         147 ILGGVT--------TSTFCGTPDYIAP  165 (318)
T ss_pred             CcCCCc--------ccceecCccccCH
Confidence            221111        1125689999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.96  E-value=1.5e-28  Score=211.84  Aligned_cols=171  Identities=23%  Similarity=0.352  Sum_probs=134.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC---CCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS---KGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~---~~~~  121 (234)
                      ..+|+..+.||+|+||.||+|.+..+++.||||.+....    ....+|+.++..++||||+++.+++.....   ....
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            357999999999999999999999999999999885332    233579999999999999999887644321   2234


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC-CceEEcc
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND-MVAHVGD  200 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~-~~vki~d  200 (234)
                      ++++||||+++ ++.+++.......  ..+++..+..++.|++.||.|||++   +|+||||||+||+++.+ +.+||+|
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~--~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNN--HALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence            56799999964 7877775422111  1578888899999999999999999   99999999999999865 4799999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|+.+......         ....||+.|+||
T Consensus       215 FGla~~~~~~~~~---------~~~~~t~~y~aP  239 (440)
T PTZ00036        215 FGSAKNLLAGQRS---------VSYICSRFYRAP  239 (440)
T ss_pred             cccchhccCCCCc---------ccCCCCcCccCH
Confidence            9999865432211         125689999998

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.96  E-value=1.4e-29  Score=221.56  Aligned_cols=174  Identities=29%  Similarity=0.504  Sum_probs=141.9

Q ss_pred             CCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      +-...+.||+|+||+||+|+..     .....||||.++..... ..++|.+|++++..++|||||+|+|+|...     
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-----  561 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG-----  561 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-----
Confidence            3444678999999999999864     34578999999866544 668999999999999999999999999543     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCc--------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHL--------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN  192 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~  192 (234)
                      +.+++|+|||+.|||.+|++.+....        .+..++..+.+.++.||+.||.||.++   .+|||||.++|+||..
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence            34799999999999999998643321        133488899999999999999999999   9999999999999999


Q ss_pred             CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..|||+|||+++-.....+......      ..-..+||||
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~------t~lPIRWMpp  674 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGN------TLLPIRWMPP  674 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCC------ceeeeecCCH
Confidence            99999999999997665554442211      2345689987

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=2.4e-28  Score=202.07  Aligned_cols=169  Identities=25%  Similarity=0.476  Sum_probs=135.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCe----EEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEM----VVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|+..+.||+|+||.||+|.+..++.    .||+|.++... ....+.+.+|+.++..++||||++++++|...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            468899999999999999998765544    48999986432 33456788999999999999999999988532     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                       ..++++||+++|+|.+++.....     .+++...+.++.|++.||.|||++   +++||||||+||+++.++.+||+|
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D  152 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD  152 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence             24799999999999999886542     467778889999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++............      ...++..|+||
T Consensus       153 fG~a~~~~~~~~~~~~~------~~~~~~~y~ap  180 (316)
T cd05108         153 FGLAKLLGADEKEYHAE------GGKVPIKWMAL  180 (316)
T ss_pred             ccccccccCCCcceecc------CCccceeecCh
Confidence            99998765432211100      12345678887

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=218.41  Aligned_cols=163  Identities=31%  Similarity=0.554  Sum_probs=140.0

Q ss_pred             cChHHHHHHhcCC---------CCCceeecccceEEEEEEECCCC---eEEEEEEeeccc-chhhHHHHHHHHHHHhcCC
Q 039258           36 VSYAELSKATCEF---------SQSNMIGQGSYGSVYKGILGEDE---MVVAVKVINLKQ-KGAFRSFVAECEALRNIRH  102 (234)
Q Consensus        36 ~~~~~~~~~~~~~---------~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h  102 (234)
                      +++++...+..+|         .+.++||.|.||.||.|+.+..+   ..||||.++... +.....|+.|+.+|..+.|
T Consensus       610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH  689 (996)
T KOG0196|consen  610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH  689 (996)
T ss_pred             ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence            4566665555544         44789999999999999987544   689999998653 4456789999999999999


Q ss_pred             CCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039258          103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD  182 (234)
Q Consensus       103 ~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~d  182 (234)
                      |||++|.|+.....     ..+||+|||++|+|..||+++.+     .|++.+...+.+.|+.|+.||.+.   +.||||
T Consensus       690 PNIIrLEGVVTks~-----PvMIiTEyMENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsdm---~YVHRD  756 (996)
T KOG0196|consen  690 PNIIRLEGVVTKSK-----PVMIITEYMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSDM---NYVHRD  756 (996)
T ss_pred             CcEEEEEEEEecCc-----eeEEEhhhhhCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhhc---Cchhhh
Confidence            99999999975433     36899999999999999998764     588889999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCceEEccCccccccCCCc
Q 039258          183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDH  211 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG~a~~~~~~~  211 (234)
                      |..+|||++.+-.+|++|||+++.+.++.
T Consensus       757 LAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  757 LAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhhheeeccceEEEeccccceeecccCC
Confidence            99999999999999999999999887665

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.96  E-value=1.7e-28  Score=207.56  Aligned_cols=176  Identities=22%  Similarity=0.398  Sum_probs=136.4

Q ss_pred             hcCCCCCceeecccceEEEEEEE-----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~  117 (234)
                      ..+|++.+.||+|+||.||+|.+     ..++..||+|+++... ....+.+.+|+.++..+ +||||++++++|..   
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~---  110 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV---  110 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence            44688899999999999999974     3456789999986432 23346788999999999 89999999998743   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCC----------------------------------------------------
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDH----------------------------------------------------  145 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------------------------------------------  145 (234)
                        .+..++||||+++|+|.+++......                                                    
T Consensus       111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence              33468999999999999998653210                                                    


Q ss_pred             -----------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          146 -----------------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       146 -----------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                                       .....+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                             0012467778899999999999999999   99999999999999999999999999998654


Q ss_pred             CCccCCCCCCCCccccccccccccCC
Q 039258          209 SDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ........      ....++..|+||
T Consensus       266 ~~~~~~~~------~~~~~~~~y~aP  285 (375)
T cd05104         266 NDSNYVVK------GNARLPVKWMAP  285 (375)
T ss_pred             Cccccccc------CCCCCCcceeCh
Confidence            43211110      012355678887

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=9.5e-29  Score=206.69  Aligned_cols=162  Identities=25%  Similarity=0.435  Sum_probs=133.9

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      .++||+|.||+||-|.++.+|+.||||+++.-  .......+..|+.+|..+.||.|+.+..-|+     +.+.+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E-----T~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE-----TPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec-----CCceEEEEeh
Confidence            46899999999999999999999999999632  1222367889999999999999999988774     4455899999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC---CCCceEEccCcccc
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSK  205 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~---~~~~vki~dfG~a~  205 (234)
                      -+ .|+..+-+......    ++++.....+..||+.||.|||.+   +|+|.||||+|+|+.   +.-.+|+||||+|+
T Consensus       644 Kl-~GDMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  644 KL-HGDMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             hh-cchHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence            99 55776655433222    788888899999999999999999   999999999999995   44589999999999


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +......         ++..+|||.|.||
T Consensus       716 iIgEksF---------RrsVVGTPAYLaP  735 (888)
T KOG4236|consen  716 IIGEKSF---------RRSVVGTPAYLAP  735 (888)
T ss_pred             ecchhhh---------hhhhcCCccccCH
Confidence            8776432         2237899999998

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=1.3e-28  Score=208.24  Aligned_cols=177  Identities=22%  Similarity=0.392  Sum_probs=136.9

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCC-----CeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGED-----EMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSID  116 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~  116 (234)
                      ...+|++.+.||+|+||.||+|.+..+     +..||+|.++... ....+.+.+|+.++..+ +|+||++++++|..  
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence            345788999999999999999986443     3579999997442 23346788999999999 89999999998743  


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCC---------------------------------------------------
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDH---------------------------------------------------  145 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------------------------------------------------  145 (234)
                         .+..++||||+++++|.+++......                                                   
T Consensus       114 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         114 ---GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             ---CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence               34479999999999999998643210                                                   


Q ss_pred             -------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCCcc
Q 039258          146 -------------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL  212 (234)
Q Consensus       146 -------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~  212 (234)
                                   .....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.......
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                         0112467788899999999999999999   999999999999999999999999999986544321


Q ss_pred             CCCCCCCCccccccccccccCC
Q 039258          213 DTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       213 ~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ....      ....++..||||
T Consensus       268 ~~~~------~~~~~~~~y~aP  283 (374)
T cd05106         268 YVVK------GNARLPVKWMAP  283 (374)
T ss_pred             eeec------cCCCCccceeCH
Confidence            1110      012355679887

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=3.6e-28  Score=200.37  Aligned_cols=167  Identities=25%  Similarity=0.452  Sum_probs=136.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+|...+.||+|+||.||+|.+..++..+|+|.++... ......+.+|++++..++|+|++++++++..     .+..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence            46888999999999999999999999999999997442 2233567889999999999999999998753     23479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++ +|.+++.....     .+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence            99999975 88888866542     467788889999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........        ...||+.|+||
T Consensus       152 ~~~~~~~~~~~--------~~~~~~~y~aP  173 (309)
T cd07872         152 RAKSVPTKTYS--------NEVVTLWYRPP  173 (309)
T ss_pred             eecCCCccccc--------cccccccccCC
Confidence            76433221110        13478888887

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=3.1e-28  Score=204.88  Aligned_cols=170  Identities=24%  Similarity=0.318  Sum_probs=136.7

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~  120 (234)
                      ...+|+..+.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.++..++||||+++++++..... ...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            356799999999999999999999999999999998633  23344678899999999999999999998754322 122


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++ ++.+.+..        .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence            346899999965 67666532        466777888999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++........         ....||+.|+||
T Consensus       167 fg~a~~~~~~~~~---------~~~~~t~~y~aP  191 (359)
T cd07876         167 FGLARTACTNFMM---------TPYVVTRYYRAP  191 (359)
T ss_pred             CCCccccccCccC---------CCCcccCCCCCc
Confidence            9999754332111         114688999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=1.8e-28  Score=197.76  Aligned_cols=167  Identities=28%  Similarity=0.410  Sum_probs=141.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|+..+.||+|+||.||+|.+..++..+|+|.++.........+.+|+.++..++|||++++++.+..     .+..++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEE
Confidence            367778899999999999999999999999999976554445678889999999999999999998743     234799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++...+      .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             EEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence            999999999999987654      578889999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........        ....|+..|+||
T Consensus       155 ~~~~~~~~~--------~~~~~~~~y~aP  175 (267)
T cd06645         155 QITATIAKR--------KSFIGTPYWMAP  175 (267)
T ss_pred             EccCccccc--------ccccCcccccCh
Confidence            654321111        114688889887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=3.7e-28  Score=196.18  Aligned_cols=150  Identities=24%  Similarity=0.425  Sum_probs=128.1

Q ss_pred             hcCCCCCceeecccceEEEEEEEC---CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG---EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|.+.   ..+..+|+|.++... ......+.+|+..+..++|||++++++++..     .
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----G   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----C
Confidence            346888999999999999999864   346789999987542 2334678899999999999999999998743     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      +..++||||+++++|.+++.....     .+++..++.++.|++.|++|+|++   +++|+||||+||+++.++.++++|
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d  150 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG  150 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence            447999999999999999876432     578889999999999999999999   999999999999999999999999


Q ss_pred             Ccccccc
Q 039258          201 FGLSKFL  207 (234)
Q Consensus       201 fG~a~~~  207 (234)
                      ||.+...
T Consensus       151 fg~~~~~  157 (266)
T cd05064         151 FRRLQED  157 (266)
T ss_pred             Ccccccc
Confidence            9987653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=5.6e-28  Score=196.35  Aligned_cols=160  Identities=26%  Similarity=0.378  Sum_probs=130.8

Q ss_pred             eecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           54 IGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        54 lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      ||+|+||.||++....++..+|+|.+...   .......+..|++++..++||||+++++.+..     ..+.++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence            69999999999999999999999998632   12223455679999999999999999988743     34579999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~  210 (234)
                      ++++|.+++......    .+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++......
T Consensus        76 ~g~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          76 NGGDLKYHIYNVGER----GLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             CCCCHHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            999999888654322    477788889999999999999999   9999999999999999999999999998865432


Q ss_pred             ccCCCCCCCCccccccccccccCC
Q 039258          211 HLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       211 ~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ....         ...||+.|+||
T Consensus       149 ~~~~---------~~~~~~~y~aP  163 (277)
T cd05607         149 KTIT---------QRAGTNGYMAP  163 (277)
T ss_pred             ceee---------ccCCCCCccCH
Confidence            2111         13588889987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-29  Score=209.99  Aligned_cols=169  Identities=27%  Similarity=0.446  Sum_probs=139.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      ...+.+.||+|.||.|.+|.-. .+..||+|.++.. .+.....|.+|+.+|.+++||||++++|+|...++     +++
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----icm  612 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LCM  612 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hHH
Confidence            4456789999999999999873 3689999999744 44556899999999999999999999999976554     799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ++||+++|+|.+|+..+...    .......+.++.||+.|++||.+.   ++||||+.++|+|++.++++||+|||+++
T Consensus       613 I~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccc
Confidence            99999999999999887432    223345577999999999999998   99999999999999999999999999999


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+....+...+.      ..+-..+||||
T Consensus       686 ~lysg~yy~vqg------r~vlpiRwmaw  708 (807)
T KOG1094|consen  686 NLYSGDYYRVQG------RAVLPIRWMAW  708 (807)
T ss_pred             ccccCCceeeec------ceeeeeeehhH
Confidence            776655544321      13455678875

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-29  Score=208.06  Aligned_cols=168  Identities=23%  Similarity=0.332  Sum_probs=144.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+-|++.+.||+|.|++|-+|++--||..||||+++...-  .....+.+|+..|+.++|||||+++.+.     .++..
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTK   91 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTK   91 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccce
Confidence            4568888999999999999999999999999999975432  2345788999999999999999999986     45556


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee-CCCCceEEccC
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL-DNDMVAHVGDF  201 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~-~~~~~vki~df  201 (234)
                      +|+|+|+-++|+|++|+.++..     .+.+..+..++.||+.|+.|+|..   -+|||||||+|+.+ ..-|.||+.||
T Consensus        92 lyLiLELGD~GDl~DyImKHe~-----Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDF  163 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEE-----GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDF  163 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhc-----cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeec
Confidence            8999999999999999988764     688899999999999999999998   99999999999988 47799999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++-.+.+...-.         .+||+..|.||
T Consensus       164 GFSNkf~PG~kL~---------TsCGSLAYSAP  187 (864)
T KOG4717|consen  164 GFSNKFQPGKKLT---------TSCGSLAYSAP  187 (864)
T ss_pred             cccccCCCcchhh---------cccchhhccCc
Confidence            9987655543221         27999999998

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=8.5e-28  Score=196.04  Aligned_cols=166  Identities=24%  Similarity=0.360  Sum_probs=136.6

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      |+..+.||+|+||+||+|.+..+++.+|+|.+....   ......+.+|++++..++|+|++.+.+.+..     .+..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEEE
Confidence            667789999999999999999999999999986432   2233557889999999999999999888743     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||+++++|.+++......    .+++..+..++.|++.||.|+|+.   +|+||||+|+||+++.++.++|+|||++
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGNP----GFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             EEEEeccCccHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence            999999999999888654321    588899999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........         ....|+..|+||
T Consensus       150 ~~~~~~~~~---------~~~~g~~~~~aP  170 (285)
T cd05632         150 VKIPEGESI---------RGRVGTVGYMAP  170 (285)
T ss_pred             eecCCCCcc---------cCCCCCcCccCh
Confidence            754322111         114588899988

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=5.7e-28  Score=218.90  Aligned_cols=154  Identities=25%  Similarity=0.331  Sum_probs=129.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...   .....+++.+|++++..++|||++++++++..     .+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence            5788999999999999999999999999999998643   22334678999999999999999999998743     344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCC-----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          123 KALVFEYMENGSLEDWLHQTNDH-----LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                      .++||||+++++|.+++......     ......++..++.++.|++.||+|+|++   +++||||||+||+++.++.++
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            79999999999999998642110     0112345667788999999999999999   999999999999999999999


Q ss_pred             EccCcccccc
Q 039258          198 VGDFGLSKFL  207 (234)
Q Consensus       198 i~dfG~a~~~  207 (234)
                      |+|||+++..
T Consensus       154 LiDFGLAk~i  163 (932)
T PRK13184        154 ILDWGAAIFK  163 (932)
T ss_pred             EEecCcceec
Confidence            9999999876

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=9.7e-28  Score=195.72  Aligned_cols=167  Identities=25%  Similarity=0.396  Sum_probs=137.2

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .|+..+.||+|+||.||+|.+..+++.+|+|.+....   ......+..|+.++..++|++++.+.+.+..     .++.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence            3677889999999999999999999999999986432   2223457789999999999999999988743     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++......    .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||+
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEA----GFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGL  148 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999988654321    578888999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........         ...||..|+||
T Consensus       149 ~~~~~~~~~~~---------~~~g~~~y~aP  170 (285)
T cd05630         149 AVHVPEGQTIK---------GRVGTVGYMAP  170 (285)
T ss_pred             eeecCCCcccc---------CCCCCccccCh
Confidence            87544322110         14588999988

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=3.4e-28  Score=204.31  Aligned_cols=170  Identities=22%  Similarity=0.304  Sum_probs=137.6

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~  120 (234)
                      ...+|+..+.||+|+||.||+|.+..++..+|+|.+...  .......+.+|+.++..++||||+++++++..... ...
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            346799999999999999999999989999999998643  22334677889999999999999999998754322 122


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++ ++.+.+..        .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEee
Confidence            346899999965 77776643        466778888999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++.........         ...||+.|+||
T Consensus       163 fg~~~~~~~~~~~~---------~~~~t~~y~aP  187 (355)
T cd07874         163 FGLARTAGTSFMMT---------PYVVTRYYRAP  187 (355)
T ss_pred             CcccccCCCccccC---------CccccCCccCH
Confidence            99998654322111         25689999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=5.8e-28  Score=196.70  Aligned_cols=185  Identities=25%  Similarity=0.334  Sum_probs=147.6

Q ss_pred             cChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeee
Q 039258           36 VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSS  114 (234)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~  114 (234)
                      ...+.+.....+|++.+.||+|+||.||+|.+..++..+|+|++..... ....+..|+.++..+ +|+|++++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            3345566677889999999999999999999999999999998864322 235677899999999 69999999998865


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                      ....+....++||||+++++|.+++.......  ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~  161 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG--ERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccC--ccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence            54445566899999999999999876432111  1567788889999999999999998   999999999999999999


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .++++|||++..........        ....|++.|+||
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~y~aP  193 (286)
T cd06638         162 GVKLVDFGVSAQLTSTRLRR--------NTSVGTPFWMAP  193 (286)
T ss_pred             CEEEccCCceeecccCCCcc--------ccccCCCcccCh
Confidence            99999999988654321111        013588888887

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.96  E-value=9.8e-28  Score=197.79  Aligned_cols=166  Identities=24%  Similarity=0.372  Sum_probs=138.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+.... ......+.+|++++..++||||+++++++..     .+..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEE
Confidence            36888999999999999999999999999999987542 2334668899999999999999999998853     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++....      .+++..+..++.|++.||.|+|++.  +++|+||+|+||+++.++.++++|||++
T Consensus        76 lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS  147 (308)
T ss_pred             EEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCc
Confidence            9999999999999997654      5778888999999999999999731  8999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........          ...|+..|+||
T Consensus       148 ~~~~~~~~~----------~~~~~~~~~aP  167 (308)
T cd06615         148 GQLIDSMAN----------SFVGTRSYMSP  167 (308)
T ss_pred             ccccccccc----------cCCCCcCccCh
Confidence            765332111          14678888887

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-28  Score=200.23  Aligned_cols=172  Identities=28%  Similarity=0.433  Sum_probs=137.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHH--hcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALR--NIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +..++.+.||+|.||.||+|.++  |+.||||++...++   +.+.+|.++..  .++|+||..+++.-.... ..-..+
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEE
Confidence            45667889999999999999995  45799999975544   45667888886  469999999988643322 334457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeecCCCCCCeeeCCCCceEE
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN-----CQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-----~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                      |||++|.+.|||++|+...       .++....+.++..++.||++||..     +.+.|.|||||++||||.+++..-|
T Consensus       285 wLvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            9999999999999999874       688888899999999999999953     3567999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+|+|-....+.......    ....+||.+||||
T Consensus       358 ADLGLAv~h~~~t~~idi~----~N~rVGTKRYMAP  389 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIP----PNPRVGTKRYMAP  389 (513)
T ss_pred             eeceeeEEecccCCcccCC----CCCccceeeccCh
Confidence            9999998765543222111    1236899999999

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.9e-30  Score=218.91  Aligned_cols=166  Identities=25%  Similarity=0.397  Sum_probs=143.8

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      |.+.-.||.|+||+||+|..+.++...|.|++........+.++-|+++|..+.||+|+++++.|+..     +.+||..
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nkLwili  108 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NKLWILI  108 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----CceEEEE
Confidence            56667799999999999999999999999999888888889999999999999999999999987533     3379999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      |||.||-....+.+.+.     .+++.++..++.|++.||.|||++   +|||||||..|||+.-+|.++++|||.+.-.
T Consensus       109 EFC~GGAVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             eecCCchHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc
Confidence            99999999988877664     789999999999999999999999   9999999999999999999999999976532


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .....        .+-.+.|||+||||
T Consensus       181 ~~t~q--------kRDsFIGTPYWMAP  199 (1187)
T KOG0579|consen  181 KSTRQ--------KRDSFIGTPYWMAP  199 (1187)
T ss_pred             hhHHh--------hhccccCCcccccc
Confidence            22111        11138899999998

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=195.24  Aligned_cols=169  Identities=25%  Similarity=0.407  Sum_probs=139.4

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcceeeEee
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKALVFEY  129 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~lv~e~  129 (234)
                      .+.||+|+||.|-.|....++.++|||++.........+..+|++++...+ |+||++++++|+..     ...|+|||-
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-----~~FYLVfEK  157 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD-----TRFYLVFEK  157 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-----ceEEEEEec
Confidence            357999999999999999999999999998776677789999999999995 99999999998543     336999999


Q ss_pred             cCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC---ceEEccCccccc
Q 039258          130 MENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM---VAHVGDFGLSKF  206 (234)
Q Consensus       130 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~---~vki~dfG~a~~  206 (234)
                      +.||+|.+.+.++.      -+++.++..+..+|+.||.|||.+   ||.||||||+|||.....   -+|||||.++..
T Consensus       158 m~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             ccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccc
Confidence            99999999998876      688999999999999999999999   999999999999996443   489999998876


Q ss_pred             cCCCccCCCCCCCCccccccccccccCC
Q 039258          207 LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........++. -.+-+|+..||||
T Consensus       229 ~k~~~~~spastP~-L~tPvGSAEfMAP  255 (463)
T KOG0607|consen  229 IKLNNDCSPASTPE-LLTPVGSAEFMAP  255 (463)
T ss_pred             cccCCCCCCCCCcc-ccCcccchhhcch
Confidence            54322211111121 1224799999998

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=5.5e-28  Score=202.11  Aligned_cols=169  Identities=25%  Similarity=0.344  Sum_probs=138.2

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~  120 (234)
                      ...+|+..+.||+|+||.||+|.+..++..||+|.+....  ......+.+|+.++..++||||+++++++..... ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3467999999999999999999999999999999986432  2233567789999999999999999987753221 122


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...+++|+++ +++|.+++...       .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence            3458999988 77998887532       578889999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++.......           ...||+.|+||
T Consensus       162 fg~~~~~~~~~~-----------~~~~t~~y~aP  184 (343)
T cd07878         162 FGLARQADDEMT-----------GYVATRWYRAP  184 (343)
T ss_pred             CccceecCCCcC-----------CccccccccCc
Confidence            999986543211           15688999998

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=6.9e-28  Score=217.02  Aligned_cols=167  Identities=30%  Similarity=0.421  Sum_probs=139.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|.+.+.||+|+||.||+|.+..+++.||||+++...   ......+..|+.++..++|+||+++++.+..     .++
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----ANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CCE
Confidence            56888999999999999999999899999999996432   2334678889999999999999999987643     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++...+      .+++..++.++.||+.||.|||.+   +|+||||||+|||++.++.+||+|||
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence            799999999999999997654      467788899999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++..........        ...||+.|++|
T Consensus       150 ls~~~~~~~~~~~--------~~~~t~~~~~p  173 (669)
T cd05610         150 LSKVTLNRELNMM--------DILTTPSMAKP  173 (669)
T ss_pred             CCccccCCccccc--------ccccCccccCc
Confidence            9987654332211        14577777766

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.96  E-value=9.9e-28  Score=193.86  Aligned_cols=175  Identities=27%  Similarity=0.397  Sum_probs=142.4

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCC-CC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKG-AD  121 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~-~~  121 (234)
                      +.+.|+..+.||+|+||.||+|.+..+++.+|+|.+..... ....+..|+.++..+ +|+|++++.+.+......+ ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            45668888999999999999999999999999999875432 235678899999988 6999999999886543322 34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..+++|||+++++|.+++......    .+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence            578999999999999998764322    578888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........        ....|++.|+||
T Consensus       156 g~~~~~~~~~~~~--------~~~~g~~~y~aP  180 (272)
T cd06637         156 GVSAQLDRTVGRR--------NTFIGTPYWMAP  180 (272)
T ss_pred             CCceecccccccC--------CcccccccccCH
Confidence            9988654321111        124588888887

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.1e-28  Score=196.07  Aligned_cols=169  Identities=23%  Similarity=0.381  Sum_probs=142.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||++.+..++..+|+|++........+.+..|++++..++|+|++++++.+..     ....+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEE
Confidence            3468889999999999999999988899999999976655556788999999999999999999998743     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++.....     .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++|+|||++
T Consensus        79 lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~  150 (280)
T cd06611          79 ILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS  150 (280)
T ss_pred             EEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence            99999999999999876432     578889999999999999999999   9999999999999999999999999987


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....||+.|+||
T Consensus       151 ~~~~~~~~~~--------~~~~~~~~y~~P  172 (280)
T cd06611         151 AKNKSTLQKR--------DTFIGTPYWMAP  172 (280)
T ss_pred             hhhccccccc--------ceeecchhhcCH
Confidence            7543321111        114577788877

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=7.5e-28  Score=204.98  Aligned_cols=178  Identities=23%  Similarity=0.383  Sum_probs=137.9

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCC-----CeEEEEEEeeccc-chhhHHHHHHHHHHHhcC-CCCceeEEEEeeec
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGED-----EMVVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLTKIITICSSI  115 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~  115 (234)
                      ....+|++.+.||+|+||.||+|.+...     +..||+|.+.... ....+.+.+|++++..+. ||||+++++++.. 
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-  112 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-  112 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence            3456788999999999999999987432     3579999996432 233467899999999996 9999999999843 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCCc-------------------------------------------------
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDHL-------------------------------------------------  146 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------------------------------------------------  146 (234)
                          ....++||||+++|+|.+++.......                                                 
T Consensus       113 ----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         113 ----SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             ----CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence                344799999999999999886532100                                                 


Q ss_pred             -----------------------------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 039258          147 -----------------------------------------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP  185 (234)
Q Consensus       147 -----------------------------------------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~  185 (234)
                                                               ....+++..+..++.|++.|+.|+|++   +++|+||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp  265 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAA  265 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCh
Confidence                                                     011366778889999999999999999   999999999


Q ss_pred             CCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          186 SNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       186 ~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+++.++.+|++|||+++..........      .....+++.|+||
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~------~~~~~~~~~y~aP  308 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSNYVS------KGSTFLPVKWMAP  308 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceeccccccccc------cCCcCCCcceECh
Confidence            999999999999999999986543221111      0113467789888

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.95  E-value=3.5e-28  Score=207.72  Aligned_cols=152  Identities=28%  Similarity=0.402  Sum_probs=131.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-C-----CCceeEEEEeeecCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-H-----RNLTKIITICSSIDSKGA  120 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~l~~~~~~~~~~~~  120 (234)
                      +|.+.+.||+|+||.|-+|++..|++.||||+++. .+....+...|+.+|..++ |     -|+|+++++|..     .
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-----r  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-----R  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-----c
Confidence            67889999999999999999999999999999973 3445577788999999997 4     389999999743     4


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC--CCCceEE
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD--NDMVAHV  198 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~--~~~~vki  198 (234)
                      +++|||+|.++ .+|+++++.+...    +++...+..+..||+.||.+||+.   +|||.||||||||+.  ....|||
T Consensus       261 ~HlciVfELL~-~NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  261 NHLCIVFELLS-TNLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             cceeeeehhhh-hhHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence            55899999995 5999999987654    688889999999999999999999   999999999999995  3458999


Q ss_pred             ccCccccccCCCcc
Q 039258          199 GDFGLSKFLSSDHL  212 (234)
Q Consensus       199 ~dfG~a~~~~~~~~  212 (234)
                      +|||++.+.....+
T Consensus       333 IDFGSSc~~~q~vy  346 (586)
T KOG0667|consen  333 IDFGSSCFESQRVY  346 (586)
T ss_pred             EecccccccCCcce
Confidence            99999998665443

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=2.3e-27  Score=191.75  Aligned_cols=159  Identities=27%  Similarity=0.505  Sum_probs=128.5

Q ss_pred             CCCCceeecccceEEEEEEECCCCe--EEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCCc
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEM--VVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGADF  122 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~~  122 (234)
                      +.+.+.||+|+||.||+|.+..++.  .+|+|.++..  .....+.+.+|++++..++|+|++++++.+..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999999876654  6999988643  23445678899999999999999999998754322 12234


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .+++|||+++++|.+++...........+++..+..++.|++.|+.|+|++   +++||||||+||+++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999875432211222578888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCC
Q 039258          203 LSKFLSS  209 (234)
Q Consensus       203 ~a~~~~~  209 (234)
                      +++....
T Consensus       158 ~~~~~~~  164 (272)
T cd05075         158 LSKKIYN  164 (272)
T ss_pred             cccccCc
Confidence            9987654

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=9.3e-29  Score=181.59  Aligned_cols=165  Identities=24%  Similarity=0.443  Sum_probs=137.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|.||+|++|+++++.+.||+|.+...  ++......++|+-+++.++|.||++++++..+.     ..+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeE
Confidence            466677899999999999999999999999999744  455567889999999999999999999987433     3368


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +|+|||+ .+|..++...++     .+....+..++.|++.|+.|+|+.   .+.|||+||.|.+++.+|+.|++|||++
T Consensus        78 lvfe~cd-qdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   78 LVFEFCD-QDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             EeHHHhh-HHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence            9999995 499999887664     455667788999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCc-cCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDH-LDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~-~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.+.-.. ...         +-+.|..|.+|
T Consensus       149 rafgipvrcys---------aevvtlwyrpp  170 (292)
T KOG0662|consen  149 RAFGIPVRCYS---------AEVVTLWYRPP  170 (292)
T ss_pred             hhcCCceEeee---------ceeeeeeccCc
Confidence            9766543 111         12456677666

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=2.4e-27  Score=192.96  Aligned_cols=153  Identities=31%  Similarity=0.514  Sum_probs=131.2

Q ss_pred             cCCCCCceeecccceEEEEEEE----CCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGIL----GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|++.+.||+|+||.||+|..    ..++..||+|.+........+.+.+|++++..++|||++++++++...   +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence            4688889999999999999974    356789999998765555557788999999999999999999987542   233


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df  152 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF  152 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence            46899999999999999875432     477888899999999999999999   9999999999999999999999999


Q ss_pred             ccccccCC
Q 039258          202 GLSKFLSS  209 (234)
Q Consensus       202 G~a~~~~~  209 (234)
                      |++.....
T Consensus       153 g~~~~~~~  160 (284)
T cd05081         153 GLTKVLPQ  160 (284)
T ss_pred             cccccccC
Confidence            99987644

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.95  E-value=1e-27  Score=202.08  Aligned_cols=169  Identities=22%  Similarity=0.301  Sum_probs=137.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~  121 (234)
                      ..+|+..+.||+|+||.||+|.+..+++.||||.+...  .......+.+|+.++..++|||++++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            46799999999999999999999999999999998643  23334677889999999999999999988754322 1234


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++ +|.+.+..        .+++..+..++.|++.||.|+|++   +|+||||||+||+++.++.+||+||
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence            46899999965 77777643        356677888999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++.........         ...||+.|+||
T Consensus       171 G~a~~~~~~~~~~---------~~~~t~~y~aP  194 (364)
T cd07875         171 GLARTAGTSFMMT---------PYVVTRYYRAP  194 (364)
T ss_pred             CCccccCCCCccc---------CCcccCCcCCH
Confidence            9998654322111         14689999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.95  E-value=1.3e-27  Score=191.72  Aligned_cols=165  Identities=33%  Similarity=0.546  Sum_probs=136.9

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccchh--hHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      |+..+.||+|+||.||++.+..++..+|+|++.......  .....+|+.++..++||||+++++++..     ....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            567789999999999999999999999999998554322  2234569999999999999999998754     344789


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      |||++++++|.+++....      .+++..+..++.|++.||.+||++   +++|+||||+||+++.++.++++|||.+.
T Consensus        76 v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             cccccccccccccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            999999889999998444      678889999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........        ....+|..|+||
T Consensus       147 ~~~~~~~~~--------~~~~~~~~y~aP  167 (260)
T PF00069_consen  147 KLSENNENF--------NPFVGTPEYMAP  167 (260)
T ss_dssp             ESTSTTSEB--------SSSSSSGGGSCH
T ss_pred             ccccccccc--------cccccccccccc
Confidence            542111111        115688899987

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.95  E-value=5.4e-30  Score=201.48  Aligned_cols=164  Identities=27%  Similarity=0.425  Sum_probs=144.9

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      |+++..||+|+||.||++.++.+|..+|||.+...  ...+.+.+|+.+|..++.|++++++|.++...     -+||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLWIVM  107 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLWIVM  107 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceEeeh
Confidence            77888999999999999999999999999998754  35588899999999999999999999764322     269999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      |||-.|++.+.++.++.     ++++.++..+....+.||+|||..   .-||||||..|||++.+|.+|++|||.|.++
T Consensus       108 EYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             hhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh
Confidence            99999999999987765     788889999999999999999998   8899999999999999999999999999988


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+......        ++.|||-||||
T Consensus       180 TDTMAKRN--------TVIGTPFWMAP  198 (502)
T KOG0574|consen  180 TDTMAKRN--------TVIGTPFWMAP  198 (502)
T ss_pred             hhhHHhhC--------ccccCcccccH
Confidence            77554432        26799999998

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.4e-27  Score=190.60  Aligned_cols=159  Identities=29%  Similarity=0.521  Sum_probs=130.0

Q ss_pred             CCCCceeecccceEEEEEEECC---CCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCC
Q 039258           48 FSQSNMIGQGSYGSVYKGILGE---DEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGAD  121 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~  121 (234)
                      |++.+.||+|+||.||+|....   ++..+|+|.++...  ......+.+|++.+..++|||++++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998754   34789999987432  2334678999999999999999999998754332 2334


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..+++|||+++++|..++...........+++..+..++.|++.||.|+|++   +++|+||||+||+++.++.+|++||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence            4689999999999999886543222223678888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCC
Q 039258          202 GLSKFLSS  209 (234)
Q Consensus       202 G~a~~~~~  209 (234)
                      |+++....
T Consensus       158 g~~~~~~~  165 (273)
T cd05035         158 GLSKKIYS  165 (273)
T ss_pred             cceeeccc
Confidence            99987654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.1e-27  Score=206.63  Aligned_cols=163  Identities=28%  Similarity=0.366  Sum_probs=135.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|....      ..+.+|+++++.++|+||+++++++...     +..++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~l  237 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTCL  237 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEE
Confidence            368889999999999999999999999999996421      3356899999999999999999987532     34689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      |||++. ++|.+++.....     .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       238 v~e~~~-~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~  308 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC  308 (461)
T ss_pred             EEEccC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCce
Confidence            999994 699988865432     588899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........      .....||+.|+||
T Consensus       309 ~~~~~~~~~~------~~~~~GT~~Y~AP  331 (461)
T PHA03211        309 FARGSWSTPF------HYGIAGTVDTNAP  331 (461)
T ss_pred             eccccccccc------ccccCCCcCCcCH
Confidence            6543221111      1125699999998

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=2.1e-27  Score=194.13  Aligned_cols=164  Identities=28%  Similarity=0.388  Sum_probs=139.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++....   ......+.+|++++..++||||+++++.+..     ...
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence            36888999999999999999999999999999986432   2334678899999999999999999998743     344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.+||+|||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence            799999999999999997764      678888999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.......           ....|++.|+||
T Consensus       147 ~~~~~~~~~-----------~~~~~~~~y~aP  167 (290)
T cd05580         147 FAKRVKGRT-----------YTLCGTPEYLAP  167 (290)
T ss_pred             CccccCCCC-----------CCCCCCccccCh
Confidence            988654431           014588888887

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=3e-27  Score=193.30  Aligned_cols=169  Identities=25%  Similarity=0.343  Sum_probs=140.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ...|++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|+.++..++|+|++++++.+...     ...+
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEE
Confidence            35688899999999999999999999999999999766555567888999999999999999999987532     3479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|..++.+...     .+++..+..++.|++.++.|+|+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        86 lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~  157 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVS  157 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccc
Confidence            99999999999888765432     578889999999999999999998   9999999999999999999999999988


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....|++.|+||
T Consensus       158 ~~~~~~~~~~--------~~~~~~~~y~aP  179 (292)
T cd06644         158 AKNVKTLQRR--------DSFIGTPYWMAP  179 (292)
T ss_pred             eecccccccc--------ceecCCccccCc
Confidence            7533221110        013467778777

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.4e-27  Score=200.85  Aligned_cols=162  Identities=22%  Similarity=0.345  Sum_probs=134.3

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ...+|++.+.||+|+||.||+|.+..++..||+|+....      ....|+.++..++|+||+++++++...     ...
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  132 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AIT  132 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeC-----Cee
Confidence            345799999999999999999999999999999975322      235689999999999999999987543     346


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++|||++. ++|.+++.....     .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       133 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        133 CMVLPHYS-SDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             EEEEEccC-CcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence            89999995 589988876432     578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++........         ....||+.|+||
T Consensus       204 a~~~~~~~~~---------~~~~gt~~y~aP  225 (357)
T PHA03209        204 AQFPVVAPAF---------LGLAGTVETNAP  225 (357)
T ss_pred             ccccccCccc---------ccccccccccCC
Confidence            8753322111         125689999998

>PHA02988 hypothetical protein; Provisional

Probab=99.95  E-value=3.4e-27  Score=192.45  Aligned_cols=166  Identities=23%  Similarity=0.295  Sum_probs=134.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccch---hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +......||+|++|.||+|..  ++..||||.++.....   ..+.+.+|+.+|.+++||||+++++++.... .+....
T Consensus        21 ~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~   97 (283)
T PHA02988         21 DKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRL   97 (283)
T ss_pred             CCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCce
Confidence            344346899999999999998  6789999999643222   2467889999999999999999999875421 223456


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++|+|.+++....      .+++.....++.|++.|+.|+|+..  +++||||||+||+++.++.+|++|||+
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~  169 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGL  169 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccch
Confidence            89999999999999998654      5677888999999999999999731  788999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.......           ...||+.|+||
T Consensus       170 ~~~~~~~~~-----------~~~~~~~y~aP  189 (283)
T PHA02988        170 EKILSSPPF-----------KNVNFMVYFSY  189 (283)
T ss_pred             Hhhhccccc-----------cccCcccccCH
Confidence            986543221           13578888887

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=2.9e-27  Score=192.33  Aligned_cols=166  Identities=24%  Similarity=0.394  Sum_probs=138.3

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      |++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|++++..++|+|++++++.+..     ....++||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEEE
Confidence            5677889999999999999999999999999875555556778899999999999999999998753     23468999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|..++.....     .+++..+..++.|++.||.|+|+.   +++|+||+|+||+++.++.++++|||++...
T Consensus        82 e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          82 EFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             EecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence            99999999888765322     578888999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......        ....||+.|+||
T Consensus       154 ~~~~~~~--------~~~~~~~~y~aP  172 (282)
T cd06643         154 TRTIQRR--------DSFIGTPYWMAP  172 (282)
T ss_pred             ccccccc--------ccccccccccCH
Confidence            3321111        014578888887

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=2.6e-27  Score=194.33  Aligned_cols=167  Identities=28%  Similarity=0.417  Sum_probs=140.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|+..+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.++..++|+|++++++.+..     .+..+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEE
Confidence            4678999999999999999999988999999999976554455778899999999999999999998753     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++.+.       .+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++
T Consensus        93 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~  162 (297)
T cd06656          93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (297)
T ss_pred             EeecccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence            999999999999998653       467788899999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....|++.|+||
T Consensus       163 ~~~~~~~~~~--------~~~~~~~~y~aP  184 (297)
T cd06656         163 AQITPEQSKR--------STMVGTPYWMAP  184 (297)
T ss_pred             eEccCCccCc--------CcccCCccccCH
Confidence            7654322111        013577788877

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.95  E-value=3.6e-27  Score=191.68  Aligned_cols=160  Identities=27%  Similarity=0.385  Sum_probs=133.9

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      +|+..+.||+|+||.||+|.+..++..+|+|.+... .....+.+..|++++..++|||++++++.+...     +..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEE
Confidence            577888999999999999999999999999998644 223345688999999999999999999988543     33689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|..+.          .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.
T Consensus        77 v~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~  143 (279)
T cd06619          77 CTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVST  143 (279)
T ss_pred             EEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence            99999999886542          456777889999999999999999   99999999999999999999999999988


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ........          ...||..|+||
T Consensus       144 ~~~~~~~~----------~~~~~~~y~aP  162 (279)
T cd06619         144 QLVNSIAK----------TYVGTNAYMAP  162 (279)
T ss_pred             eccccccc----------CCCCChhhcCc
Confidence            65432111          14688889887

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.95  E-value=4.7e-27  Score=188.30  Aligned_cols=168  Identities=21%  Similarity=0.341  Sum_probs=138.9

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      +|++.+.||+|+||.||++.+..++..+|+|.++.. .....+.+..|+.+++.++|+|++++++.+..     .+..++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-----DGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence            477889999999999999999999999999998643 23344678889999999999999999998743     345799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      +|||+++++|.+++......    .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||++.
T Consensus        76 v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGK----LFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence            99999999999988754322    467888899999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........        ....|++.|+||
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~~aP  169 (255)
T cd08219         149 LLTSPGAYA--------CTYVGTPYYVPP  169 (255)
T ss_pred             eeccccccc--------ccccCCccccCH
Confidence            654322111        114577888887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.95  E-value=4.1e-27  Score=194.60  Aligned_cols=170  Identities=25%  Similarity=0.336  Sum_probs=130.6

Q ss_pred             CceeecccceEEEEEEEC--CCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           51 SNMIGQGSYGSVYKGILG--EDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      .+.||+|+||.||+|.+.  .++..+|+|.+....  ....+.+|+.++..++||||+++++++...   .....+++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence            468999999999999975  366899999986432  224577899999999999999999987532   2345789999


Q ss_pred             ecCCCCHHHHhhhccC---CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee----CCCCceEEccC
Q 039258          129 YMENGSLEDWLHQTND---HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL----DNDMVAHVGDF  201 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~----~~~~~vki~df  201 (234)
                      |+. ++|.+++.....   ......+++..+..++.|++.||.|||++   +++||||||+|||+    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            995 588888764321   11122578888999999999999999999   99999999999999    45678999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++..........     ......||+.|+||
T Consensus       157 G~a~~~~~~~~~~~-----~~~~~~~t~~y~aP  184 (317)
T cd07868         157 GFARLFNSPLKPLA-----DLDPVVVTFWYRAP  184 (317)
T ss_pred             CceeccCCCCcccc-----ccCCccccccccCC
Confidence            99987543321111     01125689999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=3.8e-27  Score=193.50  Aligned_cols=167  Identities=25%  Similarity=0.458  Sum_probs=136.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+|+..+.||+|+||.||+|.+..++..||+|.++... ......+.+|+.++..++||||+++++++..     ....+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-----CCeEE
Confidence            46888999999999999999999999999999987442 2233567789999999999999999998753     33479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||++ ++|.+++.....     .+++..+..++.|++.||.|+|+.   +++|+||||+||+++.++.++++|||++
T Consensus        81 lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             EEEeccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcch
Confidence            9999996 599988876432     467788899999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........        ...+++.|+||
T Consensus       152 ~~~~~~~~~~~--------~~~~~~~y~~P  173 (301)
T cd07873         152 RAKSIPTKTYS--------NEVVTLWYRPP  173 (301)
T ss_pred             hccCCCCCccc--------ccceeecccCc
Confidence            76433211110        13467788887

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=3.7e-27  Score=193.29  Aligned_cols=166  Identities=27%  Similarity=0.419  Sum_probs=139.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|+..+.||+|+||.||+|.+..++..+|+|.+..........+.+|+.++..+.|+|++++++.+..     ....++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence            478889999999999999999988999999999976554445778899999999999999999998753     234799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++...       .+++.++..++.|++.|+.|+|++   +++|+||+|+||+++.++.++|+|||++.
T Consensus        95 v~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             eecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence            99999999999998643       467788899999999999999999   99999999999999999999999999988


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........        ....|++.|+||
T Consensus       165 ~~~~~~~~~--------~~~~~~~~y~aP  185 (296)
T cd06654         165 QITPEQSKR--------STMVGTPYWMAP  185 (296)
T ss_pred             hcccccccc--------CcccCCccccCH
Confidence            644322111        114588888887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.8e-27  Score=216.67  Aligned_cols=181  Identities=23%  Similarity=0.383  Sum_probs=143.3

Q ss_pred             HHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           40 ELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        40 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      +......+|++.+.||+|+||.||+|.+..++..+|+|++...  .......+..|+.++..++||||+++++++...  
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de--   84 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK--   84 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec--
Confidence            3344567899999999999999999999999999999998743  223446788999999999999999999987542  


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCC----CCeeecCCCCCCeeeCC-
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQ----PPMVHGDIKPSNVLLDN-  192 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~----~~ivH~dlk~~nil~~~-  192 (234)
                       ....++|||||+++++|.+++......  ...+++..++.++.||+.||.|||+...    .+|||+||||+|||++. 
T Consensus        85 -~~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~  161 (1021)
T PTZ00266         85 -ANQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG  161 (1021)
T ss_pred             -CCCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence             234578999999999999998763211  1157888999999999999999998510    25999999999999953 


Q ss_pred             ----------------CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 ----------------DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ----------------~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                                      ...+||+|||++..........         ...||+.|+||
T Consensus       162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~---------s~vGTp~YmAP  210 (1021)
T PTZ00266        162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---------SCVGTPYYWSP  210 (1021)
T ss_pred             ccccccccccccccCCCCceEEccCCcccccccccccc---------ccCCCccccCH
Confidence                            2348999999998654332111         25699999998

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.9e-28  Score=217.65  Aligned_cols=174  Identities=26%  Similarity=0.478  Sum_probs=140.2

Q ss_pred             CCCCCceeecccceEEEEEEECCCC-----eEEEEEEeec-ccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDE-----MVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .-+..+.||+|+||.||.|......     ..||+|.++. .+.+...+|++|..+|+.++||||++++|+|....    
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~----  768 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG----  768 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC----
Confidence            3456789999999999999976432     3489998864 35667789999999999999999999999996522    


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                       ..+|++|||++|+|.+||++...+. .+..++..+.+.++.||+.|+.||+++   ..|||||..+|+|++....|||+
T Consensus       769 -~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  769 -PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             -CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence             2589999999999999999863221 234678899999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+|+...+..+......      ..=...||||
T Consensus       845 DFGlArDiy~~~yyr~~~~------a~lPvkWm~P  873 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGE------AMLPVKWMPP  873 (1025)
T ss_pred             ccchhHhhhhchheeccCc------cccceecCCH
Confidence            9999995444444433211      1123579987

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=7.4e-27  Score=188.26  Aligned_cols=172  Identities=25%  Similarity=0.376  Sum_probs=138.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|+..+.||+|+||.||.|.+..++..||+|.+....     ....+.+.+|+.++..++|||++++++++...   ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence            46888999999999999999999999999999886321     12345788899999999999999999976432   12


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...+++|||+++++|.+++....      .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence            45689999999999999987654      467788899999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++...........     ......|+..|+||
T Consensus       150 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~aP  178 (265)
T cd06652         150 FGASKRLQTICLSGT-----GMKSVTGTPYWMSP  178 (265)
T ss_pred             Ccccccccccccccc-----ccccCCCCccccCh
Confidence            999886543211100     00114588889887

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=4.9e-27  Score=190.73  Aligned_cols=151  Identities=26%  Similarity=0.494  Sum_probs=128.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCe----EEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEM----VVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ..+|+..+.||+|+||+||+|.+..++.    .||+|++.... ....+.+.+|+.++..++|+|++.+++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            3468889999999999999999766654    58999986432 33346788999999999999999999987432    


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                        ..++++||+++++|.+++.....     .+++..++.++.|++.|+.|+|++   +++|+||||+||+++.++.+||+
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~  151 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT  151 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence              24799999999999999876432     578889999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCC
Q 039258          200 DFGLSKFLSS  209 (234)
Q Consensus       200 dfG~a~~~~~  209 (234)
                      |||+++....
T Consensus       152 dfG~~~~~~~  161 (279)
T cd05109         152 DFGLARLLDI  161 (279)
T ss_pred             CCCceeeccc
Confidence            9999987653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.1e-29  Score=202.29  Aligned_cols=169  Identities=25%  Similarity=0.348  Sum_probs=141.2

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~  119 (234)
                      ...+|..+.+||+|+||+|.++..+.+++.+|||+++..   +....+....|-.+|... +-|.++++..++.     +
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ-----T  421 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ-----T  421 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh-----h
Confidence            345788899999999999999999999999999999732   344455566777788776 4678888888764     4


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      -+.+|.||||+.||+|...+.+.+      ++.+..+..++.+|+-||-+||++   +||.||||..|+|+|..|++||+
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~  492 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIA  492 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEee
Confidence            455899999999999999999887      677778899999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++.-..+....        .++||||-|+||
T Consensus       493 DFGmcKEni~~~~TT--------kTFCGTPdYiAP  519 (683)
T KOG0696|consen  493 DFGMCKENIFDGVTT--------KTFCGTPDYIAP  519 (683)
T ss_pred             ecccccccccCCcce--------eeecCCCccccc
Confidence            999998643322211        138999999998

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.95  E-value=4e-27  Score=189.82  Aligned_cols=171  Identities=26%  Similarity=0.409  Sum_probs=138.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||.||+|++..++..+|+|.++..   .......+.+|+++++.++|||++++++.+...     +.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence            4788999999999999999999999999999988632   223345688899999999999999999987532     34


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .+++|||+++++|.+++.......  ..+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQK--RLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhcc--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence            689999999999999886432111  1467788899999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++...........        ...|++.|+||
T Consensus       152 ~~~~~~~~~~~~~--------~~~~~~~~~aP  175 (267)
T cd08228         152 LGRFFSSKTTAAH--------SLVGTPYYMSP  175 (267)
T ss_pred             cceeccchhHHHh--------cCCCCccccCh
Confidence            9886543221110        14577788887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00284 protein kinase; Provisional

Probab=99.95  E-value=2.7e-27  Score=205.72  Aligned_cols=168  Identities=21%  Similarity=0.341  Sum_probs=131.1

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCC------CceeEEEEeee
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHR------NLTKIITICSS  114 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~l~~~~~~  114 (234)
                      +.....+|++.+.||+|+||+||+|.+..++..||||+++... ........|+.++..++|.      +++.+++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3344578999999999999999999999999999999996432 1224456677777776544      57778777642


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~  193 (234)
                          ...++++|||++ +++|.+++...+      .+++..+..++.||+.||.|||+ .   +||||||||+|||++.+
T Consensus       203 ----~~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~  268 (467)
T PTZ00284        203 ----ETGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETS  268 (467)
T ss_pred             ----CCceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecC
Confidence                234578999998 779999887654      57888899999999999999997 5   89999999999999765


Q ss_pred             C----------------ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          194 M----------------VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       194 ~----------------~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +                .+||+|||.+.......           ...+||+.|+||
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~-----------~~~~gt~~Y~AP  314 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERHSR-----------TAIVSTRHYRSP  314 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccCcccc-----------ccccCCccccCc
Confidence            4                49999999875322111           126799999998

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.95  E-value=4.6e-27  Score=192.01  Aligned_cols=185  Identities=26%  Similarity=0.328  Sum_probs=147.3

Q ss_pred             cChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeee
Q 039258           36 VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSS  114 (234)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~  114 (234)
                      +.+.++..+..+|.....||+|+||.||++....++..+|+|++.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344555666888999999999999999999999999999999986432 2235677899999988 79999999999876


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                      .+.......++||||+++++|.+++.......  ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~  165 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICG--QRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence            55444456799999999999999886421111  1577888999999999999999998   999999999999999999


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+|++|||++...........        ...|+..|+||
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~--------~~~~~~~y~aP  197 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRLRRN--------TSVGTPFWMAP  197 (291)
T ss_pred             CEEEeecccchhccccccccc--------CccCCccccCh
Confidence            999999999886543221110        13477778877

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=7.3e-27  Score=186.85  Aligned_cols=143  Identities=26%  Similarity=0.492  Sum_probs=124.0

Q ss_pred             eeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecC
Q 039258           53 MIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYME  131 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~  131 (234)
                      .||+|+||.||+|.+..++..+|+|.+... .......+.+|++++..++|||++++++++..     ....++||||++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~   76 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELVQ   76 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeecc
Confidence            589999999999999989999999987533 23334678999999999999999999998743     334789999999


Q ss_pred             CCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          132 NGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       132 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      +++|.+++.....     .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.+|++|||++....
T Consensus        77 ~~~L~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          77 GGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             CCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccc
Confidence            9999999875432     467888899999999999999999   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=3.9e-27  Score=197.06  Aligned_cols=157  Identities=22%  Similarity=0.393  Sum_probs=127.6

Q ss_pred             hcCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~  117 (234)
                      ..+|++.+.||+|+||.||+|.+.     .+++.||||.++... ......+.+|+.++..+ +|+|++++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            356899999999999999999853     456899999997432 23346788999999999 689999999987532  


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCc---------------------------------------------------
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHL---------------------------------------------------  146 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---------------------------------------------------  146 (234)
                        ....+++|||+++++|.+++.......                                                   
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              234689999999999999986532100                                                   


Q ss_pred             ----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          147 ----------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       147 ----------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                                ....+++..+..++.|++.|+.|+|++   +++||||||+||+++.++.+|++|||++....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccc
Confidence                      011357778889999999999999999   99999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.95  E-value=5.7e-27  Score=188.77  Aligned_cols=151  Identities=27%  Similarity=0.583  Sum_probs=130.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|...+.||+|+||.||+|.+..++..+|+|.+... ......+.+|++++..++|+|++++++++..     .+..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEE
Confidence            4577788999999999999999988999999998643 2234678899999999999999999998743     234689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      +|||+++++|.+++......    .+++..++.++.|++.||.|+|++   +++|+||||+||+++.++.+|++|||++.
T Consensus        80 v~e~~~~~~L~~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQ----EVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence            99999999999998764321    577888899999999999999999   99999999999999999999999999998


Q ss_pred             ccCC
Q 039258          206 FLSS  209 (234)
Q Consensus       206 ~~~~  209 (234)
                      ....
T Consensus       153 ~~~~  156 (263)
T cd05052         153 LMTG  156 (263)
T ss_pred             cccc
Confidence            7654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.95  E-value=5.4e-27  Score=189.46  Aligned_cols=147  Identities=24%  Similarity=0.383  Sum_probs=119.4

Q ss_pred             ceeecccceEEEEEEECC--CCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           52 NMIGQGSYGSVYKGILGE--DEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      +.||+|+||.||+|....  ....+++|.+.... ......+.+|+..+..++|+||+++++.+..     ....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEE
Confidence            358999999999997532  44678888875432 2334568899999999999999999998743     334699999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      |+++++|.+++........ ...++.....++.|++.|++|+|++   +++||||||+||+++.++.+|++|||++...
T Consensus        76 ~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVA-QMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             eCCCCcHHHHHHhcccccc-ccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccccccc
Confidence            9999999999976542211 1345667788999999999999999   9999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=6.9e-27  Score=190.06  Aligned_cols=169  Identities=26%  Similarity=0.446  Sum_probs=133.3

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCe----EEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEM----VVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|+..+.||+|+||+||+|.+..++.    .+++|.+.... ......+..|+..+..+.||||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence            467888999999999999999876664    57777775332 2234567788888999999999999998632      


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++++||+++++|.+++.....     .+++..+..++.|++.|+.|+|++   +++|+||||+||+++.++.+|++|
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D  152 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD  152 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence            225789999999999999976432     578888999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++...........      ....|+..|+||
T Consensus       153 fg~~~~~~~~~~~~~~------~~~~~~~~y~~p  180 (279)
T cd05111         153 FGVADLLYPDDKKYFY------SEHKTPIKWMAL  180 (279)
T ss_pred             CccceeccCCCccccc------CCCCCcccccCH
Confidence            9999865433211100      013466778877

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.95  E-value=1.8e-27  Score=191.27  Aligned_cols=153  Identities=28%  Similarity=0.570  Sum_probs=132.5

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ...+|+..+.||+|+||.||+|.+.. +..+|+|.+..........+..|+.++..++|+|++++++++..     ....
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-----GEPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-----CCCe
Confidence            34568889999999999999999977 78899999976554455678899999999999999999998743     3447


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++......    .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.+|++|||+
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~  150 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQ----VLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL  150 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence            8999999999999999764322    577888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCC
Q 039258          204 SKFLSS  209 (234)
Q Consensus       204 a~~~~~  209 (234)
                      +.....
T Consensus       151 ~~~~~~  156 (261)
T cd05148         151 ARLIKE  156 (261)
T ss_pred             hhhcCC
Confidence            987644

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.1e-27  Score=207.04  Aligned_cols=183  Identities=27%  Similarity=0.389  Sum_probs=157.0

Q ss_pred             cChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeee
Q 039258           36 VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSS  114 (234)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~  114 (234)
                      ..++.++-...-|.+...||.|.+|.||+++++.+++..|+|+........ +.+..|.+++... .|||++.+++++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            344555555667888999999999999999999999999999997543322 5566788888877 69999999999998


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                      .+...++.+|+|||||.+|+..+++++-...    ++.|..+..|++.++.|+.+||.+   .++|||+|-.|||++.++
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~----rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~  160 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGN----RLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENA  160 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhccc----chhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccC
Confidence            8888899999999999999999999876522    788999999999999999999999   999999999999999999


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .||++|||.+.+++......        .++.|||.||||
T Consensus       161 ~VKLvDFGvSaQldsT~grR--------nT~iGtP~WMAP  192 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDSTVGRR--------NTFIGTPYWMAP  192 (953)
T ss_pred             cEEEeeeeeeeeeecccccc--------cCcCCCcccccc
Confidence            99999999998876543322        237899999998

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.95  E-value=8.2e-27  Score=186.68  Aligned_cols=168  Identities=29%  Similarity=0.411  Sum_probs=139.8

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.||+|.+..++..+++|.+...  .......+.+|+++++.++|||++++++.+..     .+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence            477788999999999999999999999999998643  23345678899999999999999999998743     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++......    .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||++
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRGR----PLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence            999999999999999765221    577888899999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....|++.|+||
T Consensus       149 ~~~~~~~~~~--------~~~~~~~~y~aP  170 (256)
T cd08529         149 KLLSDNTNFA--------NTIVGTPYYLSP  170 (256)
T ss_pred             eeccCccchh--------hccccCccccCH
Confidence            8665432211        114577888887

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1e-26  Score=186.97  Aligned_cols=170  Identities=26%  Similarity=0.427  Sum_probs=138.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|+..+.||+|++|.||.|.+..++..+|+|.+....     ......+.+|++++..++|||++++++++..     .
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-----D   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-----C
Confidence            46888999999999999999998899999999986432     1123567889999999999999999998753     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++|+||+++++|.+++....      .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            35799999999999999987654      567788889999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++..........     ......|+..|+||
T Consensus       148 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~aP  176 (263)
T cd06625         148 FGASKRLQTICSSGT-----GMKSVTGTPYWMSP  176 (263)
T ss_pred             cccceeccccccccc-----cccCCCcCccccCc
Confidence            999876543211110     00114577888887

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.95  E-value=8.6e-27  Score=187.98  Aligned_cols=150  Identities=29%  Similarity=0.518  Sum_probs=128.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCC---CeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGED---EMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|+..+.||+|+||.||+|.+..+   ...+|+|.++... ......+.+|+.++..++|||++++++.+..     ..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----SR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----CC
Confidence            4688899999999999999998643   4689999986442 3334678899999999999999999998743     33


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..+++|||+++++|.+++.....     .+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++||
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~df  150 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF  150 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECcc
Confidence            46899999999999999876432     578888999999999999999998   9999999999999999999999999


Q ss_pred             ccccccC
Q 039258          202 GLSKFLS  208 (234)
Q Consensus       202 G~a~~~~  208 (234)
                      |++....
T Consensus       151 g~~~~~~  157 (266)
T cd05033         151 GLSRRLE  157 (266)
T ss_pred             chhhccc
Confidence            9998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=4.1e-28  Score=218.48  Aligned_cols=186  Identities=24%  Similarity=0.380  Sum_probs=142.5

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC--
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS--  117 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~--  117 (234)
                      ..+...+|+.+..||+||||.||+++++-+|+.||||.+... +......+.+|+.++++++|||||+++..+.....  
T Consensus       474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            356677899999999999999999999999999999999755 34455788999999999999999999876522111  


Q ss_pred             --------------------------------------------------------------------------------
Q 039258          118 --------------------------------------------------------------------------------  117 (234)
Q Consensus       118 --------------------------------------------------------------------------------  117 (234)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHH
Q 039258          118 --------------------------------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS  165 (234)
Q Consensus       118 --------------------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~  165 (234)
                                                      +....+||-||||+...+.+++..+....     .....+.++++|+.
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-----~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-----QRDEAWRLFREILE  708 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-----hhHHHHHHHHHHHH
Confidence                                            00145789999999866777776543210     23466889999999


Q ss_pred             HHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC----------CccCCCCCCCCccccccccccccCC
Q 039258          166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS----------DHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       166 ~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~----------~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||.|+|++   |+|||||||.||+++.++.|||.|||+|.....          +.............+.+||.-|+||
T Consensus       709 GLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  709 GLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            99999999   999999999999999999999999999987220          0111111111122347899999998

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=1.4e-26  Score=186.67  Aligned_cols=172  Identities=28%  Similarity=0.509  Sum_probs=138.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc---------hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK---------GAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      +|.+...||+|+||.||+|.+..++..+|+|.+.....         ...+.+.+|+.++..++|||++++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            47778899999999999999988889999998863321         122568889999999999999999998753   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                        .++.+++|||+++++|.+++....      .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++
T Consensus        78 --~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          78 --ADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             --CCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence              344689999999999999997654      567788889999999999999998   999999999999999999999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||+++............  .......|+..|+||
T Consensus       147 l~dfg~~~~~~~~~~~~~~~--~~~~~~~~~~~y~~p  181 (267)
T cd06628         147 ISDFGISKKLEANSLSTKTN--GARPSLQGSVFWMAP  181 (267)
T ss_pred             ecccCCCcccccccccCCcc--ccccccCCCcCccCh
Confidence            99999998765322111110  011124578888887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.6e-27  Score=187.18  Aligned_cols=168  Identities=31%  Similarity=0.442  Sum_probs=141.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|+..+.||+|+||.||+|.+..++..+++|++........+.+.+|++++..++|||++++++.+..     ....++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            568889999999999999999988889999999986655556788999999999999999999998743     334799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      +|||+++++|.+++.....     .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++.
T Consensus        78 ~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             EEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence            9999999999998876522     578889999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ...|+..|+||
T Consensus       150 ~~~~~~~~~~--------~~~~~~~y~~P  170 (262)
T cd06613         150 QLTATIAKRK--------SFIGTPYWMAP  170 (262)
T ss_pred             hhhhhhhccc--------cccCCccccCc
Confidence            6543221110        14577778877

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=6.4e-27  Score=188.62  Aligned_cols=170  Identities=21%  Similarity=0.393  Sum_probs=138.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc------chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      +|+..+.||+|+||.||++.+..++..+|+|.+....      ....+.+.+|+.++..++|+|++++++.+..     .
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-----D   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-----C
Confidence            4778899999999999999999999999999996432      1234678899999999999999999998743     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC-ceEEc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVG  199 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~-~vki~  199 (234)
                      +..++||||+++++|.+++....      .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++ .++++
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence            34689999999999999987654      577888899999999999999999   999999999999998665 69999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++...........    .......||..|+||
T Consensus       147 dfg~~~~~~~~~~~~~----~~~~~~~~~~~~~~P  177 (268)
T cd06630         147 DFGAAARLAAKGTGAG----EFQGQLLGTIAFMAP  177 (268)
T ss_pred             ccccccccccccccCC----ccccccccccceeCH
Confidence            9999887654321111    111124578888887

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=9e-27  Score=189.72  Aligned_cols=173  Identities=27%  Similarity=0.472  Sum_probs=137.5

Q ss_pred             cCCCCCceeecccceEEEEEEE----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGIL----GEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..|+..+.||+|+||.||+|..    ..++..||+|.++... ......+.+|+++++.++|||++++.+++...   +.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            4578899999999999999974    3567899999986442 33446789999999999999999999987542   22


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....     .+++..+..++.|++.|+.|+|++   +++|+||||+||+++.++.++++|
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~d  152 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD  152 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECC
Confidence            446899999999999999865432     467888999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++.............     ....|+..|+||
T Consensus       153 fg~~~~~~~~~~~~~~~-----~~~~~~~~y~ap  181 (284)
T cd05079         153 FGLTKAIETDKEYYTVK-----DDLDSPVFWYAP  181 (284)
T ss_pred             CccccccccCccceeec-----CCCCCCccccCH
Confidence            99998765432211000     013456667776

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.95  E-value=9e-27  Score=186.83  Aligned_cols=149  Identities=29%  Similarity=0.517  Sum_probs=126.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|+..+.||+|+||.||++.+.. +..+|+|.+... ......+.+|+.++..++|||++++++++..     ....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCEEE
Confidence            457888999999999999998754 457999987633 2233678899999999999999999998743     234799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++.....     .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.+|++|||.++
T Consensus        77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence            9999999999999875432     467888899999999999999999   99999999999999999999999999988


Q ss_pred             ccCC
Q 039258          206 FLSS  209 (234)
Q Consensus       206 ~~~~  209 (234)
                      ....
T Consensus       149 ~~~~  152 (256)
T cd05114         149 YVLD  152 (256)
T ss_pred             ccCC
Confidence            6543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=9.3e-27  Score=188.93  Aligned_cols=177  Identities=24%  Similarity=0.424  Sum_probs=136.3

Q ss_pred             HhcCCCCCceeecccceEEEEEEECC-----CCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGE-----DEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      ...+|+..+.||+|+||.||+|.+..     ++..+|+|.+.... ......+.+|+.++..++|+|++++++++..   
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~---   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence            34568999999999999999998642     35789999885332 2233568899999999999999999998732   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCc----cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHL----EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~  193 (234)
                        ....++||||+++++|.+++.......    ....+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.+
T Consensus        81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence              334689999999999999987533211    112456778889999999999999998   99999999999999999


Q ss_pred             CceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          194 MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       194 ~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.++++|||+++............      ...+++.|+||
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~------~~~~~~~y~aP  190 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGG------KGLLPVRWMSP  190 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCC------CCccCHhhcCh
Confidence            999999999987654322211100      02356778887

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=1.1e-26  Score=187.45  Aligned_cols=173  Identities=27%  Similarity=0.380  Sum_probs=137.3

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+..++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++..++|+||+++++++..     .+.
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~   79 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGF   79 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCE
Confidence            344555556789999999999999988999999999876555555788999999999999999999998743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-CCceEEccC
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDF  201 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-~~~vki~df  201 (234)
                      .++++||+++++|.+++.....   ....++..+..++.|++.|+.|+|++   +++|+||+|+||+++. ++.++|+||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecc
Confidence            7899999999999999876421   11226677888999999999999999   9999999999999975 679999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++...........        ...|++.|+||
T Consensus       154 g~~~~~~~~~~~~~--------~~~~~~~~~aP  178 (268)
T cd06624         154 GTSKRLAGINPCTE--------TFTGTLQYMAP  178 (268)
T ss_pred             hhheecccCCCccc--------cCCCCccccCh
Confidence            99876533211100        13467778877

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=9.3e-27  Score=190.08  Aligned_cols=176  Identities=26%  Similarity=0.474  Sum_probs=139.0

Q ss_pred             hcCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ..+|.+.+.||+|+||.||++...     .++..+|+|.+..........+.+|++++.+++|||++++++++..     
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            346888899999999999999853     3456799999875554555778999999999999999999998743     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCC-------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDH-------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN  192 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~  192 (234)
                      .+..++||||+++++|.+++......       .....+++..+..++.|++.||.|+|++   +++||||||+||+++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~  155 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGE  155 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence            34579999999999999998754311       1112478889999999999999999999   9999999999999999


Q ss_pred             CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.++++|||++.............      ...++..|+||
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~~~------~~~~~~~y~aP  191 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTDYYRVGG------HTMLPIRWMPP  191 (288)
T ss_pred             CCcEEeccCCccccccCCceeecCC------CCCccccccCH
Confidence            9999999999988654322111100      13356778887

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.95  E-value=9.3e-27  Score=189.31  Aligned_cols=175  Identities=26%  Similarity=0.490  Sum_probs=137.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCC-----eEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDE-----MVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      .+|++.+.||+|+||.||+|.....+     ..+|+|.+.... ......+.+|+.++..++|||++++++++..     
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-----   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-----
Confidence            46888999999999999999876544     689999986443 2334678899999999999999999998743     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCcc----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCee
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLE----------VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVL  189 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil  189 (234)
                      ....+++|||+++++|.+++........          ...+++..+..++.|++.|+.|||++   +++|+||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence            2346899999999999999976432111          12577888899999999999999999   9999999999999


Q ss_pred             eCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          190 LDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       190 ~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.++.++|+|||++.............      ...+++.|+||
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~------~~~~~~~y~aP  195 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYYRVQS------KSLLPVRWMPP  195 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccccccC------CCcccccccCH
Confidence            9999999999999998654322111100      13467789887

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=1.3e-26  Score=188.62  Aligned_cols=168  Identities=26%  Similarity=0.414  Sum_probs=135.9

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.||+|.+..++..||+|.+....  ......+.+|+.++..++|||++++++++..     .+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence            4778899999999999999999999999999986432  2234667889999999999999999998753     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||++ ++|.+++......   ..+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.++|+|||++
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  148 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPKG---QYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA  148 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCCC---CcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence            9999997 5898888654321   1578889999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........        ...+++.|+||
T Consensus       149 ~~~~~~~~~~~--------~~~~~~~y~aP  170 (285)
T cd07861         149 RAFGIPVRVYT--------HEVVTLWYRAP  170 (285)
T ss_pred             eecCCCccccc--------CCcccccccCh
Confidence            76543211100        12467778887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=1.1e-26  Score=190.62  Aligned_cols=166  Identities=28%  Similarity=0.439  Sum_probs=140.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|+..+.||.|+||.||+|.+..+++.|++|.+........+.+.+|+.++..++|+|++.+++.+..     ....++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEEE
Confidence            468889999999999999999999999999999975544445778899999999999999999998743     334799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      |+||+++++|.+++...       .+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        94 v~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          94 VMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             EEEecCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence            99999999999988643       467889999999999999999999   99999999999999999999999999988


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........        ....|+..|+||
T Consensus       164 ~~~~~~~~~--------~~~~~~~~y~aP  184 (296)
T cd06655         164 QITPEQSKR--------STMVGTPYWMAP  184 (296)
T ss_pred             hcccccccC--------CCcCCCccccCc
Confidence            654332111        014578888887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=3.9e-27  Score=200.44  Aligned_cols=164  Identities=24%  Similarity=0.355  Sum_probs=133.7

Q ss_pred             hcCCCCCceeecccceEEEEEEEC--CCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG--EDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|.+.+.||+|+||.||+|...  .++..||+|.+...     ....+|++++..++||||+++++.+..     ...
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-----KST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-----CCE
Confidence            346999999999999999999764  35678999987532     234579999999999999999988743     344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .+++||++. ++|.+++....      .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.++|+|||
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence            799999995 68999885443      678899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++...........      .....||+.|+||
T Consensus       231 ~a~~~~~~~~~~~------~~~~~gt~~y~aP  256 (392)
T PHA03207        231 AACKLDAHPDTPQ------CYGWSGTLETNSP  256 (392)
T ss_pred             cccccCccccccc------ccccccccCccCH
Confidence            9976554322111      1125699999998

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.95  E-value=1.6e-26  Score=185.18  Aligned_cols=169  Identities=25%  Similarity=0.402  Sum_probs=138.8

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|++.+.||+|++|.||++.+..++..+|+|.+....  ....+.+.+|+++++.++|+|++++.+.+..    .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence            4788899999999999999999889999999986432  2334568889999999999999999887532    233468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||+++++|.+++......    .+++.++..++.|++.|+.++|++   +++|+||+|+||+++.++.++++|||++
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGK----LLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence            999999999999998764321    578889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....|++.|+||
T Consensus       150 ~~~~~~~~~~--------~~~~~~~~y~aP  171 (257)
T cd08223         150 RVLENQCDMA--------STLIGTPYYMSP  171 (257)
T ss_pred             EEecccCCcc--------ccccCCcCccCh
Confidence            8764322111        124588889988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.95  E-value=4.8e-27  Score=196.12  Aligned_cols=176  Identities=22%  Similarity=0.392  Sum_probs=136.4

Q ss_pred             cCCCCCceeecccceEEEEEEECC-----CCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGE-----DEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSK  118 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~  118 (234)
                      .+|++.+.||+|+||.||+|....     +++.||+|+++... ....+.+..|+.++..+ +|+||++++++|...   
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~---   83 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP---   83 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence            468889999999999999997543     45789999986432 22345678899999999 799999999987532   


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCC-----------------------------------------------------
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDH-----------------------------------------------------  145 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------------------------------------------  145 (234)
                       ...++++|||+++++|.+++......                                                     
T Consensus        84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             34468999999999999998643210                                                     


Q ss_pred             --ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccc
Q 039258          146 --LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI  223 (234)
Q Consensus       146 --~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~  223 (234)
                        .....+++..+..++.||+.||.|+|++   +|+||||||+||+++.++.++|+|||+++.+..........      
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~------  233 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG------  233 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhcc------
Confidence              0012567888999999999999999999   99999999999999999999999999998764432211100      


Q ss_pred             cccccccccCC
Q 039258          224 GIKGTVGYVAP  234 (234)
Q Consensus       224 ~~~gt~~y~aP  234 (234)
                      ...++..|+||
T Consensus       234 ~~~~~~~y~aP  244 (337)
T cd05054         234 DARLPLKWMAP  244 (337)
T ss_pred             CCCCCccccCc
Confidence            13456778887

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=8.3e-27  Score=198.57  Aligned_cols=175  Identities=23%  Similarity=0.400  Sum_probs=135.5

Q ss_pred             cCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSK  118 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~  118 (234)
                      .+|.+.+.||+|+||.||+|++.     .++..||+|+++... ....+.+.+|+.+|..+. ||||+++++++..    
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~----  112 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK----  112 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc----
Confidence            45778899999999999999864     345789999997442 223357889999999997 9999999998843    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCC-----------------------------------------------------
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDH-----------------------------------------------------  145 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------------------------------------------  145 (234)
                       ....++||||+++|+|.+++......                                                     
T Consensus       113 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         113 -GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             -CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence             23479999999999999998653210                                                     


Q ss_pred             ---------------------------------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 039258          146 ---------------------------------------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPS  186 (234)
Q Consensus       146 ---------------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~  186 (234)
                                                             .....+++.....++.|++.||.|+|++   +++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                   0011356677888999999999999998   9999999999


Q ss_pred             CeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          187 NVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       187 nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++.++.+|++|||+++..........      .....|+..|+||
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~------~~~~~~~~~y~aP  310 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYIS------KGSTFLPLKWMAP  310 (401)
T ss_pred             eEEEeCCCEEEEEecCcceeccccccccc------CCCcCCCCceeCh
Confidence            99999999999999999986533221110      0113467788887

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=5.1e-27  Score=195.47  Aligned_cols=170  Identities=18%  Similarity=0.176  Sum_probs=126.2

Q ss_pred             HHHHHhcCCCCCceeecccceEEEEEEECC-CCeEEEEEEeecc-----cchhhHHHHHHHHHHHhcCCCCcee-EEEEe
Q 039258           40 ELSKATCEFSQSNMIGQGSYGSVYKGILGE-DEMVVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLTK-IITIC  112 (234)
Q Consensus        40 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~-l~~~~  112 (234)
                      +.......|+..+.||+|+||+||+|++.. ++..+|||.+...     .....+.+.+|+++|..++|+|++. +++. 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            344556789999999999999999999876 6777899987522     1223456899999999999999885 4432 


Q ss_pred             eecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCCeeeC
Q 039258          113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDI-KPSNVLLD  191 (234)
Q Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dl-k~~nil~~  191 (234)
                              +..++||||+++++|... ..         ..   ...++.|++.+|.|+|++   +|+|||| ||+|||++
T Consensus        91 --------~~~~LVmE~~~G~~L~~~-~~---------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~  146 (365)
T PRK09188         91 --------GKDGLVRGWTEGVPLHLA-RP---------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG  146 (365)
T ss_pred             --------CCcEEEEEccCCCCHHHh-Cc---------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc
Confidence                    125899999999999632 11         11   135678999999999999   9999999 99999999


Q ss_pred             CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          192 NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       192 ~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .++.+||+|||+|+.+..............-....+++.|+||
T Consensus       147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~p  189 (365)
T PRK09188        147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAP  189 (365)
T ss_pred             CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCc
Confidence            8899999999999987654322221111111135677778877

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.95  E-value=8.7e-27  Score=189.11  Aligned_cols=175  Identities=30%  Similarity=0.502  Sum_probs=138.5

Q ss_pred             cCCCCCceeecccceEEEEEEECC-----CCeEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGE-----DEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      .+|.+.+.||+|+||.||+|.+..     ++..+|+|.++..... ..+.+.+|++++..++|+|++++++++...    
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG----   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC----
Confidence            457888999999999999998743     3578999998754333 446889999999999999999999987543    


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccC--------CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTND--------HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                       ...++||||+++++|.+++...+.        ......+++..+..++.|++.|+.|+|++   +++|+||+|+||+++
T Consensus        81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~  156 (280)
T cd05049          81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVG  156 (280)
T ss_pred             -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEc
Confidence             447999999999999999976532        11122577888899999999999999999   999999999999999


Q ss_pred             CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          192 NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       192 ~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .++.++++|||++.............      ...+++.|+||
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~~~~~~------~~~~~~~y~aP  193 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDYYRVGG------HTMLPIRWMPP  193 (280)
T ss_pred             CCCeEEECCcccceecccCcceecCC------CCcccceecCh
Confidence            99999999999987654322111100      12356778887

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.95  E-value=1.8e-26  Score=184.91  Aligned_cols=168  Identities=24%  Similarity=0.374  Sum_probs=140.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.|+.++...++..+++|.+...  .......+.+|+++++.++|+|++++++++..     ....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            478889999999999999999999999999998644  23344678899999999999999999998753     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||+++++|.+++......    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.+||+|||++
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKGQ----LFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             EEEEecCCCcHHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence            999999999999998765321    578889999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....|++.|+||
T Consensus       149 ~~~~~~~~~~--------~~~~~~~~y~ap  170 (256)
T cd08221         149 KILGSEYSMA--------ETVVGTPYYMSP  170 (256)
T ss_pred             EEcccccccc--------cccCCCccccCH
Confidence            8664432111        114578888887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=2.5e-26  Score=185.31  Aligned_cols=172  Identities=24%  Similarity=0.400  Sum_probs=138.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|+..+.||+|+||.||+|.+..++..+|+|.+....     ......+.+|+.++..++|||++++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence            47889999999999999999999999999999986331     12335688899999999999999999876431   23


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++++||+++++|.+++....      .+++.....++.|++.||.|+|++   +++|+||+|+||+++.++.++|+|
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            45689999999999999997654      467788889999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++............     .....|+..|+||
T Consensus       150 fg~~~~~~~~~~~~~~-----~~~~~~~~~y~aP  178 (266)
T cd06651         150 FGASKRLQTICMSGTG-----IRSVTGTPYWMSP  178 (266)
T ss_pred             CCCccccccccccCCc-----cccCCccccccCH
Confidence            9998765432111100     0113477888887

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=204.88  Aligned_cols=152  Identities=28%  Similarity=0.524  Sum_probs=129.2

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      ++.||+|+.|.||+|+.  .++.||||.++.-.+       .++.=|++|+|+||+.+.|+|....     -+|||||||
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsP-----cyCIiMEfC  194 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSP-----CYCIIMEFC  194 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCc-----eeEEeeecc
Confidence            66799999999999987  446799997753222       3567789999999999999995432     259999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~  210 (234)
                      +.|.|+..++..+      ..+....+.+..+|+.|++|||..   .|||||||.-|||+..+..|||+|||.++...+.
T Consensus       195 a~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  195 AQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             ccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            9999999999876      677788889999999999999999   9999999999999999999999999999876654


Q ss_pred             ccCCCCCCCCccccccccccccCC
Q 039258          211 HLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       211 ~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+.         +.|+||..||||
T Consensus       266 STk---------MSFaGTVaWMAP  280 (904)
T KOG4721|consen  266 STK---------MSFAGTVAWMAP  280 (904)
T ss_pred             hhh---------hhhhhhHhhhCH
Confidence            322         238999999998

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=1.5e-26  Score=188.93  Aligned_cols=168  Identities=27%  Similarity=0.431  Sum_probs=134.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|...+.||+|+||.||+|.+..++..+|+|.+.... ......+.+|+.++..++|+|++++.+++..     ....
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~~   78 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL   78 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----CCeE
Confidence            467889999999999999999999899999999986442 2223467789999999999999999998743     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+. +++.+++.....     .+++..+..++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~  149 (291)
T cd07870          79 TFVFEYMH-TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGL  149 (291)
T ss_pred             EEEEeccc-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccc
Confidence            89999995 688877754432     466777888999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.........        ....+++.|+||
T Consensus       150 ~~~~~~~~~~~--------~~~~~~~~y~aP  172 (291)
T cd07870         150 ARAKSIPSQTY--------SSEVVTLWYRPP  172 (291)
T ss_pred             ccccCCCCCCC--------CCccccccccCC
Confidence            87543321110        013467788887

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=5.8e-27  Score=190.90  Aligned_cols=168  Identities=25%  Similarity=0.391  Sum_probs=136.9

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      +|++.+.||+|+||.||++.+..++..+|+|.+... .......+.+|++++..++|+|++++++.+..     .+..++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEEE
Confidence            578889999999999999999989999999988654 23334678899999999999999999997643     345789


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++.....   ...+++..+..++.|++.|+.|||++.  +++|+||+|+||+++.++.++++|||++.
T Consensus        77 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~  151 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSG  151 (286)
T ss_pred             EEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence            9999999999988876421   115788899999999999999999631  89999999999999999999999999987


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........          ..|++.|+||
T Consensus       152 ~~~~~~~~~----------~~~~~~y~aP  170 (286)
T cd06622         152 NLVASLAKT----------NIGCQSYMAP  170 (286)
T ss_pred             cccCCcccc----------CCCccCccCc
Confidence            654321111          3466677776

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.4e-26  Score=185.87  Aligned_cols=148  Identities=30%  Similarity=0.521  Sum_probs=126.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      +|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+|++++..++|+|++++++++..     .++.++|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv   77 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-----QRPIFIV   77 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----CCceEEE
Confidence            5788899999999999999885 45679999985332 223568889999999999999999998642     3457899


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      |||+++++|.+++.....     .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.+|++|||+++.
T Consensus        78 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~  149 (256)
T cd05059          78 TEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARY  149 (256)
T ss_pred             EecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCccccee
Confidence            999999999999876432     577888999999999999999999   999999999999999999999999999886


Q ss_pred             cCC
Q 039258          207 LSS  209 (234)
Q Consensus       207 ~~~  209 (234)
                      ..+
T Consensus       150 ~~~  152 (256)
T cd05059         150 VLD  152 (256)
T ss_pred             ccc
Confidence            543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.95  E-value=1.3e-26  Score=188.44  Aligned_cols=182  Identities=26%  Similarity=0.366  Sum_probs=144.9

Q ss_pred             ChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeec
Q 039258           37 SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSI  115 (234)
Q Consensus        37 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~  115 (234)
                      +..++....+.|+..+.||+|+||.||+|.+..++..+|+|++..... ....+..|+.++..+ +|+|++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            444555566789999999999999999999999999999999865432 335678899999888 699999999987543


Q ss_pred             CC-CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          116 DS-KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       116 ~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                      .. ......+++|||+++++|.+++......    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN----ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            22 2345679999999999999998764322    467778889999999999999999   999999999999999999


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .++|+|||++..........        ....|++.|+||
T Consensus       159 ~~~l~dfg~~~~~~~~~~~~--------~~~~~~~~y~aP  190 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVGRR--------NTFIGTPYWMAP  190 (282)
T ss_pred             CEEEeeCcchhhhhccccCC--------CcccccccccCH
Confidence            99999999987653221110        114578888887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-28  Score=190.20  Aligned_cols=169  Identities=25%  Similarity=0.315  Sum_probs=137.6

Q ss_pred             HhcCCCCC-ceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCC
Q 039258           44 ATCEFSQS-NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        44 ~~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+.+|.+. ++||-|-.|+|..|.++.|++.+|+|++....     ...+|+++--.. .|||||.++++|.... .+..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSY-QGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhc-cCce
Confidence            34567554 68999999999999999999999999996443     345788876555 5999999999986543 3455


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC---CCCceEE
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHV  198 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~---~~~~vki  198 (234)
                      -+.+|||.++||.|++.+.+++..    .+++.++..|+.||+.|+.|||+.   +|.||||||+|+|..   .+..+|+
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~----afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQ----AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccc----cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence            568999999999999999988754    799999999999999999999999   999999999999995   4567999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+|+.......-   .      +-|-||.|.||
T Consensus       206 tDfGFAK~t~~~~~L---~------TPc~TPyYvaP  232 (400)
T KOG0604|consen  206 TDFGFAKETQEPGDL---M------TPCFTPYYVAP  232 (400)
T ss_pred             cccccccccCCCccc---c------CCcccccccCH
Confidence            999999965432111   1      13578888887

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=1.5e-26  Score=186.82  Aligned_cols=151  Identities=30%  Similarity=0.531  Sum_probs=128.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCC---eEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDE---MVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|++.+.||+|+||.||+|.+..++   ..+|+|.++... ....+.+..|+.++..++|||++++++++..     .+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CC
Confidence            46788899999999999999876433   479999986432 2234678899999999999999999998743     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++.....     .+++..+..++.|++.|+.|+|++   +++|+||||+||+++.++.++++||
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df  150 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF  150 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence            57999999999999999976532     467888899999999999999999   9999999999999999999999999


Q ss_pred             ccccccCC
Q 039258          202 GLSKFLSS  209 (234)
Q Consensus       202 G~a~~~~~  209 (234)
                      |++.....
T Consensus       151 g~~~~~~~  158 (267)
T cd05066         151 GLSRVLED  158 (267)
T ss_pred             Cccccccc
Confidence            99987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.95  E-value=1.9e-26  Score=184.67  Aligned_cols=165  Identities=27%  Similarity=0.452  Sum_probs=137.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      +|+..+.||+|+||.||+|....++..+++|.+....     +...+.+.+|+++++.++|+|++++++++..     ..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-----ED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-----CC
Confidence            4777889999999999999998889999999986432     2244678899999999999999999998743     24


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++++||+++++|.+++....      .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.+||+||
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            4789999999999999987653      467788889999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........         ...|+..|+||
T Consensus       147 ~~~~~~~~~~~~~---------~~~~~~~y~~p  170 (258)
T cd06632         147 GMAKQVVEFSFAK---------SFKGSPYWMAP  170 (258)
T ss_pred             ccceecccccccc---------ccCCCcceeCH
Confidence            9988654432111         14577778876

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.95  E-value=1.3e-26  Score=190.68  Aligned_cols=153  Identities=29%  Similarity=0.524  Sum_probs=125.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCe--EEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEM--VVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ++|++.+.||+|+||.||+|.++.++.  .+|+|.++.. .......+.+|++++..+ +|+|++++++++..     ..
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-----~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----CC
Confidence            467888999999999999999877664  4577766532 233446788899999999 89999999998743     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHL----------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                      ..++||||+++++|.+++.......          ....+++..++.++.|++.|++|||++   +++||||||+||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEec
Confidence            4799999999999999997643211          112467888999999999999999999   999999999999999


Q ss_pred             CCCceEEccCccccc
Q 039258          192 NDMVAHVGDFGLSKF  206 (234)
Q Consensus       192 ~~~~vki~dfG~a~~  206 (234)
                      .++.+||+|||++..
T Consensus       159 ~~~~~kl~dfg~~~~  173 (303)
T cd05088         159 ENYVAKIADFGLSRG  173 (303)
T ss_pred             CCCcEEeCccccCcc
Confidence            999999999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=8.6e-27  Score=194.40  Aligned_cols=174  Identities=25%  Similarity=0.359  Sum_probs=140.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.++..++|+|++++++++...........
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            45799999999999999999999999999999998632 23344668889999999999999999988755444444557


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++++||+++ +|.+.+...       .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~~-~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             EEEehhccc-CHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            899999964 888777543       578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........     ......||+.|+||
T Consensus       153 ~~~~~~~~~~~~-----~~~~~~~~~~y~aP  178 (336)
T cd07849         153 ARIADPEHDHTG-----FLTEYVATRWYRAP  178 (336)
T ss_pred             eeeccccccccC-----CcCCcCcCCCccCh
Confidence            886544221111     01124688889988

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=1.7e-26  Score=188.58  Aligned_cols=148  Identities=27%  Similarity=0.502  Sum_probs=127.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+|+..+.||+|++|.||+|.++.++..||+|.+..... .....+.+|++++..++|+||+++++++..     .+..+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-----KKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-----CCeEE
Confidence            468889999999999999999988899999999864322 223456789999999999999999998743     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++ +|.+++.....     .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.+|++|||++
T Consensus        80 lv~e~~~~-~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  150 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA  150 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccc
Confidence            99999975 99998876432     567888899999999999999999   9999999999999999999999999998


Q ss_pred             ccc
Q 039258          205 KFL  207 (234)
Q Consensus       205 ~~~  207 (234)
                      +..
T Consensus       151 ~~~  153 (291)
T cd07844         151 RAK  153 (291)
T ss_pred             ccc
Confidence            754

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-27  Score=204.37  Aligned_cols=163  Identities=28%  Similarity=0.432  Sum_probs=137.1

Q ss_pred             eeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecCC
Q 039258           53 MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMEN  132 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~  132 (234)
                      +||+|+||+||-|++..++..+|||-+..++....+.+..|+.+-+.++|.|||+++|.+     ..+++.-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            899999999999999999999999999866656667889999999999999999999986     334567899999999


Q ss_pred             CCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC-CCCceEEccCccccccCCCc
Q 039258          133 GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDH  211 (234)
Q Consensus       133 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~-~~~~vki~dfG~a~~~~~~~  211 (234)
                      |+|.++++..=+   +.+-.+...-.+..||++||.|||++   .|||||||..|+|++ -.|.+||+|||.++.+-.-.
T Consensus       657 GSLSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  657 GSLSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             CcHHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            999999986422   22336777888999999999999999   999999999999996 67899999999988653211


Q ss_pred             cCCCCCCCCccccccccccccCC
Q 039258          212 LDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       212 ~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                        +    +..  ++.||..||||
T Consensus       731 --P----~TE--TFTGTLQYMAP  745 (1226)
T KOG4279|consen  731 --P----CTE--TFTGTLQYMAP  745 (1226)
T ss_pred             --c----ccc--ccccchhhhCh
Confidence              1    110  27899999998

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.95  E-value=2.3e-26  Score=185.15  Aligned_cols=171  Identities=27%  Similarity=0.428  Sum_probs=139.4

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++|++.+.||+|+||.||+|.+..++..+|+|.++..   .......+.+|++++..++|+|++++++.+..     .+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            4788899999999999999999989999999988632   22335678899999999999999999998753     234


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++......  ...+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence            68999999999999998653221  11577888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++...........        ...|++.|+||
T Consensus       152 ~~~~~~~~~~~~~--------~~~~~~~y~ap  175 (267)
T cd08224         152 LGRFFSSKTTAAH--------SLVGTPYYMSP  175 (267)
T ss_pred             eeeeccCCCcccc--------eecCCccccCH
Confidence            9886543221110        13577778877

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.5e-26  Score=189.47  Aligned_cols=157  Identities=27%  Similarity=0.476  Sum_probs=127.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCC--------------CeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEE
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGED--------------EMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKII  109 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~  109 (234)
                      .++|++.+.||+|+||.||+|++..+              ...||+|.+... .......+.+|++++..++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            35788899999999999999987543              246899998643 233346788999999999999999999


Q ss_pred             EEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCC------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 039258          110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDH------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDI  183 (234)
Q Consensus       110 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dl  183 (234)
                      +++..     ....++||||+++++|.+++......      .....+++..++.++.|++.|+.|||++   +++|+||
T Consensus        84 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl  155 (295)
T cd05097          84 GVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL  155 (295)
T ss_pred             EEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence            98743     33469999999999999998653210      0011357788899999999999999999   9999999


Q ss_pred             CCCCeeeCCCCceEEccCccccccCC
Q 039258          184 KPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       184 k~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      ||+||+++.++.+|++|||++.....
T Consensus       156 kp~Nill~~~~~~kl~dfg~~~~~~~  181 (295)
T cd05097         156 ATRNCLVGNHYTIKIADFGMSRNLYS  181 (295)
T ss_pred             ChhhEEEcCCCcEEeccccccccccc
Confidence            99999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=1.8e-26  Score=186.53  Aligned_cols=168  Identities=24%  Similarity=0.483  Sum_probs=136.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc----------hhhHHHHHHHHHHHhcCCCCceeEEEEeeecC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK----------GAFRSFVAECEALRNIRHRNLTKIITICSSID  116 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~  116 (234)
                      +|...+.||+|+||.||+|....++..+|+|.++....          ...+.+..|+.++..++|+|++++++++..  
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence            47778899999999999999988899999998853211          112467789999999999999999998743  


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCce
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~v  196 (234)
                         ....++||||+++++|.+++...+      .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.+
T Consensus        80 ---~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          80 ---EEYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             ---CCceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence               344689999999999999997764      577888899999999999999998   99999999999999999999


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++|||++..........      ......|+..|+||
T Consensus       148 ~l~d~~~~~~~~~~~~~~------~~~~~~~~~~y~~P  179 (272)
T cd06629         148 KISDFGISKKSDDIYDND------QNMSMQGSVFWMAP  179 (272)
T ss_pred             EEeecccccccccccccc------ccccccCCccccCH
Confidence            999999987644321111      01124577778876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-26  Score=186.96  Aligned_cols=178  Identities=27%  Similarity=0.374  Sum_probs=143.8

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCC-CCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDS-KGA  120 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~-~~~  120 (234)
                      ...++|++.+.||+|+||.||+|.+..++..+++|++..... ....+.+|+.++.++ +|+|++++++++..... ...
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            456789999999999999999999988899999999875433 336788999999999 69999999999865443 334


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++......  ...+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence            5678999999999999988653210  01577888999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++...........        ...|+..|+||
T Consensus       157 ~~~~~~~~~~~~~~~--------~~~~~~~y~aP  182 (275)
T cd06608         157 FGVSAQLDSTLGRRN--------TFIGTPYWMAP  182 (275)
T ss_pred             Cccceecccchhhhc--------CccccccccCH
Confidence            999876543221110        14577788877

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=2.6e-26  Score=185.50  Aligned_cols=168  Identities=24%  Similarity=0.409  Sum_probs=128.8

Q ss_pred             ceeecccceEEEEEEEC--CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           52 NMIGQGSYGSVYKGILG--EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      +.||+|+||.||+|...  .++..+|+|.++... ......+.+|+.++..++|||++++++.+...     ...++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEE
Confidence            35899999999999864  345789999886443 22335688899999999999999999987432     34689999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      |+++++|.+++...... .....++..+..++.|++.|+.|+|++   +++|+||||+||+++.+++++++|||++....
T Consensus        76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999999999754321 111345667778999999999999999   99999999999999999999999999987543


Q ss_pred             CCccCCCCCCCCccccccccccccCC
Q 039258          209 SDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......      .....|+..|+||
T Consensus       152 ~~~~~~~------~~~~~~~~~y~aP  171 (269)
T cd05087         152 KEDYYVT------PDQLWVPLRWIAP  171 (269)
T ss_pred             Ccceeec------CCCcCCcccccCH
Confidence            2211110      0114577788887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=1.8e-26  Score=187.73  Aligned_cols=175  Identities=22%  Similarity=0.413  Sum_probs=135.3

Q ss_pred             cCCCCCceeecccceEEEEEEEC----CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILG----EDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|+..+.||+|+||.||+|...    .++..+|+|.+... .......+.+|++++..++|||++++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence            35777889999999999999853    45678999998643 22334678889999999999999999998643     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCC-----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCee
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDH-----------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVL  189 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil  189 (234)
                      ...++||||+++++|.+++......           .....+++...+.++.|++.|+.|+|++   +++|+||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence            3468999999999999998643210           0112467788899999999999999999   9999999999999


Q ss_pred             eCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          190 LDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       190 ~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.++.+|++|||+++...........      ....++..|+||
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~------~~~~~~~~y~aP  195 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQ------PKSLLPIRWMPP  195 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecc------cCCCccceecCh
Confidence            999999999999999865433211110      113356678877

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.95  E-value=2e-26  Score=185.06  Aligned_cols=149  Identities=26%  Similarity=0.484  Sum_probs=126.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|++.+.||+|+||.||.|.+.. +..+|+|.+.... .....+.+|+.++..++|||++++++++..     ....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence            357788899999999999998754 3469999886432 233678899999999999999999998743     234699


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      +|||+++++|.+++.....     .+++..++.++.|++.|+.|+|+.   +++|+||+|+||+++.++.+|++|||.++
T Consensus        77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence            9999999999999876432     578889999999999999999999   99999999999999999999999999988


Q ss_pred             ccCC
Q 039258          206 FLSS  209 (234)
Q Consensus       206 ~~~~  209 (234)
                      ....
T Consensus       149 ~~~~  152 (256)
T cd05113         149 YVLD  152 (256)
T ss_pred             ecCC
Confidence            6544

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=1.1e-26  Score=188.44  Aligned_cols=142  Identities=25%  Similarity=0.435  Sum_probs=116.5

Q ss_pred             eeecccceEEEEEEECC------------------------CCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeE
Q 039258           53 MIGQGSYGSVYKGILGE------------------------DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI  108 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l  108 (234)
                      .||+|+||.||+|....                        ....|++|+++.........+.+|+.++..++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997531                        124689999865544444678889999999999999999


Q ss_pred             EEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCe
Q 039258          109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV  188 (234)
Q Consensus       109 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~ni  188 (234)
                      ++++...     ...++||||+++++|..++.....     .+++.++..++.|++.||+|+|++   +++||||||+||
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni  148 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI  148 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence            9998543     346899999999999998865432     567888999999999999999999   999999999999


Q ss_pred             eeCCCC-------ceEEccCcccccc
Q 039258          189 LLDNDM-------VAHVGDFGLSKFL  207 (234)
Q Consensus       189 l~~~~~-------~vki~dfG~a~~~  207 (234)
                      +++..+       .+|++|||++...
T Consensus       149 ll~~~~~~~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076         149 LLARLGLAEGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             EEeccCcccCccceeeecCCcccccc
Confidence            997543       4899999987643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.95  E-value=2.8e-26  Score=184.33  Aligned_cols=143  Identities=29%  Similarity=0.546  Sum_probs=121.6

Q ss_pred             eeecccceEEEEEEEC--CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEee
Q 039258           53 MIGQGSYGSVYKGILG--EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEY  129 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~  129 (234)
                      .||+|+||.||+|.++  .++..||+|++.... ....+.+.+|+.++.+++|+|++++++++..      ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence            3899999999999875  445679999986543 2334678899999999999999999998732      235899999


Q ss_pred             cCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          130 MENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       130 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      +++++|.+++.....     .+++..++.++.|++.|+.|+|++   +++|+||||+||+++.++.+|++|||++.....
T Consensus        76 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          76 ASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            999999999875432     578889999999999999999999   999999999999999999999999999986544

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=2.7e-26  Score=186.66  Aligned_cols=149  Identities=25%  Similarity=0.421  Sum_probs=128.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.||+|.+..++..||+|.+....  ....+.+.+|+.++..++|+|++++++++..     ....+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEEE
Confidence            6888899999999999999999899999999986432  2233567899999999999999999998753     23468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||++++.|..+.....      .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        77 ~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (286)
T cd07847          77 LVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFA  147 (286)
T ss_pred             EEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccc
Confidence            9999999877777765433      578889999999999999999998   9999999999999999999999999999


Q ss_pred             cccCC
Q 039258          205 KFLSS  209 (234)
Q Consensus       205 ~~~~~  209 (234)
                      .....
T Consensus       148 ~~~~~  152 (286)
T cd07847         148 RILTG  152 (286)
T ss_pred             eecCC
Confidence            87644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.95  E-value=3.2e-26  Score=189.14  Aligned_cols=170  Identities=26%  Similarity=0.351  Sum_probs=130.2

Q ss_pred             CceeecccceEEEEEEECC--CCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           51 SNMIGQGSYGSVYKGILGE--DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      ...||+|+||.||+|.+..  ++..+|+|.+....  ....+.+|+.++..++|||++++++++...   .....++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEe
Confidence            4689999999999999754  56889999886332  224577899999999999999999987542   2345689999


Q ss_pred             ecCCCCHHHHhhhccC---CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee----CCCCceEEccC
Q 039258          129 YMENGSLEDWLHQTND---HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL----DNDMVAHVGDF  201 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~----~~~~~vki~df  201 (234)
                      |++ ++|.+++.....   ......+++..+..++.|++.||.|+|+.   +++||||||+||++    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            996 588888754321   11122577888899999999999999999   99999999999999    45678999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++..........     ......||+.|+||
T Consensus       157 G~a~~~~~~~~~~~-----~~~~~~~t~~y~aP  184 (317)
T cd07867         157 GFARLFNSPLKPLA-----DLDPVVVTFWYRAP  184 (317)
T ss_pred             cceeccCCCccccc-----ccCcceecccccCc
Confidence            99987654322111     01125689999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.7e-26  Score=184.13  Aligned_cols=172  Identities=24%  Similarity=0.403  Sum_probs=139.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-----cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|.+.+.||+|+||.||+|.+..++..+|+|.+...     .......+.+|++++..++|+|++++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence            4688899999999999999999999999999988532     123346788999999999999999999986432   23


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++++||+++++|.+++....      .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence            44689999999999999987654      467788899999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++..........     ......|+..|+||
T Consensus       150 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~aP  178 (264)
T cd06653         150 FGASKRIQTICMSGT-----GIKSVTGTPYWMSP  178 (264)
T ss_pred             cccccccccccccCc-----cccccCCcccccCH
Confidence            999986543211100     00124578888887

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.95  E-value=3.8e-26  Score=187.95  Aligned_cols=147  Identities=27%  Similarity=0.402  Sum_probs=128.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++|+..+.||+|+||.||++.+..++..|++|.+....   ......+.+|++++..++||||+++++.+..     .++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-----KRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-----CCE
Confidence            36888999999999999999999999999999986432   2234567889999999999999999988743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence            799999999999999997654      577888889999999999999999   99999999999999999999999999


Q ss_pred             cccc
Q 039258          203 LSKF  206 (234)
Q Consensus       203 ~a~~  206 (234)
                      +++.
T Consensus       147 ~~~~  150 (305)
T cd05609         147 LSKI  150 (305)
T ss_pred             Cccc
Confidence            9874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=3.1e-26  Score=187.40  Aligned_cols=176  Identities=24%  Similarity=0.393  Sum_probs=137.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCC----------------eEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCcee
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDE----------------MVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTK  107 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~  107 (234)
                      ..+|++.+.||+|+||.||+|.+..++                ..+|+|.+.... ....+.+.+|++++..++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            457889999999999999999876433                568999986442 234467889999999999999999


Q ss_pred             EEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCc-----cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039258          108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-----EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD  182 (234)
Q Consensus       108 l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~d  182 (234)
                      +++++...     +..+++||++++++|.+++.......     ....+++..+..++.|++.|+.|||++   +++|+|
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            99987432     45799999999999999987643110     112478888999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+||+++.++.++++|||+++............      ...+++.|+||
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~------~~~~~~~y~aP  201 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG------RAPLPIRWMAW  201 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcceeecC------cCCCCceecCH
Confidence            99999999999999999999988654332111100      13466788887

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.9e-26  Score=189.44  Aligned_cols=150  Identities=28%  Similarity=0.392  Sum_probs=130.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +|+..+.||+|+||.||+|.+..++..+|+|.+.....   ...+.+..|++++..++|+||+++++.+..     ....
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCEE
Confidence            68888999999999999999998999999999974422   244678899999999999999999988743     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      +++|||+++++|.+++......    .+++..+..++.|++.||.|+|+.   +++|+||||+||+++.++.++++|||+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPGK----CLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCCC----ccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence            9999999999999998754322    578888899999999999999999   999999999999999999999999999


Q ss_pred             ccccC
Q 039258          204 SKFLS  208 (234)
Q Consensus       204 a~~~~  208 (234)
                      +....
T Consensus       150 ~~~~~  154 (316)
T cd05574         150 SKQSD  154 (316)
T ss_pred             hhccc
Confidence            87654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.6e-26  Score=186.06  Aligned_cols=176  Identities=22%  Similarity=0.399  Sum_probs=137.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCC-----CeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGED-----EMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      ..+|++.+.||+|+||.||+|.+...     +..+|+|.+.... ......+.+|+.++..++|+|++++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG---   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC---
Confidence            34688889999999999999987643     4789999986442 23345688999999999999999999987532   


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCc----cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHL----EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                        ...++||||+++++|.+++.......    ....+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++
T Consensus        82 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          82 --QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence              44799999999999999987543211    111367788899999999999999998   999999999999999999


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+|++|||+++............      ...++..|+||
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~------~~~~~~~y~aP  190 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGG------KGLLPVRWMAP  190 (277)
T ss_pred             CEEECCcccchhhccCcccccCC------CCCccccccCH
Confidence            99999999988654332111100      13466778887

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.95  E-value=5.8e-28  Score=190.50  Aligned_cols=175  Identities=26%  Similarity=0.384  Sum_probs=139.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCC----eEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDE----MVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ..|+....||+|+||.||+|..+++.    .++|+|.++..+  .......-+|+.+++.++|+|++.+..++-..    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            45888899999999999999766543    379999887442  23345677899999999999999999887543    


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC----Cc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND----MV  195 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~----~~  195 (234)
                      ...+++++||.+. +|.+.+.-+..... ..++..-+..++.||+.|+.|||++   =|+||||||.|||+..+    |.
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence            2347899999976 99999987654333 3677788899999999999999999   89999999999999766    89


Q ss_pred             eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+|||+++.+.+.-..-...     -.++.|.+|.||
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~-----d~VVVTiWYRAP  208 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASL-----DPVVVTIWYRAP  208 (438)
T ss_pred             eEeecccHHHHhhccccccccC-----CceEEEEEecCh
Confidence            9999999999876643221111     126789999998

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=2.9e-26  Score=187.18  Aligned_cols=158  Identities=23%  Similarity=0.449  Sum_probs=127.0

Q ss_pred             HhcCCCCCceeecccceEEEEEEECC-----CCeEEEEEEeecccc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGE-----DEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      ...+|++.+.||+|+||.||+|..+.     .+..||+|.++.... .....+.+|+.++..++|+|++++++.+..   
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK---   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence            34578899999999999999997642     346899998864322 223467889999999999999999998743   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCc----cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHL----EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~  193 (234)
                        .+..++||||+++++|.+++.......    .....+...+..++.|++.|+.|+|++   +++|+||||+||+++.+
T Consensus        81 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~  155 (288)
T cd05061          81 --GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD  155 (288)
T ss_pred             --CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence              234699999999999999997533211    112345667888999999999999999   99999999999999999


Q ss_pred             CceEEccCccccccCC
Q 039258          194 MVAHVGDFGLSKFLSS  209 (234)
Q Consensus       194 ~~vki~dfG~a~~~~~  209 (234)
                      +.++++|||+++....
T Consensus       156 ~~~~L~Dfg~~~~~~~  171 (288)
T cd05061         156 FTVKIGDFGMTRDIYE  171 (288)
T ss_pred             CcEEECcCCccccccc
Confidence            9999999999886543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=2.6e-26  Score=188.11  Aligned_cols=157  Identities=26%  Similarity=0.477  Sum_probs=128.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECC----------------CCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCcee
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGE----------------DEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTK  107 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~  107 (234)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|.+... .......+.+|+.++..++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3568999999999999999986432                3457999998644 2334467889999999999999999


Q ss_pred             EEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCcc-----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039258          108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE-----VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD  182 (234)
Q Consensus       108 l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~d  182 (234)
                      +++++...     +..+++|||+++++|.+++........     ...+++..+..++.|++.|+.|+|++   +++|+|
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d  155 (296)
T cd05095          84 LLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRD  155 (296)
T ss_pred             EEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            99987432     346999999999999999876432111     12466778899999999999999999   999999


Q ss_pred             CCCCCeeeCCCCceEEccCccccccCC
Q 039258          183 IKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      |||+||+++.++.++++|||+++....
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05095         156 LATRNCLVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             CChheEEEcCCCCEEeccCcccccccC
Confidence            999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.94  E-value=1.2e-26  Score=188.73  Aligned_cols=166  Identities=24%  Similarity=0.441  Sum_probs=135.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.||+|.+..++..+|+|.++...  ......+.+|++++..++|+|++++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence            4778899999999999999999999999999996432  2223567789999999999999999988643     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +++||++ ++|.+++.....     .+++..+..++.||+.||.|||++   +++|+||+|+||+++.++.++|+|||++
T Consensus        76 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence            9999996 588888765432     578889999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.........        ....+++.|+||
T Consensus       147 ~~~~~~~~~~--------~~~~~~~~y~aP  168 (284)
T cd07839         147 RAFGIPVRCY--------SAEVVTLWYRPP  168 (284)
T ss_pred             hccCCCCCCc--------CCCccccCCcCh
Confidence            8654321110        013467788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.94  E-value=2.7e-26  Score=186.64  Aligned_cols=167  Identities=28%  Similarity=0.411  Sum_probs=139.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+....  ......+.+|+.++..++|+|++++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence            4788899999999999999999899999999997543  3334678899999999999999999998743     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+ +++|.+++.....     .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++
T Consensus        76 ~v~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             EEeccc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            999999 9999999876442     578889999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........       ....|+..|+||
T Consensus       147 ~~~~~~~~~~~-------~~~~~~~~y~aP  169 (286)
T cd07832         147 RLFSEEEPRLY-------SHQVATRWYRAP  169 (286)
T ss_pred             ccccCCCCCcc-------ccccCcccccCc
Confidence            87654321110       013578888887

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.94  E-value=2.7e-26  Score=184.92  Aligned_cols=168  Identities=28%  Similarity=0.510  Sum_probs=134.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+..+ ..+|+|.++... ...+.+.+|++++..++|+|++++++.+.      ....+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence            35688999999999999999988655 459999986432 23367889999999999999999998752      12358


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++......    .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.++|+|||.+
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGK----YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             EEEEcCCCCcHHHHHhhcccc----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence            999999999999999764221    467888899999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........       ....++..|+||
T Consensus       150 ~~~~~~~~~~~-------~~~~~~~~y~~P  172 (262)
T cd05071         150 RLIEDNEYTAR-------QGAKFPIKWTAP  172 (262)
T ss_pred             eeccccccccc-------cCCcccceecCH
Confidence            86544321111       013356678887

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.94  E-value=3.2e-26  Score=184.95  Aligned_cols=151  Identities=28%  Similarity=0.551  Sum_probs=128.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCC---eEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDE---MVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|++.+.||+|+||.||+|.+..++   ..||+|.++.. .......+..|+.++..++|||++++++++..     ..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----CC
Confidence            35778899999999999999987655   46999998644 33345678999999999999999999998742     33


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++.....     .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df  150 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF  150 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence            46899999999999999876432     577888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCC
Q 039258          202 GLSKFLSS  209 (234)
Q Consensus       202 G~a~~~~~  209 (234)
                      |++.....
T Consensus       151 g~~~~~~~  158 (269)
T cd05065         151 GLSRFLED  158 (269)
T ss_pred             cccccccc
Confidence            99886544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.94  E-value=2.6e-26  Score=188.11  Aligned_cols=149  Identities=29%  Similarity=0.501  Sum_probs=128.5

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-----hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-----GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      +|+..+.||+|+||.||+|.+..++..||+|.+.....     .....+..|++++..++|+|++++++++..     .+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence            47778899999999999999998899999999974422     123456789999999999999999998743     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+ +++|.+++.....     .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.++|+||
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKSI-----VLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence            579999999 8899999876431     578888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCC
Q 039258          202 GLSKFLSS  209 (234)
Q Consensus       202 G~a~~~~~  209 (234)
                      |++.....
T Consensus       147 g~~~~~~~  154 (298)
T cd07841         147 GLARSFGS  154 (298)
T ss_pred             eeeeeccC
Confidence            99987644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.94  E-value=2.5e-26  Score=187.81  Aligned_cols=158  Identities=26%  Similarity=0.446  Sum_probs=129.8

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCC-----CeEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGED-----EMVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSID  116 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~  116 (234)
                      ...+|+..+.||+|+||.||++.+...     ...+|+|.+... .......+.+|++++.++ +|+|++++++++..  
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence            345688889999999999999987643     378999998643 223345688999999999 79999999998743  


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCC----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDH----------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPS  186 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~  186 (234)
                         ....+++|||+++++|.+++......          .....+++..++.++.|++.|+.|||++   +++|+||||+
T Consensus        88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~  161 (293)
T cd05053          88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR  161 (293)
T ss_pred             ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence               33479999999999999998753210          1122578889999999999999999999   9999999999


Q ss_pred             CeeeCCCCceEEccCccccccCC
Q 039258          187 NVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       187 nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      ||+++.++.+|++|||+++.+..
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~  184 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHH  184 (293)
T ss_pred             eEEEcCCCeEEeCcccccccccc
Confidence            99999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.94  E-value=1.6e-26  Score=186.29  Aligned_cols=171  Identities=25%  Similarity=0.413  Sum_probs=138.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||.||+|.+..++..+|+|.+...   .......+.+|+.++..++|+|++++++.+..     .+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence            3678888999999999999999889999999988642   22234578899999999999999999998753     234


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .+++|||+++++|.+++......  ...+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence            68999999999999988743211  11578888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++...........        ...|+..|+||
T Consensus       152 ~~~~~~~~~~~~~--------~~~~~~~~~ap  175 (267)
T cd08229         152 LGRFFSSKTTAAH--------SLVGTPYYMSP  175 (267)
T ss_pred             hhhccccCCcccc--------cccCCcCccCH
Confidence            9886544321110        14577788887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.4e-26  Score=188.58  Aligned_cols=166  Identities=24%  Similarity=0.344  Sum_probs=138.3

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+|++.+.||+|+||.||++.+..++..+|+|++.... ....+.+.+|++++..++|||++++++.+...     ...+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEEE
Confidence            46788899999999999999999889999999986442 33457789999999999999999999987543     4579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++...+      .+++..+..++.+++.++.|||+..  +++|+||+|+||+++.++.++++|||++
T Consensus        80 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             EEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcc
Confidence            9999999999999887654      5778888999999999999999631  8999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........          ...|+..|+||
T Consensus       152 ~~~~~~~~~----------~~~~~~~~~aP  171 (284)
T cd06620         152 GELINSIAD----------TFVGTSTYMSP  171 (284)
T ss_pred             cchhhhccC----------ccccCcccCCH
Confidence            754322111          14588888887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.1e-26  Score=185.30  Aligned_cols=150  Identities=27%  Similarity=0.523  Sum_probs=128.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCC----eEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDE----MVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|+..+.||+|+||.||+|.+..++    ..+|+|...... ......+.+|+.++..++|||++++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            46788899999999999999986554    368999886443 3344678899999999999999999998854      


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....     .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.+|++|
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d  152 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD  152 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence            236899999999999999876543     478889999999999999999998   999999999999999999999999


Q ss_pred             CccccccCC
Q 039258          201 FGLSKFLSS  209 (234)
Q Consensus       201 fG~a~~~~~  209 (234)
                      ||+++....
T Consensus       153 fg~~~~~~~  161 (279)
T cd05057         153 FGLAKLLDV  161 (279)
T ss_pred             CcccccccC
Confidence            999987653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=3.4e-26  Score=184.43  Aligned_cols=157  Identities=25%  Similarity=0.477  Sum_probs=125.9

Q ss_pred             eeecccceEEEEEEECC------------CCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           53 MIGQGSYGSVYKGILGE------------DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .||+|+||.||+|....            ....+++|.+..........+.+|+.++..++||||+++++++...     
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-----   76 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-----   76 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            58999999999998532            2246899988755555556788899999999999999999987532     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc-----
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV-----  195 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~-----  195 (234)
                      ...+++|||+++++|..++.....     .+++..+..++.|++.|+.|+|++   +++||||||+||+++.++.     
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~  148 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECG  148 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCC
Confidence            346899999999999888765432     578888999999999999999999   9999999999999976553     


Q ss_pred             --eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 --AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 --vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                        ++++|||++.......            ...|+..|+||
T Consensus       149 ~~~~l~d~g~~~~~~~~~------------~~~~~~~y~aP  177 (262)
T cd05077         149 PFIKLSDPGIPITVLSRQ------------ECVERIPWIAP  177 (262)
T ss_pred             ceeEeCCCCCCccccCcc------------cccccccccCh
Confidence              8999999987543211            13467778887

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.94  E-value=2.9e-26  Score=184.29  Aligned_cols=151  Identities=23%  Similarity=0.517  Sum_probs=127.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|... ++..+|+|.+.... ...+.+.+|+.++..++|+|++++++.+..     ....+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcE
Confidence            346888999999999999999874 45679999876432 234678899999999999999999988643     34468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||+++++|.+++......    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGG----KVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence            999999999999998764321    567778889999999999999998   9999999999999999999999999999


Q ss_pred             cccCC
Q 039258          205 KFLSS  209 (234)
Q Consensus       205 ~~~~~  209 (234)
                      .....
T Consensus       151 ~~~~~  155 (261)
T cd05072         151 RVIED  155 (261)
T ss_pred             eecCC
Confidence            87544

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=2.6e-26  Score=184.08  Aligned_cols=143  Identities=27%  Similarity=0.532  Sum_probs=121.1

Q ss_pred             ceeecccceEEEEEEECCCC----------eEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           52 NMIGQGSYGSVYKGILGEDE----------MVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      +.||+|+||.||+|.+..++          ..+++|.+...... ...+.+|+.+++.++|||++++++++..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            36899999999999997665          46888877544332 5788899999999999999999998754      2


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC-------
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-------  194 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~-------  194 (234)
                      ..++||||+++++|.+++.....     .+++..+..++.|++.||.|+|++   +++|+||||+||+++.++       
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~  145 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP  145 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence            25899999999999999986543     467788899999999999999998   999999999999998777       


Q ss_pred             ceEEccCccccccCC
Q 039258          195 VAHVGDFGLSKFLSS  209 (234)
Q Consensus       195 ~vki~dfG~a~~~~~  209 (234)
                      .+|++|||++.....
T Consensus       146 ~~kl~Dfg~a~~~~~  160 (259)
T cd05037         146 FIKLSDPGIPITVLS  160 (259)
T ss_pred             eEEeCCCCccccccc
Confidence            799999999886543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.94  E-value=2.2e-26  Score=185.28  Aligned_cols=146  Identities=38%  Similarity=0.661  Sum_probs=122.6

Q ss_pred             CCceeecccceEEEEEEEC----CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           50 QSNMIGQGSYGSVYKGILG----EDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        50 ~~~~lG~G~fg~V~~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +.+.||.|.||.||+|.+.    ..+..|+||.++.. .....+.+.+|++.+.+++||||+++++++...     ...+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-----cccc
Confidence            3568999999999999987    34688999999643 233467899999999999999999999998622     2268


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++......    .+++..+..++.|++.||.|||++   +++|++|+++||+++.++.+||+|||++
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~----~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~  150 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKE----PLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS  150 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTT----TSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred             ccccccccccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence            999999999999999887221    678889999999999999999999   9999999999999999999999999999


Q ss_pred             ccc
Q 039258          205 KFL  207 (234)
Q Consensus       205 ~~~  207 (234)
                      ...
T Consensus       151 ~~~  153 (259)
T PF07714_consen  151 RPI  153 (259)
T ss_dssp             EET
T ss_pred             ccc
Confidence            876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.8e-26  Score=183.11  Aligned_cols=151  Identities=28%  Similarity=0.524  Sum_probs=128.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+.. +..||+|.++... ...+.+.+|+.++..++|+|++++++++..     ....+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCee
Confidence            3568888999999999999998754 4679999986433 234678899999999999999999998743     23468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||+++++|.+++......    .+++..+..++.|++.|+.++|++   +++|+||+|+||+++.++.++++|||++
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGR----ALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             eeeecccCCcHHHHHhccCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence            999999999999998764311    578889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCC
Q 039258          205 KFLSS  209 (234)
Q Consensus       205 ~~~~~  209 (234)
                      .....
T Consensus       151 ~~~~~  155 (261)
T cd05068         151 RVIKE  155 (261)
T ss_pred             EEccC
Confidence            87653

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=200.66  Aligned_cols=169  Identities=27%  Similarity=0.416  Sum_probs=142.2

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---ch-----hhHHHHHHHHHHHhcC---CCCceeEEE
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KG-----AFRSFVAECEALRNIR---HRNLTKIIT  110 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~e~~~l~~l~---h~~i~~l~~  110 (234)
                      .....+|+..+.+|.|+||.|++|.++...-+|+||.+....   ..     ..-..--|+++|+.++   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            344457899999999999999999999888999999986321   11     1123456999999997   999999999


Q ss_pred             EeeecCCCCCCcceeeEeec-CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCee
Q 039258          111 ICSSIDSKGADFKALVFEYM-ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVL  189 (234)
Q Consensus       111 ~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil  189 (234)
                      +|+     +++++||+||-. ++.+|++++....      .+++..+..|+.|++.|+.+||+.   +|||||||-+|++
T Consensus       637 fFE-----ddd~yyl~te~hg~gIDLFd~IE~kp------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvi  702 (772)
T KOG1152|consen  637 FFE-----DDDYYYLETEVHGEGIDLFDFIEFKP------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVI  702 (772)
T ss_pred             eee-----cCCeeEEEecCCCCCcchhhhhhccC------ccchHHHHHHHHHHHhcccccccc---CceecccccccEE
Confidence            984     456679999976 5779999998776      688899999999999999999999   9999999999999


Q ss_pred             eCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          190 LDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       190 ~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.+|-+|++|||.|.........          .++||..|.||
T Consensus       703 vd~~g~~klidfgsaa~~ksgpfd----------~f~gtv~~aap  737 (772)
T KOG1152|consen  703 VDSNGFVKLIDFGSAAYTKSGPFD----------VFVGTVDYAAP  737 (772)
T ss_pred             EecCCeEEEeeccchhhhcCCCcc----------eeeeeccccch
Confidence            999999999999999876654332          27899999998

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.94  E-value=4.1e-26  Score=186.39  Aligned_cols=155  Identities=25%  Similarity=0.438  Sum_probs=126.0

Q ss_pred             CCCCCceeecccceEEEEEEECC-----CCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGE-----DEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      +|++.+.||+|+||.||+|....     ....+++|.+.... .....++.+|+.++..++||||+++++.+..     .
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence            46778899999999999998743     23578899886432 2334678899999999999999999998743     2


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCC------------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDH------------------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD  182 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~d  182 (234)
                      +..+++|||+++++|.+++......                  .....+++..++.++.|++.|+.|||+.   +++|+|
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence            3468999999999999998653211                  1112477888999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCceEEccCccccccCC
Q 039258          183 IKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      |+|+||+++.++.+||+|||+++....
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~  179 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYE  179 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccC
Confidence            999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.94  E-value=3.5e-26  Score=186.93  Aligned_cols=175  Identities=28%  Similarity=0.478  Sum_probs=137.5

Q ss_pred             cCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+........+.+.+|++++..++|+|++++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-----G   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-----C
Confidence            45777889999999999999853     3456799999865544445678899999999999999999998743     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCC----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDH----------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL  190 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~  190 (234)
                      +..++||||+++++|.+++......          .....+++..++.++.|++.|+.|+|++   +++|+||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence            4479999999999999999764321          0111477888999999999999999999   99999999999999


Q ss_pred             CCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          191 DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       191 ~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.++.++++|||++............      ....|+..|+||
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~------~~~~~~~~y~aP  194 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVG------GHTMLPIRWMPP  194 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecC------CCCCcceeecCh
Confidence            99999999999998765432211100      013467788887

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.94  E-value=9.2e-27  Score=190.63  Aligned_cols=164  Identities=27%  Similarity=0.409  Sum_probs=135.3

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      |+....||+|+||.||++.+..++..+|||.+........+.+.+|+..+..++|+|++++++.+..     .+..++||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~lv~   98 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWVVM   98 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEEEE
Confidence            3445569999999999999988899999999875544455678899999999999999999988643     34579999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++...       .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++|+|||++...
T Consensus        99 e~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658          99 EFLEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             eCCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            999999999987542       467788899999999999999999   9999999999999999999999999998764


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......        ....|+..|+||
T Consensus       169 ~~~~~~~--------~~~~~~~~y~aP  187 (292)
T cd06658         169 SKEVPKR--------KSLVGTPYWMAP  187 (292)
T ss_pred             ccccccC--------ceeecCccccCH
Confidence            3322111        114588889887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=3.4e-26  Score=187.37  Aligned_cols=167  Identities=29%  Similarity=0.420  Sum_probs=139.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|...+.||+|+||.||++....++..+|+|.+........+.+..|+.++..++|||++++++.+...     ...+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEE
Confidence            35788899999999999999999888899999998755444457788999999999999999999987543     3468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +|+||+++++|.+++...       .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++|+|||++
T Consensus        93 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~  162 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (293)
T ss_pred             EEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcce
Confidence            999999999999998753       456778899999999999999999   9999999999999999999999999988


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....|++.|+||
T Consensus       163 ~~~~~~~~~~--------~~~~~~~~y~~P  184 (293)
T cd06647         163 AQITPEQSKR--------STMVGTPYWMAP  184 (293)
T ss_pred             eccccccccc--------ccccCChhhcCc
Confidence            7654322111        014577788887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.94  E-value=6.4e-26  Score=182.30  Aligned_cols=170  Identities=28%  Similarity=0.493  Sum_probs=139.6

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.||+|.+..++..+++|.++....  ...+.+..|++++..++|+||+++++.+..     .+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence            47788999999999999999988899999999975533  356788999999999999999999998633     34578


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +|+||+++++|.+++....      .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.+||+|||++
T Consensus        76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence            9999999999999987653      467778889999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .............    .....|+..|+||
T Consensus       147 ~~~~~~~~~~~~~----~~~~~~~~~~~~P  172 (264)
T cd06626         147 VKLKNNTTTMGEE----VQSLAGTPAYMAP  172 (264)
T ss_pred             cccCCCCCccccc----ccCCcCCcCccCh
Confidence            8765432211100    0013467778877

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.94  E-value=4.6e-26  Score=189.31  Aligned_cols=146  Identities=21%  Similarity=0.223  Sum_probs=123.9

Q ss_pred             CCceeecc--cceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           50 QSNMIGQG--SYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        50 ~~~~lG~G--~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      +.++||+|  +|++||++.++.++..||+|.++...  ....+.+.+|+++++.++||||+++++++...     +..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence            45689999  78899999999999999999997442  22335677899999999999999999988543     34799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++......    .+++..+..++.|++.||.|+|++   +++||||||+||+++.++.++++||+.+.
T Consensus        77 v~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             EEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence            99999999999998764321    477888999999999999999999   99999999999999999999999998655


Q ss_pred             cc
Q 039258          206 FL  207 (234)
Q Consensus       206 ~~  207 (234)
                      ..
T Consensus       150 ~~  151 (327)
T cd08227         150 SM  151 (327)
T ss_pred             cc
Confidence            43

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=6.9e-26  Score=185.24  Aligned_cols=157  Identities=22%  Similarity=0.395  Sum_probs=130.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +|+..+.||+|+||.||+|.+..++..||+|.++...  ......+.+|+.++..+. |+|++++++++...+..+....
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6888999999999999999999999999999986432  223467888999999995 6999999998866554344456


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-CCceEEccCc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDFG  202 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-~~~vki~dfG  202 (234)
                      ++||||+++ +|.+++...... ....+++..+..++.||+.||.|||++   +++|+||+|+||+++. ++.+|++|||
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            899999975 898888654321 112578899999999999999999999   9999999999999997 8899999999


Q ss_pred             cccccC
Q 039258          203 LSKFLS  208 (234)
Q Consensus       203 ~a~~~~  208 (234)
                      ++....
T Consensus       157 ~~~~~~  162 (295)
T cd07837         157 LGRAFS  162 (295)
T ss_pred             cceecC
Confidence            988653

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=5.6e-26  Score=184.91  Aligned_cols=149  Identities=32%  Similarity=0.524  Sum_probs=126.3

Q ss_pred             CCCCceeecccceEEEEEEE----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           48 FSQSNMIGQGSYGSVYKGIL----GEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      |+..+.||+|+||+||++..    ..++..||+|.++... ......+.+|++++..++|||++++++++...   ....
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCce
Confidence            48889999999999988653    3567899999987442 23346788999999999999999999987532   2344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .+++|||+++++|.+++...       .+++.++..++.|++.|+.|+|++   +++|+||||+||+++.++.++++|||
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence            68999999999999998653       578899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCC
Q 039258          203 LSKFLSS  209 (234)
Q Consensus       203 ~a~~~~~  209 (234)
                      +++....
T Consensus       153 ~~~~~~~  159 (283)
T cd05080         153 LAKAVPE  159 (283)
T ss_pred             cccccCC
Confidence            9986654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.94  E-value=1.6e-26  Score=185.44  Aligned_cols=165  Identities=31%  Similarity=0.480  Sum_probs=138.5

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +|++.+.||+|+||.||+|.+..++..+|+|++....   ....+.+.+|+++++.++|||++++++.+.     +....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence            4788899999999999999999899999999996432   234577899999999999999999988763     34457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++|+||+++++|.+++....      .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||+
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence            99999999999999997653      577888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........         ...|+..|+||
T Consensus       147 ~~~~~~~~~~~---------~~~~~~~y~~P  168 (258)
T cd05578         147 ATKVTPDTLTT---------STSGTPGYMAP  168 (258)
T ss_pred             ccccCCCcccc---------ccCCChhhcCH
Confidence            88654432111         13477778777

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=6.3e-26  Score=182.34  Aligned_cols=167  Identities=26%  Similarity=0.504  Sum_probs=128.8

Q ss_pred             ceeecccceEEEEEEECC---CCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGE---DEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+..   .+..+|+|.+... .....+.+.+|+.+++.++|||++++++.+...+    ...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEE
Confidence            368999999999998643   3468999988532 2334567889999999999999999999764322    2358999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++.....     ..++...+.++.|++.|+.|+|+.   +++|+||+|+||+++.++.+|++|||+++..
T Consensus        77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999876432     345667788999999999999998   9999999999999999999999999999865


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........    .....++..|+||
T Consensus       149 ~~~~~~~~~~----~~~~~~~~~y~aP  171 (262)
T cd05058         149 YDKEYYSVHN----HTGAKLPVKWMAL  171 (262)
T ss_pred             cCCcceeecc----cccCcCCccccCh
Confidence            4432111110    0113456678887

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.94  E-value=5.3e-26  Score=187.00  Aligned_cols=172  Identities=22%  Similarity=0.398  Sum_probs=135.8

Q ss_pred             hcCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~  117 (234)
                      .++|...+.||+|+||.||++.+.     .++..+|+|.++... ....+.+.+|+.++.++ +|+||+++++.+...  
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG--  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence            346888999999999999999752     345689999986442 23346788999999999 799999999987432  


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                         +..+++|||+++++|.+++......    .+++.++..++.|++.|+.|+|++   +++|+||||+||+++.++.++
T Consensus       112 ---~~~~lv~e~~~~~~L~~~i~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~  181 (302)
T cd05055         112 ---GPILVITEYCCYGDLLNFLRRKRES----FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK  181 (302)
T ss_pred             ---CceEEEEEcCCCCcHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence               3469999999999999998754321    378889999999999999999999   999999999999999999999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++|||+++............      ...++..|+||
T Consensus       182 l~dfg~~~~~~~~~~~~~~~------~~~~~~~y~aP  212 (302)
T cd05055         182 ICDFGLARDIMNDSNYVVKG------NARLPVKWMAP  212 (302)
T ss_pred             ECCCcccccccCCCceeecC------CCCcccccCCH
Confidence            99999998654322111000      12356678887

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.94  E-value=3.9e-26  Score=187.81  Aligned_cols=150  Identities=29%  Similarity=0.536  Sum_probs=125.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCe----EEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEM----VVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|+..+.||+|+||.||+|.+..++.    .+|+|.+.... ......+.+|+.++..++|||++++++++...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence            457788899999999999999876664    57888886432 22334678899999999999999999987532     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                       ..++++||+++++|.+++.....     .+++..+..++.|++.|+.|+|++   +++|+||||+||+++.++.+|++|
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~D  152 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITD  152 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcc
Confidence             24689999999999999876542     467788899999999999999999   999999999999999999999999


Q ss_pred             CccccccCC
Q 039258          201 FGLSKFLSS  209 (234)
Q Consensus       201 fG~a~~~~~  209 (234)
                      ||+++....
T Consensus       153 fg~~~~~~~  161 (303)
T cd05110         153 FGLARLLEG  161 (303)
T ss_pred             ccccccccC
Confidence            999987643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.94  E-value=8.1e-26  Score=182.11  Aligned_cols=171  Identities=25%  Similarity=0.481  Sum_probs=136.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc------chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      +|+..+.||+|+||.||+|.. .++..+|+|.+....      ......+.+|+++++.++|+|++++.+++..     .
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence            478889999999999999987 467889999986432      1223568889999999999999999998743     2


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...+++|||+++++|.+++....      .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence            45799999999999999997654      567788889999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++............  ........|+..|+||
T Consensus       146 fg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~p  177 (265)
T cd06631         146 FGCARRLAWVGLHGTH--SNMLKSMHGTPYWMAP  177 (265)
T ss_pred             chhhHhhhhccccccc--cccccccCCCccccCh
Confidence            9998865332111100  0011124578888887

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.94  E-value=6.5e-26  Score=182.96  Aligned_cols=151  Identities=27%  Similarity=0.554  Sum_probs=128.4

Q ss_pred             cCCCCCceeecccceEEEEEEECCCC---eEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDE---MVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ++|+..+.||+|+||.||+|....++   ..+|+|.++... ....+.+..|++++..++|+|++++.+++...     +
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-----K   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----C
Confidence            46888899999999999999987554   379999986442 33346788999999999999999999987433     3


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++.....     .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.+|++||
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df  151 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDF  151 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCC
Confidence            46899999999999999876432     578888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCC
Q 039258          202 GLSKFLSS  209 (234)
Q Consensus       202 G~a~~~~~  209 (234)
                      |++.....
T Consensus       152 g~~~~~~~  159 (268)
T cd05063         152 GLSRVLED  159 (268)
T ss_pred             ccceeccc
Confidence            99886543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-27  Score=198.78  Aligned_cols=166  Identities=30%  Similarity=0.546  Sum_probs=139.5

Q ss_pred             CCCCceeecccceEEEEEEECC----CCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           48 FSQSNMIGQGSYGSVYKGILGE----DEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+..+.||.|-||.||+|.+..    ...-||||..+.. .....+.|++|+.+|+.++||||++++|+|...      .
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P  464 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P  464 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence            3446789999999999998753    2357999998753 445578899999999999999999999999543      2


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .|||||.++.|.|.+|+..+.+     .++......++.||+.||.|||++   +.|||||..+|||+....-||++|||
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             eeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence            6999999999999999988765     567777888999999999999999   99999999999999988889999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++.+.++.+.....       ..-...||||
T Consensus       537 LSR~~ed~~yYkaS~-------~kLPIKWmaP  561 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASR-------GKLPIKWMAP  561 (974)
T ss_pred             hhhhccccchhhccc-------cccceeecCc
Confidence            999998876655321       2234578887

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.94  E-value=5.7e-26  Score=182.34  Aligned_cols=172  Identities=26%  Similarity=0.388  Sum_probs=139.5

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|++.+.||.|+||.||++.+..++..+|+|.++..  .....+++..|+++++.++|+|++++++.+...   .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            477889999999999999999999999999998643  233446788999999999999999999876432   234468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH-----HNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-----~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      ++|||+++++|.+++......  ...+++..++.++.|++.|+.|+|     +.   +++|+||+|+||+++.++.+|++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence            999999999999998764211  115788889999999999999999     76   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++..........        ....|++.|+||
T Consensus       153 d~g~~~~~~~~~~~~--------~~~~~~~~~~~p  179 (265)
T cd08217         153 DFGLAKILGHDSSFA--------KTYVGTPYYMSP  179 (265)
T ss_pred             cccccccccCCcccc--------cccccCCCccCh
Confidence            999988765432111        013577888887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.94  E-value=1.6e-26  Score=189.73  Aligned_cols=164  Identities=27%  Similarity=0.394  Sum_probs=135.4

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      |.....||+|+||.||++.+..++..||+|.++.......+.+.+|+.++..++|||++++++.+..     .+..+++|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence            3344579999999999999988899999999975544445678899999999999999999998753     34479999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++...       .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++|+|||++...
T Consensus        98 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659          98 EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             ecCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            999999999877542       467888999999999999999999   9999999999999999999999999998755


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......        ....|+..|+||
T Consensus       168 ~~~~~~~--------~~~~~~~~y~aP  186 (297)
T cd06659         168 SKDVPKR--------KSLVGTPYWMAP  186 (297)
T ss_pred             ccccccc--------cceecCccccCH
Confidence            4322111        114588888887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.94  E-value=9.4e-26  Score=182.39  Aligned_cols=159  Identities=31%  Similarity=0.533  Sum_probs=128.0

Q ss_pred             CCCCceeecccceEEEEEEEC---CCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC-C
Q 039258           48 FSQSNMIGQGSYGSVYKGILG---EDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA-D  121 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~-~  121 (234)
                      |++.+.||+|+||.||+|.+.   .++..+|+|++...  .....+++.+|+.+++.++|||++++++++......+. .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566788999999999999864   35789999998643  23345678899999999999999999998765433222 2


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..+++++|+++++|.+++...........+++.....++.|++.|++|+|++   +++|+||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2468899999999998875432222233578888899999999999999998   9999999999999999999999999


Q ss_pred             ccccccCC
Q 039258          202 GLSKFLSS  209 (234)
Q Consensus       202 G~a~~~~~  209 (234)
                      |+++....
T Consensus       158 g~~~~~~~  165 (273)
T cd05074         158 GLSKKIYS  165 (273)
T ss_pred             cccccccC
Confidence            99986543

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.94  E-value=7.5e-26  Score=183.26  Aligned_cols=174  Identities=22%  Similarity=0.389  Sum_probs=136.9

Q ss_pred             cCCCCCceeecccceEEEEEEECC-----CCeEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGE-----DEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      .+|+..+.||+|+||.||+|..+.     +...+++|.+...... ....+.+|+.++.+++|+|++++++++..     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-----   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence            468889999999999999999753     3467999988654333 45678999999999999999999998743     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCce
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHL---EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~v  196 (234)
                      .+..++||||+++++|.+++.......   ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence            344699999999999999987644211   112478889999999999999999999   99999999999999999999


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++|||++............       ...++..|+||
T Consensus       157 ~l~~~~~~~~~~~~~~~~~~-------~~~~~~~y~~P  187 (275)
T cd05046         157 KVSLLSLSKDVYNSEYYKLR-------NALIPLRWLAP  187 (275)
T ss_pred             EEcccccccccCcccccccC-------CceeEEeecCh
Confidence            99999998754332211110       13456677776

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.94  E-value=7.3e-26  Score=181.75  Aligned_cols=142  Identities=28%  Similarity=0.510  Sum_probs=121.5

Q ss_pred             eeecccceEEEEEEE--CCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           53 MIGQGSYGSVYKGIL--GEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      .||+|+||.||+|.+  ..++..+|+|+++...  ....+.+..|+.++..+.|||++++++++..      ...++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence            589999999999975  3567899999986432  2344678899999999999999999998632      23589999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      |+++++|.+++....      .+++..+..++.|++.|+.|+|++   +++|+||||.||+++.++.+|++|||++....
T Consensus        76 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~  146 (257)
T cd05116          76 LAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG  146 (257)
T ss_pred             cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence            999999999987654      577888999999999999999999   99999999999999999999999999998654


Q ss_pred             C
Q 039258          209 S  209 (234)
Q Consensus       209 ~  209 (234)
                      .
T Consensus       147 ~  147 (257)
T cd05116         147 A  147 (257)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=8.3e-26  Score=181.23  Aligned_cols=148  Identities=35%  Similarity=0.498  Sum_probs=125.4

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|+..+.||+|+||.||++...  +..+|+|.++...  ..+.+..|+.++..++|+|++++++++...    ....++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEE
Confidence            46888899999999999999774  5679999885332  346788999999999999999999876432    234689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      +|||+++++|.+++......    .+++..++.++.|++.|+.|+|++   +++|+||+|+||+++.++.+|++|||++.
T Consensus        78 v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence            99999999999998765422    467788899999999999999999   99999999999999999999999999987


Q ss_pred             ccC
Q 039258          206 FLS  208 (234)
Q Consensus       206 ~~~  208 (234)
                      ...
T Consensus       151 ~~~  153 (256)
T cd05082         151 EAS  153 (256)
T ss_pred             ecc
Confidence            543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.94  E-value=6.8e-26  Score=184.31  Aligned_cols=158  Identities=25%  Similarity=0.348  Sum_probs=125.0

Q ss_pred             eeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHH---hcCCCCceeEEEEeeecCCCCCCcceee
Q 039258           53 MIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALR---NIRHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      .||+|+||.||++.+..++..+|+|.+....   ......+.+|..++.   ..+|||++.+.+.+..     .+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            3899999999999999999999999986432   111223344444333   3469999999888743     2346899


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      |||+++++|.+++....      .+++..+..++.|++.||.|+|++   +++|+||||+||+++.++.++++|||++..
T Consensus        76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            99999999999887654      578889999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCccCCCCCCCCccccccccccccCC
Q 039258          207 LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......          ...||+.|+||
T Consensus       147 ~~~~~~~----------~~~~~~~y~aP  164 (279)
T cd05633         147 FSKKKPH----------ASVGTHGYMAP  164 (279)
T ss_pred             ccccCcc----------CcCCCcCccCH
Confidence            4332111          13588889887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=6.3e-26  Score=183.68  Aligned_cols=165  Identities=32%  Similarity=0.421  Sum_probs=139.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      +|+..+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+++++.++|+|++++.+.+...     ...++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEEE
Confidence            5788889999999999999999999999999987543 33446788999999999999999999987532     45799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      |+||+++++|.+++...       .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||+++
T Consensus        77 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  146 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSG  146 (274)
T ss_pred             EEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccce
Confidence            99999999999998754       567888999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ...|++.|+||
T Consensus       147 ~~~~~~~~~~--------~~~~~~~y~~P  167 (274)
T cd06609         147 QLTSTMSKRN--------TFVGTPFWMAP  167 (274)
T ss_pred             eecccccccc--------cccCCccccCh
Confidence            7654321111        14577888887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.94  E-value=8.1e-26  Score=182.69  Aligned_cols=166  Identities=25%  Similarity=0.384  Sum_probs=125.9

Q ss_pred             eeecccceEEEEEEECCC--CeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEee
Q 039258           53 MIGQGSYGSVYKGILGED--EMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEY  129 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~  129 (234)
                      .||+|+||.||+|.....  ...+++|.+.... ....+.+.+|+.++..++|||++++++.+..     ....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEec
Confidence            589999999999975432  3456677765432 2344688999999999999999999998753     3446999999


Q ss_pred             cCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          130 MENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       130 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      +++++|.+++.......  ...++..+..++.|++.||.|+|++   +++|+||||+||+++.++.++++|||++.....
T Consensus        77 ~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          77 CELGDLKSYLSQEQWHR--RNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             CCCCcHHHHHHhhhccc--ccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCc
Confidence            99999999997643211  1345667788999999999999998   999999999999999999999999999864322


Q ss_pred             CccCCCCCCCCccccccccccccCC
Q 039258          210 DHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       210 ~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......      .....|+..|+||
T Consensus       152 ~~~~~~------~~~~~~~~~y~aP  170 (268)
T cd05086         152 EDYIET------EDDKCVPLRWLAP  170 (268)
T ss_pred             chhhhc------ccCCcCcccccCc
Confidence            111000      0014577778877

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=6.4e-26  Score=184.29  Aligned_cols=170  Identities=24%  Similarity=0.344  Sum_probs=131.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHH-HHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEA-LRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ++|++.+.||+|+||.||++.+..++..||+|.++... ......+..|+.. ++..+|||++++++++...     ...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcE
Confidence            36888899999999999999999999999999987542 2223455566665 5567899999999987532     336


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      +++|||++ ++|.+++.......  ..+++..+..++.|++.|+.|+|+++  +++|+||+|+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDKG--LTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            89999996 58888876532111  25788999999999999999999742  799999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........         ...|+..|+||
T Consensus       151 ~~~~~~~~~~~---------~~~~~~~y~aP  172 (283)
T cd06617         151 SGYLVDSVAKT---------IDAGCKPYMAP  172 (283)
T ss_pred             ccccccccccc---------cccCCccccCh
Confidence            88654322111         13467777776

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.94  E-value=6e-26  Score=181.87  Aligned_cols=168  Identities=24%  Similarity=0.354  Sum_probs=137.9

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.+|.+....+++.+|+|.+...  .......+.+|+.+++.++|+|++++.+++..     .+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-----NGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-----CCeEE
Confidence            478889999999999999999989999999998643  23344678899999999999999999998743     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++......    .+++..++.++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||++
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGV----LFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence            999999999999998764321    467888899999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....|++.|+||
T Consensus       149 ~~~~~~~~~~--------~~~~~~~~~~~p  170 (256)
T cd08218         149 RVLNSTVELA--------RTCIGTPYYLSP  170 (256)
T ss_pred             eecCcchhhh--------hhccCCccccCH
Confidence            8654322111        013467777776

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.94  E-value=7.4e-26  Score=185.58  Aligned_cols=153  Identities=26%  Similarity=0.520  Sum_probs=125.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCe--EEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEM--VVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|++.+.||+|+||.||+|....++.  .+++|.++.. .....+.+.+|++++.++ +|||++++++++..     .+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----RG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----CC
Confidence            468888999999999999999876654  4788887632 233446788999999999 79999999998743     23


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHL----------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                      ..+++|||+++++|.+++.......          ....+++..+..++.|++.|+.|+|++   +++|+||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            4689999999999999997643111          112477888999999999999999998   999999999999999


Q ss_pred             CCCceEEccCccccc
Q 039258          192 NDMVAHVGDFGLSKF  206 (234)
Q Consensus       192 ~~~~vki~dfG~a~~  206 (234)
                      .++.+|++|||++..
T Consensus       154 ~~~~~kl~dfg~~~~  168 (297)
T cd05089         154 ENLASKIADFGLSRG  168 (297)
T ss_pred             CCCeEEECCcCCCcc
Confidence            999999999999864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=7.2e-26  Score=181.22  Aligned_cols=166  Identities=31%  Similarity=0.453  Sum_probs=140.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      ++|+..+.||+|+||.||+|.+..++..+++|.+.....  .+.+.+|+++++.++|+|++++++.+...     ...++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEE
Confidence            578889999999999999999988889999999864432  57889999999999999999999987532     45789


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ++||+++++|.+++.....     .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.
T Consensus        76 ~~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          76 VMEYCGAGSVSDIMKITNK-----TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             EEecCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence            9999999999999875432     578889999999999999999999   99999999999999999999999999988


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ...|+..|+||
T Consensus       148 ~~~~~~~~~~--------~~~~~~~y~~P  168 (256)
T cd06612         148 QLTDTMAKRN--------TVIGTPFWMAP  168 (256)
T ss_pred             hcccCccccc--------cccCCccccCH
Confidence            7654321110        13477788887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.94  E-value=5.3e-26  Score=185.94  Aligned_cols=169  Identities=25%  Similarity=0.392  Sum_probs=137.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|+..+.||+|+||.||+|.+..++..+|+|.++...  ......+.+|++++..++|||++++.+++...   +....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            46888899999999999999999899999999997443  22234567899999999999999999987543   22557


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++ +|.+++.....     .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++++|||+
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence            999999974 99998876442     578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........        ...+++.|+||
T Consensus       153 ~~~~~~~~~~~~--------~~~~~~~~~aP  175 (293)
T cd07843         153 AREYGSPLKPYT--------QLVVTLWYRAP  175 (293)
T ss_pred             eeeccCCccccc--------cccccccccCc
Confidence            886554321110        13467778887

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.94  E-value=3e-26  Score=186.37  Aligned_cols=174  Identities=21%  Similarity=0.343  Sum_probs=134.3

Q ss_pred             CCCCCceeecccceEEEEEEECCC-----CeEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGED-----EMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      +|.+.+.||+|+||.||+|.+..+     +..||+|.++..... ..+.+.+|+.++..++||||+++++++...     
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-----   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence            466678899999999999987543     578999999744322 346688899999999999999999987433     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccC----------CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee
Q 039258          121 DFKALVFEYMENGSLEDWLHQTND----------HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL  190 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~  190 (234)
                      ...++++||+++++|.+++.....          ......+++..+..++.|++.||.|+|++   +++||||||+||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~  157 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence            346899999999999999853211          01112467788899999999999999999   99999999999999


Q ss_pred             CCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          191 DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       191 ~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.++.+|++|||+++............      ...+++.|+||
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~------~~~~~~~y~aP  195 (283)
T cd05091         158 FDKLNVKISDLGLFREVYAADYYKLMG------NSLLPIRWMSP  195 (283)
T ss_pred             cCCCceEecccccccccccchheeecc------CccCCccccCH
Confidence            999999999999988654322111100      12356788887

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=2.9e-26  Score=191.31  Aligned_cols=172  Identities=25%  Similarity=0.337  Sum_probs=139.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .++|...+.||+|+||.||+|.+..++..||||.+...  .......+.+|+.++..++|+|++++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788899999999999999999999999999998643  2223456778999999999999999998775443333345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++|+||+. ++|.+++....      .+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.+||+|||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence            689999995 68988887654      678889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++..........        ....|+..|+||
T Consensus       154 ~~~~~~~~~~~~--------~~~~~~~~y~aP  177 (337)
T cd07858         154 LARTTSEKGDFM--------TEYVVTRWYRAP  177 (337)
T ss_pred             cccccCCCcccc--------cccccccCccCh
Confidence            998654321110        014577788887

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.94  E-value=1.1e-25  Score=185.06  Aligned_cols=177  Identities=25%  Similarity=0.431  Sum_probs=139.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC---C
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK---G  119 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~---~  119 (234)
                      ..+|+..+.||+|+||.||+|.+..++..||+|.+....  ......+.+|+.++..++|||++++++++......   .
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            446889999999999999999999999999999986432  22234567899999999999999999987654321   2


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      ....++||||+. ++|.+++.....     .+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.+||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNV-----KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEEC
Confidence            344689999996 488888765432     578889999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++............    ......++..|+||
T Consensus       162 dfg~~~~~~~~~~~~~~----~~~~~~~~~~y~aP  192 (310)
T cd07865         162 DFGLARAFSLSKNSKPN----RYTNRVVTLWYRPP  192 (310)
T ss_pred             cCCCcccccCCcccCCC----CccCcccCccccCc
Confidence            99999866443221100    00113577788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.94  E-value=8.9e-26  Score=180.68  Aligned_cols=167  Identities=26%  Similarity=0.469  Sum_probs=137.6

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.||+|.+..++..+|+|.+...  .......+..|+++++.++|||++++++.+..     ....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence            477889999999999999999999999999998643  23345678899999999999999999987642     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC-CceEEccCcc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND-MVAHVGDFGL  203 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~-~~vki~dfG~  203 (234)
                      +||||+++++|.+++......    .+++..+..++.|++.++.|+|++   +++|+||+|+||+++.+ +.++++|||+
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNS----LLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             EEEecCCCCCHHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            999999999999999765322    478888999999999999999999   99999999999999754 5689999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........         ...|+..|+||
T Consensus       149 ~~~~~~~~~~~---------~~~~~~~y~aP  170 (256)
T cd08220         149 SKILSSKSKAY---------TVVGTPCYISP  170 (256)
T ss_pred             ceecCCCcccc---------ccccCCcccCc
Confidence            98765432111         14578888887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=6.8e-26  Score=183.10  Aligned_cols=150  Identities=27%  Similarity=0.487  Sum_probs=127.4

Q ss_pred             cCCCCCceeecccceEEEEEEECCC---CeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGED---EMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|+..+.||+|+||.||+|.+..+   ...+|+|...... ....+.+.+|+.++..++|||++++++++..      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            4578889999999999999987543   4579999886443 3445678999999999999999999998742      2


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++.....     .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~  151 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF  151 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence            25799999999999999976432     478888999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCC
Q 039258          202 GLSKFLSS  209 (234)
Q Consensus       202 G~a~~~~~  209 (234)
                      |+++....
T Consensus       152 g~~~~~~~  159 (270)
T cd05056         152 GLSRYLED  159 (270)
T ss_pred             ceeeeccc
Confidence            99886544

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.94  E-value=9e-26  Score=185.61  Aligned_cols=176  Identities=22%  Similarity=0.401  Sum_probs=135.7

Q ss_pred             hcCCCCCceeecccceEEEEEEEC-------CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeec
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG-------EDEMVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSI  115 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~  115 (234)
                      ..+|++.+.||+|+||.||+|.+.       .++..+|+|.+... .....+.+.+|+.++..+ +||||+++++.+...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456788899999999999999753       23457999998643 233446788999999999 799999999987432


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCCc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDHL----------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP  185 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~  185 (234)
                           ...+++|||+++++|.+++.......          ....+++..+..++.|++.|+.|||++   +++|+||||
T Consensus        94 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  165 (304)
T cd05101          94 -----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA  165 (304)
T ss_pred             -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence                 34689999999999999997643211          112467778889999999999999999   999999999


Q ss_pred             CCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          186 SNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       186 ~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+++.++.+|++|||+++............      ...+++.|+||
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~------~~~~~~~y~aP  208 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTT------NGRLPVKWMAP  208 (304)
T ss_pred             ceEEEcCCCcEEECCCccceeccccccccccc------CCCCCceeeCc
Confidence            99999999999999999998764432211100      12356678887

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=8.1e-26  Score=183.47  Aligned_cols=166  Identities=28%  Similarity=0.444  Sum_probs=137.3

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..|+..+.||+|+||.||+|.+..++..+|+|.++... ......+.+|+.++..+.|+|++++++.+..     ....+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEE
Confidence            35777889999999999999999889999999987443 3345678899999999999999999998754     33479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++...       .+++.++..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||++
T Consensus        79 lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~  148 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             EEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence            999999999999988643       467778889999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....++..|+||
T Consensus       149 ~~~~~~~~~~--------~~~~~~~~y~ap  170 (277)
T cd06640         149 GQLTDTQIKR--------NTFVGTPFWMAP  170 (277)
T ss_pred             eeccCCcccc--------ccccCcccccCH
Confidence            7654322111        013467778776

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=6.8e-26  Score=184.25  Aligned_cols=155  Identities=29%  Similarity=0.510  Sum_probs=129.0

Q ss_pred             cCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .++...++||+|+||.||++...     .++..+|+|.+..........+.+|++++..++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence            45777889999999999999742     3567899999875555556789999999999999999999998743     2


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCC---------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDH---------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                      ...+++|||+++++|.+++......         .....+++..+..++.|++.|+.|+|++   +++|+||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence            3469999999999999998764321         0112467888999999999999999999   999999999999999


Q ss_pred             CCCceEEccCccccccC
Q 039258          192 NDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       192 ~~~~vki~dfG~a~~~~  208 (234)
                      .++.+|++|||++....
T Consensus       157 ~~~~~kL~dfg~~~~~~  173 (280)
T cd05092         157 QGLVVKIGDFGMSRDIY  173 (280)
T ss_pred             CCCCEEECCCCceeEcC
Confidence            99999999999987654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.94  E-value=1.1e-25  Score=180.30  Aligned_cols=169  Identities=32%  Similarity=0.567  Sum_probs=136.0

Q ss_pred             ceeecccceEEEEEEECCC---CeEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGED---EMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+...   +..+++|.+...... ..+.+.+|++.+..++|+|++++++++..     ....+++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            3689999999999999765   889999999754332 35788899999999999999999998753     34579999


Q ss_pred             eecCCCCHHHHhhhccCC---ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          128 EYMENGSLEDWLHQTNDH---LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ||+++++|.+++......   .....+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence            999999999999875210   0001678899999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........      .....++..|+||
T Consensus       153 ~~~~~~~~~~~------~~~~~~~~~y~aP  176 (262)
T cd00192         153 RDVYDDDYYRK------KTGGKLPIRWMAP  176 (262)
T ss_pred             ccccccccccc------ccCCCcCccccCH
Confidence            87654321110      0114577888887

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.94  E-value=1.8e-26  Score=187.18  Aligned_cols=165  Identities=28%  Similarity=0.450  Sum_probs=135.9

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .|+..+.||+|+||.||+|.+..++..||+|.++... ....+.+.+|+.+++.++|+|++++++.+..     ....++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceEE
Confidence            3566778999999999999998889999999987442 3344678899999999999999999998743     345799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++...       .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||++.
T Consensus        80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06642          80 IMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             EEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence            99999999999988542       567788899999999999999998   99999999999999999999999999988


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........        ....|+..|+||
T Consensus       150 ~~~~~~~~~--------~~~~~~~~y~aP  170 (277)
T cd06642         150 QLTDTQIKR--------NTFVGTPFWMAP  170 (277)
T ss_pred             cccCcchhh--------hcccCcccccCH
Confidence            654322111        013577778876

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.94  E-value=2.3e-26  Score=187.20  Aligned_cols=166  Identities=28%  Similarity=0.423  Sum_probs=135.7

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.||+|.+..++..+|+|.+....  ....+.+.+|++++..++|||++++++++.     +....+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeEE
Confidence            5788899999999999999998889999999885332  223456788999999999999999999874     334579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|..+.....      .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++
T Consensus        77 lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~  147 (286)
T cd07846          77 LVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA  147 (286)
T ss_pred             EEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeee
Confidence            9999999888887765433      578889999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........        ...|+..|+||
T Consensus       148 ~~~~~~~~~~~--------~~~~~~~y~aP  169 (286)
T cd07846         148 RTLAAPGEVYT--------DYVATRWYRAP  169 (286)
T ss_pred             eeccCCccccC--------cccceeeccCc
Confidence            86543221100        13467778777

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.94  E-value=1.2e-25  Score=180.76  Aligned_cols=149  Identities=28%  Similarity=0.544  Sum_probs=126.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|++.+.||+|+||.||+|... ++..+|+|.+..... ..+.+.+|+.++++++|+|++++++.+..      ...++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~l   77 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIYI   77 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcEE
Confidence            46888999999999999999875 456699999864322 33678899999999999999999987521      23589


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      +|||+++++|.+++......    .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||++.
T Consensus        78 v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeee
Confidence            99999999999998764321    578888999999999999999999   99999999999999999999999999998


Q ss_pred             ccCC
Q 039258          206 FLSS  209 (234)
Q Consensus       206 ~~~~  209 (234)
                      ....
T Consensus       151 ~~~~  154 (260)
T cd05070         151 LIED  154 (260)
T ss_pred             eccC
Confidence            6544

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.94  E-value=1.5e-25  Score=178.98  Aligned_cols=144  Identities=29%  Similarity=0.536  Sum_probs=121.6

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      +.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++..++|||++++++++...     +..++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECC
Confidence            36899999999999864 57789999986443 22335688999999999999999999987533     3468999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      ++++|.+++.....     .+.+..+..++.|++.++.|+|++   +++|+||+|+||+++.++.+|++|||++.....
T Consensus        75 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          75 PGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            99999999865432     467888899999999999999999   999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.94  E-value=9.2e-26  Score=183.16  Aligned_cols=156  Identities=26%  Similarity=0.417  Sum_probs=129.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECC-----CCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGE-----DEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      ..+|++.+.||+|+||.||+|.+..     ++..||+|.+.... ......+.+|+.++..++|+|++++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER---   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            4568889999999999999999976     67889999886432 33345689999999999999999999987432   


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccC-CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC---
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTND-HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM---  194 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~---  194 (234)
                        +..++||||+++++|.+++..... ......+++..++.++.||+.|+.|||++   +++|+||+|+||+++.++   
T Consensus        82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence              335899999999999999876532 11122578889999999999999999999   999999999999997544   


Q ss_pred             ceEEccCccccccC
Q 039258          195 VAHVGDFGLSKFLS  208 (234)
Q Consensus       195 ~vki~dfG~a~~~~  208 (234)
                      .+|++|||+++...
T Consensus       157 ~~kl~dfg~~~~~~  170 (277)
T cd05036         157 VAKIADFGMARDIY  170 (277)
T ss_pred             ceEeccCccccccC
Confidence            69999999998763

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-25  Score=185.78  Aligned_cols=175  Identities=25%  Similarity=0.396  Sum_probs=137.9

Q ss_pred             CCCCCceeecccceEEEEEEECC--CCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGE--DEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .|++.+.||+|+||.||+|.+..  ++..||+|.+....   ....+.+.+|+.++..++|||++++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            37778899999999999999987  78999999997532   33446778899999999999999999988542   234


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC----CCceE
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN----DMVAH  197 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~----~~~vk  197 (234)
                      ..++||||+++ ++.+++....... ...+++..+..++.|++.|+.|||++   +++|+||+|+||+++.    ++.+|
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence            57999999964 7877775432211 12577888899999999999999999   9999999999999998    89999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++|||++...........     ......+|+.|+||
T Consensus       153 l~Dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aP  184 (316)
T cd07842         153 IGDLGLARLFNAPLKPLA-----DLDPVVVTIWYRAP  184 (316)
T ss_pred             ECCCccccccCCCccccc-----ccCCccccccccCH
Confidence            999999987644322111     00124578889887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=1.1e-25  Score=183.06  Aligned_cols=168  Identities=26%  Similarity=0.444  Sum_probs=136.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      +|+..+.||+|++|.||+|.+..++..||+|.++.... .....+.+|+.++..++|+|++++++.+...     +..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence            47888999999999999999999999999999975432 2345677899999999999999999987543     34689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++ +|.+++......   ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.
T Consensus        76 v~e~~~~-~l~~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~  148 (284)
T cd07836          76 VFEYMDK-DLKKYMDTHGVR---GALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR  148 (284)
T ss_pred             EEecCCc-cHHHHHHhcCCC---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence            9999975 898888754321   1578899999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ...++..|+||
T Consensus       149 ~~~~~~~~~~--------~~~~~~~y~~P  169 (284)
T cd07836         149 AFGIPVNTFS--------NEVVTLWYRAP  169 (284)
T ss_pred             hhcCCccccc--------cccccccccCh
Confidence            6543211100        12466777776

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.4e-25  Score=179.89  Aligned_cols=149  Identities=35%  Similarity=0.566  Sum_probs=129.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|+..+.||+|+||.||+|...  ++.+|+|.+..... ..+++..|+.++..++|+|++++++++..     .+..+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeE
Confidence            456888999999999999999874  67899999975533 45778999999999999999999998753     34468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++......    .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRA----VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence            999999999999999765422    478889999999999999999999   9999999999999999999999999999


Q ss_pred             cccC
Q 039258          205 KFLS  208 (234)
Q Consensus       205 ~~~~  208 (234)
                      +...
T Consensus       150 ~~~~  153 (256)
T cd05039         150 KEAS  153 (256)
T ss_pred             cccc
Confidence            8763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.94  E-value=1.9e-26  Score=185.34  Aligned_cols=157  Identities=24%  Similarity=0.435  Sum_probs=126.7

Q ss_pred             eeecccceEEEEEEECCCC-------eEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           53 MIGQGSYGSVYKGILGEDE-------MVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .||+|+||.||+|.+...+       ..+++|.+........+.+..|+.++..++|||++++++++...     ...++
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~l   76 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESIM   76 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcEE
Confidence            5899999999999886543       34888888655444556788899999999999999999987543     33689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc--------eE
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV--------AH  197 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~--------vk  197 (234)
                      ||||+++++|.+++.....     .+++..++.++.|++.|+.|+|++   +++||||||+||+++.++.        ++
T Consensus        77 v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~  148 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIK  148 (258)
T ss_pred             EEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEE
Confidence            9999999999999876542     567888899999999999999999   9999999999999976654        69


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++|||++.......            ...++..|+||
T Consensus       149 l~d~g~~~~~~~~~------------~~~~~~~y~aP  173 (258)
T cd05078         149 LSDPGISITVLPKE------------ILLERIPWVPP  173 (258)
T ss_pred             ecccccccccCCch------------hccccCCccCc
Confidence            99999886543211            13467778777

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.94  E-value=7.1e-26  Score=186.54  Aligned_cols=155  Identities=25%  Similarity=0.434  Sum_probs=127.3

Q ss_pred             cCCCCCceeecccceEEEEEEECC-------CCeEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGE-------DEMVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSID  116 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~  116 (234)
                      .+|.+.+.||+|+||.||++.+..       +...+|+|.++.. .......+..|++++..+ +|+|++++++++..  
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--
Confidence            468899999999999999998643       2357999998743 223346788899999999 79999999998743  


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHL----------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPS  186 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~  186 (234)
                         .+..++||||+++++|.+++.......          ....+++..++.++.|++.||+|+|++   +++|+||||+
T Consensus        96 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  169 (307)
T cd05098          96 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  169 (307)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHH
Confidence               234789999999999999997643210          111467788999999999999999998   9999999999


Q ss_pred             CeeeCCCCceEEccCccccccC
Q 039258          187 NVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       187 nil~~~~~~vki~dfG~a~~~~  208 (234)
                      ||+++.++.+|++|||++....
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~  191 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIH  191 (307)
T ss_pred             heEEcCCCcEEECCCccccccc
Confidence            9999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.94  E-value=9.4e-26  Score=184.18  Aligned_cols=167  Identities=26%  Similarity=0.373  Sum_probs=134.8

Q ss_pred             CCCCCceeecccceEEEEEEEC---CCCeEEEEEEeeccc----chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILG---EDEMVVAVKVINLKQ----KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSK  118 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~  118 (234)
                      +|++.+.||+|+||.||++...   .++..||+|+++...    ....+.+.+|+.++..+ +|+||+.+.+++..    
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----   76 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT----   76 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence            4778899999999999999874   478899999986421    12335678899999999 58999999887643    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                       ....++||||+++++|.+++....      .+++..+..++.|++.||.|+|+.   +++|+||+|+||+++.++.+||
T Consensus        77 -~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  146 (290)
T cd05613          77 -DTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL  146 (290)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence             344689999999999999987654      567788888999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||++...........       ....|+..|+||
T Consensus       147 ~dfg~~~~~~~~~~~~~-------~~~~~~~~y~aP  175 (290)
T cd05613         147 TDFGLSKEFHEDEVERA-------YSFCGTIEYMAP  175 (290)
T ss_pred             eeCccceeccccccccc-------ccccCCcccCCh
Confidence            99999986544321111       014577888887

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.94  E-value=1.4e-25  Score=180.20  Aligned_cols=167  Identities=29%  Similarity=0.456  Sum_probs=140.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ++|...+.||+|++|.||+|.+..++..+++|.+..... .....+..|+..+..++|+|++++++++...     ...+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEE
Confidence            368888999999999999999999999999999875533 3457789999999999999999999987533     4479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      +||||+++++|.+++....      .+++.....++.|++.|+.|+|+ .   +++|+||+|+||+++.++.++++|||+
T Consensus        76 lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~  146 (264)
T cd06623          76 IVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI  146 (264)
T ss_pred             EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence            9999999999999998653      67888999999999999999999 8   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........        ...|+..|+||
T Consensus       147 ~~~~~~~~~~~~--------~~~~~~~y~~p  169 (264)
T cd06623         147 SKVLENTLDQCN--------TFVGTVTYMSP  169 (264)
T ss_pred             ceecccCCCccc--------ceeecccccCH
Confidence            886644322210        13467777776

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.94  E-value=9.9e-26  Score=189.25  Aligned_cols=170  Identities=22%  Similarity=0.292  Sum_probs=137.0

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~  120 (234)
                      ...+|+..+.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.++..++|+|++++++++..... .+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            356799999999999999999999999999999998532  22334567789999999999999999998754322 223


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||++ ++|.+.+..        .++...+..++.|++.||.|||++   +++|+||||+||+++.++.+|++|
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            45689999996 488887753        256677888999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++.........         ...||+.|+||
T Consensus       162 fg~~~~~~~~~~~~---------~~~~~~~y~aP  186 (353)
T cd07850         162 FGLARTAGTSFMMT---------PYVVTRYYRAP  186 (353)
T ss_pred             CccceeCCCCCCCC---------CCcccccccCH
Confidence            99998654422111         14578888887

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=9.8e-26  Score=182.75  Aligned_cols=165  Identities=28%  Similarity=0.439  Sum_probs=136.9

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcC---CCCceeEEEEeeecCCCCCCc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIR---HRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .|+..+.||+|+||.||+|.+..++..+|+|.++.. .......+.+|+.++..++   |||++++++++..     ...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence            477788999999999999999889999999998644 2334467888999999986   9999999998743     334


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++...       .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence            68999999999999988643       577888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++..........        ....|+..|+||
T Consensus       147 ~~~~~~~~~~~~--------~~~~~~~~y~aP  170 (277)
T cd06917         147 VAALLNQNSSKR--------STFVGTPYWMAP  170 (277)
T ss_pred             ceeecCCCcccc--------ccccCCcceeCH
Confidence            998765432111        114577888887

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.94  E-value=1.2e-25  Score=182.57  Aligned_cols=165  Identities=29%  Similarity=0.455  Sum_probs=135.6

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      -|+..+.||+|+||.||+|.+..++..+|+|...... ......+.+|+.++..++|||++++++.+..     .++.++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEEE
Confidence            3777889999999999999998889999999986443 2334678889999999999999999998743     344799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++...       .+++..+..++.|++.++.++|++   +++|+||+|+||+++.++.++++|||++.
T Consensus        80 v~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06641          80 IMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG  149 (277)
T ss_pred             EEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence            99999999999988642       467888899999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........        ....|+..|+||
T Consensus       150 ~~~~~~~~~--------~~~~~~~~y~~P  170 (277)
T cd06641         150 QLTDTQIKR--------NTFVGTPFWMAP  170 (277)
T ss_pred             ecccchhhh--------ccccCCccccCh
Confidence            654321110        013467777776

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.94  E-value=9e-26  Score=184.11  Aligned_cols=157  Identities=29%  Similarity=0.509  Sum_probs=129.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECC-----CCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGE-----DEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      .++|+..+.||+|+||.||+|.+..     ++..+|+|.+.... ......+.+|+.++..++|||++++++++..    
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~----   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV----   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence            4578889999999999999998743     56899999986442 2234668899999999999999999998743    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccC----------------CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTND----------------HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD  182 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~d  182 (234)
                       .+..+++|||+++++|.+++.....                ......+++..++.++.|++.|+.|+|++   +++|+|
T Consensus        80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence             2346999999999999999975321                01122467788899999999999999999   999999


Q ss_pred             CCCCCeeeCCCCceEEccCccccccCC
Q 039258          183 IKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      |+|+||+++.++.++++|||++.....
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~  182 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYS  182 (288)
T ss_pred             ccHhheEecCCCceEECccccceeccc
Confidence            999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=2.1e-25  Score=181.21  Aligned_cols=153  Identities=27%  Similarity=0.493  Sum_probs=130.4

Q ss_pred             cCCCCCceeecccceEEEEEEEC----CCCeEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILG----EDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..|+..+.||+|+||.||+|.+.    .++..+|+|.+...... ....+.+|++++..++|+|++++++++...   +.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence            35777889999999999999864    34789999999755432 457789999999999999999999987432   23


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...+++|||+++++|.+++.....     .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.++++|
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence            456899999999999999976542     478888999999999999999999   999999999999999999999999


Q ss_pred             CccccccCC
Q 039258          201 FGLSKFLSS  209 (234)
Q Consensus       201 fG~a~~~~~  209 (234)
                      ||++.....
T Consensus       153 fg~~~~~~~  161 (284)
T cd05038         153 FGLAKVLPE  161 (284)
T ss_pred             ccccccccc
Confidence            999987653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.94  E-value=4.3e-26  Score=190.02  Aligned_cols=174  Identities=26%  Similarity=0.365  Sum_probs=139.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++.+.||+|+||.||+|....++..||+|.+....  ......+.+|+.++..++||||+++++++.... ......
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            67888999999999999999999999999999986432  233466788999999999999999988765433 234567


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+. ++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~  153 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM  153 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence            99999995 58988886543      578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........    .......|+..|+||
T Consensus       154 ~~~~~~~~~~~~----~~~~~~~~~~~y~~P  180 (334)
T cd07855         154 ARGLSSSPTEHK----YFMTEYVATRWYRAP  180 (334)
T ss_pred             ceeecccCcCCC----cccccccccccccCh
Confidence            986544321110    000124577888887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.4e-25  Score=182.97  Aligned_cols=170  Identities=26%  Similarity=0.357  Sum_probs=137.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      +|...+.||.|++|.||+|.+..++..+|+|.+.... ......+.+|++++..++||||+++++++...   ..+..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence            5778889999999999999999999999999987442 23446789999999999999999999987532   2345689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++......  ...+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.
T Consensus        79 v~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            99999999999887643211  11577888899999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ........          ...++..|+||
T Consensus       154 ~~~~~~~~----------~~~~~~~y~~p  172 (287)
T cd06621         154 ELVNSLAG----------TFTGTSFYMAP  172 (287)
T ss_pred             cccccccc----------cccCCccccCH
Confidence            54432111          13466677776

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.94  E-value=1.8e-25  Score=178.90  Aligned_cols=168  Identities=31%  Similarity=0.589  Sum_probs=136.7

Q ss_pred             CCCCceeecccceEEEEEEECCCC----eEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDE----MVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      +++.+.||+|+||.||+|.+..++    ..+|+|.+...... ..+.+..|++.+..++|+|++++++.+...     ..
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence            356778999999999999998765    89999999644322 457889999999999999999999987543     34


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .+++||++++++|.+++......    .+++..+..++.|++.|+.++|+.   +++|+||+|+||+++.++.++++|||
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence            68999999999999998765421    278899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++............       ...+++.|+||
T Consensus       149 ~~~~~~~~~~~~~~-------~~~~~~~y~~P  173 (258)
T smart00219      149 LSRDLYDDDYYKKK-------GGKLPIRWMAP  173 (258)
T ss_pred             Cceecccccccccc-------cCCCcccccCh
Confidence            99876544222110       02266778777

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.3e-26  Score=197.42  Aligned_cols=148  Identities=22%  Similarity=0.318  Sum_probs=130.1

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      -|..++.||-|+||+|+++....|...+|+|.+...+   +........|-++|....++.||+|+-.|.     +.+.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ-----DkdnL  704 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL  704 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec-----cCCce
Confidence            4778999999999999999998999999999996443   223345677899999999999999987763     44558


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      |+||+|++||++.++|...+      -|++..+..++.++..|+++.|..   |+|||||||.|||+|.+|++|+.|||+
T Consensus       705 YFVMdYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGL  775 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL  775 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccc
Confidence            99999999999999998877      788889999999999999999999   999999999999999999999999999


Q ss_pred             ccccC
Q 039258          204 SKFLS  208 (234)
Q Consensus       204 a~~~~  208 (234)
                      |.-+.
T Consensus       776 CTGfR  780 (1034)
T KOG0608|consen  776 CTGFR  780 (1034)
T ss_pred             cccce
Confidence            97654

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.94  E-value=1.5e-25  Score=186.86  Aligned_cols=156  Identities=25%  Similarity=0.445  Sum_probs=127.2

Q ss_pred             cCCCCCceeecccceEEEEEEECC-------CCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGE-------DEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSID  116 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~  116 (234)
                      .+|++.+.||+|+||.||+|.+..       ++..+|+|.++... ....+.+.+|++++.++ +||||+++++++..  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence            358889999999999999998643       23478999886432 23346788999999999 79999999998743  


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHL----------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPS  186 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~  186 (234)
                         .+..+++|||+++++|.+++.......          ....+++..++.++.|++.|+.|||++   +++|+||||+
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence               234689999999999999987643210          112467778889999999999999999   9999999999


Q ss_pred             CeeeCCCCceEEccCccccccCC
Q 039258          187 NVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       187 nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      ||+++.++.+||+|||+++....
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~  186 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHN  186 (334)
T ss_pred             eEEEcCCCcEEECCcccceeccc
Confidence            99999999999999999986544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=2e-25  Score=179.45  Aligned_cols=149  Identities=26%  Similarity=0.525  Sum_probs=124.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|.+...||+|+||.||+|.+..+. .+|+|.+.... ...+.+.+|+.++..++|+|++++++++.      .+..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence            45778889999999999999886554 58999875332 23367889999999999999999988752      123589


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      +|||+++++|.+++......    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        78 v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence            99999999999999764321    467888899999999999999999   99999999999999999999999999998


Q ss_pred             ccCC
Q 039258          206 FLSS  209 (234)
Q Consensus       206 ~~~~  209 (234)
                      ....
T Consensus       151 ~~~~  154 (260)
T cd05069         151 LIED  154 (260)
T ss_pred             EccC
Confidence            6543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-27  Score=180.95  Aligned_cols=163  Identities=21%  Similarity=0.281  Sum_probs=141.6

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+..+|++.+.||+|||+.|++++...++..+|+|.+........+..++|++..++++|||++++++........+...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            45678999999999999999999999999999999998776666788999999999999999999988766555556677


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .||++.|...|+|.+.+......+.  .+++.+++.++.+++.|+.++|+. ..+.+||||||.|||+...+.+++.|||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~--~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGN--FVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence            8999999999999999876532211  588999999999999999999998 2249999999999999999999999999


Q ss_pred             cccccC
Q 039258          203 LSKFLS  208 (234)
Q Consensus       203 ~a~~~~  208 (234)
                      .+....
T Consensus       175 S~~~a~  180 (302)
T KOG2345|consen  175 SATQAP  180 (302)
T ss_pred             Cccccc
Confidence            988654

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.94  E-value=1.4e-25  Score=185.45  Aligned_cols=156  Identities=25%  Similarity=0.466  Sum_probs=127.4

Q ss_pred             cCCCCCceeecccceEEEEEEECC-------CCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGE-------DEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSID  116 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~  116 (234)
                      .+|.+.+.||+|+||.||+|.+..       ....+|+|.++... ......+..|+.++..+ +||||+++++++..  
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc--
Confidence            468889999999999999998632       34579999986432 23346688899999999 69999999998743  


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCC----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDH----------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPS  186 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~  186 (234)
                         .+..+++|||+++++|.+++......          .....+++..+..++.|++.|+.|+|++   +++|+||||+
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  163 (314)
T cd05099          90 ---EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR  163 (314)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence               34478999999999999999764321          0112477888899999999999999999   9999999999


Q ss_pred             CeeeCCCCceEEccCccccccCC
Q 039258          187 NVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       187 nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      ||+++.++.+|++|||+++....
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~  186 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHD  186 (314)
T ss_pred             eEEEcCCCcEEEccccccccccc
Confidence            99999999999999999986543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.94  E-value=9.1e-26  Score=183.59  Aligned_cols=167  Identities=25%  Similarity=0.437  Sum_probs=135.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||.|+||.||+|.+..++..+|||.+....  ......+..|+++++.++|||++++++++..     .+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence            4788899999999999999999899999999886432  2233578899999999999999999998742     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+. ++|.+++......    .+++..+..++.|++.|++|+|+.   +++|+||+|+||+++.++.+|++|||++
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPLS----GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence            9999995 5898888654322    578888999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........        ...+++.|+||
T Consensus       148 ~~~~~~~~~~~--------~~~~~~~y~aP  169 (284)
T cd07860         148 RAFGVPVRTYT--------HEVVTLWYRAP  169 (284)
T ss_pred             hhcccCccccc--------cccccccccCC
Confidence            76543211110        12356777776

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.94  E-value=1.5e-25  Score=180.13  Aligned_cols=149  Identities=23%  Similarity=0.539  Sum_probs=126.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.++..++|+|++++++++.      .+..+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcE
Confidence            456888999999999999999864 457899999864332 3467889999999999999999998752      23368


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||+++++|.+++......    .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence            999999999999998654322    577888899999999999999998   9999999999999999999999999999


Q ss_pred             cccC
Q 039258          205 KFLS  208 (234)
Q Consensus       205 ~~~~  208 (234)
                      ....
T Consensus       150 ~~~~  153 (260)
T cd05067         150 RLIE  153 (260)
T ss_pred             eecC
Confidence            8665

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-27  Score=199.72  Aligned_cols=163  Identities=26%  Similarity=0.548  Sum_probs=140.2

Q ss_pred             HHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           39 AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        39 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      +++.....+.+...+||-|.||.||.|.|+.-...||||.++.... ..+.|++|+.+|+.++|||+++|+|+|..... 
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP-  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP-  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC-
Confidence            3444445566667899999999999999999899999999974432 34789999999999999999999999965433 


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                          .|||+|||.+|+|.+|++++++.    .++..-.++++.||..|++||..+   .+|||||..+|+|+..+..||+
T Consensus       338 ----FYIiTEfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  338 ----FYIITEFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             ----eEEEEecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEe
Confidence                69999999999999999998754    455566788999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCC
Q 039258          199 GDFGLSKFLSSDHLDT  214 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~  214 (234)
                      +|||+++.+..+.+..
T Consensus       407 ADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             eccchhhhhcCCceec
Confidence            9999999988776544

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=1.7e-25  Score=183.54  Aligned_cols=157  Identities=30%  Similarity=0.457  Sum_probs=131.2

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC----
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS----  117 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~----  117 (234)
                      ...+|++.+.||+|+||.||+|.+..++..||+|.++...  ......+.+|++++..++|||++++++++.....    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567899999999999999999999889999999997432  2333567789999999999999999998754331    


Q ss_pred             -CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCce
Q 039258          118 -KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       118 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~v  196 (234)
                       .+....++|+||+++ ++...+.....     .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLV-----HFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence             123467999999975 77777765421     578889999999999999999999   99999999999999999999


Q ss_pred             EEccCccccccCC
Q 039258          197 HVGDFGLSKFLSS  209 (234)
Q Consensus       197 ki~dfG~a~~~~~  209 (234)
                      ||+|||++.....
T Consensus       156 kl~dfg~~~~~~~  168 (302)
T cd07864         156 KLADFGLARLYNS  168 (302)
T ss_pred             EeCcccccccccC
Confidence            9999999986654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.94  E-value=1.4e-25  Score=182.11  Aligned_cols=144  Identities=23%  Similarity=0.354  Sum_probs=123.3

Q ss_pred             eecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           54 IGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        54 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      ||+|+||.||+|.+..+++.+|+|.+....   ......+..|++++..++|||++++.+.+..     .+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence            689999999999999999999999986432   2233566789999999999999999988743     34479999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      ++++|.+++......    .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||++.....
T Consensus        76 ~~~~L~~~l~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          76 NGGDLKYHIYNVGEP----GFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             CCCcHHHHHHHcCcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            999999998765431    578889999999999999999999   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.94  E-value=1.9e-25  Score=181.51  Aligned_cols=158  Identities=25%  Similarity=0.343  Sum_probs=124.5

Q ss_pred             eeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHH---HHHhcCCCCceeEEEEeeecCCCCCCcceee
Q 039258           53 MIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECE---ALRNIRHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~---~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      .||+|+||.||+|.+..+++.||+|.+....   ......+..|..   .+....||+++.+.+.+..     .+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence            4899999999999998899999999986432   111122333433   3444579999999888743     3447899


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      |||+++++|.+++....      .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++..
T Consensus        76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            99999999999887543      588899999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCccCCCCCCCCccccccccccccCC
Q 039258          207 LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......          ...|+..|+||
T Consensus       147 ~~~~~~~----------~~~~~~~y~aP  164 (278)
T cd05606         147 FSKKKPH----------ASVGTHGYMAP  164 (278)
T ss_pred             cCccCCc----------CcCCCcCCcCc
Confidence            4332111          14588889887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.9e-25  Score=177.31  Aligned_cols=166  Identities=31%  Similarity=0.526  Sum_probs=139.7

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|++|.||++.+..++..+++|.+.....  .....+.+|++++..++|+|++++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence            47788999999999999999988899999999975433  445778999999999999999999998743     24478


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++||++++++|.+++....      .+++..+..++.|++.|+.++|++   +++|+||+|+||+++.++.++|+|||++
T Consensus        76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence            9999999999999987653      678888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....|+..|+||
T Consensus       147 ~~~~~~~~~~--------~~~~~~~~y~~p  168 (254)
T cd06627         147 TKLNDVSKDD--------ASVVGTPYWMAP  168 (254)
T ss_pred             eecCCCcccc--------cccccchhhcCH
Confidence            8765432211        114577778877

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.94  E-value=9.4e-26  Score=183.65  Aligned_cols=167  Identities=26%  Similarity=0.381  Sum_probs=136.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.||+|.+..++..||+|.++..  .......+.+|+++++.++|+|++++++++..     .+..+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            688899999999999999999989999999998643  23344678899999999999999999998754     33479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||++++.+..+.....      .+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.+|++|||++
T Consensus        77 iv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~  147 (288)
T cd07833          77 LVFEYVERTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFA  147 (288)
T ss_pred             EEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecc
Confidence            9999998766655554332      577888999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........       ....|+..|+||
T Consensus       148 ~~~~~~~~~~~-------~~~~~~~~~~~P  170 (288)
T cd07833         148 RALRARPASPL-------TDYVATRWYRAP  170 (288)
T ss_pred             cccCCCccccc-------cCcccccCCcCC
Confidence            87654332010       014577788887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.94  E-value=2.2e-25  Score=183.67  Aligned_cols=153  Identities=30%  Similarity=0.458  Sum_probs=129.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|+..+.||+|+||.||+|.+..++..||+|.++...  ......+.+|+.++..++|+|++++++++...   ..+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            457899999999999999999999999999999987442  22234567899999999999999999987532   2234


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++ +|.+++.....     .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.+||+|||
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNMPT-----PFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            6899999964 88888875432     578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCC
Q 039258          203 LSKFLSS  209 (234)
Q Consensus       203 ~a~~~~~  209 (234)
                      ++.....
T Consensus       154 ~~~~~~~  160 (309)
T cd07845         154 LARTYGL  160 (309)
T ss_pred             eeeecCC
Confidence            9987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.94  E-value=3.3e-25  Score=178.33  Aligned_cols=174  Identities=29%  Similarity=0.389  Sum_probs=141.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ++|++.+.||.|+||.||+|....++..+++|++.... ......+.+|++.++.++|+|++++++.+..     ....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence            36888999999999999999998889999999986432 2245678999999999999999999988743     33468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++||++++++|.+++......   ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~  149 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPR---GGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS  149 (267)
T ss_pred             EEEeccCCCcHHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence            999999999999999764320   1577888899999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..+........    .......|+..|+||
T Consensus       150 ~~~~~~~~~~~----~~~~~~~~~~~y~~P  175 (267)
T cd06610         150 ASLADGGDRTR----KVRKTFVGTPCWMAP  175 (267)
T ss_pred             HHhccCccccc----cccccccCChhhcCh
Confidence            87655432210    011125688889887

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.8e-25  Score=178.30  Aligned_cols=143  Identities=29%  Similarity=0.508  Sum_probs=122.7

Q ss_pred             ceeecccceEEEEEEECCCC---eEEEEEEeecccc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDE---MVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+..++   ..+|+|.+..... ...+.+.+|+.++..+.|+|++++++++..      ...++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence            36899999999999876544   7899999874432 234678899999999999999999997632      2358999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++....      .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.+|++|||+++..
T Consensus        75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence            9999999999998654      578889999999999999999999   9999999999999999999999999999876


Q ss_pred             CC
Q 039258          208 SS  209 (234)
Q Consensus       208 ~~  209 (234)
                      ..
T Consensus       146 ~~  147 (257)
T cd05060         146 GA  147 (257)
T ss_pred             ec
Confidence            44

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.5e-25  Score=180.00  Aligned_cols=152  Identities=28%  Similarity=0.556  Sum_probs=129.3

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ...+|++.+.||+|+||.||+|... ++..+|+|.+.... .....+.+|+.++..++|+|++++++++..     ....
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   76 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPI   76 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCce
Confidence            3567889999999999999999975 44679999986432 234678899999999999999999998643     2346


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++......    .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||+
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~----~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~  149 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGK----KLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL  149 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccc
Confidence            9999999999999999764322    578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCC
Q 039258          204 SKFLSS  209 (234)
Q Consensus       204 a~~~~~  209 (234)
                      +.....
T Consensus       150 ~~~~~~  155 (261)
T cd05034         150 ARLIED  155 (261)
T ss_pred             ceeccc
Confidence            886653

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3.9e-27  Score=213.27  Aligned_cols=172  Identities=27%  Similarity=0.454  Sum_probs=140.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      +-+++....||.|.||.||.|.+..+|...|+|-++..  .........+|..++..++|||+++++|+-.+.+     .
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----k 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----K 1308 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----H
Confidence            34677788999999999999999999999999988632  3334567889999999999999999999854333     3


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .+|.||||++|+|.+.+...+      ...+.-..-+-.|++.|+.|||+.   ||||||+||+||+++.+|.+|..|||
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccc
Confidence            689999999999999998765      344455566788999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .|..+........    ..-....||+.||||
T Consensus      1380 sa~ki~~~~~~~~----~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMP----GELQSMMGTPMYMAP 1407 (1509)
T ss_pred             ceeEecCchhcCC----HHHHhhcCCchhcCc
Confidence            9987766521211    111136799999999

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.94  E-value=2.3e-25  Score=185.49  Aligned_cols=173  Identities=25%  Similarity=0.340  Sum_probs=136.9

Q ss_pred             CCCCCceeecccceEEEEEEECCC--CeEEEEEEeecc--cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGED--EMVVAVKVINLK--QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      +|+..+.||+|+||.||++.+..+  +..+|+|.+...  .....+.+.+|++++..+ +||||+++++.+.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            477788999999999999999877  889999998632  222346778899999999 5999999998764432 2234


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++++|++. ++|.+++....      .+++..+..++.|++.||.|+|++   +++|+||||+||+++.++.++|+||
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence            4688999985 68999886544      578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++............    ......||+.|+||
T Consensus       150 g~a~~~~~~~~~~~~----~~~~~~g~~~y~aP  178 (332)
T cd07857         150 GLARGFSENPGENAG----FMTEYVATRWYRAP  178 (332)
T ss_pred             CCceecccccccccc----cccCcccCccccCc
Confidence            999876543221110    01125688999998

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.94  E-value=3.4e-25  Score=180.66  Aligned_cols=164  Identities=26%  Similarity=0.402  Sum_probs=136.1

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      |+..+.||+|++|.||++.+..++..+++|.++.......+.+.+|+.+++.++|+|++++++.+..     .+..++++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v~   95 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVVM   95 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEEE
Confidence            5556789999999999999988899999999875544445668899999999999999999998743     34469999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++...       .+++..+..++.|++.|+.|+|++   +++||||+|+||+++.++.++++|||++...
T Consensus        96 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648          96 EFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             eccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            999999999998762       567788899999999999999999   9999999999999999999999999988754


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......        ....|++.|+||
T Consensus       166 ~~~~~~~--------~~~~~~~~y~aP  184 (285)
T cd06648         166 SKEVPRR--------KSLVGTPYWMAP  184 (285)
T ss_pred             ccCCccc--------ccccCCccccCH
Confidence            3321111        114578888887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.93  E-value=2e-25  Score=178.79  Aligned_cols=146  Identities=31%  Similarity=0.535  Sum_probs=124.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|++.+.||+|+||.||++..  ++..+|+|.+....  ....+.+|+.++..++|||++++++++...      ..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEE
Confidence            4588899999999999999864  66789999986432  336788999999999999999999987421      2589


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      +|||+++++|.+++......    .+++..+..++.|++.|+.|+|++   +++||||+|+||+++.++.++++|||++.
T Consensus        76 v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRA----LVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence            99999999999999765422    567888899999999999999998   99999999999999999999999999987


Q ss_pred             ccC
Q 039258          206 FLS  208 (234)
Q Consensus       206 ~~~  208 (234)
                      ...
T Consensus       149 ~~~  151 (254)
T cd05083         149 VGS  151 (254)
T ss_pred             ecc
Confidence            643

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.93  E-value=4.1e-25  Score=178.71  Aligned_cols=146  Identities=31%  Similarity=0.547  Sum_probs=120.5

Q ss_pred             eeecccceEEEEEEECCCCe--EEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           53 MIGQGSYGSVYKGILGEDEM--VVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      .||+|+||.||+|....++.  .+++|.++.. .....+.+.+|++++.++ +|||++++++++..     ....++|||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~e   76 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAIE   76 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEEE
Confidence            58999999999999887764  4688887632 233446788999999999 79999999998743     234689999


Q ss_pred             ecCCCCHHHHhhhccCC----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          129 YMENGSLEDWLHQTNDH----------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                      |+++++|.+++......          .....+++..+..++.|++.|++|+|++   +++|+||||+||+++.++.+|+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl  153 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI  153 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEE
Confidence            99999999998754311          0112467888999999999999999998   9999999999999999999999


Q ss_pred             ccCccccc
Q 039258          199 GDFGLSKF  206 (234)
Q Consensus       199 ~dfG~a~~  206 (234)
                      +|||++..
T Consensus       154 ~dfgl~~~  161 (270)
T cd05047         154 ADFGLSRG  161 (270)
T ss_pred             CCCCCccc
Confidence            99999863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.93  E-value=2.5e-25  Score=186.21  Aligned_cols=169  Identities=22%  Similarity=0.333  Sum_probs=136.6

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC-CC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK-GA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~-~~  120 (234)
                      ...+|+..+.||+|+||.||+|.+..++..||+|.+...  .......+.+|++++..++|+||+++++++...... ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            456799999999999999999999999999999998532  222345678999999999999999999987543221 11


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++|||++ +++|.+++...       .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            2358999999 77998887642       577888999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++........           ...+++.|+||
T Consensus       162 fg~~~~~~~~~~-----------~~~~~~~y~aP  184 (343)
T cd07880         162 FGLARQTDSEMT-----------GYVVTRWYRAP  184 (343)
T ss_pred             cccccccccCcc-----------ccccCCcccCH
Confidence            999886433211           13467778776

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=5.4e-26  Score=198.89  Aligned_cols=175  Identities=22%  Similarity=0.274  Sum_probs=128.0

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCC-eEEEEEEe--------------e---cccchhhHHHHHHHHHHHhcCCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDE-MVVAVKVI--------------N---LKQKGAFRSFVAECEALRNIRHRN  104 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~-~~vavK~~--------------~---~~~~~~~~~~~~e~~~l~~l~h~~  104 (234)
                      ....+|++.+.||+|+||+||+|..+... ...+.|.+              .   .........+.+|+.+|..++|+|
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34568999999999999999998765322 22222211              0   011123356789999999999999


Q ss_pred             ceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039258          105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIK  184 (234)
Q Consensus       105 i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk  184 (234)
                      |+++++++...     +..++|+|++. ++|.+++........ .......+..++.|++.||.|||++   +|+|||||
T Consensus       225 Iv~l~~~~~~~-----~~~~lv~e~~~-~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLK  294 (501)
T PHA03210        225 ILKIEEILRSE-----ANTYMITQKYD-FDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIK  294 (501)
T ss_pred             cCcEeEEEEEC-----CeeEEEEeccc-cCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            99999998543     33689999985 588887754321111 1233556778999999999999999   99999999


Q ss_pred             CCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          185 PSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       185 ~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||++.++.+||+|||+++.+.......       .....||..|+||
T Consensus       295 P~NILl~~~~~vkL~DFGla~~~~~~~~~~-------~~~~~gt~~y~aP  337 (501)
T PHA03210        295 LENIFLNCDGKIVLGDFGTAMPFEKEREAF-------DYGWVGTVATNSP  337 (501)
T ss_pred             HHHEEECCCCCEEEEeCCCceecCcccccc-------cccccCCcCCCCc
Confidence            999999999999999999998765432111       1125799999998

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.93  E-value=4.1e-25  Score=182.03  Aligned_cols=163  Identities=28%  Similarity=0.407  Sum_probs=133.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..|+..+.||+|+||.||+|.+..++..||+|.+....   ......+.+|++++..++|||++++.+++...     +.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----Ce
Confidence            34888899999999999999998889999999986432   22335688999999999999999999998643     33


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||++ +++.+++.....     .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence            689999996 588777764332     578888999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.......            ...|++.|+||
T Consensus       161 ~~~~~~~~~------------~~~~~~~y~aP  180 (307)
T cd06607         161 SASLVSPAN------------SFVGTPYWMAP  180 (307)
T ss_pred             cceecCCCC------------CccCCccccCc
Confidence            987543321            13466777776

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.93  E-value=3.1e-25  Score=178.41  Aligned_cols=158  Identities=27%  Similarity=0.380  Sum_probs=132.3

Q ss_pred             eecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           54 IGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        54 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      ||.|+||.||+|.+..++..+|+|++....   ....+.+.+|+.++..++|||++++++.+..     ....+++|||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence            689999999999998889999999996432   2334678899999999999999999998743     33479999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~  210 (234)
                      ++++|.+++....      .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||++......
T Consensus        76 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          76 LGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             CCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            9999999997654      477888899999999999999998   9999999999999999999999999999876543


Q ss_pred             ccCCCCCCCCccccccccccccCC
Q 039258          211 HLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       211 ~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ....         ...|++.|+||
T Consensus       147 ~~~~---------~~~~~~~~~~P  161 (262)
T cd05572         147 QKTW---------TFCGTPEYVAP  161 (262)
T ss_pred             cccc---------cccCCcCccCh
Confidence            2110         14577788887

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.93  E-value=1.8e-25  Score=183.04  Aligned_cols=162  Identities=27%  Similarity=0.405  Sum_probs=134.0

Q ss_pred             CCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEee
Q 039258           50 QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEY  129 (234)
Q Consensus        50 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~  129 (234)
                      ....||+|+||.||++....++..+|+|.+..........+.+|+.+++.++|+|++++++.+..     .+..++||||
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~   98 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVMEF   98 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEEec
Confidence            34579999999999999999999999999865544455678899999999999999999998753     3457999999


Q ss_pred             cCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          130 MENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       130 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      +++++|.+++...       .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        99 ~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657          99 LEGGALTDIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             CCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            9999999877542       467788899999999999999999   999999999999999999999999998875543


Q ss_pred             CccCCCCCCCCccccccccccccCC
Q 039258          210 DHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       210 ~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .....        ....|++.|+||
T Consensus       169 ~~~~~--------~~~~~~~~y~~p  185 (292)
T cd06657         169 EVPRR--------KSLVGTPYWMAP  185 (292)
T ss_pred             ccccc--------cccccCccccCH
Confidence            21111        114577888887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.93  E-value=1.3e-25  Score=180.19  Aligned_cols=167  Identities=28%  Similarity=0.410  Sum_probs=132.4

Q ss_pred             eecccceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           54 IGQGSYGSVYKGILGEDEMVVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        54 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      ||+|+||.||++.+..++..+++|.+.....   ...+.+.+|++++..++|+|++++++.+.     +....+++|||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence            6899999999999998899999999864322   34467888999999999999999987763     344579999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~  210 (234)
                      ++++|.+++....      .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.++++|||++......
T Consensus        76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            9999999997654      578889999999999999999999   9999999999999999999999999998864432


Q ss_pred             ccCCCCCCCCccccccccccccCC
Q 039258          211 HLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       211 ~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ................++..|+||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~P  170 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAP  170 (265)
T ss_pred             cccccccccccccCcccCccccCH
Confidence            211000000011124577778877

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.93  E-value=3.8e-25  Score=179.64  Aligned_cols=158  Identities=26%  Similarity=0.418  Sum_probs=130.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECC----CCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGE----DEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ..+|+..+.||+|+||.||+|.+..    ++..|++|.+... .......+.+|+.++..++|+|++++++++...    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            4568888999999999999999865    3588999988643 233346788999999999999999999987532    


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCC--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDH--LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                      +...++++||+++++|.+++......  .....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence            33468999999999999998764321  1112578889999999999999999999   999999999999999999999


Q ss_pred             EccCccccccCC
Q 039258          198 VGDFGLSKFLSS  209 (234)
Q Consensus       198 i~dfG~a~~~~~  209 (234)
                      ++|||+++.+..
T Consensus       158 l~d~g~~~~~~~  169 (280)
T cd05043         158 ITDNALSRDLFP  169 (280)
T ss_pred             ECCCCCcccccC
Confidence            999999986543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.93  E-value=3.5e-25  Score=177.50  Aligned_cols=165  Identities=25%  Similarity=0.423  Sum_probs=132.5

Q ss_pred             ceeecccceEEEEEEECC-C--CeEEEEEEeecccc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGE-D--EMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|++|.||+|.+.. .  ...+|+|.+..... ...+.+.+|+.++..++|||++++++.+..      ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            368999999999998754 2  34799999975544 455788999999999999999999998743      4468999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++.....    ..+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.+|++|||++...
T Consensus        75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence            99999999999977542    1578888999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......... .    ...++..|+||
T Consensus       148 ~~~~~~~~~~-~----~~~~~~~y~~p  169 (257)
T cd05040         148 PQNEDHYVME-E----HLKVPFAWCAP  169 (257)
T ss_pred             cccccceecc-c----CCCCCceecCH
Confidence            5422111000 0    13466778876

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.93  E-value=1e-25  Score=181.37  Aligned_cols=165  Identities=26%  Similarity=0.411  Sum_probs=137.7

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      +|+..+.||+|+||.||++.+..++..+|+|.+.... ......+.+|++++..++|||++++++.+...     ...++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEEE
Confidence            5777889999999999999999999999999986542 33446788999999999999999999987443     45799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++||+++++|.+++.....     .+++..+..++.|++.|+.|+|+ .   +++|+||+|+||+++.++.++++|||.+
T Consensus        77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~  148 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQG-----RIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVS  148 (265)
T ss_pred             EEEecCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence            9999998999999876531     67788889999999999999999 7   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........          ..|+..|+||
T Consensus       149 ~~~~~~~~~~----------~~~~~~y~~P  168 (265)
T cd06605         149 GQLVNSLAKT----------FVGTSSYMAP  168 (265)
T ss_pred             hhhHHHHhhc----------ccCChhccCH
Confidence            7654321111          3467778776

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.93  E-value=6e-25  Score=179.77  Aligned_cols=150  Identities=27%  Similarity=0.471  Sum_probs=125.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|+..+.||+|++|.||+|.+..+++.||+|.+....  ....+.+.+|++++..++|+|++++++++..     ....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence            46888999999999999999999899999999986432  2233567889999999999999999998743     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-CCceEEccCc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDFG  202 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-~~~vki~dfG  202 (234)
                      ++||||++ ++|.+++......    .+++..+..++.|++.||+|||++   +++|+||+|+||+++. ++.+|++|||
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPDF----AKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCCC----CcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence            99999996 5888887654321    356777888999999999999999   9999999999999984 5679999999


Q ss_pred             cccccC
Q 039258          203 LSKFLS  208 (234)
Q Consensus       203 ~a~~~~  208 (234)
                      ++....
T Consensus       149 ~~~~~~  154 (294)
T PLN00009        149 LARAFG  154 (294)
T ss_pred             cccccC
Confidence            997654

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.93  E-value=8e-25  Score=176.93  Aligned_cols=166  Identities=25%  Similarity=0.357  Sum_probs=130.7

Q ss_pred             hHHHHHHhcCCCCCcee--ecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeee
Q 039258           38 YAELSKATCEFSQSNMI--GQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSS  114 (234)
Q Consensus        38 ~~~~~~~~~~~~~~~~l--G~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~  114 (234)
                      ..+......+|++.+.+  |+|+||.||++..+.++..+|+|.+.......     .|+.....+ +|+|++++++.+..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34445555667776666  99999999999999999999999986432111     122222223 69999999998754


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                      .     +..++||||+++++|.+++....      .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++
T Consensus        81 ~-----~~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         81 L-----KGHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             C-----CeeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence            3     34799999999999999997654      678899999999999999999999   999999999999999887


Q ss_pred             -ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 -VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 -~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                       .++++|||++.......            ...|+..|+||
T Consensus       147 ~~~~l~dfg~~~~~~~~~------------~~~~~~~y~aP  175 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTPS------------CYDGTLDYFSP  175 (267)
T ss_pred             CeEEEecCccceecCCCc------------cCCCCCcccCh
Confidence             99999999987654321            13477788887

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.93  E-value=6e-25  Score=178.61  Aligned_cols=168  Identities=30%  Similarity=0.458  Sum_probs=136.5

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      |++.+.||+|+||.||+|.+..++..+|+|.+....  ......+.+|++++..++|+|++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            567789999999999999999899999999997552  333466888999999999999999999875431   245799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++ +|.+++.....     .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++.
T Consensus        78 v~e~~~~-~l~~~~~~~~~-----~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPEV-----KFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             Eeccccc-cHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence            9999975 89888866431     578889999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........       ....++..|+||
T Consensus       149 ~~~~~~~~~~-------~~~~~~~~y~~P  170 (287)
T cd07840         149 PYTKRNSADY-------TNRVITLWYRPP  170 (287)
T ss_pred             eccCCCcccc-------cccccccccCCc
Confidence            7654321110       012456778777

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-26  Score=189.39  Aligned_cols=176  Identities=27%  Similarity=0.434  Sum_probs=143.9

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cc----hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QK----GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~----~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      +|-.+.+||+|+|+.||+|.+....+.||||+-...   .+    ...+..-+|.++-+.+.||-||++++++...    
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD----  539 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD----  539 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec----
Confidence            566688999999999999999888999999987532   11    1234567899999999999999999998542    


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC---CCCce
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVA  196 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~---~~~~v  196 (234)
                      .+..|-|+|||+|.+|.-|++.+.      ..++.++..|+-||+.||.||.+. ..+|||=||||.|||+.   ..|.+
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhk------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHK------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhh------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccccee
Confidence            334699999999999999999876      688999999999999999999987 56899999999999993   56899


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||.|||++++++++....... -.-.+...||.+|.+|
T Consensus       613 KITDFGLSKIMdddSy~~vdG-meLTSQgAGTYWYLPP  649 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDG-MELTSQGAGTYWYLPP  649 (775)
T ss_pred             EeeecchhhhccCCccCcccc-eeeecccCceeeecCc
Confidence            999999999988765543211 1111236799999988

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.93  E-value=6.6e-25  Score=175.35  Aligned_cols=170  Identities=27%  Similarity=0.429  Sum_probs=140.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|+||.||++.+..++..+++|.+.....  .....+.+|++++..++|+|++++.+.+...     ...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence            47788899999999999999988899999999975432  4456788999999999999999999886432     4578


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +++|++++++|.+++......  ...+++..+..++.+++.|+.|+|++   +++|+||+|+||+++.++.++++|||++
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~  150 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKE--GKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS  150 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhcc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence            999999999999998775310  11678889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....|++.|+||
T Consensus       151 ~~~~~~~~~~--------~~~~~~~~y~~p  172 (258)
T cd08215         151 KVLSSTVDLA--------KTVVGTPYYLSP  172 (258)
T ss_pred             eecccCccee--------cceeeeecccCh
Confidence            8765432111        014577888887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.93  E-value=9.5e-25  Score=180.71  Aligned_cols=161  Identities=29%  Similarity=0.423  Sum_probs=132.4

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      |+..+.||+|+||.||++.+..++..+|+|.+....   ......+..|+++++.++|+|++++++++...     ...+
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~  101 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTAW  101 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeEE
Confidence            677889999999999999998899999999986432   22335788899999999999999999987543     3368


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||++ +++.+.+.....     .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||++
T Consensus       102 lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~  172 (317)
T cd06635         102 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA  172 (317)
T ss_pred             EEEeCCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCc
Confidence            9999996 488887765432     578888999999999999999999   9999999999999999999999999988


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......            ...|++.|+||
T Consensus       173 ~~~~~~~------------~~~~~~~y~aP  190 (317)
T cd06635         173 SIASPAN------------SFVGTPYWMAP  190 (317)
T ss_pred             cccCCcc------------cccCCccccCh
Confidence            7543211            13467777776

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=8.8e-25  Score=174.61  Aligned_cols=143  Identities=31%  Similarity=0.556  Sum_probs=123.2

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      +.||+|+||.||+|.+.. +..||+|.+...... ....+.+|++++..++|+|++++++++...     ...++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcC
Confidence            368999999999999877 889999998654332 456789999999999999999999987533     3468999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      ++++|.+++.....     .+++..+..++.+++.++.|+|++   +++|+||+|+||+++.++.++++|||++....
T Consensus        75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            99999999876432     467788899999999999999999   99999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.93  E-value=5.4e-25  Score=180.36  Aligned_cols=178  Identities=21%  Similarity=0.311  Sum_probs=125.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCC---CeEEEEEEeecccchhh-----------HHHHHHHHHHHhcCCCCceeEEE
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGED---EMVVAVKVINLKQKGAF-----------RSFVAECEALRNIRHRNLTKIIT  110 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~l~~  110 (234)
                      ..+|.+.+.||+|+||.||+|.+..+   +..+|+|+.........           .....+...+..+.|+|++.+++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            35799999999999999999998777   66778887643322110           11223334455678999999998


Q ss_pred             EeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee
Q 039258          111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL  190 (234)
Q Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~  190 (234)
                      ++.... ....+.++++|++. .++.+.+....      ..++..+..++.|++.|+.|+|++   +++||||||+|||+
T Consensus        91 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         91 CGSFKR-CRMYYRFILLEKLV-ENTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             eeeEec-CCceEEEEEEehhc-cCHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            764332 12234467888773 46766665432      345677889999999999999999   99999999999999


Q ss_pred             CCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          191 DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       191 ~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.++.++|+|||+|+.+......... .........||+.|+||
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~-~~~~~~~~~gt~~y~ap  202 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEY-SKEQKDLHRGTLYYAGL  202 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCccccc-ccccccccCCCccccCH
Confidence            99999999999999876543211110 01111124699999997

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.93  E-value=3.2e-25  Score=179.63  Aligned_cols=150  Identities=28%  Similarity=0.464  Sum_probs=130.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|...+.||+|+||.||+|....++..+|+|++...   .....+.+..|.+++..+. |+|++++++++..     ..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cc
Confidence            3688889999999999999999999999999998642   2233466788999999998 9999999887643     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++|||++++++|.+++....      .+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++++||
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence            4799999999999999998764      688889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCC
Q 039258          202 GLSKFLSS  209 (234)
Q Consensus       202 G~a~~~~~  209 (234)
                      |++.....
T Consensus       147 ~~~~~~~~  154 (280)
T cd05581         147 GTAKVLDP  154 (280)
T ss_pred             ccccccCC
Confidence            99887654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=7.3e-28  Score=185.15  Aligned_cols=176  Identities=25%  Similarity=0.430  Sum_probs=140.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeec--ccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC---
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA---  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~---  120 (234)
                      ..|....++|+|.||.|++|+.+++++.||+|.+-.  ..++.....++|+.+|..++|+|++.++..|......+.   
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            346667789999999999999999999999987643  344556778999999999999999999998876554432   


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ..+++|+.+|+. +|+-++.+..-     +++...+..++.++..||.|+|.+   .|+|||+|++|+|++.++.+||+|
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v-----r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV-----RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc-----cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence            346899999975 99999887532     788999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++.+...........    ...+.|.+|.+|
T Consensus       168 FGlar~fs~~~n~~kpry----tnrvvTLwYrpp  197 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRY----TNRVVTLWYRPP  197 (376)
T ss_pred             cccccceecccccCCCCc----ccceeeeecCCH
Confidence            999986654322211110    013457777765

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.93  E-value=9.3e-25  Score=175.60  Aligned_cols=150  Identities=22%  Similarity=0.501  Sum_probs=126.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|.+.+.||+|+||.||++... .+..+|+|.+.... ...+.+.+|+.++..++|+|++++++.+..      ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence            456888999999999999999864 44569999886432 234678899999999999999999988643      2358


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||+++++|.+++......    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++..+.+|++|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCcc----ccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence            999999999999999764321    567778889999999999999998   9999999999999999999999999998


Q ss_pred             cccCC
Q 039258          205 KFLSS  209 (234)
Q Consensus       205 ~~~~~  209 (234)
                      .....
T Consensus       150 ~~~~~  154 (260)
T cd05073         150 RVIED  154 (260)
T ss_pred             eeccC
Confidence            76543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.93  E-value=8.7e-25  Score=178.14  Aligned_cols=169  Identities=27%  Similarity=0.422  Sum_probs=139.8

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ....|+....||+|+||.||+|.+..++..+++|++..... ..+.+..|++.+..++|+|++++++.+...     ...
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEE
Confidence            45568888899999999999999988889999999975543 456788999999999999999999987543     447


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++++||+++++|.+++....     ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccch
Confidence            99999999999999998754     1578888999999999999999998   999999999999999999999999998


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........        ....|+..|+||
T Consensus       163 ~~~~~~~~~~~--------~~~~~~~~y~~P  185 (286)
T cd06614         163 AAQLTKEKSKR--------NSVVGTPYWMAP  185 (286)
T ss_pred             hhhhccchhhh--------ccccCCcccCCH
Confidence            87544321110        113466777776

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.93  E-value=4.5e-25  Score=176.69  Aligned_cols=168  Identities=23%  Similarity=0.384  Sum_probs=136.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|...+.||+|+||.||+|....++..+|+|.+....  ....+.+.+|+++++.++|+|++++++.+..     ....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence            4778889999999999999999999999999986432  2234577899999999999999999998743     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC-ceEEccCcc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGL  203 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~-~vki~dfG~  203 (234)
                      +++||+++++|.+++......    .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++ .++++|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGV----LFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence            999999999999998764322    467888999999999999999999   999999999999998775 569999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........        ....|++.|+||
T Consensus       149 ~~~~~~~~~~~--------~~~~~~~~~~ap  171 (257)
T cd08225         149 ARQLNDSMELA--------YTCVGTPYYLSP  171 (257)
T ss_pred             chhccCCcccc--------cccCCCccccCH
Confidence            88654322110        013477788887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.93  E-value=1e-24  Score=174.69  Aligned_cols=148  Identities=28%  Similarity=0.554  Sum_probs=125.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|+..+.||+|+||.||++.+. .+..+|+|.+.... .....+.+|++++..++|||++++++++..     ....++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCceEE
Confidence            36778899999999999999875 35679999886332 223568899999999999999999998743     234689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++.....     .+++..+..++.|++.++.|+|+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence            9999999999999875432     467788899999999999999999   99999999999999999999999999987


Q ss_pred             ccC
Q 039258          206 FLS  208 (234)
Q Consensus       206 ~~~  208 (234)
                      ...
T Consensus       149 ~~~  151 (256)
T cd05112         149 FVL  151 (256)
T ss_pred             ecc
Confidence            654

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.93  E-value=3.9e-25  Score=178.42  Aligned_cols=149  Identities=28%  Similarity=0.504  Sum_probs=122.1

Q ss_pred             eeecccceEEEEEEECCCC------eEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           53 MIGQGSYGSVYKGILGEDE------MVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .||+|+||.||+|.+....      ..+|+|.+.... ......+.+|+.+++.++||||+++++++..     ....++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQYI   76 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeEE
Confidence            5899999999999876433      789999885432 2345678899999999999999999998743     234699


Q ss_pred             eEeecCCCCHHHHhhhccCCc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC-----ceEEc
Q 039258          126 VFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-----VAHVG  199 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~-----~vki~  199 (234)
                      ||||+++++|.+++....... ....+++..++.++.|++.|+.|+|++   +++|+||+|+||+++.++     .++++
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEEC
Confidence            999999999999997643211 122467888999999999999999998   999999999999998776     89999


Q ss_pred             cCccccccCC
Q 039258          200 DFGLSKFLSS  209 (234)
Q Consensus       200 dfG~a~~~~~  209 (234)
                      |||+++....
T Consensus       154 dfg~~~~~~~  163 (269)
T cd05044         154 DFGLARDIYK  163 (269)
T ss_pred             Cccccccccc
Confidence            9999986543

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.93  E-value=9.6e-25  Score=182.78  Aligned_cols=173  Identities=23%  Similarity=0.347  Sum_probs=138.2

Q ss_pred             HHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           40 ELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        40 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      .+-....+|+..+.||+|+||.||+|.+..++..||+|.+....  ....+.+.+|++++..++|+||+++.+++.....
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            34456678999999999999999999998899999999986432  2233567889999999999999999998754322


Q ss_pred             -CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCce
Q 039258          118 -KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       118 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~v  196 (234)
                       ......+++++++ +++|.+++...       .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.+
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence             1223457888887 77998877542       477888899999999999999999   99999999999999999999


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|||++........           ...|+..|+||
T Consensus       160 kl~dfg~~~~~~~~~~-----------~~~~~~~y~aP  186 (345)
T cd07877         160 KILDFGLARHTDDEMT-----------GYVATRWYRAP  186 (345)
T ss_pred             EEeccccccccccccc-----------ccccCCCccCH
Confidence            9999999875432110           14577778877

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.93  E-value=6e-25  Score=180.79  Aligned_cols=181  Identities=25%  Similarity=0.388  Sum_probs=138.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC---CC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS---KG  119 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~---~~  119 (234)
                      ..+|++.+.||+|+||.||+|.+..++..+|+|.+....  ......+.+|++++..++|+||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467999999999999999999999999999999986432  2223456789999999999999999887644322   12


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      ....++||||+++ ++...+.....     .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.++++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSV-----KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence            3456899999964 77777654322     588899999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCC---CCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASE---TPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aP  234 (234)
                      |||++.............   .........|++.|+||
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP  195 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCCh
Confidence            999998654432211100   00111124577888887

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.93  E-value=3.3e-25  Score=184.19  Aligned_cols=173  Identities=24%  Similarity=0.338  Sum_probs=140.6

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+....  ....+.+.+|++++..++|+|++++.+++......+....+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999998889999999986432  33446788999999999999999999987655433344579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||++ ++|.+++....      .+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++++|||++
T Consensus        81 lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             EEecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence            9999996 48988887544      678888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ............     .....++..|+||
T Consensus       151 ~~~~~~~~~~~~-----~~~~~~~~~y~aP  175 (330)
T cd07834         151 RGVDPDEDEKGF-----LTEYVVTRWYRAP  175 (330)
T ss_pred             Eeeccccccccc-----ccccccccCcCCc
Confidence            876554311000     0114577788887

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.93  E-value=5.4e-25  Score=183.59  Aligned_cols=174  Identities=28%  Similarity=0.412  Sum_probs=137.7

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ...+|+..+.||+|+||.||+|.+..++..+|+|.+...  .......+.+|+.++..+ +|+||+++++++...   +.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence            345788899999999999999999888999999988532  223335677899999999 999999999987432   23


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||++ ++|.+++...       .+.+.....++.|++.||.|||++   +++|+||+|+||+++.++.+|++|
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence            34689999996 5998888653       456777888999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++...........   ........||..|+||
T Consensus       151 ~g~~~~~~~~~~~~~---~~~~~~~~~~~~y~aP  181 (337)
T cd07852         151 FGLARSLSELEENPE---NPVLTDYVATRWYRAP  181 (337)
T ss_pred             ccchhcccccccccc---CcchhcccccccccCc
Confidence            999987654322110   0111124688889988

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.4e-26  Score=181.02  Aligned_cols=167  Identities=23%  Similarity=0.322  Sum_probs=139.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ++|+.+.+||+|+|++|.+++++.|.+.+|+|+++..   ......=.+.|-.+.... +||.++.+..+|     ++..
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qtes  324 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QTES  324 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----cccc
Confidence            5799999999999999999999999999999999732   222333345566667665 699999988876     4556


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .++.|.||++||+|.-.+....      .+++..+..+..+|+.||.|||++   |||.||||..|+|+|..|++|+.|+
T Consensus       325 rlffvieyv~ggdlmfhmqrqr------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdy  395 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY  395 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhh------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeeccc
Confidence            6899999999999988887665      789999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++.--.+.-        -.+++||||.|+||
T Consensus       396 gmcke~l~~gd--------~tstfcgtpnyiap  420 (593)
T KOG0695|consen  396 GMCKEGLGPGD--------TTSTFCGTPNYIAP  420 (593)
T ss_pred             chhhcCCCCCc--------ccccccCCCcccch
Confidence            99986322211        11239999999998

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.93  E-value=1e-24  Score=177.26  Aligned_cols=148  Identities=26%  Similarity=0.486  Sum_probs=126.9

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      |+..+.||.|++|.||+|.+..++..||+|.+....  ......+.+|++++..++|+|++++++++..     .+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence            567889999999999999999899999999987443  2233567889999999999999999998743     355799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      +|||++ ++|.+++......    .+++..+..++.|++.||.|+|++   +++|+||+|+||+++.++.++++|||++.
T Consensus        76 v~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPLT----GLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             EEeccC-cCHHHHHhhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            999995 6899988765421    578889999999999999999998   99999999999999999999999999987


Q ss_pred             ccC
Q 039258          206 FLS  208 (234)
Q Consensus       206 ~~~  208 (234)
                      ...
T Consensus       148 ~~~  150 (283)
T cd07835         148 AFG  150 (283)
T ss_pred             ccC
Confidence            653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=1.9e-24  Score=172.01  Aligned_cols=166  Identities=34%  Similarity=0.477  Sum_probs=139.7

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      +|+..+.||+|++|.||++.+..++..+++|.+..........+.+|++.+..++|+|++++++.+...     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence            477788999999999999999888999999999755444557889999999999999999999987543     346899


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      +||+++++|.+++.....     .+++..+..++.|++.++.++|++   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          76 MEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EecCCCCcHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence            999999999999876531     578888999999999999999998   999999999999999999999999999886


Q ss_pred             cCCCccCCCCCCCCccccccccccccCC
Q 039258          207 LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......         ....|+..|+||
T Consensus       148 ~~~~~~~---------~~~~~~~~~~~P  166 (253)
T cd05122         148 LSDTKAR---------NTMVGTPYWMAP  166 (253)
T ss_pred             ccccccc---------cceecCCcccCH
Confidence            6543210         014577778776

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1e-25  Score=189.23  Aligned_cols=170  Identities=20%  Similarity=0.296  Sum_probs=139.0

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEee--cccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN--LKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKG  119 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~  119 (234)
                      .....|++++.||+||.+.||++..... ..+|+|.+.  ..+.+....+..|+.+|.+++ |.+|++|+++-     -+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~  431 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VT  431 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----cc
Confidence            3345799999999999999999987544 456666554  235566788999999999996 89999999984     35


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      .+++|+||||- ..+|.+++......     .+...+..+..|++.++.++|..   ||||-||||.|+|+- .|.+||+
T Consensus       432 d~~lYmvmE~G-d~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLI  501 (677)
T KOG0596|consen  432 DGYLYMVMECG-DIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLI  501 (677)
T ss_pred             CceEEEEeecc-cccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEee
Confidence            67799999998 46999999887643     22237789999999999999999   999999999999985 4689999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+|.....+.+......      -+||+.||||
T Consensus       502 DFGIA~aI~~DTTsI~kds------QvGT~NYMsP  530 (677)
T KOG0596|consen  502 DFGIANAIQPDTTSIVKDS------QVGTVNYMSP  530 (677)
T ss_pred             eechhcccCccccceeecc------ccCcccccCH
Confidence            9999999888876654332      5799999998

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.93  E-value=1.2e-24  Score=176.72  Aligned_cols=165  Identities=24%  Similarity=0.334  Sum_probs=131.4

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCccee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      |++.+.||+|+||.||+|.+..++..+|+|.++... ........+|+..+.++. |+|++++++++...   ..+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            566788999999999999999899999999986432 222234457888898885 99999999987542   1245799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||++ +++.+++.....     .+++..+..++.|++.||.|+|++   +++|+||+|+||+++. +.+||+|||+++
T Consensus        78 v~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          78 VFELMD-MNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             EEecCC-ccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence            999996 588888876432     578889999999999999999999   9999999999999999 999999999998


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........         ...++..|+||
T Consensus       148 ~~~~~~~~~---------~~~~~~~y~aP  167 (282)
T cd07831         148 GIYSKPPYT---------EYISTRWYRAP  167 (282)
T ss_pred             ccccCCCcC---------CCCCCcccCCh
Confidence            654322111         13467778877

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.93  E-value=4.9e-25  Score=184.30  Aligned_cols=174  Identities=26%  Similarity=0.394  Sum_probs=136.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC------
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK------  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~------  118 (234)
                      ..+|+..+.||.|+||.||+|.+..++..||+|.+........+.+.+|++++..++|||++++++++......      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36789999999999999999999999999999999765555557788999999999999999998776432211      


Q ss_pred             ---CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC-CCC
Q 039258          119 ---GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDM  194 (234)
Q Consensus       119 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~-~~~  194 (234)
                         .....++||||++ ++|.+++...       .+++..+..++.|++.|+.|||+.   +++|+||||+||+++ .++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence               1134689999996 5888887542       477888999999999999999999   999999999999997 456


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .++++|||++...........  ..   ....|+..|+||
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~--~~---~~~~~~~~y~aP  187 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKG--YL---SEGLVTKWYRSP  187 (342)
T ss_pred             eEEECCcccceecCCcccccc--cc---ccccccccccCH
Confidence            789999999876533211110  00   013467778887

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.93  E-value=2e-24  Score=172.49  Aligned_cols=170  Identities=28%  Similarity=0.466  Sum_probs=140.6

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+..+.||+|++|.||+|.+..++..+++|++.....  ...+.+.+|++.+++++|+|++++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            47778899999999999999998999999999875432  34578899999999999999999999875331   24578


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +++|++++++|.+++....      .+++..+..++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||.+
T Consensus        78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence            9999999999999988654      678889999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........      .....++..|+||
T Consensus       149 ~~~~~~~~~~~------~~~~~~~~~y~~p  172 (260)
T cd06606         149 KRLGDIETGEG------TGSVRGTPYWMAP  172 (260)
T ss_pred             Eeccccccccc------ccCCCCCccccCH
Confidence            87665432100      0013477777776

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.93  E-value=1e-24  Score=181.38  Aligned_cols=150  Identities=23%  Similarity=0.319  Sum_probs=126.8

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ...++|+..+.||+|+||.||+|.+..++..+|+|.+...  .....+.+..|++++..++|||++++.+++...    .
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~   82 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----L   82 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----C
Confidence            3567899999999999999999999999999999988532  223346778899999999999999999987532    2


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...+++|||+ +++|.+++...       .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~d  151 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICD  151 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCc
Confidence            2368999998 56898887643       466677788999999999999999   999999999999999999999999


Q ss_pred             Ccccccc
Q 039258          201 FGLSKFL  207 (234)
Q Consensus       201 fG~a~~~  207 (234)
                      ||++...
T Consensus       152 fg~~~~~  158 (328)
T cd07856         152 FGLARIQ  158 (328)
T ss_pred             ccccccc
Confidence            9998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.93  E-value=1.2e-24  Score=181.39  Aligned_cols=148  Identities=22%  Similarity=0.429  Sum_probs=125.1

Q ss_pred             cCCC-CCceeecccceEEEEEEECCCCeEEEEEEeecccchh--------------hHHHHHHHHHHHhcCCCCceeEEE
Q 039258           46 CEFS-QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--------------FRSFVAECEALRNIRHRNLTKIIT  110 (234)
Q Consensus        46 ~~~~-~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~l~~  110 (234)
                      .+|. +.+.||+|+||.||+|.+..++..||+|.+.......              ...+.+|++++..++|+|++++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 4578999999999999999899999999986432111              125778999999999999999999


Q ss_pred             EeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee
Q 039258          111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL  190 (234)
Q Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~  190 (234)
                      ++..     .++.++||||++ ++|.+++....      .+++.....++.|++.|+.|||+.   +++|+||+|+||++
T Consensus        88 ~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill  152 (335)
T PTZ00024         88 VYVE-----GDFINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI  152 (335)
T ss_pred             EEec-----CCcEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence            8743     345799999996 59999887544      578889999999999999999998   99999999999999


Q ss_pred             CCCCceEEccCccccccC
Q 039258          191 DNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       191 ~~~~~vki~dfG~a~~~~  208 (234)
                      +.++.++++|||++....
T Consensus       153 ~~~~~~kl~dfg~~~~~~  170 (335)
T PTZ00024        153 NSKGICKIADFGLARRYG  170 (335)
T ss_pred             CCCCCEEECCccceeecc
Confidence            999999999999998765

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=1.5e-24  Score=175.16  Aligned_cols=169  Identities=25%  Similarity=0.459  Sum_probs=133.4

Q ss_pred             CCCCCceeecccceEEEEEEECC-CCeEEEEEEeeccc----------chhhHHHHHHHHHHHh-cCCCCceeEEEEeee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGE-DEMVVAVKVINLKQ----------KGAFRSFVAECEALRN-IRHRNLTKIITICSS  114 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~i~~l~~~~~~  114 (234)
                      +|++.+.||+|+||.||+|.+.. ++..+|+|.+....          ......+.+|+.++.+ ++|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888899999999999999987 67899999885321          1233557788888875 799999999998743


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~  193 (234)
                           .+..+++|||+++++|.+++......  ...+++..++.++.|++.|+.|+|+ .   +++|+||+|+||+++.+
T Consensus        81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~  150 (269)
T cd08528          81 -----NDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED  150 (269)
T ss_pred             -----CCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC
Confidence                 34579999999999999988542211  1157888899999999999999996 5   89999999999999999


Q ss_pred             CceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          194 MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       194 ~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.++++|||++.........         ....|+..|+||
T Consensus       151 ~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~~P  182 (269)
T cd08528         151 DKVTITDFGLAKQKQPESKL---------TSVVGTILYSCP  182 (269)
T ss_pred             CcEEEecccceeeccccccc---------ccccCcccCcCh
Confidence            99999999999865443211         014577788877

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.93  E-value=1.1e-24  Score=204.38  Aligned_cols=159  Identities=31%  Similarity=0.510  Sum_probs=127.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ...+...+.||+|+||.||+|.+..++..||+|.++.....    ...|++.+.+++||||++++++|...     +..+
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~  759 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE-----KGAY  759 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC-----CCCE
Confidence            34677788999999999999999889999999988643221    13468889999999999999998543     3368


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++.         .+++..+..++.|++.|++|+|..+..+++|||+||+||+++.++.+++. ||.+
T Consensus       760 lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~  829 (968)
T PLN00113        760 LIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP  829 (968)
T ss_pred             EEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence            9999999999999985         36678889999999999999995545599999999999999988887775 5554


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......            ...||+.||||
T Consensus       830 ~~~~~~~------------~~~~t~~y~aP  847 (968)
T PLN00113        830 GLLCTDT------------KCFISSAYVAP  847 (968)
T ss_pred             cccccCC------------CccccccccCc
Confidence            4322110            13578899998

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.7e-24  Score=173.99  Aligned_cols=157  Identities=27%  Similarity=0.386  Sum_probs=125.5

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHH-hcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALR-NIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+..+++.+|+|.+....   ......+..|..++. ..+|+|++++++.+..     .+..++||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence            46899999999999999899999999986432   112233455555444 4589999999998753     33479999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++....      .+++.++..++.|++.||.|+|+.   +++|+||+|+||+++.++.++++|||++...
T Consensus        77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            9999999999997654      577888899999999999999999   9999999999999999999999999998754


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ....            ...|+..|+||
T Consensus       148 ~~~~------------~~~~~~~y~~p  162 (260)
T cd05611         148 LENK------------KFVGTPDYLAP  162 (260)
T ss_pred             cccc------------cCCCCcCccCh
Confidence            3211            13466777776

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.93  E-value=2.8e-24  Score=174.80  Aligned_cols=170  Identities=26%  Similarity=0.448  Sum_probs=134.0

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhc---CCCCceeEEEEeeecCCCCCCc
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      |++.+.||+|+||.||+|.++.++..+|+|.++...  ......+.+|+.++..+   +|+|++++++++...+..+...
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999998889999999997432  22234566777777655   5999999999987655433344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .+++|||+. ++|.+++......    .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKP----GLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence            789999996 4899888764321    578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++..........         ...++..|+||
T Consensus       153 ~~~~~~~~~~~~---------~~~~~~~~~~P  175 (287)
T cd07838         153 LARIYSFEMALT---------SVVVTLWYRAP  175 (287)
T ss_pred             cceeccCCcccc---------cccccccccCh
Confidence            988764432111         13466777776

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=1e-26  Score=198.79  Aligned_cols=168  Identities=30%  Similarity=0.448  Sum_probs=146.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|.....+|+|+||.||+++++.+++..|+|+++.......+-..+|+-+++..+||||+.+++.+-..+     .+|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcE
Confidence            457888999999999999999999999999999999776666677889999999999999999999774433     379


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      |+||||.+|+|++.=...+      .+++.++...+++.+.|+.|+|++   +-+|||||-.||+++..|.+|++|||.+
T Consensus        89 icMEycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs  159 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS  159 (829)
T ss_pred             EEEEecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence            9999999999998755444      788899999999999999999999   8899999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..+...-.+...        +.||+.||||
T Consensus       160 aqitati~Krks--------fiGtpywmap  181 (829)
T KOG0576|consen  160 AQITATIAKRKS--------FIGTPYWMAP  181 (829)
T ss_pred             hhhhhhhhhhhc--------ccCCccccch
Confidence            877664443332        7899999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-25  Score=167.00  Aligned_cols=174  Identities=22%  Similarity=0.314  Sum_probs=136.3

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCC
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~  119 (234)
                      +....+......||+|++|.|-+.++..+|...|+|.++.. ..+..++.+.|+++.... .-|.++.++|.......  
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd--  119 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD--  119 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc--
Confidence            33334455567899999999999999999999999999744 233446788888877654 68999999997643322  


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                         .||.||.|+. ||..+-.+.....  ...++.-.-.++..+..||.|||++.  .+||||+||+|||++..|++|+|
T Consensus       120 ---vwIcME~M~t-Sldkfy~~v~~~g--~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiC  191 (282)
T KOG0984|consen  120 ---VWICMELMDT-SLDKFYRKVLKKG--GTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKIC  191 (282)
T ss_pred             ---EEEeHHHhhh-hHHHHHHHHHhcC--CcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEc
Confidence               6899999954 8877654422111  15677777889999999999999975  89999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++..+.++.....         ..|...||||
T Consensus       192 DFGIsG~L~dSiAkt~---------daGCkpYmaP  217 (282)
T KOG0984|consen  192 DFGISGYLVDSIAKTM---------DAGCKPYMAP  217 (282)
T ss_pred             ccccceeehhhhHHHH---------hcCCCccCCh
Confidence            9999998887654443         3488899998

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=9.8e-26  Score=196.63  Aligned_cols=151  Identities=28%  Similarity=0.507  Sum_probs=130.7

Q ss_pred             CCCCceeecccceEEEEEEECCCC----eEEEEEEeec-ccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDE----MVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ....++||+|+||+||+|.+...+    .+||+|++.. ...+....+++|+-.|.++.|||+++|+++|....      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            455789999999999999986444    6899999863 34455688999999999999999999999986433      


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +.||++|+++|+|.++++.+..     .+-....+.+..||++||.|||++   ++|||||..+|+||.....+||.|||
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg  843 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG  843 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence            5799999999999999998765     455567789999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCcc
Q 039258          203 LSKFLSSDHL  212 (234)
Q Consensus       203 ~a~~~~~~~~  212 (234)
                      +++.+..+..
T Consensus       844 la~ll~~d~~  853 (1177)
T KOG1025|consen  844 LAKLLAPDEK  853 (1177)
T ss_pred             hhhccCcccc
Confidence            9998876643

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.92  E-value=1.4e-24  Score=177.14  Aligned_cols=167  Identities=25%  Similarity=0.351  Sum_probs=133.2

Q ss_pred             CCCCCceeecccceEEEEEEEC---CCCeEEEEEEeeccc----chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILG---EDEMVVAVKVINLKQ----KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSK  118 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~  118 (234)
                      +|++.+.||+|+||.||++...   .++..+|+|+++...    ......+..|+.++..+ +|+|++++.+.+..    
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~----   76 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT----   76 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence            4777889999999999999864   456889999986321    22335678899999999 59999999887633    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                       ....++||||+++++|.+++....      .+++..+..++.|++.+|.|||+.   +++|+||+|+||+++.++.+++
T Consensus        77 -~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l  146 (288)
T cd05583          77 -DTKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL  146 (288)
T ss_pred             -CCEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence             344789999999999999987643      577788889999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++..........       ....|+..|+||
T Consensus       147 ~dfg~~~~~~~~~~~~~-------~~~~~~~~y~aP  175 (288)
T cd05583         147 TDFGLSKEFLAEEEERA-------YSFCGTIEYMAP  175 (288)
T ss_pred             EECcccccccccccccc-------ccccCCccccCH
Confidence            99999876543321110       114577778876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.92  E-value=5.6e-24  Score=175.80  Aligned_cols=161  Identities=29%  Similarity=0.420  Sum_probs=131.8

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      |...+.||+|+||.||+|.+..++..+++|.+....   ......+..|++++..++|||++++++++...     ...+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence            555678999999999999999899999999986432   22335688899999999999999999987543     3468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+. +++.+++.....     .+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++++|||++
T Consensus        98 lv~e~~~-~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence            9999995 588887765432     577888899999999999999999   9999999999999999999999999987


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......            ...|+..|+||
T Consensus       169 ~~~~~~~------------~~~~~~~y~aP  186 (313)
T cd06633         169 SKSSPAN------------SFVGTPYWMAP  186 (313)
T ss_pred             cccCCCC------------CccccccccCh
Confidence            6432110            14577778887

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=2e-24  Score=175.57  Aligned_cols=165  Identities=27%  Similarity=0.401  Sum_probs=133.3

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCccee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      |++.+.||+|+||.||+|....++..+++|.+..... .......+|+..+.+++ |+|++++++++..     .+..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            5677899999999999999988899999999864322 12234567899999998 9999999998754     345799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+ +++|.+++......    .+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++++|||++.
T Consensus        76 v~e~~-~~~l~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKGK----PFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             EEecC-CCCHHHHHHhcccc----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence            99999 77999988765311    578889999999999999999999   99999999999999999999999999988


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........         ...|+..|+||
T Consensus       148 ~~~~~~~~~---------~~~~~~~~~aP  167 (283)
T cd07830         148 EIRSRPPYT---------DYVSTRWYRAP  167 (283)
T ss_pred             eccCCCCcC---------CCCCcccccCc
Confidence            654432111         13467777776

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.92  E-value=2.7e-24  Score=178.78  Aligned_cols=142  Identities=22%  Similarity=0.324  Sum_probs=120.7

Q ss_pred             eeecc--cceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           53 MIGQG--SYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        53 ~lG~G--~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      .||+|  +||+||++.+..+++.||+|++....  ....+.+.+|+.++..++||||+++++++..     .++.++|||
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~e   79 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVISP   79 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEEe
Confidence            46666  99999999999999999999987432  2334678889999999999999999999853     344799999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      |+.++++.+++......    .+++..+..++.|++.||+|+|++   +++||||||+||+++.++.++++||+.+..
T Consensus        80 ~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          80 FMAYGSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             cccCCCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            99999999998765322    577888889999999999999998   999999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.92  E-value=3.4e-24  Score=176.68  Aligned_cols=162  Identities=28%  Similarity=0.445  Sum_probs=132.7

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .|+..+.||+|+||.||+|.+..++..+|+|.+...   ......++.+|++++..++|+|++++.+++...     ...
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Cee
Confidence            467778899999999999999988999999998632   223345688899999999999999999987543     346


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+. +++.+++.....     .+++..+..++.|++.|+.|+|++   +++|+||+|+||+++.++.++++|||+
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  161 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS  161 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccc
Confidence            89999996 588887764432     467888899999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.......            ...|++.|+||
T Consensus       162 ~~~~~~~~------------~~~~~~~y~aP  180 (308)
T cd06634         162 ASIMAPAN------------XFVGTPYWMAP  180 (308)
T ss_pred             ceeecCcc------------cccCCccccCH
Confidence            87644321            13467777776

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=3.5e-24  Score=179.17  Aligned_cols=167  Identities=24%  Similarity=0.364  Sum_probs=133.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC-CCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK-GAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~-~~~  121 (234)
                      ..+|...+.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.++..++|+|++++++++...... ...
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            36788899999999999999999889999999998632  222335678999999999999999999987543321 123


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+. .+|..+...        .+++..+..++.|++.|+.|+|+.   +++||||+|+||+++.++.++++||
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMGH--------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             eEEEEecccc-cCHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence            3589999995 477665421        467788889999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++.......           ...|++.|+||
T Consensus       162 g~~~~~~~~~~-----------~~~~~~~y~aP  183 (342)
T cd07879         162 GLARHADAEMT-----------GYVVTRWYRAP  183 (342)
T ss_pred             CCCcCCCCCCC-----------CceeeecccCh
Confidence            99875432110           14577788887

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.2e-24  Score=171.73  Aligned_cols=171  Identities=23%  Similarity=0.374  Sum_probs=142.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      -.|.++++||+|.||+++.|.+.-+++.||||....+++  ..++..|....+.|. -++|...+-+     ...+.+..
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence            469999999999999999999998999999999864443  367788999998885 4677766543     23455668


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-----CCceEEc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-----DMVAHVG  199 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-----~~~vki~  199 (234)
                      +|||++ |.||.+++.-+++     +|+...+..++.|++.-++|+|++   .+|.|||||+|+|+..     ...+.++
T Consensus       101 LVidLL-GPSLEDLFD~CgR-----~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii  171 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGR-----RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII  171 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcC-----cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence            999999 8899999988875     799999999999999999999999   9999999999999953     2458899


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA  233 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  233 (234)
                      |||+|+.+.+..+.......+.++ +.||.+|||
T Consensus       172 DFGmAK~YrDp~TkqHIPYrE~KS-LsGTARYMS  204 (449)
T KOG1165|consen  172 DFGMAKEYRDPKTKQHIPYREHKS-LSGTARYMS  204 (449)
T ss_pred             eccchhhhcCccccccCccccccc-cccceeeeE
Confidence            999999999888777655544443 779999997

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.92  E-value=5e-25  Score=171.31  Aligned_cols=166  Identities=21%  Similarity=0.341  Sum_probs=134.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +.+.+..||.|+-|.|++++.+.++...|||.+... .....++++..++++.+-+ -|.||+.+|+|....+     .+
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-----V~  167 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-----VF  167 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-----HH
Confidence            344567899999999999999999999999999643 4556678888999887775 7999999999865433     58


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      |.||.|. ..+..++..-..     ++++.-+-.+..-++.||.||.++  ++|+|||+||+|||+|..|++|+||||++
T Consensus       168 IcMelMs-~C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIs  239 (391)
T KOG0983|consen  168 ICMELMS-TCAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGIS  239 (391)
T ss_pred             HHHHHHH-HHHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeeccccc
Confidence            9999994 356666654332     566666667777899999999986  49999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..+.+......         ..|.+.||||
T Consensus       240 GrlvdSkAhtr---------sAGC~~YMaP  260 (391)
T KOG0983|consen  240 GRLVDSKAHTR---------SAGCAAYMAP  260 (391)
T ss_pred             ceeeccccccc---------ccCCccccCc
Confidence            88777654432         4599999998

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.92  E-value=2.2e-24  Score=175.90  Aligned_cols=170  Identities=23%  Similarity=0.304  Sum_probs=129.6

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|+....||+|+||.||++.+..++..+|+|.+.... ......+.+|+.++.++. |+|++++++++...     ...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence            4556678999999999999999999999999986432 233457888999999996 99999999987532     3358


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++|||+. +++.++....... ....+++..+..++.|++.|++|+|+..  +++||||+|+||+++.++.++++|||++
T Consensus        80 ~~~e~~~-~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          80 ICMELMD-ISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             EEEeccc-CCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchh
Confidence            9999985 4665543221000 0015788889999999999999999632  8999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........         ...|+..|+||
T Consensus       156 ~~~~~~~~~~---------~~~~~~~y~aP  176 (288)
T cd06616         156 GQLVDSIAKT---------RDAGCRPYMAP  176 (288)
T ss_pred             HHhccCCccc---------cccCccCccCH
Confidence            7654432111         13467778877

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.92  E-value=1.4e-24  Score=181.63  Aligned_cols=169  Identities=22%  Similarity=0.349  Sum_probs=136.7

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~  120 (234)
                      ..++|+..+.||+|+||.||+|.+..++..||+|.+...  .......+.+|+.+++.++|+|++++.+++...+. ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            456799999999999999999999999999999998642  22233567789999999999999998886643322 222


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++|+||+ +++|.+++...       .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence            3468999999 66999988652       578888999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++........           ...++..|+||
T Consensus       162 fg~~~~~~~~~~-----------~~~~~~~y~aP  184 (343)
T cd07851         162 FGLARHTDDEMT-----------GYVATRWYRAP  184 (343)
T ss_pred             cccccccccccc-----------CCcccccccCH
Confidence            999886543211           13467778776

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.92  E-value=2.8e-24  Score=171.92  Aligned_cols=168  Identities=27%  Similarity=0.408  Sum_probs=136.9

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +|++.+.||+|+||.||++.+..++..+++|.+...  .......+.+|+++++.++|+|++++.+.+..     ....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            477888999999999999999889999999998643  22334567889999999999999999887643     24579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++......  ...+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.+|++|||++
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~  150 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS  150 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence            999999999999998763211  11577888899999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........          ..|++.|+||
T Consensus       151 ~~~~~~~~~~----------~~~~~~~~~P  170 (256)
T cd08530         151 KVLKKNMAKT----------QIGTPHYMAP  170 (256)
T ss_pred             hhhccCCccc----------ccCCccccCH
Confidence            8765531111          2366677766

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=7.3e-24  Score=173.63  Aligned_cols=151  Identities=23%  Similarity=0.324  Sum_probs=123.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|+..+.||+|+||.||+|.+..++..+|+|.++... ......+..|+.++.... |+|++++++++...     ..
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----SD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-----Ce
Confidence            356888999999999999999999889999999997432 223355677887776664 99999999987542     34


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+++|||+. +++.+++.....     .+++..+..++.|++.|+.|+|+ .   +++|+||+|+||+++.++.+||+||
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~df  159 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDF  159 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECcc
Confidence            699999985 477777665332     57788888999999999999997 5   8999999999999999999999999


Q ss_pred             ccccccCC
Q 039258          202 GLSKFLSS  209 (234)
Q Consensus       202 G~a~~~~~  209 (234)
                      |++.....
T Consensus       160 g~~~~~~~  167 (296)
T cd06618         160 GISGRLVD  167 (296)
T ss_pred             ccchhccC
Confidence            99876543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.92  E-value=5.5e-24  Score=184.35  Aligned_cols=181  Identities=19%  Similarity=0.273  Sum_probs=127.0

Q ss_pred             HhcCCCCCceeecccceEEEEEEEC----------------CCCeEEEEEEeecccchhhH--------------HHHHH
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILG----------------EDEMVVAVKVINLKQKGAFR--------------SFVAE   93 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~----------------~~~~~vavK~~~~~~~~~~~--------------~~~~e   93 (234)
                      ...+|.+.++||+|+||.||+|...                ..++.||||.+........+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3568999999999999999999752                23467999998643322222              23446


Q ss_pred             HHHHHhcCCCCc-----eeEEEEeeecCCC---CCCcceeeEeecCCCCHHHHhhhccCC------------------cc
Q 039258           94 CEALRNIRHRNL-----TKIITICSSIDSK---GADFKALVFEYMENGSLEDWLHQTNDH------------------LE  147 (234)
Q Consensus        94 ~~~l~~l~h~~i-----~~l~~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~  147 (234)
                      +..+.+++|.++     +.++++|......   .....++||||+++++|.+++......                  ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766544     5667766432111   123468999999999999998643210                  00


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccc
Q 039258          148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG  227 (234)
Q Consensus       148 ~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~g  227 (234)
                      ...+.+..+..++.|++.+|.|+|++   +++||||||+||+++.++.+||+|||++...........       ....+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-------~~g~~  372 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-------LYGML  372 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-------cccCC
Confidence            11234567788999999999999999   999999999999999999999999999875433211110       00234


Q ss_pred             cccccCC
Q 039258          228 TVGYVAP  234 (234)
Q Consensus       228 t~~y~aP  234 (234)
                      |+.|+||
T Consensus       373 tp~Y~aP  379 (507)
T PLN03224        373 DPRYSPP  379 (507)
T ss_pred             CcceeCh
Confidence            7888887

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.92  E-value=5.8e-24  Score=172.60  Aligned_cols=165  Identities=26%  Similarity=0.424  Sum_probs=134.8

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      |+..+.||+|++|.||+|.+..++..+++|.++...  ......+.+|++++..++|+|++++++.+..     ....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence            566788999999999999998899999999986442  2344678889999999999999999998743     244789


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ++||+++ ++.+++.....     .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+.
T Consensus        76 v~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQR-----GLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             EEeccCC-CHHHHHHhhcc-----cCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            9999975 89888876432     578889999999999999999999   99999999999999999999999999988


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ...++..|+||
T Consensus       147 ~~~~~~~~~~--------~~~~~~~~~~P  167 (283)
T cd05118         147 SFGSPVRPYT--------HYVVTRWYRAP  167 (283)
T ss_pred             ecCCCccccc--------CccCcccccCc
Confidence            7655431100        12366677776

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=4.9e-24  Score=172.96  Aligned_cols=148  Identities=28%  Similarity=0.507  Sum_probs=127.7

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      |+..+.||+|+||.||+|....++..+|+|.+....  ....+.+..|+.+++.++|+|++++++++...     ...++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence            556778999999999999999999999999997542  33446778899999999999999999987432     45799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      |||+++ ++|.+++.....     .+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++.
T Consensus        76 v~e~~~-~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRPG-----PLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             EecCcC-cCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence            999997 599999987531     578889999999999999999999   99999999999999999999999999988


Q ss_pred             ccCC
Q 039258          206 FLSS  209 (234)
Q Consensus       206 ~~~~  209 (234)
                      ....
T Consensus       147 ~~~~  150 (282)
T cd07829         147 AFGI  150 (282)
T ss_pred             ccCC
Confidence            6543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.92  E-value=2.2e-24  Score=190.43  Aligned_cols=177  Identities=20%  Similarity=0.230  Sum_probs=117.8

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCC----CeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeee-cCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGED----EMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSS-IDSK  118 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~-~~~~  118 (234)
                      ...+|...+.||+|+||.||+|.+..+    +..||+|.+......  +....|  .+....+.++..+...+.. ....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            456799999999999999999999888    899999987532211  111111  1111112222222111111 1113


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCc--------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHL--------------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIK  184 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk  184 (234)
                      +....++||||+.+++|.+++.......              .........+..++.|++.||.|+|++   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            3455789999999999999987542100              000112234567899999999999999   99999999


Q ss_pred             CCCeeeCC-CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          185 PSNVLLDN-DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       185 ~~nil~~~-~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||++. ++.+||+|||+|+.+........       ..+.||+.||||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~-------~~~~~t~~Y~AP  326 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIP-------KEFLLDPRYAAP  326 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCC-------cccccCCCccCh
Confidence            99999985 67999999999986543222111       126789999998

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.91  E-value=8e-24  Score=168.77  Aligned_cols=159  Identities=31%  Similarity=0.424  Sum_probs=131.1

Q ss_pred             eecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           54 IGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        54 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      ||+|+||.||++.+..++..+|+|++....   ......+..|++++..++|+|++++++.+.     .....+++||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence            689999999999998889999999986432   223457888999999999999999988763     344579999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~  210 (234)
                      ++++|.+++....      .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            9999999997654      577888899999999999999998   9999999999999999999999999998765443


Q ss_pred             ccCCCCCCCCccccccccccccCC
Q 039258          211 HLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       211 ~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ....        ....|+..|+||
T Consensus       147 ~~~~--------~~~~~~~~~~~P  162 (250)
T cd05123         147 GSRT--------NTFCGTPEYLAP  162 (250)
T ss_pred             CCcc--------cCCcCCccccCh
Confidence            1100        114567778776

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.8e-24  Score=163.75  Aligned_cols=172  Identities=26%  Similarity=0.382  Sum_probs=139.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCC-CCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH-RNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+.|.+.+.||+|+||.+|+|....+|..||||+.....+  ..++..|..+...+++ ..|..+..+.     ....+.
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~yn   86 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYN   86 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhc-----cccccc
Confidence            4578999999999999999999999999999999864332  3567889999999975 4555555443     334556


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC---CCCceEEcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGD  200 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~---~~~~vki~d  200 (234)
                      .+||+.+ |++|.+++.-+.+     .++...++.++-|++.-++|+|.+   +.|||||||+|+|..   ....+.++|
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence            8999999 8899999987764     688899999999999999999999   999999999999995   456789999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA  233 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  233 (234)
                      ||+|+.+.+..+.......+.. .+.||..|.|
T Consensus       158 FGLaKky~d~~t~~HIpyre~r-~ltGTaRYAS  189 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDR-NLTGTARYAS  189 (341)
T ss_pred             ccchhhhccccccccCccccCC-ccceeeeehh
Confidence            9999988776665544333332 3779998875

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.91  E-value=1e-23  Score=174.04  Aligned_cols=139  Identities=25%  Similarity=0.268  Sum_probs=116.7

Q ss_pred             cceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecCCCCH
Q 039258           58 SYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSL  135 (234)
Q Consensus        58 ~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L  135 (234)
                      ++|.|+.++...++..||+|.+...  .......+.+|++++..++|+||+++++++..     .+..+++|||+++++|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEeccCCCCH
Confidence            4455666666678999999999744  33445678999999999999999999998743     3446999999999999


Q ss_pred             HHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          136 EDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       136 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      .+++......    .+++..+..++.|++.||.|||++   +|+|+||+|+||+++.++.+|++|||.+....
T Consensus        87 ~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          87 EDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeec
Confidence            9999865322    577888899999999999999999   99999999999999999999999999887654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-24  Score=175.98  Aligned_cols=169  Identities=24%  Similarity=0.337  Sum_probs=136.5

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-C-CC----ceeEEEEeee
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-H-RN----LTKIITICSS  114 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~~----i~~l~~~~~~  114 (234)
                      -.....+|.+.+.+|+|+||+|.+|.+..++..||+|+++.-. ...++.+-|++++.++. + |+    ++++.+++  
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--  160 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--  160 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--
Confidence            3445778999999999999999999999999999999997332 23466778999999984 2 22    56666665  


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC--
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN--  192 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~--  192 (234)
                         +-.++.+||+|.+ |.|+++++.+++..    +++...+..++.|++.++.|||+.   +++|.||||+|||+.+  
T Consensus       161 ---dyrghiCivfell-G~S~~dFlk~N~y~----~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  161 ---DYRGHICIVFELL-GLSTFDFLKENNYI----PFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSE  229 (415)
T ss_pred             ---hccCceEEEEecc-ChhHHHHhccCCcc----ccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccc
Confidence               3345689999999 77999999987643    788899999999999999999999   9999999999999832  


Q ss_pred             ------------------CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 ------------------DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ------------------~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                                        +..|+++|||.|..-...++           ..+.|..|.||
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----------~iVsTRHYRAP  278 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----------TIVSTRHYRAP  278 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----------eeeeccccCCc
Confidence                              12589999999997655442           26788899988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=3.5e-24  Score=164.47  Aligned_cols=140  Identities=17%  Similarity=0.160  Sum_probs=105.6

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccch--h-------h-----------------HHHHHHHHHHHhcCCCC
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG--A-------F-----------------RSFVAECEALRNIRHRN  104 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~~  104 (234)
                      ...||+|+||.||+|.+. +|+.||+|+++.....  .       .                 .....|+..+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            357999999999999986 8999999999743211  0       0                 12234899999998776


Q ss_pred             ceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCC
Q 039258          105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDI  183 (234)
Q Consensus       105 i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-h~~~~~~ivH~dl  183 (234)
                      +.......  ..    . .++||||++++++........      .++...+..++.|++.++.++ |+.   +++||||
T Consensus        81 v~~p~~~~--~~----~-~~iVmE~i~g~~l~~~~~~~~------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl  144 (190)
T cd05147          81 IPCPEPIL--LK----S-HVLVMEFIGDDGWAAPRLKDA------PLSESKARELYLQVIQIMRILYQDC---RLVHADL  144 (190)
T ss_pred             CCCCcEEE--ec----C-CEEEEEEeCCCCCcchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            54332221  01    1 279999998876655433222      577788999999999999999 688   9999999


Q ss_pred             CCCCeeeCCCCceEEccCccccccC
Q 039258          184 KPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       184 k~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      ||+||+++ ++.++++|||+|....
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccCC
Confidence            99999998 4789999999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.91  E-value=7.9e-24  Score=170.05  Aligned_cols=169  Identities=24%  Similarity=0.336  Sum_probs=130.6

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-----cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      +|.+.+.||+|+||.||++.+..++..+++|+++..     .......+..|+.+++.++|||++++++.+..     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence            477889999999999999999877766777776521     12233456778999999999999999987643     23


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++.......  ..+++..++.++.|++.|+.|+|+.   +++|+||+|+|++++. +.++++||
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~  149 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTG--KTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF  149 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence            4689999999999999886532111  1578889999999999999999999   9999999999999975 56999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........        ....|++.|+||
T Consensus       150 g~~~~~~~~~~~~--------~~~~~~~~~~~p  174 (260)
T cd08222         150 GVSRLLMGSCDLA--------TTFTGTPYYMSP  174 (260)
T ss_pred             CceeecCCCcccc--------cCCCCCcCccCH
Confidence            9987654322111        014477778776

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.91  E-value=5.5e-25  Score=167.22  Aligned_cols=151  Identities=25%  Similarity=0.447  Sum_probs=128.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.+|+|.|+.|+.|....+.+.++||+++.-.+   +.+.+|+.+|..+. ||||++++++...+.+.+   .
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt---p  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKT---P  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccC---c
Confidence            3468889999999999999999988999999999974432   56779999999997 999999999987665543   4


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC-CCCceEEccCc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFG  202 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~-~~~~vki~dfG  202 (234)
                      .+++||+.+.+...+-.         .++..++..++.+++.||.|+|++   ||+|||+||.|+++| ....++++|+|
T Consensus       111 aLiFE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             hhHhhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence            78999998877766543         567778899999999999999999   999999999999998 45679999999


Q ss_pred             cccccCCCccC
Q 039258          203 LSKFLSSDHLD  213 (234)
Q Consensus       203 ~a~~~~~~~~~  213 (234)
                      +|.++.+....
T Consensus       179 LAEFYHp~~eY  189 (338)
T KOG0668|consen  179 LAEFYHPGKEY  189 (338)
T ss_pred             hHhhcCCCcee
Confidence            99999876543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=2.6e-23  Score=159.96  Aligned_cols=141  Identities=20%  Similarity=0.213  Sum_probs=108.3

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccch---------------------h-----hHHHHHHHHHHHhcCCCC
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---------------------A-----FRSFVAECEALRNIRHRN  104 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~~  104 (234)
                      ...||+|+||.||+|.+. +|+.||||+++.....                     .     ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 8999999999743211                     0     112357889999999888


Q ss_pred             ceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCC
Q 039258          105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDI  183 (234)
Q Consensus       105 i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dl  183 (234)
                      +.....+...  .     .++||||++++++........      .++......++.|++.++.++|+ +   +++||||
T Consensus        81 i~~p~~~~~~--~-----~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDl  144 (190)
T cd05145          81 VPVPEPILLK--K-----NVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDL  144 (190)
T ss_pred             CCCceEEEec--C-----CEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence            7443333211  1     379999998875543322222      45677888999999999999999 8   9999999


Q ss_pred             CCCCeeeCCCCceEEccCccccccCC
Q 039258          184 KPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       184 k~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      ||+||+++ ++.++++|||++.....
T Consensus       145 kP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         145 SEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             ChhhEEEE-CCCEEEEEcccceecCC
Confidence            99999998 78999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.91  E-value=1.9e-23  Score=165.95  Aligned_cols=133  Identities=18%  Similarity=0.166  Sum_probs=112.3

Q ss_pred             ccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecCCCCHH
Q 039258           57 GSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLE  136 (234)
Q Consensus        57 G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~  136 (234)
                      |.||.||++.+..+++.+|+|.+.....     ..+|...+....|||++++++.+..     .+..+++|||+++++|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCCHH
Confidence            8999999999999999999999864421     2234444555679999999988643     34579999999999999


Q ss_pred             HHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          137 DWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       137 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      +++....      .+++..+..++.|++.|+.|+|++   +++|+||||+||+++.++.++++|||.+....
T Consensus        74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~  136 (237)
T cd05576          74 SHISKFL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE  136 (237)
T ss_pred             HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence            9987654      578889999999999999999998   99999999999999999999999999876543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-25  Score=173.65  Aligned_cols=169  Identities=24%  Similarity=0.345  Sum_probs=128.3

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCccee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+.+..||.|+||+|++..++.+|+..|||.+.... ....++++.|.+...+- +-|||++++|+++....     -||
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cWi  140 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CWI  140 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----eee
Confidence            344668999999999999999999999999997543 34557888898876655 67999999998864332     589


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      .||.|+ .||..+-..-.. ......++.-.-.+..-...||+||....  .|||||+||+|||++..|.+|+||||++.
T Consensus       141 CMELMd-~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcG  216 (361)
T KOG1006|consen  141 CMELMD-ISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICG  216 (361)
T ss_pred             eHHHHh-hhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchH
Confidence            999995 476654321100 00114555555556666788999998763  89999999999999999999999999999


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.++-....         -.|...||||
T Consensus       217 qLv~SiAkT~---------daGCrpYmAP  236 (361)
T KOG1006|consen  217 QLVDSIAKTV---------DAGCRPYMAP  236 (361)
T ss_pred             hHHHHHHhhh---------ccCCccccCh
Confidence            8776543332         4589999998

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-25  Score=174.10  Aligned_cols=171  Identities=21%  Similarity=0.319  Sum_probs=133.2

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeec--ccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +.+..+.||-|+||+||.+.+..+|+.||+|.+..  ..-...+++.+|+.+|..++|.|+...+++..-....--.-+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            45557789999999999999999999999998752  2333457889999999999999998887765321111111257


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +++|.+.. +|..++....      .++...+.-+..||+.|+.|||+.   +|.||||||.|.|++.+...||||||+|
T Consensus       134 V~TELmQS-DLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA  203 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA  203 (449)
T ss_pred             HHHHHHHh-hhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence            88898854 8888877654      677788888999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.-..+.......       -+.|..|.||
T Consensus       204 Rvee~d~~~hMTq-------EVVTQYYRAP  226 (449)
T KOG0664|consen  204 RTWDQRDRLNMTH-------EVVTQYYRAP  226 (449)
T ss_pred             cccchhhhhhhHH-------HHHHHHhccH
Confidence            9765544332211       2456667666

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=6.6e-24  Score=182.65  Aligned_cols=149  Identities=26%  Similarity=0.456  Sum_probs=126.3

Q ss_pred             CCCceeecccceEEEEEEECCC---CeEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           49 SQSNMIGQGSYGSVYKGILGED---EMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      +..++||+|.||+|++|.|...   ...||||++...... ....|++|+..|.+|+|+|+++|+|+.-.      ....
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~m  186 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPAM  186 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chhh
Confidence            3456799999999999998742   368999999865443 66899999999999999999999998632      2357


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +|||+++.|+|.+.+......    .+.......++.||+.|+.||.++   +.|||||..+|+|+.....|||+|||+.
T Consensus       187 MV~ELaplGSLldrLrka~~~----~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKA----ILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             HHhhhcccchHHHHHhhcccc----ceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccce
Confidence            999999999999999873222    455666778999999999999999   9999999999999999999999999999


Q ss_pred             cccCCC
Q 039258          205 KFLSSD  210 (234)
Q Consensus       205 ~~~~~~  210 (234)
                      +-+...
T Consensus       260 RaLg~n  265 (1039)
T KOG0199|consen  260 RALGEN  265 (1039)
T ss_pred             eccCCC
Confidence            987653

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.6e-25  Score=184.52  Aligned_cols=165  Identities=23%  Similarity=0.341  Sum_probs=139.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +++....||-|+||.|-++........+|+|+++..   +....+....|-.+|...+.|.|++++..|     .+..++
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyv  495 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYV  495 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhh
Confidence            455677899999999999887665556899998643   222335677899999999999999999876     456678


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      |+.||-|-||.|...++.++      .|....+..++..+++|++|||++   +||.|||||+|++++.+|-+|+.|||+
T Consensus       496 YmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGF  566 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGF  566 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhh
Confidence            99999999999999999987      566777888999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+.+.......         ++||||.|.||
T Consensus       567 AKki~~g~KTw---------TFcGTpEYVAP  588 (732)
T KOG0614|consen  567 AKKIGSGRKTW---------TFCGTPEYVAP  588 (732)
T ss_pred             HHHhccCCcee---------eecCCcccccc
Confidence            99877643222         39999999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.89  E-value=6.2e-22  Score=155.01  Aligned_cols=150  Identities=32%  Similarity=0.534  Sum_probs=129.6

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceee
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      |...+.||+|++|.||++....++..+++|.+...... ..+.+.+|++.+..++|+|++++++.+...     ...+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence            55678899999999999999888899999999755443 557888999999999999999999986432     346899


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      +|++++++|.+++.....     .+++.....++.+++.++.++|+.   +++|+|+++.|++++.++.++++|||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             EeccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            999999999999886541     167788899999999999999998   999999999999999999999999999987


Q ss_pred             cCCC
Q 039258          207 LSSD  210 (234)
Q Consensus       207 ~~~~  210 (234)
                      ....
T Consensus       148 ~~~~  151 (225)
T smart00221      148 IHRD  151 (225)
T ss_pred             ecCc
Confidence            6554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-22  Score=168.27  Aligned_cols=139  Identities=22%  Similarity=0.401  Sum_probs=120.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-----C---CCceeEEEEeeecCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-----H---RNLTKIITICSSIDS  117 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~l~~~~~~~~~  117 (234)
                      .+|.+.++||+|.|++||+|++..+++.||+|+.+.. ....+..+.|+.+|..++     |   ..||+|++.|.....
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            6888899999999999999999999999999999743 445678899999999884     2   268999999876654


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~  193 (234)
                       ++.++++|+|++ |.+|..+|...+..    .++...+..|+.|++.||.|||..|  +|||.||||+|||+..+
T Consensus       157 -NG~HVCMVfEvL-GdnLLklI~~s~Yr----Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  157 -NGQHVCMVFEVL-GDNLLKLIKYSNYR----GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             -CCcEEEEEehhh-hhHHHHHHHHhCCC----CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence             566789999999 88999999877654    6888999999999999999999987  99999999999999543

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=7.8e-22  Score=153.14  Aligned_cols=142  Identities=18%  Similarity=0.315  Sum_probs=107.9

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-----CCCCceeEEEEeeecCCCCCCc
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-----RHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ....+.||+|+||.||.  +..+... +||++........+.+.+|+.++..+     .||||+++++++....  +.+.
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence            44567899999999996  6666555 69988755444457789999999999     5799999999986542  2233


Q ss_pred             -ceeeEee--cCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHH-HHHHhCCCCCeeecCCCCCCeeeCC----CC
Q 039258          123 -KALVFEY--MENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI-EYLHHNCQPPMVHGDIKPSNVLLDN----DM  194 (234)
Q Consensus       123 -~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l-~~lh~~~~~~ivH~dlk~~nil~~~----~~  194 (234)
                       ..+||||  +++++|.+++.+.       .+++.  ..++.|++.++ .|||++   +|+||||||+||+++.    +.
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCC
Confidence             3478999  5578999999653       23333  35577888777 999999   9999999999999963    34


Q ss_pred             ceEEccC-ccccc
Q 039258          195 VAHVGDF-GLSKF  206 (234)
Q Consensus       195 ~vki~df-G~a~~  206 (234)
                      .++|+|| |....
T Consensus       147 ~~~LiDg~G~~~~  159 (210)
T PRK10345        147 IPVVCDNIGESTF  159 (210)
T ss_pred             cEEEEECCCCcce
Confidence            7999994 55443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=5.2e-22  Score=176.94  Aligned_cols=158  Identities=25%  Similarity=0.457  Sum_probs=129.8

Q ss_pred             CCCCCceeecccceEEEEEEEC----C---CCeEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILG----E---DEMVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDS  117 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~----~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~  117 (234)
                      +..+.+.||+|.||.|++|...    .   ....||||.++.. .....+.+..|+++|..+ +|+|++.++|+|..   
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---  373 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---  373 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence            3455669999999999999743    1   1568999999743 334567899999999988 69999999999965   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhcc---CCccc-------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTN---DHLEV-------FKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSN  187 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~n  187 (234)
                        ...+++|+||+..|+|.++++...   .....       -.++..+.+.++.||+.|++||+++   ++|||||..+|
T Consensus       374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN  448 (609)
T KOG0200|consen  374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN  448 (609)
T ss_pred             --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence              344789999999999999998766   10001       1378889999999999999999999   99999999999


Q ss_pred             eeeCCCCceEEccCccccccCCCcc
Q 039258          188 VLLDNDMVAHVGDFGLSKFLSSDHL  212 (234)
Q Consensus       188 il~~~~~~vki~dfG~a~~~~~~~~  212 (234)
                      ||+..+..+||+|||+|+.......
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~  473 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDY  473 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCc
Confidence            9999999999999999996555433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-21  Score=162.85  Aligned_cols=176  Identities=23%  Similarity=0.326  Sum_probs=133.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCC-eEEEEEEeecccchhhHHHHHHHHHHHhcCC----CCceeEEEEeeecCCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDE-MVVAVKVINLKQKGAFRSFVAECEALRNIRH----RNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~l~~~~~~~~~~~~~  121 (234)
                      .|.+.+.||+|+||.||.|.+..++ ..+|+|+...........+..|..++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999987664 7899999875433322367788888888863    47777776642    2455


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC-----Cce
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND-----MVA  196 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~-----~~v  196 (234)
                      +.++||+.+ |.+|.++.......    .++...++.++.|++.+|.++|+.   |++||||||.|+++...     ..+
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~~----~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPPG----RFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCCC----CcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence            679999998 88999988665422    788899999999999999999999   99999999999999743     469


Q ss_pred             EEccCccccc--cCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKF--LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~--~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+.|||+++.  +.................+.||..|.|+
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~  206 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI  206 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccH
Confidence            9999999983  3222211101111112346799999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.4e-22  Score=157.63  Aligned_cols=148  Identities=20%  Similarity=0.361  Sum_probs=122.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..|++.+.||+|-||.+.+|+++.++.++++|.+.... ...+.|.+|...--.+ .|.||+.-+++-    .++.++++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Yv   98 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAYV   98 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceEE
Confidence            45888999999999999999999999999999986432 3447889998866556 488988776643    34556788


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee-C-CCCceEEccCc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL-D-NDMVAHVGDFG  202 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~-~-~~~~vki~dfG  202 (234)
                      .++||++.|+|.+-+...       .+-+.....++.|++.|+.|+|++   ++||||||.+|||+ + +..++|+||||
T Consensus        99 F~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             EeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence            999999999999877654       466677889999999999999999   99999999999999 3 44589999999


Q ss_pred             cccccC
Q 039258          203 LSKFLS  208 (234)
Q Consensus       203 ~a~~~~  208 (234)
                      ..+-.+
T Consensus       169 ~t~k~g  174 (378)
T KOG1345|consen  169 LTRKVG  174 (378)
T ss_pred             cccccC
Confidence            987544

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.86  E-value=1.7e-20  Score=144.65  Aligned_cols=144  Identities=35%  Similarity=0.617  Sum_probs=124.1

Q ss_pred             eecccceEEEEEEECCCCeEEEEEEeecccch-hhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecCC
Q 039258           54 IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMEN  132 (234)
Q Consensus        54 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~  132 (234)
                      ||+|.+|.||++....++..+++|+....... ..+.+.+|++.+..+.|++++++++++...     ...++++|++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence            68999999999999888899999999755332 346789999999999999999999987543     346899999998


Q ss_pred             CCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-CCceEEccCccccccCCC
Q 039258          133 GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       133 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-~~~vki~dfG~a~~~~~~  210 (234)
                      ++|.+++.....     .+++..+..++.+++.++.++|+.   +++|+||+|.||+++. ++.++++|||.+......
T Consensus        76 ~~l~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          76 GSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             CcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            999999876521     567788899999999999999999   9999999999999998 899999999999866543

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.86  E-value=8.7e-22  Score=172.35  Aligned_cols=165  Identities=30%  Similarity=0.439  Sum_probs=125.2

Q ss_pred             CCCceeecccceE-EEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcceee
Q 039258           49 SQSNMIGQGSYGS-VYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        49 ~~~~~lG~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      .-.+.+|.|+-|+ ||+|..  .+++||||.+-..   ...-..+|+..|..- +||||+++++.     ..+..+.||.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIa  581 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIA  581 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee--CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEE
Confidence            3356788998875 899998  5679999987422   223457899999887 59999999886     2456778999


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC---C--CceEEccC
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---D--MVAHVGDF  201 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~---~--~~vki~df  201 (234)
                      .|.| ..+|.+++...... .. .........+..|++.||++||+.   +||||||||.|||++.   +  ..++|+||
T Consensus       582 lELC-~~sL~dlie~~~~d-~~-~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  582 LELC-ACSLQDLIESSGLD-VE-MQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             ehHh-hhhHHHHHhccccc-hh-hcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccc
Confidence            9999 56999999875111 10 111145577889999999999998   9999999999999964   2  46899999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++.+..+.+.-.     ...+..||.+|+||
T Consensus       656 glsKkl~~~~sS~~-----r~s~~sGt~GW~AP  683 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFS-----RLSGGSGTSGWQAP  683 (903)
T ss_pred             ccccccCCCcchhh-----cccCCCCcccccCH
Confidence            99998776544332     12346799999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.86  E-value=6e-21  Score=150.71  Aligned_cols=154  Identities=34%  Similarity=0.518  Sum_probs=128.1

Q ss_pred             cceEEEEEEECCCCeEEEEEEeecccchh-hHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecCCCCHH
Q 039258           58 SYGSVYKGILGEDEMVVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLE  136 (234)
Q Consensus        58 ~fg~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~  136 (234)
                      +||.||+|.+..++..+++|++....... .+.+.+|++.+..++|+|++++++.+...     ...++++|++++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence            58999999998889999999997554333 57889999999999999999999987543     3468999999988999


Q ss_pred             HHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCCccCCCC
Q 039258          137 DWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS  216 (234)
Q Consensus       137 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~  216 (234)
                      +++....      .++...+..++.+++.++.++|+.   +++|+||+|+||+++.++.++++|||.+..........  
T Consensus        76 ~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~--  144 (244)
T smart00220       76 DLLKKRG------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLT--  144 (244)
T ss_pred             HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccccc--
Confidence            9987654      367788899999999999999999   99999999999999999999999999988765432111  


Q ss_pred             CCCCccccccccccccCC
Q 039258          217 ETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       217 ~~~~~~~~~~gt~~y~aP  234 (234)
                             ...|+..|+||
T Consensus       145 -------~~~~~~~~~~p  155 (244)
T smart00220      145 -------TFVGTPEYMAP  155 (244)
T ss_pred             -------cccCCcCCCCH
Confidence                   14467777776

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=7.2e-21  Score=150.88  Aligned_cols=149  Identities=18%  Similarity=0.158  Sum_probs=112.6

Q ss_pred             HHhcCCCCCceeecccceEEEEEE-ECCCCeEEEEEEeecccch------------------------hhHHHHHHHHHH
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGI-LGEDEMVVAVKVINLKQKG------------------------AFRSFVAECEAL   97 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l   97 (234)
                      .....|++.+.||+|+||.||+|. +..+|..||+|+++.....                        ....+..|++++
T Consensus        25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L  104 (237)
T smart00090       25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL  104 (237)
T ss_pred             hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence            333458889999999999999998 6678999999999743210                        012356799999


Q ss_pred             HhcCCCC--ceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 039258           98 RNIRHRN--LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQ  175 (234)
Q Consensus        98 ~~l~h~~--i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~  175 (234)
                      ..+.+.+  +.+.+...         ..++||||+++.++........      .........++.|++.++.++|+.  
T Consensus       105 ~~L~~~~i~~p~~~~~~---------~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~--  167 (237)
T smart00090      105 QRLYEAGVPVPKPIAWR---------RNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE--  167 (237)
T ss_pred             HHHHhcCCCCCeeeEec---------CceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc--
Confidence            9997533  34444321         1379999999878766543222      344455678899999999999999  


Q ss_pred             CC-eeecCCCCCCeeeCCCCceEEccCccccccCCC
Q 039258          176 PP-MVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       176 ~~-ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~  210 (234)
                       + ++|+|+||+||+++ +++++++|||.+......
T Consensus       168 -g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      168 -GELVHGDLSEYNILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             -CCEEeCCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence             8 99999999999999 789999999998865543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.3e-21  Score=165.74  Aligned_cols=148  Identities=24%  Similarity=0.322  Sum_probs=122.8

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      +...|.....+|.|+|+.|..|.+..+++..++|++....    ....+|+.++... +|||++.+.+.+.     ++..
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~-----~~~~  390 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE-----DGKE  390 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceec-----CCce
Confidence            4556777788999999999999999999999999996442    2234667666655 7999999999873     3455


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee-CCCCceEEccC
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL-DNDMVAHVGDF  201 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~-~~~~~vki~df  201 (234)
                      .++|||.+.++.+.+.+....      .++ .++..++.+|+.++.|||++   ++|||||||+|||+ +..++++|+||
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~------~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF  460 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKP------EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF  460 (612)
T ss_pred             eeeeehhccccHHHHHHHhcc------hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence            799999999988888776543      233 67788999999999999999   99999999999999 58899999999


Q ss_pred             ccccccCCC
Q 039258          202 GLSKFLSSD  210 (234)
Q Consensus       202 G~a~~~~~~  210 (234)
                      |.++....+
T Consensus       461 G~a~~~~~~  469 (612)
T KOG0603|consen  461 GFWSELERS  469 (612)
T ss_pred             chhhhCchh
Confidence            999987665

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=4e-20  Score=144.40  Aligned_cols=146  Identities=18%  Similarity=0.181  Sum_probs=112.8

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccch---hhHH------HHHHHHHHHhcCCCCceeEEEEee
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFRS------FVAECEALRNIRHRNLTKIITICS  113 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~---~~~~------~~~e~~~l~~l~h~~i~~l~~~~~  113 (234)
                      ...++|...+++|.|+||.||+...  ++..+|+|++......   ....      +.+|+..+.++.|+++..+.+++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            3457899999999999999999755  3557999999643221   1122      578999999999999999888755


Q ss_pred             ecCCC---CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee
Q 039258          114 SIDSK---GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL  190 (234)
Q Consensus       114 ~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~  190 (234)
                      ..+..   .....+++|||++|.+|.++..          .++    ....+++.++..+|+.   +++|+|++|.|+++
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili  168 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV  168 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence            43211   1234689999999999987732          222    2345899999999999   99999999999999


Q ss_pred             CCCCceEEccCccccccC
Q 039258          191 DNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       191 ~~~~~vki~dfG~a~~~~  208 (234)
                      ++++ ++++|||......
T Consensus       169 ~~~g-i~liDfg~~~~~~  185 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTA  185 (232)
T ss_pred             eCCC-EEEEECCCccccc
Confidence            9888 9999999887653

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2e-19  Score=140.42  Aligned_cols=136  Identities=20%  Similarity=0.319  Sum_probs=107.9

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecccc--------hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--------GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +.||+|++|.||+|.+  .+..+++|.......        .....+.+|++++..+.|+++.....++...     ...
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence            5789999999999987  566789997643211        1124577899999999988876655554322     225


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      +++|||++|++|.+++....         . ....++.+++.++.++|+.   +++|+|++|+||+++ ++.++++|||.
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence            89999999999999886432         1 5678899999999999999   999999999999999 78899999999


Q ss_pred             ccccC
Q 039258          204 SKFLS  208 (234)
Q Consensus       204 a~~~~  208 (234)
                      +....
T Consensus       141 a~~~~  145 (211)
T PRK14879        141 AEFSK  145 (211)
T ss_pred             ccCCC
Confidence            88643

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=3.6e-19  Score=136.56  Aligned_cols=133  Identities=16%  Similarity=0.147  Sum_probs=102.8

Q ss_pred             CCCceeecccceEEEEEEECCCCeEEEEEEeecccc----hhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcc
Q 039258           49 SQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK----GAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .....|++|+||+|+.+..  .+.+++.+.+.....    .....+.+|+++|..+. |++++.++++.    .     .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~-----~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----G-----R   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----C-----E
Confidence            4467899999999997655  556777666653321    11235789999999995 57888888762    1     4


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCCeeeCCCCceEEccCc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDI-KPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dl-k~~nil~~~~~~vki~dfG  202 (234)
                      +++|||++|.+|.+....             ....++.|++.++.++|++   ||+|||| ||+|||++.++.++|+|||
T Consensus        74 ~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             EEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence            899999999888654321             1134677899999999999   9999999 7999999999999999999


Q ss_pred             cccccC
Q 039258          203 LSKFLS  208 (234)
Q Consensus       203 ~a~~~~  208 (234)
                      +|....
T Consensus       138 ~A~~~~  143 (218)
T PRK12274        138 LAVRGN  143 (218)
T ss_pred             CceecC
Confidence            998544

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=2.8e-19  Score=138.35  Aligned_cols=146  Identities=23%  Similarity=0.220  Sum_probs=110.1

Q ss_pred             HHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccch----------------------hhHHHHHHHHH
Q 039258           39 AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG----------------------AFRSFVAECEA   96 (234)
Q Consensus        39 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~   96 (234)
                      .++......|...+.||+|+||.||+|... +++.+|||+++.....                      .......|..+
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            344444555888899999999999999874 7899999987632210                      11235678888


Q ss_pred             HHhcCCCC--ceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC
Q 039258           97 LRNIRHRN--LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC  174 (234)
Q Consensus        97 l~~l~h~~--i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~  174 (234)
                      +..+.+++  +...++.         ...++||||+++++|......            .....++.+++.++.++|+. 
T Consensus        87 l~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~-  144 (198)
T cd05144          87 LKALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH-  144 (198)
T ss_pred             HHHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC-
Confidence            88887774  3444332         124899999999888765321            12356778999999999998 


Q ss_pred             CCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          175 QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       175 ~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                        +++|+||+|+||+++.++.++++|||++.....
T Consensus       145 --gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         145 --GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             --CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence              999999999999999999999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.81  E-value=4.3e-20  Score=154.82  Aligned_cols=157  Identities=20%  Similarity=0.332  Sum_probs=127.4

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCC------CCceeEEEEeeecCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH------RNLTKIITICSSIDS  117 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~l~~~~~~~~~  117 (234)
                      ...+|.+....|+|-|+.|..|.+...+..||||++... +.-.+.=++|+++|.+|+-      -|+++++..|.    
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~----  504 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK----  504 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh----
Confidence            345788888899999999999999988999999999743 2222445789999999973      26777776553    


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-CCce
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DMVA  196 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-~~~v  196 (234)
                       ..+++|+|+|-+. -+|.+.+...+.+.   .+....+..++.|+..||..|..+   +++|.||||.|||++. ...+
T Consensus       505 -hknHLClVFE~Ls-lNLRevLKKyG~nv---GL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  505 -HKNHLCLVFEPLS-LNLREVLKKYGRNV---GLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             -hcceeEEEehhhh-chHHHHHHHhCccc---ceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence             4566899999984 59999999877543   677888999999999999999987   9999999999999984 5678


Q ss_pred             EEccCccccccCCCccC
Q 039258          197 HVGDFGLSKFLSSDHLD  213 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~  213 (234)
                      ||||||.|.........
T Consensus       577 KLCDfGSA~~~~eneit  593 (752)
T KOG0670|consen  577 KLCDFGSASFASENEIT  593 (752)
T ss_pred             eeccCcccccccccccc
Confidence            99999999887665433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.81  E-value=5.4e-20  Score=150.46  Aligned_cols=149  Identities=30%  Similarity=0.403  Sum_probs=126.2

Q ss_pred             HHHHHHhcCCCCCceeecccceEEEEEEECC---CCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeee
Q 039258           39 AELSKATCEFSQSNMIGQGSYGSVYKGILGE---DEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSS  114 (234)
Q Consensus        39 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~  114 (234)
                      +.++.....|...+.||.|+|++||++.+..   +++.||+|.+...+  ...++..|+++|..+. +.||+.+.+++  
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~--  104 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCF--  104 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhh--
Confidence            3455666789999999999999999999876   77899999986442  3367889999999985 78999999886  


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC-CC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-ND  193 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~-~~  193 (234)
                         ..++...+||||++..+..++..         .++...+..+++.++.||.++|.+   ||||||+||.|+|.+ ..
T Consensus       105 ---rnnd~v~ivlp~~~H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t  169 (418)
T KOG1167|consen  105 ---RNNDQVAIVLPYFEHDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRT  169 (418)
T ss_pred             ---ccCCeeEEEecccCccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccccc
Confidence               44566799999999888888876         345678889999999999999999   999999999999997 55


Q ss_pred             CceEEccCccccc
Q 039258          194 MVAHVGDFGLSKF  206 (234)
Q Consensus       194 ~~vki~dfG~a~~  206 (234)
                      +.-.++|||+|..
T Consensus       170 ~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  170 QRGVLVDFGLAQR  182 (418)
T ss_pred             CCceEEechhHHH
Confidence            6778999999983

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=7.3e-19  Score=155.14  Aligned_cols=141  Identities=23%  Similarity=0.306  Sum_probs=107.8

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEe--eccc------chhhHHHHHHHHHHHhcCCCCceeEEEEeee
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI--NLKQ------KGAFRSFVAECEALRNIRHRNLTKIITICSS  114 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~--~~~~------~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~  114 (234)
                      .....|...+.||+|+||.||+|.+....  +++|..  +...      ....+++.+|++++..++|++++....++..
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            33445566789999999999999875443  344432  1111      1123568899999999999998876655433


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                      .     ...++||||+++++|.+++.              ....++.+++.++.++|+.   +++|||+||+||++ .++
T Consensus       408 ~-----~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~  464 (535)
T PRK09605        408 P-----EEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDD  464 (535)
T ss_pred             C-----CCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECC
Confidence            2     22479999999999998875              2356788999999999999   99999999999999 577


Q ss_pred             ceEEccCccccccC
Q 039258          195 VAHVGDFGLSKFLS  208 (234)
Q Consensus       195 ~vki~dfG~a~~~~  208 (234)
                      .++++|||+++...
T Consensus       465 ~~~liDFGla~~~~  478 (535)
T PRK09605        465 RLYLIDFGLGKYSD  478 (535)
T ss_pred             cEEEEeCcccccCC
Confidence            89999999998754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.81  E-value=5.5e-20  Score=145.86  Aligned_cols=167  Identities=22%  Similarity=0.277  Sum_probs=129.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC-CCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK-GADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~-~~~~  122 (234)
                      .+|..++.+|.|.- .|.-+.+.-++++||+|.+...  .....++..+|..++..++|+|+++++.++.-.... .-.-
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35777788898888 7888888888999999977422  233446778999999999999999999987432221 1112


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++|||+++ .+|...+....+        =.....++.|++.|+.|+|+.   +|+||||||+||++..++.+||.|||
T Consensus        96 ~y~v~e~m~-~nl~~vi~~elD--------H~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVILMELD--------HETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHHHHhhh-hHHHHHHHHhcc--------hHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            479999995 488888774433        245678899999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+.-..+.-.         ...+.|..|.||
T Consensus       164 ~ar~e~~~~~m---------tpyVvtRyyrap  186 (369)
T KOG0665|consen  164 LARTEDTDFMM---------TPYVVTRYYRAP  186 (369)
T ss_pred             hhcccCccccc---------CchhheeeccCc
Confidence            99865544111         126678888887

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=1.1e-18  Score=134.93  Aligned_cols=132  Identities=24%  Similarity=0.356  Sum_probs=101.2

Q ss_pred             eeecccceEEEEEEECCCCeEEEEEEeeccc---c-----hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           53 MIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---K-----GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .||+|+||.||+|.+  ++..+++|......   .     ...+++.+|++++..+.|+++.....++...     ...+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence            489999999999985  45679999864221   1     1125677899999999887654333332221     2247


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||++|++|.+++....      .       .++.+++.++.++|+.   +++|+|++|+||+++ ++.++++|||++
T Consensus        74 lv~e~~~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             EEEEEECCccHHHHHhhcH------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence            9999999999998875422      1       6788999999999999   999999999999999 789999999998


Q ss_pred             cccC
Q 039258          205 KFLS  208 (234)
Q Consensus       205 ~~~~  208 (234)
                      ....
T Consensus       137 ~~~~  140 (199)
T TIGR03724       137 KYSD  140 (199)
T ss_pred             cCCC
Confidence            8643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.75  E-value=5.3e-17  Score=132.72  Aligned_cols=171  Identities=35%  Similarity=0.523  Sum_probs=132.9

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccch---hhHHHHHHHHHHHhcCCC-CceeEEEEeeecCCCCCCcc
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFRSFVAECEALRNIRHR-NLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~l~~~~~~~~~~~~~~~  123 (234)
                      |...+.||.|+||.||.+.+.   ..+++|.+......   ....+.+|+.++..+.|+ +++.+.+.+...     ...
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence            566788999999999999987   67899998644222   357899999999999988 799999887322     225


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC-ceEEccCc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFG  202 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~-~vki~dfG  202 (234)
                      +++++++.++++.+++......   ..++......+..|++.++.|+|..   +++|||+||+|++++..+ .++++|||
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence            8999999999999776654321   2467788899999999999999999   999999999999999888 79999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++............  .......||..|+||
T Consensus       148 ~~~~~~~~~~~~~~~--~~~~~~~~t~~~~~p  177 (384)
T COG0515         148 LAKLLPDPGSTSSIP--ALPSTSVGTPGYMAP  177 (384)
T ss_pred             cceecCCCCcccccc--ccccccccccccCCH
Confidence            998554433221100  011126799999987

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=1.6e-17  Score=127.14  Aligned_cols=137  Identities=22%  Similarity=0.285  Sum_probs=96.3

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccch--hhHH----------------------HHHHHHHHHhcCCCC--
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG--AFRS----------------------FVAECEALRNIRHRN--  104 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~~--  104 (234)
                      .+.||+|+||.||+|.+. +++.||||++......  ....                      ...|.+.+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 7889999998643211  0011                      134566666654332  


Q ss_pred             ceeEEEEeeecCCCCCCcceeeEeecCCCCHHH-HhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecC
Q 039258          105 LTKIITICSSIDSKGADFKALVFEYMENGSLED-WLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGD  182 (234)
Q Consensus       105 i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~d  182 (234)
                      +.+.+++.         ..++||||++++.+.. .+....       .. .....++.+++.++.++|. .   +++|+|
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D  140 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYREA---GLVHGD  140 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence            34444431         1489999998854321 111111       10 4567888999999999998 7   999999


Q ss_pred             CCCCCeeeCCCCceEEccCccccccCC
Q 039258          183 IKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      |+|+||+++ ++.++++|||.+.....
T Consensus       141 l~p~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         141 LSEYNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CChhhEEEE-CCcEEEEECcccccccC
Confidence            999999999 88999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=3.6e-16  Score=124.26  Aligned_cols=141  Identities=17%  Similarity=0.135  Sum_probs=103.7

Q ss_pred             Cceee-cccceEEEEEEECCCCeEEEEEEeeccc-------------chhhHHHHHHHHHHHhcCCCCc--eeEEEEeee
Q 039258           51 SNMIG-QGSYGSVYKGILGEDEMVVAVKVINLKQ-------------KGAFRSFVAECEALRNIRHRNL--TKIITICSS  114 (234)
Q Consensus        51 ~~~lG-~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~l~~~~~~  114 (234)
                      ...|| .|+.|+||.+...  +..+++|.+....             ......+.+|++++..+.|+++  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            44687 7889999988773  5678898774211             1223567889999999988774  566665432


Q ss_pred             cCCCCCCcceeeEeecCC-CCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC
Q 039258          115 IDSKGADFKALVFEYMEN-GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~  193 (234)
                      .. ......++|||++++ .+|.+++...       .++..    .+.+++.++.++|++   ||+|+||||+|||++.+
T Consensus       114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~  178 (239)
T PRK01723        114 RH-GLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD  178 (239)
T ss_pred             ec-CcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence            11 111123599999997 6898887542       23332    356899999999999   99999999999999988


Q ss_pred             CceEEccCccccccC
Q 039258          194 MVAHVGDFGLSKFLS  208 (234)
Q Consensus       194 ~~vki~dfG~a~~~~  208 (234)
                      +.++++|||.+....
T Consensus       179 ~~v~LIDfg~~~~~~  193 (239)
T PRK01723        179 GKFWLIDFDRGELRT  193 (239)
T ss_pred             CCEEEEECCCcccCC
Confidence            899999999988644

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=4.4e-16  Score=114.30  Aligned_cols=135  Identities=20%  Similarity=0.275  Sum_probs=105.7

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCC--CCceeEEEEeeecCCCCCCcceeeEe
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH--RNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      .+.||+|.++.||++....  ..+++|.......  ...+..|+..+..+++  .++++++.+...     .+..+++||
T Consensus         3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~v~e   73 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-----DGWSYLLME   73 (155)
T ss_pred             ceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEEEEE
Confidence            5679999999999999844  5789998864332  4578889999999976  478888776532     244689999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      |+++.++..+             +......++.+++.++.++|.....+++|+|++|+|++++..+.++++|||.+...
T Consensus        74 ~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          74 WIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            9988766543             22344667788999999999853336999999999999998899999999998853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=1.2e-16  Score=145.30  Aligned_cols=144  Identities=28%  Similarity=0.353  Sum_probs=103.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC---CCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR---HRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ...|.+.++||+|+||.||+|.... |+.||+|+-+....-..--.   .+++.+|+   -+.|..+..++.     .++
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~---~q~~~RLk~~~~~~~~~~~~a~~-----~~~  767 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC---LQVMERLKPQMLPSIMHISSAHV-----FQN  767 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh---HHHHHhhchhhhcchHHHHHHHc-----cCC
Confidence            3457788999999999999999877 89999999864432111000   11122222   112222322221     122


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC-------CCC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-------NDM  194 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~-------~~~  194 (234)
                      ..++|+||.+.|+|.+++....      ...+.-++.+..|++..|+.+|..   +|||+||||.|+|+.       .+.
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             cceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence            2479999999999999998443      567778889999999999999999   999999999999993       245


Q ss_pred             ceEEccCccccc
Q 039258          195 VAHVGDFGLSKF  206 (234)
Q Consensus       195 ~vki~dfG~a~~  206 (234)
                      .++|+|||-+--
T Consensus       839 ~l~lIDfG~siD  850 (974)
T KOG1166|consen  839 GLYLIDFGRSID  850 (974)
T ss_pred             ceEEEeccccee
Confidence            689999998754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1.2e-16  Score=141.62  Aligned_cols=167  Identities=22%  Similarity=0.318  Sum_probs=121.7

Q ss_pred             CCCceeecccceEEEEEEECCCCeEEEEEEeec---c--cc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           49 SQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL---K--QK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~--~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .....+|.|++|.|+.+.........+.|....   .  .. .....+..|+.+-..++|+|++..+..+.....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            346789999999888777654444344443321   1  11 111225667777778899998766554432221     


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      ..-+||||++ +|+.++....      .++..++-.++.|++.||.|+|+.   |+.|||+|++|+++..++.+||+|||
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             chhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence            2344999999 9999998764      567778889999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+.....+.....    ....+++|+..|+||
T Consensus       466 ~~~vf~~~~e~~~----~~~~g~~gS~pY~ap  493 (601)
T KOG0590|consen  466 AASVFRYPWEKNI----HESSGIVGSDPYLAP  493 (601)
T ss_pred             cceeeccCcchhh----hhhcCcccCCcCcCc
Confidence            9987665544321    122347899999998

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.64  E-value=4.7e-16  Score=126.90  Aligned_cols=165  Identities=22%  Similarity=0.366  Sum_probs=130.0

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCC-----eEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeec
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDE-----MVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSI  115 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~  115 (234)
                      .....+++...++-+|.||.||.|.+++.+     +.|-+|.++.. ++-....++.|.-++..+.|||+..+.+++.. 
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie-  358 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-  358 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee-
Confidence            334456777888999999999999876443     45666766532 33445778999999999999999999998754 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCC--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDH--LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~  193 (234)
                         .....++.+-++.-|+|..|+..+...  .....++..+...++.|++.|++|+|..   ++||.||..+|+++|..
T Consensus       359 ---~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  359 ---DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             ---ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence               233457788888788999999854322  2234567778889999999999999999   99999999999999999


Q ss_pred             CceEEccCccccccCCCccC
Q 039258          194 MVAHVGDFGLSKFLSSDHLD  213 (234)
Q Consensus       194 ~~vki~dfG~a~~~~~~~~~  213 (234)
                      -++|++|=.+++-+.+..+.
T Consensus       433 LqVkltDsaLSRDLFP~DYh  452 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYH  452 (563)
T ss_pred             eeEEeccchhccccCccccc
Confidence            99999999999987665443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.62  E-value=3.7e-16  Score=144.05  Aligned_cols=90  Identities=11%  Similarity=0.170  Sum_probs=65.4

Q ss_pred             CCceeEEEEeeecCC--CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 039258          103 RNLTKIITICSSIDS--KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVH  180 (234)
Q Consensus       103 ~~i~~l~~~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH  180 (234)
                      .||..+++.|.....  ......+.+||++ +++|.+++.....     .+++..++.++.||+.||.|||++   +|+|
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---gIvH  103 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR-----SVDAFECFHVFRQIVEIVNAAHSQ---GIVV  103 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            466666666522221  1223457788988 5699999975322     588889999999999999999999   9999


Q ss_pred             cCCCCCCeeeCCCCceEEccC
Q 039258          181 GDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       181 ~dlk~~nil~~~~~~vki~df  201 (234)
                      |||||+|||++..+.+|++||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~  124 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIES  124 (793)
T ss_pred             ccCCchhEEEcccCcEEEeec
Confidence            999999999965444433333

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=3e-14  Score=122.51  Aligned_cols=142  Identities=20%  Similarity=0.233  Sum_probs=94.1

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecccchhh----------------------------------------HHHH
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF----------------------------------------RSFV   91 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~   91 (234)
                      +.||+|++|.||+|+.. +|+.||||+.+..-....                                        -++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999975 678999999853211000                                        0244


Q ss_pred             HHHHHHHhcC----CCCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHH-H
Q 039258           92 AECEALRNIR----HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS-A  166 (234)
Q Consensus        92 ~e~~~l~~l~----h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~-~  166 (234)
                      +|+..+..+.    +.+-+.+-.++.....    ..++||||++|.+|.++......     ...   ...++.+++. .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~~-----~~~---~~~ia~~~~~~~  269 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDEA-----GLD---RKALAENLARSF  269 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHhc-----CCC---HHHHHHHHHHHH
Confidence            4555555542    2222333223221111    14899999999999887653211     111   1234444444 4


Q ss_pred             HHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       167 l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      +..+|..   |++|+|++|.||+++.+++++++|||++..+.+
T Consensus       270 l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       270 LNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            5678888   999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.56  E-value=3.2e-14  Score=124.11  Aligned_cols=147  Identities=18%  Similarity=0.175  Sum_probs=93.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc----------------------------------hhhHH--
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK----------------------------------GAFRS--   89 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----------------------------------~~~~~--   89 (234)
                      .+|+. +.||+|++|.||+|+.+.+|+.||||+.+..-.                                  ...+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35665 789999999999999988899999999963210                                  00111  


Q ss_pred             ----HHHHHHHHHhcC----CCCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHh--hhccCCccccccCHHHHHHH
Q 039258           90 ----FVAECEALRNIR----HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL--HQTNDHLEVFKLSLIQRVNI  159 (234)
Q Consensus        90 ----~~~e~~~l~~l~----h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~~~~  159 (234)
                          +.+|+..+..+.    +.+.+.+-.++.....    ..++||||++|+++.+.-  ...+..  ...+....+..+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d~~~l~~~g~d--~~~la~~~v~~~  272 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSDVAALRAAGTD--MKLLAERGVEVF  272 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHhHHHHHhcCCC--HHHHHHHHHHHH
Confidence                334444444442    3333333233221111    147999999999998753  222211  112333334444


Q ss_pred             HHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC----ceEEccCccccccCC
Q 039258          160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM----VAHVGDFGLSKFLSS  209 (234)
Q Consensus       160 ~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~----~vki~dfG~a~~~~~  209 (234)
                      +.|+.       ..   |++|+|++|.||+++.++    .++++|||+...+..
T Consensus       273 ~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            45543       34   999999999999998887    999999999987654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.46  E-value=7.3e-15  Score=126.24  Aligned_cols=156  Identities=25%  Similarity=0.276  Sum_probs=123.0

Q ss_pred             eeecccceEEEEEEE---CCCCeEEEEEEeecccch--hhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcceee
Q 039258           53 MIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQKG--AFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      .+|+|.||.|++++.   ...+..+|+|+.+.....  .......|-.++..++ ||.++++...+.     +....+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq-----t~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ-----TDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec-----cccchhHh
Confidence            379999999987653   245678999998643211  1114456777888886 999999987763     33346899


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      +++..++++...+.+..      .+.+.....+...++.+++++|..   ++++||+|++||+++.+|++++.|||+++.
T Consensus        76 ld~~rgg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske  146 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEV------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE  146 (612)
T ss_pred             hhhcccchhhhccccCC------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence            99999999998887765      566777788888999999999999   999999999999999999999999999987


Q ss_pred             cCCCccCCCCCCCCccccccccccccCC
Q 039258          207 LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .-+...            .|||..||||
T Consensus       147 ~v~~~~------------~cgt~eymAp  162 (612)
T KOG0603|consen  147 AVKEKI------------ACGTYEYRAP  162 (612)
T ss_pred             hHhhhh------------cccchhhhhh
Confidence            544321            3799999998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=2.1e-12  Score=98.89  Aligned_cols=136  Identities=19%  Similarity=0.202  Sum_probs=95.8

Q ss_pred             ceeecccceEEEEEEECC------CCeEEEEEEeecc-----c-------c----------hhhHHHH----HHHHHHHh
Q 039258           52 NMIGQGSYGSVYKGILGE------DEMVVAVKVINLK-----Q-------K----------GAFRSFV----AECEALRN   99 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~------~~~~vavK~~~~~-----~-------~----------~~~~~~~----~e~~~l~~   99 (234)
                      -.||.|.-+.||.|....      .+..+|||+.+..     .       +          ...+.+.    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            368999999999998643      3578999988621     0       0          1122333    79999998


Q ss_pred             cC--CCCceeEEEEeeecCCCCCCcceeeEeecCCCCHHH-HhhhccCCccccccCHHHHHHHHHHHHHHHHHH-HhCCC
Q 039258          100 IR--HRNLTKIITICSSIDSKGADFKALVFEYMENGSLED-WLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQ  175 (234)
Q Consensus       100 l~--h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-h~~~~  175 (234)
                      +.  .-+++.++.+.    .     .+|||||+.+..+.. .+.+.       .++......+..+++.++..+ |..  
T Consensus        83 l~~~Gv~vP~pi~~~----~-----~~lvME~Ig~~~~~~~~Lkd~-------~~~~~~~~~i~~~i~~~l~~l~H~~--  144 (197)
T cd05146          83 MQKAGIPCPEVVVLK----K-----HVLVMSFIGDDQVPAPKLKDA-------KLNDEEMKNAYYQVLSMMKQLYKEC--  144 (197)
T ss_pred             HHHcCCCCCeEEEec----C-----CEEEEEEcCCCCccchhhhcc-------ccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence            85  34666777642    1     379999996543322 22221       233445566778999999988 788  


Q ss_pred             CCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          176 PPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       176 ~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                       ++||+||++.||+++ ++.+.++|||-+-..
T Consensus       145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             -CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence             999999999999997 467999999977654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=8.2e-13  Score=99.34  Aligned_cols=131  Identities=17%  Similarity=0.149  Sum_probs=92.8

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCc-eeEEEEeeecCCCCCCcceeeEeec
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-TKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      +.++.|.++.||++...  +..+++|+...... ....+..|+..+..+.+.++ .+++....     +  ..++|||++
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-----~--~~~lv~e~i   73 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-----E--TGVLITEFI   73 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-----C--CCeEEEEec
Confidence            46788999999999864  67899999754321 12345788888888865443 44554421     1  137999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC--QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ++.++.+.  .        ..    ......+++.++..+|+..  ..+++|+|++|.||+++ ++.++++|||.+..-
T Consensus        74 ~G~~l~~~--~--------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          74 EGSELLTE--D--------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             CCCccccc--c--------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            99776543  0        01    1234568999999999871  11259999999999999 668999999998853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=9.5e-12  Score=92.88  Aligned_cols=131  Identities=26%  Similarity=0.335  Sum_probs=94.4

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecc--------cchhhHHHHHHHHHHHhcCCC--CceeEEEEeeecCCCCCC
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLK--------QKGAFRSFVAECEALRNIRHR--NLTKIITICSSIDSKGAD  121 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~--~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+++|+-+.++.+.+.  |..+.+|.=..+        .+-..++..+|+.++.+++-.  +.+.++++.  +     +
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~-----~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P-----D   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C-----C
Confidence            35789999999998663  334666654211        112235678899999988643  444455542  2     1


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ...|+|||++|..|.+.+....             ..++..+-.-+.-||..   +|+|+||.++|+++...+ +.++||
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~~-------------~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEAR-------------PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhcc-------------hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence            2369999999888887876541             34566777788999999   999999999999997664 999999


Q ss_pred             ccccccC
Q 039258          202 GLSKFLS  208 (234)
Q Consensus       202 G~a~~~~  208 (234)
                      |++..-.
T Consensus       136 GLg~~s~  142 (204)
T COG3642         136 GLGEFSD  142 (204)
T ss_pred             Ccccccc
Confidence            9998543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.38  E-value=1.8e-11  Score=91.21  Aligned_cols=145  Identities=23%  Similarity=0.308  Sum_probs=99.7

Q ss_pred             CCceeecccceEEEEEEECCCCeEEEEEEeecc--------cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           50 QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--------QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        50 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ....+-||+-+.|+++.+  .|+.+.||.-..+        ..-...+..+|+..+.++.--.|....-++.+...    
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence            466788999999999987  5566677754321        12234678899999998864333222222222222    


Q ss_pred             cceeeEeecCC-CCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC---CceE
Q 039258          122 FKALVFEYMEN-GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND---MVAH  197 (234)
Q Consensus       122 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~---~~vk  197 (234)
                       -.|+|||+++ .++.+++......    .....-...++.+|-..+.-||.+   +++|+||.++||++..+   ..+.
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence             2699999976 3677887764321    122223367888999999999999   99999999999999543   3568


Q ss_pred             EccCccccccC
Q 039258          198 VGDFGLSKFLS  208 (234)
Q Consensus       198 i~dfG~a~~~~  208 (234)
                      ++|||++..-.
T Consensus       157 lIdfgls~~s~  167 (229)
T KOG3087|consen  157 LIDFGLSSVSR  167 (229)
T ss_pred             EEeecchhccc
Confidence            99999987643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.36  E-value=1.9e-12  Score=104.32  Aligned_cols=157  Identities=23%  Similarity=0.328  Sum_probs=95.2

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCC----------CCceeEEEEee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRH----------RNLTKIITICS  113 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~~i~~l~~~~~  113 (234)
                      .+.....||.|+++.||.+.+.+|++.+|+|+.-...   ....+.+.+|.-....+.+          -.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3455778999999999999999999999999986432   2334566666543333221          11111122211


Q ss_pred             ecCC-------CC-CC----cceeeEeecCCCCHHHHhhh---ccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039258          114 SIDS-------KG-AD----FKALVFEYMENGSLEDWLHQ---TNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPM  178 (234)
Q Consensus       114 ~~~~-------~~-~~----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~i  178 (234)
                      ....       .+ ..    ..+++|.-+. +||.+++..   ....  .........+.+-.|++..++++|+.   |+
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl  166 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSY---GL  166 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence            1100       00 01    1256677664 488887643   2211  11233334456668999999999999   99


Q ss_pred             eecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          179 VHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       179 vH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      +|+||+|+|++++.+|.+++.||+.....+.
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~  197 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGT  197 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCc
Confidence            9999999999999999999999987765443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=2e-12  Score=106.26  Aligned_cols=95  Identities=25%  Similarity=0.328  Sum_probs=73.5

Q ss_pred             CCCCceeEEEEeeecCC----------------------CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHH
Q 039258          101 RHRNLTKIITICSSIDS----------------------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN  158 (234)
Q Consensus       101 ~h~~i~~l~~~~~~~~~----------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~  158 (234)
                      +||||+++.++|.+.-.                      ..+..+|+||.-.+ .+|.+++..+.       .+......
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-------~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-------RSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-------CchHHHHH
Confidence            59999999987754322                      23445789998884 59999998764       33445667


Q ss_pred             HHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC--CCC--ceEEccCccccc
Q 039258          159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD--NDM--VAHVGDFGLSKF  206 (234)
Q Consensus       159 ~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~--~~~--~vki~dfG~a~~  206 (234)
                      +..|+++|+.|||..   ++.|||+|+.|||+.  +++  ...++|||++--
T Consensus       346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA  394 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA  394 (598)
T ss_pred             HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence            888999999999999   999999999999993  333  468999997653

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.34  E-value=2e-13  Score=115.37  Aligned_cols=102  Identities=30%  Similarity=0.524  Sum_probs=78.2

Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      +++|.|++|+-.+|.+|+.......   ..+....+.++.|++.|+.|   +   +.+|+|+||.||....+..+||.||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e---~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGE---ERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCccc---ccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhh
Confidence            5789999999899999997543211   34556778899999999999   6   8999999999999998889999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+........+..  ........-+||..||+|
T Consensus       401 gl~ts~~~~~~~~--~~~a~~t~~~gt~~YmsP  431 (516)
T KOG1033|consen  401 GLVTSQDKDETVA--PAAASHTQQVGTLLYMSP  431 (516)
T ss_pred             hheeecccCCccc--chhhhhhhcccccccCCH
Confidence            9988766554111  111112235799999998

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=2.8e-10  Score=89.08  Aligned_cols=145  Identities=22%  Similarity=0.286  Sum_probs=96.8

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhcCC--CCceeEEEEeeecCCCCCCcceeeEe
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRH--RNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      +.|+.|.++.||++...+ |..+++|+...... .....+..|++++..+.+  .++.+++.+.....  ..+..+++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            468999999999998743 57899999864322 134578899999999875  34566776643211  1124579999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN-----------------------------------  173 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-----------------------------------  173 (234)
                      +++|.++.+.+.. .      .+++.+...++.+++..+..+|+.                                   
T Consensus        81 ~i~G~~l~~~~~~-~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          81 RVDGRVLRDRLLR-P------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EeCCEecCCCCCC-C------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            9998776654321 0      233333344444555555555431                                   


Q ss_pred             ------------------CCCCeeecCCCCCCeeeCC--CCceEEccCccccc
Q 039258          174 ------------------CQPPMVHGDIKPSNVLLDN--DMVAHVGDFGLSKF  206 (234)
Q Consensus       174 ------------------~~~~ivH~dlk~~nil~~~--~~~vki~dfG~a~~  206 (234)
                                        ....++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                              1235799999999999988  56689999998774

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.21  E-value=3.2e-12  Score=113.63  Aligned_cols=171  Identities=26%  Similarity=0.354  Sum_probs=126.8

Q ss_pred             hcCCCCCceeecccceEEEEEEEC-CCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG-EDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~  120 (234)
                      ...|...+.||+|+|+.|-..... .....+|+|.+....  .........|..+-..+. |.|++.+++....     .
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-----~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-----P   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-----C
Confidence            345777778999999999887764 344567777765432  233345556777777776 9999999887533     3


Q ss_pred             CcceeeEeecCCCCHHHHhh-hccCCccccccCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecCCCCCCeeeCCCC-ceE
Q 039258          121 DFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDM-VAH  197 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~~~~ivH~dlk~~nil~~~~~-~vk  197 (234)
                      ...++++++.+++++++-+. ....     ..+...+-.++.|+..++.|+| ..   ++.|+|++|+|.+++..+ ..+
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~-----~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~  165 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDST-----GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK  165 (601)
T ss_pred             cccccccCcccccccccccccCCcc-----CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence            34689999999999998873 2211     2344556778999999999999 87   999999999999999888 999


Q ss_pred             EccCccccccCC-CccCCCCCCCCccccccc-cccccCC
Q 039258          198 VGDFGLSKFLSS-DHLDTASETPSSSIGIKG-TVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~-~~~~~~~~~~~~~~~~~g-t~~y~aP  234 (234)
                      ++|||+|..+.. .......      ...+| ++.|+||
T Consensus       166 ~~df~~At~~~~~~g~~~~~------~~~~g~s~~y~a~  198 (601)
T KOG0590|consen  166 IADFGLATAYRNKNGAERSL------KDRCGSSPPYGAP  198 (601)
T ss_pred             CCCchhhccccccCCcceee------ecccCCCCCCCCc
Confidence            999999998766 3332221      12567 8999987

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.20  E-value=5.1e-12  Score=99.27  Aligned_cols=137  Identities=24%  Similarity=0.435  Sum_probs=108.3

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEe
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      ..+|.+...|..|+|++++++  +++|+++...  ....+.|..|+..|+.+.||||..+++.|.++.     .+.++.+
T Consensus       195 ~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv~isq  267 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLVIISQ  267 (448)
T ss_pred             hhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----CceEeee
Confidence            446788899999999997654  6678876442  233477999999999999999999999996553     3689999


Q ss_pred             ecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      |++.++|+..+.+....    ...-.+++.++.+++.|+.|||+.. +-|-.--|.++++++|.+-+++|+
T Consensus       268 ~mp~gslynvlhe~t~v----vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSV----VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             eccchHHHHHHhcCccE----EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee
Confidence            99999999999876542    4556789999999999999999862 123344688999999988777664

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.18  E-value=1.1e-11  Score=112.81  Aligned_cols=141  Identities=24%  Similarity=0.253  Sum_probs=108.5

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-hhhH---HHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFR---SFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~~---~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++...+.||++.|=+|.+|++.+.  .|+||++-...+ -..+   +.++|+. ...+++||+..+.-+.     .+...
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            566778899999999999988544  388999854432 2223   3444555 5567899988776542     33444


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      -|+|-+|.. .+|++.+..+.      -+...+.+-|+.|++.|+.-+|..   +|+|+|||.+|||+..-+=+.++||.
T Consensus        96 AylvRqyvk-hnLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen   96 AYLVRQYVK-HNLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             HHHHHHHHh-hhhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence            578888984 59999998765      456667778999999999999999   99999999999999877778999998


Q ss_pred             ccc
Q 039258          203 LSK  205 (234)
Q Consensus       203 ~a~  205 (234)
                      .-+
T Consensus       166 sFK  168 (1431)
T KOG1240|consen  166 SFK  168 (1431)
T ss_pred             ccC
Confidence            654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.16  E-value=2.2e-11  Score=110.45  Aligned_cols=139  Identities=30%  Similarity=0.427  Sum_probs=91.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|...+++..|+||.||..+++.+.+++|+|+-+..-            +++     ||..+.+         +  .+
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------------ilR-----nilt~a~---------n--pf  133 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------------ILR-----NILTFAG---------N--PF  133 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccch------------hhh-----ccccccC---------C--cc
Confidence            457888999999999999999999999999996532110            111     1211111         0  13


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +|      ||-...++..+      .++.        +++.+++|+|+-   +|+|||+||.|.++..-|++|+.|||+.
T Consensus       134 vv------gDc~tllk~~g------~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs  190 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIG------PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS  190 (1205)
T ss_pred             ee------chhhhhcccCC------CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence            33      34444444433      2222        336789999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCC----CC---CCCccccccccccccCC
Q 039258          205 KFLSSDHLDTA----SE---TPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~----~~---~~~~~~~~~gt~~y~aP  234 (234)
                      +.-........    .+   ..-...++|||+.|+||
T Consensus       191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP  227 (1205)
T KOG0606|consen  191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP  227 (1205)
T ss_pred             hhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence            86432211110    00   00111237999999998

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.13  E-value=1.2e-09  Score=83.40  Aligned_cols=126  Identities=25%  Similarity=0.267  Sum_probs=79.0

Q ss_pred             EEEEEEECCCCeEEEEEEeecc--------------cc------------hhhHHHHHHHHHHHhcCCC--CceeEEEEe
Q 039258           61 SVYKGILGEDEMVVAVKVINLK--------------QK------------GAFRSFVAECEALRNIRHR--NLTKIITIC  112 (234)
Q Consensus        61 ~V~~~~~~~~~~~vavK~~~~~--------------~~------------~~~~~~~~e~~~l~~l~h~--~i~~l~~~~  112 (234)
                      .||.|.. ..+..+|+|+.+..              .+            .......+|.+.|.++...  ++++++.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3788876 45678999988521              00            0123567899999999755  567777652


Q ss_pred             eecCCCCCCcceeeEeecC--CCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHH-HHhCCCCCeeecCCCCCCee
Q 039258          113 SSIDSKGADFKALVFEYME--NGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY-LHHNCQPPMVHGDIKPSNVL  189 (234)
Q Consensus       113 ~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~-lh~~~~~~ivH~dlk~~nil  189 (234)
                          .     .+|||||++  |..+..+....        ++......++.+++..+.. +|..   |++|+||.+.||+
T Consensus        80 ----~-----~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl  139 (188)
T PF01163_consen   80 ----R-----NVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL  139 (188)
T ss_dssp             ----T-----TEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred             ----C-----CEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence                1     379999998  54444433221        1112334566677775555 5677   9999999999999


Q ss_pred             eCCCCceEEccCccccccC
Q 039258          190 LDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       190 ~~~~~~vki~dfG~a~~~~  208 (234)
                      ++.+ .+.++|||.+....
T Consensus       140 v~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  140 VDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             EETT-CEEE--GTTEEETT
T ss_pred             eecc-eEEEEecCcceecC
Confidence            9877 89999999877543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.11  E-value=2.4e-10  Score=86.31  Aligned_cols=73  Identities=23%  Similarity=0.282  Sum_probs=61.3

Q ss_pred             CCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCCcc
Q 039258          133 GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL  212 (234)
Q Consensus       133 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~  212 (234)
                      |+|.+++...+.     .+++..+..++.|++.||.|+|++   +      ||+||+++.++.+|+  ||++....... 
T Consensus         1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-
Confidence            588898876442     588999999999999999999987   5      999999999999999  99988654321 


Q ss_pred             CCCCCCCCccccccccccccCC
Q 039258          213 DTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       213 ~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                                  ..||+.||||
T Consensus        64 ------------~~g~~~y~aP   73 (176)
T smart00750       64 ------------SRVDPYFMAP   73 (176)
T ss_pred             ------------CCCcccccCh
Confidence                        2488999998

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=8.5e-09  Score=83.16  Aligned_cols=146  Identities=13%  Similarity=0.036  Sum_probs=94.9

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecccc-h----------hhHHHHHHHHHHHhcCCCC--ceeEEEEeeecCCC
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-G----------AFRSFVAECEALRNIRHRN--LTKIITICSSIDSK  118 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~----------~~~~~~~e~~~l~~l~h~~--i~~l~~~~~~~~~~  118 (234)
                      +.+-......|.+...  .|+.+.||....... .          ....+.+|...+..+...+  .+.++.+.+.....
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3444444444666654  456789996632210 0          0114778888888774322  33444443321111


Q ss_pred             CCCcceeeEeecCCC-CHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-----
Q 039258          119 GADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-----  192 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-----  192 (234)
                      ....-++|||++++. +|.+++......    .........++.+++..+.-||+.   |++|+|+++.|||++.     
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~----~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATN----PPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence            122347999999875 788887542111    234455668889999999999999   9999999999999974     


Q ss_pred             --CCceEEccCccccc
Q 039258          193 --DMVAHVGDFGLSKF  206 (234)
Q Consensus       193 --~~~vki~dfG~a~~  206 (234)
                        +..+.++||+.+..
T Consensus       179 ~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        179 EEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCceEEEEECCcccc
Confidence              46789999998864

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.03  E-value=4.2e-10  Score=96.56  Aligned_cols=98  Identities=34%  Similarity=0.578  Sum_probs=84.9

Q ss_pred             HhcCCCCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 039258           98 RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP  177 (234)
Q Consensus        98 ~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~  177 (234)
                      +.+.|.|+.+++|.+...     ...++|.+||..|+|.+.+....     ..+.+.....+.++++.|+.|+|..   +
T Consensus         2 ~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~s---~   68 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHNS---P   68 (484)
T ss_pred             cccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhcC---c
Confidence            467899999999998654     34689999999999999998743     2567777888999999999999987   5


Q ss_pred             e-eecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          178 M-VHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       178 i-vH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      | .|+.+++.|+++|..+.+|++|||+.....
T Consensus        69 i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   69 IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             ceeeeeeccccceeeeeEEEEechhhhccccc
Confidence            5 899999999999999999999999988774

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.01  E-value=3.5e-09  Score=83.81  Aligned_cols=142  Identities=25%  Similarity=0.221  Sum_probs=98.5

Q ss_pred             HHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc------------------cch----hhHHHHHHHHHH
Q 039258           40 ELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK------------------QKG----AFRSFVAECEAL   97 (234)
Q Consensus        40 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------------------~~~----~~~~~~~e~~~l   97 (234)
                      .+.....-..++..||-|.-+.||.|... .|.++|||.-+..                  ..+    ......+|.+.|
T Consensus        85 ~l~~r~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L  163 (304)
T COG0478          85 ALVKRGIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEAL  163 (304)
T ss_pred             HHHHcChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHH
Confidence            33333334567889999999999999885 6788999976421                  001    124567899999


Q ss_pred             HhcCCC--CceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 039258           98 RNIRHR--NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQ  175 (234)
Q Consensus        98 ~~l~h~--~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~  175 (234)
                      ..+...  .+.+.+++         +...+|||+++|..|...-.           .....-.+...|+.-+.-+-..  
T Consensus       164 ~~L~~~G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r~-----------~~en~~~il~~il~~~~~~~~~--  221 (304)
T COG0478         164 QRLYPEGVKVPKPIAW---------NRHAVVMEYIEGVELYRLRL-----------DVENPDEILDKILEEVRKAYRR--  221 (304)
T ss_pred             HHhhhcCCCCCCcccc---------ccceeeeehcccceeecccC-----------cccCHHHHHHHHHHHHHHHHHc--
Confidence            998643  66666665         22479999999876655431           1122233444455555544455  


Q ss_pred             CCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          176 PPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       176 ~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                       |+||+|+++=||+++.+|.+.++||==+.
T Consensus       222 -GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         222 -GIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             -CccccCCchheEEEecCCCEEEEeCcccc
Confidence             99999999999999999999999996443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.95  E-value=4.5e-09  Score=91.86  Aligned_cols=125  Identities=19%  Similarity=0.249  Sum_probs=100.4

Q ss_pred             EEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhcc
Q 039258           64 KGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN  143 (234)
Q Consensus        64 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  143 (234)
                      .|..+.++.+|.|...+...........+.+..|+.++||||++++...+.     .+.+|||+|-+.  .|..++.+.+
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-----~~~~ylvTErV~--Pl~~~lk~l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-----EGTLYLVTERVR--PLETVLKELG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-----cCceEEEeeccc--cHHHHHHHhH
Confidence            466677888999999876655445667788999999999999999987643     335799999984  6777777544


Q ss_pred             CCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          144 DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                               ......-+.||+.||.|||+.|  +++|+++.-..+.++..|.-||.+|..+..
T Consensus       103 ---------~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~  154 (690)
T KOG1243|consen  103 ---------KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSK  154 (690)
T ss_pred             ---------HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence                     2344556789999999999664  899999999999999999999999987653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.89  E-value=2.4e-08  Score=77.74  Aligned_cols=111  Identities=25%  Similarity=0.303  Sum_probs=81.8

Q ss_pred             HHHHHHHHHHHhcCCC--CceeEEEEeeecCCCCCCcceeeEeecCCC-CHHHHhhhccCCccccccCHHHHHHHHHHHH
Q 039258           88 RSFVAECEALRNIRHR--NLTKIITICSSIDSKGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA  164 (234)
Q Consensus        88 ~~~~~e~~~l~~l~h~--~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~  164 (234)
                      .+..+|...+..+...  ..+..+.+........ ...++|+|++++. +|.+++....      ..+......++.+++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALA  128 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHH
Confidence            5677888887777532  3345555544432222 3347999999874 7999887633      133445677889999


Q ss_pred             HHHHHHHhCCCCCeeecCCCCCCeeeCCCC---ceEEccCccccccC
Q 039258          165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM---VAHVGDFGLSKFLS  208 (234)
Q Consensus       165 ~~l~~lh~~~~~~ivH~dlk~~nil~~~~~---~vki~dfG~a~~~~  208 (234)
                      ..+.-||++   |++|+|+++.|||++.+.   .+.++||+-++...
T Consensus       129 ~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  129 RLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            999999999   999999999999998776   89999999877543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.88  E-value=8.2e-08  Score=74.06  Aligned_cols=142  Identities=19%  Similarity=0.130  Sum_probs=97.6

Q ss_pred             ecccceEEEEEEECCCCeEEEEEEeecc-c-----chhhHHHHHHHHHHHhcCC--CCceeEEEEeeecCCCCCCcceee
Q 039258           55 GQGSYGSVYKGILGEDEMVVAVKVINLK-Q-----KGAFRSFVAECEALRNIRH--RNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        55 G~G~fg~V~~~~~~~~~~~vavK~~~~~-~-----~~~~~~~~~e~~~l~~l~h--~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      |+||.+-|+.-...+.  .+=+|.-... .     +-....|.+|+..+..+..  -.+.+.. ++..........-+||
T Consensus        27 ~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            5688888888765333  4667765310 0     2234689999999998853  2344444 2221112223335799


Q ss_pred             EeecCC-CCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc--eEEccCcc
Q 039258          127 FEYMEN-GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV--AHVGDFGL  203 (234)
Q Consensus       127 ~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~--vki~dfG~  203 (234)
                      +|-+++ .+|.+++.+..-.    +.+......+..+++..+.-||+.   |+.|+|+.+.||+++.++.  ++++||.-
T Consensus       104 Te~L~g~~~L~~~l~~~~~~----~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk  176 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVS----PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEK  176 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcC----CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence            997753 5899888654311    345555678889999999999999   9999999999999986666  99999987


Q ss_pred             ccc
Q 039258          204 SKF  206 (234)
Q Consensus       204 a~~  206 (234)
                      ++.
T Consensus       177 ~r~  179 (216)
T PRK09902        177 SRR  179 (216)
T ss_pred             cch
Confidence            764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.80  E-value=5.8e-09  Score=89.95  Aligned_cols=153  Identities=27%  Similarity=0.314  Sum_probs=116.7

Q ss_pred             hcCCCCCceeec--ccceEEEEEEE--CCCCeEEEEEEee--cccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQ--GSYGSVYKGIL--GEDEMVVAVKVIN--LKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~--G~fg~V~~~~~--~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~  117 (234)
                      ...|...+-+|.  |.+|.||.+..  ..++..+|+|.-+  ...+....+=.+|+.-.++++ |+|.++.+..+     
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----  187 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----  187 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----
Confidence            345666778999  99999999888  7788889999743  222233333356676666774 88988866654     


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHH----HHHHHHhCCCCCeeecCCCCCCeeeCCC
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS----AIEYLHHNCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~----~l~~lh~~~~~~ivH~dlk~~nil~~~~  193 (234)
                      .+.+.+++-+|++ +.+|.++.....+     .++....+....+...    |+.++|..   +++|-|++|+|+....+
T Consensus       188 e~~~~lfiqtE~~-~~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~  258 (524)
T KOG0601|consen  188 EGSGILFIQTELC-GESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSD  258 (524)
T ss_pred             ccCCcceeeeccc-cchhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccc
Confidence            3445578889988 5688888776553     3566677778888888    99999999   99999999999999888


Q ss_pred             -CceEEccCccccccCCCc
Q 039258          194 -MVAHVGDFGLSKFLSSDH  211 (234)
Q Consensus       194 -~~vki~dfG~a~~~~~~~  211 (234)
                       ...++.|||+.....+..
T Consensus       259 ~~s~~~~df~~v~~i~~~~  277 (524)
T KOG0601|consen  259 WTSCKLTDFGLVSKISDGN  277 (524)
T ss_pred             cceeecCCcceeEEccCCc
Confidence             788999999988776654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.79  E-value=4.9e-08  Score=83.42  Aligned_cols=148  Identities=15%  Similarity=0.166  Sum_probs=110.7

Q ss_pred             eEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecCC-CCHHHH
Q 039258           60 GSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMEN-GSLEDW  138 (234)
Q Consensus        60 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~  138 (234)
                      .+.|+|...-+|..|++|.+...........-.-++.++++.|+|+|.+.+++..... +..-+++|++|.++ ++|.++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHHHH
Confidence            4689999988999999999953322222122234778899999999999988763332 34457899999875 467775


Q ss_pred             hhhc-cC--------CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          139 LHQT-ND--------HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       139 l~~~-~~--------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      --.. ..        .......++...+.++.|+..||.++|+.   |..-+-|.+.+|+++.+.+++|+.-|+...+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            3221 11        12233567788999999999999999999   999999999999999888999998888777666


Q ss_pred             Cc
Q 039258          210 DH  211 (234)
Q Consensus       210 ~~  211 (234)
                      +.
T Consensus       446 d~  447 (655)
T KOG3741|consen  446 DP  447 (655)
T ss_pred             CC
Confidence            55

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=1.6e-07  Score=81.97  Aligned_cols=142  Identities=18%  Similarity=0.211  Sum_probs=85.9

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeeccc----------------------ch------------hhH------HHH
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ----------------------KG------------AFR------SFV   91 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------------------~~------------~~~------~~~   91 (234)
                      ..|+.++-|.||+|+... |+.||||+....-                      +.            ..+      ++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            578999999999999854 8999999885210                      00            001      234


Q ss_pred             HHHHHHHhcC-----CCCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHH
Q 039258           92 AECEALRNIR-----HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA  166 (234)
Q Consensus        92 ~e~~~l~~l~-----h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~  166 (234)
                      +|+..+..+.     .++ +.+=.++.....    .-.++|||++|..+.+.......     ......+.....++..-
T Consensus       210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~----~~VLtmE~i~Gi~i~d~~~l~~~-----g~d~k~ia~~~~~~f~~  279 (517)
T COG0661         210 REAANAERFRENFKDDPD-VYVPKVYWEYTT----RRVLTMEWIDGIKISDIAALKSA-----GIDRKELAELLVRAFLR  279 (517)
T ss_pred             HHHHHHHHHHHHcCCCCC-eEeceeehhccC----CcEEEEEeeCCEecccHHHHHhc-----CCCHHHHHHHHHHHHHH
Confidence            4555555442     233 222223221111    13799999999988887432211     12212222211121111


Q ss_pred             HHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       167 l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      .-+-|     |..|.|..|.||+++.++++.+.|||+...+.+
T Consensus       280 q~~~d-----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         280 QLLRD-----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHhc-----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            11223     899999999999999999999999999876554

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.61  E-value=1.4e-06  Score=67.60  Aligned_cols=143  Identities=17%  Similarity=0.175  Sum_probs=85.1

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHH---------HHHHHHHHHhcCC---CCceeEEEE
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS---------FVAECEALRNIRH---RNLTKIITI  111 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h---~~i~~l~~~  111 (234)
                      ..++|...+.+-......|-+-.-  .+..+.+|..........+.         ..+.+..+.++..   .....++-+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            345677777777766666665544  45678899876432221111         2233333333322   122222222


Q ss_pred             eeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                      .+-....-....+++|||++|..|.+...          +++    .+...+.+++.-+|..   |+.|+|..|.|++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~  169 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS  169 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence            21111111122368999999987766532          111    2334577788999999   999999999999998


Q ss_pred             CCCceEEccCccccc
Q 039258          192 NDMVAHVGDFGLSKF  206 (234)
Q Consensus       192 ~~~~vki~dfG~a~~  206 (234)
                      .+ .++++||+..+.
T Consensus       170 ~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  170 NN-GIRIIDTQGKRM  183 (229)
T ss_pred             CC-cEEEEECccccc
Confidence            55 599999987664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.58  E-value=5.7e-08  Score=83.91  Aligned_cols=149  Identities=23%  Similarity=0.273  Sum_probs=107.7

Q ss_pred             HHhcCCCCCceeecccceEEEEEEEC-CCCeEEEEEEeecccch--hhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILG-EDEMVVAVKVINLKQKG--AFRSFVAECEALRNI-RHRNLTKIITICSSIDSK  118 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~  118 (234)
                      ....+|..+..||.|.|+.|+.+..+ .++..|++|-+...-..  ....-+.|+-+...+ .|.+++..+..+...+  
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r--  339 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR--  339 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc--
Confidence            34567888999999999999988866 67788999877532111  111224455555555 4777777655443222  


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC-CceE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND-MVAH  197 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~-~~vk  197 (234)
                         ..++-.||++++++...+....      .+.+...+.+..|++.++.++|++   .++|+|++|+||++.++ +.-+
T Consensus       340 ---~~~ip~e~~~~~s~~l~~~~~~------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~  407 (524)
T KOG0601|consen  340 ---QGYIPLEFCEGGSSSLRSVTSQ------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSK  407 (524)
T ss_pred             ---cccCchhhhcCcchhhhhHHHH------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhh
Confidence               2468899999988776653322      455566778889999999999998   99999999999999875 6778


Q ss_pred             EccCcccc
Q 039258          198 VGDFGLSK  205 (234)
Q Consensus       198 i~dfG~a~  205 (234)
                      +.|||...
T Consensus       408 ~~~~~~~t  415 (524)
T KOG0601|consen  408 LGDFGCWT  415 (524)
T ss_pred             cccccccc
Confidence            88998775

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.58  E-value=9.2e-07  Score=66.00  Aligned_cols=131  Identities=20%  Similarity=0.225  Sum_probs=87.6

Q ss_pred             CCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCce-eEEEEeeecCCCCCCcceeeE
Q 039258           49 SQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT-KIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      ...+.|++|++|.||+|.++.  ..+|+|+-..  ++....+..|+++|..+...++. +++.+-.         .++.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---------~~i~m   91 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRG--GEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE---------DFIRM   91 (201)
T ss_pred             hhhhhhhcccccEEEEeeccC--ceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech---------hhhhh
Confidence            446689999999999999854  4789998643  33447788999999999876654 4554421         25779


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC-CCCeeeCCCCceEEccCccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIK-PSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk-~~nil~~~~~~vki~dfG~a~~  206 (234)
                      ||++|.+|.+......         -.+    ...++..---|-..   ||-|+.|. |...++.+++.+.|+||..|+.
T Consensus        92 e~i~G~~L~~~~~~~~---------rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          92 EYIDGRPLGKLEIGGD---------RKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhcCcchhhhhhccc---------HHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9999988887755321         011    12233332233334   88888875 4444555555899999999985


Q ss_pred             cC
Q 039258          207 LS  208 (234)
Q Consensus       207 ~~  208 (234)
                      ..
T Consensus       156 k~  157 (201)
T COG2112         156 KK  157 (201)
T ss_pred             cc
Confidence            43

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.47  E-value=1.7e-07  Score=75.99  Aligned_cols=103  Identities=23%  Similarity=0.426  Sum_probs=83.0

Q ss_pred             HHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhC
Q 039258           94 CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN  173 (234)
Q Consensus        94 ~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~  173 (234)
                      ++.+-.+-|.|+++++.++.+....+.....++.||+..|++.+++++-....  ..+.......++.||+.||.|||+.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~--~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ--KALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh--hhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            44555566899999988876655555666788999999999999998743321  1566677789999999999999985


Q ss_pred             CCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          174 CQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       174 ~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                       .++|+|+++....+.+..++-+|+.
T Consensus       196 -~PpiihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  196 -DPPIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             -CCccccCCcchhheeecCCceEEec
Confidence             7789999999999999999988874

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.45  E-value=5.1e-06  Score=65.55  Aligned_cols=142  Identities=14%  Similarity=0.185  Sum_probs=78.7

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCC--ceeEEEEeeecCCCCCCcceeeEee
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRN--LTKIITICSSIDSKGADFKALVFEY  129 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~l~~~~~~~~~~~~~~~~lv~e~  129 (234)
                      ..||+|..+.||+.    .+..+++|......  ......+|.+++..+....  +.+.+.+...     .....+|||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-----~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVED-----GGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEec-----CCeeeeeeee
Confidence            46899999999984    23457788875322  2245678999998875333  3555665422     2224689999


Q ss_pred             cCCCC-HH--------------HHhhh-----ccCCccccccCHHHHHHHHH----------HHHH-HHHHHHhC-CCCC
Q 039258          130 MENGS-LE--------------DWLHQ-----TNDHLEVFKLSLIQRVNIAI----------DVAS-AIEYLHHN-CQPP  177 (234)
Q Consensus       130 ~~~~~-L~--------------~~l~~-----~~~~~~~~~~~~~~~~~~~~----------qi~~-~l~~lh~~-~~~~  177 (234)
                      ++|.+ +.              ..+..     +.-......+... ...+..          .+.. ...++... ....
T Consensus        76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            98853 11              11111     1000000011100 000000          0111 11222211 1335


Q ss_pred             eeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          178 MVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       178 ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      ++|+|+.|.|++++.++ +.++||+.+..
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            78999999999999877 99999998774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=2.7e-06  Score=74.43  Aligned_cols=138  Identities=21%  Similarity=0.254  Sum_probs=86.0

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecccc-------------------------------hhhH------HHHHHH
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-------------------------------GAFR------SFVAEC   94 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-------------------------------~~~~------~~~~e~   94 (234)
                      +.||.-+.|.||+|+.++ |+.||||+=+..-+                               ...+      +|.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            478999999999999876 88999997642100                               0011      245555


Q ss_pred             HHHHhc----CCCC------ceeEEEEeeecCCCCCCcceeeEeecCCCCHHHH--hhhccCCccccccCHHHHHHHHHH
Q 039258           95 EALRNI----RHRN------LTKIITICSSIDSKGADFKALVFEYMENGSLEDW--LHQTNDHLEVFKLSLIQRVNIAID  162 (234)
Q Consensus        95 ~~l~~l----~h~~------i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~~~~~~~q  162 (234)
                      +...++    .|-+      |.+++--+.       ..-.|+|||++|..+.+.  +.+.+       .+...+.....+
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s-------t~RVLtME~~~G~~i~Dl~~i~~~g-------i~~~~i~~~l~~  311 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS-------TKRVLTMEYVDGIKINDLDAIDKRG-------ISPHDILNKLVE  311 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC-------cceEEEEEecCCccCCCHHHHHHcC-------CCHHHHHHHHHH
Confidence            554443    2434      333333221       113799999999876664  44433       333333333333


Q ss_pred             HHHHHHHHHhCCCCCeeecCCCCCCeeeC----CCCceEEccCccccccCC
Q 039258          163 VASAIEYLHHNCQPPMVHGDIKPSNVLLD----NDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       163 i~~~l~~lh~~~~~~ivH~dlk~~nil~~----~~~~vki~dfG~a~~~~~  209 (234)
                      ...-+-+.|     |.+|.|-.|.||++.    .++.+.+.|||+......
T Consensus       312 ~~~~qIf~~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  312 AYLEQIFKT-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHHHhc-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            322222333     899999999999997    367899999999876543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.35  E-value=1.1e-05  Score=63.55  Aligned_cols=152  Identities=20%  Similarity=0.214  Sum_probs=96.3

Q ss_pred             cChHHHHHHhcCCCCCc---eeecccceEEEEEEECCCCeEEEEEEeeccc-------------------chhhHH----
Q 039258           36 VSYAELSKATCEFSQSN---MIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-------------------KGAFRS----   89 (234)
Q Consensus        36 ~~~~~~~~~~~~~~~~~---~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------~~~~~~----   89 (234)
                      .+...+........+..   .|++|.-+.||+|.. .++..+|+|+.+...                   +...++    
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            34444444445554444   455677778999875 457889999986321                   001111    


Q ss_pred             -HHHHHHHHHhcC--CCCceeEEEEeeecCCCCCCcceeeEeecCCC-CHHHHhhhccCCccccccCHHHHHHHHHHHHH
Q 039258           90 -FVAECEALRNIR--HRNLTKIITICSSIDSKGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS  165 (234)
Q Consensus        90 -~~~e~~~l~~l~--h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~  165 (234)
                       ..+|+..|.++.  +-.+.+.+.+.         ...||||++... .-+-.+.       ....+...+..+..++++
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-------Dv~~e~~e~~~~~~~~v~  177 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRLK-------DVPLELEEAEGLYEDVVE  177 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCcc-------cCCcCchhHHHHHHHHHH
Confidence             345777777775  33445555543         137999999432 1111111       112333356677788888


Q ss_pred             HHHHHHh-CCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          166 AIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       166 ~l~~lh~-~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      .+.-|-. .   ++||+||+.=|||+. ++.+.|+|||=|....
T Consensus       178 ~~~~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         178 YMRRLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHhc---CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            8887776 5   999999999999999 8899999999776443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.23  E-value=2.2e-05  Score=61.55  Aligned_cols=150  Identities=20%  Similarity=0.258  Sum_probs=81.8

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCC--CceeEEEEeeecCCCCCCcceeeEe
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHR--NLTKIITICSSIDSKGADFKALVFE  128 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~l~~~~~~~~~~~~~~~~lv~e  128 (234)
                      .+.++.|..+.||+.....  ..+++|.....  .....+..|..++..+...  .+.+++......  ......+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEEEE
Confidence            3568999999999998755  47899987533  3446677888888877522  355666543222  22333689999


Q ss_pred             ecCCCCHHH----------------Hhhhc-cCCccccccCHH---------HHHHH------------HHHHHH-HHHH
Q 039258          129 YMENGSLED----------------WLHQT-NDHLEVFKLSLI---------QRVNI------------AIDVAS-AIEY  169 (234)
Q Consensus       129 ~~~~~~L~~----------------~l~~~-~~~~~~~~~~~~---------~~~~~------------~~qi~~-~l~~  169 (234)
                      ++++.++..                .+..- ............         .....            ...+.. .+..
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            999877766                11110 000000000000         00000            011222 2333


Q ss_pred             HHhC----CCCCeeecCCCCCCeeeC-CCCceEEccCccccc
Q 039258          170 LHHN----CQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKF  206 (234)
Q Consensus       170 lh~~----~~~~ivH~dlk~~nil~~-~~~~vki~dfG~a~~  206 (234)
                      +++.    ....++|+|+.+.||+++ .++.+-++||+.+..
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            3321    233699999999999998 666678999998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.08  E-value=2.9e-05  Score=59.41  Aligned_cols=104  Identities=21%  Similarity=0.240  Sum_probs=79.2

Q ss_pred             HHHHHHHhcCC-CCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHH
Q 039258           92 AECEALRNIRH-RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL  170 (234)
Q Consensus        92 ~e~~~l~~l~h-~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  170 (234)
                      .|.-++..+++ +++++++|.|-         -+++.||...+++...-..   -......+|..+..++.+++..+.++
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~---l~~~~~~~w~~R~~iA~~lL~~l~~l   75 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRP---LSQFLQSPWEQRAKIALQLLELLEEL   75 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccc---cccccccCHHHHHHHHHHHHHHHHHH
Confidence            47778888875 68999999982         2689999976655422000   00011467889999999999999999


Q ss_pred             HhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       171 h~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      +......+.-.|++++|+-++.++++|++|...+...
T Consensus        76 ~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   76 DHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             hcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            9864446777999999999999999999999876654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.02  E-value=0.00028  Score=54.25  Aligned_cols=130  Identities=22%  Similarity=0.348  Sum_probs=88.1

Q ss_pred             cCCCCCceeecccc-eEEEEEEECCCCeEEEEEEeec---cc-----------c-------hhhHHHHHHHHHHHhcCC-
Q 039258           46 CEFSQSNMIGQGSY-GSVYKGILGEDEMVVAVKVINL---KQ-----------K-------GAFRSFVAECEALRNIRH-  102 (234)
Q Consensus        46 ~~~~~~~~lG~G~f-g~V~~~~~~~~~~~vavK~~~~---~~-----------~-------~~~~~~~~e~~~l~~l~h-  102 (234)
                      .+++.++.||.|.- |.|++++.  .|..+|+|+...   ..           +       .....|..|+....+++. 
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67888999999999 99999988  566999999421   00           0       122457889888888753 


Q ss_pred             --CCc--eeEEEEeeecC-C------------CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHH
Q 039258          103 --RNL--TKIITICSSID-S------------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS  165 (234)
Q Consensus       103 --~~i--~~l~~~~~~~~-~------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~  165 (234)
                        .++  ++.+|+..... .            .......||.||++...               .++...    +.+|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~----~~~~~~  175 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRD----IPQMLR  175 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhH----HHHHHH
Confidence              344  77888774431 0            11222357778776532               122222    345666


Q ss_pred             HHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       166 ~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      -+..+|..   +|+-+|+++.|..     .-+|+|||.+
T Consensus       176 dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  176 DLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            78889988   9999999999975     2389999864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.00  E-value=0.00018  Score=57.33  Aligned_cols=144  Identities=15%  Similarity=0.076  Sum_probs=79.2

Q ss_pred             eecccc-eEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcceeeEeecC
Q 039258           54 IGQGSY-GSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKALVFEYME  131 (234)
Q Consensus        54 lG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~  131 (234)
                      |-.|.+ +.||+....  +..+.+|+.....   .....+|++++..+. +--+.+++++....     +..++|||+++
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e~i~   75 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLTSAVP   75 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEEEeeC
Confidence            344555 679988653  3568888875332   234567888888774 33355666654321     23479999998


Q ss_pred             CCCHHHHh----------------hh-ccCCccccccCH--HHHHHHHH--------------------HHHHHHHHHHh
Q 039258          132 NGSLEDWL----------------HQ-TNDHLEVFKLSL--IQRVNIAI--------------------DVASAIEYLHH  172 (234)
Q Consensus       132 ~~~L~~~l----------------~~-~~~~~~~~~~~~--~~~~~~~~--------------------qi~~~l~~lh~  172 (234)
                      |.++....                .. +.-......+..  ........                    ........+-.
T Consensus        76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  155 (244)
T cd05150          76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA  155 (244)
T ss_pred             CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence            87665431                10 100000001110  00000000                    01111222211


Q ss_pred             C----CCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          173 N----CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       173 ~----~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      .    .+..++|+|+.|.|+++++++.+.|+||+.+..-
T Consensus       156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g  194 (244)
T cd05150         156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA  194 (244)
T ss_pred             hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence            1    1235899999999999998777789999988753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=97.98  E-value=0.00018  Score=67.25  Aligned_cols=82  Identities=15%  Similarity=0.261  Sum_probs=54.3

Q ss_pred             CceeecccceEEEEEEECCCC--eEEEEEEeeccc-chhhHHHHHHHHHHHhcC-CCCc--eeEEEEeeecCCCCCCcce
Q 039258           51 SNMIGQGSYGSVYKGILGEDE--MVVAVKVINLKQ-KGAFRSFVAECEALRNIR-HRNL--TKIITICSSIDSKGADFKA  124 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~l~~~~~~~~~~~~~~~~  124 (234)
                      ...++.|.+..+|+......+  ..+++|...... ......+.+|+.+|..+. |+++  .+++.+|....  ..+..+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCCce
Confidence            567888999999988765432  467777764322 112346789999999985 6654  67777764322  123357


Q ss_pred             eeEeecCCCC
Q 039258          125 LVFEYMENGS  134 (234)
Q Consensus       125 lv~e~~~~~~  134 (234)
                      +|||+++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999998753

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.96  E-value=0.00044  Score=53.33  Aligned_cols=135  Identities=19%  Similarity=0.312  Sum_probs=86.3

Q ss_pred             CCceeecccceEEEEEEECCCCeEEEEEEeeccc----------------chhhHHHHHHHHHHHhcC------CCCcee
Q 039258           50 QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ----------------KGAFRSFVAECEALRNIR------HRNLTK  107 (234)
Q Consensus        50 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~  107 (234)
                      ....||+|+.=.||..-+   +....||+.....                ....++..+|+.....+.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            356799999998987422   2335788886443                122456677777666555      778999


Q ss_pred             EEEEeeecCCCCCCcceeeEeecC------CCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 039258          108 IITICSSIDSKGADFKALVFEYME------NGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHG  181 (234)
Q Consensus       108 l~~~~~~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~  181 (234)
                      ++|+..+...     .-+|+|.+.      ..+|.+++.+..       ++. ....   .+-.-..|+-+.   .|+.+
T Consensus        82 ~~G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~~~~-------~~~-~~~~---~L~~f~~~l~~~---~Iv~~  142 (199)
T PF10707_consen   82 FYGFVETNLG-----LGLVVELIRDADGNISPTLEDYLKEGG-------LTE-ELRQ---ALDEFKRYLLDH---HIVIR  142 (199)
T ss_pred             EeEEEecCCc-----eEEEEEEEECCCCCcCccHHHHHHcCC-------ccH-HHHH---HHHHHHHHHHHc---CCeec
Confidence            9998754332     467888763      237888886543       333 2222   233344567777   89999


Q ss_pred             CCCCCCeeeCC--CC--ceEEcc-Cccccc
Q 039258          182 DIKPSNVLLDN--DM--VAHVGD-FGLSKF  206 (234)
Q Consensus       182 dlk~~nil~~~--~~--~vki~d-fG~a~~  206 (234)
                      |++|.||++..  ++  .+.++| ||-...
T Consensus       143 dl~~~NIv~~~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  143 DLNPHNIVVQRRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             CCCcccEEEEecCCCceEEEEEeCCCCccc
Confidence            99999999942  22  466665 565443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.90  E-value=0.0002  Score=56.70  Aligned_cols=31  Identities=32%  Similarity=0.519  Sum_probs=25.9

Q ss_pred             CeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          177 PMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       177 ~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      .++|+|+.+.|++++..+..-|+||+.+..-
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            5899999999999987655569999987653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.74  E-value=0.0019  Score=55.22  Aligned_cols=76  Identities=20%  Similarity=0.142  Sum_probs=52.3

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecc----c---chhhHHHHHHHHHHHhcC---CCCceeEEEEeeecCCCCC
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLK----Q---KGAFRSFVAECEALRNIR---HRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~---h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+.||.|.+..||++....+++.+.||.-...    .   +...++...|.+.|..+.   ...+++++.+..       
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-------  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-------  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-------
Confidence            35789999999999998655468999986411    1   123466778888888763   245677776621       


Q ss_pred             CcceeeEeecCCC
Q 039258          121 DFKALVFEYMENG  133 (234)
Q Consensus       121 ~~~~lv~e~~~~~  133 (234)
                      ...++|||++++.
T Consensus       104 ~~~~lVME~L~~~  116 (401)
T PRK09550        104 ELAVTVMEDLSDH  116 (401)
T ss_pred             CCCEEEEecCCCc
Confidence            2247999998763

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.73  E-value=0.00033  Score=56.22  Aligned_cols=142  Identities=14%  Similarity=0.091  Sum_probs=75.4

Q ss_pred             eecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCc-eeEEEEeeecCCCCCCcceeeEeecCC
Q 039258           54 IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-TKIITICSSIDSKGADFKALVFEYMEN  132 (234)
Q Consensus        54 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~l~~~~~~~~~~~~~~~~lv~e~~~~  132 (234)
                      +..|-.+.+|+...  ++..+++|+.........-...+|..++..+....+ .+++...    .     -++||||++|
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~-----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----E-----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----C-----CEEEEEeccC
Confidence            44577788998763  456788887643322211134678888888753322 3444432    1     2589999987


Q ss_pred             CCHHH--------------Hhhh-ccCCccccccCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCCeeecC
Q 039258          133 GSLED--------------WLHQ-TNDHLEVFKLSLIQ-RVNIAIDV---------ASAIEYLHHN-----CQPPMVHGD  182 (234)
Q Consensus       133 ~~L~~--------------~l~~-~~~~~~~~~~~~~~-~~~~~~qi---------~~~l~~lh~~-----~~~~ivH~d  182 (234)
                      ..+..              .+.+ +.-......+.... ...+..++         ...+..+-..     .+..++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            55431              1111 11110011111111 11111111         1111112111     122589999


Q ss_pred             CCCCCeeeCCCCceEEccCcccccc
Q 039258          183 IKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      +.|.|++++.++ +.++||..|..-
T Consensus       153 l~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       153 VHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             CCcCcEEEeCCC-CEEEeccccCcC
Confidence            999999998776 789999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.69  E-value=0.0015  Score=53.70  Aligned_cols=79  Identities=9%  Similarity=0.042  Sum_probs=53.4

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCC---CCceeEEEEeeecCCCCCCcceeeE
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH---RNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      .+.||.|..+.||...... + .+.+|..+..  .....+..|.+.|+.+..   ..+.++++++....  ..+..++||
T Consensus        19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVm   92 (297)
T PRK10593         19 VECISEQPYAALWALYDSQ-G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLL   92 (297)
T ss_pred             eeecCCccceeEEEEEcCC-C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEE
Confidence            5579999999999976432 2 4677875321  122578899999988853   35778887764321  123358999


Q ss_pred             eecCCCCH
Q 039258          128 EYMENGSL  135 (234)
Q Consensus       128 e~~~~~~L  135 (234)
                      |++++.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99987654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=97.61  E-value=1.2e-05  Score=74.17  Aligned_cols=145  Identities=21%  Similarity=0.246  Sum_probs=97.8

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+.+.+-+-+|.++.+..+....++...+.|+.....   ....+....+-.++....+|-++....-+     .-....
T Consensus       805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rsP~  879 (1205)
T KOG0606|consen  805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRSPL  879 (1205)
T ss_pred             cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCCCc
Confidence            4556667788999999998887777666666654321   11223333343344444556555443321     122336


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      .++++|+.+++|.+.+.+.+.      ....-+..+...+.++.++||..   .++|+|++|.|.+...++..++.|||.
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGC------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCC------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccc
Confidence            799999999999999887652      22222334445677889999987   789999999999999999999999985


Q ss_pred             cc
Q 039258          204 SK  205 (234)
Q Consensus       204 a~  205 (234)
                      ..
T Consensus       951 ~~  952 (1205)
T KOG0606|consen  951 LS  952 (1205)
T ss_pred             cc
Confidence            44

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.60  E-value=0.0011  Score=52.40  Aligned_cols=74  Identities=16%  Similarity=0.173  Sum_probs=44.9

Q ss_pred             ceeecccceEEEEEEECC-CCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCC-ceeEEEEeeecCCCCCCcceeeEee
Q 039258           52 NMIGQGSYGSVYKGILGE-DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRN-LTKIITICSSIDSKGADFKALVFEY  129 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~l~~~~~~~~~~~~~~~~lv~e~  129 (234)
                      +.|..|-...+|++.... .+..+++|+........ -...+|+.++..+...+ .++++...   ..      .++|||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~---~~------~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATF---QN------GLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEe---CC------cEEEEe
Confidence            456778888999987543 34678899775332211 22346888888875333 34444432   11      479999


Q ss_pred             cCCCCH
Q 039258          130 MENGSL  135 (234)
Q Consensus       130 ~~~~~L  135 (234)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            987654

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.47  E-value=5.5e-05  Score=66.78  Aligned_cols=150  Identities=18%  Similarity=0.155  Sum_probs=96.1

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCC-ceeEEEEeeecCCCCCCcceeeEeec
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRN-LTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      +-.++|+++++++.+...++... .+.+...     ....-++++|-+++||| .+..++     +.+.+++.+++|+++
T Consensus       248 h~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLWIPMRIC  316 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccc-----cCCcccccchhhhhh
Confidence            45678999999998877665544 6665432     33345788999999999 333333     235567789999999


Q ss_pred             CCC-CHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          131 ENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       131 ~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      .++ +-......     ....+...+...+.+.-..+++++|+.   .-+|+|    ||+... +..+..||+....+..
T Consensus       317 s~~rs~~~~~~~-----se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  317 STGRSSALEMTV-----SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             cCCccccccCCh-----hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCc
Confidence            766 21111110     011233334445556667789999976   558888    665544 6789999998887665


Q ss_pred             CccCCCCCCCCccccccccccccCC
Q 039258          210 DHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       210 ~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .....         .+.+|+.++||
T Consensus       384 ~~~~~---------t~~~~~~~~~p  399 (829)
T KOG0576|consen  384 TMKPR---------TAIGTPEPLAP  399 (829)
T ss_pred             ccccc---------cCCCCCCCCCc
Confidence            43111         25578888876

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.32  E-value=0.0042  Score=50.84  Aligned_cols=151  Identities=17%  Similarity=0.103  Sum_probs=79.8

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCC--ceeEEEEeeec-CCCCCCcceeeE
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRN--LTKIITICSSI-DSKGADFKALVF  127 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~l~~~~~~~-~~~~~~~~~lv~  127 (234)
                      .+.+..|....+|+....  +..+++|+...   ........|++++..+.+.+  +.+++...... .....+..++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            445677777889987642  33688898753   22345667788777774332  34443321000 001123357899


Q ss_pred             eecCCCCHHH-----------Hhhh---cc-CCccc----cccCHHHH----------HHHHHHHHHHHHHHHh----CC
Q 039258          128 EYMENGSLED-----------WLHQ---TN-DHLEV----FKLSLIQR----------VNIAIDVASAIEYLHH----NC  174 (234)
Q Consensus       128 e~~~~~~L~~-----------~l~~---~~-~~~~~----~~~~~~~~----------~~~~~qi~~~l~~lh~----~~  174 (234)
                      ++++|..+..           .+..   .. .....    ....+...          ......+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998765321           1111   00 00000    00011000          0011112233444432    12


Q ss_pred             CCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          175 QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       175 ~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      +.+++|+|+.|.|++++.++.+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            34799999999999999877778999988764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.27  E-value=0.00038  Score=57.25  Aligned_cols=131  Identities=20%  Similarity=0.201  Sum_probs=87.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecc------------------cchh----hHHHHHHHHHHHhcC-CC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK------------------QKGA----FRSFVAECEALRNIR-HR  103 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------------------~~~~----~~~~~~e~~~l~~l~-h~  103 (234)
                      -+..+..||-|.-+.+|.+-+. .|.+.++|+-...                  ...|    .-...+|+..|+.+. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4677889999999999999874 4567777754310                  0111    124677999999885 32


Q ss_pred             -CceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039258          104 -NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD  182 (234)
Q Consensus       104 -~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~d  182 (234)
                       -+++.++++         .-++|||++++-.|.+.-....            .-.+...+..-+--|-..   |+||+|
T Consensus       172 fpVPkpiD~~---------RH~Vvmelv~g~Pl~~v~~v~d------------~~~ly~~lm~~Iv~la~~---GlIHgD  227 (465)
T KOG2268|consen  172 FPVPKPIDHN---------RHCVVMELVDGYPLRQVRHVED------------PPTLYDDLMGLIVRLANH---GLIHGD  227 (465)
T ss_pred             CCCCCccccc---------ceeeHHHhhcccceeeeeecCC------------hHHHHHHHHHHHHHHHHc---Cceecc
Confidence             345555543         2489999998877765432221            111222233333344445   999999


Q ss_pred             CCCCCeeeCCCCceEEccCc
Q 039258          183 IKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG  202 (234)
                      ..-=||+++.++.++++||=
T Consensus       228 FNEFNimv~dd~~i~vIDFP  247 (465)
T KOG2268|consen  228 FNEFNIMVKDDDKIVVIDFP  247 (465)
T ss_pred             cchheeEEecCCCEEEeech
Confidence            99999999999999999995

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.23  E-value=0.011  Score=48.82  Aligned_cols=152  Identities=18%  Similarity=0.180  Sum_probs=77.8

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCC--CceeEEEEeeec-CCCCCCcceeeE
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHR--NLTKIITICSSI-DSKGADFKALVF  127 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~l~~~~~~~-~~~~~~~~~lv~  127 (234)
                      .+.++.|....+|+... .++ .+++|+.....  .......|.+++..+...  .+++++...... .....+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEe-CCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45566777778998764 233 57788765321  123345566667666422  234444321100 001123457999


Q ss_pred             eecCCCCHH-----------HHhhh---ccC-Cccc----ccc-CHHHH--H----------HHHHHHHHHHHHHHh---
Q 039258          128 EYMENGSLE-----------DWLHQ---TND-HLEV----FKL-SLIQR--V----------NIAIDVASAIEYLHH---  172 (234)
Q Consensus       128 e~~~~~~L~-----------~~l~~---~~~-~~~~----~~~-~~~~~--~----------~~~~qi~~~l~~lh~---  172 (234)
                      +|++|.++.           ..+..   ... ...+    ... .+...  .          .....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999874321           11111   000 0000    000 00000  0          001112334444432   


Q ss_pred             -CCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          173 -NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       173 -~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                       ..+.+++|+|+.+.|++++.++...++||+.+..
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence             2345899999999999998887678999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.21  E-value=0.011  Score=49.69  Aligned_cols=73  Identities=16%  Similarity=0.144  Sum_probs=48.0

Q ss_pred             eeecccceEEEEEEECCCCeEEEEEEeec--c--c---chhhHHHHHHHHHHHhcC--CC-CceeEEEEeeecCCCCCCc
Q 039258           53 MIGQGSYGSVYKGILGEDEMVVAVKVINL--K--Q---KGAFRSFVAECEALRNIR--HR-NLTKIITICSSIDSKGADF  122 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~--~---~~~~~~~~~e~~~l~~l~--h~-~i~~l~~~~~~~~~~~~~~  122 (234)
                      .||.|....||++....++..++||.-..  .  .   +-...+..-|.+.|....  -| .+++++.+-       ...
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------ccc
Confidence            57999999999999754446899997631  1  1   233456677888887653  23 456666542       222


Q ss_pred             ceeeEeecCC
Q 039258          123 KALVFEYMEN  132 (234)
Q Consensus       123 ~~lv~e~~~~  132 (234)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            4689999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK05231 homoserine kinase; Provisional

Probab=97.12  E-value=0.03  Score=46.37  Aligned_cols=32  Identities=25%  Similarity=0.351  Sum_probs=26.9

Q ss_pred             CCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          175 QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       175 ~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      +.+++|+|+.+.|++++.+...-++||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            55899999999999998665557999998763

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.89  E-value=0.032  Score=45.87  Aligned_cols=34  Identities=24%  Similarity=0.300  Sum_probs=28.7

Q ss_pred             CCCeeecCCCCCCeeeCCC----CceEEccCccccccC
Q 039258          175 QPPMVHGDIKPSNVLLDND----MVAHVGDFGLSKFLS  208 (234)
Q Consensus       175 ~~~ivH~dlk~~nil~~~~----~~vki~dfG~a~~~~  208 (234)
                      +..++|+|+.+.||+++.+    +.+.++||..|..-.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~  215 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY  215 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC
Confidence            4468999999999999874    789999999887543

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.81  E-value=0.021  Score=46.44  Aligned_cols=32  Identities=31%  Similarity=0.550  Sum_probs=26.3

Q ss_pred             CeeecCCCCCCeeeCCCCce-EEccCccccccC
Q 039258          177 PMVHGDIKPSNVLLDNDMVA-HVGDFGLSKFLS  208 (234)
Q Consensus       177 ~ivH~dlk~~nil~~~~~~v-ki~dfG~a~~~~  208 (234)
                      .++|+|+.+.|++++.++++ -|+||+.+..-+
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence            58999999999999875554 599999887643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.75  E-value=0.028  Score=47.99  Aligned_cols=75  Identities=17%  Similarity=0.185  Sum_probs=50.1

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeec--c-c---chhhHHHHHHHHHHHhcC--CC-CceeEEEEeeecCCCCCC
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINL--K-Q---KGAFRSFVAECEALRNIR--HR-NLTKIITICSSIDSKGAD  121 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~-~---~~~~~~~~~e~~~l~~l~--h~-~i~~l~~~~~~~~~~~~~  121 (234)
                      .+.||.|.-.-||++.+...+..++||+-..  . .   +-..++..-|.+.|....  -| .+++++.+-       ..
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence            4578999999999999843346789997631  1 1   223467777888887663  23 566676652       22


Q ss_pred             cceeeEeecCC
Q 039258          122 FKALVFEYMEN  132 (234)
Q Consensus       122 ~~~lv~e~~~~  132 (234)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            34689999864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.66  E-value=0.015  Score=49.02  Aligned_cols=137  Identities=20%  Similarity=0.249  Sum_probs=87.0

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeec-----ccc----------------hh-hHH----HHHHHHHHHhcCCCC
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINL-----KQK----------------GA-FRS----FVAECEALRNIRHRN  104 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~----------------~~-~~~----~~~e~~~l~~l~h~~  104 (234)
                      --.|..|.-+-||-+.. ..|..+|||+.+-     .++                .. .++    ...|+..|.+++...
T Consensus       149 nGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34677888889999876 4556799998862     110                00 111    245788888887665


Q ss_pred             ceeEEEEeeecCCCCCCcceeeEeecCCCC-HHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 039258          105 LTKIITICSSIDSKGADFKALVFEYMENGS-LEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDI  183 (234)
Q Consensus       105 i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dl  183 (234)
                      |...--..-      .. ..|||+++-... -.-.|+       ...++...+..+-.|++.-+.-|...|  ++||.||
T Consensus       228 IP~PePIlL------k~-hVLVM~FlGrdgw~aPkLK-------d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADL  291 (520)
T KOG2270|consen  228 IPCPEPILL------KN-HVLVMEFLGRDGWAAPKLK-------DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADL  291 (520)
T ss_pred             CCCCCceee------ec-ceEeeeeccCCCCcCcccc-------cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccch
Confidence            543221110      01 379999983211 111111       124555667777788888888887765  9999999


Q ss_pred             CCCCeeeCCCCceEEccCcccc
Q 039258          184 KPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       184 k~~nil~~~~~~vki~dfG~a~  205 (234)
                      .-=|+|+. +|.+.|+|-+=+.
T Consensus       292 SEfN~Lyh-dG~lyiIDVSQSV  312 (520)
T KOG2270|consen  292 SEFNLLYH-DGKLYIIDVSQSV  312 (520)
T ss_pred             hhhhheEE-CCEEEEEEccccc
Confidence            99999986 4578888876443

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.56  E-value=0.077  Score=45.54  Aligned_cols=73  Identities=15%  Similarity=0.144  Sum_probs=48.8

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecc----cc---hhhHHHHHHHHHHHhcC---CCCceeEEEEeeecCCCCC
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLK----QK---GAFRSFVAECEALRNIR---HRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+.+|.|....||+....  +..++||+-...    ..   ....+...|.+.|..+.   ...+++++.++.       
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-------  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-------  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-------
Confidence            457899999999998763  346889987511    11   23455566677776553   246778888763       


Q ss_pred             CcceeeEeecCC
Q 039258          121 DFKALVFEYMEN  132 (234)
Q Consensus       121 ~~~~lv~e~~~~  132 (234)
                      +..+++||++++
T Consensus       108 d~~vlvME~L~~  119 (418)
T PLN02756        108 TMALIGMRYLEP  119 (418)
T ss_pred             CCCEEEEeecCC
Confidence            224789999976

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.55  E-value=0.084  Score=43.24  Aligned_cols=74  Identities=23%  Similarity=0.261  Sum_probs=43.4

Q ss_pred             CCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC---CCCceeEEEEeeecCCCCCCcceee
Q 039258           50 QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR---HRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        50 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      ..+.++-|....+|+..  .++..+.||+-.   .....+|..|++-|+.+.   --.+++.+.+....+     .-+++
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-----~~fLl   90 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-----DAFLL   90 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----CCEEE
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----CceEE
Confidence            35578889999999876  566789999876   223366778888777773   345667777653322     23899


Q ss_pred             EeecCCC
Q 039258          127 FEYMENG  133 (234)
Q Consensus       127 ~e~~~~~  133 (234)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=96.50  E-value=0.042  Score=46.22  Aligned_cols=32  Identities=16%  Similarity=0.412  Sum_probs=27.1

Q ss_pred             CeeecCCCCCCeeeCC-CCceEEccCccccccC
Q 039258          177 PMVHGDIKPSNVLLDN-DMVAHVGDFGLSKFLS  208 (234)
Q Consensus       177 ~ivH~dlk~~nil~~~-~~~vki~dfG~a~~~~  208 (234)
                      .++|+|+++.||+++. ++.+.++||..+..-.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~  233 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASYNP  233 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence            5899999999999975 4689999999887543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=96.47  E-value=0.051  Score=46.58  Aligned_cols=145  Identities=14%  Similarity=0.130  Sum_probs=82.4

Q ss_pred             CCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeee--cCCCCCCccee
Q 039258           49 SQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSS--IDSKGADFKAL  125 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~--~~~~~~~~~~l  125 (234)
                      ..+..||+|+-+.+|..-.-.+   .+.|+..........   +.+..|... .||-+..-+-|-..  .....+..+-+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchhhc---hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            3467899999999996433222   356777544332211   222333333 45533220100000  00011111334


Q ss_pred             eEeecCCC-CHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          126 VFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       126 v~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .|..+++. .+..+..-..+......+.|...+..+++++.+...+|+.   |.+-+|+.++|+|+..++.+.+.|=.
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence            55555442 2333332221111122466788899999999999999999   99999999999999999998887644

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.44  E-value=0.075  Score=44.06  Aligned_cols=34  Identities=32%  Similarity=0.592  Sum_probs=29.2

Q ss_pred             CCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          176 PPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       176 ~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      ..++|+|+.+.|+++++.+.+-++||+++..-++
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            3589999999999999888889999999886443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.31  E-value=0.0081  Score=50.39  Aligned_cols=90  Identities=16%  Similarity=0.144  Sum_probs=59.9

Q ss_pred             CCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039258          103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD  182 (234)
Q Consensus       103 ~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~d  182 (234)
                      ..++.+...|... ..+..+.|++|++- |+++...-          .-.+++++.++.+.+.-+.-+..+.  ..=|||
T Consensus       282 ~g~~~~e~~~vv~-~de~~y~yl~~kdh-gt~is~ik----------~~~~~e~lsff~s~~sil~~lekkf--~fehrn  347 (488)
T COG5072         282 CGSVFLETLKVVS-LDETLYLYLHFKDH-GTPISIIK----------ADRSEEELSFFWSCISILDILEKKF--PFEHRN  347 (488)
T ss_pred             ccchhhhcceEEe-cCCceEEEEEEecC-Cceeeeee----------cccHHHHHHHHHHHHHHHhhhhhcC--Cccccc
Confidence            3444444444333 23455667888876 55553221          1224567778877666666565543  677999


Q ss_pred             CCCCCeeeCCCCceEEccCcccccc
Q 039258          183 IKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      +...|||++ .|+|.++||.+++.-
T Consensus       348 lt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         348 LTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ccccceeee-cCceEEEEeeeeecc
Confidence            999999999 999999999999953

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.91  E-value=0.3  Score=38.66  Aligned_cols=69  Identities=26%  Similarity=0.392  Sum_probs=42.5

Q ss_pred             eEEEEEEECCC-CeEEEEEEeecccchhhHHHHHHHHHHHhcCC---CCceeEEEEeeecCCCCCCcceeeEeecCCCCH
Q 039258           60 GSVYKGILGED-EMVVAVKVINLKQKGAFRSFVAECEALRNIRH---RNLTKIITICSSIDSKGADFKALVFEYMENGSL  135 (234)
Q Consensus        60 g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L  135 (234)
                      |.|..|..-.+ ..++.+|+-   .......|..|+.-|..+.-   -++.+.+.+-     ...++.++||||++.+.+
T Consensus        27 G~inea~~v~dg~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G-----~~~~~sylVle~L~~~~~   98 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVG-----ASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccccceeEeecCCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEec-----CCCCeeEEEEeeccCCCC
Confidence            45555554433 357788864   34445778888877776643   3455565542     334567999999986544


Q ss_pred             H
Q 039258          136 E  136 (234)
Q Consensus       136 ~  136 (234)
                      .
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            3

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.22  E-value=0.088  Score=45.08  Aligned_cols=58  Identities=22%  Similarity=0.235  Sum_probs=35.4

Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecCCCCCCeeeC
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~~~~ivH~dlk~~nil~~  191 (234)
                      .++-+|..|.++..++....       .++.-...++.-.+.|+.-+- -.   +.+|.|+.|.||++-
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~-------~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKS-------QPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIR  379 (565)
T ss_pred             eeeeeccccccHHhhhhccc-------ChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEE
Confidence            46667888888888887543       222222333333333333221 12   799999999999994

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.15  E-value=0.28  Score=41.06  Aligned_cols=30  Identities=20%  Similarity=0.392  Sum_probs=25.8

Q ss_pred             eeecCCCCCCeeeC-CCCceEEccCcccccc
Q 039258          178 MVHGDIKPSNVLLD-NDMVAHVGDFGLSKFL  207 (234)
Q Consensus       178 ivH~dlk~~nil~~-~~~~vki~dfG~a~~~  207 (234)
                      ..|+|+.+.||+++ .++.++++||..|..-
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            68999999999997 4578999999988753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=94.58  E-value=0.048  Score=49.08  Aligned_cols=45  Identities=22%  Similarity=0.499  Sum_probs=38.8

Q ss_pred             HHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       163 i~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      ++.|+.|+|..  .++||+++.|++|.++.++..||+.|+++.....
T Consensus       108 v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~  152 (700)
T KOG2137|consen  108 VADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG  152 (700)
T ss_pred             ccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCC
Confidence            44899999975  3899999999999999999999999998775444

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=93.83  E-value=0.026  Score=55.52  Aligned_cols=132  Identities=11%  Similarity=-0.010  Sum_probs=83.3

Q ss_pred             EEEEEeeccc-----chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccc
Q 039258           74 VAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEV  148 (234)
Q Consensus        74 vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  148 (234)
                      +.+++.+.-+     +...++.+.|.+.++.+.|+++.....-.   .+......++.++++.+|.+++.+.+......+
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI---~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ 1331 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRI---PPSESTEEYIRSLYVEFGKLFSIIIKGLEESPD 1331 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccC---CCCCChHHHHHHHHHHHhHHHHHHHhccccCCc
Confidence            3556654222     23345666777777778899876554432   233445568999999999999998765432111


Q ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCCeeeCCCCceEEccCccccccCCC
Q 039258          149 FKLSLIQRVNIAIDVASAIEYLHHNC--QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       149 ~~~~~~~~~~~~~qi~~~l~~lh~~~--~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~  210 (234)
                        ....-+.....+......-+|+..  ..-.+|+++++-|.++..+..+|+.++|++++..++
T Consensus      1332 --ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~ 1393 (2724)
T KOG1826|consen 1332 --LDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV 1393 (2724)
T ss_pred             --chhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch
Confidence              111112222222244455555432  224689999999999999999999999999955443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.70  E-value=0.17  Score=41.62  Aligned_cols=29  Identities=28%  Similarity=0.308  Sum_probs=25.3

Q ss_pred             CCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          176 PPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       176 ~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      .+++|+|+.+.|++++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999665

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PTZ00296 choline kinase; Provisional

Probab=93.69  E-value=1.1  Score=39.02  Aligned_cols=29  Identities=24%  Similarity=0.465  Sum_probs=24.3

Q ss_pred             CeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          177 PMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       177 ~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      ..+|.|+.+.|||.+.+ .++++||..|..
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg~  313 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSGY  313 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeeccccc
Confidence            57899999999987654 499999988774

>PTZ00384 choline kinase; Provisional

Probab=93.57  E-value=1.5  Score=37.61  Aligned_cols=29  Identities=28%  Similarity=0.265  Sum_probs=24.1

Q ss_pred             CeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          177 PMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       177 ~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      ...|.|+-+.||+.+. ..+.++||.-|..
T Consensus       228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~~  256 (383)
T PTZ00384        228 LFCHNDLFFTNILDFN-QGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeccCCcccEEecC-CCEEEEEeccccC
Confidence            5789999999998754 4699999987764

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.47  E-value=0.063  Score=40.95  Aligned_cols=31  Identities=13%  Similarity=0.107  Sum_probs=26.1

Q ss_pred             CeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          177 PMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       177 ~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      ..+|+|+.|.|++++.++ ++++||+.|..-+
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD  108 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGD  108 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence            468999999999998776 8999999887533

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.85  E-value=0.072  Score=41.34  Aligned_cols=30  Identities=27%  Similarity=0.584  Sum_probs=21.3

Q ss_pred             CeeecCCCCCCeee-CCCCceEEccCccccc
Q 039258          177 PMVHGDIKPSNVLL-DNDMVAHVGDFGLSKF  206 (234)
Q Consensus       177 ~ivH~dlk~~nil~-~~~~~vki~dfG~a~~  206 (234)
                      -+.|+|+.+.||++ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            57899999999999 7889999999998774

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=91.90  E-value=0.09  Score=37.03  Aligned_cols=45  Identities=24%  Similarity=0.186  Sum_probs=32.2

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHh
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRN   99 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~   99 (234)
                      ...||.|+.|.||+|+.+. |+.||||+.+..-   .+.+...+.+|..
T Consensus        16 ~~PlasASiaQVh~a~l~~-g~~VaVKV~rP~i---~~~i~~Dl~~l~~   60 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLKD-GEEVAVKVQRPGI---EEQIEADLRILRR   60 (119)
T ss_pred             cchhhheehhhheeeeecc-cchhhhhhcchHH---HHHHHHHHHHHHH
Confidence            3579999999999999854 7899999986432   2444455555543

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.84  E-value=0.16  Score=39.05  Aligned_cols=31  Identities=29%  Similarity=0.442  Sum_probs=26.0

Q ss_pred             CeeecCCCCCCeeeCCCC-----ceEEccCcccccc
Q 039258          177 PMVHGDIKPSNVLLDNDM-----VAHVGDFGLSKFL  207 (234)
Q Consensus       177 ~ivH~dlk~~nil~~~~~-----~vki~dfG~a~~~  207 (234)
                      .++|+|+.+.|+++..++     .+.++||..+..-
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g  156 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYG  156 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCCcC
Confidence            689999999999997443     5899999988753

subfamily of choline kinases

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=91.58  E-value=0.35  Score=39.96  Aligned_cols=32  Identities=25%  Similarity=0.378  Sum_probs=28.3

Q ss_pred             CCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          175 QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       175 ~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      +.+++|+|+.+.|++++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            44799999999999999988899999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=90.70  E-value=0.31  Score=38.48  Aligned_cols=87  Identities=11%  Similarity=0.165  Sum_probs=54.5

Q ss_pred             HHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHH
Q 039258           88 RSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI  167 (234)
Q Consensus        88 ~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l  167 (234)
                      .-+..+.+++++++  .|+++..      . +...+-+++|.|-.....              +     ..+..--+.+|
T Consensus       103 ~~y~nky~v~Armh--GilrL~N------D-n~~~yGvIlE~Cy~~~i~--------------~-----~N~i~agi~~L  154 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKN------D-NNYKYGVILERCYKIKIN--------------F-----SNFITAGIKDL  154 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeec------C-CCceeEEEEeeccCcccc--------------h-----hHHHHHhHHHH
Confidence            34566778887775  3555542      1 222346888988432110              0     11111113456


Q ss_pred             HHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       168 ~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      .-.|+. ..+.+|+|..|+||+.|..|.+|+.|-+.
T Consensus       155 ~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  155 MDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence            667743 33799999999999999999999999874

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=90.64  E-value=0.58  Score=45.23  Aligned_cols=33  Identities=27%  Similarity=0.388  Sum_probs=26.8

Q ss_pred             CCCCeeecCCCCCCeeeCCCC--ceE-EccCccccc
Q 039258          174 CQPPMVHGDIKPSNVLLDNDM--VAH-VGDFGLSKF  206 (234)
Q Consensus       174 ~~~~ivH~dlk~~nil~~~~~--~vk-i~dfG~a~~  206 (234)
                      .+.++||+|+.+.||+++.++  ++. |+|||-+..
T Consensus       201 Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        201 LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            355899999999999998764  565 999997653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	234
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-26
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-24
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-19
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-19
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-16
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-16
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-15
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-14
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-06
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-04
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-04
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		4e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-04
3soa_A	444	Full-Length Human Camkii Length = 444		5e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  113 bits (283), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFV 91
           Q    S  EL  A+  FS  N++G+G +G VYKG L +  +V   ++   + +G    F 
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKL 151
            E E +    HRNL ++   C +   +      LV+ YM NGS+   L +  +      L
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRERPESQP--PL 136
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
              +R  IA+  A  + YLH +C P ++H D+K +N+LLD +  A VGDFGL+K +  D+
Sbjct: 137 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DY 194
Query: 212 LDTASETPSSSIGIKGTVGYVAP 234
            D           ++GT+G++AP
Sbjct: 195 KDX-----HVXXAVRGTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFV 91
           Q    S  EL  A+  F   N++G+G +G VYKG L +  +V   ++   + +G    F 
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKL 151
            E E +    HRNL ++   C +   +      LV+ YM NGS+   L +  +      L
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRERPESQP--PL 128
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
              +R  IA+  A  + YLH +C P ++H D+K +N+LLD +  A VGDFGL+K +  D+
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DY 186
Query: 212 LDTASETPSSSIGIKGTVGYVAP 234
            D           ++G +G++AP
Sbjct: 187 KDX-----HVXXAVRGXIGHIAP 204

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 25  DTLPMEKQFPMVSY----AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN 80
           D L      P  SY     +L +AT  F    +IG G +G VYKG+L  D   VA+K   
Sbjct: 14  DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRT 72
Query: 81  LKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
            +       F  E E L   RH +L  +I  C   +        L+++YMENG+L+  L+
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLY 127
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
            ++  L    +S  QR+ I I  A  + YLH      ++H D+K  N+LLD + V  + D
Sbjct: 128 GSD--LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182
Query: 201 FGLSKF---LSSDHLDTASETPSSSIGIKGTVGYVAP 234
           FG+SK    L   HL            +KGT+GY+ P
Sbjct: 183 FGISKKGTELGQTHLXXV---------VKGTLGYIDP 210

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 25  DTLPMEKQFPMVSY----AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN 80
           D L      P  SY     +L +AT  F    +IG G +G VYKG+L  D   VA+K   
Sbjct: 14  DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRT 72
Query: 81  LKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
            +       F  E E L   RH +L  +I  C   +        L+++YMENG+L+  L+
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLY 127
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
            ++  L    +S  QR+ I I  A  + YLH      ++H D+K  N+LLD + V  + D
Sbjct: 128 GSD--LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182
Query: 201 FGLSKF---LSSDHLDTASETPSSSIGIKGTVGYVAP 234
           FG+SK    L   HL            +KGT+GY+ P
Sbjct: 183 FGISKKGTELDQTHLXXV---------VKGTLGYIDP 210

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 93/191 (48%), Gaps = 22/191 (11%)
Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLTKIIT 110
           +IG+G YG+VYKG L  DE  VAVKV +   +   ++F+ E    R   + H N+ + I 
Sbjct: 20  LIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIV 74
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
               + + G     LV EY  NGSL  +L   T+D         +    +A  V   + Y
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD--------WVSSCRLAHSVTRGLAY 126
Query: 170 LH------HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
           LH       + +P + H D+   NVL+ ND    + DFGLS  L+ + L    E  +++I
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 224 GIKGTVGYVAP 234
              GT+ Y+AP
Sbjct: 187 SEVGTIRYMAP 197

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 30  EKQFPMVSYAELSKATCEFSQ------SNMIGQGSYGSVYKGILGEDEMVVAVK----VI 79
           + +F   S+ EL   T  F +       N +G+G +G VYKG +  +   VAVK    ++
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 66
Query: 80  NLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL 139
           ++  +   + F  E + +   +H NL +++       S G D   LV+ YM NGSL D L
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGSLLDRL 121
Query: 140 HQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG 199
              +       LS   R  IA   A+ I +LH N     +H DIK +N+LLD    A + 
Sbjct: 122 SCLDG---TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKIS 175
Query: 200 DFGLSKFLSSDHLDTASETPSSSI---GIKGTVGYVAP 234
           DFGL++         ASE  + ++    I GT  Y+AP
Sbjct: 176 DFGLAR---------ASEKFAQTVMXSRIVGTTAYMAP 204

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 30  EKQFPMVSYAELSKATCEFSQ------SNMIGQGSYGSVYKGILGEDEMVVAVK----VI 79
           + +F   S+ EL   T  F +       N +G+G +G VYKG +  +   VAVK    ++
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 66
Query: 80  NLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL 139
           ++  +   + F  E + +   +H NL +++       S G D   LV+ YM NGSL D L
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGSLLDRL 121
Query: 140 HQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG 199
              +       LS   R  IA   A+ I +LH N     +H DIK +N+LLD    A + 
Sbjct: 122 SCLDG---TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKIS 175
Query: 200 DFGLSKFLSSDHLDTASETPSSSI---GIKGTVGYVAP 234
           DFGL++         ASE  + ++    I GT  Y+AP
Sbjct: 176 DFGLAR---------ASEKFAQTVMXXRIVGTTAYMAP 204

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 34  PMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAE 93
           P  +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 60
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
              ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ 
Sbjct: 61  AAVMKEIKHPNLVQLLGVC----TREPPF-YIIIEFMTYGNLLDYLRECNRQ----EVNA 111
Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
           +  + +A  ++SA+EYL        +H D+   N L+  + +  V DFGLS+ ++ D   
Sbjct: 112 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--- 165
Query: 214 TASETPSSSIGIKGTVGYVAP 234
               T ++  G K  + + AP
Sbjct: 166 ----TXTAHAGAKFPIKWTAP 182

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      ++S +  
Sbjct: 63  MKEIKHPNLVQLLGVC----TREPPF-YIIIEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 164
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 165 -TYTAHAGAKFPIKWTAP 181

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      ++S +  
Sbjct: 63  MKEIKHPNLVQLLGVC----TREPPF-YIIIEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 164
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 165 -TYTAHAGAKFPIKWTAP 181

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 30  EKQFPMVSYAELSKATCEFSQ------SNMIGQGSYGSVYKGILGEDEMVVAVK----VI 79
           + +F   S+ EL   T  F +       N +G+G +G VYKG +  +   VAVK    ++
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMV 60
Query: 80  NLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL 139
           ++  +   + F  E + +   +H NL +++       S G D   LV+ YM NGSL D L
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELL----GFSSDGDDL-CLVYVYMPNGSLLDRL 115
Query: 140 HQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG 199
              +       LS   R  IA   A+ I +LH N     +H DIK +N+LLD    A + 
Sbjct: 116 SCLDG---TPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKIS 169
Query: 200 DFGLSKFLSSDHLDTASETPSSSI---GIKGTVGYVAP 234
           DFGL++         ASE  +  +    I GT  Y+AP
Sbjct: 170 DFGLAR---------ASEKFAQXVMXXRIVGTTAYMAP 198

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 96/188 (51%), Gaps = 20/188 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   ++ I+H NL 
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +C    ++   F  ++ E+M  G+L D+L + N      ++S +  + +A  ++SA
Sbjct: 71  QLLGVC----TREPPF-YIIIEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSA 121
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D       T ++  G K
Sbjct: 122 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TXTAHAGAK 171
Query: 227 GTVGYVAP 234
             + + AP
Sbjct: 172 FPIKWTAP 179

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 100/201 (49%), Gaps = 20/201 (9%)
Query: 34  PMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAE 93
           P  +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 63
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
              ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ 
Sbjct: 64  AAVMKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNA 114
Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
           +  + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D   
Sbjct: 115 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--- 168
Query: 214 TASETPSSSIGIKGTVGYVAP 234
               T ++  G K  + + AP
Sbjct: 169 ----TYTAHAGAKFPIKWTAP 185

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 23/192 (11%)
Query: 46  CEFSQSNMIGQGSYGSVYKGIL-GEDEMVVAVKVINLKQKGAFR--SFVAECEALRNIRH 102
           C+ +    IG GS+G+V++    G D   VAVK++  +   A R   F+ E   ++ +RH
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWHGSD---VAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+   +   +   +      ++V EY+  GSL   LH++    +   L   +R+++A D
Sbjct: 94  PNIVLFMGAVTQPPNL-----SIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYD 145
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           VA  + YLH N  PP+VH ++K  N+L+D      V DFGLS+  +S  L        SS
Sbjct: 146 VAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--------SS 196
Query: 223 IGIKGTVGYVAP 234
               GT  ++AP
Sbjct: 197 KSAAGTPEWMAP 208

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 96/192 (50%), Gaps = 23/192 (11%)
Query: 46  CEFSQSNMIGQGSYGSVYKGIL-GEDEMVVAVKVINLKQKGAFR--SFVAECEALRNIRH 102
           C+ +    IG GS+G+V++    G D   VAVK++  +   A R   F+ E   ++ +RH
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWHGSD---VAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+   +   +   +      ++V EY+  GSL   LH++    +   L   +R+++A D
Sbjct: 94  PNIVLFMGAVTQPPNL-----SIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYD 145
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           VA  + YLH N  PP+VH D+K  N+L+D      V DFGLS+  +S  L +        
Sbjct: 146 VAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA---- 200
Query: 223 IGIKGTVGYVAP 234
               GT  ++AP
Sbjct: 201 ----GTPEWMAP 208

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      ++S +  
Sbjct: 63  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 164
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 165 -TYTAHAGAKFPIKWTAP 181

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 98/198 (49%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      ++S +  
Sbjct: 68  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVL 118
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL        +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 119 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 169
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 170 -TYTAHAGAKFPIKWTAP 186

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      ++S +  
Sbjct: 63  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVL 113
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 164
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 165 -TYTAHAGAKFPIKWTAP 181

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 68  MKEIKHPNLVQLLGVC----TREPPF-YIIIEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL        +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 119 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 169
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 170 -TYTAHAGAKFPIKWTAP 186

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 68  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 169
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 170 -TXTAHAGAKFPIKWTAP 186

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 63  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 113
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 164
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 165 -TYTAHAGAKFPIKWTAP 181

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 63
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 64  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 114
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL        +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 115 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 165
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 166 -TYTAPAGAKFPIKWTAP 182

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 65  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 115
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 116 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 166
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 167 -TYTAPAGAKFPIKWTAP 183

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 96/188 (51%), Gaps = 20/188 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   ++ I+H NL 
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +C    ++   F  ++ E+M  G+L D+L + N      ++S +  + +A  ++SA
Sbjct: 71  QLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSA 121
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D       T ++  G K
Sbjct: 122 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TFTAHAGAK 171
Query: 227 GTVGYVAP 234
             + + AP
Sbjct: 172 FPIKWTAP 179

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 68  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL        +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 119 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 169
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 170 -TYTAHAGAKFPIKWTAP 186

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 63  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 113
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 114 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 164
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 165 -TYTAHAGAKFPIKWTAP 181

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 65  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 115
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 116 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 166
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 167 -TYTAHAGAKFPIKWTAP 183

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 75
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 76  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 126
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 127 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 177
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 178 -TYTAHAGAKFPIKWTAP 194

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 65  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 115
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 116 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 166
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 167 -TYTAHAGAKFPIKWTAP 183

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      +++ +  
Sbjct: 68  MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVNAVVL 118
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D      
Sbjct: 119 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 169
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 170 -TYTAHAGAKFPIKWTAP 186

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 96/188 (51%), Gaps = 20/188 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           + +  + +G G +G VY+G+  +  + VAVK +  +       F+ E   ++ I+H NL 
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +C+    +   F  ++ E+M  G+L D+L + N      ++S +  + +A  ++SA
Sbjct: 71  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSA 121
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +EYL    +   +H D+   N L+  + +  V DFGLS+ ++ D       T ++  G K
Sbjct: 122 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TXTAHAGAK 171
Query: 227 GTVGYVAP 234
             + + AP
Sbjct: 172 FPIKWTAP 179

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 93/188 (49%), Gaps = 20/188 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           + +  + +G G YG VY G+  +  + VAVK +  +       F+ E   ++ I+H NL 
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 91
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +C+           +V EYM  G+L D+L + N      +++ +  + +A  ++SA
Sbjct: 92  QLLGVCTLEPPF-----YIVTEYMPYGNLLDYLRECNRE----EVTAVVLLYMATQISSA 142
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +EYL    +   +H D+   N L+  + V  V DFGLS+ ++ D       T ++  G K
Sbjct: 143 MEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGD-------TYTAHAGAK 192
Query: 227 GTVGYVAP 234
             + + AP
Sbjct: 193 FPIKWTAP 200

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 41/217 (18%)
Query: 37  SYAELSKATCEFSQS---------NMIGQGSYGSVYKGIL---GEDEMVVAVKVI----N 80
           ++ + ++A  EF++           +IG G +G V  G L   G+ E+ VA+K +     
Sbjct: 15  TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 74
Query: 81  LKQKGAFRSFVAECEALRNIRHRN---LTKIITICSSIDSKGADFKALVFEYMENGSLED 137
            KQ+   R F++E   +    H N   L  ++T  + +         ++ E+MENGSL+ 
Sbjct: 75  EKQR---RDFLSEASIMGQFDHPNVIHLEGVVTKSTPV--------MIITEFMENGSLDS 123
Query: 138 WLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
           +L Q +    V     IQ V +   +A+ ++YL        VH D+   N+L+++++V  
Sbjct: 124 FLRQNDGQFTV-----IQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCK 175
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           V DFGLS+FL     DT+  T +S++G K  + + AP
Sbjct: 176 VSDFGLSRFLED---DTSDPTYTSALGGKIPIRWTAP 209

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 269
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N      ++S +  
Sbjct: 270 MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVL 320
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A  ++SA+EYL        +H ++   N L+  + +  V DFGLS+ ++ D      
Sbjct: 321 LYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------ 371
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 372 -TYTAHAGAKFPIKWTAP 388

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 100/191 (52%), Gaps = 30/191 (15%)
Query: 53  MIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQKGAF-----RSFVAECEALRNIRHRN 104
           +IG G +G V +G L   G+ E  VA+K +    KG +     R F++E   +    H N
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEHPN 78
Query: 105 LTKIITICSSIDSKGADFKALVF-EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           + ++  + ++          ++  E+MENG+L+ +L + ND     + ++IQ V +   +
Sbjct: 79  IIRLEGVVTN------SMPVMILTEFMENGALDSFL-RLNDG----QFTVIQLVGMLRGI 127
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
           AS + YL    +   VH D+   N+L+++++V  V DFGLS+FL  +  D    T +SS+
Sbjct: 128 ASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP---TETSSL 181
Query: 224 GIKGTVGYVAP 234
           G K  + + AP
Sbjct: 182 GGKIPIRWTAP 192

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 21/184 (11%)
Query: 51  SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           S  IG GS+G+VYKG    D  V  +KV++   +  F++F  E   LR  RH N+   + 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPE-QFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
             +       D  A+V ++ E  SL   LH      ++F+L     ++IA   A  ++YL
Sbjct: 100 YMTK------DNLAIVTQWCEGSSLYKHLHVQETKFQMFQL-----IDIARQTAQGMDYL 148
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H      ++H D+K +N+ L   +   +GDFGL+   S        E P+      G+V 
Sbjct: 149 HAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT------GSVL 199
Query: 231 YVAP 234
           ++AP
Sbjct: 200 WMAP 203

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 23/191 (12%)
Query: 49  SQSNMIGQGSYGSVYKGIL----GEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHR 103
           ++  +IG G +G VYKG+L    G+ E+ VA+K +        R  F+ E   +    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+ ++  + S           ++ EYMENG+L+ +L + +      + S++Q V +   +
Sbjct: 107 NIIRLEGVISKYKPM-----MIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGI 156
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
           A+ ++YL +      VH D+   N+L+++++V  V DFGLS+ L  D      E   ++ 
Sbjct: 157 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEATYTTS 208
Query: 224 GIKGTVGYVAP 234
           G K  + + AP
Sbjct: 209 GGKIPIRWTAP 219

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 100/191 (52%), Gaps = 30/191 (15%)
Query: 53  MIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQKGAF-----RSFVAECEALRNIRHRN 104
           +IG G +G V +G L   G+ E  VA+K +    KG +     R F++E   +    H N
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEHPN 76
Query: 105 LTKIITICSSIDSKGADFKALVF-EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           + ++  + ++          ++  E+MENG+L+ +L + ND     + ++IQ V +   +
Sbjct: 77  IIRLEGVVTN------SMPVMILTEFMENGALDSFL-RLNDG----QFTVIQLVGMLRGI 125
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
           AS + YL    +   VH D+   N+L+++++V  V DFGLS+FL  +  D    T +SS+
Sbjct: 126 ASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP---TYTSSL 179
Query: 224 GIKGTVGYVAP 234
           G K  + + AP
Sbjct: 180 GGKIPIRWTAP 190

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 160
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 161 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 77  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 128
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 129 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 178

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 82  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 133
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 134 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 183

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 84  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 135
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 136 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 185

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 76  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 127
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 128 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 177

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 81  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 132
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 96  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 147
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 83  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 134
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 135 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 184

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 96  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 147
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
           +Y +      + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 308
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           ++ I+H NL +++ +C    ++   F  ++ E+M  G+L D+L + N   EV  + L+  
Sbjct: 309 MKEIKHPNLVQLLGVC----TREPPF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY- 361
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
             +A  ++SA+EYL    +   +H ++   N L+  + +  V DFGLS+ ++ D      
Sbjct: 362 --MATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------ 410
Query: 217 ETPSSSIGIKGTVGYVAP 234
            T ++  G K  + + AP
Sbjct: 411 -TYTAHAGAKFPIKWTAP 427

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 85  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 136
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 137 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 186

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 35/216 (16%)
Query: 32  QFPMVSYAELSKATCEFSQ------SNMIGQGSYGSVYKGILGEDEMVVAVK----VINL 81
           +F   S+ EL   T  F +       N  G+G +G VYKG +  +   VAVK    ++++
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV--NNTTVAVKKLAAMVDI 59
Query: 82  KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ 141
             +   + F  E +     +H NL +++       S G D   LV+ Y  NGSL D L  
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELL----GFSSDGDDL-CLVYVYXPNGSLLDRLSC 114
Query: 142 TNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF 201
            +       LS   R  IA   A+ I +LH N     +H DIK +N+LLD    A + DF
Sbjct: 115 LDG---TPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDF 168
Query: 202 GLSKFLSSDHLDTASETPSSSIG---IKGTVGYVAP 234
           GL++         ASE  +  +    I GT  Y AP
Sbjct: 169 GLAR---------ASEKFAQXVXXSRIVGTTAYXAP 195

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L +  + ++  KL     +     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 32/193 (16%)
Query: 52  NMIGQGSYGSVYKGIL---GEDEMVVAVKVINL----KQKGAFRSFVAECEALRNIRHRN 104
            +IG G +G V  G L   G+ E+ VA+K +      KQ+   R F++E   +    H N
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPN 69
Query: 105 ---LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
              L  ++T  + +         ++ E+MENGSL+ +L Q +    V     IQ V +  
Sbjct: 70  VIHLEGVVTKSTPV--------MIITEFMENGSLDSFLRQNDGQFTV-----IQLVGMLR 116
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
            +A+ ++YL        VH  +   N+L+++++V  V DFGLS+FL     DT+  T +S
Sbjct: 117 GIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTYTS 170
Query: 222 SIGIKGTVGYVAP 234
           ++G K  + + AP
Sbjct: 171 ALGGKIPIRWTAP 183

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L    + ++  KL     +     +   +EY
Sbjct: 81  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQAHAERIDHIKL-----LQYTSQICKGMEY 132
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 82/163 (50%), Gaps = 15/163 (9%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           E      IG+G +G V  G    ++  VAVK I  K     ++F+AE   +  +RH NL 
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +   ++ KG  +  +V EYM  GSL D+L      +    L     +  ++DV  A
Sbjct: 250 QLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEA 301
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           +EYL  N     VH D+   NVL+  D VA V DFGL+K  SS
Sbjct: 302 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 82/163 (50%), Gaps = 15/163 (9%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           E      IG+G +G V  G    ++  VAVK I  K     ++F+AE   +  +RH NL 
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +   ++ KG  +  +V EYM  GSL D+L      +    L     +  ++DV  A
Sbjct: 63  QLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEA 114
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           +EYL  N     VH D+   NVL+  D VA V DFGL+K  SS
Sbjct: 115 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 82/163 (50%), Gaps = 15/163 (9%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           E      IG+G +G V  G    ++  VAVK I  K     ++F+AE   +  +RH NL 
Sbjct: 13  ELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 68
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +   ++ KG  +  +V EYM  GSL D+L      +    L     +  ++DV  A
Sbjct: 69  QLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEA 120
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           +EYL  N     VH D+   NVL+  D VA V DFGL+K  SS
Sbjct: 121 MEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 160

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 82/163 (50%), Gaps = 15/163 (9%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           E      IG+G +G V  G    ++  VAVK I  K     ++F+AE   +  +RH NL 
Sbjct: 22  ELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +   ++ KG  +  +V EYM  GSL D+L      +    L     +  ++DV  A
Sbjct: 78  QLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEA 129
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           +EYL  N     VH D+   NVL+  D VA V DFGL+K  SS
Sbjct: 130 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 89/190 (46%), Gaps = 20/190 (10%)
Query: 42  SKATCEFSQSNM-----IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVA 92
           S+   +F + ++     +G+G++GSV    Y  +      VVAVK +    +   R F  
Sbjct: 2   SRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 93  ECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLS 152
           E E L++++H N+ K   +C S   +      L+ EY+  GSL D+L +  + ++  KL 
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL- 117
Query: 153 LIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
               +     +   +EYL        +H ++   N+L++N+    +GDFGL+K L  D  
Sbjct: 118 ----LQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE 170
Query: 213 DTASETPSSS 222
               + P  S
Sbjct: 171 YYKVKEPGES 180

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 15/173 (8%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV    Y  +      VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ E++  GSL ++L +  + ++  KL     +     +   +EY
Sbjct: 81  GVCYSAGRRNL---KLIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGMEY 132
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           L        +H D+   N+L++N+    +GDFGL+K L  D      + P  S
Sbjct: 133 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 36/226 (15%)
Query: 20  VRKPIDTLPMEKQFPMV-SYAELSKATCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVA 75
           VR  +D    E     V  +A+   A+C      +IG G +G V  G L   G+ E+ VA
Sbjct: 3   VRTFVDPFTFEDPNQAVREFAKEIDASC-IKIEKVIGVGEFGEVCSGRLKVPGKREICVA 61
Query: 76  VKVINL----KQKGAFRSFVAECEALRNIRHRN---LTKIITICSSIDSKGADFKALVFE 128
           +K +      KQ+   R F++E   +    H N   L  ++T C  +         ++ E
Sbjct: 62  IKTLKAGYTDKQR---RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITE 110
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           YMENGSL+ +L + +      + ++IQ V +   + S ++YL        VH D+   N+
Sbjct: 111 YMENGSLDAFLRKNDG-----RFTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNI 162
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           L+++++V  V DFG+S+ L  D      E   ++ G K  + + AP
Sbjct: 163 LVNSNLVCKVSDFGMSRVLEDD-----PEAAYTTRGGKIPIRWTAP 203

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +      A   A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 73  ST------APQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 121
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D+   +GDFGL+
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 83/163 (50%), Gaps = 8/163 (4%)
Query: 52  NMIGQGSYGSVYKGILGEDE---MVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLT 106
            ++G+G +GSV +G L +++   + VAVK + L    +     F++E   +++  H N+ 
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +C  + S+G     ++  +M+ G L  +L  +        + L   +   +D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           +EYL +      +H D+   N +L +DM   V DFGLSK + S
Sbjct: 160 MEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 31/201 (15%)
Query: 38  YAELSKATCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL----KQKGAFRSF 90
           +A+   A+C      +IG G +G V  G L   G+ E+ VA+K +      KQ+   R F
Sbjct: 1   FAKEIDASC-IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR---RDF 56
Query: 91  VAECEALRNIRHRN---LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE 147
           ++E   +    H N   L  ++T C  +         ++ EYMENGSL+ +L + +    
Sbjct: 57  LSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG--- 105
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
             + ++IQ V +   + S ++YL        VH D+   N+L+++++V  V DFG+S+ L
Sbjct: 106 --RFTVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVL 160
Query: 208 SSDHLDTASETPSSSIGIKGT 228
             D  + A  T    I I+ T
Sbjct: 161 EDDP-EAAYTTRGGKIPIRWT 180

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 35/207 (16%)
Query: 38  YAELSKATCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL----KQKGAFRSF 90
           +A+   A+C      +IG G +G V  G L   G+ E+ VA+K +      KQ+   R F
Sbjct: 7   FAKEIDASC-IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR---RDF 62
Query: 91  VAECEALRNIRHRN---LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE 147
           ++E   +    H N   L  ++T C  +         ++ EYMENGSL+ +L + +    
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG--- 111
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
             + ++IQ V +   + S ++YL        VH D+   N+L+++++V  V DFG+S+ L
Sbjct: 112 --RFTVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVL 166
Query: 208 SSDHLDTASETPSSSIGIKGTVGYVAP 234
             D      E   ++ G K  + + AP
Sbjct: 167 EDD-----PEAAYTTRGGKIPIRWTAP 188

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 75  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 123
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D+   +GDFGL+
Sbjct: 124 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 153

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 78  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 126
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D+   +GDFGL+
Sbjct: 127 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 73  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 121
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D+   +GDFGL+
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 73  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 121
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D+   +GDFGL+
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 78  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 126
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D+   +GDFGL+
Sbjct: 127 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 101 STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 149
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D+   +GDFGL+
Sbjct: 150 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 100 STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 148
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D+   +GDFGL+
Sbjct: 149 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 178

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 93  STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 141
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D+   +GDFGL+
Sbjct: 142 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH      E+ KL     ++IA   A  ++YLH
Sbjct: 101 STKPQL------AIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH 149
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D+   +GDFGL+
Sbjct: 150 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 25/198 (12%)
Query: 38  YAELSKATCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL----KQKGAFRSF 90
           +A+  +A+C  +   +IG G +G V  G L   G+ E+ VA+K + +    KQ+   R F
Sbjct: 15  FAKEIEASC-ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR---RDF 70
Query: 91  VAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK 150
           + E   +    H N+  +  + +   SK      +V EYMENGSL+ +L + +      +
Sbjct: 71  LGEASIMGQFDHPNIIHLEGVVTK--SKPV---MIVTEYMENGSLDTFLKKNDG-----Q 120
Query: 151 LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            ++IQ V +   +++ ++YL        VH D+   N+L+++++V  V DFGLS+ L  D
Sbjct: 121 FTVIQLVGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177
Query: 211 HLDTASETPSSSIGIKGT 228
             + A  T    I I+ T
Sbjct: 178 P-EAAYTTRGGKIPIRWT 194

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 24/181 (13%)
Query: 54  IGQGSYGSV-----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G++G V     Y     +D+M+VAVK +      A + F  E E L N++H ++ K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF----------KLSLIQRVN 158
             +C        D   +VFEYM++G L  +L        +           +L L Q ++
Sbjct: 83  YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDTASE 217
           IA  +AS + YL        VH D+   N L+  +++  +GDFG+S+   S+D+      
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 218 T 218
           T
Sbjct: 195 T 195

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +      A   A+V ++ E  SL   LH +    E+ KL     ++IA   A  ++YLH
Sbjct: 89  ST------APQLAIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 137
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D    +GDFGL+
Sbjct: 138 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 33/209 (15%)
Query: 37  SYAELSKATCEFSQS---------NMIGQGSYGSVYKGIL---GEDEMVVAVKVINL--- 81
           +Y E  +A   F++           +IG G  G V  G L   G+ ++ VA+K +     
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 82  -KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
            +Q+   R F++E   +    H N+ ++  + +           +V EYMENGSL+ +L 
Sbjct: 91  ERQR---RDFLSEASIMGQFDHPNIIRLEGVVTR-----GRLAMIVTEYMENGSLDTFL- 141
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
           +T+D     + +++Q V +   V + + YL        VH D+   NVL+D+++V  V D
Sbjct: 142 RTHDG----QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSD 194
Query: 201 FGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           FGLS+ L  D  D A  T    I I+ T 
Sbjct: 195 FGLSRVLEDDP-DAAXTTTGGKIPIRWTA 222

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 33/209 (15%)
Query: 37  SYAELSKATCEFSQS---------NMIGQGSYGSVYKGIL---GEDEMVVAVKVINL--- 81
           +Y E  +A   F++           +IG G  G V  G L   G+ ++ VA+K +     
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 82  -KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
            +Q+   R F++E   +    H N+ ++  + +           +V EYMENGSL+ +L 
Sbjct: 91  ERQR---RDFLSEASIMGQFDHPNIIRLEGVVTR-----GRLAMIVTEYMENGSLDTFL- 141
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
           +T+D     + +++Q V +   V + + YL        VH D+   NVL+D+++V  V D
Sbjct: 142 RTHDG----QFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 201 FGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           FGLS+ L  D  D A  T    I I+ T 
Sbjct: 195 FGLSRVLEDDP-DAAYTTTGGKIPIRWTA 222

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH +    E+ KL     ++IA   A  ++YLH
Sbjct: 89  STKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 137
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D    +GDFGL+
Sbjct: 138 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            +          A+V ++ E  SL   LH +    E+ KL     ++IA   A  ++YLH
Sbjct: 77  STKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 125
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 ++H D+K +N+ L  D    +GDFGL+
Sbjct: 126 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 155

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 16  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                  +   +V EYM  GSL D+L  +T  +L      L Q V++A  +AS + Y+  
Sbjct: 74  E------EPIXIVTEYMSKGSLLDFLKGETGKYL-----RLPQLVDMAAQIASGMAYVER 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 VH D++ +N+L+  ++V  V DFGL++ +  D+  TA +      G K  + + 
Sbjct: 123 MN---YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEXTARQ------GAKFPIKWT 172
Query: 233 AP 234
           AP
Sbjct: 173 AP 174

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 38/215 (17%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA----- 86
           +FP      L+    E+ +   IG+G +G V+KG L +D+ VVA+K + L          
Sbjct: 7   EFPKSRLPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 87  --FRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTND 144
             F+ F  E   + N+ H N+ K+  +  +          +V E++  G   D  H+  D
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR-------MVMEFVPCG---DLYHRLLD 114
Query: 145 HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-----DMVAHVG 199
                K S+  ++ + +D+A  IEY+  N  PP+VH D++  N+ L +      + A V 
Sbjct: 115 KAHPIKWSV--KLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           DFGLS+           ++  S  G+ G   ++AP
Sbjct: 172 DFGLSQ-----------QSVHSVSGLLGNFQWMAP 195

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 28  PMEKQFPMVSYAELSKA--TCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL- 81
           P   + P  +  E +K       S   ++G G +G V  G L    + E+ VA+K + + 
Sbjct: 25  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 82  ---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
              KQ+   R F+ E   +    H N+ ++  + +   SK      +V EYMENGSL+ +
Sbjct: 85  YTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSF 136
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L + +    V     IQ V +   +AS ++YL        VH D+   N+L+++++V  V
Sbjct: 137 LRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKV 188
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            DFGLS+ L  D  + A  T    I I+ T
Sbjct: 189 SDFGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 28  PMEKQFPMVSYAELSKA--TCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL- 81
           P   + P  +  E +K       S   ++G G +G V  G L    + E+ VA+K + + 
Sbjct: 25  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 82  ---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
              KQ+   R F+ E   +    H N+ ++  + +   SK      +V EYMENGSL+ +
Sbjct: 85  YTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSF 136
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L + +    V     IQ V +   +AS ++YL        VH D+   N+L+++++V  V
Sbjct: 137 LRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKV 188
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            DFGLS+ L  D  + A  T    I I+ T
Sbjct: 189 SDFGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 54  IGQGSYGSVYKG-ILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIIT 110
           IG G +G V+ G  L +D+  VA+K I   ++GA     F+ E E +  + H  L ++  
Sbjct: 15  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C            LVFE+ME+G L D+L           L     + + +DV   + YL
Sbjct: 70  VCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 119
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
              C   ++H D+   N L+  + V  V DFG+++F+  D         +SS G K  V 
Sbjct: 120 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVK 169
Query: 231 YVAP 234
           + +P
Sbjct: 170 WASP 173

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 28  PMEKQFPMVSYAELSKA--TCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL- 81
           P   + P  +  E +K       S   ++G G +G V  G L    + E+ VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 82  ---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
              KQ+   R F+ E   +    H N+ ++  + +   SK      +V EYMENGSL+ +
Sbjct: 85  YTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSF 136
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L + +    V     IQ V +   +AS ++YL        VH D+   N+L+++++V  V
Sbjct: 137 LRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKV 188
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            DFGLS+ L  D  + A  T    I I+ T
Sbjct: 189 SDFGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 28  PMEKQFPMVSYAELSKA--TCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL- 81
           P   + P  +  E +K       S   ++G G +G V  G L    + E+ VA+K + + 
Sbjct: 23  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 82
Query: 82  ---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
              KQ+   R F+ E   +    H N+ ++  + +   SK      +V EYMENGSL+ +
Sbjct: 83  YTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSF 134
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L + +    V     IQ V +   +AS ++YL        VH D+   N+L+++++V  V
Sbjct: 135 LRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKV 186
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            DFGLS+ L  D  + A  T    I I+ T
Sbjct: 187 SDFGLSRVLEDDP-EAAYTTRGGKIPIRWT 215

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 54  IGQGSYGSVYKG-ILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIIT 110
           IG G +G V+ G  L +D+  VA+K I   ++GA     F+ E E +  + H  L ++  
Sbjct: 18  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C            LVFE+ME+G L D+L           L     + + +DV   + YL
Sbjct: 73  VCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 122
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
              C   ++H D+   N L+  + V  V DFG+++F+  D         +SS G K  V 
Sbjct: 123 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVK 172
Query: 231 YVAP 234
           + +P
Sbjct: 173 WASP 176

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 54  IGQGSYGSVYKG-ILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIIT 110
           IG G +G V+ G  L +D+  VA+K I   ++GA     F+ E E +  + H  L ++  
Sbjct: 13  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C            LVFE+ME+G L D+L           L     + + +DV   + YL
Sbjct: 68  VCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 117
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
              C   ++H D+   N L+  + V  V DFG+++F+  D         +SS G K  V 
Sbjct: 118 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVK 167
Query: 231 YVAP 234
           + +P
Sbjct: 168 WASP 171

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 92/188 (48%), Gaps = 24/188 (12%)
Query: 48  FSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL----KQKGAFRSFVAECEALRNI 100
            S   ++G G +G V  G L    + E+ VA+K + +    KQ+   R F+ E   +   
Sbjct: 35  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQF 91
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            H N+ ++  + +   SK      +V EYMENGSL+ +L + +    V     IQ V + 
Sbjct: 92  DHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGML 141
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPS 220
             +AS ++YL        VH D+   N+L+++++V  V DFGLS+ L  D  + A  T  
Sbjct: 142 RGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP-EAAYTTRG 197
Query: 221 SSIGIKGT 228
             I I+ T
Sbjct: 198 GKIPIRWT 205

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 24/187 (12%)
Query: 49  SQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL----KQKGAFRSFVAECEALRNIR 101
           S   ++G G +G V  G L    + E+ VA+K + +    KQ+   R F+ E   +    
Sbjct: 19  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFD 75
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+ ++  + +   SK      +V EYMENGSL+ +L + +    V     IQ V +  
Sbjct: 76  HPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLR 125
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
            +AS ++YL        VH D+   N+L+++++V  V DFGLS+ L  D  + A  T   
Sbjct: 126 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP-EAAYTTRGG 181
Query: 222 SIGIKGT 228
            I I+ T
Sbjct: 182 KIPIRWT 188

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 28  PMEKQFPMVSYAELSKA--TCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL- 81
           P   + P  +  E +K       S   ++G G +G V  G L    + E+ VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 82  ---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
              KQ+   R F+ E   +    H N+ ++  + +   SK      +V EYMENGSL+ +
Sbjct: 85  YTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSF 136
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L + +    V     IQ V +   +AS ++YL        VH D+   N+L+++++V  V
Sbjct: 137 LRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKV 188
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            DFGLS+ L  D  + A  T    I I+ T
Sbjct: 189 SDFGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 28  PMEKQFPMVSYAELSKA--TCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL- 81
           P   + P  +  E +K       S   ++G G +G V  G L    + E+ VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 82  ---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
              KQ+   R F+ E   +    H N+ ++  + +   SK      +V EYMENGSL+ +
Sbjct: 85  YTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSF 136
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L + +    V     IQ V +   +AS ++YL        VH D+   N+L+++++V  V
Sbjct: 137 LRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKV 188
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            DFGLS+ L  D  + A  T    I I+ T
Sbjct: 189 SDFGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 19  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                  +   +V EYM  GSL D+L  +T  +L      L Q V++A  +AS + Y+  
Sbjct: 77  E------EPIYIVTEYMSKGSLLDFLKGETGKYL-----RLPQLVDMAAQIASGMAYVER 125
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K  + + 
Sbjct: 126 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWT 175
Query: 233 AP 234
           AP
Sbjct: 176 AP 177

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA----- 86
           +FP      L+    E+ +   IG+G +G V+KG L +D+ VVA+K + L          
Sbjct: 7   EFPKSRLPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 87  --FRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTND 144
             F+ F  E   + N+ H N+ K+  +  +          +V E++  G   D  H+  D
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR-------MVMEFVPCG---DLYHRLLD 114
Query: 145 HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-----DMVAHVG 199
                K S+  ++ + +D+A  IEY+  N  PP+VH D++  N+ L +      + A V 
Sbjct: 115 KAHPIKWSV--KLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           DFG           T+ ++  S  G+ G   ++AP
Sbjct: 172 DFG-----------TSQQSVHSVSGLLGNFQWMAP 195

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVIEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                VH D++ +N+L+  ++V  V DFGL++ +  D+  TA +      G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEXTARQ------GAKFPIKWTA 183
Query: 234 P 234
           P
Sbjct: 184 P 184

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                  +   +V EYM  GSL D+L  +T  +L      L Q V++A  +AS + Y+  
Sbjct: 250 E------EPIYIVTEYMSKGSLLDFLKGETGKYLR-----LPQLVDMAAQIASGMAYVER 298
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 VH D++ +N+L+  ++V  V DFGL++ +  D+  TA +      G K  + + 
Sbjct: 299 MN---YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQ------GAKFPIKWT 348
Query: 233 AP 234
           AP
Sbjct: 349 AP 350

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ IRH  L ++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 234 P 234
           P
Sbjct: 184 P 184

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                  +   +V EYM  GSL D+L  +T  +L      L Q V++A  +AS + Y+  
Sbjct: 250 E------EPIYIVTEYMSKGSLLDFLKGETGKYLR-----LPQLVDMAAQIASGMAYVER 298
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 VH D++ +N+L+  ++V  V DFGL++ +  D+  TA +      G K  + + 
Sbjct: 299 MN---YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQ------GAKFPIKWT 348
Query: 233 AP 234
           AP
Sbjct: 349 AP 350

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 275 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                  +   +V EYM  GSL D+L  +T  +L      L Q V++A  +AS + Y+  
Sbjct: 333 E------EPIYIVTEYMSKGSLLDFLKGETGKYLR-----LPQLVDMAAQIASGMAYVER 381
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 VH D++ +N+L+  ++V  V DFGL++ +  D+  TA +      G K  + + 
Sbjct: 382 MN---YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQ------GAKFPIKWT 431
Query: 233 AP 234
           AP
Sbjct: 432 AP 433

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVIEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                VH D++ +N+L+  ++V  V DFGL++ +  D+  TA +      G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQ------GAKFPIKWTA 183
Query: 234 P 234
           P
Sbjct: 184 P 184

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 28  PMEKQFPMVSYAELSKA--TCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL- 81
           P   + P  +  E +K       S   ++G G +G V  G L    + E+ VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 82  ---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
              KQ+   R F+ E   +    H N+ ++  + +   SK      +V EYMENGSL+ +
Sbjct: 85  YTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSF 136
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L + +    V     IQ V +   +AS ++YL        VH D+   N+L+++++V  V
Sbjct: 137 LRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKV 188
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            DFGL++ L  D  + A  T    I I+ T
Sbjct: 189 SDFGLARVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 23  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                  +   +V EYM  GSL D+L  +T  +L      L Q V+++  +AS + Y+  
Sbjct: 81  E------EPIYIVTEYMNKGSLLDFLKGETGKYL-----RLPQLVDMSAQIASGMAYVER 129
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K  + + 
Sbjct: 130 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEW-------TARQGAKFPIKWT 179
Query: 233 AP 234
           AP
Sbjct: 180 AP 181

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 54  IGQGSYGSVYKG-ILGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIIT 110
           IG G +G V+ G  L +D+  VA+K I   ++G+     F+ E E +  + H  L ++  
Sbjct: 35  IGSGQFGLVHLGYWLNKDK--VAIKTI---KEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C            LVFE+ME+G L D+L           L     + + +DV   + YL
Sbjct: 90  VCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 139
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
              C   ++H D+   N L+  + V  V DFG+++F+  D         +SS G K  V 
Sbjct: 140 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVK 189
Query: 231 YVAP 234
           + +P
Sbjct: 190 WASP 193

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                  +   +V EYM  GSL D+L  +T  +L      L Q V++A  +AS + Y+  
Sbjct: 250 E------EPIYIVGEYMSKGSLLDFLKGETGKYLR-----LPQLVDMAAQIASGMAYVER 298
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 VH D++ +N+L+  ++V  V DFGL++ +  D+  TA +      G K  + + 
Sbjct: 299 MN---YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQ------GAKFPIKWT 348
Query: 233 AP 234
           AP
Sbjct: 349 AP 350

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 15  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 73  E------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 122
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K  + + A
Sbjct: 123 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 172
Query: 234 P 234
           P
Sbjct: 173 P 173

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA----- 86
           +FP      L+    E+ +   IG+G +G V+KG L +D+ VVA+K + L          
Sbjct: 7   EFPKSRLPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 87  --FRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTND 144
             F+ F  E   + N+ H N+ K+  +  +          +V E++  G   D  H+  D
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR-------MVMEFVPCG---DLYHRLLD 114
Query: 145 HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-----DMVAHVG 199
                K S+  ++ + +D+A  IEY+  N  PP+VH D++  N+ L +      + A V 
Sbjct: 115 KAHPIKWSV--KLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           DF LS+           ++  S  G+ G   ++AP
Sbjct: 172 DFSLSQ-----------QSVHSVSGLLGNFQWMAP 195

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 17  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 75  E------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 124
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K  + + A
Sbjct: 125 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 174
Query: 234 P 234
           P
Sbjct: 175 P 175

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 23  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLH-QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                  +   +V EYM  GSL D+L  +T  +L      L Q V+++  +AS + Y+  
Sbjct: 81  E------EPIYIVTEYMNKGSLLDFLKGETGKYL-----RLPQLVDMSAQIASGMAYVER 129
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K  + + 
Sbjct: 130 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWT 179
Query: 233 AP 234
           AP
Sbjct: 180 AP 181

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 28  PMEKQFPMVSYAELSKA--TCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL- 81
           P   + P  +  E +K       S   ++G G +G V  G L    + E+ VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 82  ---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
              KQ+   R F+ E   +    H N+ ++  + +   SK      +V EYMENGSL+ +
Sbjct: 85  YTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEYMENGSLDSF 136
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L + +    V     IQ V +   +AS ++YL        VH D+   N+L+++++V  V
Sbjct: 137 LRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKV 188
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            DFGL + L  D  + A  T    I I+ T
Sbjct: 189 SDFGLGRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 234 P 234
           P
Sbjct: 184 P 184

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 21/178 (11%)
Query: 54  IGQGSYGSV-----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G++G V     Y     +D+++VAVK +      A + F  E E L N++H ++ K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF-------KLSLIQRVNIAI 161
             +C        D   +VFEYM++G L  +L        +        +L+  Q ++IA 
Sbjct: 81  YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDTASET 218
            +A+ + YL        VH D+   N L+  +++  +GDFG+S+   S+D+      T
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVCEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 234 P 234
           P
Sbjct: 184 P 184

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLTKI 108
           +G+G +G V    Y          VAVK +  +  G        E E LRN+ H N+ K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
             IC+     G +   L+ E++ +GSL+++L +  +     K++L Q++  A+ +   ++
Sbjct: 89  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMD 140
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           YL        VH D+   NVL++++    +GDFGL+K + +D
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 37/214 (17%)
Query: 37  SYAELSKATCEFSQS---------NMIGQGSYGSVYKGIL---GEDEMVVAVKVINL--- 81
           +Y + ++A  +F++           +IG G +G V  G L   G+ ++ VA+K + +   
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 82  -KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
            KQ+   R F+ E   +    H N+  +      + ++G     +V E+MENG+L+ +L 
Sbjct: 85  EKQR---RDFLCEASIMGQFDHPNVVHL----EGVVTRGKPV-MIVIEFMENGALDAFLR 136
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
           + +      + ++IQ V +   +A+ + YL        VH D+   N+L+++++V  V D
Sbjct: 137 KHDG-----QFTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSD 188
Query: 201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           FGLS+ +  D      E   ++ G K  V + AP
Sbjct: 189 FGLSRVIEDD-----PEAVYTTTGGKIPVRWTAP 217

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLTKI 108
           +G+G +G V    Y          VAVK +  +  G        E E LRN+ H N+ K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
             IC+     G +   L+ E++ +GSL+++L +  +     K++L Q++  A+ +   ++
Sbjct: 77  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMD 128
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           YL        VH D+   NVL++++    +GDFGL+K + +D
Sbjct: 129 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 167

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 87/180 (48%), Gaps = 23/180 (12%)
Query: 54  IGQGSYGSVY----KGILGE-DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G++G V+      +L E D+M+VAVK +    + A + F  E E L  ++H+++ + 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF---------KLSLIQRVNI 159
             +C    ++G     +VFEYM +G L  +L       ++           L L Q + +
Sbjct: 109 FGVC----TEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDTASET 218
           A  VA+ + YL        VH D+   N L+   +V  +GDFG+S+   S+D+      T
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 90/189 (47%), Gaps = 12/189 (6%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDE---MVVAVKVI--NLKQKGAFRSFVAECEALRNIR 101
           +F+   M+G+G +GSV +  L +++   + VAVK++  ++        F+ E   ++   
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 102 HRNLTKIITICSSIDSKGA-DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
           H ++ K++ +     +KG      ++  +M++G L  +L  +      F L L   V   
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDT--ASE 217
           +D+A  +EYL        +H D+   N +L  DM   V DFGLS K  S D+     AS+
Sbjct: 144 VDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 218 TPSSSIGIK 226
            P   + ++
Sbjct: 201 LPVKWLALE 209

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 193 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGNMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK-LSLIQRVNIAIDVASAIEYLHH 172
                  +   +V EYM  GSL D+L       E+ K L L Q V++A  +AS + Y+  
Sbjct: 251 E------EPIYIVTEYMSKGSLLDFLKG-----EMGKYLRLPQLVDMAAQIASGMAYVER 299
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 VH D++ +N+L+  ++V  V DFGL + +  D+  TA +      G K  + + 
Sbjct: 300 MN---YVHRDLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQ------GAKFPIKWT 349
Query: 233 AP 234
           AP
Sbjct: 350 AP 351

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 87/180 (48%), Gaps = 23/180 (12%)
Query: 54  IGQGSYGSVY----KGILGE-DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G++G V+      +L E D+M+VAVK +    + A + F  E E L  ++H+++ + 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF---------KLSLIQRVNI 159
             +C    ++G     +VFEYM +G L  +L       ++           L L Q + +
Sbjct: 86  FGVC----TEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDTASET 218
           A  VA+ + YL        VH D+   N L+   +V  +GDFG+S+   S+D+      T
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 87/180 (48%), Gaps = 23/180 (12%)
Query: 54  IGQGSYGSVY----KGILGE-DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G++G V+      +L E D+M+VAVK +    + A + F  E E L  ++H+++ + 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF---------KLSLIQRVNI 159
             +C    ++G     +VFEYM +G L  +L       ++           L L Q + +
Sbjct: 80  FGVC----TEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK-FLSSDHLDTASET 218
           A  VA+ + YL        VH D+   N L+   +V  +GDFG+S+   S+D+      T
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 54  IGQGSYGSVYKG-ILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIIT 110
           IG G +G V+ G  L +D+  VA+K I   ++GA     F+ E E +  + H  L ++  
Sbjct: 15  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C            LVFE+ME+G L D+L           L     + + +DV   + YL
Sbjct: 70  VCLEQAPI-----CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 119
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
               +  ++H D+   N L+  + V  V DFG+++F+  D         +SS G K  V 
Sbjct: 120 E---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVK 169
Query: 231 YVAP 234
           + +P
Sbjct: 170 WASP 173

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  G L D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVMEYMSKGCLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 234 P 234
           P
Sbjct: 184 P 184

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 28  PMEKQFPMVSYAELSKA--TCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL- 81
           P   + P  +  E +K       S   ++G G +G V  G L    + E+ VA+K + + 
Sbjct: 25  PHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 82  ---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
              KQ+   R F+ E   +    H N+ ++  + +   SK      +V E MENGSL+ +
Sbjct: 85  YTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEXMENGSLDSF 136
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L + +    V     IQ V +   +AS ++YL        VH D+   N+L+++++V  V
Sbjct: 137 LRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKV 188
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            DFGLS+ L  D  + A  T    I I+ T
Sbjct: 189 SDFGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                VH D+  +N+L+  ++V  V DFGL++ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLAAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 234 P 234
           P
Sbjct: 184 P 184

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 93/180 (51%), Gaps = 26/180 (14%)
Query: 51  SNMIGQGSYGSVYKGILGEDEMV---VAVKVINLKQKGAFRSFVA----ECEALRNIRHR 103
            + +G G++G V    +GE ++    VAVK++N +QK      V     E + L+  RH 
Sbjct: 16  GDTLGVGTFGKVK---IGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           ++ K+  + S+      DF  +V EY+  G L D++ +     E+    L Q++      
Sbjct: 72  HIIKLYQVIST----PTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------ 120
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS-SDHLDTASETPSSS 222
            SA++Y H +    +VH D+KP NVLLD  M A + DFGLS  +S  + L T+  +P+ +
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 28/184 (15%)
Query: 54  IGQGSYGSVYKG-ILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIIT 110
           IG G +G V+ G  L +D+  VA+K I   ++GA     F+ E E +  + H  L ++  
Sbjct: 16  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C            LV E+ME+G L D+L           L     + + +DV   + YL
Sbjct: 71  VCLEQAPI-----CLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL 120
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
              C   ++H D+   N L+  + V  V DFG+++F+  D         +SS G K  V 
Sbjct: 121 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTKFPVK 170
Query: 231 YVAP 234
           + +P
Sbjct: 171 WASP 174

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLTKI 108
           +G+G +G V    Y         +VAVK +        RS +  E + LR + H ++ K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
              C   +  GA    LV EY+  GSL D+L + +       + L Q +  A  +   + 
Sbjct: 99  KGCC---EDAGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 148
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           YLH       +H D+   NVLLDND +  +GDFGL+K +   H
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 28  PMEKQFPMVSYAELSKA--TCEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL- 81
           P   + P  +  E +K       S   ++G G +G V  G L    + E+ VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 82  ---KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
              KQ+   R F+ E   +    H N+ ++  + +   SK      +V E MENGSL+ +
Sbjct: 85  YTEKQR---RDFLGEASIMGQFDHPNIIRLEGVVTK--SKPV---MIVTEXMENGSLDSF 136
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L + +    V     IQ V +   +AS ++YL        VH D+   N+L+++++V  V
Sbjct: 137 LRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKV 188
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            DFGLS+ L  D  + A  T    I I+ T
Sbjct: 189 SDFGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 91/188 (48%), Gaps = 24/188 (12%)
Query: 48  FSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINL----KQKGAFRSFVAECEALRNI 100
            S   ++G G +G V  G L    + E+ VA+K + +    KQ+   R F+ E   +   
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQF 74
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            H N+ ++  + +   SK      +V E MENGSL+ +L + +    V     IQ V + 
Sbjct: 75  DHPNIIRLEGVVTK--SKPV---MIVTEXMENGSLDSFLRKHDAQFTV-----IQLVGML 124
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPS 220
             +AS ++YL        VH D+   N+L+++++V  V DFGLS+ L  D  + A  T  
Sbjct: 125 RGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP-EAAYTTRG 180
Query: 221 SSIGIKGT 228
             I I+ T
Sbjct: 181 GKIPIRWT 188

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +GQG +G V+ G        VA+K +         +F+ E + ++ +RH  L ++  + S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  G L D+L           L L Q V++A  +AS + Y+   
Sbjct: 84  E------EPIYIVTEYMSKGCLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 133
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K  + + A
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 234 P 234
           P
Sbjct: 184 P 184

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 27  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 84  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 133
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 134 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTARE------GAKFPIKWT 183
Query: 233 AP 234
           AP
Sbjct: 184 AP 185

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 29  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 86  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 135
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 136 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTARE------GAKFPIKWT 185
Query: 233 AP 234
           AP
Sbjct: 186 AP 187

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 30  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 87  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 136
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 137 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTARE------GAKFPIKWT 186
Query: 233 AP 234
           AP
Sbjct: 187 AP 188

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 78  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTARE------GAKFPIKWT 177
Query: 233 AP 234
           AP
Sbjct: 178 AP 179

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 94/193 (48%), Gaps = 26/193 (13%)
Query: 23  PIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI-LGEDEMV---VAVKV 78
           P  T P + Q  ++   EL +         ++G G++G+VYKGI + E E V   VA+K+
Sbjct: 22  PSGTAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKI 74
Query: 79  IN-LKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLED 137
           +N      A   F+ E   + ++ H +L +++ +C S   +      LV + M +G L +
Sbjct: 75  LNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLE 128
Query: 138 WLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
           ++H+  D++    L     +N  + +A  + YL       +VH D+   NVL+ +     
Sbjct: 129 YVHEHKDNIGSQLL-----LNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVK 180
Query: 198 VGDFGLSKFLSSD 210
           + DFGL++ L  D
Sbjct: 181 ITDFGLARLLEGD 193

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 23  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 80  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 129
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 130 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTARE------GAKFPIKWT 179
Query: 233 AP 234
           AP
Sbjct: 180 AP 181

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 29/173 (16%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-----GAFRSFVAECEALRNIR 101
            + + + +G+G + +VYK        +VA+K I L  +     G  R+ + E + L+ + 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLE-----DWLHQTNDHLEVFKLSLIQR 156
           H N   II +  +   K     +LVF++ME   LE     + L  T  H++ + L  +Q 
Sbjct: 71  HPN---IIGLLDAFGHKSN--ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ- 123
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
                     +EYLH +    ++H D+KP+N+LLD + V  + DFGL+K   S
Sbjct: 124 ---------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 78  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTARE------GAKFPIKWT 177
Query: 233 AP 234
           AP
Sbjct: 178 AP 179

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 22  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 79  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 128
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 129 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTARE------GAKFPIKWT 178
Query: 233 AP 234
           AP
Sbjct: 179 AP 180

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 29  MEKQFPMVSYAE----LSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M+ Q P   + E    + + T +  +   +G G +G V+ G        VAVK  +LKQ 
Sbjct: 4   MQTQKPQKPWWEDEWEVPRETLKLVER--LGAGQFGEVWMGYYN-GHTKVAVK--SLKQG 58
Query: 85  G-AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN 143
             +  +F+AE   ++ ++H+ L ++  + +       +   ++ EYMENGSL D+L   +
Sbjct: 59  SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPS 112
Query: 144 DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
                 KL++ + +++A  +A  + ++        +H D++ +N+L+ + +   + DFGL
Sbjct: 113 G----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGL 165
Query: 204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           ++ +  D+  TA E      G K  + + AP
Sbjct: 166 ARLI-EDNEYTARE------GAKFPIKWTAP 189

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 27  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 84  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 133
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 134 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTARE------GAKFPIKWT 183
Query: 233 AP 234
           AP
Sbjct: 184 AP 185

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 26  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 83  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 132
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 133 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTARE------GAKFPIKWT 182
Query: 233 AP 234
           AP
Sbjct: 183 AP 184

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 25/165 (15%)
Query: 51  SNMIGQGSYGSVYKGILGEDEMV---VAVKVINLKQKGAFRSFVA----ECEALRNIRHR 103
            + +G G++G V    +GE ++    VAVK++N +QK      V     E + L+  RH 
Sbjct: 16  GDTLGVGTFGKVK---IGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           ++ K+  + S+      DF  +V EY+  G L D++ +     E+    L Q++      
Sbjct: 72  HIIKLYQVIST----PTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------ 120
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
            SA++Y H +    +VH D+KP NVLLD  M A + DFGLS  +S
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 93/188 (49%), Gaps = 24/188 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIITI 111
           IG+G +G V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N+   I  
Sbjct: 37  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 90
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             + D+       LV +Y E+GSL D+L++       + +++   + +A+  AS + +LH
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLH 143
Query: 172 HNC-----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
                   +P + H D+K  N+L+  +    + D GL+    S   DT    P+  +G K
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA-TDTIDIAPNHRVGTK 202
Query: 227 GTVGYVAP 234
               Y+AP
Sbjct: 203 ---RYMAP 207

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 93/188 (49%), Gaps = 24/188 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIITI 111
           IG+G +G V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N+   I  
Sbjct: 12  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 65
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             + D+       LV +Y E+GSL D+L++       + +++   + +A+  AS + +LH
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLH 118
Query: 172 HNC-----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
                   +P + H D+K  N+L+  +    + D GL+    S   DT    P+  +G K
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA-TDTIDIAPNHRVGTK 177
Query: 227 GTVGYVAP 234
               Y+AP
Sbjct: 178 ---RYMAP 182

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 93/188 (49%), Gaps = 24/188 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIITI 111
           IG+G +G V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N+   I  
Sbjct: 17  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 70
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             + D+       LV +Y E+GSL D+L++       + +++   + +A+  AS + +LH
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLH 123
Query: 172 HNC-----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
                   +P + H D+K  N+L+  +    + D GL+    S   DT    P+  +G K
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA-TDTIDIAPNHRVGTK 182
Query: 227 GTVGYVAP 234
               Y+AP
Sbjct: 183 ---RYMAP 187

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 78  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTARE------GAKFPIKWT 177
Query: 233 AP 234
           AP
Sbjct: 178 AP 179

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 93/188 (49%), Gaps = 24/188 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIITI 111
           IG+G +G V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N+   I  
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 64
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             + D+       LV +Y E+GSL D+L++       + +++   + +A+  AS + +LH
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLH 117
Query: 172 HNC-----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
                   +P + H D+K  N+L+  +    + D GL+    S   DT    P+  +G K
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA-TDTIDIAPNHRVGTK 176
Query: 227 GTVGYVAP 234
               Y+AP
Sbjct: 177 ---RYMAP 181

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 93/188 (49%), Gaps = 24/188 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIITI 111
           IG+G +G V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N+   I  
Sbjct: 14  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 67
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             + D+       LV +Y E+GSL D+L++       + +++   + +A+  AS + +LH
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLH 120
Query: 172 HNC-----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
                   +P + H D+K  N+L+  +    + D GL+    S   DT    P+  +G K
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA-TDTIDIAPNHRVGTK 179
Query: 227 GTVGYVAP 234
               Y+AP
Sbjct: 180 ---RYMAP 184

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 16  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 73  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 123 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTARE------GAKFPIKWT 172
Query: 233 AP 234
           AP
Sbjct: 173 AP 174

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 93/188 (49%), Gaps = 24/188 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIITI 111
           IG+G +G V++G    +E  VAVK+ + +++   RS+  E E  + +  RH N+   I  
Sbjct: 50  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA- 103
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             + D+       LV +Y E+GSL D+L++       + +++   + +A+  AS + +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLH 156
Query: 172 HNC-----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
                   +P + H D+K  N+L+  +    + D GL+    S   DT    P+  +G K
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS-ATDTIDIAPNHRVGTK 215
Query: 227 GTVGYVAP 234
               Y+AP
Sbjct: 216 ---RYMAP 220

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 20/168 (11%)
Query: 51  SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTK 107
            ++IG+G++G V K  + +D + +   +  +K+   K   R F  E E L  + H     
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH--PN 77
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLH-----QTNDHLEVFK-----LSLIQRV 157
           II +  + + +G  +  L  EY  +G+L D+L      +T+    +       LS  Q +
Sbjct: 78  IINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           + A DVA  ++YL    Q   +H D+   N+L+  + VA + DFGLS+
Sbjct: 136 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 20/168 (11%)
Query: 51  SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTK 107
            ++IG+G++G V K  + +D + +   +  +K+   K   R F  E E L  + H     
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH--PN 87
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLH-----QTNDHLEVFK-----LSLIQRV 157
           II +  + + +G  +  L  EY  +G+L D+L      +T+    +       LS  Q +
Sbjct: 88  IINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           + A DVA  ++YL    Q   +H D+   N+L+  + VA + DFGLS+
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 26/188 (13%)
Query: 55  GQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSS 114
            +G +G V+K  L  +   VAVK+  ++ K ++++   E  +L  ++H N+ + I     
Sbjct: 33  ARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSWQNEY-EVYSLPGMKHENILQFIGAEKR 89
Query: 115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC 174
             S   D   L+  + E GSL       +D L+   +S  +  +IA  +A  + YLH + 
Sbjct: 90  GTSVDVDL-WLITAFHEKGSL-------SDFLKANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 175 -------QPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETPSSSIGIK 226
                  +P + H DIK  NVLL N++ A + DFGL+ KF        A ++   + G  
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF-------EAGKSAGDTHGQV 194
Query: 227 GTVGYVAP 234
           GT  Y+AP
Sbjct: 195 GTRRYMAP 202

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G +G V+ G    +   VA+K +         SF+ E + ++ ++H  L ++  + S
Sbjct: 17  LGNGQFGEVWMGTWNGN-TKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +V EYM  GSL D+L       E   L L   V++A  VA+ + Y+   
Sbjct: 75  E------EPIYIVTEYMNKGSLLDFLKDG----EGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                +H D++ +N+L+ N ++  + DFGL++ +  D+  TA +      G K  + + A
Sbjct: 125 N---YIHRDLRSANILVGNGLICKIADFGLARLI-EDNEXTARQ------GAKFPIKWTA 174
Query: 234 P 234
           P
Sbjct: 175 P 175

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 90/187 (48%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 96  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 146
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +++L        VH D+   N +LD      V DFGL++    D LD   ++  +  G K
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMLDKEFDSVHNKTGAK 199
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 200 LPVKWMA 206

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 51/219 (23%)
Query: 43  KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH 102
           +   +F +  ++GQG++G V K     D    A+K I   ++    + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 103 -------------RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH------QTN 143
                        RN  K +T   ++  K   F  +  EY ENG+L D +H      Q +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMT---AVKKKSTLF--IQMEYCENGTLYDLIHSENLNQQRD 116
Query: 144 DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
           ++  +F+            +  A+ Y+H      ++H D+KP N+ +D      +GDFGL
Sbjct: 117 EYWRLFR-----------QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGL 162
Query: 204 SK---------FLSSDHLDTASETPSSSIGIKGTVGYVA 233
           +K          L S +L  +S+  +S+I   GT  YVA
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAI---GTAMYVA 198

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 86/169 (50%), Gaps = 19/169 (11%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV---VAVKVIN-LKQKGAFRSFVAECEALRNIR 101
           E  +  ++G G++G+VYKGI + E E V   VA+K++N      A   F+ E   + ++ 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H +L +++ +C S   +      LV + M +G L +++H+  D++    L     +N  +
Sbjct: 76  HPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKDNIGSQLL-----LNWCV 124
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            +A  + YL       +VH D+   NVL+ +     + DFGL++ L  D
Sbjct: 125 QIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 170

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLTKI 108
           +G+G +G V    Y         +VAVK +        RS +  E + LR + H ++ K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
              C   + +G     LV EY+  GSL D+L + +       + L Q +  A  +   + 
Sbjct: 82  KGCC---EDQGEKSLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 131
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           YLH       +H ++   NVLLDND +  +GDFGL+K +   H
Sbjct: 132 YLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH 171

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 95/201 (47%), Gaps = 27/201 (13%)
Query: 18  GSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVK 77
           G++ + +   P    +P++ + ++          ++IG+G++G V K  + +D + +   
Sbjct: 1   GALNRKVKNNPDPTIYPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLRMDAA 53
Query: 78  VINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGS 134
           +  +K+   K   R F  E E L  + H     II +  + + +G  +  L  EY  +G+
Sbjct: 54  IKRMKEYASKDDHRDFAGELEVLCKLGHH--PNIINLLGACEHRG--YLYLAIEYAPHGN 109
Query: 135 LEDWLH-----QTNDHLEVFK-----LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIK 184
           L D+L      +T+    +       LS  Q ++ A DVA  ++YL    Q   +H ++ 
Sbjct: 110 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLA 166
Query: 185 PSNVLLDNDMVAHVGDFGLSK 205
             N+L+  + VA + DFGLS+
Sbjct: 167 ARNILVGENYVAKIADFGLSR 187

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 94  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 144
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++YL        VH D+   N +LD      V DFGL++    D  D    +  +  G K
Sbjct: 145 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEXXSVHNKTGAK 197
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 198 LPVKWMA 204

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 54  IGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLTKI 108
           +G+G +G V    Y         +VAVK +        RS +  E + LR + H ++ K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
              C   + +G     LV EY+  GSL D+L + +       + L Q +  A  +   + 
Sbjct: 82  KGCC---EDQGEKSLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 131
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           YLH       +H ++   NVLLDND +  +GDFGL+K +   H
Sbjct: 132 YLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH 171

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNL 105
           +F     +G+G +G V++     D+   A+K I L  +   R  V  E +AL  + H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 106 TKIIT--ICSSIDSKGADFKALVFEYME-----NGSLEDWLHQTNDHLEVFKLSLIQRVN 158
            +     +  +   K       V+ Y++       +L+DW+   N    + +      ++
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCLH 122
Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASET 218
           I + +A A+E+LH      ++H D+KPSN+    D V  VGDFGL   +  D  +    T
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 219 P----SSSIGIKGTVGYVAP 234
           P    +   G  GT  Y++P
Sbjct: 180 PMPAYARHTGQVGTKLYMSP 199

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 85/165 (51%), Gaps = 14/165 (8%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIRH 102
           ++ +F Q   +G G+Y +VYKG+     + VA+K + L  ++G   + + E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL--HQTNDHLEVFKLSLIQRVNIA 160
            N+ ++  +  + +        LVFE+M+N  L+ ++      +     +L+L++     
Sbjct: 63  ENIVRLYDVIHTENK-----LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +     + + H N    ++H D+KP N+L++      +GDFGL++
Sbjct: 117 L--LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 26/183 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIITI 111
           +G G +G V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L ++  +
Sbjct: 16  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
           C+    +   F  ++ EYM NG L ++L +     +  +L     + +  DV  A+EYL 
Sbjct: 72  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 121
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
                  +H D+   N L+++  V  V DFGLS+++  D         +SS+G K  V +
Sbjct: 122 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRW 171
Query: 232 VAP 234
             P
Sbjct: 172 SPP 174

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 91/182 (50%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G  G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 21  LGAGQAGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 78  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 127
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H D++ +N+L+ + +   + DFGL++ +  D   TA E      G K  + + 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLI-EDAEXTARE------GAKFPIKWT 177
Query: 233 AP 234
           AP
Sbjct: 178 AP 179

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 93/182 (51%), Gaps = 24/182 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-AFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G +G V+ G        VAVK  +LKQ   +  +F+AE   ++ ++H+ L ++  + 
Sbjct: 17  LGAGQFGEVWMGYYN-GHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
           +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 74  TQ------EPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE 123
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                 +H +++ +N+L+ + +   + DFGL++ +  D+  TA E      G K  + + 
Sbjct: 124 RN---YIHRNLRAANILVSDTLSCKIADFGLARLI-EDNEYTARE------GAKFPIKWT 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 32/188 (17%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLTK 107
           IG+G++G V+ G L  D  +VAVK        +LK K     F+ E   L+   H N+ +
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 176
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +I +C+           +V E ++ G    +L      L V   +L+Q V    D A+ +
Sbjct: 177 LIGVCTQKQP-----IYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVG---DAAAGM 226
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           EYL   C    +H D+   N L+    V  + DFG+S+       + A    ++S G++ 
Sbjct: 227 EYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-------EEADGVXAASGGLRQ 276
Query: 228 T-VGYVAP 234
             V + AP
Sbjct: 277 VPVKWTAP 284

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 93  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 143
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +++L        VH D+   N +LD      V DFGL++ +     D+      + + +K
Sbjct: 144 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 200

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 95  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +++L        VH D+   N +LD      V DFGL++ +     D+      + + +K
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 100 SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 150
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +++L        VH D+   N +LD      V DFGL++ +     D+      + + +K
Sbjct: 151 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 207

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 154 SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 204
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +++L        VH D+   N +LD      V DFGL++ +     D+      + + +K
Sbjct: 205 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 95  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +++L        VH D+   N +LD      V DFGL++ +     D+      + + +K
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 26/183 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIITI 111
           +G G +G V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L ++  +
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
           C+    +   F  ++ EYM NG L ++L +     +  +L     + +  DV  A+EYL 
Sbjct: 68  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 117
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
                  +H D+   N L+++  V  V DFGLS+++  D         +SS+G K  V +
Sbjct: 118 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRW 167
Query: 232 VAP 234
             P
Sbjct: 168 SPP 170

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 96  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 146
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +++L        VH D+   N +LD      V DFGL++ +     D+      + + +K
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 203

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 95  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++YL        VH D+   N +LD      V DFGL++    D  D    +  +  G K
Sbjct: 146 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAK 198
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 199 LPVKWMA 205

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 24/158 (15%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVI------NLKQKGAFRSFVAECEALRNIRHRNLTK 107
           IG+G++G V+ G L  D  +VAVK        +LK K     F+ E   L+   H N+ +
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 176
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +I +C+           +V E ++ G    +L      L V   +L+Q V    D A+ +
Sbjct: 177 LIGVCTQKQP-----IYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVG---DAAAGM 226
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           EYL   C    +H D+   N L+    V  + DFG+S+
Sbjct: 227 EYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 26/183 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIITI 111
           +G G +G V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L ++  +
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
           C+    +   F  ++ EYM NG L ++L +     +  +L     + +  DV  A+EYL 
Sbjct: 88  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 137
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
                  +H D+   N L+++  V  V DFGLS+++  D         +SS+G K  V +
Sbjct: 138 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRW 187
Query: 232 VAP 234
             P
Sbjct: 188 SPP 190

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 87  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 137
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++YL        VH D+   N +LD      V DFGL++    D  D    +  +  G K
Sbjct: 138 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAK 190
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 191 LPVKWMA 197

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 26/183 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIITI 111
           +G G +G V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L ++  +
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
           C+    +   F  ++ EYM NG L ++L +     +  +L     + +  DV  A+EYL 
Sbjct: 73  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 122
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
                  +H D+   N L+++  V  V DFGLS+++  D         +SS+G K  V +
Sbjct: 123 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRW 172
Query: 232 VAP 234
             P
Sbjct: 173 SPP 175

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 26/183 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIITI 111
           +G G +G V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L ++  +
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
           C+    +   F  ++ EYM NG L ++L +     +  +L     + +  DV  A+EYL 
Sbjct: 88  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 137
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
                  +H D+   N L+++  V  V DFGLS+++  D         +SS+G K  V +
Sbjct: 138 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-------ETSSVGSKFPVRW 187
Query: 232 VAP 234
             P
Sbjct: 188 SPP 190

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 114 SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 164
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++YL        VH D+   N +LD      V DFGL++    D  D    +  +  G K
Sbjct: 165 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAK 217
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 218 LPVKWMA 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 90  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 140
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++YL        VH D+   N +LD      V DFGL++    D  D    +  +  G K
Sbjct: 141 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAK 193
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 194 LPVKWMA 200

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 93  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 143
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++YL        VH D+   N +LD      V DFGL++    D  D    +  +  G K
Sbjct: 144 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAK 196
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 197 LPVKWMA 203

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 92  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 142
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++YL        VH D+   N +LD      V DFGL++    D  D    +  +  G K
Sbjct: 143 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAK 195
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 196 LPVKWMA 202

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 89/167 (53%), Gaps = 14/167 (8%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRN 104
           ++ +   IGQG++G V+K    +    VA+K + ++  ++G   + + E + L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 105 LTKIITICSSIDSKGADFKA---LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           +  +I IC +  S     KA   LVF++ E+    D     ++ L  F LS I+RV   +
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEH----DLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
              + + Y+H N    ++H D+K +NVL+  D V  + DFGL++  S
Sbjct: 135 --LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 26/183 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIITI 111
           +G G +G V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L ++  +
Sbjct: 23  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
           C+    +   F  ++ EYM NG L ++L +     +  +L     + +  DV  A+EYL 
Sbjct: 79  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 128
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
                  +H D+   N L+++  V  V DFGLS+++  D         +SS+G K  V +
Sbjct: 129 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRW 178
Query: 232 VAP 234
             P
Sbjct: 179 SPP 181

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLTK 107
           +G+G +G V          G  EMV AVK +        RS +  E E LR + H ++ K
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMV-AVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
               C   + +G     LV EY+  GSL D+L +         + L Q +  A  +   +
Sbjct: 76  YKGCC---EDQGEKSVQLVMEYVPLGSLRDYLPRHC-------VGLAQLLLFAQQICEGM 125
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
            YLH       +H  +   NVLLDND +  +GDFGL+K +   H
Sbjct: 126 AYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 166

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 94  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 144
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++YL        VH D+   N +LD      V DFGL++    D  D    +  +  G K
Sbjct: 145 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAK 197
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 198 LPVKWMA 204

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 95  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++YL        VH D+   N +LD      V DFGL++    D  D    +  +  G K
Sbjct: 146 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAK 198
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 199 LPVKWMA 205

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLTK 107
           +G+G +G V          G  EMV AVK +        RS +  E E LR + H ++ K
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMV-AVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
               C   + +G     LV EY+  GSL D+L +         + L Q +  A  +   +
Sbjct: 75  YKGCC---EDQGEKSVQLVMEYVPLGSLRDYLPRHC-------VGLAQLLLFAQQICEGM 124
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
            YLH       +H  +   NVLLDND +  +GDFGL+K +   H
Sbjct: 125 AYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 165

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 29/192 (15%)
Query: 26  TLPMEKQFP---MVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL- 81
           TL  + Q P    VS A  + +   + +   +G+G+YG VYK I       VA+K I L 
Sbjct: 11  TLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE 70
Query: 82  -KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
            +++G   + + E   L+ ++HRN   II + S I         L+FEY EN  L+ ++ 
Sbjct: 71  HEEEGVPGTAIREVSLLKELQHRN---IIELKSVIHHNHR--LHLIFEYAEN-DLKKYMD 124
Query: 141 QTND-HLEVFKLSLIQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLL-----DND 193
           +  D  + V K  L Q +N        + + H   C    +H D+KP N+LL        
Sbjct: 125 KNPDVSMRVIKSFLYQLIN-------GVNFCHSRRC----LHRDLKPQNLLLSVSDASET 173
Query: 194 MVAHVGDFGLSK 205
            V  +GDFGL++
Sbjct: 174 PVLKIGDFGLAR 185

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 51  SNMIGQGSYGSVYKGILGEDE---MVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L +++   +  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++     +  V  L     +   + VA  
Sbjct: 113 SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 163
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++YL        VH D+   N +LD      V DFGL++    D  D    +  +  G K
Sbjct: 164 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAK 216
Query: 227 GTVGYVA 233
             V ++A
Sbjct: 217 LPVKWMA 223

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIR 101
           AT  +     IG G+YG+VYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 102 ---HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN 158
              H N+ +++ +C++  +       LVFE+++   L  +L    D      L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKD 116
Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           +       +++LH NC   +VH D+KP N+L+ +     + DFGL++  S
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 93/192 (48%), Gaps = 33/192 (17%)
Query: 55  GQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSS 114
            +G +G V+K  L  D   VAVK+  L+ K +++S   E  +   ++H NL + I    +
Sbjct: 24  ARGRFGCVWKAQLMND--FVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFI----A 76
Query: 115 IDSKGADFKA---LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            + +G++ +    L+  + + GSL        D+L+   ++  +  ++A  ++  + YLH
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSL-------TDYLKGNIITWNELCHVAETMSRGLSYLH 129
Query: 172 HNC--------QPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETPSSS 222
            +         +P + H D K  NVLL +D+ A + DFGL+ +F          + P  +
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRF-------EPGKPPGDT 182
Query: 223 IGIKGTVGYVAP 234
            G  GT  Y+AP
Sbjct: 183 HGQVGTRRYMAP 194

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIR 101
           AT  +     IG G+YG+VYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 102 ---HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN 158
              H N+ +++ +C++  +       LVFE+++   L  +L    D      L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKD 116
Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           +       +++LH NC   +VH D+KP N+L+ +     + DFGL++  S
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIR 101
           AT  +     IG G+YG+VYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 102 ---HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN 158
              H N+ +++ +C++  +       LVFE+++   L  +L    D      L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKD 116
Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           +       +++LH NC   +VH D+KP N+L+ +     + DFGL++  S
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 96/187 (51%), Gaps = 19/187 (10%)
Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGA 86
           M KQ+  V          ++ +   IGQG++G V+K    +    VA+K + ++  ++G 
Sbjct: 1   MAKQYDSVE-CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59
Query: 87  FRSFVAECEALRNIRHRNLTKIITICSSIDS-----KGADFKALVFEYMENGSLEDWLHQ 141
             + + E + L+ ++H N+  +I IC +  S     KG+ +  LVF++ E+    D    
Sbjct: 60  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY--LVFDFCEH----DLAGL 113
Query: 142 TNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF 201
            ++ L  F LS I+RV   +   + + Y+H N    ++H D+K +NVL+  D V  + DF
Sbjct: 114 LSNVLVKFTLSEIKRVMQML--LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168
Query: 202 GLSKFLS 208
           GL++  S
Sbjct: 169 GLARAFS 175

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 88/162 (54%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITI 111
           IGQG++G V+K    +    VA+K + ++  ++G   + + E + L+ ++H N+  +I I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 112 CSSIDS-----KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           C +  S     KG+ +  LVF++ E+    D     ++ L  F LS I+RV   +   + 
Sbjct: 86  CRTKASPYNRCKGSIY--LVFDFCEH----DLAGLLSNVLVKFTLSEIKRVMQML--LNG 137
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           + Y+H N    ++H D+K +NVL+  D V  + DFGL++  S
Sbjct: 138 LYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 23  PIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK 82
           P D LP         +A   +   ++   ++IG+G    V + +        AVK++ + 
Sbjct: 79  PEDELP--------DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVT 130
Query: 83  QKGAFRSFVAEC-EALRNIRH--RNLTKIITICSSIDS-KGADFKALVFEYMENGSLEDW 138
            +      + E  EA R   H  R +     I + IDS + + F  LVF+ M  G L D+
Sbjct: 131 AERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDY 190
Query: 139 LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           L       E   LS  +  +I   +  A+ +LH N    +VH D+KP N+LLD++M   +
Sbjct: 191 L------TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241
Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            DFG S      HL+   +       + GT GY+AP
Sbjct: 242 SDFGFSC-----HLEPGEKLRE----LCGTPGYLAP 268

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 91/169 (53%), Gaps = 18/169 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRN 104
           ++ +   IGQG++G V+K    +    VA+K + ++  ++G   + + E + L+ ++H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 105 LTKIITICSSIDS-----KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           +  +I IC +  S     KG+ +  LVF++ E+    D     ++ L  F LS I+RV  
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIY--LVFDFCEH----DLAGLLSNVLVKFTLSEIKRVMQ 132
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
            +   + + Y+H N    ++H D+K +NVL+  D V  + DFGL++  S
Sbjct: 133 ML--LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 61
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +E    
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 116
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 117 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 63
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +E    
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 70
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +E    
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 67
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +E    
Sbjct: 68  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 122
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 123 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 76
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +E    
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 131
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 69
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +E    
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 70
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +E    
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 69
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +E    
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 31/167 (18%)
Query: 52  NMIGQGSYGSVYKGILGEDEMV---VAVKVINLKQK-------GAFRSFVAECEALRNIR 101
           + +G G++G V    +G+ E+    VAVK++N +QK       G  R    E + L+  R
Sbjct: 22  DTLGVGTFGKVK---VGKHELTGHKVAVKILN-RQKIRSLDVVGKIRR---EIQNLKLFR 74
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H ++ K+  + S+     +D   +V EY+  G L D++ +     E     L Q++    
Sbjct: 75  HPHIIKLYQVIST----PSDI-FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI---- 125
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
              S ++Y H +    +VH D+KP NVLLD  M A + DFGLS  +S
Sbjct: 126 --LSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 98
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +E    
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 153
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 154 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 51/219 (23%)
Query: 43  KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH 102
           +   +F +  ++GQG++G V K     D    A+K I   ++    + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 103 -------------RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH------QTN 143
                        RN  K +T   ++  K   F  +  EY EN +L D +H      Q +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMT---AVKKKSTLF--IQMEYCENRTLYDLIHSENLNQQRD 116
Query: 144 DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
           ++  +F+            +  A+ Y+H      ++H D+KP N+ +D      +GDFGL
Sbjct: 117 EYWRLFR-----------QILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGL 162
Query: 204 SK---------FLSSDHLDTASETPSSSIGIKGTVGYVA 233
           +K          L S +L  +S+  +S+I   GT  YVA
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAI---GTAMYVA 198

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 26/183 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIITI 111
           +G G +G V  G     +  VA+K+I   ++G+     F+ E + + N+ H  L ++  +
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
           C+    +   F  ++ EYM NG L ++L +     +  +L     + +  DV  A+EYL 
Sbjct: 73  CTK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE 122
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
                  +H D+   N L+++  V  V DFGLS+++  D         +SS G K  V +
Sbjct: 123 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSRGSKFPVRW 172
Query: 232 VAP 234
             P
Sbjct: 173 SPP 175

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 19/171 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLTKIIT 110
           +G+GS+G V           VA+K+IN K   K   +  +  E   LR +RH ++ K+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +  S D        +V EY  N  L D++ Q +   E       Q++       SA+EY 
Sbjct: 72  VIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQI------ISAVEYC 119
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS-SDHLDTASETPS 220
           H +    +VH D+KP N+LLD  +   + DFGLS  ++  + L T+  +P+
Sbjct: 120 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN 167

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 19/171 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLTKIIT 110
           +G+GS+G V           VA+K+IN K   K   +  +  E   LR +RH ++ K+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +  S D        +V EY  N  L D++ Q +   E       Q++       SA+EY 
Sbjct: 81  VIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQI------ISAVEYC 128
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS-SDHLDTASETPS 220
           H +    +VH D+KP N+LLD  +   + DFGLS  ++  + L T+  +P+
Sbjct: 129 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN 176

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 19/171 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLTKIIT 110
           +G+GS+G V           VA+K+IN K   K   +  +  E   LR +RH ++ K+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +  S D        +V EY  N  L D++ Q +   E       Q++       SA+EY 
Sbjct: 82  VIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQI------ISAVEYC 129
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS-SDHLDTASETPS 220
           H +    +VH D+KP N+LLD  +   + DFGLS  ++  + L T+  +P+
Sbjct: 130 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPN 177

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 14  VRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI-LGEDEM 72
           +RR    R+ ++ L    + P  +   + K T EF +  ++G G++G+VYKG+ + E E 
Sbjct: 18  LRRLLQERELVEPLTPSGEAPNQALLRILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEK 76
Query: 73  V-VAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE 128
           V + V ++ L++     A +  + E   + ++ + ++ +++ IC +   +      L+ +
Sbjct: 77  VKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQ 130
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
            M  G L D++ +  D++    L     +N  + +A  + YL       +VH D+   NV
Sbjct: 131 LMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDRR---LVHRDLAARNV 182
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L+       + DFGL+K L ++  +  +E
Sbjct: 183 LVKTPQHVKITDFGLAKLLGAEEKEYHAE 211

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVA-ECEALRNIRHRNLTKIIT 110
           +G+GS+G V           VA+K+IN K   K   +  +  E   LR +RH ++ K+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +  S D        +V EY  N  L D++ Q +   E       Q++       SA+EY 
Sbjct: 76  VIKSKDEI-----IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQI------ISAVEYC 123
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS-SDHLDTASETPSSS 222
           H +    +VH D+KP N+LLD  +   + DFGLS  ++  + L T+  +P+ +
Sbjct: 124 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 173

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 35/196 (17%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVIN---LKQKGAFRSFVAECEALRNIR 101
           +    ++G+GS+G V   IL +D++     AVKVI+   +KQK    S + E + L+ + 
Sbjct: 34  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+ K+       + KG  +  LV E    G L D +      +   + S +    I  
Sbjct: 91  HPNIMKLYEF---FEDKGYFY--LVGEVYTGGELFDEI------ISRKRFSEVDAARIIR 139
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASET 218
            V S I Y+H N    +VH D+KP N+LL++   D    + DFGL     S H + AS+ 
Sbjct: 140 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFE-ASKK 190
Query: 219 PSSSIGIKGTVGYVAP 234
               I   GT  Y+AP
Sbjct: 191 MKDKI---GTAYYIAP 203

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 31/162 (19%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR----------HR 103
           +G+G+YG V+K I      VVAVK I       F +F    +A R  R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+  ++ +  + + +      LVF+YME       LH     +    L  + +  +   +
Sbjct: 70  NIVNLLNVLRADNDRDV---YLVFDYMETD-----LHAV---IRANILEPVHKQYVVYQL 118
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
              I+YLH      ++H D+KPSN+LL+ +    V DFGLS+
Sbjct: 119 IKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 16/175 (9%)
Query: 42  SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR-----SFVAECEA 96
           S AT  +     IG G+YG+VYK         VA+K + +   G        S V E   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 97  LRNIR---HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
           LR +    H N+ +++ +C++  +       LVFE+++   L  +L    D      L  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPA 119
Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
               ++       +++LH NC   +VH D+KP N+L+ +     + DFGL++  S
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 81/178 (45%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFR---SFV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 63
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +E    
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N  +  D    +GDFG+++
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 35/196 (17%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVIN---LKQKGAFRSFVAECEALRNIR 101
           +    ++G+GS+G V   IL +D++     AVKVI+   +KQK    S + E + L+ + 
Sbjct: 28  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+ K+       + KG  +  LV E    G L D +      +   + S +    I  
Sbjct: 85  HPNIMKLYEF---FEDKG--YFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIR 133
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASET 218
            V S I Y+H N    +VH D+KP N+LL++   D    + DFGLS          AS+ 
Sbjct: 134 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------ASKK 184
Query: 219 PSSSIGIKGTVGYVAP 234
               I   GT  Y+AP
Sbjct: 185 MKDKI---GTAYYIAP 197

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 30/172 (17%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI------NLKQKGAFRSFVAECEALRNI 100
           ++    ++G+GSYG V K    +   +VA+K         + +K A R    E + L+ +
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQL 81
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV--N 158
           RH NL  ++ +C     K      LVFE++++  L+D        LE+F   L  +V   
Sbjct: 82  RHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDD--------LELFPNGLDYQVVQK 128
Query: 159 IAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
               + + I + H HN    ++H DIKP N+L+    V  + DFG ++ L++
Sbjct: 129 YLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 23/200 (11%)
Query: 35  MVSYAELSKATCEFSQSNMIGQGSYGSVYKGIL---GED-EMVVAVKVINLKQ-KGAFRS 89
           M   A + K T E  +  ++G G +G+V+KG+    GE  ++ V +KVI  K  + +F++
Sbjct: 3   MKVLARIFKET-ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 61
Query: 90  FVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF 149
                 A+ ++ H ++ +++ +C      G+  + LV +Y+  GSL D + Q   H    
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQ-LVTQYLPLGSLLDHVRQ---HRGAL 112
Query: 150 KLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
              L+  +N  + +A  + YL  +    MVH ++   NVLL +     V DFG++  L  
Sbjct: 113 GPQLL--LNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167
Query: 210 DH---LDTASETPSSSIGIK 226
           D    L + ++TP   + ++
Sbjct: 168 DDKQLLYSEAKTPIKWMALE 187

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 31/199 (15%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F +  +IG G +G V+K     D     +K +    + A R    E +AL  + H N+ 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 107 KIITI---------CSSIDSKGADFKALV--FEYMENGSLEDWLHQTNDHLEVFKLSLIQ 155
                          SS +S  +  K L    E+ + G+LE W+ +        KL  + 
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----KLDKVL 123
Query: 156 RVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTA 215
            + +   +   ++Y+H      +++ D+KPSN+ L +     +GDFGL   L +D     
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR 180
Query: 216 SETPSSSIGIKGTVGYVAP 234
           S         KGT+ Y++P
Sbjct: 181 S---------KGTLRYMSP 190

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   M VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  F L L   +  A  +++A+ Y
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAY 126
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+ ++    +GDFGLS+++       AS+
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASK 171

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 35/196 (17%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVIN---LKQKGAFRSFVAECEALRNIR 101
           +    ++G+GS+G V   IL +D++     AVKVI+   +KQK    S + E + L+ + 
Sbjct: 51  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+ K+       + KG  +  LV E    G L D +      +   + S +    I  
Sbjct: 108 HPNIMKLYEF---FEDKG--YFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIR 156
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASET 218
            V S I Y+H N    +VH D+KP N+LL++   D    + DFGLS          AS+ 
Sbjct: 157 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------ASKK 207
Query: 219 PSSSIGIKGTVGYVAP 234
               I   GT  Y+AP
Sbjct: 208 MKDKI---GTAYYIAP 220

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 91/196 (46%), Gaps = 35/196 (17%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVIN---LKQKGAFRSFVAECEALRNIR 101
           +    ++G+GS+G V   IL +D++     AVKVI+   +KQK    S + E + L+ + 
Sbjct: 52  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+ K+       + KG  +  LV E    G L D +      +   + S +    I  
Sbjct: 109 HPNIMKLYEF---FEDKG--YFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIR 157
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASET 218
            V S I Y+H N    +VH D+KP N+LL++   D    + DFGLS          AS+ 
Sbjct: 158 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------ASKK 208
Query: 219 PSSSIGIKGTVGYVAP 234
               I   GT  Y+AP
Sbjct: 209 MKDKI---GTAYYIAP 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 27/210 (12%)
Query: 18  GSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGIL---GED-EMV 73
           G   +P+D  P EK   ++  A + K T E  +  ++G G +G+V+KG+    GE  ++ 
Sbjct: 8   GESIEPLD--PSEKANKVL--ARIFKET-ELRKLKVLGSGVFGTVHKGVWIPEGESIKIP 62
Query: 74  VAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMEN 132
           V +KVI  K  + +F++      A+ ++ H ++ +++ +C      G+  + LV +Y+  
Sbjct: 63  VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQ-LVTQYLPL 116
Query: 133 GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN 192
           GSL D + Q   H       L+  +N  + +A  + YL  +    MVH ++   NVLL +
Sbjct: 117 GSLLDHVRQ---HRGALGPQLL--LNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKS 168
Query: 193 DMVAHVGDFGLSKFLSSDH---LDTASETP 219
                V DFG++  L  D    L + ++TP
Sbjct: 169 PSQVQVADFGVADLLPPDDKQLLYSEAKTP 198

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 32/195 (16%)
Query: 54  IGQGSYGSVYKG-----ILGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +GQGS+G VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----VFKLSLIQRVNIAI 161
            +++ + S    KG     +V E M +G L+ +L       E        +L + + +A 
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
           ++A  + YL+       VH D+   N ++ +D    +GDFG+++ +         ET   
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--------XETDXX 186
Query: 222 SIGIKG--TVGYVAP 234
             G KG   V ++AP
Sbjct: 187 RKGGKGLLPVRWMAP 201

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 32/195 (16%)
Query: 54  IGQGSYGSVYKG-----ILGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +GQGS+G VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 79
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----VFKLSLIQRVNIAI 161
            +++ + S    KG     +V E M +G L+ +L       E        +L + + +A 
Sbjct: 80  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 134
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
           ++A  + YL+       VH D+   N ++ +D    +GDFG+++ +         ET   
Sbjct: 135 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--------XETDXX 183
Query: 222 SIGIKG--TVGYVAP 234
             G KG   V ++AP
Sbjct: 184 RKGGKGLLPVRWMAP 198

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 90/196 (45%), Gaps = 35/196 (17%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVIN---LKQKGAFRSFVAECEALRNIR 101
           +    ++G+GS+G V   IL +D++     AVKVI+   +KQK    S + E + L+ + 
Sbjct: 28  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+ K+       + KG  +  LV E    G L D +      +   + S +    I  
Sbjct: 85  HPNIXKLYEF---FEDKG--YFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIR 133
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASET 218
            V S I Y H N    +VH D+KP N+LL++   D    + DFGLS          AS+ 
Sbjct: 134 QVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------ASKK 184
Query: 219 PSSSIGIKGTVGYVAP 234
               I   GT  Y+AP
Sbjct: 185 XKDKI---GTAYYIAP 197

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 84/184 (45%), Gaps = 28/184 (15%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS--FVAECEALRNIRHRNLTKIITI 111
           +G G +G V  G   + +  VAVK+I   ++G+     F  E + +  + H  L K   +
Sbjct: 16  LGSGQFGVVKLGKW-KGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 112 CSSIDSKGADFK-ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           CS       ++   +V EY+ NG L ++L      LE  +L     + +  DV   + +L
Sbjct: 72  CSK------EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFL 120
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
             +     +H D+   N L+D D+   V DFG+++++  D          SS+G K  V 
Sbjct: 121 ESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-------VSSVGTKFPVK 170
Query: 231 YVAP 234
           + AP
Sbjct: 171 WSAP 174

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 54  IGQGSYGSVYKG-----ILGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +GQGS+G VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----VFKLSLIQRVNIAI 161
            +++ + S    KG     +V E M +G L+ +L       E        +L + + +A 
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           ++A  + YL+       VH D+   N ++ +D    +GDFG+++
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 32/195 (16%)
Query: 54  IGQGSYGSVYKG-----ILGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +GQGS+G VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----VFKLSLIQRVNIAI 161
            +++ + S    KG     +V E M +G L+ +L       E        +L + + +A 
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
           ++A  + YL+       VH D+   N ++ +D    +GDFG+++ +         ET   
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--------XETDXX 186
Query: 222 SIGIKG--TVGYVAP 234
             G KG   V ++AP
Sbjct: 187 RKGGKGLLPVRWMAP 201

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 54  IGQGSYGSVYKG-----ILGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +GQGS+G VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----VFKLSLIQRVNIAI 161
            +++ + S    KG     +V E M +G L+ +L       E        +L + + +A 
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           ++A  + YL+       VH D+   N ++ +D    +GDFG+++
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 54  IGQGSYGSVYKG-----ILGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +GQGS+G VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 81
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----VFKLSLIQRVNIAI 161
            +++ + S    KG     +V E M +G L+ +L       E        +L + + +A 
Sbjct: 82  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           ++A  + YL+       VH D+   N ++ +D    +GDFG+++
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 96/216 (44%), Gaps = 45/216 (20%)
Query: 43  KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH 102
           +   +F +  ++GQG++G V K     D    A+K I   ++    + ++E   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVXLLASLNH 61
Query: 103 RNLTK----------IITICSSIDSKGADFKALVFEYMENGSLEDWLH------QTNDHL 146
           + + +           +   +++  K   F  +  EY EN +L D +H      Q +++ 
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLF--IQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 147 EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK- 205
            +F+            +  A+ Y+H      ++H ++KP N+ +D      +GDFGL+K 
Sbjct: 120 RLFR-----------QILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKN 165
Query: 206 --------FLSSDHLDTASETPSSSIGIKGTVGYVA 233
                    L S +L  +S+  +S+I   GT  YVA
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAI---GTAXYVA 198

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 32/192 (16%)
Query: 54  IGQGSYGSVYKGIL-GEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIIT 110
           +G+G YG V++G+  GE    VAVK+ + + +   +S+  E E    +  RH N+   I 
Sbjct: 16  VGKGRYGEVWRGLWHGES---VAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIA 69
Query: 111 ICSSIDSKGADFK-ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
             S + S+ +  +  L+  Y E+GSL D+L +     +  +  L  R  +A+  A  + +
Sbjct: 70  --SDMTSRNSSTQLWLITHYHEHGSLYDFLQR-----QTLEPHLALR--LAVSAACGLAH 120
Query: 170 LH-----HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS--SDHLDTASETPSSS 222
           LH        +P + H D K  NVL+ +++   + D GL+   S  SD+LD  +      
Sbjct: 121 LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-- 178
Query: 223 IGIKGTVGYVAP 234
               GT  Y+AP
Sbjct: 179 ----GTKRYMAP 186

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 30/178 (16%)
Query: 51  SNMIGQGSYGSVYKGILGE---DEMVVAVKV------INLKQKGAFRSFVAECEALRNIR 101
           + ++G+G +G VY+G+      +++ VAVK       ++ K+K     F++E   ++N+ 
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-----FMSEAVIMKNLD 83
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H ++ K+I I         +   ++ E    G L  +L +  + L+V  L L      ++
Sbjct: 84  HPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-----SL 132
Query: 162 DVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASET 218
            +  A+ YL   NC    VH DI   N+L+ +     +GDFGLS+++  +    AS T
Sbjct: 133 QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 186

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 87/187 (46%), Gaps = 30/187 (16%)
Query: 54  IGQGSYGSVYKGILGEDEMV---VAVKVINL---KQKGAFRSFVAECEALRNIRHRNLTK 107
           +G G   +VY   L ED ++   VA+K I +   +++   + F  E      + H+N+  
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +I +      +  D   LV EY+E  +L +++           LS+   +N    +   I
Sbjct: 76  MIDV-----DEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGI 124
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           ++ H      +VH DIKP N+L+D++    + DFG++K LS   L       + +  + G
Sbjct: 125 KHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-------TQTNHVLG 174
Query: 228 TVGYVAP 234
           TV Y +P
Sbjct: 175 TVQYFSP 181

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 30/178 (16%)
Query: 51  SNMIGQGSYGSVYKGILGE---DEMVVAVKV------INLKQKGAFRSFVAECEALRNIR 101
           + ++G+G +G VY+G+      +++ VAVK       ++ K+K     F++E   ++N+ 
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-----FMSEAVIMKNLD 67
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H ++ K+I I         +   ++ E    G L  +L +  + L+V  L L      ++
Sbjct: 68  HPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-----SL 116
Query: 162 DVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASET 218
            +  A+ YL   NC    VH DI   N+L+ +     +GDFGLS+++  +    AS T
Sbjct: 117 QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 170

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 47  EFSQSNMI---GQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHR 103
           +F Q N +    +   G ++KG    +++VV V  +        R F  EC  LR   H 
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+  ++  C    S  A    L+  +M  GSL + LH+  +    F +   Q V  A+D+
Sbjct: 68  NVLPVLGACQ---SPPAPHPTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDM 120
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           A  + +L H  +P +    +   +V++D DM A +
Sbjct: 121 ARGMAFL-HTLEPLIPRHALNSRSVMIDEDMTARI 154

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 13/183 (7%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GSYG   K     D  ++  K ++     +   +  V+E   LR ++H N   I+  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVRY 70
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
              I  +      +V EY E G L   + +     +      + RV   + +A    +  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
            +    ++H D+KP+NV LD      +GDFGL++ L+ D  D A E         GT  Y
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE-DFAKE-------FVGTPYY 182
Query: 232 VAP 234
           ++P
Sbjct: 183 MSP 185

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 30/178 (16%)
Query: 51  SNMIGQGSYGSVYKGILGE---DEMVVAVKV------INLKQKGAFRSFVAECEALRNIR 101
           + ++G+G +G VY+G+      +++ VAVK       ++ K+K     F++E   ++N+ 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-----FMSEAVIMKNLD 71
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H ++ K+I I         +   ++ E    G L  +L +  + L+V  L L      ++
Sbjct: 72  HPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-----SL 120
Query: 162 DVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASET 218
            +  A+ YL   NC    VH DI   N+L+ +     +GDFGLS+++  +    AS T
Sbjct: 121 QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 174

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 44/212 (20%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F +  +IG G +G V+K     D     ++ +    + A R    E +AL  + H N+ 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIV 68
Query: 107 KIITICSSIDS---------KGADFKA---------------LVFEYMENGSLEDWLHQT 142
                    D          + +D+                 +  E+ + G+LE W+ + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 143 NDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG 202
                  KL  +  + +   +   ++Y+H      ++H D+KPSN+ L +     +GDFG
Sbjct: 129 RGE----KLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           L   L +D   T S         KGT+ Y++P
Sbjct: 182 LVTSLKNDGKRTRS---------KGTLRYMSP 204

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 81/178 (45%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 76
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +     
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 32/192 (16%)
Query: 54  IGQGSYGSVYKGIL-GEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIIT 110
           +G+G YG V++G   GE+   VAVK+ + + +   +S+  E E    +  RH N+   I 
Sbjct: 16  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 111 ICSSIDSKGADFK-ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
             S + S+ +  +  L+  Y E GSL D+L  T        L  +  + I + +AS + +
Sbjct: 70  --SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAH 120
Query: 170 LH-----HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF--LSSDHLDTASETPSSS 222
           LH        +P + H D+K  N+L+  +    + D GL+     S++ LD  +      
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-- 178
Query: 223 IGIKGTVGYVAP 234
               GT  Y+AP
Sbjct: 179 ----GTKRYMAP 186

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 27/184 (14%)
Query: 41  LSKATCEFSQSNM-----IGQGSYGSVYKGILGEDE---MVVAVKVIN---LKQKGAFRS 89
           L   TC   + ++     +G GS+G V +G         + VAVK +    L Q  A   
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 90  FVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF 149
           F+ E  A+ ++ HRNL ++  +  +   K      +V E    GSL D L +   H   F
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH---F 118
Query: 150 KLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL-- 207
            L  + R   A+ VA  + YL        +H D+   N+LL    +  +GDFGL + L  
Sbjct: 119 LLGTLSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
Query: 208 SSDH 211
           + DH
Sbjct: 174 NDDH 177

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 16/192 (8%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNL 105
           ++    +IG G+   V        +  VA+K INL++ + +    + E +A+    H N 
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN- 69
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI---D 162
             I++  +S   K  D   LV + +  GS+ D +       E  K  ++    IA    +
Sbjct: 70  --IVSYYTSFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILRE 124
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           V   +EYLH N Q   +H D+K  N+LL  D    + DFG+S FL++    T ++   + 
Sbjct: 125 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 223 IGIKGTVGYVAP 234
           +   GT  ++AP
Sbjct: 182 V---GTPCWMAP 190

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
           +EK   +VS  +  K    F +   IGQG+ G+VY  +       VA++ +NL+Q+    
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQTNDHLE 147
             + E   +R  ++ N      I + +DS    D   +V EY+  GSL D + +T   ++
Sbjct: 63  LIINEILVMRENKNPN------IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMD 114
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
             +++ + R     +   A+E+LH N    ++H DIK  N+LL  D    + DFG    +
Sbjct: 115 EGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 208 SSDHLDTASETPSSSIGIKGTVGYVAP 234
           + +         S    + GT  ++AP
Sbjct: 167 TPEQ--------SKRSTMVGTPYWMAP 185

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 27/184 (14%)
Query: 41  LSKATCEFSQSNM-----IGQGSYGSVYKGILGEDE---MVVAVKVIN---LKQKGAFRS 89
           L   TC   + ++     +G GS+G V +G         + VAVK +    L Q  A   
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 90  FVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF 149
           F+ E  A+ ++ HRNL ++  +  +   K      +V E    GSL D L +   H   F
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH---F 118
Query: 150 KLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL-- 207
            L  + R   A+ VA  + YL        +H D+   N+LL    +  +GDFGL + L  
Sbjct: 119 LLGTLSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
Query: 208 SSDH 211
           + DH
Sbjct: 174 NDDH 177

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 32/192 (16%)
Query: 54  IGQGSYGSVYKGIL-GEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIIT 110
           +G+G YG V++G   GE+   VAVK+ + + +   +S+  E E    +  RH N+   I 
Sbjct: 16  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69
Query: 111 ICSSIDSKGADFK-ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
             S + S+ +  +  L+  Y E GSL D+L  T        L  +  + I + +AS + +
Sbjct: 70  --SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAH 120
Query: 170 LH-----HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF--LSSDHLDTASETPSSS 222
           LH        +P + H D+K  N+L+  +    + D GL+     S++ LD  +      
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-- 178
Query: 223 IGIKGTVGYVAP 234
               GT  Y+AP
Sbjct: 179 ----GTKRYMAP 186

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
           +EK   +VS  +  K    F +   IGQG+ G+VY  +       VA++ +NL+Q+    
Sbjct: 7   LEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 63
Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQTNDHLE 147
             + E   +R  ++ N      I + +DS    D   +V EY+  GSL D + +T   ++
Sbjct: 64  LIINEILVMRENKNPN------IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMD 115
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
             +++ + R     +   A+E+LH N    ++H DIK  N+LL  D    + DFG    +
Sbjct: 116 EGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 167
Query: 208 SSDHLDTASETPSSSIGIKGTVGYVAP 234
           + +         S    + GT  ++AP
Sbjct: 168 TPEQ--------SKRSXMVGTPYWMAP 186

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 81/178 (45%), Gaps = 22/178 (12%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FV 91
           E   A  + + S  +GQGS+G VY+G+       E E  VA+K +N  +  + R    F+
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 66
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---- 147
            E   ++     ++ +++ + S           ++ E M  G L+ +L      +     
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 121
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   SL + + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++
Sbjct: 122 LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRHRN 104
           ++ +   +G+G+YG VYK    +   +VA+K I L  + +G   + + E   L+ + H N
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           +  +I +  S          LVFE+ME   L+  L +    L        Q   I I + 
Sbjct: 81  IVSLIDVIHS-----ERCLTLVFEFMEK-DLKKVLDENKTGL--------QDSQIKIYLY 126
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             +  + H  Q  ++H D+KP N+L+++D    + DFGL++
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRHRN 104
           ++ +   +G+G+YG VYK    +   +VA+K I L  + +G   + + E   L+ + H N
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           +  +I +  S          LVFE+ME   L+  L +    L        Q   I I + 
Sbjct: 81  IVSLIDVIHS-----ERCLTLVFEFMEK-DLKKVLDENKTGL--------QDSQIKIYLY 126
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             +  + H  Q  ++H D+KP N+L+++D    + DFGL++
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 80  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 128
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 129 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 181

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 77  NPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKDNIGSQYL-----LNWCV 125
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 126 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 32/192 (16%)
Query: 54  IGQGSYGSVYKGIL-GEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIIT 110
           +G+G YG V++G   GE+   VAVK+ + + +   +S+  E E    +  RH N+   I 
Sbjct: 45  VGKGRYGEVWRGSWQGEN---VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 98
Query: 111 ICSSIDSKGADFK-ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
             S + S+ +  +  L+  Y E GSL D+L  T        L  +  + I + +AS + +
Sbjct: 99  --SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAH 149
Query: 170 LH-----HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF--LSSDHLDTASETPSSS 222
           LH        +P + H D+K  N+L+  +    + D GL+     S++ LD  +      
Sbjct: 150 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-- 207
Query: 223 IGIKGTVGYVAP 234
               GT  Y+AP
Sbjct: 208 ----GTKRYMAP 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 78  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 126
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 127 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 79  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 127
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 128 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
           +EK   +VS  +  K    F +   IGQG+ G+VY  +       VA++ +NL+Q+    
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQTNDHLE 147
             + E   +R  ++ N      I + +DS    D   +V EY+  GSL D + +T   ++
Sbjct: 63  LIINEILVMRENKNPN------IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMD 114
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
             +++ + R     +   A+E+LH N    ++H DIK  N+LL  D    + DFG    +
Sbjct: 115 EGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 208 SSDHLDTASETPSSSIGIKGTVGYVAP 234
           + +         S    + GT  ++AP
Sbjct: 167 TPEQ--------SKRSXMVGTPYWMAP 185

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 84/155 (54%), Gaps = 15/155 (9%)
Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIIT 110
           + +G+G+Y +VYKG     + +VA+K I L+ ++GA  + + E   L++++H N   I+T
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN---IVT 64
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +   I ++ +    LVFEY++   L+ +L    +        +I   N+ + +   +  L
Sbjct: 65  LHDIIHTEKS--LTLVFEYLDK-DLKQYLDDCGN--------IINMHNVKLFLFQLLRGL 113
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            +  +  ++H D+KP N+L++      + DFGL++
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 77  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 125
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 126 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 125 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   M VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  F L L   +  A  +++A+ Y
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAY 506
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+ ++    +GDFGLS+++       AS+
Sbjct: 507 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
           +EK   +VS  +  K    F +   IGQG+ G+VY  +       VA++ +NL+Q+    
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 62
Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQTNDHLE 147
             + E   +R  ++ N      I + +DS    D   +V EY+  GSL D + +T   ++
Sbjct: 63  LIINEILVMRENKNPN------IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMD 114
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
             +++ + R     +   A+E+LH N    ++H DIK  N+LL  D    + DFG    +
Sbjct: 115 EGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 208 SSDHLDTASETPSSSIGIKGTVGYVAP 234
           + +         S    + GT  ++AP
Sbjct: 167 TPEQ--------SKRSEMVGTPYWMAP 185

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 16/192 (8%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNL 105
           ++    +IG G+   V        +  VA+K INL++ + +    + E +A+    H N 
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN- 74
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI---D 162
             I++  +S   K  D   LV + +  GS+ D +       E  K  ++    IA    +
Sbjct: 75  --IVSYYTSFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILRE 129
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           V   +EYLH N Q   +H D+K  N+LL  D    + DFG+S FL++    T ++   + 
Sbjct: 130 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 223 IGIKGTVGYVAP 234
           +   GT  ++AP
Sbjct: 187 V---GTPCWMAP 195

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 86/181 (47%), Gaps = 21/181 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G +G V+ G    +   VAVK +      + ++F+ E   ++ ++H  L ++  + +
Sbjct: 21  LGAGQFGEVWMGYYN-NSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             +        ++ EYM  GSL D+L       E  K+ L + ++ +  +A  + Y+   
Sbjct: 79  REEPI-----YIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIERK 129
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                +H D++ +NVL+   ++  + DFGL++ +  D+  TA E      G K  + + A
Sbjct: 130 N---YIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTARE------GAKFPIKWTA 179
Query: 234 P 234
           P
Sbjct: 180 P 180

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 33/194 (17%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHR 103
           +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVNIAI 161
           N+ ++           A    L+ EY   G++         + E+ KLS    QR    I
Sbjct: 73  NILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSRFDEQRTATYI 118
Query: 162 -DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPS 220
            ++A+A+ Y H      ++H DIKP N+LL ++    + DFG S    S   DT      
Sbjct: 119 TELANALSYCHSKR---VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT------ 169
Query: 221 SSIGIKGTVGYVAP 234
               + GT+ Y+ P
Sbjct: 170 ----LCGTLDYLPP 179

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 46/196 (23%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ----------------------- 83
           +++  + IG+GSYG V       D    A+KV++ K+                       
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 84  ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
              +G       E   L+ + H N+ K++ +   +D    D   +VFE +  G +     
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPV----- 125
Query: 141 QTNDHLEVFKLSLIQRVNIAI---DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
                +EV  L  +          D+   IEYLH+     ++H DIKPSN+L+  D    
Sbjct: 126 -----MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIK 177
Query: 198 VGDFGLS-KFLSSDHL 212
           + DFG+S +F  SD L
Sbjct: 178 IADFGVSNEFKGSDAL 193

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 33/172 (19%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 104
           FS    IG GS+G+VY      +  VVA+K ++   K +   ++  + E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 105 LTKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
                    +I  +G   +     LV EY         L   +D LEV K  L Q V IA
Sbjct: 116 ---------TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 157
Query: 161 IDVASAIE---YLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
                A++   YLH HN    M+H D+K  N+LL    +  +GDFG +  ++
Sbjct: 158 AVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 77/183 (42%), Gaps = 13/183 (7%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GSYG   K     D  ++  K ++     +   +  V+E   LR ++H N   I+  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVRY 70
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
              I  +      +V EY E G L   + +     +      + RV   + +A    +  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
            +    ++H D+KP+NV LD      +GDFGL++ L+ D         S +    GT  Y
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--------TSFAKAFVGTPYY 182
Query: 232 VAP 234
           ++P
Sbjct: 183 MSP 185

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 38/195 (19%)
Query: 47  EFSQSNM-----IGQGSYGSVYK----GILG-EDEMVVAVKVINLKQKGAFRS-FVAECE 95
           E+ ++N+     IG+G++G V++    G+L  E   +VAVK++  +     ++ F  E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 96  ALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF------ 149
            +    + N+ K++ +C+           L+FEYM  G L ++L   + H          
Sbjct: 103 LMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 150 ------------KLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
                        LS  +++ IA  VA+ + YL        VH D+   N L+  +MV  
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 214
Query: 198 VGDFGLSK-FLSSDH 211
           + DFGLS+   S+D+
Sbjct: 215 IADFGLSRNIYSADY 229

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA--ECEALRNIRHRN 104
           ++ +   IG+GSYG V+K    +   +VA+K     +       +A  E   L+ ++H N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           L  ++ +      +      LVFEY ++  L    H+ + +       L++  +I     
Sbjct: 64  LVNLLEV-----FRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVK--SITWQTL 112
Query: 165 SAIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS--SDHLDTASET 218
            A+ + H HNC    +H D+KP N+L+    V  + DFG ++ L+  SD+ D    T
Sbjct: 113 QAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   M VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  + L L   +  A  +++A+ Y
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAY 126
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+ ++    +GDFGLS+++       AS+
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 81/172 (47%), Gaps = 15/172 (8%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS----FVAECEALRNIRHRNLTKII 109
           IG+GS+ +VYKG+  + E  V V    L+ +   +S    F  E E L+ ++H N+ +  
Sbjct: 34  IGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
               S   KG     LV E   +G+L+ +L +     +V K+ +++  +    +   +++
Sbjct: 92  DSWEST-VKGKKCIVLVTELXTSGTLKTYLKR----FKVXKIKVLR--SWCRQILKGLQF 144
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVA-HVGDFGLSKFLSSDHLDTASETPS 220
           LH    PP++H D+K  N+ +     +  +GD GL+    +        TP 
Sbjct: 145 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE 195

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 24/186 (12%)
Query: 28  PMEKQFPMVSYAELSKATCE-FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           P  +Q   +    L+K   E F     +G+GSYGSVYK I  E   +VA+K + +  +  
Sbjct: 10  PPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESD 67
Query: 87  FRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK----ALVFEYMENGSLEDWLHQT 142
            +  + E   ++     ++ K           G+ FK     +V EY   GS+ D +   
Sbjct: 68  LQEIIKEISIMQQCDSPHVVKYY---------GSYFKNTDLWIVMEYCGAGSVSDIIRLR 118
Query: 143 NDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG 202
           N  L   +++ I +  +       +EYLH   +   +H DIK  N+LL+ +  A + DFG
Sbjct: 119 NKTLTEDEIATILQSTL-----KGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFG 170
Query: 203 LSKFLS 208
           ++  L+
Sbjct: 171 VAGQLT 176

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 45  TCEFSQSNM-----IGQGSYGSVYKGILGEDE---MVVAVKVIN---LKQKGAFRSFVAE 93
           TC   + ++     +G GS+G V +G         + VAVK +    L Q  A   F+ E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
             A+ ++ HRNL ++  +  +   K      +V E    GSL D L +   H   F L  
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH---FLLGT 112
Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL--SSDH 211
           + R   A+ VA  + YL        +H D+   N+LL    +  +GDFGL + L  + DH
Sbjct: 113 LSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G+GS+G V      + +  VA+K I+   LK+         E   L+ +RH ++ K+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           + ++      D   +V EY   G L D++ +     E       Q++        AIEY 
Sbjct: 77  VITT----PTDI-VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI------ICAIEYC 124
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS-DHLDTASETPS 220
           H +    +VH D+KP N+LLD+++   + DFGLS  ++  + L T+  +P+
Sbjct: 125 HRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN 172

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 33/172 (19%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 104
           FS    IG GS+G+VY      +  VVA+K ++   K +   ++  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 105 LTKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
                    +I  +G   +     LV EY         L   +D LEV K  L Q V IA
Sbjct: 77  ---------TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 118
Query: 161 IDVASAIE---YLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
                A++   YLH HN    M+H D+K  N+LL    +  +GDFG +  ++
Sbjct: 119 AVTHGALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 5/159 (3%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GSYG   K     D  ++  K ++     +   +  V+E   LR ++H N   I+  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVRY 70
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
              I  +      +V EY E G L   + +     +      + RV   + +A    +  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            +    ++H D+KP+NV LD      +GDFGL++ L+ D
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 169

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   M VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  F L L   +  A  +++A+ Y
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAY 126
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+       +GDFGLS+++       AS+
Sbjct: 127 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 171

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 83/189 (43%), Gaps = 26/189 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           E     ++G+G++G V K      +  VA+K I  + +   ++F+ E   L  + H N+ 
Sbjct: 10  EIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQI--ESESERKAFIVELRQLSRVNHPNIV 65
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           K+   C        +   LV EY E GSL + LH   + L  +  +    ++  +  +  
Sbjct: 66  KLYGAC-------LNPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAA--HAMSWCLQCSQG 115
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLL-DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           + YLH      ++H D+KP N+LL     V  + DFG           TA +  +     
Sbjct: 116 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----------TACDIQTHMTNN 164
Query: 226 KGTVGYVAP 234
           KG+  ++AP
Sbjct: 165 KGSAAWMAP 173

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 45  TCEFSQSNM-----IGQGSYGSVYKGILGE---DEMVVAVKVIN---LKQKGAFRSFVAE 93
           TC   + ++     +G GS+G V +G         + VAVK +    L Q  A   F+ E
Sbjct: 6   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
             A+ ++ HRNL ++  +  +   K      +V E    GSL D L +   H   F L  
Sbjct: 66  VNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH---FLLGT 116
Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL--SSDH 211
           + R   A+ VA  + YL        +H D+   N+LL    +  +GDFGL + L  + DH
Sbjct: 117 LSRY--AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 45  TCEFSQSNM-----IGQGSYGSVYKGILGE---DEMVVAVKVIN---LKQKGAFRSFVAE 93
           TC   + ++     +G GS+G V +G         + VAVK +    L Q  A   F+ E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
             A+ ++ HRNL ++  +  +   K      +V E    GSL D L +   H   F L  
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH---FLLGT 112
Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL--SSDH 211
           + R   A+ VA  + YL        +H D+   N+LL    +  +GDFGL + L  + DH
Sbjct: 113 LSRY--AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 83/189 (43%), Gaps = 26/189 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           E     ++G+G++G V K      +  VA+K I  + +   ++F+ E   L  + H N+ 
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           K+   C        +   LV EY E GSL + LH   + L  +  +    ++  +  +  
Sbjct: 65  KLYGAC-------LNPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAA--HAMSWCLQCSQG 114
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLL-DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           + YLH      ++H D+KP N+LL     V  + DFG           TA +  +     
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----------TACDIQTHMTNN 163
Query: 226 KGTVGYVAP 234
           KG+  ++AP
Sbjct: 164 KGSAAWMAP 172

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 67  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 112
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S   DT   
Sbjct: 113 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT--- 166
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 167 -------LCGTLDYLPP 176

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 125 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 86  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 134
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 135 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 187

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 45  TCEFSQSNM-----IGQGSYGSVYKGILGEDE---MVVAVKVIN---LKQKGAFRSFVAE 93
           TC   + ++     +G GS+G V +G         + VAVK +    L Q  A   F+ E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
             A+ ++ HRNL ++  +  +   K      +V E    GSL D L +   H   F L  
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH---FLLGT 112
Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL--SSDH 211
           + R   A+ VA  + YL        +H D+   N+LL    +  +GDFGL + L  + DH
Sbjct: 113 LSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 78  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 126
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 127 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 45  TCEFSQSNM-----IGQGSYGSVYKGILGE---DEMVVAVKVIN---LKQKGAFRSFVAE 93
           TC   + ++     +G GS+G V +G         + VAVK +    L Q  A   F+ E
Sbjct: 6   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
             A+ ++ HRNL ++  +  +   K      +V E    GSL D L +   H   F L  
Sbjct: 66  VNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH---FLLGT 116
Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL--SSDH 211
           + R   A+ VA  + YL        +H D+   N+LL    +  +GDFGL + L  + DH
Sbjct: 117 LSRY--AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 73  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 121
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 122 QIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 174

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 54  IGQGSYGSVYKG-----ILGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +GQGS+G VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----VFKLSLIQRVNIAI 161
            +++ + S    KG     +V E M +G L+ +L       E        +L + + +A 
Sbjct: 83  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           ++A  + YL+       VH ++   N ++ +D    +GDFG+++
Sbjct: 138 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 83  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 131
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 132 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 79  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 127
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 128 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 54  IGQGSYGSVYKG-----ILGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +GQGS+G VY+G     I GE E  VAVK +N  +  + R    F+ E   ++     ++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 83
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----VFKLSLIQRVNIAI 161
            +++ + S    KG     +V E M +G L+ +L       E        +L + + +A 
Sbjct: 84  VRLLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 138
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           ++A  + YL+       VH ++   N ++ +D    +GDFG+++
Sbjct: 139 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 79  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 127
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 128 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 79  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 127
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 128 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 125 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 70  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 118
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 101 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 149
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 150 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 202

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 82  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 130
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 131 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 183

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 27/183 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIITI 111
           IG+G YG V+ G    ++  VAVKV    ++    S+  E E  + +  RH N+   I  
Sbjct: 45  IGKGRYGEVWMGKWRGEK--VAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFI-- 97
Query: 112 CSSIDSKGADFKA-LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
            + I   G+  +  L+ +Y ENGSL D+L  T        L     + +A    S + +L
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHL 150
Query: 171 HHNC-----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLS-SDHLDTASETPSSSI 223
           H        +P + H D+K  N+L+  +    + D GL+ KF+S ++ +D     P++ +
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP---PNTRV 207
Query: 224 GIK 226
           G K
Sbjct: 208 GTK 210

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 34/175 (19%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F++   IG+GS+G V+KGI    + VVA+K+I+L++       + +              
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE------------- 55
Query: 108 IITICSSIDSK------GADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            IT+ S  DS       G+  K     ++ EY+  GS         D LE   L   Q  
Sbjct: 56  -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 107
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
            I  ++   ++YLH   +   +H DIK +NVLL       + DFG++  L+   +
Sbjct: 108 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 159

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 34/175 (19%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F++   IG+GS+G V+KGI    + VVA+K+I+L++       + +              
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE------------- 70
Query: 108 IITICSSIDSK------GADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            IT+ S  DS       G+  K     ++ EY+  GS         D LE   L   Q  
Sbjct: 71  -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 122
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
            I  ++   ++YLH   +   +H DIK +NVLL       + DFG++  L+   +
Sbjct: 123 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 34/175 (19%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F++   IG+GS+G V+KGI    + VVA+K+I+L++       + +              
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE------------- 55
Query: 108 IITICSSIDSK------GADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            IT+ S  DS       G+  K     ++ EY+  GS         D LE   L   Q  
Sbjct: 56  -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 107
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
            I  ++   ++YLH   +   +H DIK +NVLL       + DFG++  L+   +
Sbjct: 108 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 159

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 83/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+D++  +   L    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKDFMDASA--LTGIPLPLIK--SYLFQ 111
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 21/171 (12%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G++  V   + IL   E  VAVK+I+  Q    + +    E   ++ + H N+ K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I+++   +  LV EY   G + D+L       E    +  +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 128
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETP 219
            H   Q  +VH D+K  N+LLD DM   + DFG S +F   + LDT   +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 27  LPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGED---EMVVAVKVINLKQ 83
           +P   + P    AE  +   +F   +++G G++  V   IL ED   + +VA+K I  K 
Sbjct: 1   MPGAVEGPRWKQAEDIRDIYDFR--DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKA 55
Query: 84  -KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQT 142
            +G   S   E   L  I+H N   I+ +    +S G  +  L+ + +  G L D + + 
Sbjct: 56  LEGKEGSMENEIAVLHKIKHPN---IVALDDIYESGGHLY--LIMQLVSGGELFDRIVEK 110
Query: 143 NDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVL---LDNDMVAHVG 199
             + E     LI        V  A++YLH      +VH D+KP N+L   LD D    + 
Sbjct: 111 GFYTERDASRLI------FQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 200 DFGLSKFLSSDHLDTASETPSSSIGIK-GTVGYVAP 234
           DFGLSK           E P S +    GT GYVAP
Sbjct: 162 DFGLSKM----------EDPGSVLSTACGTPGYVAP 187

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   + VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  + L L   +  A  +++A+ Y
Sbjct: 106 GVITE------NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAY 154
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+ ++    +GDFGLS+++       AS+
Sbjct: 155 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 199

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 86/181 (47%), Gaps = 21/181 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G +G V+ G    +   VAVK +      + ++F+ E   ++ ++H  L ++  + +
Sbjct: 20  LGAGQFGEVWMGYYN-NSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             +        ++ E+M  GSL D+L       E  K+ L + ++ +  +A  + Y+   
Sbjct: 78  KEEPI-----YIITEFMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIERK 128
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
                +H D++ +NVL+   ++  + DFGL++ +  D+  TA E      G K  + + A
Sbjct: 129 N---YIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTARE------GAKFPIKWTA 178
Query: 234 P 234
           P
Sbjct: 179 P 179

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   + VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  + L L   +  A  +++A+ Y
Sbjct: 83  GVITE------NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAY 131
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+ ++    +GDFGLS+++       AS+
Sbjct: 132 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 21/171 (12%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G++  V   + IL   E  VAVK+I+  Q    + +    E   ++ + H N+ K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I+++   +  LV EY   G + D+L       E    +  +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 128
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETP 219
            H   Q  +VH D+K  N+LLD DM   + DFG S +F   + LDT   +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 34/175 (19%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F++   IG+GS+G V+KGI    + VVA+K+I+L++       + +              
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE------------- 75
Query: 108 IITICSSIDSK------GADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            IT+ S  DS       G+  K     ++ EY+  GS         D LE   L   Q  
Sbjct: 76  -ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-------ALDLLEPGPLDETQIA 127
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
            I  ++   ++YLH   +   +H DIK +NVLL       + DFG++  L+   +
Sbjct: 128 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 179

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   + VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  + L L   +  A  +++A+ Y
Sbjct: 78  GVITE------NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAY 126
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+ ++    +GDFGLS+++       AS+
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   M VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  F L L   +  A  +++A+ Y
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAY 506
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+       +GDFGLS+++       AS+
Sbjct: 507 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 551

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   + VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  + L L   +  A  +++A+ Y
Sbjct: 80  GVITE------NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAY 128
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+ ++    +GDFGLS+++       AS+
Sbjct: 129 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 173

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++ +  L+D++  +   L    L LI+  +    
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEFL-SMDLKDFMDASA--LTGIPLPLIK--SYLFQ 114
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 115 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   + VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  + L L   +  A  +++A+ Y
Sbjct: 81  GVITE------NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAY 129
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+ ++    +GDFGLS+++       AS+
Sbjct: 130 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 174

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 18/168 (10%)
Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G +G V++GI    E   + VA+K   N         F+ E   +R   H ++ K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            + +       +   ++ E    G L  +L      +  + L L   +  A  +++A+ Y
Sbjct: 75  GVITE------NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAY 123
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
           L        VH DI   NVL+ ++    +GDFGLS+++       AS+
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 34/175 (19%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F++ + IG+GS+G VYKGI    + VVA+K+I+L++       + +              
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQE------------- 67
Query: 108 IITICSSIDSK------GADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            IT+ S  DS       G+  K+    ++ EY+  GS  D L      LE   ++ I R 
Sbjct: 68  -ITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILR- 123
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
               ++   ++YLH   +   +H DIK +NVLL       + DFG++  L+   +
Sbjct: 124 ----EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 171

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 21/200 (10%)
Query: 41  LSKATC-EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS-FVAECEALR 98
           L   TC  +     +G G +G V + I  +    VA+K    +     R  +  E + ++
Sbjct: 9   LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 68
Query: 99  NIRHRNLTKIITICSSIDSKGA-DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            + H N+     +   +      D   L  EY E G L  +L+Q  +   + +  +    
Sbjct: 69  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI---R 125
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSKFLSSDHLDT 214
            +  D++SA+ YLH N    ++H D+KP N++L      ++  + D G +K L    L T
Sbjct: 126 TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 182
Query: 215 ASETPSSSIGIKGTVGYVAP 234
                       GT+ Y+AP
Sbjct: 183 E---------FVGTLQYLAP 193

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 21/200 (10%)
Query: 41  LSKATC-EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS-FVAECEALR 98
           L   TC  +     +G G +G V + I  +    VA+K    +     R  +  E + ++
Sbjct: 8   LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 99  NIRHRNLTKIITICSSIDSKGA-DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            + H N+     +   +      D   L  EY E G L  +L+Q  +   + +  +    
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI---R 124
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSKFLSSDHLDT 214
            +  D++SA+ YLH N    ++H D+KP N++L      ++  + D G +K L    L T
Sbjct: 125 TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181
Query: 215 ASETPSSSIGIKGTVGYVAP 234
                       GT+ Y+AP
Sbjct: 182 E---------FVGTLQYLAP 192

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++ +  L+D++  +   L    L LI+  +    
Sbjct: 64  PNIVKLLDVIHTENKL-----YLVFEFL-SMDLKDFMDASA--LTGIPLPLIK--SYLFQ 113
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 114 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G +         + E+ KLS    QR  
Sbjct: 71  RHPNILRLYGYFHD-----ATRVYLILEYAPRGEV---------YKELQKLSKFDEQRTA 116
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 117 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 165
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 166 --SRRXXLXGTLDYLPP 180

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 30/197 (15%)
Query: 27  LPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINL 81
           +P+  Q       E+S +   F +   +G+  +G VYKG L     GE    VA+K +  
Sbjct: 9   MPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 82  KQKGAFRS-FVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           K +G  R  F  E      ++H N+  ++ + +          +++F Y  +G L ++L 
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL-----SMIFSYCSHGDLHEFLV 121
Query: 141 QTNDHLEV----------FKLSLIQRVNIAIDVASAIEYL--HHNCQPPMVHGDIKPSNV 188
             + H +V            L     V++   +A+ +EYL  HH     +VH D+   NV
Sbjct: 122 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNV 176
Query: 189 LLDNDMVAHVGDFGLSK 205
           L+ + +   + D GL +
Sbjct: 177 LVYDKLNVKISDLGLFR 193

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 50  QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
              ++G+G +G   K    E   V+ +K +    +   R+F+ E + +R + H N+ K I
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +      K  +F   + EY++ G+L   +   +      +    QRV+ A D+AS + Y
Sbjct: 74  GVLYK--DKRLNF---ITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAY 123
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
           LH      ++H D+   N L+  +    V DFGL++ +
Sbjct: 124 LHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLM 158

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G++  V   + IL   E  VAVK+I+  Q    + +    E   ++ + H N+ K+ 
Sbjct: 15  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWL--HQTNDHLEVFKLSLIQRVNIAIDVASAI 167
            +   I+++   +  LV EY   G + D+L  H      E        R      + SA+
Sbjct: 73  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGWMKEKEA-------RAKFR-QIVSAV 119
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETP 219
           +Y H   Q  +VH D+K  N+LLD DM   + DFG S +F   + LDT   +P
Sbjct: 120 QYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 169

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 86/176 (48%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 78  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 126
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFG +K L ++  +  +E
Sbjct: 127 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 67  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 112
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S    T S 
Sbjct: 113 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS- 168
Query: 218 TPSSSIGIKGTVGYVAP 234
                    GT+ Y+ P
Sbjct: 169 ---------GTLDYLPP 176

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 30/197 (15%)
Query: 45  TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHR 103
           + +F   +++G+G+YG V          +VA+K I    K  F    + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ-------TNDHLEVFKLSLIQR 156
           N+  I  I      +   F+     Y+    ++  LH+       ++DH++ F    ++ 
Sbjct: 70  NIITIFNI-----QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR- 123
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
                    A++ LH +    ++H D+KPSN+L++++    V DFGL++ +     D + 
Sbjct: 124 ---------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 217 ETPSSSIGIKGTVGYVA 233
            T   S    G   YVA
Sbjct: 172 PTGQQS----GMTEYVA 184

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 86/176 (48%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 78  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 126
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFG +K L ++  +  +E
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 86/176 (48%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 80  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 128
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFG +K L ++  +  +E
Sbjct: 129 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 181

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 30/197 (15%)
Query: 45  TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHR 103
           + +F   +++G+G+YG V          +VA+K I    K  F    + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ-------TNDHLEVFKLSLIQR 156
           N+  I  I      +  +   ++ E M+       LH+       ++DH++ F    ++ 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQYFIYQTLR- 123
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
                    A++ LH +    ++H D+KPSN+L++++    V DFGL++ +     D + 
Sbjct: 124 ---------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 217 ETPSSSIGIKGTVGYVA 233
            T   S    G V +VA
Sbjct: 172 PTGQQS----GMVEFVA 184

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
           +EK   +VS  +  K    F +   IGQG+ G+VY  +       VA++ +NL+Q+    
Sbjct: 7   LEKLRIIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE 63
Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSK-GADFKALVFEYMENGSLEDWLHQTNDHLE 147
             + E   +R  ++ N      I + +DS    D   +V EY+  GSL D + +T   ++
Sbjct: 64  LIINEILVMRENKNPN------IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMD 115
Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
             +++ + R     +   A+E+LH N    ++H +IK  N+LL  D    + DFG    +
Sbjct: 116 EGQIAAVCR-----ECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQI 167
Query: 208 SSDHLDTASETPSSSIGIKGTVGYVAP 234
           + +         S    + GT  ++AP
Sbjct: 168 TPEQ--------SKRSTMVGTPYWMAP 186

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 28  PMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVK---VINLKQK 84
           P +   P + Y  L+     F     IG+G +  VY+     D + VA+K   + +L   
Sbjct: 18  PQKALRPDMGYNTLA----NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA 73
Query: 85  GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTND 144
            A    + E + L+ + H N+ K     S I+    +   +V E  + G L   +     
Sbjct: 74  KARADCIKEIDLLKQLNHPNVIKYYA--SFIEDNELN---IVLELADAGDLSRMI----K 124
Query: 145 HLEVFKLSLIQRV--NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG 202
           H +  K  + +R      + + SA+E++H      ++H DIKP+NV +    V  +GD G
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 181
Query: 203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           L +F SS    TA+ +      + GT  Y++P
Sbjct: 182 LGRFFSSK--TTAAHS------LVGTPYYMSP 205

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 37/204 (18%)
Query: 39  AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEM---VVAVKVINLKQ-KGAFRSFVAEC 94
           AE  K   EF ++  +G G++  V   +L E++    + AVK I  K  KG   S   E 
Sbjct: 17  AEDIKKIFEFKET--LGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEI 71
Query: 95  EALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI 154
             LR I+H N+  +  I  S      +   LV + +  G L D + +   + E    +LI
Sbjct: 72  AVLRKIKHENIVALEDIYES-----PNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLI 126
Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFL-SSD 210
           ++V        A+ YLH   +  +VH D+KP N+L    D +    + DFGLSK     D
Sbjct: 127 RQV------LDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 211 HLDTASETPSSSIGIKGTVGYVAP 234
            + TA  TP          GYVAP
Sbjct: 178 VMSTACGTP----------GYVAP 191

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 81/163 (49%), Gaps = 20/163 (12%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRHRN 104
           ++ +   IG+G+YG+V+K    E   +VA+K + L    +G   S + E   L+ ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL--EVFKLSLIQRVNIAID 162
           + ++  +  S D K      LVFE+ +   L+ +    N  L  E+ K  L Q       
Sbjct: 63  IVRLHDVLHS-DKK----LTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ------- 109
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H      ++H D+KP N+L++ +    + DFGL++
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 21/171 (12%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G++  V   + +L   E  VAVK+I+  Q    + +    E   ++ + H N+ K+ 
Sbjct: 23  IGKGNFAKVKLARHVLTGRE--VAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I+++   +  LV EY   G + D+L       E    +  +++       SA++Y
Sbjct: 81  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 129
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETP 219
            H   Q  +VH D+K  N+LLD DM   + DFG S +F   + LDT   +P
Sbjct: 130 CH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSP 177

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 21/171 (12%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G++  V   + IL   E  VAV++I+  Q    + +    E   ++ + H N+ K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I+++   +  LV EY   G + D+L       E    +  +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 128
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETP 219
            H   Q  +VH D+K  N+LLD DM   + DFG S +F   + LDT   +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 86/176 (48%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++  G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 83  NPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 131
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 132 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 92  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 137
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S   D    
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD--- 191
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 192 -------LCGTLDYLPP 201

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 26/192 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHR 103
           +F    +IG+GS+G V       +E+  AVKV+  K   +K   +  ++E    RN+  +
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE----RNVLLK 94
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AID 162
           N+     +      + AD    V +Y+  G L         HL+  +  L  R    A +
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGEL-------FYHLQRERCFLEPRARFYAAE 147
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           +ASA+ YLH      +V+ D+KP N+LLD+     + DFGL K           E  S++
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK--------ENIEHNSTT 196
Query: 223 IGIKGTVGYVAP 234
               GT  Y+AP
Sbjct: 197 STFCGTPEYLAP 208

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 33/194 (17%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHR 103
           +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVNIAI 161
           N+ ++           A    L+ EY   G++         + E+ KLS    QR    I
Sbjct: 73  NILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSRFDEQRTATYI 118
Query: 162 -DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPS 220
            ++A+A+ Y H      ++H DIKP N+LL ++    + DFG S    S          S
Sbjct: 119 TELANALSYCHSKR---VIHRDIKPENLLLGSNGELKIADFGWSVHAPS----------S 165
Query: 221 SSIGIKGTVGYVAP 234
               + GT+ Y+ P
Sbjct: 166 RRTTLCGTLDYLPP 179

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 33/202 (16%)
Query: 39  AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECE 95
           A+   A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 96  ALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI- 154
              ++RH N+ ++           A    L+ EY   G++         + E+ KLS   
Sbjct: 61  IQSHLRHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFD 106
Query: 155 -QRVNIAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
            QR    I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S   
Sbjct: 107 EQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 160
Query: 213 DTASETPSSSIGIKGTVGYVAP 234
                  S    + GT+ Y+ P
Sbjct: 161 -------SRRAALCGTLDYLPP 175

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 21/171 (12%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G++  V   + IL   E  VA+K+I+  Q    + +    E   ++ + H N+ K+ 
Sbjct: 20  IGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I+++   +  L+ EY   G + D+L       E    S  +++       SA++Y
Sbjct: 78  EV---IETEKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQY 126
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETP 219
            H   Q  +VH D+K  N+LLD DM   + DFG S +F     LDT   +P
Sbjct: 127 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSP 174

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 31/187 (16%)
Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR--SFVAECEALRNIRHRNLTKIIT 110
           ++G G++  V+         + A+K I  K+  AFR  S   E   L+ I+H N+  +  
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           I  S          LV + +  G L D + +   + E     +IQ+V       SA++YL
Sbjct: 74  IYES-----TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV------LSAVKYL 122
Query: 171 HHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           H N    +VH D+KP N+L    + +    + DFGLSK   +  + TA  TP        
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP-------- 171
Query: 228 TVGYVAP 234
             GYVAP
Sbjct: 172 --GYVAP 176

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 92  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 137
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S    T   
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 191
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 192 -------LCGTLDYLPP 201

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 86/176 (48%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 78  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 126
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFG +K L ++  +  +E
Sbjct: 127 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S   D    
Sbjct: 115 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD--- 168
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 169 -------LCGTLDYLPP 178

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G +         + E+ KLS    QR  
Sbjct: 71  RHPNILRLYGYFHD-----ATRVYLILEYAPRGEV---------YKELQKLSKFDEQRTA 116
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S    T   
Sbjct: 117 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 170
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 171 -------LCGTLDYLPP 180

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 86/176 (48%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 83  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 131
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFG +K L ++  +  +E
Sbjct: 132 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 184

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 86/176 (48%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFG +K L ++  +  +E
Sbjct: 125 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 177

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 20/110 (18%)
Query: 134 SLEDWLHQTNDHLEVFKLSLIQR-----VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           +L+DW+++        + SL  R     ++I I +A A+E+LH      ++H D+KPSN+
Sbjct: 147 NLKDWMNR--------RCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNI 195
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETP----SSSIGIKGTVGYVAP 234
               D V  VGDFGL   +  D  +    TP    ++  G  GT  Y++P
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSP 245

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G +G V+     +    VAVK +      +  +F+AE   ++ ++H  L K+  + +
Sbjct: 23  LGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 81  K------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 128
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
            Q   +H D++ +N+L+   +V  + DFGL++ +  D+  TA E      G K  + + A
Sbjct: 129 -QRNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTARE------GAKFPIKWTA 180
Query: 234 P 234
           P
Sbjct: 181 P 181

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 103 RNLTKIITICSSIDSKGADFKALVFEY--MENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            N+ K++ +  + +        LVFE+  M+     D    T   L + K  L Q     
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ----- 114
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 115 --LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S    T   
Sbjct: 112 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 165
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 166 -------LCGTLDYLPP 175

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 86/176 (48%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++  G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 83  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 131
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 132 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G +G V+     +    VAVK +      +  +F+AE   ++ ++H  L K+  + +
Sbjct: 196 LGAGQFGEVWMATYNK-HTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 254 K------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 301
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
            Q   +H D++ +N+L+   +V  + DFGL++ +  D+  TA E      G K  + + A
Sbjct: 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTARE------GAKFPIKWTA 353
Query: 234 P 234
           P
Sbjct: 354 P 354

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 112 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 160
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 161 --SRRTDLCGTLDYLPP 175

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 65  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 110
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 111 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 159
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 160 --SRRTTLCGTLDYLPP 174

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 86/176 (48%), Gaps = 19/176 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMV-VAVKVINLKQ---KGAFRSFVAECEALRNIR 101
           EF +  ++  G++G+VYKG+ + E E V + V +  L++     A +  + E   + ++ 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +   +      L+ + M  G L D++ +  D++    L     +N  +
Sbjct: 76  NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCV 124
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++  +  +E
Sbjct: 125 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 70  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 115
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S    T   
Sbjct: 116 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 169
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 170 -------LCGTLDYLPP 179

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 103 RNLTKIITICSSIDSKGADFKALVFEY--MENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            N+ K++ +  + +        LVFE+  M+     D    T   L + K  L Q     
Sbjct: 63  PNIVKLLDVIHTENKL-----YLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ----- 112
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 113 --LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 17/176 (9%)
Query: 52  NMIGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           + +G+G++GSV    Y  +      +VAVK +        R F  E + L+ +    + K
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
              +       G     LV EY+ +G L D+L +    L+  +L L      +  +   +
Sbjct: 73  YRGVSYG---PGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 124
Query: 168 EYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           EYL    C    VH D+   N+L++++    + DFGL+K L  D        P  S
Sbjct: 125 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 67  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 112
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 113 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 161
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 162 --SRRTDLCGTLDYLPP 176

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 115 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 163
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 164 --SRRAALCGTLDYLPP 178

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 115 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 163
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 164 --SRRTTLCGTLDYLPP 178

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 69  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 118
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 69  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 118
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            N+ K++ +  + +        LVFE++     +  D    T   L + K  L Q     
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ----- 114
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 115 --LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 114
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 115 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 64  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 113
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 114 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 112 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 160
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 161 --SRRTDLCGTLDYLPP 175

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 71  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 116
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S    T   
Sbjct: 117 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 170
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 171 -------LCGTLDYLPP 180

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +  + H+N+ +
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 99  CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 154 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +  + H+N+ +
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 113 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 168 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 66  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 115
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 116 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 71  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 116
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S    T   
Sbjct: 117 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 170
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 171 -------LCGTLDYLPP 180

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 34/175 (19%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F++   IG+GS+G V+KGI    + VVA+K+I+L++       + +              
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE------------- 71
Query: 108 IITICSSIDSK------GADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            IT+ S  DS       G+  K     ++ EY+  GS  D L       + F+++ + + 
Sbjct: 72  -ITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLK- 127
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
               ++   ++YLH   +   +H DIK +NVLL       + DFG++  L+   +
Sbjct: 128 ----EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 175

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 52  NMIGQGSYGSVYKGILGED---EMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTK 107
           +++G G++  V   IL ED   + +VA+K I  +  +G   S   E   L  I+H N   
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN--- 77
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           I+ +    +S G  +  L+ + +  G L D + +   + E     LI        V  A+
Sbjct: 78  IVALDDIYESGGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLI------FQVLDAV 129
Query: 168 EYLHHNCQPPMVHGDIKPSNVL---LDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
           +YLH      +VH D+KP N+L   LD D    + DFGLSK           E P S + 
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPGSVLS 176
Query: 225 IK-GTVGYVAP 234
              GT GYVAP
Sbjct: 177 TACGTPGYVAP 187

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 71  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 116
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 117 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 165
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 166 --SRRTDLCGTLDYLPP 180

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 112 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 160
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 161 --SRRTELCGTLDYLPP 175

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 112 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 160
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 161 --SRRTXLCGTLDYLPP 175

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 111
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 111
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 52  NMIGQGSYGSVYKGILGED---EMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTK 107
           +++G G++  V   IL ED   + +VA+K I  +  +G   S   E   L  I+H N   
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN--- 77
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           I+ +    +S G  +  L+ + +  G L D + +   + E     LI        V  A+
Sbjct: 78  IVALDDIYESGGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLI------FQVLDAV 129
Query: 168 EYLHHNCQPPMVHGDIKPSNVL---LDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
           +YLH      +VH D+KP N+L   LD D    + DFGLSK           E P S + 
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPGSVLS 176
Query: 225 IK-GTVGYVAP 234
              GT GYVAP
Sbjct: 177 TACGTPGYVAP 187

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 83  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 128
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S    T   
Sbjct: 129 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 182
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 183 -------LCGTLDYLPP 192

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 114
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 115 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 64  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 113
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 114 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S    T   
Sbjct: 115 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--- 168
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 169 -------LCGTLDYLPP 178

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 63  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 112
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 63  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 112
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 66  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 115
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 116 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 111
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 110
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 111
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 110
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 64  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 113
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 114 LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 68  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 113
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 114 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 162
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 163 --SRRXXLCGTLDYLPP 177

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 66  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 111
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 112 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 160
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 161 --SRRXXLCGTLDYLPP 175

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 111
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 110
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 52  NMIGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           + +G+G++GSV    Y  +      +VAVK +        R F  E + L+ +    + K
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
              +       G     LV EY+ +G L D+L +    L+  +L L      +  +   +
Sbjct: 76  YRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 127
Query: 168 EYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           EYL    C    VH D+   N+L++++    + DFGL+K L  D
Sbjct: 128 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD 167

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 63  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 112
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 111
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 115 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 163
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 164 --SRRXXLCGTLDYLPP 178

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G++  V   + IL   E  VAVK+I+  Q    + +    E   ++ + H N+ K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I+++   +  LV EY   G + D+L       E    +  +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 128
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETP 219
            H   Q  +VH D+K  N+LLD DM   + DFG S +F   + LD     P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAP 176

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 52  NMIGQGSYGSVYKGILGED---EMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTK 107
           +++G G++  V   IL ED   + +VA+K I  +  +G   S   E   L  I+H N   
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN--- 77
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           I+ +    +S G  +  L+ + +  G L D + +   + E     LI        V  A+
Sbjct: 78  IVALDDIYESGGHLY--LIMQLVSGGELFDRIVEKGFYTERDASRLI------FQVLDAV 129
Query: 168 EYLHHNCQPPMVHGDIKPSNVL---LDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
           +YLH      +VH D+KP N+L   LD D    + DFGLSK           E P S + 
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPGSVLS 176
Query: 225 IK-GTVGYVAP 234
              GT GYVAP
Sbjct: 177 TACGTPGYVAP 187

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 63  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 108
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S        
Sbjct: 109 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------- 157
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT+ Y+ P
Sbjct: 158 --SRRTTLCGTLDYLPP 172

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 28/200 (14%)
Query: 45  TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHR 103
           + +F   +++G+G+YG V          +VA+K I    K  F    + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ-------TNDHLEVFKLSLIQR 156
           N+  I  I      +   F+     Y+    ++  LH+       ++DH++ F    ++ 
Sbjct: 70  NIITIFNI-----QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR- 123
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
                    A++ LH +    ++H D+KPSN+L++++    V DFGL++ +     D + 
Sbjct: 124 ---------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 217 ETPSSS--IGIKGTVGYVAP 234
            T   S       T  Y AP
Sbjct: 172 PTGQQSGMTEXVATRWYRAP 191

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 63  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 112
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 111
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 110
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 52  NMIGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           + +G+G++GSV    Y  +      +VAVK +        R F  E + L+ +    + K
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
              +       G     LV EY+ +G L D+L +    L+  +L L      +  +   +
Sbjct: 77  YRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 128
Query: 168 EYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           EYL    C    VH D+   N+L++++    + DFGL+K L  D
Sbjct: 129 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD 168

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 139 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 194 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGILG-----EDEMVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTK 107
           +G G++G VY+G +         + VAVK +  +  +     F+ E   +    H+N+ +
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 113 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 168 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 90  CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 145 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 86/200 (43%), Gaps = 45/200 (22%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAF-----------RSFVAECEALR 98
           +G G+YG V   K   G  E   A+KVI   Q  KG +                E   L+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEK--AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 99  NIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN 158
           ++ H N+ K+  +    D K   +  LV E+ E G L + +   N H    K       N
Sbjct: 102 SLDHPNIIKLFDVFE--DKK---YFYLVTEFYEGGELFEQI--INRH----KFDECDAAN 150
Query: 159 IAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDND---MVAHVGDFGLSKFLSSDHLDT 214
           I   + S I YLH HN    +VH DIKP N+LL+N    +   + DFGLS F S D+   
Sbjct: 151 IMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--- 203
Query: 215 ASETPSSSIGIKGTVGYVAP 234
                   +   GT  Y+AP
Sbjct: 204 ---KLRDRL---GTAYYIAP 217

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 52  NMIGQGSYGSV----YKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           + +G+G++GSV    Y  +      +VAVK +        R F  E + L+ +    + K
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
              +       G     LV EY+ +G L D+L +    L+  +L L      +  +   +
Sbjct: 89  YRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 140
Query: 168 EYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           EYL    C    VH D+   N+L++++    + DFGL+K L  D
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD 180

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 111
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 98  CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 153 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 115 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 169
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 170 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 33/202 (16%)
Query: 39  AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECE 95
           A+   A  +F     +G+G +G+VY       + ++A+KV+    L++ G       E E
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 96  ALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI- 154
              ++RH N+ ++       DS       L+ EY   G++         + E+ KLS   
Sbjct: 61  IQSHLRHPNILRLYGYFH--DSTRV---YLILEYAPLGTV---------YRELQKLSKFD 106
Query: 155 -QRVNIAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
            QR    I ++A+A+ Y H      ++H DIKP N+LL +     + DFG S    S   
Sbjct: 107 EQRTATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 160
Query: 213 DTASETPSSSIGIKGTVGYVAP 234
                  S    + GT+ Y+ P
Sbjct: 161 -------SRRAALCGTLDYLPP 175

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 99  CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 154 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 83/163 (50%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE+++   L+ ++  +   L    L LI+  +    
Sbjct: 65  PNIVKLLDVIHTENKL-----YLVFEHVDQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 114
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 115 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 81/163 (49%), Gaps = 20/163 (12%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRHRN 104
           ++ +   IG+G+YG+V+K    E   +VA+K + L    +G   S + E   L+ ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL--EVFKLSLIQRVNIAID 162
           + ++  +  S D K      LVFE+ +   L+ +    N  L  E+ K  L Q       
Sbjct: 63  IVRLHDVLHS-DKK----LTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ------- 109
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H      ++H D+KP N+L++ +    + +FGL++
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 116 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 170
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 171 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 105 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 160 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 21/190 (11%)
Query: 50  QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFV-AECEALRNIR-HRNLTK 107
           Q +++G+G++  V   I        AVK+I  KQ G  RS V  E E L   + HRN+ +
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +I      D        LVFE M  GS+   +H+     E+    ++Q      DVASA+
Sbjct: 76  LIEFFEEEDRF-----YLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASAL 124
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVG--DFGLSKFLSSDHLDTASETPSSSIG 224
           ++LH+     + H D+KP N+L ++ + V+ V   DFGL   +  +   +   TP   + 
Sbjct: 125 DFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP-ELLT 180
Query: 225 IKGTVGYVAP 234
             G+  Y+AP
Sbjct: 181 PCGSAEYMAP 190

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 98  CIGV--SLQSLP---RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 153 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 125 CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 180 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 113 CIGV--SLQSLP---RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 168 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 11/151 (7%)
Query: 42  SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI- 100
           S+ T EF +   IG G +GSV+K +   D  + A+K    + K      V E  ALR + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 101 RHRNLTKIITICSSIDSKGADFKALV-FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
            H  L +   +     +   D   L+  EY   GSL D + +    +  FK + ++  ++
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK--DL 118
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
            + V   + Y+H      +VH DIKPSN+ +
Sbjct: 119 LLQVGRGLRYIHSMS---LVHMDIKPSNIFI 146

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 11/151 (7%)
Query: 42  SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI- 100
           S+ T EF +   IG G +GSV+K +   D  + A+K    + K      V E  ALR + 
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 58
Query: 101 RHRNLTKIITICSSIDSKGADFKALV-FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
            H  L +   +     +   D   L+  EY   GSL D + +    +  FK + ++  ++
Sbjct: 59  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK--DL 116
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
            + V   + Y+H      +VH DIKPSN+ +
Sbjct: 117 LLQVGRGLRYIHSMS---LVHMDIKPSNIFI 144

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 11/151 (7%)
Query: 42  SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI- 100
           S+ T EF +   IG G +GSV+K +   D  + A+K    + K      V E  ALR + 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 62
Query: 101 RHRNLTKIITICSSIDSKGADFKALV-FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
            H  L +   +     +   D   L+  EY   GSL D + +    +  FK + ++  ++
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK--DL 120
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
            + V   + Y+H      +VH DIKPSN+ +
Sbjct: 121 LLQVGRGLRYIHSMS---LVHMDIKPSNIFI 148

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 11/151 (7%)
Query: 42  SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI- 100
           S+ T EF +   IG G +GSV+K +   D  + A+K    + K      V E  ALR + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 101 RHRNLTKIITICSSIDSKGADFKALV-FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
            H  L +   +     +   D   L+  EY   GSL D + +    +  FK + ++  ++
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK--DL 118
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
            + V   + Y+H      +VH DIKPSN+ +
Sbjct: 119 LLQVGRGLRYIHSMS---LVHMDIKPSNIFI 146

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNLTK 107
           +G G++G VY+G    +  D   + V V  L +  + +    F+ E   +    H+N+ +
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
            I +  S+ S     + ++ E M  G L+ +L +T     +   L+++  +++A D+A  
Sbjct: 99  CIGV--SLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSK 205
            +YL  N     +H DI   N LL       VA +GDFG+++
Sbjct: 154 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 21/171 (12%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G++  V   + IL   E  VAV++I+  Q    + +    E   ++ + H N+ K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I+++   +  LV EY   G + D+L       E    +  +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI------VSAVQY 128
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETP 219
            H   Q  +VH D+K  N+LLD DM   + DFG S +F   + LD    +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSP 176

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G++  V   + IL   E  VA+K+I+  Q    + +    E   ++ + H N+ K+ 
Sbjct: 23  IGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I+++   +  L+ EY   G + D+L       E    S  +++       SA++Y
Sbjct: 81  EV---IETEKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQY 129
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETP 219
            H   Q  +VH D+K  N+LLD DM   + DFG S +F     LD     P
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP 177

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 139
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 182

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 30/184 (16%)
Query: 40  ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS-FVAE 93
           E+S +   F +   +G+  +G VYKG L     GE    VA+K +  K +G  R  F  E
Sbjct: 5   EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEV----- 148
                 ++H N+  ++ + +          +++F Y  +G L ++L   + H +V     
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPL-----SMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 149 -----FKLSLIQRVNIAIDVASAIEYL--HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF 201
                  L     V++   +A+ +EYL  HH     +VH D+   NVL+ + +   + D 
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDL 172
Query: 202 GLSK 205
           GL +
Sbjct: 173 GLFR 176

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF-RSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  +   + +  + E + L   RH N+ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 135
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 136 -GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDH 178

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 135
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 136 -GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 178

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+K I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            N+ K++ +  + +        LVFE++     +  D    T   L + K  L Q     
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ----- 110
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 111 --LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 139
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 182

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 135
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 136 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 178

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 27/193 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHR 103
           +F    ++G+GS+ +V            A+K++  +   ++        E + +  + H 
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 104 NLTKIITICSSIDSKGADFKALVF--EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
              K+   C   D K      L F   Y +NG L  ++ +     E        R   A 
Sbjct: 98  FFVKLY-FCFQDDEK------LYFGLSYAKNGELLKYIRKIGSFDET-----CTRFYTA- 144
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
           ++ SA+EYLH      ++H D+KP N+LL+ DM   + DFG +K LS +     +     
Sbjct: 145 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX--- 198
Query: 222 SIGIKGTVGYVAP 234
                GT  YV+P
Sbjct: 199 ---FVGTAQYVSP 208

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILR--------- 139
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 41  LSKATCEFSQSNMIGQGSYGSVYKGI-LGEDEMVVAVKVINLK--QKGAFRSFVAECEAL 97
           L +A  ++     IG+G+YG V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 98  RNIR---HRNLTKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLS 152
           R++    H N+ ++  +C+   +       LVFE+++    +  D + +     E  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 153 LIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           + Q       +   +++LH +    +VH D+KP N+L+ +     + DFGL++  S
Sbjct: 126 MFQ-------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF-RSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  +   + +  + E + L   RH N+ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 135
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 136 -GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 178

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 41  LSKATCEFSQSNMIGQGSYGSVYKGI-LGEDEMVVAVKVINLK--QKGAFRSFVAECEAL 97
           L +A  ++     IG+G+YG V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 98  RNIR---HRNLTKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLS 152
           R++    H N+ ++  +C+   +       LVFE+++    +  D + +     E  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 153 LIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           + Q       +   +++LH +    +VH D+KP N+L+ +     + DFGL++  S
Sbjct: 126 MFQ-------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 41  LSKATCEFSQSNMIGQGSYGSVYKGI-LGEDEMVVAVKVINLK--QKGAFRSFVAECEAL 97
           L +A  ++     IG+G+YG V+K   L      VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 98  RNIR---HRNLTKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLS 152
           R++    H N+ ++  +C+   +       LVFE+++    +  D + +     E  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 153 LIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           + Q       +   +++LH +    +VH D+KP N+L+ +     + DFGL++  S
Sbjct: 126 MFQ-------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 17/160 (10%)
Query: 54  IGQGSYGSVYKGI--LGEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G G++GSV +G+  + + ++ VA+KV+    +K      + E + +  + +  + ++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C       A+   LV E    G L  +L    + + V  ++      +   V+  ++YL
Sbjct: 78  VCQ------AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLHQVSMGMKYL 126
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               +   VH D+   NVLL N   A + DFGLSK L +D
Sbjct: 127 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 137
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 138 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 180

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 139
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 140
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 141 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 183

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 141
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 142 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 184

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 132
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 133 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 175

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 139
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 140
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 141 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 183

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 16/168 (9%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 105
            ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 106 TKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
             I  I  +   +      +V + ME     L    H +NDH+  F   +++        
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR-------- 155
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
              ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 156 --GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 198

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 133
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 134 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 176

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 69  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 114
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + +FG S    S    T   
Sbjct: 115 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT--- 168
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 169 -------LCGTLDYLPP 178

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 23/189 (12%)
Query: 51  SNMIGQGSYGSVYKGILGEDEMVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           S+++GQG+  +V++G   +   + A+KV  N+         + E E L+ + H+N+ K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            I     ++    K L+ E+   GSL   L + ++    + L   + + +  DV   + +
Sbjct: 74  AIEEETTTR---HKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNH 127
Query: 170 LHHNCQPPMVHGDIKPSNVLL----DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           L  N    +VH +IKP N++     D   V  + DFG ++ L  D            + +
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---------EQFVSL 175
Query: 226 KGTVGYVAP 234
            GT  Y+ P
Sbjct: 176 YGTEEYLHP 184

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 133
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 134 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 176

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 143
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 144 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 186

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 135
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 136 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 178

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 44  ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI 100
           A  +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI--QRVN 158
           RH N+ ++           A    L+ EY   G++         + E+ KLS    QR  
Sbjct: 68  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 113
Query: 159 IAI-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
             I ++A+A+ Y H      ++H DIKP N+LL +     + +FG S    S    T   
Sbjct: 114 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT--- 167
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT+ Y+ P
Sbjct: 168 -------LCGTLDYLPP 177

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 27/198 (13%)
Query: 23  PIDTLPMEKQFPMVSYAELSKATCEFSQSNMI------GQGSYGSVYKGI--LGEDEMVV 74
           P+DT   E   P     EL        + N++      G G++GSV +G+  + + ++ V
Sbjct: 309 PMDTSVFES--PFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV 366
Query: 75  AVKVINL-KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENG 133
           A+KV+    +K      + E + +  + +  + ++I +C       A+   LV E    G
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AEALMLVMEMAGGG 420
Query: 134 SLEDWLHQTNDHLEVFKLS-LIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN 192
            L  +L    + + V  ++ L+ +V++ +       ++H N         +   NVLL N
Sbjct: 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN---------LAARNVLLVN 471
Query: 193 DMVAHVGDFGLSKFLSSD 210
              A + DFGLSK L +D
Sbjct: 472 RHYAKISDFGLSKALGAD 489

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 28/187 (14%)
Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           ++G+G+YG VY G    +++ +A+K I  +     +    E    ++++H+N   I+   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN---IVQYL 85
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQT----NDHLEVFKLSLIQRVNIAIDVASAIE 168
            S    G  F  +  E +  GSL   L        D+ +       Q       +   ++
Sbjct: 86  GSFSENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-------ILEGLK 136
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           YLH N    +VH DIK  NVL++    V  + DFG SK L+   ++  +ET        G
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTET------FTG 185
Query: 228 TVGYVAP 234
           T+ Y+AP
Sbjct: 186 TLQYMAP 192

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G  G V+  +  + +  VA+K I L    + +  + E + +R + H N+ K+  I  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 114 SIDSKGADFKA---------LVFEYMENGSLEDWLHQ---TNDHLEVFKLSLIQRVNIAI 161
              S+  D            +V EYME   L + L Q     +H  +F   L++      
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR------ 131
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDFGLSKFL 207
                ++Y+H      ++H D+KP+N+ ++  D+V  +GDFGL++ +
Sbjct: 132 ----GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 14/165 (8%)
Query: 51  SNMIGQGSYGSVYKGILGEDEMVVAVKVI-NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           S+++GQG+  +V++G   +   + A+KV  N+         + E E L+ + H+N+ K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            I     ++    K L+ E+   GSL   L + ++    + L   + + +  DV   + +
Sbjct: 74  AIEEETTTR---HKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNH 127
Query: 170 LHHNCQPPMVHGDIKPSNVLL----DNDMVAHVGDFGLSKFLSSD 210
           L  N    +VH +IKP N++     D   V  + DFG ++ L  D
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHR 103
           +F     +G+G +G+VY     +++ ++A+KV+    L+++G       E E   ++RH 
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+ ++       D K      L+ E+   G L   L +     E    + ++      ++
Sbjct: 76  NILRMYNYFH--DRKRI---YLMLEFAPRGELYKELQKHGRFDEQRSATFME------EL 124
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           A A+ Y H      ++H DIKP N+L+       + DFG S
Sbjct: 125 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS 162

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 16/168 (9%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 105
            ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 106 TKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
             I  I  +   +      +V + ME     L    H +NDH+  F   +++        
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR-------- 137
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
              ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 138 --GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 180

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q  AF++   E + +R + H N+ +
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 132
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q  AF++   E + +R + H N+ +
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 132
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 28/187 (14%)
Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           ++G+G+YG VY G    +++ +A+K I  +     +    E    ++++H+N   I+   
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN---IVQYL 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQT----NDHLEVFKLSLIQRVNIAIDVASAIE 168
            S    G  F  +  E +  GSL   L        D+ +       Q       +   ++
Sbjct: 72  GSFSENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-------ILEGLK 122
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           YLH N    +VH DIK  NVL++    V  + DFG SK L+   ++  +ET        G
Sbjct: 123 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTET------FTG 171
Query: 228 TVGYVAP 234
           T+ Y+AP
Sbjct: 172 TLQYMAP 178

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 86/205 (41%), Gaps = 38/205 (18%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAE 93
           ++AE     C      M+G+GS+G V K      +   AVKVIN    K K    + + E
Sbjct: 19  TFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILRE 71
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
            E L+ + H N+ K+  I     S       +V E    G L D + +        + S 
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSF-----YIVGELYTGGELFDEIIKRK------RFSE 120
Query: 154 IQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSS 209
                I   V S I Y+H HN    +VH D+KP N+LL++   D    + DFGLS     
Sbjct: 121 HDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLS----- 171
Query: 210 DHLDTASETPSSSIGIKGTVGYVAP 234
               T  +  +      GT  Y+AP
Sbjct: 172 ----TCFQQNTKMKDRIGTAYYIAP 192

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 86/205 (41%), Gaps = 38/205 (18%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAE 93
           ++AE     C      M+G+GS+G V K      +   AVKVIN    K K    + + E
Sbjct: 19  TFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILRE 71
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
            E L+ + H N+ K+  I     S       +V E    G L D + +        + S 
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSF-----YIVGELYTGGELFDEIIKRK------RFSE 120
Query: 154 IQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSS 209
                I   V S I Y+H HN    +VH D+KP N+LL++   D    + DFGLS     
Sbjct: 121 HDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLS----- 171
Query: 210 DHLDTASETPSSSIGIKGTVGYVAP 234
               T  +  +      GT  Y+AP
Sbjct: 172 ----TCFQQNTKMKDRIGTAYYIAP 192

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 114 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 164
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     + +        GT  YV+P
Sbjct: 165 LLNEDMHIQITDFGTAKVLSPESKQARANS------FVGTAQYVSP 204

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/151 (23%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G VYK    E  ++ A KVI+ K +     ++ E + L +  H N+ K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             ++       ++ E+   G+++  + +    L   ++ ++ +  +      A+ YLH N
Sbjct: 105 YENNLW-----ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-----DALNYLHDN 154
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
               ++H D+K  N+L   D    + DFG+S
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 81/163 (49%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+  I L  + +G   + + E   L+ + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE---VVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 62  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 111
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 81/163 (49%), Gaps = 21/163 (12%)
Query: 48  FSQSNMIGQGSYGSVYKG---ILGEDEMVVAVKVINL--KQKGAFRSFVAECEALRNIRH 102
           F +   IG+G+YG VYK    + GE   VVA+  I L  + +G   + + E   L+ + H
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE---VVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K++ +  + +        LVFE++    L+ ++  +   L    L LI+  +    
Sbjct: 61  PNIVKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMDASA--LTGIPLPLIK--SYLFQ 110
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   + + H +    ++H D+KP N+L++ +    + DFGL++
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/151 (23%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G VYK    E  ++ A KVI+ K +     ++ E + L +  H N+ K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             ++       ++ E+   G+++  + +    L   ++ ++ +  +      A+ YLH N
Sbjct: 105 YENNLW-----ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-----DALNYLHDN 154
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
               ++H D+K  N+L   D    + DFG+S
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 110 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 160
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     + +        GT  YV+P
Sbjct: 161 LLNEDMHIQITDFGTAKVLSPESKQARANS------FVGTAQYVSP 200

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/151 (23%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G VYK    E  ++ A KVI+ K +     ++ E + L +  H N+ K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             ++       ++ E+   G+++  + +    L   ++ ++ +  +      A+ YLH N
Sbjct: 105 YENNLW-----ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-----DALNYLHDN 154
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
               ++H D+K  N+L   D    + DFG+S
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 16/168 (9%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 105
            ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 106 TKIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
             I  I  +   +      +V + ME     L    H +NDH+  F   +++        
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR-------- 137
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
              ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 138 --GLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDH 180

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 91  YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 141
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 142 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 181

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           ++  + IG+G+YG V       +++ VA++ I+  + +   +  + E + L   RH N+ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 107 KIITICSSIDSKGADFKALVFEYMENG--SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
            I  I  +   +      +V + ME     L    H +NDH+  F   +++         
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR--------- 139
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 140 -GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 90  YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 140
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 141 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 180

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 89  YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 139
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     S+   ++  + GT  YV+P
Sbjct: 140 LLNEDMHIQITDFGTAKVLSPE-----SKQARANXFV-GTAQYVSP 179

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 86/205 (41%), Gaps = 38/205 (18%)
Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAE 93
           ++AE     C      M+G+GS+G V K      +   AVKVIN    K K    + + E
Sbjct: 19  TFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILRE 71
Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
            E L+ + H N+ K+  I     S       +V E    G L D + +        + S 
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSF-----YIVGELYTGGELFDEIIKRK------RFSE 120
Query: 154 IQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSS 209
                I   V S I Y+H HN    +VH D+KP N+LL++   D    + DFGLS     
Sbjct: 121 HDAARIIKQVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLS----- 171
Query: 210 DHLDTASETPSSSIGIKGTVGYVAP 234
               T  +  +      GT  Y+AP
Sbjct: 172 ----TCFQQNTKMKDRIGTAYYIAP 192

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 88  YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 138
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     S+   ++  + GT  YV+P
Sbjct: 139 LLNEDMHIQITDFGTAKVLSPE-----SKQARANXFV-GTAQYVSP 178

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 40/73 (54%), Gaps = 9/73 (12%)
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
           ++ SA+EYLH      ++H D+KP N+LL+ DM   + DFG +K LS +     + +   
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS--- 193
Query: 222 SIGIKGTVGYVAP 234
                GT  YV+P
Sbjct: 194 ---FVGTAQYVSP 203

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 111 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 161
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +         + +    GT  YV+P
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPE------SKQARANAFVGTAQYVSP 201

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHR 103
           +F     +G+G +G+VY     +++ ++A+KV+    L+++G       E E   ++RH 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+ ++       D K      L+ E+   G L   L +     E    + ++      ++
Sbjct: 75  NILRMYNYFH--DRKRI---YLMLEFAPRGELYKELQKHGRFDEQRSATFME------EL 123
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           A A+ Y H      ++H DIKP N+L+       + DFG S
Sbjct: 124 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS 161

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q  AF++   E + +R + H N+ +
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 132
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 47  EFSQSNMIGQGSYGSVYKGIL---GED-EMVVAVKVI--NLKQKGAFRSFVAECEALRNI 100
           E  +  ++G G++G+VYKGI    GE+ ++ VA+KV+  N   K A +  + E   +  +
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGV 76
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
               +++++ IC +   +      LV + M  G L D + +    L    L     +N  
Sbjct: 77  GSPYVSRLLGICLTSTVQ------LVTQLMPYGCLLDHVRENRGRLGSQDL-----LNWC 125
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           + +A  + YL       +VH D+   NVL+ +     + DFGL++ L  D 
Sbjct: 126 MQIAKGMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 173

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 28  PMEKQFPMVSYAELSKATC-----------EFSQSNMIGQGSYGSVYKGILGEDEMVVAV 76
           P+ ++  ++ Y E +K              +F    +IG+G++G V    L   + V A+
Sbjct: 45  PLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAM 104
Query: 77  KVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLE 136
           K++N K +   R+  A     R++     +K IT          +   LV +Y   G L 
Sbjct: 105 KILN-KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL-YLVMDYYVGGDLL 162
Query: 137 DWLHQTNDHL--EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM 194
             L +  D L  E+ +  L + V IAID    + Y         VH DIKP N+L+D + 
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMV-IAIDSVHQLHY---------VHRDIKPDNILMDMNG 212
Query: 195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
              + DFG    L  D       T  SS+ + GT  Y++P
Sbjct: 213 HIRLADFGSCLKLMEDG------TVQSSVAV-GTPDYISP 245

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF---------RSFVAECEALR 98
           +    ++G+G    V + I        AVK+I++   G+F          + + E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 99  NIR-HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            +  H N   II +  + ++    F  LVF+ M+ G L D+L       E   LS  +  
Sbjct: 79  KVSGHPN---IIQLKDTYETN--TFFFLVFDLMKKGELFDYL------TEKVTLSEKETR 127
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            I   +   I  LH   +  +VH D+KP N+LLD+DM   + DFG S       LD   +
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC-----QLDPGEK 179
Query: 218 TPSSSIGIKGTVGYVAP 234
             S    + GT  Y+AP
Sbjct: 180 LRS----VCGTPSYLAP 192

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 95  YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 145
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     S+   ++  + GT  YV+P
Sbjct: 146 LLNEDMHIQITDFGTAKVLSPE-----SKQARANXFV-GTAQYVSP 185

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 111 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 161
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 201

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 27/195 (13%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKG--- 85
           Q P     E  +   +F ++  +G G++G V +     LG+++ V+ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 86  AFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTND 144
              + ++E + + ++ +H N+  ++  C+     G     ++ EY   G L ++L + + 
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKSR 146
Query: 145 HLEV--------FKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMV 195
            LE           LS    ++ +  VA  + +L   NC    +H D+   NVLL N  V
Sbjct: 147 VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHV 202
Query: 196 AHVGDFGLSKFLSSD 210
           A +GDFGL++ + +D
Sbjct: 203 AKIGDFGLARDIMND 217

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 113 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 163
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 164 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 203

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 113 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 163
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 164 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 203

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/73 (36%), Positives = 43/73 (58%), Gaps = 9/73 (12%)
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
           ++ SA+EYLH      ++H D+KP N+LL+ DM   + DFG +K LS +     S+   +
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQARA 188
Query: 222 SIGIKGTVGYVAP 234
           +  + GT  YV+P
Sbjct: 189 NXFV-GTAQYVSP 200

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 114 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 164
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 165 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 204

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 111 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 161
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 201

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 116 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 166
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 167 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 206

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 111 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 161
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 201

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 113 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 163
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 164 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 203

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE----MVVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 104
           +G+G++G V     +G D+     V  V V  LK           ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L               H    +LS  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+ A  VA  +EYL    C    +H D+   NVL+  D V  + DFGL++ +   H+D
Sbjct: 151 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH--HID 204
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 205 XXKKTTNGRLPVK----WMAP 221

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 73/152 (48%), Gaps = 15/152 (9%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G +G V+     +    VAVK +      +  +F+AE   ++ ++H  L K+  + +
Sbjct: 190 LGAGQFGEVWMATYNK-HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 248 K------EPIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 295
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            Q   +H D++ +N+L+   +V  + DFGL++
Sbjct: 296 -QRNYIHRDLRAANILVSASLVCKIADFGLAR 326

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 113 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 163
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 164 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 203

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
           Y +NG L  ++ +     E        R   A ++ SA+EYLH      ++H D+KP N+
Sbjct: 113 YAKNGELLKYIRKIGSFDET-----CTRFYTA-EIVSALEYLHGKG---IIHRDLKPENI 163
Query: 189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           LL+ DM   + DFG +K LS +     +          GT  YV+P
Sbjct: 164 LLNEDMHIQITDFGTAKVLSPESKQARANX------FVGTAQYVSP 203

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 94/189 (49%), Gaps = 21/189 (11%)
Query: 51  SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFV-AECEALRNIR-HRNLTKI 108
           S ++G+G+Y  V   +  ++    AVK+I  KQ G  RS V  E E L   + ++N+ ++
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIE-KQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           I      D++      LVFE ++ GS+   + Q   H    + S + R     DVA+A++
Sbjct: 77  IEFFED-DTRF----YLVFEKLQGGSILAHI-QKQKHFNEREASRVVR-----DVAAALD 125
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVG--DFGLSKFLSSDHLDTASETPSSSIGI 225
           +LH      + H D+KP N+L ++ + V+ V   DF L   +  ++  T   TP  +   
Sbjct: 126 FLHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 226 KGTVGYVAP 234
            G+  Y+AP
Sbjct: 183 -GSAEYMAP 190

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKG--- 85
           Q P     E  +   +F ++  +G G++G V +     LG+++ V+ V V  LK      
Sbjct: 26  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 83
Query: 86  AFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN- 143
              + ++E + + ++ +H N+  ++  C+     G     ++ EY   G L ++L +   
Sbjct: 84  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKAE 138
Query: 144 ---DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVG 199
              D  +   L L   ++ +  VA  + +L   NC    +H D+   NVLL N  VA +G
Sbjct: 139 ADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIG 194
Query: 200 DFGLSKFLSSD 210
           DFGL++ + +D
Sbjct: 195 DFGLARDIMND 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 81/181 (44%), Gaps = 16/181 (8%)
Query: 52  NMIGQGSYGSVYKGIL---GEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLTK 107
            +IG+G +G VY G      ++ +  A+K ++ + +     +F+ E   +R + H N+  
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +I I   +  +G     ++  YM +G L  ++     +  V  L     ++  + VA  +
Sbjct: 87  LIGIM--LPPEG--LPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGM 137
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           EYL    +   VH D+   N +LD      V DFGL++ +      +  +   + + +K 
Sbjct: 138 EYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194
Query: 228 T 228
           T
Sbjct: 195 T 195

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKG--- 85
           Q P     E  +   +F ++  +G G++G V +     LG+++ V+ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 86  AFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN- 143
              + ++E + + ++ +H N+  ++  C+     G     ++ EY   G L ++L +   
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKAE 146
Query: 144 ---DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVG 199
              D  +   L L   ++ +  VA  + +L   NC    +H D+   NVLL N  VA +G
Sbjct: 147 ADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIG 202
Query: 200 DFGLSKFLSSD 210
           DFGL++ + +D
Sbjct: 203 DFGLARDIMND 213

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 65/155 (41%), Gaps = 11/155 (7%)
Query: 47  EFSQSNMI---GQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHR 103
           +F Q N +    +   G ++KG    +++VV V  +        R F  EC  LR   H 
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+  ++  C    S  A    L+  +   GSL + LH+  +    F +   Q V  A+D 
Sbjct: 68  NVLPVLGACQ---SPPAPHPTLITHWXPYGSLYNVLHEGTN----FVVDQSQAVKFALDX 120
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
           A    +L H  +P +    +   +V +D D  A +
Sbjct: 121 ARGXAFL-HTLEPLIPRHALNSRSVXIDEDXTARI 154

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 79/194 (40%), Gaps = 37/194 (19%)
Query: 41  LSKATCEFSQSNMI-----GQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGA---FRS 89
           L     EF + N++     G+G +G V K     L        V V  LK+  +    R 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 90  FVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN------ 143
            ++E   L+ + H ++ K+   CS           L+ EY + GSL  +L ++       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 144 ------------DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD 191
                       DH +   L++   ++ A  ++  ++YL    +  +VH D+   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 192 NDMVAHVGDFGLSK 205
                 + DFGLS+
Sbjct: 185 EGRKMKISDFGLSR 198

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 21/190 (11%)
Query: 50  QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFV-AECEALRNIR-HRNLTK 107
           Q +++G+G++  V   I        AVK+I  KQ G  RS V  E E L   + HRN+ +
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +I      D        LVFE M  GS+   +H+     E+    ++Q      DVASA+
Sbjct: 76  LIEFFEEEDRF-----YLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASAL 124
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVG--DFGLSKFLSSDHLDTASETPSSSIG 224
           ++LH+     + H D+KP N+L ++ + V+ V   DF L   +  +   +   TP   + 
Sbjct: 125 DFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP-ELLT 180
Query: 225 IKGTVGYVAP 234
             G+  Y+AP
Sbjct: 181 PCGSAEYMAP 190

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINL-----KQKGAFRSFVAECEALRNIRHRNLTKI 108
           IG+GS+G        ED     +K IN+     K++   R  VA    L N++H N   I
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVA---VLANMKHPN---I 85
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           +    S +  G+ +  +V +Y E G   D   + N    V      Q ++  + +  A++
Sbjct: 86  VQYRESFEENGSLY--IVMDYCEGG---DLFKRINAQKGVL-FQEDQILDWFVQICLALK 139
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           ++H      ++H DIK  N+ L  D    +GDFG+++ L+S
Sbjct: 140 HVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 79/194 (40%), Gaps = 37/194 (19%)
Query: 41  LSKATCEFSQSNMI-----GQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGA---FRS 89
           L     EF + N++     G+G +G V K     L        V V  LK+  +    R 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 90  FVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN------ 143
            ++E   L+ + H ++ K+   CS           L+ EY + GSL  +L ++       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 144 ------------DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD 191
                       DH +   L++   ++ A  ++  ++YL    +  +VH D+   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 192 NDMVAHVGDFGLSK 205
                 + DFGLS+
Sbjct: 185 EGRKMKISDFGLSR 198

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/150 (23%), Positives = 74/150 (49%), Gaps = 22/150 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGE-------DEMVVAVKVINLKQKGAFRSFVAECEALRNI 100
           F++S  +GQG++  ++KG+  E        E  V +KV++   +    SF      +  +
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            H++L     +C        D   LV E+++ GSL+ +L +  + + +     + ++ +A
Sbjct: 70  SHKHLVLNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNKNCINI-----LWKLEVA 119
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
             +A+A+ +L  N    ++HG++   N+LL
Sbjct: 120 KQLAAAMHFLEENT---LIHGNVCAKNILL 146

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/194 (22%), Positives = 79/194 (40%), Gaps = 37/194 (19%)
Query: 41  LSKATCEFSQSNMI-----GQGSYGSVYKGI---LGEDEMVVAVKVINLKQKGA---FRS 89
           L     EF + N++     G+G +G V K     L        V V  LK+  +    R 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 90  FVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN------ 143
            ++E   L+ + H ++ K+   CS           L+ EY + GSL  +L ++       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 144 ------------DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD 191
                       DH +   L++   ++ A  ++  ++YL    +  +VH D+   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVA 184
Query: 192 NDMVAHVGDFGLSK 205
                 + DFGLS+
Sbjct: 185 EGRKMKISDFGLSR 198

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 84/206 (40%), Gaps = 49/206 (23%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS---------FVAECEAL 97
           E+  S  +G G+ G V      +    VA+K+I+ K+K A  S            E E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 69
Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLED------WLHQTNDHLEVFKL 151
           + + H  + KI     + D        +V E ME G L D       L +    L  +++
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLS 208
            L            A++YLH N    ++H D+KP NVLL   + D +  + DFG SK L 
Sbjct: 124 LL------------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 209 SDHLDTASETPSSSIGIKGTVGYVAP 234
              L            + GT  Y+AP
Sbjct: 169 ETSLMRT---------LCGTPTYLAP 185

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 84/206 (40%), Gaps = 49/206 (23%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS---------FVAECEAL 97
           E+  S  +G G+ G V      +    VA+K+I+ K+K A  S            E E L
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 68
Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLED------WLHQTNDHLEVFKL 151
           + + H  + KI     + D        +V E ME G L D       L +    L  +++
Sbjct: 69  KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLS 208
            L            A++YLH N    ++H D+KP NVLL   + D +  + DFG SK L 
Sbjct: 123 LL------------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 167
Query: 209 SDHLDTASETPSSSIGIKGTVGYVAP 234
              L            + GT  Y+AP
Sbjct: 168 ETSLMRT---------LCGTPTYLAP 184

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 84/206 (40%), Gaps = 49/206 (23%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS---------FVAECEAL 97
           E+  S  +G G+ G V      +    VA+K+I+ K+K A  S            E E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 69
Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLED------WLHQTNDHLEVFKL 151
           + + H  + KI     + D        +V E ME G L D       L +    L  +++
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLS 208
            L            A++YLH N    ++H D+KP NVLL   + D +  + DFG SK L 
Sbjct: 124 LL------------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 209 SDHLDTASETPSSSIGIKGTVGYVAP 234
              L            + GT  Y+AP
Sbjct: 169 ETSLMRT---------LCGTPTYLAP 185

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 84/206 (40%), Gaps = 49/206 (23%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS---------FVAECEAL 97
           E+  S  +G G+ G V      +    VA+K+I+ K+K A  S            E E L
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 69
Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLED------WLHQTNDHLEVFKL 151
           + + H  + KI     + D        +V E ME G L D       L +    L  +++
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLS 208
            L            A++YLH N    ++H D+KP NVLL   + D +  + DFG SK L 
Sbjct: 124 LL------------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 209 SDHLDTASETPSSSIGIKGTVGYVAP 234
              L            + GT  Y+AP
Sbjct: 169 ETSLMRT---------LCGTPTYLAP 185

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLTKII 109
           +G G++G+V KG     ++V  V V  LK +    A +   +AE   ++ + +  + ++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            IC       A+   LV E  E G L  +L Q N H++    ++I+ V+    V+  ++Y
Sbjct: 79  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 126
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           L    +   VH D+   NVLL     A + DFGLSK L +D     ++T       K  V
Sbjct: 127 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG-----KWPV 178
Query: 230 GYVAP 234
            + AP
Sbjct: 179 KWYAP 183

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 88/202 (43%), Gaps = 30/202 (14%)
Query: 42  SKATC------EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVA 92
           S ATC      +F   N++G+GS+  VY+       + VA+K+I+ K   + G  +    
Sbjct: 1   SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 93  ECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLS 152
           E +    ++H ++ ++         + +++  LV E   NG +  +L        V   S
Sbjct: 61  EVKIHCQLKHPSILELYNYF-----EDSNYVYLVLEMCHNGEMNRYLKN-----RVKPFS 110
Query: 153 LIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL 212
             +  +    + + + YLH +    ++H D+  SN+LL  +M   + DFGL+  L   H 
Sbjct: 111 ENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH- 166
Query: 213 DTASETPSSSIGIKGTVGYVAP 234
                       + GT  Y++P
Sbjct: 167 -------EKHYTLCGTPNYISP 181

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 132
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 84/206 (40%), Gaps = 49/206 (23%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS---------FVAECEAL 97
           E+  S  +G G+ G V      +    VA+K+I+ K+K A  S            E E L
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEIL 75
Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLED------WLHQTNDHLEVFKL 151
           + + H  + KI     + D        +V E ME G L D       L +    L  +++
Sbjct: 76  KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLS 208
            L            A++YLH N    ++H D+KP NVLL   + D +  + DFG SK L 
Sbjct: 130 LL------------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 174
Query: 209 SDHLDTASETPSSSIGIKGTVGYVAP 234
              L            + GT  Y+AP
Sbjct: 175 ETSLMRT---------LCGTPTYLAP 191

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 105
            ++  + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 106 TKIITICSSIDSKGADFKALVFEYM--ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
             I  I  +   +      LV   M  +   L    H +NDH+  F   +++        
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR-------- 155
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
              ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH
Sbjct: 156 --GLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 198

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 22/170 (12%)
Query: 46  CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHR 103
            E +   +IG G +G VY+     DE+ V     +  +       +   E +    ++H 
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+  +  +C    +       LV E+   G L       N  L   ++     VN A+ +
Sbjct: 67  NIIALRGVCLKEPNL-----CLVMEFARGGPL-------NRVLSGKRIPPDILVNWAVQI 114
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLL-----DNDM---VAHVGDFGLSK 205
           A  + YLH     P++H D+K SN+L+     + D+   +  + DFGL++
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE----MVVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 104
           +G+G++G V     +G D+     V  V V  LK           ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L               H    +LS  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+ A  VA  +EYL    C    +H D+   NVL+  D V  + DFGL++ +   H+D
Sbjct: 151 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH--HID 204
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 205 YYKKTTNGRLPVK----WMAP 221

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE----MVVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 104
           +G+G++G V     +G D+     V  V V  LK           ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L               H    +LS  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+ A  VA  +EYL    C    +H D+   NVL+  D V  + DFGL++ +   H+D
Sbjct: 151 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH--HID 204
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 205 YYKKTTNGRLPVK----WMAP 221

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE----MVVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 104
           +G+G++G V     +G D+     V  V V  LK           ++E E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L               H    +LS  
Sbjct: 81  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+ A  VA  +EYL    C    +H D+   NVL+  D V  + DFGL++ +   H+D
Sbjct: 136 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH--HID 189
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 190 YYKKTTNGRLPVK----WMAP 206

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLTKII 109
           +G G++G+V KG     ++V  V V  LK +    A +   +AE   ++ + +  + ++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            IC       A+   LV E  E G L  +L Q N H++    ++I+ V+    V+  ++Y
Sbjct: 75  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 122
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           L    +   VH D+   NVLL     A + DFGLSK L +D     ++T       K  V
Sbjct: 123 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 174
Query: 230 GYVAP 234
            + AP
Sbjct: 175 KWYAP 179

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 132
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 132
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE----MVVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 104
           +G+G++G V     +G D+     V  V V  LK           ++E E ++ I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L               H    +LS  
Sbjct: 89  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+ A  VA  +EYL    C    +H D+   NVL+  D V  + DFGL++ +   H+D
Sbjct: 144 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH--HID 197
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 198 YYKKTTNGRLPVK----WMAP 214

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 24/185 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLTKII 109
           +G G++G+V KG     ++V  V V  LK +    A +   +AE   ++ + +  + ++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            IC       A+   LV E  E G L  +L Q N H  V   ++I+ V+    V+  ++Y
Sbjct: 85  GICE------AESWMLVMEMAELGPLNKYLQQ-NRH--VKDKNIIELVH---QVSMGMKY 132
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           L    +   VH D+   NVLL     A + DFGLSK L +D     ++T       K  V
Sbjct: 133 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 184
Query: 230 GYVAP 234
            + AP
Sbjct: 185 KWYAP 189

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE----MVVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 104
           +G+G++G V     +G D+     V  V V  LK           ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L               H    +LS  
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+ A  VA  +EYL    C    +H D+   NVL+  D V  + DFGL++ +   H+D
Sbjct: 151 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH--HID 204
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 205 YYKKTTNGRLPVK----WMAP 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 86/201 (42%), Gaps = 27/201 (13%)
Query: 39  AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEA 96
           A  ++ T ++     +G+G++  V + +        A K+IN K+  A   +    E   
Sbjct: 24  ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
            R ++H N   I+ +  SI  +G  F  LVF+ +  G L +         ++        
Sbjct: 84  CRLLKHPN---IVRLHDSISEEG--FHYLVFDLVTGGELFE---------DIVAREYYSE 129
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND---MVAHVGDFGLSKFLSSDHLD 213
            + +  +   +E ++H  Q  +VH D+KP N+LL +        + DFGL+  +  +   
Sbjct: 130 ADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-- 187
Query: 214 TASETPSSSIGIKGTVGYVAP 234
                  +  G  GT GY++P
Sbjct: 188 ------QAWFGFAGTPGYLSP 202

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE----MVVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 104
           +G+G++G V     +G D+     V  V V  LK           ++E E ++ I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L               H    +LS  
Sbjct: 88  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+ A  VA  +EYL    C    +H D+   NVL+  D V  + DFGL++ +   H+D
Sbjct: 143 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH--HID 196
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 197 YYKKTTNGRLPVK----WMAP 213

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 77
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 132
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 78
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 133
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 134 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 23/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V           VAVK ++L+++        E   +R+  H N   ++ + S
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDN---VVDMYS 109
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
           S      D   +V E++E G+L D +  T  + E       Q   + + V  A+ YLH+ 
Sbjct: 110 SYLV--GDELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 160
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
               ++H DIK  ++LL +D    + DFG    +S        E P     + GT  ++A
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-------KEVPKRKX-LVGTPYWMA 209
Query: 234 P 234
           P
Sbjct: 210 P 210

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 29/199 (14%)
Query: 23  PIDTLPMEKQF-------PMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVA 75
           P+DT   E  F       P   Y +    T E  +   +G G++G+V KG     ++V  
Sbjct: 342 PMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKE---LGSGNFGTVKKGYYQMKKVVKT 398
Query: 76  VKVINLKQKG---AFR-SFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYME 131
           V V  LK +    A +   +AE   ++ + +  + ++I IC       A+   LV E  E
Sbjct: 399 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVMEMAE 452
Query: 132 NGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD 191
            G L  +L Q N H++   +     + +   V+  ++YL  +     VH D+   NVLL 
Sbjct: 453 LGPLNKYLQQ-NRHVKDKNI-----IELVHQVSMGMKYLEESN---FVHRDLAARNVLLV 503
Query: 192 NDMVAHVGDFGLSKFLSSD 210
               A + DFGLSK L +D
Sbjct: 504 TQHYAKISDFGLSKALRAD 522

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE----MVVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 104
           +G+G++G V     +G D+     V  V V  LK           ++E E ++ I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L               H    +LS  
Sbjct: 85  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+ A  VA  +EYL    C    +H D+   NVL+  D V  + DFGL++ +   H+D
Sbjct: 140 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH--HID 193
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 194 YYKKTTNGRLPVK----WMAP 210

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 90
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 145
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 96
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 151
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 85
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 140
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 81
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 136
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLTKII 109
           +G G++G+V KG     ++V  V V  LK +    A +   +AE   ++ + +  + ++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            IC       A+   LV E  E G L  +L Q N H++    ++I+ V+    V+  ++Y
Sbjct: 79  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 126
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           L    +   VH D+   NVLL     A + DFGLSK L +D     ++T       K  V
Sbjct: 127 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 178
Query: 230 GYVAP 234
            + AP
Sbjct: 179 KWYAP 183

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 89
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 144
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 84/195 (43%), Gaps = 27/195 (13%)
Query: 45  TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRH 102
           T E+     IG+G++  V + +        A K+IN K+  A   +    E    R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N   I+ +  SI  +G  F  LVF+ +  G L + +     + E      IQ++     
Sbjct: 63  SN---IVRLHDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI----- 112
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDND---MVAHVGDFGLSKFLSSDHLDTASETP 219
               +E + H  Q  +VH D+KP N+LL +        + DFGL+  +  D         
Sbjct: 113 ----LEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-------- 160
Query: 220 SSSIGIKGTVGYVAP 234
            +  G  GT GY++P
Sbjct: 161 QAWFGFAGTPGYLSP 175

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 46  CEFSQSNMIGQGSYGSVY--KGILGED-EMVVAVKVIN---LKQKGAFRSFVAECEALRN 99
            +F    ++GQGS+G V+  K I G D   + A+KV+    LK +   R+ + E + L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 100 IRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           + H     I+ +  +  ++G  +  L+ +++  G L   L +     EV       +  +
Sbjct: 83  VNH---PFIVKLHYAFQTEGKLY--LILDFLRGGDLFTRLSK-----EVMFTEEDVKFYL 132
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
           A ++A A+++LH      +++ D+KP N+LLD +    + DFGLSK  S DH   A    
Sbjct: 133 A-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKA---- 183
Query: 220 SSSIGIKGTVGYVAP 234
                  GTV Y+AP
Sbjct: 184 ---YSFCGTVEYMAP 195

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLTKII 109
           +G G++G+V KG     ++V  V V  LK +    A +   +AE   ++ + +  + ++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            IC       A+   LV E  E G L  +L Q N H++    ++I+ V+    V+  ++Y
Sbjct: 73  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 120
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           L    +   VH D+   NVLL     A + DFGLSK L +D     ++T       K  V
Sbjct: 121 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 172
Query: 230 GYVAP 234
            + AP
Sbjct: 173 KWYAP 177

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE----MVVAVKVINLKQKGA---FRSFVAECEALRNI-RHRN 104
           +G+G++G V     +G D+     V  V V  LK           ++E E ++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L               H    +LS  
Sbjct: 137 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+ A  VA  +EYL    C    +H D+   NVL+  D V  + DFGL++ +   H+D
Sbjct: 192 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIH--HID 245
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 246 YYKKTTNGRLPVK----WMAP 262

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 113
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL-IQRVNIAI-DVA 164
           +     SS + K   +  LV +Y     + + +++   H    K +L +  V + +  + 
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 166
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 111
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL-IQRVNIAI-DVA 164
           +     SS + K   +  LV +Y     + + +++   H    K +L +  V + +  + 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF---------RSFVAECEALR 98
           +    ++G+G    V + I        AVK+I++   G+F          + + E + LR
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 99  NIR-HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            +  H N   II +  + ++    F  LVF+ M+ G L D+L       E   LS  +  
Sbjct: 66  KVSGHPN---IIQLKDTYETNT--FFFLVFDLMKKGELFDYL------TEKVTLSEKETR 114
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            I   +   I  LH   +  +VH D+KP N+LLD+DM   + DFG S       LD   +
Sbjct: 115 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC-----QLDPGEK 166
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT  Y+AP
Sbjct: 167 LRE----VCGTPSYLAP 179

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLTKII 109
           +G G++G+V KG     ++V  V V  LK +    A +   +AE   ++ + +  + ++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            IC       A+   LV E  E G L  +L Q N H++    ++I+ V+    V+  ++Y
Sbjct: 95  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 142
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           L    +   VH D+   NVLL     A + DFGLSK L +D     ++T       K  V
Sbjct: 143 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 194
Query: 230 GYVAP 234
            + AP
Sbjct: 195 KWYAP 199

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLTKII 109
           +G G++G+V KG     ++V  V V  LK +    A +   +AE   ++ + +  + ++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            IC       A+   LV E  E G L  +L Q N H++    ++I+ V+    V+  ++Y
Sbjct: 95  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 142
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           L    +   VH D+   NVLL     A + DFGLSK L +D     ++T       K  V
Sbjct: 143 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 194
Query: 230 GYVAP 234
            + AP
Sbjct: 195 KWYAP 199

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 33/197 (16%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF---------RSFVAECEALR 98
           +    ++G+G    V + I        AVK+I++   G+F          + + E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 99  NIR-HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            +  H N   II +  + ++    F  LVF+ M+ G L D+L       E   LS  +  
Sbjct: 79  KVSGHPN---IIQLKDTYETNT--FFFLVFDLMKKGELFDYL------TEKVTLSEKETR 127
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            I   +   I  LH   +  +VH D+KP N+LLD+DM   + DFG S       LD   +
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC-----QLDPGEK 179
Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT  Y+AP
Sbjct: 180 LRE----VCGTPSYLAP 192

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 82
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 137
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 89
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 144
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 115
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL-IQRVNIAI-DVA 164
           +     SS + K   +  LV +Y+      + +++   H    K +L +  V + +  + 
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 171 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 105
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLH--QTNDHLEVFKLSLIQRVNIAIDVA 164
           +     SS + K   +  LV +Y+         H  +    L V  + L         + 
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-----YQLF 160
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 24/185 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLTKII 109
           +G G++G+V KG     ++V  V V  LK +    A +   +AE   ++ + +  + ++I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            IC       A+   LV E  E G L  +L Q N H++    ++I+ V+    V+  ++Y
Sbjct: 93  GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVK--DKNIIELVH---QVSMGMKY 140
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           L    +   VH D+   NVLL     A + DFGLSK L +D     ++T       K  V
Sbjct: 141 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-----KWPV 192
Query: 230 GYVAP 234
            + AP
Sbjct: 193 KWYAP 197

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 27/195 (13%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKG--- 85
           Q P     E  +   +F ++  +G G++G V +     LG+++ V+ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 86  AFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTND 144
              + ++E + + ++ +H N+  ++  C+     G     ++ EY   G L ++L + + 
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKSR 146
Query: 145 HLEV---FKL-----SLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMV 195
            LE    F +     S    ++ +  VA  + +L   NC    +H D+   NVLL N  V
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHV 202
Query: 196 AHVGDFGLSKFLSSD 210
           A +GDFGL++ + +D
Sbjct: 203 AKIGDFGLARDIMND 217

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 16/164 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K   + Q   F++   E + +R + H N+ +
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKN--RELQIMRKLDHCNIVR 156
Query: 108 I-ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL-IQRVNIAI-DVA 164
           +     SS + K   +  LV +Y     + + +++   H    K +L +  V + +  + 
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            ++ Y+H      + H DIKP N+LLD D  V  + DFG +K L
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 21/156 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+G+YG VYK      E   A+K I L+++  G   + + E   L+ ++H N+ K+  +
Sbjct: 10  IGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE--VFKLSLIQRVNIAIDVASAIEY 169
             +          LVFE+++   L+  L      LE    K  L+Q +N        I Y
Sbjct: 69  IHTKKRL-----VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN-------GIAY 115
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            H      ++H D+KP N+L++ +    + DFGL++
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/150 (23%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGE-------DEMVVAVKVINLKQKGAFRSFVAECEALRNI 100
           F++S  +GQG++  ++KG+  E        E  V +KV++   +    SF      +  +
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            H++L     +C        D   LV E+++ GSL+ +L +  + + +     + ++ +A
Sbjct: 70  SHKHLVLNYGVCFC-----GDENILVQEFVKFGSLDTYLKKNKNCINI-----LWKLEVA 119
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
             +A A+ +L  N    ++HG++   N+LL
Sbjct: 120 KQLAWAMHFLEENT---LIHGNVCAKNILL 146

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 21/156 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+G+YG VYK      E   A+K I L+++  G   + + E   L+ ++H N+ K+  +
Sbjct: 10  IGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE--VFKLSLIQRVNIAIDVASAIEY 169
             +          LVFE+++   L+  L      LE    K  L+Q +N        I Y
Sbjct: 69  IHT-----KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN-------GIAY 115
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            H      ++H D+KP N+L++ +    + DFGL++
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 41/220 (18%)
Query: 28  PMEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ 83
           PM ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K 
Sbjct: 2   PMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KL 57
Query: 84  KGAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLED 137
              F+S +       E   L++++H N+  ++ + +   S        +  ++    L +
Sbjct: 58  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 117
Query: 138 WLH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM 194
            +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D 
Sbjct: 118 IVKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDC 164
Query: 195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
              + DFGL           A  T     G   T  Y AP
Sbjct: 165 ELKILDFGL-----------ARHTDDEMTGYVATRWYRAP 193

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---AFR-SFVAECEALRNIRHRNLTKII 109
           +G G++G+V KG     ++V  V V  LK +    A +   +AE   ++ + +  + ++I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            IC       A+   LV E  E G L  +L Q N H++   +     + +   V+  ++Y
Sbjct: 438 GICE------AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNI-----IELVHQVSMGMKY 485
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           L  +     VH D+   NVLL     A + DFGLSK L +D
Sbjct: 486 LEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 523

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 21/156 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+G+YG VYK      E   A+K I L+++  G   + + E   L+ ++H N+ K+  +
Sbjct: 10  IGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE--VFKLSLIQRVNIAIDVASAIEY 169
             +          LVFE+++   L+  L      LE    K  L+Q +N        I Y
Sbjct: 69  IHTKKRL-----VLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN-------GIAY 115
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            H      ++H D+KP N+L++ +    + DFGL++
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 54  IGQGSYGSVY--KGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G++  V   + IL   E  VAVK+I+  Q    + +    E    + + H N+ K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I+++   +  LV EY   G + D+L       E    +  +++       SA++Y
Sbjct: 80  EV---IETEKTLY--LVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI------VSAVQY 128
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS-KFLSSDHLDTASETP 219
            H   Q  +VH D+K  N+LLD D    + DFG S +F   + LD     P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAP 176

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 83/195 (42%), Gaps = 32/195 (16%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +FS   +IG+G +G VY     +   + A+K ++ K     R  + + E L  +  R + 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIML 243
Query: 107 KIIT-------ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
            +++       +C S      D  + + + M  G L         H  + +  +    ++
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL---------HYHLSQHGVFSEADM 294
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
               A  I  L H     +V+ D+KP+N+LLD      + D GL+        D + + P
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP 347
Query: 220 SSSIGIKGTVGYVAP 234
            +S+   GT GY+AP
Sbjct: 348 HASV---GTHGYMAP 359

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 32/195 (16%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +FS   +IG+G +G VY     +   + A+K ++ K     R  + + E L  +  R + 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIML 243
Query: 107 KIIT-------ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
            +++       +C S      D  + + + M  G L   L Q      VF  + ++    
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMR--FY 297
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
           A ++   +E++H+     +V+ D+KP+N+LLD      + D GL+        D + + P
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP 347
Query: 220 SSSIGIKGTVGYVAP 234
            +S+   GT GY+AP
Sbjct: 348 HASV---GTHGYMAP 359

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 23/167 (13%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++   +IG GS+G V++  L E + V   KV+   Q   F++   E + +R ++H N+  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL---QDKRFKN--RELQIMRIVKHPNVVD 96
Query: 108 IITIC-SSIDSKGADFKALVFEYMENGSLEDWLH-----QTNDHLEVFKLSLIQRVNIAI 161
           +     S+ D K   F  LV EY+         H     QT   L + KL + Q      
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML-LIKLYMYQ------ 149
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFL 207
            +  ++ Y+H      + H DIKP N+LLD    V  + DFG +K L
Sbjct: 150 -LLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 32/195 (16%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +FS   +IG+G +G VY     +   + A+K ++ K     R  + + E L  +  R + 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIML 243
Query: 107 KIIT-------ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
            +++       +C S      D  + + + M  G L   L Q      VF  + ++    
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMR--FY 297
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
           A ++   +E++H+     +V+ D+KP+N+LLD      + D GL+        D + + P
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP 347
Query: 220 SSSIGIKGTVGYVAP 234
            +S+   GT GY+AP
Sbjct: 348 HASV---GTHGYMAP 359

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 83/195 (42%), Gaps = 32/195 (16%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +FS   +IG+G +G VY     +   + A+K ++ K     R  + + E L  +  R + 
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIML 242
Query: 107 KIIT-------ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
            +++       +C S      D  + + + M  G L         H  + +  +    ++
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL---------HYHLSQHGVFSEADM 293
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
               A  I  L H     +V+ D+KP+N+LLD      + D GL+        D + + P
Sbjct: 294 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP 346
Query: 220 SSSIGIKGTVGYVAP 234
            +S+   GT GY+AP
Sbjct: 347 HASV---GTHGYMAP 358

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 37/197 (18%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS------FVAECEALRNIR 101
           + +   +G G+YG V   +L +D++  A + I + +K +  +       + E   L+ + 
Sbjct: 23  YQRVKKLGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+ K+       D +      LV E    G L D +          K S +    I  
Sbjct: 80  HPNIMKLYEFFE--DKRNY---YLVMEVYRGGELFDEIILRQ------KFSEVDAAVIMK 128
Query: 162 DVASAIEYLH-HNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASE 217
            V S   YLH HN    +VH D+KP N+LL++   D +  + DFGLS      H +   +
Sbjct: 129 QVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSA-----HFEVGGK 179
Query: 218 TPSSSIGIKGTVGYVAP 234
                    GT  Y+AP
Sbjct: 180 MKERL----GTAYYIAP 192

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 33/195 (16%)
Query: 48  FSQSNMIGQGSYGS-VYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNL 105
           F   +++G G+ G+ VY+G+   D   VAVK I L +  +F     E + LR    H N+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRI-LPECFSFAD--REVQLLRESDEHPNV 80
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN-DHLEVFKLSLIQRVNIAIDVA 164
            +    C+  D +   F+ +  E +   +L++++ Q +  HL +  ++L+Q+        
Sbjct: 81  IRYF--CTEKDRQ---FQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTT------ 128
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLD-----NDMVAHVGDFGLSKFLSSDHLDTASETP 219
           S + +LH      +VH D+KP N+L+        + A + DFGL K L+         + 
Sbjct: 129 SGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA-----VGRHSF 180
Query: 220 SSSIGIKGTVGYVAP 234
           S   G+ GT G++AP
Sbjct: 181 SRRSGVPGTEGWIAP 195

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 46  CEFSQSNMIGQGSYGSVY--KGILGED-EMVVAVKVIN---LKQKGAFRSFVAECEALRN 99
            +F    ++GQGS+G V+  K I G D   + A+KV+    LK +   R+ + E + L  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 83
Query: 100 IRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           + H     I+ +  +  ++G  +  L+ +++  G L   L +     EV       +  +
Sbjct: 84  VNH---PFIVKLHYAFQTEGKLY--LILDFLRGGDLFTRLSK-----EVMFTEEDVKFYL 133
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
           A ++A A+++LH      +++ D+KP N+LLD +    + DFGLSK  S DH        
Sbjct: 134 A-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDH-------E 181
Query: 220 SSSIGIKGTVGYVAP 234
             +    GTV Y+AP
Sbjct: 182 KKAYSFCGTVEYMAP 196

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 52  NMIGQGSYGSVYKGIL-GEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKI 108
            +IG+G +G VY G   GE    VA+++I++++  +   ++F  E  A R  RH N+   
Sbjct: 39  ELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           +  C S         A++    +  +L   +      L+V K        IA ++   + 
Sbjct: 95  MGACMS-----PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR-----QIAQEIVKGMG 144
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
           YLH      ++H D+K  NV  DN  V  + DFGL
Sbjct: 145 YLHAKG---ILHKDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 10/162 (6%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLT 106
           F    ++G G+YG VYKG   +   + A+KV+++           E   L+    HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84
Query: 107 KIITICSSIDSKGADFK-ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
                    +  G D +  LV E+   GS+ D +  T       K + ++   IA     
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-------KGNTLKEEWIAYICRE 137
Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
            +  L H  Q  ++H DIK  NVLL  +    + DFG+S  L
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 29/195 (14%)
Query: 46  CEFSQSNMIGQGSYGSVY--KGILGED-EMVVAVKVIN---LKQKGAFRSFVAECEALRN 99
            +F    ++GQGS+G V+  K I G D   + A+KV+    LK +   R+ + E + L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 100 IRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           + H     I+ +  +  ++G  +  L+ +++  G L   L +     EV       +  +
Sbjct: 83  VNH---PFIVKLHYAFQTEGKLY--LILDFLRGGDLFTRLSK-----EVMFTEEDVKFYL 132
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
           A ++A A+++LH      +++ D+KP N+LLD +    + DFGLSK  S DH   A    
Sbjct: 133 A-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKA---- 183
Query: 220 SSSIGIKGTVGYVAP 234
                  GTV Y+AP
Sbjct: 184 ---YSFCGTVEYMAP 195

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 64
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 116
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 64
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 116
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 92/188 (48%), Gaps = 22/188 (11%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V K       +++A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 74
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 75  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKRIPE----EILGKVSIA--VLRG 126
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           + YL    Q  ++H D+KPSN+L+++     + DFG+S  L    +D+ + +        
Sbjct: 127 LAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS------FV 174
Query: 227 GTVGYVAP 234
           GT  Y+AP
Sbjct: 175 GTRSYMAP 182

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 64
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 116
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 126
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 127 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 178
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 179 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N+ ++     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 88
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  D   +V E++E G+L D +  T  + E       Q   + + V  A+  LH  
Sbjct: 89  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 139
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
               ++H DIK  ++LL +D    + DFG    +S        E P     + GT  ++A
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------KEVPRRKXLV-GTPYWMA 188
Query: 234 P 234
           P
Sbjct: 189 P 189

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/172 (23%), Positives = 79/172 (45%), Gaps = 26/172 (15%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF-RSFVAECEALRNIRHRNLT 106
           ++Q   IG+G+YG V        +  VA+K I+  +   + +  + E + L   RH N+ 
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ-------TNDHLEVFKLSLIQRVNI 159
            I  I      + +  +A+   Y+    +E  L++       +NDH+  F   +++    
Sbjct: 105 GIRDIL-----RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILR---- 155
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
                  ++Y+H      ++H D+KPSN+L++      + DFGL++    +H
Sbjct: 156 ------GLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEH 198

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N+ ++     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 84
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  D   +V E++E G+L D +  T  + E       Q   + + V  A+  LH  
Sbjct: 85  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 135
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
               ++H DIK  ++LL +D    + DFG    +S        E P     + GT  ++A
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------KEVPRRKXLV-GTPYWMA 184
Query: 234 P 234
           P
Sbjct: 185 P 185

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 64
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 116
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 49/206 (23%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS---------FVAECEAL 97
           E+  S  +G G+ G V      +    VA+++I+ K+K A  S            E E L
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEIL 208
Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLED------WLHQTNDHLEVFKL 151
           + + H  + KI     + D        +V E ME G L D       L +    L  +++
Sbjct: 209 KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLS 208
            L            A++YLH N    ++H D+KP NVLL   + D +  + DFG SK L 
Sbjct: 263 LL------------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 307
Query: 209 SDHLDTASETPSSSIGIKGTVGYVAP 234
              L            + GT  Y+AP
Sbjct: 308 ETSLMRT---------LCGTPTYLAP 324

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 64
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 116
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 45  TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRH 102
           T E+     +G+G++  V + +        A K+IN K+  A   +    E    R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N   I+ +  SI  +G  F  LVF+ +  G L + +     + E      IQ++     
Sbjct: 63  PN---IVRLHDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI----- 112
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETP 219
               +E ++H     +VH D+KP N+LL          + DFGL+  +  D         
Sbjct: 113 ----LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-------- 160
Query: 220 SSSIGIKGTVGYVAP 234
            +  G  GT GY++P
Sbjct: 161 QAWFGFAGTPGYLSP 175

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N+ ++     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 93
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  D   +V E++E G+L D +  T  + E       Q   + + V  A+  LH  
Sbjct: 94  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 144
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
               ++H DIK  ++LL +D    + DFG    +S        E P     + GT  ++A
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------KEVPRRKXLV-GTPYWMA 193
Query: 234 P 234
           P
Sbjct: 194 P 194

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N+ ++     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN--- 95
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  D   +V E++E G+L D +  T  + E       Q   + + V  A+  LH  
Sbjct: 96  --SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 146
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
               ++H DIK  ++LL +D    + DFG    +S        E P     + GT  ++A
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------KEVPRRKXLV-GTPYWMA 195
Query: 234 P 234
           P
Sbjct: 196 P 196

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 49/206 (23%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS---------FVAECEAL 97
           E+  S  +G G+ G V      +    VA+++I+ K+K A  S            E E L
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEIL 194
Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLED------WLHQTNDHLEVFKL 151
           + + H  + KI     + D        +V E ME G L D       L +    L  +++
Sbjct: 195 KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLS 208
            L            A++YLH N    ++H D+KP NVLL   + D +  + DFG SK L 
Sbjct: 249 LL------------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 209 SDHLDTASETPSSSIGIKGTVGYVAP 234
              L            + GT  Y+AP
Sbjct: 294 ETSLMRT---------LCGTPTYLAP 310

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 45  TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRH 102
           T E+     +G+G++  V + +        A K+IN K+  A   +    E    R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N   I+ +  SI  +G  F  LVF+ +  G L + +     + E      IQ++     
Sbjct: 63  PN---IVRLHDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI----- 112
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETP 219
               +E ++H     +VH D+KP N+LL          + DFGL+  +  D         
Sbjct: 113 ----LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-------- 160
Query: 220 SSSIGIKGTVGYVAP 234
            +  G  GT GY++P
Sbjct: 161 QAWFGFAGTPGYLSP 175

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 67
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 68  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 119
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 120 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 155

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 90/197 (45%), Gaps = 29/197 (14%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKG--- 85
           Q P     E  +   +F ++  +G G++G V +     LG+++ V+ V V  LK      
Sbjct: 34  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 86  AFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN- 143
              + ++E + + ++ +H N+  ++  C+     G     ++ EY   G L ++L +   
Sbjct: 92  EKEALMSELKIMSHLGQHENIVNLLGACTH----GGPV-LVITEYCCYGDLLNFLRRKRP 146
Query: 144 ---------DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDND 193
                     H    +LS    ++ +  VA  + +L   NC    +H D+   NVLL N 
Sbjct: 147 PGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNG 202
Query: 194 MVAHVGDFGLSKFLSSD 210
            VA +GDFGL++ + +D
Sbjct: 203 HVAKIGDFGLARDIMND 219

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 91
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 92  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 143
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 144 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 179

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 84/199 (42%), Gaps = 41/199 (20%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS------FVAECEALRNIR 101
           + +   +G G+YG V   +L +D++  A + I + +K +  +       + E   L+ + 
Sbjct: 6   YQRVKKLGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW--LHQTNDHLEVFKLSLIQRVNI 159
           H N+ K+       D +      LV E    G L D   L Q        K S +    I
Sbjct: 63  HPNIMKLYEFFE--DKRNY---YLVMEVYRGGELFDEIILRQ--------KFSEVDAAVI 109
Query: 160 AIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTA 215
              V S   YLH HN    +VH D+KP N+LL++   D +  + DFGLS      H +  
Sbjct: 110 MKQVLSGTTYLHKHN----IVHRDLKPENLLLESKSRDALIKIVDFGLSA-----HFEVG 160
Query: 216 SETPSSSIGIKGTVGYVAP 234
            +         GT  Y+AP
Sbjct: 161 GKMKERL----GTAYYIAP 175

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G+G+YG V K        ++AVK I        R+ V   E  R +   +++     C 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI--------RATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 114 -SIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
            ++   GA F+     +  E M+  SL+ +  Q  D  +     ++ +  IA+ +  A+E
Sbjct: 67  FTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALE 123
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           +LH      ++H D+KPSNVL++      + DFG+S +L  D
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 23/181 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N+ ++     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  D   +V E++E G+L D +  T  + E       Q   + + V  A+  LH  
Sbjct: 142 V-----GDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 189
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
               ++H DIK  ++LL +D    + DFG    +S        E P     + GT  ++A
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------KEVPRRKX-LVGTPYWMA 238
Query: 234 P 234
           P
Sbjct: 239 P 239

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 88/186 (47%), Gaps = 27/186 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G+G+YG V K        ++AVK I        R+ V   E  R +   +++     C 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI--------RATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 114 -SIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
            ++   GA F+     +  E M+  SL+ +  Q  D  +     ++ +  IA+ +  A+E
Sbjct: 111 FTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALE 167
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           +LH      ++H D+KPSNVL++      + DFG+S +L    +D+ ++T  +     G 
Sbjct: 168 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDSVAKTIDA-----GC 216
Query: 229 VGYVAP 234
             Y+AP
Sbjct: 217 KPYMAP 222

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+ +     L+ +   N  
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--IRELQVLHECNSP 83
Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            I+    +  S G    ++  E+M+ GSL+  L +     E     ++ +V+IA  V   
Sbjct: 84  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA--VIKG 135
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           + YL    +  ++H D+KPSN+L+++     + DFG+S
Sbjct: 136 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 171

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V    +     +VAVK ++L+++        E   +R+ +H N+ ++     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  D   +V E++E G+L D +  T  + E       Q   + + V  A+  LH  
Sbjct: 219 V-----GDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 266
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               ++H DIK  ++LL +D    + DFG    +S +
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 27  LPMEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK 82
           L M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K
Sbjct: 4   LEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----K 59
Query: 83  QKGAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLE 136
               F+S +       E   L++++H N+  ++ + +   S        +  ++    L 
Sbjct: 60  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 119
Query: 137 DWLH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND 193
           + +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D
Sbjct: 120 NIVKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNED 166
Query: 194 MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
               + DFGL           A  T     G   T  Y AP
Sbjct: 167 CELKILDFGL-----------ARHTDDEMTGYVATRWYRAP 196

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 16/161 (9%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G+G+YG V K        + AVK I        R+ V   E  R +   +++     C 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI--------RATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 114 -SIDSKGADFK---ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            ++   GA F+     +   + + SL+ +  Q  D  +     ++ +  IA+ +  A+E+
Sbjct: 94  FTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEH 151
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           LH      ++H D+KPSNVL++        DFG+S +L  D
Sbjct: 152 LHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDD 190

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 85/176 (48%), Gaps = 37/176 (21%)
Query: 47  EFSQSNMIGQGSYG---SVYKGILGEDEMVVAVKVINLKQKGAF------RSFVAECEAL 97
           E+     IG G+YG   S  + + G+    VA+K I      AF      +  + E + L
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQ---VAIKKI----PNAFDVVTNAKRTLRELKIL 108
Query: 98  RNIRHRNLTKIITICSSIDSKGADFKAL--VFEYMENGSLEDWLHQTN----DHLEVFKL 151
           ++ +H N+  I  I       G +FK++  V + ME+  L   +H +     +H+  F  
Sbjct: 109 KHFKHDNIIAIKDILRPTVPYG-EFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLY 166
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
            L++           ++Y+H + Q  ++H D+KPSN+L++ +    +GDFG+++ L
Sbjct: 167 QLLR----------GLKYMH-SAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGL 209

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 41/230 (17%)
Query: 18  GSVRKPIDTLPMEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMV 73
           G V +    L M ++ P     EL+K   E    +   + +G G+YGSV      +  + 
Sbjct: 13  GLVPRGSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLR 72
Query: 74  VAVKVINLKQKGAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVF 127
           VAVK    K    F+S +       E   L++++H N+  ++ + +   S        + 
Sbjct: 73  VAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 128
Query: 128 EYMENGSLEDWLH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIK 184
            ++    L + +     T+DH++     +++           ++Y+H      ++H D+K
Sbjct: 129 THLMGADLNNIVKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLK 175
Query: 185 PSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           PSN+ ++ D    + DFGL           A  T     G   T  Y AP
Sbjct: 176 PSNLAVNEDCELKILDFGL-----------ARHTDDEMTGYVATRWYRAP 214

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 27  LPMEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK 82
           L M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K
Sbjct: 5   LEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----K 60
Query: 83  QKGAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLE 136
               F+S +       E   L++++H N+  ++ + +   S        +  ++    L 
Sbjct: 61  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 120
Query: 137 DWLH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND 193
           + +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNED 167
Query: 194 MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
               + DFGL           A  T     G   T  Y AP
Sbjct: 168 CELKILDFGL-----------ARHTDDEMTGYVATRWYRAP 197

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LHQ---TNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKXQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDXE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 27  LPMEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK 82
           L M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K
Sbjct: 5   LEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----K 60
Query: 83  QKGAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLE 136
               F+S +       E   L++++H N+  ++ + +   S        +  ++    L 
Sbjct: 61  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 120
Query: 137 DWLH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND 193
           + +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D
Sbjct: 121 NIVKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNED 167
Query: 194 MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
               + DFGL           A  T     G   T  Y AP
Sbjct: 168 SELKILDFGL-----------ARHTDDEMTGYVATRWYRAP 197

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 85/176 (48%), Gaps = 37/176 (21%)
Query: 47  EFSQSNMIGQGSYG---SVYKGILGEDEMVVAVKVINLKQKGAF------RSFVAECEAL 97
           E+     IG G+YG   S  + + G+    VA+K I      AF      +  + E + L
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQ---VAIKKI----PNAFDVVTNAKRTLRELKIL 107
Query: 98  RNIRHRNLTKIITICSSIDSKGADFKAL--VFEYMENGSLEDWLHQTN----DHLEVFKL 151
           ++ +H N+  I  I       G +FK++  V + ME+  L   +H +     +H+  F  
Sbjct: 108 KHFKHDNIIAIKDILRPTVPYG-EFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLY 165
Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
            L++           ++Y+H + Q  ++H D+KPSN+L++ +    +GDFG+++ L
Sbjct: 166 QLLR----------GLKYMH-SAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGL 208

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 28/186 (15%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           +G+G++  V + +     +  A K+IN K+  A  F+    E    R ++H N   I+ +
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN---IVRL 69
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             SI  +   F  LVF+ +  G L + +     + E      IQ+      +  +I Y H
Sbjct: 70  HDSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ------ILESIAYCH 121
Query: 172 HNCQPPMVHGDIKPSNVLLDND---MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            N    +VH ++KP N+LL +        + DFGL+  ++            +  G  GT
Sbjct: 122 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---------EAWHGFAGT 169
Query: 229 VGYVAP 234
            GY++P
Sbjct: 170 PGYLSP 175

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/190 (21%), Positives = 84/190 (44%), Gaps = 18/190 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI--NLKQKGAFR-SFVAECEALRNIRHRN 104
           +    ++G G    V+      D   VAVKV+  +L +  +F   F  E +    + H  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           +  +     + ++       +V EY++  +L D +H          ++  + + +  D  
Sbjct: 74  IVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADAC 126
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            A+ + H N    ++H D+KP+N+L+       V DFG+++ + +D  ++  +T      
Sbjct: 127 QALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAI-ADSGNSVXQT----AA 178
Query: 225 IKGTVGYVAP 234
           + GT  Y++P
Sbjct: 179 VIGTAQYLSP 188

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/190 (20%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI--NLKQKGAFR-SFVAECEALRNIRHRN 104
           +    ++G G    V+      D   VAVKV+  +L +  +F   F  E +    + H  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           +  +     + ++       +V EY++  +L D +H          ++  + + +  D  
Sbjct: 74  IVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADAC 126
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            A+ + H N    ++H D+KP+N+++       V DFG+++ + +D  ++ ++T      
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQT----AA 178
Query: 225 IKGTVGYVAP 234
           + GT  Y++P
Sbjct: 179 VIGTAQYLSP 188

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/190 (20%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI--NLKQKGAFR-SFVAECEALRNIRHRN 104
           +    ++G G    V+      D   VAVKV+  +L +  +F   F  E +    + H  
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           +  +     + ++       +V EY++  +L D +H          ++  + + +  D  
Sbjct: 74  IVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADAC 126
Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            A+ + H N    ++H D+KP+N+++       V DFG+++ + +D  ++ ++T      
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQT----AA 178
Query: 225 IKGTVGYVAP 234
           + GT  Y++P
Sbjct: 179 VIGTAQYLSP 188

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-- 72
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MXGTLPYV 174
Query: 233 AP 234
           AP
Sbjct: 175 AP 176

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 28/186 (15%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           +G+G++  V + +     +  A K+IN K+  A  F+    E    R ++H N   I+ +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN---IVRL 70
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             SI  +   F  LVF+ +  G L + +     + E      IQ+      +  +I Y H
Sbjct: 71  HDSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ------ILESIAYCH 122
Query: 172 HNCQPPMVHGDIKPSNVLLDND---MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            N    +VH ++KP N+LL +        + DFGL+  ++            +  G  GT
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---------EAWHGFAGT 170
Query: 229 VGYVAP 234
            GY++P
Sbjct: 171 PGYLSP 176

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 28/186 (15%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           +G+G++  V + +     +  A K+IN K+  A  F+    E    R ++H N   I+ +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN---IVRL 70
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             SI  +   F  LVF+ +  G L + +     + E      IQ+      +  +I Y H
Sbjct: 71  HDSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ------ILESIAYCH 122
Query: 172 HNCQPPMVHGDIKPSNVLLDND---MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            N    +VH ++KP N+LL +        + DFGL+  ++            +  G  GT
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---------EAWHGFAGT 170
Query: 229 VGYVAP 234
            GY++P
Sbjct: 171 PGYLSP 176

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MXGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 28/186 (15%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           +G+G++  V + +     +  A K+IN K+  A  F+    E    R ++H N   I+ +
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN---IVRL 93
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             SI  +   F  LVF+ +  G L + +     + E      IQ+      +  +I Y H
Sbjct: 94  HDSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ------ILESIAYCH 145
Query: 172 HNCQPPMVHGDIKPSNVLLDND---MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            N    +VH ++KP N+LL +        + DFGL+  ++            +  G  GT
Sbjct: 146 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---------AWHGFAGT 193
Query: 229 VGYVAP 234
            GY++P
Sbjct: 194 PGYLSP 199

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LHQ---TNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKXQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 94/207 (45%), Gaps = 34/207 (16%)
Query: 25  DTLPMEKQFPMVSYAELSKATCEFSQSNM-----IGQGSYGSVYKG-ILGEDEM----VV 74
           D LP+++    + Y     +  EF +  +     +G+G++G V +    G D+      V
Sbjct: 4   DELPLDEHCERLPY---DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTV 60
Query: 75  AVKVINLKQKGA----FRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEY 129
           AVK++   ++GA     R+ ++E + L +I  H N+  ++  C+     G     +V E+
Sbjct: 61  AVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EF 113
Query: 130 MENGSLEDWLHQTNDHLEVFK------LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDI 183
            + G+L  +L    +    +K      L+L   +  +  VA  +E+L        +H D+
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDL 170
Query: 184 KPSNVLLDNDMVAHVGDFGLSKFLSSD 210
              N+LL    V  + DFGL++ +  D
Sbjct: 171 AARNILLSEKNVVKIXDFGLARDIYKD 197

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 25/192 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 103
           +F    +IG+G++G V    +   E + A+K++N   + ++     F  E + L N   +
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAID 162
            +T +         +  +   LV +Y   G L   L +  D L E      I  + +AID
Sbjct: 135 WITAL-----HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID 189
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
              +I  LH+      VH DIKP NVLLD +    + DFG    ++ D       T  SS
Sbjct: 190 ---SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG------TVQSS 234
Query: 223 IGIKGTVGYVAP 234
           + + GT  Y++P
Sbjct: 235 VAV-GTPDYISP 245

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGXVATRWYRAP 191

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 48  FSQSNMIGQGSYGSVY--KGILGEDE-----MVVAVKVINLKQKGAFRSFVAECEALRNI 100
           F    ++G G+YG V+  + I G D      M V  K   +++         E + L +I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
           R       +      ++K      L+ +Y+  G L   L Q     E         V I 
Sbjct: 116 RQSPFLVTLHYAFQTETK----LHLILDYINGGELFTHLSQRERFTE-------HEVQIY 164
Query: 161 I-DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
           + ++  A+E+LH   +  +++ DIK  N+LLD++    + DFGLSK   +D  + A +  
Sbjct: 165 VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-- 219
Query: 220 SSSIGIKGTVGYVAP 234
                  GT+ Y+AP
Sbjct: 220 -----FCGTIEYMAP 229

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVINLK---QKGAFRSFVAECEALRNI 100
           +F    ++G+G++G V   IL  ++      A+K++  +    K      V E   L+N 
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI- 159
           RH  LT +     + D         V EY   G L  + H + +     ++   +R    
Sbjct: 63  RHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRE-----RVFTEERARFY 110
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             ++ SA+EYLH      +V+ DIK  N++LD D    + DFGL K
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVINLK---QKGAFRSFVAECEALRNI 100
           +F    ++G+G++G V   IL  ++      A+K++  +    K      V E   L+N 
Sbjct: 9   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI- 159
           RH  LT +     + D         V EY   G L  + H + +     ++   +R    
Sbjct: 66  RHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRE-----RVFTEERARFY 113
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             ++ SA+EYLH      +V+ DIK  N++LD D    + DFGL K
Sbjct: 114 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 156

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVINLK---QKGAFRSFVAECEALRNI 100
           +F    ++G+G++G V   IL  ++      A+K++  +    K      V E   L+N 
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI- 159
           RH  LT +     + D         V EY   G L  + H + +     ++   +R    
Sbjct: 63  RHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRE-----RVFTEERARFY 110
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             ++ SA+EYLH      +V+ DIK  N++LD D    + DFGL K
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G+G Y  V++ I   +   V VK++   +K   +    E + L N+R      IIT+  
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLR--GGPNIITLAD 99
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
            +    +   ALVFE++ N   +       D+   F +          ++  A++Y H  
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM---------YEILKALDYCHSM 150
Query: 174 CQPPMVHGDIKPSNVLLDNDMVA-HVGDFGLSKF 206
               ++H D+KP NV++D++     + D+GL++F
Sbjct: 151 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 12  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 67
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 68  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 127
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 128 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDXE 174
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 175 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 202

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 25/192 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 103
           +F    +IG+G++G V    +   E + A+K++N   + ++     F  E + L N   +
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAID 162
            +T +         +  +   LV +Y   G L   L +  D L E      I  + +AID
Sbjct: 151 WITAL-----HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAID 205
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
              +I  LH+      VH DIKP NVLLD +    + DFG    ++ D       T  SS
Sbjct: 206 ---SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG------TVQSS 250
Query: 223 IGIKGTVGYVAP 234
           + + GT  Y++P
Sbjct: 251 VAV-GTPDYISP 261

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVINLK---QKGAFRSFVAECEALRNI 100
           +F    ++G+G++G V   IL  ++      A+K++  +    K      V E   L+N 
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI- 159
           RH  LT +     + D         V EY   G L  + H + +     ++   +R    
Sbjct: 63  RHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRE-----RVFTEERARFY 110
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             ++ SA+EYLH      +V+ DIK  N++LD D    + DFGL K
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVINLK---QKGAFRSFVAECEALRNI 100
           +F    ++G+G++G V   IL  ++      A+K++  +    K      V E   L+N 
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI- 159
           RH  LT +     + D         V EY   G L  + H + +     ++   +R    
Sbjct: 63  RHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRE-----RVFTEERARFY 110
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             ++ SA+EYLH      +V+ DIK  N++LD D    + DFGL K
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 68
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 69  KPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 128
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 129 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 175
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 176 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 203

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 33/195 (16%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVINLK---QKGAFRSFVAECEALRNI 100
           +F    ++G+G++G V   IL  ++      A+K++  +    K      V E   L+N 
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI- 159
           RH  LT +     + D         V EY   G L  + H + +     ++   +R    
Sbjct: 63  RHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRE-----RVFTEERARFY 110
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
             ++ SA+EYLH      +V+ DIK  N++LD D    + DFGL K   SD         
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-------- 159
Query: 220 SSSIGIKGTVGYVAP 234
           ++     GT  Y+AP
Sbjct: 160 ATMKXFCGTPEYLAP 174

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/164 (21%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 74  VAVKVI--NLKQKGAFR-SFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM 130
           VAVKV+  +L +  +F   F  E +    + H  +  +     + ++       +V EY+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEA-ETPAGPLPYIVMEYV 98
Query: 131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
           +  +L D +H          ++  + + +  D   A+ + H N    ++H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 191 DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
                  V DFG+++ + +D  ++ ++T      + GT  Y++P
Sbjct: 150 SATNAVKVMDFGIARAI-ADSGNSVTQT----AAVIGTAQYLSP 188

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 68
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 69  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 128
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 129 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 175
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 176 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 203

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 13  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 68
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 69  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 128
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 129 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 175
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 176 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 203

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 20  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 75
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 76  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 135
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 136 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 182
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 183 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 210

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 33/195 (16%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVINLK---QKGAFRSFVAECEALRNI 100
           +F    ++G+G++G V   IL  ++      A+K++  +    K      V E   L+N 
Sbjct: 11  DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI- 159
           RH  LT +     + D         V EY   G L  + H + +     ++   +R    
Sbjct: 68  RHPFLTALKYAFQTHDRL-----CFVMEYANGGEL--FFHLSRE-----RVFTEERARFY 115
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
             ++ SA+EYLH      +V+ DIK  N++LD D    + DFGL K   SD         
Sbjct: 116 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-------- 164
Query: 220 SSSIGIKGTVGYVAP 234
           ++     GT  Y+AP
Sbjct: 165 ATMKXFCGTPEYLAP 179

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 26/184 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIIT 110
           IG+GS+G V      + + + A+K +N +   ++   R+   E + ++ + H  L   + 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL---VN 79
Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +  S   +   F  +V + +  G L   L Q N H +   + L        ++  A++YL
Sbjct: 80  LWYSFQDEEDMF--MVVDLLLGGDLRYHLQQ-NVHFKEETVKLF-----ICELVMALDYL 131
Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
            +     ++H D+KP N+LLD     H+ DF ++  L         ET  +++   GT  
Sbjct: 132 QNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML-------PRETQITTMA--GTKP 179
Query: 231 YVAP 234
           Y+AP
Sbjct: 180 YMAP 183

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 58
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 59  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 118
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 119 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDSE 165
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 166 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 193

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 12  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 67
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 68  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 127
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 128 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 174
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 175 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 202

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 76
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 77  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 136
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 137 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 183
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 184 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 211

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 27/205 (13%)
Query: 35  MVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFV 91
           +V   E+     +F    +IG+G++  V    + +   V A+K++N   + ++G    F 
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 92  AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL--EVF 149
            E + L N   R +T++         +  ++  LV EY   G L   L +  + +  E+ 
Sbjct: 110 EERDVLVNGDRRWITQL-----HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 164
Query: 150 KLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           +  L + V +AID    + Y         VH DIKP N+LLD      + DFG    L +
Sbjct: 165 RFYLAEIV-MAIDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214
Query: 210 DHLDTASETPSSSIGIKGTVGYVAP 234
           D       T  S + + GT  Y++P
Sbjct: 215 DG------TVRSLVAV-GTPDYLSP 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 3   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 58
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 59  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 118
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 119 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 165
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 166 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 193

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 70/155 (45%), Gaps = 21/155 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G VYK    E   + A KVI  K +     ++ E E L    H  + K++    
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL---- 74
Query: 114 SIDSKGADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
                GA +      ++ E+   G+++  + + +  L   ++ ++ R      +  A+ +
Sbjct: 75  -----GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALNF 124
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           LH      ++H D+K  NVL+  +    + DFG+S
Sbjct: 125 LHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 36/204 (17%)
Query: 32  QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI---LGEDEMVVAVKVINLKQKG--- 85
           Q P     E  +   +F ++  +G G++G V +     LG+++ V+ V V  LK      
Sbjct: 19  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 76
Query: 86  AFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN- 143
              + ++E + + ++ +H N+  ++  C+     G     ++ EY   G L ++L +   
Sbjct: 77  EKEALMSELKIMSHLGQHENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAE 131
Query: 144 ----------------DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPS 186
                           D  +   L L   ++ +  VA  + +L   NC    +H D+   
Sbjct: 132 AMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAAR 187
Query: 187 NVLLDNDMVAHVGDFGLSKFLSSD 210
           NVLL N  VA +GDFGL++ + +D
Sbjct: 188 NVLLTNGHVAKIGDFGLARDIMND 211

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 70/155 (45%), Gaps = 21/155 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G VYK    E   + A KVI  K +     ++ E E L    H  + K++    
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL---- 82
Query: 114 SIDSKGADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
                GA +      ++ E+   G+++  + + +  L   ++ ++ R      +  A+ +
Sbjct: 83  -----GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALNF 132
Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           LH      ++H D+K  NVL+  +    + DFG+S
Sbjct: 133 LHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 94/207 (45%), Gaps = 34/207 (16%)
Query: 25  DTLPMEKQFPMVSYAELSKATCEFSQSNM-----IGQGSYGSVYKG-ILGEDEM----VV 74
           D LP+++    + Y     +  EF +  +     +G+G++G V +    G D+      V
Sbjct: 4   DELPLDEHCERLPY---DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTV 60
Query: 75  AVKVINLKQKGA----FRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEY 129
           AVK++   ++GA     R+ ++E + L +I  H N+  ++  C+     G     +V E+
Sbjct: 61  AVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EF 113
Query: 130 MENGSLEDWLHQTNDHLEVFK------LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDI 183
            + G+L  +L    +    +K      L+L   +  +  VA  +E+L        +H D+
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDL 170
Query: 184 KPSNVLLDNDMVAHVGDFGLSKFLSSD 210
              N+LL    V  + DFGL++ +  D
Sbjct: 171 AARNILLSEKNVVKICDFGLARDIYKD 197

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 25  DTLPMEKQFPMVSYAELSKATCEFSQSNM-----IGQGSYGSVYKG-ILGEDEM----VV 74
           D LP+++    + Y     +  EF +  +     +G+G++G V +    G D+      V
Sbjct: 6   DELPLDEHCERLPY---DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTV 62
Query: 75  AVKVINLKQKGA----FRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEY 129
           AVK++   ++GA     R+ ++E + L +I  H N+  ++  C+     G     +V E+
Sbjct: 63  AVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EF 115
Query: 130 MENGSLEDWLHQTNDHLEVFK--------LSLIQRVNIAIDVASAIEYLHHNCQPPMVHG 181
            + G+L  +L    +    +K        L+L   +  +  VA  +E+L        +H 
Sbjct: 116 CKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHR 172
Query: 182 DIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           D+   N+LL    V  + DFGL++ +  D
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 42  SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA----ECEAL 97
           +K   ++   +++G+GSYG V + +  E     AVK++  K+     +  A    E + L
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
           R +RH+N+ +++ +  + + +      +V EY   G     + +  D +   +  + Q  
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKM---YMVMEYCVCG-----MQEMLDSVPEKRFPVCQAH 112
Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK----FLSSDHLD 213
                +   +EYLH      +VH DIKP N+LL       +   G+++    F + D   
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 214 TASETPS 220
           T+  +P+
Sbjct: 170 TSQGSPA 176

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/164 (21%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 74  VAVKVI--NLKQKGAFR-SFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM 130
           VAVKV+  +L +  +F   F  E +    + H  +  +     + ++       +V EY+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 98
Query: 131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
           +  +L D +H          ++  + + +  D   A+ + H N    ++H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 191 DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
                  V DFG+++ + +D  ++ ++T      + GT  Y++P
Sbjct: 150 SATNAVKVMDFGIARAI-ADSGNSVTQT----AAVIGTAQYLSP 188

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MXGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MXGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 79/185 (42%), Gaps = 42/185 (22%)
Query: 40  ELSKATCEFSQS----NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAE 93
           EL+K   E  Q       +G G+YGSV           VAVK ++   +     R    E
Sbjct: 18  ELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRE 77
Query: 94  CEALRNIRHRN---LTKIITICSSIDS----------KGADFKALVFEYMENGSLEDWLH 140
              L++++H N   L  + T  +SI+            GAD   +V    ++ +L D   
Sbjct: 78  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSD--- 130
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
              +H++     L++           ++Y+H      ++H D+KPSNV ++ D    + D
Sbjct: 131 ---EHVQFLVYQLLR----------GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILD 174
Query: 201 FGLSK 205
           FGL++
Sbjct: 175 FGLAR 179

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 27/191 (14%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHR 103
           +F     +G+G +G+VY     +   +VA+KV+    ++++G       E E   ++ H 
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+ ++       D +      L+ EY   G L   L ++    E    ++++      ++
Sbjct: 84  NILRLYNYF--YDRRRI---YLILEYAPRGELYKELQKSCTFDEQRTATIME------EL 132
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
           A A+ Y H      ++H DIKP N+LL       + DFG S    S    T         
Sbjct: 133 ADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC------- 182
Query: 224 GIKGTVGYVAP 234
              GT+ Y+ P
Sbjct: 183 ---GTLDYLPP 190

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS G V           VAVK+++L+++        E   +R+ +H N+ ++     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                G +   L+ E+++ G+L D + Q        +L+  Q   +   V  A+ YLH  
Sbjct: 113 V----GEELWVLM-EFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ 160
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               ++H DIK  ++LL  D    + DFG    +S D
Sbjct: 161 G---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + IG G+YGSV      +  + VAVK    K    
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 63
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 124 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDXELK 170
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 171 ILDFGL-----------ARHTDDEMTGYVATRWYRAP 196

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MXGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 27/191 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL 105
           +S    IG G    V++ +L E + + A+K +NL++       S+  E   L  ++  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 68
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGS--LEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            KII +    D +  D    ++  ME G+  L  WL +         +   +R +   ++
Sbjct: 69  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKKS------IDPWERKSYWKNM 117
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+  +H   Q  +VH D+KP+N L+ + M+  + DFG++  +     DT S    S +
Sbjct: 118 LEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQV 170
Query: 224 GIKGTVGYVAP 234
              GTV Y+ P
Sbjct: 171 ---GTVNYMPP 178

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/164 (21%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 74  VAVKVI--NLKQKGAFR-SFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM 130
           VAVKV+  +L +  +F   F  E +    + H  +  +     + ++       +V EY+
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 115
Query: 131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
           +  +L D +H          ++  + + +  D   A+ + H N    ++H D+KP+N+++
Sbjct: 116 DGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 166
Query: 191 DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
                  V DFG+++ + +D  ++ ++T +    + GT  Y++P
Sbjct: 167 SATNAVKVMDFGIARAI-ADSGNSVTQTAA----VIGTAQYLSP 205

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 27/191 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL 105
           +S    IG G    V++ +L E + + A+K +NL++       S+  E   L  ++  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 67
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGS--LEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            KII +    D +  D    ++  ME G+  L  WL +         +   +R +   ++
Sbjct: 68  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKKS------IDPWERKSYWKNM 116
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+  +H   Q  +VH D+KP+N L+ + M+  + DFG++  +     DT S    S +
Sbjct: 117 LEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQV 169
Query: 224 GIKGTVGYVAP 234
              GTV Y+ P
Sbjct: 170 ---GTVNYMPP 177

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+G+YGSV K +      ++AVK I        RS V E E  + +   ++    + C 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI--------RSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV-------NIAIDVASA 166
            I      F   +F   +     + +  + D    +  S++  V        I +    A
Sbjct: 82  YI----VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           + +L  N +  ++H DIKPSN+LLD      + DFG+S  L    +D+ ++T  +     
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDA----- 186
Query: 227 GTVGYVAP 234
           G   Y+AP
Sbjct: 187 GCRPYMAP 194

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 11/72 (15%)
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           + S +E+LH   Q  +++ D+KP NVLLD+D    + D GL+  L +    T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 223 IGIKGTVGYVAP 234
            G  GT G++AP
Sbjct: 348 -GYAGTPGFMAP 358

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 27/186 (14%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           +G+G++  V + +        A K+IN K+  A   +    E    R ++H N   I+ +
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN---IVRL 86
Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             SI  +G  +  L+F+ +  G L + +     + E      IQ++         +E + 
Sbjct: 87  HDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQI---------LEAVL 135
Query: 172 HNCQPPMVHGDIKPSNVLLDNDM---VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           H  Q  +VH D+KP N+LL + +      + DFGL+  +  +          +  G  GT
Sbjct: 136 HCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--------QAWFGFAGT 187
Query: 229 VGYVAP 234
            GY++P
Sbjct: 188 PGYLSP 193

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 27/191 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL 105
           +S    IG G    V++ +L E + + A+K +NL++       S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGS--LEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            KII +    D +  D    ++  ME G+  L  WL +         +   +R +   ++
Sbjct: 88  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 136
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+  +H   Q  +VH D+KP+N L+ + M+  + DFG++  +     DT S    S +
Sbjct: 137 LEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQV 189
Query: 224 GIKGTVGYVAP 234
              GTV Y+ P
Sbjct: 190 ---GTVNYMPP 197

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 11/72 (15%)
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           + S +E+LH   Q  +++ D+KP NVLLD+D    + D GL+  L +    T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 223 IGIKGTVGYVAP 234
            G  GT G++AP
Sbjct: 348 -GYAGTPGFMAP 358

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 11/72 (15%)
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           + S +E+LH   Q  +++ D+KP NVLLD+D    + D GL+  L +    T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 223 IGIKGTVGYVAP 234
            G  GT G++AP
Sbjct: 348 -GYAGTPGFMAP 358

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 38/72 (52%), Gaps = 11/72 (15%)
Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           + S +E+LH   Q  +++ D+KP NVLLD+D    + D GL+  L +    T        
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 223 IGIKGTVGYVAP 234
            G  GT G++AP
Sbjct: 348 -GYAGTPGFMAP 358

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 27/191 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL 105
           +S    IG G    V++ +L E + + A+K +NL++       S+  E   L  ++  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 71
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGS--LEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            KII +    D +  D    ++  ME G+  L  WL +         +   +R +   ++
Sbjct: 72  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKKS------IDPWERKSYWKNM 120
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+  +H   Q  +VH D+KP+N L+ + M+  + DFG++  +     DT S    S +
Sbjct: 121 LEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQV 173
Query: 224 GIKGTVGYVAP 234
              GTV Y+ P
Sbjct: 174 ---GTVNYMPP 181

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 25  DTLPMEKQFPMVSYAELSKATCEFSQSNM-----IGQGSYGSVYKG-ILGEDEMVVAVKV 78
           D LP+++    + Y     +  EF +  +     +G+G++G V +    G D+      V
Sbjct: 5   DELPLDEHCERLPY---DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTV 61
Query: 79  -INLKQKGA----FRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMEN 132
            + + ++GA     R+ ++E + L +I  H N+  ++  C+     G     +V E+ + 
Sbjct: 62  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKF 117
Query: 133 GSLEDWLHQTNDHLEVFK---------LSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGD 182
           G+L  +L    +    +K         L+L   +  +  VA  +E+L    C    +H D
Sbjct: 118 GNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHRD 173
Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           +   N+LL    V  + DFGL++ +  D
Sbjct: 174 LAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 107/232 (46%), Gaps = 44/232 (18%)
Query: 32  QFPM---VSYAELSK-ATCEFSQSNM-----IGQGSYGSVYKG-ILGEDE------MVVA 75
           Q PM   VS  EL +    EF +  +     +G+G++G V     +G D+      + VA
Sbjct: 12  QDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 76  VKVI-NLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENG 133
           VK++ +   +      V+E E ++ I +H+N+  ++  C+     G  +  ++ EY   G
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKG 126
Query: 134 SLEDWLHQTN----------DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGD 182
           +L ++L              + +   +++    V+    +A  +EYL    C    +H D
Sbjct: 127 NLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRD 182
Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +   NVL+  + V  + DFGL++ +  +++D   +T +  + +K    ++AP
Sbjct: 183 LAARNVLVTENNVMKIADFGLARDI--NNIDXXKKTTNGRLPVK----WMAP 228

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 107/232 (46%), Gaps = 44/232 (18%)
Query: 32  QFPM---VSYAELSK-ATCEFSQSNM-----IGQGSYGSVYKG-ILGEDE------MVVA 75
           Q PM   VS  EL +    EF +  +     +G+G++G V     +G D+      + VA
Sbjct: 12  QDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 76  VKVI-NLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENG 133
           VK++ +   +      V+E E ++ I +H+N+  ++  C+     G  +  ++ EY   G
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKG 126
Query: 134 SLEDWLHQTN----------DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGD 182
           +L ++L              + +   +++    V+    +A  +EYL    C    +H D
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRD 182
Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +   NVL+  + V  + DFGL++ +  +++D   +T +  + +K    ++AP
Sbjct: 183 LAARNVLVTENNVMKIADFGLARDI--NNIDXXKKTTNGRLPVK----WMAP 228

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 25  DTLPMEKQFPMVSYAELSKATCEFSQSNM-----IGQGSYGSVYKG-ILGEDEMVVAVKV 78
           D LP+++    + Y     +  EF +  +     +G+G++G V +    G D+      V
Sbjct: 4   DELPLDEHCERLPY---DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 60
Query: 79  -INLKQKGA----FRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMEN 132
            + + ++GA     R+ ++E + L +I  H N+  ++  C+     G     +V E+ + 
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKF 116
Query: 133 GSLEDWLHQTNDHLEVFK----------LSLIQRVNIAIDVASAIEYL-HHNCQPPMVHG 181
           G+L  +L    +    +K          L+L   +  +  VA  +E+L    C    +H 
Sbjct: 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHR 172
Query: 182 DIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           D+   N+LL    V  + DFGL++ +  D
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +    VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMAGFVATRWYRAP 191

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 89/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + D+GL           A  T     G   T  Y AP
Sbjct: 164 LKILDYGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 27/191 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL 105
           +S    IG G    V++ +L E + + A+K +NL++       S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGS--LEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            KII +    D +  D    ++  ME G+  L  WL +         +   +R +   ++
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 164
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+  +H   Q  +VH D+KP+N L+ + M+  + DFG++  +     DT S    S +
Sbjct: 165 LEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQV 217
Query: 224 GIKGTVGYVAP 234
              GTV Y+ P
Sbjct: 218 ---GTVNYMPP 225

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +    VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMAGFVATRWYRAP 191

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 63
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 124 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDXELK 170
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 171 ILDFGL-----------ARHTDDEMTGYVATRWYRAP 196

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 174
Query: 233 AP 234
           AP
Sbjct: 175 AP 176

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 174
Query: 233 AP 234
           AP
Sbjct: 175 AP 176

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 174
Query: 233 AP 234
           AP
Sbjct: 175 AP 176

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 174
Query: 233 AP 234
           AP
Sbjct: 175 AP 176

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 174
Query: 233 AP 234
           AP
Sbjct: 175 AP 176

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 27/191 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL 105
           +S    IG G    V++ +L E + + A+K +NL++       S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGS--LEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            KII +    D +  D    ++  ME G+  L  WL +         +   +R +   ++
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKKS------IDPWERKSYWKNM 164
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+  +H   Q  +VH D+KP+N L+ + M+  + DFG++  +     DT S    S +
Sbjct: 165 LEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQV 217
Query: 224 GIKGTVGYVAP 234
              GTV Y+ P
Sbjct: 218 ---GTVNYMPP 225

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 70
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 121
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 172
Query: 233 AP 234
           AP
Sbjct: 173 AP 174

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 39/75 (52%), Gaps = 14/75 (18%)
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
           A +V  A+EYLH      +++ D+KP N+LLD +    + DFG +K++           P
Sbjct: 112 AAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-----------P 157
Query: 220 SSSIGIKGTVGYVAP 234
             +  + GT  Y+AP
Sbjct: 158 DVTYXLCGTPDYIAP 172

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 40/212 (18%)
Query: 25  DTLPMEKQFPMVSYAELSKATCEFSQSNM-----IGQGSYGSVYKG-ILGEDEM----VV 74
           D LP+++    + Y     +  EF +  +     +G+G++G V +    G D+      V
Sbjct: 41  DELPLDEHCERLPY---DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 97
Query: 75  AVKVINLKQKGA----FRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEY 129
           AVK++   ++GA     R+ ++E + L +I  H N+  ++  C+     G     +V E+
Sbjct: 98  AVKML---KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EF 150
Query: 130 MENGSLEDWLHQTNDHLEVFK----------LSLIQRVNIAIDVASAIEYL-HHNCQPPM 178
            + G+L  +L    +    +K          L+L   +  +  VA  +E+L    C    
Sbjct: 151 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---- 206
Query: 179 VHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           +H D+   N+LL    V  + DFGL++ +  D
Sbjct: 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKD 238

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 174
Query: 233 AP 234
           AP
Sbjct: 175 AP 176

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 15/161 (9%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G V++ +      V   K IN        +   E   +  + H    K+I +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH---PKLINLHD 115
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
           + + K      L+ E++  G L D +       E +K+S  + +N        ++++H +
Sbjct: 116 AFEDKYE--MVLILEFLSGGELFDRIAA-----EDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVG--DFGLSKFLSSDHL 212
               +VH DIKP N++ +    + V   DFGL+  L+ D +
Sbjct: 169 S---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +    VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 164 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 25  DTLPMEKQFPMVSYAELSKATCEFSQSNM-----IGQGSYGSVYKG-ILGEDEMVVAVKV 78
           D LP+++    + Y     +  EF +  +     +G+G++G V +    G D+      V
Sbjct: 4   DELPLDEHCERLPY---DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 60
Query: 79  -INLKQKGA----FRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMEN 132
            + + ++GA     R+ ++E + L +I  H N+  ++  C+     G     +V E+ + 
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKF 116
Query: 133 GSLEDWLHQTNDHLEVFK----------LSLIQRVNIAIDVASAIEYL-HHNCQPPMVHG 181
           G+L  +L    +    +K          L+L   +  +  VA  +E+L    C    +H 
Sbjct: 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHR 172
Query: 182 DIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           D+   N+LL    V  + DFGL++ +  D
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKD 201

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 65
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 126 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 172
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 173 ILDFGL-----------ARHTADEMTGYVATRWYRAP 198

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 107/232 (46%), Gaps = 44/232 (18%)
Query: 32  QFPM---VSYAELSK-ATCEFSQSNM-----IGQGSYGSVYKG-ILGEDE------MVVA 75
           Q PM   VS  EL +    EF +  +     +G+G++G V     +G D+      + VA
Sbjct: 12  QDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 76  VKVI-NLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENG 133
           VK++ +   +      V+E E ++ I +H+N   IIT+  +    G  +  ++ EY   G
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKN---IITLLGACTQDGPLY--VIVEYASKG 126
Query: 134 SLEDWLHQTN----------DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGD 182
           +L ++L              + +   +++    V+    +A  +EYL    C    +H D
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRD 182
Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +   NVL+  + V  + DFGL++ +  +++D   +T +  + +K    ++AP
Sbjct: 183 LAARNVLVTENNVMKIADFGLARDI--NNIDYYKKTTNGRLPVK----WMAP 228

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +    VAVK    K  
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLS 76
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 77  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 136
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 137 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 183
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 184 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 211

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 65
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 126 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 172
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 173 ILDFGL-----------ARHTADEMTGYVATRWYRAP 198

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+ K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 71
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 173
Query: 233 AP 234
           AP
Sbjct: 174 AP 175

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +    VAVK    K  
Sbjct: 20  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLS 75
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 76  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 135
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 136 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 182
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 183 LKILDFGL-----------ARHTDDEMTGYVATRWYRAP 210

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 25  DTLPMEKQFPMVSYAELSKATCEFSQSNM-----IGQGSYGSVYKG-ILGEDEMVVAVKV 78
           D LP+++    + Y     +  EF +  +     +G+G++G V +    G D+      V
Sbjct: 4   DELPLDEHCERLPY---DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 60
Query: 79  -INLKQKGA----FRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMEN 132
            + + ++GA     R+ ++E + L +I  H N+  ++  C+     G     +V E+ + 
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKF 116
Query: 133 GSLEDWLHQTNDHLEVFK----------LSLIQRVNIAIDVASAIEYL-HHNCQPPMVHG 181
           G+L  +L    +    +K          L+L   +  +  VA  +E+L    C    +H 
Sbjct: 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHR 172
Query: 182 DIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           D+   N+LL    V  + DFGL++ +  D
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKD 201

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 49  SQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           S++ ++G G +G V+K       + +A K+I  +          E   +  + H NL   
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL--- 148
Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           I +  + +SK      LV EY++ G L D +       E + L+ +  +     +   I 
Sbjct: 149 IQLYDAFESKND--IVLVMEYVDGGELFDRIID-----ESYNLTELDTILFMKQICEGIR 201
Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG--DFGLSK 205
           ++H   Q  ++H D+KP N+L  N     +   DFGL++
Sbjct: 202 HMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 41/214 (19%)
Query: 34  PMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS 89
           P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    F+S
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQS 57
Query: 90  FV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH--- 140
            +       E   L++++H N+  ++ + +   S        +  ++    L + +    
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
            T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    + D
Sbjct: 118 LTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 164
Query: 201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           FGL           A  T     G   T  Y AP
Sbjct: 165 FGL-----------ARHTDDEMTGYVATRWYRAP 187

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 65
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 126 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 172
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 173 ILDFGL-----------ARHTADEMTGYVATRWYRAP 198

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 25  DTLPMEKQFPMVSYAELSKATCEFSQSNM-----IGQGSYGSVYKG-ILGEDEMVVAVKV 78
           D LP+++    + Y     +  EF +  +     +G+G++G V +    G D+      V
Sbjct: 6   DELPLDEHCERLPY---DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 62
Query: 79  -INLKQKGA----FRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMEN 132
            + + ++GA     R+ ++E + L +I  H N+  ++  C+     G     +V E+ + 
Sbjct: 63  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKF 118
Query: 133 GSLEDWLHQTNDHLEVFK----------LSLIQRVNIAIDVASAIEYL-HHNCQPPMVHG 181
           G+L  +L    +    +K          L+L   +  +  VA  +E+L    C    +H 
Sbjct: 119 GNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IHR 174
Query: 182 DIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           D+   N+LL    V  + DFGL++ +  D
Sbjct: 175 DLAARNILLSEKNVVKICDFGLARDIYKD 203

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 41/214 (19%)
Query: 34  PMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS 89
           P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    F+S
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQS 58
Query: 90  FV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH--- 140
            +       E   L++++H N+  ++ + +   S        +  ++    L + +    
Sbjct: 59  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 118
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
            T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    + D
Sbjct: 119 LTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 165
Query: 201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           FGL           A  T     G   T  Y AP
Sbjct: 166 FGL-----------ARHTDDEMTGYVATRWYRAP 188

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 41/214 (19%)
Query: 34  PMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS 89
           P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    F+S
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQS 58
Query: 90  FV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH--- 140
            +       E   L++++H N+  ++ + +   S        +  ++    L + +    
Sbjct: 59  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 118
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
            T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    + D
Sbjct: 119 LTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 165
Query: 201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           FGL           A  T     G   T  Y AP
Sbjct: 166 FGL-----------ARHTDDEMTGYVATRWYRAP 188

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 41/214 (19%)
Query: 34  PMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS 89
           P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    F+S
Sbjct: 4   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQS 59
Query: 90  FV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH--- 140
            +       E   L++++H N+  ++ + +   S        +  ++    L + +    
Sbjct: 60  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 119
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
            T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    + D
Sbjct: 120 LTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 166
Query: 201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           FGL           A  T     G   T  Y AP
Sbjct: 167 FGL-----------ARHTDDEMTGYVATRWYRAP 189

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 8   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 63
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 64  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 124 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 170
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 171 ILDFGL-----------ARHTDDEMTGYVATRWYRAP 196

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 64
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 65  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 125 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 171
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 172 ILDFGL-----------ARHTDDEMTGYVATRWYRAP 197

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +    VAVK    K  
Sbjct: 21  MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLS 76
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 77  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 136
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 137 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 183
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + DFGL           A  T     G   T  Y AP
Sbjct: 184 LKILDFGL-----------ARHTDDEMXGXVATRWYRAP 211

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 2   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 57
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 58  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 117
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 118 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 164
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 165 ILDFGL-----------ARHTDDEMTGYVATRWYRAP 190

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 107/232 (46%), Gaps = 44/232 (18%)
Query: 32  QFPM---VSYAELSK-ATCEFSQSNM-----IGQGSYGSVYKG-ILGEDE------MVVA 75
           Q PM   VS  EL +    EF +  +     +G+G++G V     +G D+      + VA
Sbjct: 12  QDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 76  VKVI-NLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENG 133
           VK++ +   +      V+E E ++ I +H+N+  ++  C+     G  +  ++ EY   G
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKG 126
Query: 134 SLEDWLHQTN----------DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGD 182
           +L ++L              + +   +++    V+    +A  +EYL    C    +H D
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRD 182
Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +   NVL+  + V  + DFGL++ +  +++D   +T +  + +K    ++AP
Sbjct: 183 LAARNVLVTENNVMRIADFGLARDI--NNIDYYKKTTNGRLPVK----WMAP 228

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 42/185 (22%)
Query: 40  ELSKATCEFSQS----NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAE 93
           EL+K   E  Q       +G G+YGSV           VAVK ++   +     R    E
Sbjct: 10  ELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRE 69
Query: 94  CEALRNIRHRN---LTKIITICSSIDS----------KGADFKALVFEYMENGSLEDWLH 140
              L++++H N   L  + T  +SI+            GAD   +V    +  +L D   
Sbjct: 70  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSD--- 122
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
              +H++     L++           ++Y+H      ++H D+KPSNV ++ D    + D
Sbjct: 123 ---EHVQFLVYQLLR----------GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 166
Query: 201 FGLSK 205
           FGL++
Sbjct: 167 FGLAR 171

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 10  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 65
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 126 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 172
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 173 ILDFGL-----------ARHTDDEMTGYVATRWYRAP 198

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVIN---LKQKGAFRSFVAECEALRNI 100
           EF    ++G+G++G V   IL +++      A+K++    +  K      + E   L+N 
Sbjct: 10  EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
           RH  LT +         +  D    V EY   G L  + H + + +     S  +     
Sbjct: 67  RHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYG 115
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            ++ SA++YLH   +  +V+ D+K  N++LD D    + DFGL K
Sbjct: 116 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 78/190 (41%), Gaps = 28/190 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F   + +G+G+   VY+      +   A+KV  LK+    +    E   L  + H N+ K
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +  I  +         +LV E +  G L D + +   + E      ++++        A+
Sbjct: 113 LKEIFETPTEI-----SLVLELVTGGELFDRIVEKGYYSERDAADAVKQI------LEAV 161
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            YLH N    +VH D+KP N+L      D    + DFGLSK +    L            
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--------- 209
Query: 225 IKGTVGYVAP 234
           + GT GY AP
Sbjct: 210 VCGTPGYCAP 219

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 5   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 60
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 61  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 121 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 167
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 168 ILDFGL-----------ARHTDDEMTGYVATRWYRAP 193

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 58
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 119 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 165
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 166 ILDFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 26  QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 81
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 82  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 141
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 142 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 188
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 189 ILDFGL-----------ARHTDDEMXGYVATRWYRAP 214

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVIN---LKQKGAFRSFVAECEALRNI 100
           EF    ++G+G++G V   IL +++      A+K++    +  K      + E   L+N 
Sbjct: 9   EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
           RH  LT +         +  D    V EY   G L  + H + + +     S  +     
Sbjct: 66  RHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYG 114
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            ++ SA++YLH   +  +V+ D+K  N++LD D    + DFGL K
Sbjct: 115 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 157

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVIN---LKQKGAFRSFVAECEALRNI 100
           EF    ++G+G++G V   IL +++      A+K++    +  K      + E   L+N 
Sbjct: 11  EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
           RH  LT +         +  D    V EY   G L  + H + + +     S  +     
Sbjct: 68  RHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYG 116
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            ++ SA++YLH   +  +V+ D+K  N++LD D    + DFGL K
Sbjct: 117 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 159

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 33/196 (16%)
Query: 48  FSQSNMIGQGSYGSVY--KGILGEDE-MVVAVKVINLKQKGAFRSF--VAECEALRNIRH 102
           F    ++G+G YG V+  + + G +   + A+KV  LK+    R+    A  +A RNI  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKAMIVRNAKDTAHTKAERNILE 76
Query: 103 R-NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---VFKLSLIQRVN 158
                 I+ +  +  + G  +  L+ EY+  G L   L +    +E    F L+      
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLY--LILEYLSGGELFMQLEREGIFMEDTACFYLA------ 128
Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASET 218
              +++ A+ +LH   Q  +++ D+KP N++L++     + DFGL K   S H  T + T
Sbjct: 129 ---EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHT 180
Query: 219 PSSSIGIKGTVGYVAP 234
                   GT+ Y+AP
Sbjct: 181 ------FCGTIEYMAP 190

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 86/226 (38%), Gaps = 61/226 (26%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSF--------VAECEALRNIRHRNL 105
           IGQGSYG V   I  +   + A+K++N   K   R            E   ++ + H N+
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMN---KNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLH------------------------- 140
            ++  +      +   +  LV E    G L D L+                         
Sbjct: 91  ARLYEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 141 ---QTNDHLEVFKLSL--IQR----VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD 191
                N  +  F+ SL  +QR     NI   + SA+ YLH+     + H DIKP N L  
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFS 202
Query: 192 NDMVAHVG--DFGLSK-FLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            +    +   DFGLSK F   ++ +    T  +     GT  +VAP
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-----GTPYFVAP 243

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 42/185 (22%)
Query: 40  ELSKATCEFSQS----NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAE 93
           EL+K   E  Q       +G G+YGSV           VAVK ++   +     R    E
Sbjct: 18  ELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRE 77
Query: 94  CEALRNIRHRN---LTKIITICSSIDS----------KGADFKALVFEYMENGSLEDWLH 140
              L++++H N   L  + T  +SI+            GAD   +V    +  +L D   
Sbjct: 78  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSD--- 130
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
              +H++     L++           ++Y+H      ++H D+KPSNV ++ D    + D
Sbjct: 131 ---EHVQFLVYQLLR----------GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILD 174
Query: 201 FGLSK 205
           FGL++
Sbjct: 175 FGLAR 179

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/114 (25%), Positives = 57/114 (50%), Gaps = 18/114 (15%)
Query: 125 LVFEYMENGSL---EDWLHQTNDHLEVFKLSLIQRVNIAID-VASAIEYLHHNCQPPMVH 180
           +++EYMEN S+   +++    + +   F    IQ +   I  V ++  Y+H+  +  + H
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCF--IPIQVIKCIIKSVLNSFSYIHN--EKNICH 175
Query: 181 GDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            D+KPSN+L+D +    + DFG S+++    +           G +GT  ++ P
Sbjct: 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK----------GSRGTYEFMPP 219

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/217 (21%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K    
Sbjct: 3   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP 58
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 59  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 141 Q---TNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 119 SQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDSELK 165
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL +            T     G   T  Y AP
Sbjct: 166 ILDFGLCR-----------HTDDEMTGYVATRWYRAP 191

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVINLK---QKGAFRSFVAECEALRNI 100
           EF    ++G+G++G V   IL +++      A+K++  +    K      + E   L+N 
Sbjct: 149 EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
           RH  LT +         +  D    V EY   G L  + H + + +     S  +     
Sbjct: 206 RHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYG 254
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            ++ SA++YLH   +  +V+ D+K  N++LD D    + DFGL K
Sbjct: 255 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 26/195 (13%)
Query: 29  MEKQFPMVSYAELSKATCE-FSQSNMIGQGSYGSV---YKGILGEDEMVVAVKVINL--- 81
           M+ QF  V  A+ +    + + Q   IG G+ G V   +  +LG   + VAVK ++    
Sbjct: 4   MDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLG---INVAVKKLSRPFQ 60
Query: 82  KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK--ALVFEYMENGSLEDWL 139
            Q  A R++  E   L+ + H+N+  ++ + +       +F+   LV E M + +L   +
Sbjct: 61  NQTHAKRAY-RELVLLKCVNHKNIISLLNVFTP-QKTLEEFQDVYLVMELM-DANLCQVI 117
Query: 140 HQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG 199
           H   DH E     L Q +         I++LH      ++H D+KPSN+++ +D    + 
Sbjct: 118 HMELDH-ERMSYLLYQML-------CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 166
Query: 200 DFGLSKFLSSDHLDT 214
           DFGL++  S++ + T
Sbjct: 167 DFGLARTASTNFMMT 181

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 107/232 (46%), Gaps = 44/232 (18%)
Query: 32  QFPM---VSYAELSK-ATCEFSQSNM-----IGQGSYGSVYKG-ILGEDE------MVVA 75
           Q PM   VS  EL +    EF +  +     +G+G++G V     +G D+      + VA
Sbjct: 12  QDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 76  VKVI-NLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENG 133
           VK++ +   +      V+E E ++ I +H+N+  ++  C+     G  +  ++ EY   G
Sbjct: 72  VKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKG 126
Query: 134 SLEDWLHQTN----------DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGD 182
           +L ++L              + +   +++    V+    +A  +EYL    C    +H D
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRD 182
Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +   NVL+  + V  + DFGL++ +  +++D   +T +  + +K    ++AP
Sbjct: 183 LAARNVLVTENNVMKIADFGLARDI--NNIDYYKKTTNGRLPVK----WMAP 228

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMV---VAVKVINLK---QKGAFRSFVAECEALRNI 100
           EF    ++G+G++G V   IL +++      A+K++  +    K      + E   L+N 
Sbjct: 152 EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
           RH  LT +         +  D    V EY   G L  + H + + +     S  +     
Sbjct: 209 RHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYG 257
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            ++ SA++YLH   +  +V+ D+K  N++LD D    + DFGL K
Sbjct: 258 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 300

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 74/186 (39%), Gaps = 25/186 (13%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G++G V+        +   +K IN  + +       AE E L+++ H N+ KI  + 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
               +       +V E  E G L + +       +      +    +   + +A+ Y H 
Sbjct: 90  EDYHNM-----YIVMETCEGGELLERIVSAQARGKALSEGYV--AELMKQMMNALAYFHS 142
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAH----VGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
                +VH D+KP N+L   D   H    + DFGL++   SD           S    GT
Sbjct: 143 QH---VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSD---------EHSTNAAGT 189
Query: 229 VGYVAP 234
             Y+AP
Sbjct: 190 ALYMAP 195

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 107/232 (46%), Gaps = 44/232 (18%)
Query: 32  QFPM---VSYAELSK-ATCEFSQSNM-----IGQGSYGSVYKG-ILGEDE------MVVA 75
           Q PM   VS  EL +    EF +  +     +G+G++G V     +G D+      + VA
Sbjct: 12  QDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 76  VKVI-NLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENG 133
           VK++ +   +      V+E E ++ I +H+N+  ++  C+     G  +  ++ EY   G
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQ---DGPLY--VIVEYASKG 126
Query: 134 SLEDWLHQTN----------DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGD 182
           +L ++L              + +   +++    V+    +A  +EYL    C    +H D
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRD 182
Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +   NVL+  + V  + DFGL++ +  +++D   +T +  + +K    ++AP
Sbjct: 183 LAARNVLVTENNVMKIADFGLARDI--NNIDYYKKTTNGRLPVK----WMAP 228

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 39/198 (19%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
            + +   +G+G +   Y+    + + V A KV            V +   L+  +   ++
Sbjct: 27  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV------------VPKSMLLKPHQKEKMS 74
Query: 107 KIITICSSIDS----------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
             I I  S+D+          +  DF  +V E     SL + LH+    +   +     R
Sbjct: 75  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR 133
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
             I       ++YLH+N    ++H D+K  N+ L++DM   +GDFGL+  +  D      
Sbjct: 134 QTI-----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG----- 180
Query: 217 ETPSSSIGIKGTVGYVAP 234
                   + GT  Y+AP
Sbjct: 181 ---ERKKDLCGTPNYIAP 195

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 81/198 (40%), Gaps = 39/198 (19%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
            + +   +G+G +   Y+    + + V A KV            V +   L+  +   ++
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV------------VPKSMLLKPHQKEKMS 90
Query: 107 KIITICSSIDS----------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
             I I  S+D+          +  DF  +V E     SL + LH+    +   +     R
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR 149
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
             I       ++YLH+N    ++H D+K  N+ L++DM   +GDFGL+  +  D     +
Sbjct: 150 QTI-----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT 201
Query: 217 ETPSSSIGIKGTVGYVAP 234
                   + GT  Y+AP
Sbjct: 202 --------LCGTPNYIAP 211

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 82/196 (41%), Gaps = 36/196 (18%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS-----FVAECEALRNIRH 102
           + +   +G G+YG V   +L  D++    + I + +K +  +      + E   L+ + H
Sbjct: 39  YQRVKKLGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
            N+ K+       D +      LV E  + G L D +      +   K + +    I   
Sbjct: 96  PNIMKLYDFFE--DKRNY---YLVMECYKGGELFDEI------IHRMKFNEVDAAVIIKQ 144
Query: 163 VASAIEYLH-HNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASET 218
           V S + YLH HN    +VH D+KP N+LL++   D +  + DFGLS            E 
Sbjct: 145 VLSGVTYLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---------EN 191
Query: 219 PSSSIGIKGTVGYVAP 234
                   GT  Y+AP
Sbjct: 192 QKKMKERLGTAYYIAP 207

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 106/232 (45%), Gaps = 44/232 (18%)
Query: 32  QFPM---VSYAELSK-ATCEFSQSNM-----IGQGSYGSVYKG-ILGEDE------MVVA 75
           Q PM   VS  EL +    EF +  +     +G+G++G V     +G D+      + VA
Sbjct: 12  QDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 76  VKVI-NLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENG 133
           VK++ +   +      V+E E ++ I +H+N+  ++  C+     G  +  ++ EY   G
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKG 126
Query: 134 SLEDWLHQTN----------DHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGD 182
           +L ++L              + +   +++    V+    +A  +EYL    C    +H D
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRD 182
Query: 183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +   NVL+  + V  + DFGL++ +  +++D    T +  + +K    ++AP
Sbjct: 183 LAARNVLVTENNVMKIADFGLARDI--NNIDYYKNTTNGRLPVK----WMAP 228

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 94/201 (46%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE------MVVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 104
           +G+G +G V     +G D+      + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L              + +   +++  
Sbjct: 149 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+    +A  +EYL    C    +H D+   NVL+  + V  + DFGL++ +  +++D
Sbjct: 204 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--NNID 257
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 258 YYKKTTNGRLPVK----WMAP 274

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/233 (21%), Positives = 93/233 (39%), Gaps = 43/233 (18%)
Query: 15  RRRGSVRKPIDTLPMEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGED 70
           ++ GS   P       K+ P     EL+K   E    +   + +G G+YGSV      + 
Sbjct: 18  KKAGSAAAPFTM--SHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKS 75
Query: 71  EMVVAVKVINLKQKGAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKA 124
            + +AVK    K    F+S +       E   L++++H N+  ++ + +   S       
Sbjct: 76  GLKIAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDV 131
Query: 125 LVFEYMENGSLEDWLH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHG 181
            +  ++    L + +     T+DH++     +++           ++Y+H      ++H 
Sbjct: 132 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHR 178
Query: 182 DIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           D+KPSN+ ++ D    + DFGL           A  T     G   T  Y AP
Sbjct: 179 DLKPSNLAVNEDCELKILDFGL-----------ARHTDDEMTGYVATRWYRAP 220

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 21/162 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG GSY    + I     M  AVK+I+  +    R    E E L  +R+     IIT+  
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEIL--LRYGQHPNIITLKD 83
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             D     +  +V E M+ G L D +      L     S  +   +   +   +EYLH  
Sbjct: 84  VYDD--GKYVYVVTELMKGGELLDKI------LRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 174 CQPPMVHGDIKPSNVLL----DNDMVAHVGDFGLSKFLSSDH 211
               +VH D+KPSN+L      N     + DFG +K L +++
Sbjct: 136 G---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 80/185 (43%), Gaps = 32/185 (17%)
Query: 40  ELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI------NLKQKGAFRS 89
           E++K   E    +     +G G+YG+V   + G     VA+K +       L  K A+R 
Sbjct: 15  EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR- 73
Query: 90  FVAECEALRNIRHRNLTKIITICSSIDSKGADFK--ALVFEYM--ENGSLEDWLHQTNDH 145
              E   L+++RH N+  ++ + +  D    DF    LV  +M  + G L        D 
Sbjct: 74  ---ELRLLKHMRHENVIGLLDVFTP-DETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 129
Query: 146 LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           ++     +++           + Y+H      ++H D+KP N+ ++ D    + DFGL++
Sbjct: 130 IQFLVYQMLK----------GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176
Query: 206 FLSSD 210
              S+
Sbjct: 177 QADSE 181

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 39/198 (19%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
            + +   +G+G +   Y+    + + V A KV            V +   L+  +   ++
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV------------VPKSMLLKPHQKEKMS 90
Query: 107 KIITICSSIDS----------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
             I I  S+D+          +  DF  +V E     SL + LH+    +   +     R
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR 149
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
             I       ++YLH+N    ++H D+K  N+ L++DM   +GDFGL+  +  D      
Sbjct: 150 QTI-----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG----- 196
Query: 217 ETPSSSIGIKGTVGYVAP 234
                   + GT  Y+AP
Sbjct: 197 ---ERKKXLCGTPNYIAP 211

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 39/198 (19%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
            + +   +G+G +   Y+    + + V A KV            V +   L+  +   ++
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV------------VPKSMLLKPHQKEKMS 90
Query: 107 KIITICSSIDS----------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
             I I  S+D+          +  DF  +V E     SL + LH+    +   +     R
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR 149
Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
             I       ++YLH+N    ++H D+K  N+ L++DM   +GDFGL+  +  D      
Sbjct: 150 QTI-----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG----- 196
Query: 217 ETPSSSIGIKGTVGYVAP 234
                   + GT  Y+AP
Sbjct: 197 ---ERKKDLCGTPNYIAP 211

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVI--NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           ++IG GSYG V +     ++ VVA+K I    +     +  + E   L  + H ++ K++
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK----LSLIQRVNIAIDVAS 165
            I    D +  D   +V E  ++           D  ++F+    L+ +    +  ++  
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADS-----------DFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            ++Y+H      ++H D+KP+N L++ D    V DFGL++
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 59/158 (37%), Gaps = 15/158 (9%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F + + +G GSYG V+K    ED  + AVK    +    FR        L  +       
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVK----RSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL--IQRVNIAIDVAS 165
               C  ++    +   L  +    G           H E +  SL   Q      D   
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGP------SLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
           A+ +LH      +VH D+KP+N+ L       +GDFGL
Sbjct: 169 ALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL 203

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 27/191 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL 105
           +S    IG G    V++ +L E + + A+K +NL++       S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGS--LEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            KII +    D +  D    ++  ME G+  L  WL +         +   +R +   ++
Sbjct: 88  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKK------SIDPWERKSYWKNM 136
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+  +H   Q  +VH D+KP+N L+ + M+  + DFG++  +  D      ++     
Sbjct: 137 LEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQV--- 189
Query: 224 GIKGTVGYVAP 234
              GTV Y+ P
Sbjct: 190 ---GTVNYMPP 197

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             +  FGL           A  T     G   T  Y AP
Sbjct: 164 LKILGFGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 73/182 (40%), Gaps = 21/182 (11%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+      +   E      + H N+ K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG-- 72
Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +  + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 73  ---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYV 232
                + H DIKP N+LLD      + DFGL+     ++ +           + GT+ YV
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------MCGTLPYV 174
Query: 233 AP 234
           AP
Sbjct: 175 AP 176

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 41/214 (19%)
Query: 34  PMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS 89
           P     EL+K   E    +   + +G G+YGSV      +    VAVK    K    F+S
Sbjct: 2   PTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQS 57
Query: 90  FV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH--- 140
            +       E   L++++H N+  ++ + +   S        +  ++    L + +    
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK 117
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
            T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    + D
Sbjct: 118 LTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 164
Query: 201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           FGL           A  T     G   T  Y AP
Sbjct: 165 FGL-----------ARHTDDEMTGYVATRWYRAP 187

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 18/191 (9%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKG--------AFRSFVAECEALRNIRHRNL 105
           IG G +G +Y           A  V+ ++ +          F   VA+ + ++    R  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
              + I     S   +FK   + +M    L   L + +     FK S +  + + I +  
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTV--LQLGIRMLD 162
Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLL--DNDMVAHVGDFGLS-KFLSSDHLDTASETPSSS 222
            +EY+H N     VHGDIK +N+LL   N    ++ D+GLS ++  + +     E P   
Sbjct: 163 VLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK- 218
Query: 223 IGIKGTVGYVA 233
            G  GT+ + +
Sbjct: 219 -GHNGTIEFTS 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 41/214 (19%)
Query: 34  PMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS 89
           P     EL+K   E    +   + +G G+YGSV      +    VAVK    K    F+S
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQS 57
Query: 90  FV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH--- 140
            +       E   L++++H N+  ++ + +   S        +  ++    L + +    
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
            T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    + D
Sbjct: 118 LTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 164
Query: 201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           FGL           A  T     G   T  Y AP
Sbjct: 165 FGL-----------ARHTDDEMAGFVATRWYRAP 187

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 94/201 (46%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE------MVVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 104
           +G+G +G V     +G D+      + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L              + +   +++  
Sbjct: 90  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+    +A  +EYL    C    +H D+   NVL+  + V  + DFGL++ +  +++D
Sbjct: 145 DLVSCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLARDI--NNID 198
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 199 YYKKTTNGRLPVK----WMAP 215

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 94/201 (46%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE------MVVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 104
           +G+G +G V     +G D+      + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L              + +   +++  
Sbjct: 92  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+    +A  +EYL    C    +H D+   NVL+  + V  + DFGL++ +  +++D
Sbjct: 147 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--NNID 200
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 201 YYKKTTNGRLPVK----WMAP 217

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 94/201 (46%), Gaps = 35/201 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDE------MVVAVKVI-NLKQKGAFRSFVAECEALRNI-RHRN 104
           +G+G +G V     +G D+      + VAVK++ +   +      V+E E ++ I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN----------DHLEVFKLSLI 154
           +  ++  C+     G  +  ++ EY   G+L ++L              + +   +++  
Sbjct: 95  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 155 QRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
             V+    +A  +EYL    C    +H D+   NVL+  + V  + DFGL++ +  +++D
Sbjct: 150 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDI--NNID 203
Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +T +  + +K    ++AP
Sbjct: 204 YYKKTTNGRLPVK----WMAP 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 27/191 (14%)
Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL 105
           +S    IG G    V++ +L E + + A+K +NL++       S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 106 TKIITICSSIDSKGADFKALVFEYMENGS--LEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            KII +    D +  D    ++  ME G+  L  WL +         +   +R +   ++
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKKS------IDPWERKSYWKNM 164
Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+  +H   Q  +VH D+KP+N L+ + M+  + DFG++  +     DT S    S +
Sbjct: 165 LEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQP---DTTSVVKDSQV 217
Query: 224 GIKGTVGYVAP 234
              G V Y+ P
Sbjct: 218 ---GAVNYMPP 225

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 87/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E    +   + +G G+YGSV      +    VAVK    K    
Sbjct: 9   QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRP 64
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 65  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 125 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 171
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 172 ILDFGL-----------ARHTDDEMTGYVATRWYRAP 197

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 42  SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRN 99
           ++ T E+     +G+G++  V + +        A  +IN K+  A   +    E    R 
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 100 IRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           ++H N   I+ +  SI  +G  +  L+F+ +  G L + +     + E      IQ++  
Sbjct: 67  LKHPN---IVRLHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQI-- 119
Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM---VAHVGDFGLSKFLSSDHLDTAS 216
                  +E + H  Q  +VH ++KP N+LL + +      + DFGL+  +  +      
Sbjct: 120 -------LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ----- 167
Query: 217 ETPSSSIGIKGTVGYVAP 234
               +  G  GT GY++P
Sbjct: 168 ---QAWFGFAGTPGYLSP 182

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 77/194 (39%), Gaps = 30/194 (15%)
Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRN------I 100
           +F    M+G+GS+G V+     +     A+K   LK+         EC  +         
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            H  LT +   C+    +   F   V EY+  G L    H  + H    K  L +    A
Sbjct: 77  EHPFLTHMF--CTFQTKENLFF---VMEYLNGGDL--MYHIQSCH----KFDLSRATFYA 125
Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPS 220
            ++   +++LH      +V+ D+K  N+LLD D    + DFG+ K    + L  A     
Sbjct: 126 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNEF 179
Query: 221 SSIGIKGTVGYVAP 234
                 GT  Y+AP
Sbjct: 180 C-----GTPDYIAP 188

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 41/214 (19%)
Query: 34  PMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS 89
           P     EL+K   E    +   + +G G+YGSV      +    VAVK    K    F+S
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQS 57
Query: 90  FV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH--- 140
            +       E   L++++H N+  ++ + +   S        +  ++    L + +    
Sbjct: 58  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD 200
            T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    + D
Sbjct: 118 LTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 164
Query: 201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           FGL           A  T     G   T  Y AP
Sbjct: 165 FGL-----------ARHTDDEMTGYVATRWYRAP 187

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + D GL           A  T     G   T  Y AP
Sbjct: 164 LKILDAGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + D GL           A  T     G   T  Y AP
Sbjct: 164 LKILDRGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIIT 110
           +IG+GSYG VY       E  VA+K +N   +     +  + E   L  ++   + ++  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 111 ICSSIDSKGADFKALVFEYMENGS---LEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +    D    D   +V E  ++      +  +  T +H++    +L+   N         
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN--------- 143
Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            ++H +    ++H D+KP+N LL+ D    V DFGL++ ++S+
Sbjct: 144 -FIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 88/217 (40%), Gaps = 41/217 (18%)
Query: 31  KQFPMVSYAELSKATCEFSQ--SNM--IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA 86
           ++ P     EL+K   E  +   N+  +G G+YGSV      +    VAVK    K    
Sbjct: 13  QERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRP 68
Query: 87  FRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           F+S +       E   L++++H N+  ++ + +   S        +  ++    L + + 
Sbjct: 69  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 128
Query: 141 ---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
               T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D    
Sbjct: 129 CQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELK 175
Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGL           A  T     G   T  Y AP
Sbjct: 176 ILDFGL-----------ARHTDDEMTGYVATRWYRAP 201

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 91/193 (47%), Gaps = 29/193 (15%)
Query: 48  FSQSNMIGQGSYGSVY---KGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIR 101
           F    ++GQGS+G V+   K    +   + A+KV+    LK +   R+ + E + L ++ 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERDILADVN 88
Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H     ++ +  +  ++G  +  L+ +++  G L   L +     EV       +  +A 
Sbjct: 89  H---PFVVKLHYAFQTEGKLY--LILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLA- 137
Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
           ++A  +++LH      +++ D+KP N+LLD +    + DFGLSK         A +    
Sbjct: 138 ELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--------EAIDHEKK 186
Query: 222 SIGIKGTVGYVAP 234
           +    GTV Y+AP
Sbjct: 187 AYSFCGTVEYMAP 199

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 29  MEKQFPMVSYAELSKATCE----FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK 84
           M ++ P     EL+K   E    +   + +G G+YGSV      +  + VAVK    K  
Sbjct: 1   MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLS 56
Query: 85  GAFRSFV------AECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDW 138
             F+S +       E   L++++H N+  ++ + +   S        +  ++    L + 
Sbjct: 57  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 139 LH---QTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV 195
           +     T+DH++     +++           ++Y+H      ++H D+KPSN+ ++ D  
Sbjct: 117 VKCQKLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCE 163
Query: 196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
             + D GL           A  T     G   T  Y AP
Sbjct: 164 LKILDGGL-----------ARHTDDEMTGYVATRWYRAP 191

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 21/162 (12%)
Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG GSY    + +     M  AVKVI+  +    R    E E L  +R+     IIT+  
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSK----RDPSEEIEIL--LRYGQHPNIITLKD 88
Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             D     +  LV E M  G L D +      L     S  +   +   +   +EYLH  
Sbjct: 89  VYDDGKHVY--LVTELMRGGELLDKI------LRQKFFSEREASFVLHTIGKTVEYLHSQ 140
Query: 174 CQPPMVHGDIKPSNVLL----DNDMVAHVGDFGLSKFLSSDH 211
               +VH D+KPSN+L      N     + DFG +K L +++
Sbjct: 141 G---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 82/178 (46%), Gaps = 32/178 (17%)
Query: 54  IGQGSYGSVYKG-ILGEDEM----VVAVKVINLKQKGA----FRSFVAECEALRNI-RHR 103
           +G+G++G V +    G D+      VAVK++   ++GA     R+ ++E + L +I  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 82
Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK----------LSL 153
           N+  ++  C+     G     +V E+ + G+L  +L    +    +K          L+L
Sbjct: 83  NVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 154 IQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
              +  +  VA  +E+L    C    +H D+   N+LL    V  + DFGL++ +  D
Sbjct: 139 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKD 192

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	234
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-67
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-62
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-52
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-51
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-46
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-44
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-44
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-44
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-43
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-43
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-43
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-40
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-30
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-29
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-29
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-29
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-27
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-24
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-24
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-24
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-22
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-21
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-20
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-20
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-20
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-20
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-19
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-18
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-18
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-15
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-11
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-09
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-07
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-07
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-07
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-06
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	3e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  210 bits (536), Expect = 1e-67
 Identities = 70/201 (34%), Positives = 106/201 (52%), Gaps = 20/201 (9%)

Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECE 95
           S  EL  A+  FS  N++G+G +G VYKG L  D  +VAVK +  +  +G    F  E E
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 96  ALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQ 155
            +    HRNL ++   C +        + LV+ YM NGS+   L +  +      L   +
Sbjct: 80  MISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPESQPP--LDWPK 132

Query: 156 RVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD--HLD 213
           R  IA+  A  + YLH +C P ++H D+K +N+LLD +  A VGDFGL+K +     H+ 
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192

Query: 214 TASETPSSSIGIKGTVGYVAP 234
           TA         ++GT+G++AP
Sbjct: 193 TA---------VRGTIGHIAP 204

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  196 bits (500), Expect = 3e-62
 Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 23/201 (11%)

Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
              +L +AT  F    +IG G +G VYKG+L  D   VA+K    +       F  E E 
Sbjct: 30  PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           L   RH +L  +I  C        +   L+++YMENG+L+  L+ ++       +S  QR
Sbjct: 89  LSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYGSDLP--TMSMSWEQR 141

Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD---HLD 213
           + I I  A  + YLH      ++H D+K  N+LLD + V  + DFG+SK  +     HL 
Sbjct: 142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198

Query: 214 TASETPSSSIGIKGTVGYVAP 234
           T          +KGT+GY+ P
Sbjct: 199 TV---------VKGTLGYIDP 210

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  175 bits (445), Expect = 4e-54
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 35/211 (16%)

Query: 37  SYAELSKATCEFSQ------SNMIGQGSYGSVYKGILGEDEMVVAVK----VINLKQKGA 86
           S+ EL   T  F +       N +G+G +G VYKG +  +   VAVK    ++++  +  
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73

Query: 87  FRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL 146
            + F  E + +   +H NL +++   S       D   LV+ YM NGSL D L   +   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDGTP 128

Query: 147 EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF 206
               LS   R  IA   A+ I +LH N     +H DIK +N+LLD    A + DFGL++ 
Sbjct: 129 ---PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182

Query: 207 LSSD---HLDTASETPSSSIGIKGTVGYVAP 234
                   + +          I GT  Y+AP
Sbjct: 183 SEKFAQTVMTSR---------IVGTTAYMAP 204

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  171 bits (434), Expect = 3e-52
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 20/206 (9%)

Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECE- 95
           + +E S          +IG+G YG+VYKG L E    VAVKV +   +   ++F+ E   
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKNI 58

Query: 96  -ALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI 154
             +  + H N+ + I     + + G     LV EY  NGSL  +L              +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-------TSDWV 111

Query: 155 QRVNIAIDVASAIEYLH------HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
               +A  V   + YLH       + +P + H D+   NVL+ ND    + DFGLS  L+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 209 SDHLDTASETPSSSIGIKGTVGYVAP 234
            + L    E  +++I   GT+ Y+AP
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAP 197

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  168 bits (427), Expect = 2e-51
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 24/205 (11%)

Query: 37  SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEA 96
               L   +       +  +G +G V+K  L  +   VAVK+  ++ K +++    E  +
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           L  ++H N+ + I       +       L+  + E GSL D+L           +S  + 
Sbjct: 72  LPGMKHENILQFIGAEKR-GTSVDVDLWLITAFHEKGSLSDFLKAN-------VVSWNEL 123

Query: 157 VNIAIDVASAIEYLHHN-------CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
            +IA  +A  + YLH +        +P + H DIK  NVLL N++ A + DFGL+    +
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 210 DHLDTASETPSSSIGIKGTVGYVAP 234
                  ++   + G  GT  Y+AP
Sbjct: 184 G------KSAGDTHGQVGTRRYMAP 202

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  155 bits (393), Expect = 2e-46
 Identities = 56/191 (29%), Positives = 93/191 (48%), Gaps = 23/191 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL-GEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHR 103
           + +    IG GS+G+V++    G D   VAVK++  +         F+ E   ++ +RH 
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD---VAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+   +   +          ++V EY+  GSL   LH++       +L   +R+++A DV
Sbjct: 95  NIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKSGAR---EQLDERRRLSMAYDV 146

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
           A  + YLH N  PP+VH ++K  N+L+D      V DFGLS+  +S  L + S       
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA----- 200

Query: 224 GIKGTVGYVAP 234
              GT  ++AP
Sbjct: 201 ---GTPEWMAP 208

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  148 bits (377), Expect = 2e-44
 Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 27/191 (14%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL-GEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHR 103
           + +    + +   G ++KG   G D   + VKV+ ++       R F  EC  LR   H 
Sbjct: 11  QLNFLTKLNENHSGELWKGRWQGND---IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+  ++  C S     A    L+  +M  GSL + LH+  +      +   Q V  A+D+
Sbjct: 68  NVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDM 120

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
           A  + +LH   +P +    +   +V++D DM A +    +     S              
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP------------- 166

Query: 224 GIKGTVGYVAP 234
           G      +VAP
Sbjct: 167 GRMYAPAWVAP 177

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  149 bits (378), Expect = 3e-44
 Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 24/190 (12%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLTKII 109
             +G+G YG V++G    +   VAVK+ + + +   +S+  E E      +RH N+   I
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
               +          L+  Y E GSL D+L  T        L  +  + I + +AS + +
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAH 120

Query: 170 LH-----HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
           LH        +P + H D+K  N+L+  +    + D GL+   S     + ++    +  
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ----STNQLDVGNNP 176

Query: 225 IKGTVGYVAP 234
             GT  Y+AP
Sbjct: 177 RVGTKRYMAP 186

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  149 bits (377), Expect = 1e-43
 Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 24/190 (12%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLTKII 109
             IG+G +G V++G    +E  VAVK+ + +++   RS+  E E      +RH N+   I
Sbjct: 48  ESIGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
              +  +        LV +Y E+GSL D+L++         +++   + +A+  AS + +
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAH 154

Query: 170 LH-----HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
           LH        +P + H D+K  N+L+  +    + D GL+    S           +   
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS----ATDTIDIAPNH 210

Query: 225 IKGTVGYVAP 234
             GT  Y+AP
Sbjct: 211 RVGTKRYMAP 220

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  148 bits (376), Expect = 1e-43
 Identities = 49/190 (25%), Positives = 75/190 (39%), Gaps = 24/190 (12%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLTKII 109
             IG+G YG V+ G    ++  VAVKV    ++    S+  E E      +RH N+   I
Sbjct: 43  KQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
                          L+ +Y ENGSL D+L  T        L     + +A    S + +
Sbjct: 98  AADIKGTGSWTQL-YLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCH 149

Query: 170 LH-----HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
           LH        +P + H D+K  N+L+  +    + D GL+    S      +E       
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS----DTNEVDIPPNT 205

Query: 225 IKGTVGYVAP 234
             GT  Y+ P
Sbjct: 206 RVGTKRYMPP 215

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  146 bits (371), Expect = 3e-43
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 36/200 (18%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI-------NLKQKGAFRSFVAECEALRN 99
           E      IG+G +G V+KG L +D+ VVA+K +         +    F+ F  E   + N
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79

Query: 100 IRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           + H N+ K+  +  +          +V E++  G L   L           +    ++ +
Sbjct: 80  LNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRL 127

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-----DMVAHVGDFGLSKFLSSDHLDT 214
            +D+A  IEY+  N  PP+VH D++  N+ L +      + A V DFGLS+         
Sbjct: 128 MLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--------- 177

Query: 215 ASETPSSSIGIKGTVGYVAP 234
             ++  S  G+ G   ++AP
Sbjct: 178 --QSVHSVSGLLGNFQWMAP 195

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  147 bits (372), Expect = 3e-43
 Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 28/190 (14%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL-GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNL 105
           E     ++G+G++G V K     +D   VA+K   ++ +   ++F+ E   L  + H N+
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWRAKD---VAIKQ--IESESERKAFIVELRQLSRVNHPNI 63

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            K+   C +          LV EY E GSL + LH           +    ++  +  + 
Sbjct: 64  VKLYGACLNPVC-------LVMEYAEGGSLYNVLHGAEPLPY---YTAAHAMSWCLQCSQ 113

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            + YLH      ++H D+KP N+LL     V  + DFG +  +            +    
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-----------THMTN 162

Query: 225 IKGTVGYVAP 234
            KG+  ++AP
Sbjct: 163 NKGSAAWMAP 172

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  138 bits (350), Expect = 2e-40
 Identities = 45/201 (22%), Positives = 77/201 (38%), Gaps = 38/201 (18%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL-GEDEMVVAVKVINLK----QKGAFRSFVAECEALRNIR 101
           E +   +IG G +G VY+    G++   VAVK               +   E +    ++
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWIGDE---VAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+  +  +C     K  +   LV E+   G L   L          ++     VN A+
Sbjct: 65  HPNIIALRGVCL----KEPNL-CLVMEFARGGPLNRVLSGK-------RIPPDILVNWAV 112

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH--------VGDFGLSKFLSSDHLD 213
            +A  + YLH     P++H D+K SN+L+   +           + DFGL++        
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172

Query: 214 TASETPSSSIGIKGTVGYVAP 234
           +A           G   ++AP
Sbjct: 173 SA----------AGAYAWMAP 183

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  139 bits (353), Expect = 2e-40
 Identities = 42/185 (22%), Positives = 76/185 (41%), Gaps = 22/185 (11%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
            +IG+G +G VY G    +   VA+++I++++  +   ++F  E  A R  RH N+   +
Sbjct: 39  ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
             C S         A++    +  +L   +           L + +   IA ++   + Y
Sbjct: 96  GACMS-----PPHLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGY 145

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           LH      ++H D+K  NV  DN  V  + DFGL             +         G +
Sbjct: 146 LH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQN---GWL 198

Query: 230 GYVAP 234
            ++AP
Sbjct: 199 CHLAP 203

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  137 bits (348), Expect = 1e-39
 Identities = 42/187 (22%), Positives = 78/187 (41%), Gaps = 19/187 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G+G +G   K    E   V+ +K +    +   R+F+ E + +R + H N+ K I +  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL- 76

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
               K       + EY++ G+L   +   +      +    QRV+ A D+AS + YLH  
Sbjct: 77  ---YKDKRL-NFITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM 127

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS------ETPSSSIGIKG 227
               ++H D+   N L+  +    V DFGL++ +  +                    + G
Sbjct: 128 ---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 228 TVGYVAP 234
              ++AP
Sbjct: 185 NPYWMAP 191

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  137 bits (346), Expect = 1e-39
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 25/183 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N+   +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
            ++         A+V ++ E  SL   LH +       K  + + ++IA   A  ++YLH
Sbjct: 89  STA------PQLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLH 137

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
                 ++H D+K +N+ L  D    +GDFGL+   S        E         G++ +
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL------SGSILW 188

Query: 232 VAP 234
           +AP
Sbjct: 189 MAP 191

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  118 bits (297), Expect = 3e-32
 Identities = 44/202 (21%), Positives = 82/202 (40%), Gaps = 23/202 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +F +  ++GQG++G V K     D    A+K I    +    + ++E   L ++ H+ + 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65

Query: 107 KIITICSSIDSKGADFKA--------LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN 158
           +         +      A        +  EY ENG+L D +H  N + +       +   
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR-----DEYWR 120

Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASET 218
           +   +  A+ Y+H      ++H D+KP N+ +D      +GDFGL+K +         ++
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 219 PSSSIGIK------GTVGYVAP 234
            +            GT  YVA 
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVAT 199

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  118 bits (297), Expect = 4e-32
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 14/162 (8%)

Query: 52  NMIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQKGA----FRSFVAECEALRNIRHRN 104
            ++G+G +GSV +G L       + VAVK   +K   +       F++E   +++  H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           + +++ +C  + S+G     ++  +M+ G L  +L  +        + L   +   +D+A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 165 SAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             +EYL + N     +H D+   N +L +DM   V DFGLSK
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSK 195

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  114 bits (288), Expect = 5e-31
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 24/203 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHRNL 105
           +F     +G+G +G V++     D+   A+K I L  +   R   + E +AL  + H   
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG- 64

Query: 106 TKIITICSSIDSKGADFKA----------LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQ 155
             I+   ++   K    K           +  +     +L+DW++      E  + S+  
Sbjct: 65  --IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVC- 120

Query: 156 RVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD----H 211
            ++I + +A A+E+LH      ++H D+KPSN+    D V  VGDFGL   +  D     
Sbjct: 121 -LHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 212 LDTASETPSSSIGIKGTVGYVAP 234
           + T     +   G  GT  Y++P
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSP 199

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  113 bits (285), Expect = 1e-30
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 17/186 (9%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIIT 110
            IG GSYG   K     D  ++  K ++     +   +  V+E   LR ++H N   I+ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVR 69

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
               I  +      +V EY E G L   + +     +      +  + +   +  A++  
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLALKEC 127

Query: 171 H--HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           H   +    ++H D+KP+NV LD      +GDFGL++ L+ D     +          GT
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--------FVGT 179

Query: 229 VGYVAP 234
             Y++P
Sbjct: 180 PYYMSP 185

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  112 bits (282), Expect = 7e-30
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)

Query: 52  NMIGQGSYGSVYKGIL---GEDEMVVAVKVI--NLKQKGAFRSFVAECEALRNIRHRNLT 106
            M+G+G +GSV +  L       + VAVK++  ++        F+ E   ++   H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 107 KIITICSSIDSKGADFKAL-VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
           K++ +     +KG     + +  +M++G L  +L  +      F L L   V   +D+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 166 AIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            +EYL   N     +H D+   N +L  DM   V DFGLS+
Sbjct: 149 GMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  111 bits (280), Expect = 1e-29
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 22/166 (13%)

Query: 54  IGQGSYGSVYKGIL----GEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLT 106
           +G+G +G V               VAVK   LK             E E LRN+ H N+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           K   IC+     G +   L+ E++ +GSL+++L   N +    K++L Q++  A+ +   
Sbjct: 87  KYKGICTE---DGGNGIKLIMEFLPSGSLKEYL-PKNKN----KINLKQQLKYAVQICKG 138

Query: 167 IEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           ++YL         VH D+   NVL++++    +GDFGL+K + +D 
Sbjct: 139 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  111 bits (279), Expect = 1e-29
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 17/163 (10%)

Query: 54  IGQGSYGSVYKGIL----GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV              VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L Q +      ++  I+ +     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYL-QKHKE----RIDHIKLLQYTSQICKGMEY 129

Query: 170 LH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           L         +H D+   N+L++N+    +GDFGL+K L  D 
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  111 bits (281), Expect = 1e-29
 Identities = 40/172 (23%), Positives = 81/172 (47%), Gaps = 25/172 (14%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL----GEDEMVVAVKVINLK---QKGAFRSFVAECEALRN 99
           EF +  ++G G++G+VYKG+      + ++ VA+K   L+      A +  + E   + +
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMAS 73

Query: 100 IRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           + + ++ +++ IC +          L+ + M  G L D++ +  D++    L     +N 
Sbjct: 74  VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNW 122

Query: 160 AIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            + +A  + YL         VH D+   NVL+       + DFGL+K L ++
Sbjct: 123 CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  110 bits (278), Expect = 1e-29
 Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 31/204 (15%)

Query: 42  SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR 101
            +   +F +  +IG G +G V+K     D     +K +    + A R    E +AL  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 102 HRNLTK-----------IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK 150
           H N+               T   +          +  E+ + G+LE W+ +        K
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----K 118

Query: 151 LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           L  +  + +   +   ++Y+H      +++ D+KPSN+ L +     +GDFGL   L +D
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

Query: 211 HLDTASETPSSSIGIKGTVGYVAP 234
              T           KGT+ Y++P
Sbjct: 176 GKRTR---------SKGTLRYMSP 190

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  111 bits (280), Expect = 1e-29
 Identities = 37/185 (20%), Positives = 74/185 (40%), Gaps = 13/185 (7%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITIC- 112
           +G+G +  V       D    A+K I   ++        E +  R   H N   I+ +  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPN---ILRLVA 93

Query: 113 SSIDSKGADFKA-LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             +  +GA  +A L+  + + G+L + + +  D         I  + + + +   +E +H
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI--LWLLLGICRGLEAIH 151

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE--TPSSSIGIKGTV 229
                   H D+KP+N+LL ++    + D G        H++ + +  T       + T+
Sbjct: 152 ---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI-HVEGSRQALTLQDWAAQRCTI 207

Query: 230 GYVAP 234
            Y AP
Sbjct: 208 SYRAP 212

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  111 bits (280), Expect = 2e-29
 Identities = 42/165 (25%), Positives = 72/165 (43%), Gaps = 21/165 (12%)

Query: 54  IGQGSYGSVYKGIL----GEDEMVVAVKVINLKQKG--AFRSFVAECEALRNIRHRNLTK 107
           +G+G++GSV              +VAVK   L+  G    R F  E + L+ +    + K
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
              +      +      LV EY+ +G L D+L Q +      +L   + +  +  +   +
Sbjct: 89  YRGVSYGPGRQSL---RLVMEYLPSGCLRDFL-QRHRA----RLDASRLLLYSSQICKGM 140

Query: 168 EYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           EYL    C    VH D+   N+L++++    + DFGL+K L  D 
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  111 bits (279), Expect = 2e-29
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 17/163 (10%)

Query: 54  IGQGSYGSVYKGIL----GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G++GSV              VVAVK +    +   R F  E E L++++H N+ K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +C S   +      L+ EY+  GSL D+L Q +      ++  I+ +     +   +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYL-QKHKE----RIDHIKLLQYTSQICKGMEY 160

Query: 170 LH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           L         +H D+   N+L++N+    +GDFGL+K L  D 
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  110 bits (277), Expect = 2e-29
 Identities = 46/186 (24%), Positives = 85/186 (45%), Gaps = 25/186 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+GS+ +VYKG+  E  + VA   +  ++  K   + F  E E L+ ++H N   I+  
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN---IVRF 90

Query: 112 CSSIDSKGADFKALVF--EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
             S +S     K +V   E M +G+L+ +L +      V K+ +++       +   +++
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRS--WCRQILKGLQF 144

Query: 170 LHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           L H   PP++H D+K  N+ +        +GD GL+    +               + GT
Sbjct: 145 L-HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----------VIGT 193

Query: 229 VGYVAP 234
             ++AP
Sbjct: 194 PEFMAP 199

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  111 bits (281), Expect = 3e-29
 Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 14/165 (8%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNL 105
           +      IG+G++G V+ G L  D  +VAVK             F+ E   L+   H N+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            ++I +C+           +V E ++ G    +L +T       +L +   + +  D A+
Sbjct: 175 VRLIGVCTQKQP-----IYIVMELVQGGDFLTFL-RTEGA----RLRVKTLLQMVGDAAA 224

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            +EYL        +H D+   N L+    V  + DFG+S+  +  
Sbjct: 225 GMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  109 bits (275), Expect = 5e-29
 Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 25/194 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNL 105
            +  S+++GQG+  +V++G   +   + A+KV N           + E E L+ + H+N 
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN- 68

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
             I+ + +  +      K L+ E+   GSL   L +       + L   + + +  DV  
Sbjct: 69  --IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE---PSNAYGLPESEFLIVLRDVVG 123

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLL----DNDMVAHVGDFGLSKFLSSDH-LDTASETPS 220
            + +L  N    +VH +IKP N++     D   V  + DFG ++ L  D    +      
Sbjct: 124 GMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS------ 174

Query: 221 SSIGIKGTVGYVAP 234
               + GT  Y+ P
Sbjct: 175 ----LYGTEEYLHP 184

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  109 bits (274), Expect = 6e-29
 Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 27/186 (14%)

Query: 36  VSYAELSKATCEFSQSN------MIGQGSYGSVYKGIL--GEDEMVVAVKVI--NLKQKG 85
           ++  E+        +         +G G++G+V KG     +    VAVK++        
Sbjct: 1   MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60

Query: 86  AFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDH 145
                +AE   ++ + +  + ++I IC +      +   LV E  E G L  +L Q N H
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYL-QQNRH 113

Query: 146 LEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           +          + +   V+  ++YL   N     VH D+   NVLL     A + DFGLS
Sbjct: 114 V-----KDKNIIELVHQVSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLS 164

Query: 205 KFLSSD 210
           K L +D
Sbjct: 165 KALRAD 170

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  108 bits (273), Expect = 9e-29
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 20/170 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNI 100
           +      +G GS+G V +G         + VAVK +    L Q  A   F+ E  A+ ++
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            HRNL ++  +  +          +V E    GSL D L +   H       L      A
Sbjct: 79  DHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGHF-----LLGTLSRYA 127

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           + VA  + YL        +H D+   N+LL    +  +GDFGL + L  +
Sbjct: 128 VQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  108 bits (271), Expect = 1e-28
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 19/160 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIITI 111
           +G G YG VY+G+  +  + VAVK +    +       F+ E   ++ I+H NL +++ +
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL- 170
           C+           ++ E+M  G+L D+L + N      ++S +  + +A  ++SA+EYL 
Sbjct: 78  CTREPP-----FYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLE 128

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
             N     +H D+   N L+  + +  V DFGLS+ ++ D
Sbjct: 129 KKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  107 bits (270), Expect = 3e-28
 Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 22/166 (13%)

Query: 52  NMIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 105
            +IG+G +G VY G L      ++  AVK   L +    G    F+ E   +++  H N+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDFSHPNV 88

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
             ++ IC    S+G+    +V  YM++G L +++ +   H      ++   +   + VA 
Sbjct: 89  LSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI-RNETH----NPTVKDLIGFGLQVAK 139

Query: 166 AIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            ++YL         VH D+   N +LD      V DFGL++ +   
Sbjct: 140 GMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  107 bits (270), Expect = 5e-28
 Identities = 45/184 (24%), Positives = 78/184 (42%), Gaps = 22/184 (11%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIIT 110
            IG+GS+G        ED     +K IN+ +           E   L N++H N   I+ 
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN---IVQ 87

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
              S +  G+ +  +V +Y E G L   ++     L  F+   I      + +  A++++
Sbjct: 88  YRESFEENGSLY--IVMDYCEGGDLFKRINAQKGVL--FQEDQILD--WFVQICLALKHV 141

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H      ++H DIK  N+ L  D    +GDFG+++ L+S      +          GT  
Sbjct: 142 HDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--------CIGTPY 190

Query: 231 YVAP 234
           Y++P
Sbjct: 191 YLSP 194

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  107 bits (270), Expect = 5e-28
 Identities = 43/190 (22%), Positives = 82/190 (43%), Gaps = 23/190 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRN 104
            +S    IG G    V++  L E + + A+K +NL++       S+  E   L  ++  +
Sbjct: 10  IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
             KII +     +    +  +V E   N  L  WL +         +   +R +   ++ 
Sbjct: 69  -DKIIRLYDYEITDQYIY--MVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNML 118

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            A+  +H +    +VH D+KP+N L+ + M+  + DFG++  +  D      ++      
Sbjct: 119 EAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------ 168

Query: 225 IKGTVGYVAP 234
             GTV Y+ P
Sbjct: 169 QVGTVNYMPP 178

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  109 bits (274), Expect = 6e-28
 Identities = 44/160 (27%), Positives = 84/160 (52%), Gaps = 19/160 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIITI 111
           +G G YG VY+G+  +  + VAVK +    +       F+ E   ++ I+H NL +++ +
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
           C+    +   F  ++ E+M  G+L D+L + N      ++S +  + +A  ++SA+EYL 
Sbjct: 285 CT----REPPFY-IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLE 335

Query: 172 -HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
             N     +H ++   N L+  + +  V DFGLS+ ++ D
Sbjct: 336 KKNF----IHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  107 bits (269), Expect = 6e-28
 Identities = 40/172 (23%), Positives = 81/172 (47%), Gaps = 25/172 (14%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL----GEDEMVVAVKVINLK---QKGAFRSFVAECEALRN 99
           EF +  ++G G++G+VYKG+      + ++ VA+K   L+      A +  + E   + +
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMAS 73

Query: 100 IRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI 159
           + + ++ +++ IC +          L+ + M  G L D++ +  D++    L     +N 
Sbjct: 74  VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNW 122

Query: 160 AIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            + +A  + YL         VH D+   NVL+       + DFGL+K L ++
Sbjct: 123 CVQIAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  107 bits (268), Expect = 7e-28
 Identities = 47/166 (28%), Positives = 71/166 (42%), Gaps = 24/166 (14%)

Query: 54  IGQGSYGSVYKGIL----GEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLT 106
           +G+G +G V              +VAVK   LK          +  E + LR + H ++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           K    C    +       LV EY+  GSL D+L +         + L Q +  A  +   
Sbjct: 97  KYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEG 146

Query: 167 IEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           + YLH  +     +H D+   NVLLDND +  +GDFGL+K +   H
Sbjct: 147 MAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (270), Expect = 8e-28
 Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 22/166 (13%)

Query: 52  NMIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 105
            +IG+G +G VY G L      ++  AVK   L +    G    F+ E   +++  H N+
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQFLTEGIIMKDFSHPNV 152

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
             ++ IC    S+G+    +V  YM++G L +++ +   H      ++   +   + VA 
Sbjct: 153 LSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI-RNETH----NPTVKDLIGFGLQVAK 203

Query: 166 AIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            +++L         VH D+   N +LD      V DFGL++ +   
Sbjct: 204 GMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  108 bits (270), Expect = 9e-28
 Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 25/194 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNL 105
            +  S+++GQG+  +V++G   +   + A+KV N +         + E E L+ + H+N 
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN- 68

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
             I+ + +  +      K L+ E+   GSL   L    +    + L   + + +  DV  
Sbjct: 69  --IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVG 123

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLL----DNDMVAHVGDFGLSKFLSSDH-LDTASETPS 220
            + +L  N    +VH +IKP N++     D   V  + DFG ++ L  D    +      
Sbjct: 124 GMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----- 175

Query: 221 SSIGIKGTVGYVAP 234
                 GT  Y+ P
Sbjct: 176 -----YGTEEYLHP 184

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  106 bits (266), Expect = 1e-27
 Identities = 43/190 (22%), Positives = 82/190 (43%), Gaps = 23/190 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRN 104
            +S    IG G    V++  L E + + A+K +NL++       S+  E   L  ++  +
Sbjct: 29  IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
             KII +     +    +  +V E   N  L  WL +         +   +R +   ++ 
Sbjct: 88  -DKIIRLYDYEITDQYIY--MVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNML 137

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            A+  +H +    +VH D+KP+N L+ + M+  + DFG++  +  D      ++      
Sbjct: 138 EAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------ 187

Query: 225 IKGTVGYVAP 234
             GTV Y+ P
Sbjct: 188 QVGTVNYMPP 197

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  105 bits (264), Expect = 1e-27
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 26/182 (14%)

Query: 37  SYAELSKATCEFSQSNM-----IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRS 89
           S A L   + E    ++     +G G +G V  G     +  VA+K+I    +G+     
Sbjct: 10  STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDE 65

Query: 90  FVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF 149
           F+ E + + N+ H  L ++  +C+           ++ EYM NG L ++L +   H    
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTKQRPI-----FIITEYMANGCLLNYL-REMRH---- 115

Query: 150 KLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS 208
           +    Q + +  DV  A+EYL         +H D+   N L+++  V  V DFGLS+++ 
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171

Query: 209 SD 210
            D
Sbjct: 172 DD 173

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (264), Expect = 2e-27
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 23/163 (14%)

Query: 54  IGQGSYGSVYKGIL--GEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKI 108
           +G G++GSV +G+    + ++ VA+KV  LK   +K      + E + +  + +  + ++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           I +C +      +   LV E    G L  +L          ++ +     +   V+  ++
Sbjct: 76  IGVCQA------EALMLVMEMAGGGPLHKFL-VGKRE----EIPVSNVAELLHQVSMGMK 124

Query: 169 YL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           YL   N     VH D+   NVLL N   A + DFGLSK L +D
Sbjct: 125 YLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  107 bits (268), Expect = 2e-27
 Identities = 42/190 (22%), Positives = 81/190 (42%), Gaps = 23/190 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRN 104
            +S    IG G    V++  L E + + A+K +NL++       S+  E   L  ++  +
Sbjct: 57  IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
             KII +     +    +  +V E   N  L  WL +         +   +R +   ++ 
Sbjct: 116 -DKIIRLYDYEITDQYIY--MVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNML 165

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            A+  +H +    +VH D+KP+N L+ + M+  + DFG++  +  D      ++      
Sbjct: 166 EAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------ 215

Query: 225 IKGTVGYVAP 234
             G V Y+ P
Sbjct: 216 QVGAVNYMPP 225

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  105 bits (265), Expect = 2e-27
 Identities = 55/181 (30%), Positives = 89/181 (49%), Gaps = 26/181 (14%)

Query: 54  IGQGSYGSVYKGIL---GEDEMVVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLT 106
           IG G  G V  G L   G+ ++ VA+K +      +Q+   R F++E   +    H N+ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFLSEASIMGQFDHPNII 113

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           ++  + +           +V EYMENGSL+ +L +T+D     + +++Q V +   V + 
Sbjct: 114 RLEGVVTRGRLA-----MIVTEYMENGSLDTFL-RTHDG----QFTIMQLVGMLRGVGAG 163

Query: 167 IEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           + YL         VH D+   NVL+D+++V  V DFGLS+ L  D  D A  T    I I
Sbjct: 164 MRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPI 218

Query: 226 K 226
           +
Sbjct: 219 R 219

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  106 bits (267), Expect = 2e-27
 Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 26/181 (14%)

Query: 54  IGQGSYGSVYKGIL---GEDEMVVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLT 106
           +G G +G V  G L    + E+ VA+K +      KQ+   R F+ E   +    H N+ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNII 109

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           ++  + +           +V EYMENGSL+ +L + +D     + ++IQ V +   +AS 
Sbjct: 110 RLEGVVTKSKPV-----MIVTEYMENGSLDSFL-RKHDA----QFTVIQLVGMLRGIASG 159

Query: 167 IEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
           ++YL         VH D+   N+L+++++V  V DFGL + L  D  + A  T    I I
Sbjct: 160 MKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-EAAYTTRGGKIPI 214

Query: 226 K 226
           +
Sbjct: 215 R 215

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  107 bits (270), Expect = 2e-27
 Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 22/186 (11%)

Query: 26  TLPMEKQFPMVSYAELSKATCEFSQS-----NMIGQGSYGSVYKGILGEDEMVVAVKVIN 80
             P   +  + +  E  ++    +         IG+G +G V  G    ++  VAVK   
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC-- 223

Query: 81  LKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLH 140
           +K     ++F+AE   +  +RH NL +++ +      +      +V EYM  GSL D+L 
Sbjct: 224 IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLR 279

Query: 141 QTNDHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVG 199
                     L     +  ++DV  A+EYL  +N     VH D+   NVL+  D VA V 
Sbjct: 280 SRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVS 331

Query: 200 DFGLSK 205
           DFGL+K
Sbjct: 332 DFGLTK 337

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  105 bits (263), Expect = 3e-27
 Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 22/166 (13%)

Query: 52  NMIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
            +IG+G +G VY G      ++ +  A+K   L +    +    F+ E   +R + H N+
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKS--LSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
             +I I      +G     ++  YM +G L  ++     +  V  L     ++  + VA 
Sbjct: 85  LALIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVAR 135

Query: 166 AIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            +EYL         VH D+   N +LD      V DFGL++ +   
Sbjct: 136 GMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDR 177

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  104 bits (262), Expect = 3e-27
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 20/162 (12%)

Query: 54  IGQGSYGSVYKGIL---GEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTKII 109
           +G+G +G VY+G+      +++ VAVK             F++E   ++N+ H ++ K+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            I         +   ++ E    G L  +L + N +     L ++  V  ++ +  A+ Y
Sbjct: 80  GIIEE------EPTWIIMELYPYGELGHYL-ERNKN----SLKVLTLVLYSLQICKAMAY 128

Query: 170 L-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           L   NC    VH DI   N+L+ +     +GDFGLS+++  +
Sbjct: 129 LESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  105 bits (264), Expect = 3e-27
 Identities = 51/166 (30%), Positives = 87/166 (52%), Gaps = 26/166 (15%)

Query: 54  IGQGSYGSVYKGIL----GEDEMVVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNL 105
           IG G +G VYKG+L    G+ E+ VA+K +      KQ+     F+ E   +    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDFLGEAGIMGQFSHHNI 108

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            ++  + S           ++ EYMENG+L+ +L +  D     + S++Q V +   +A+
Sbjct: 109 IRLEGVISKYKPM-----MIITEYMENGALDKFL-REKDG----EFSVLQLVGMLRGIAA 158

Query: 166 AIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            ++YL + N     VH D+   N+L+++++V  V DFGLS+ L  D
Sbjct: 159 GMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  105 bits (263), Expect = 3e-27
 Identities = 43/188 (22%), Positives = 80/188 (42%), Gaps = 26/188 (13%)

Query: 41  LSKATCEFSQS-----NMIGQGSYGSVYKGIL----GEDEMVVAVKVINLK-QKGAFRSF 90
           +      F ++      ++G G +G+V+KG+        ++ V +KVI  K  + +F++ 
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV 62

Query: 91  VAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK 150
                A+ ++ H ++ +++ +C            LV +Y+  GSL D + Q    L    
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGALGPQL 116

Query: 151 LSLIQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
           L     +N  + +A  + YL  H      VH ++   NVLL +     V DFG++  L  
Sbjct: 117 L-----LNWGVQIAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPP 167

Query: 210 DHLDTASE 217
           D       
Sbjct: 168 DDKQLLYS 175

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  104 bits (261), Expect = 4e-27
 Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 32/168 (19%)

Query: 54  IGQGSYGSVYKGIL---GEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTK 107
           IG+G +G V++GI        + VA+K    K          F+ E   +R   H ++ K
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 108 IITICSS----IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           +I + +     I          + E    G L  +L Q   +     L L   +  A  +
Sbjct: 81  LIGVITENPVWI----------IMELCTLGELRSFL-QVRKY----SLDLASLILYAYQL 125

Query: 164 ASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           ++A+ YL         VH DI   NVL+ ++    +GDFGLS+++   
Sbjct: 126 STALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  103 bits (260), Expect = 5e-27
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 22/178 (12%)

Query: 34  PMVSYAELSKATCEFSQS-----NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
            + +  E  ++    +         IG+G +G V  G    ++  VAVK   +K     +
Sbjct: 4   SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQ 59

Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEV 148
           +F+AE   +  +RH NL +++ +      +      +V EYM  GSL D+L         
Sbjct: 60  AFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS--- 112

Query: 149 FKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
             L     +  ++DV  A+EYL  +N     VH D+   NVL+  D VA V DFGL+K
Sbjct: 113 -VLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  103 bits (258), Expect = 7e-27
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 21/160 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           IG G +G V+ G    ++  VA+K I    +GA     F+ E E +  + H  L ++  +
Sbjct: 16  IGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL- 170
           C            LV E+ME+G L D+L +T         +    + + +DV   + YL 
Sbjct: 72  CLEQAPI-----CLVTEFMEHGCLSDYL-RTQRG----LFAAETLLGMCLDVCEGMAYLE 121

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
                   +H D+   N L+  + V  V DFG+++F+  D
Sbjct: 122 EACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  102 bits (257), Expect = 1e-26
 Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 21/160 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           +G G +G V  G   + +  VAVK+I    +G+     F  E + +  + H  L K   +
Sbjct: 16  LGSGQFGVVKLGKW-KGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL- 170
           CS           +V EY+ NG L ++L +++       L   Q + +  DV   + +L 
Sbjct: 72  CSKEYPI-----YIVTEYISNGCLLNYL-RSHGK----GLEPSQLLEMCYDVCEGMAFLE 121

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            H      +H D+   N L+D D+   V DFG+++++  D
Sbjct: 122 SHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  102 bits (257), Expect = 1e-26
 Identities = 36/173 (20%), Positives = 77/173 (44%), Gaps = 30/173 (17%)

Query: 54  IGQGSYGSVYKGIL-------GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           +GQG++  ++KG+           E  V +KV++   +    SF      +  + H++L 
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
               +C   D        LV E+++ GSL+ +L + N +     ++++ ++ +A  +A+A
Sbjct: 76  LNYGVCVCGDE-----NILVQEFVKFGSLDTYL-KKNKN----CINILWKLEVAKQLAAA 125

Query: 167 IEYL-HHNCQPPMVHGDIKPSNVLLD--------NDMVAHVGDFGLSKFLSSD 210
           + +L  +      +HG++   N+LL         N     + D G+S  +   
Sbjct: 126 MHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  102 bits (257), Expect = 2e-26
 Identities = 43/185 (23%), Positives = 76/185 (41%), Gaps = 21/185 (11%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR---SFVAECEALRNIRHRNLTKII 109
            IG+G +  VY+     D + VA+K + +      +     + E + L+ + H N   +I
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN---VI 95

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
              +S          +V E  + G L   +        +     +      + + SA+E+
Sbjct: 96  KYYASFIEDNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTVW--KYFVQLCSALEH 151

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           +H      ++H DIKP+NV +    V  +GD GL +F SS      S        + GT 
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--------LVGTP 200

Query: 230 GYVAP 234
            Y++P
Sbjct: 201 YYMSP 205

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  105 bits (262), Expect = 4e-26
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 23/163 (14%)

Query: 54  IGQGSYGSVYKGIL--GEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKI 108
           +G G++GSV +G+    + ++ VA+KV  LK   +K      + E + +  + +  + ++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           I +C +      +   LV E    G L  +L          ++ +     +   V+  ++
Sbjct: 402 IGVCQA------EALMLVMEMAGGGPLHKFL-VGKRE----EIPVSNVAELLHQVSMGMK 450

Query: 169 YL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           YL   N     VH ++   NVLL N   A + DFGLSK L +D
Sbjct: 451 YLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  102 bits (256), Expect = 5e-26
 Identities = 40/192 (20%), Positives = 78/192 (40%), Gaps = 17/192 (8%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITI 111
           ++ +G +  VY+          A+K +   ++   R+ + E   ++ +  H N   I+  
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN---IVQF 91

Query: 112 CSSI-----DSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           CS+      +S     + L+   +  G L ++L +         LS    + I      A
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR---GPLSCDTVLKIFYQTCRA 148

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS---- 222
           ++++H   +PP++H D+K  N+LL N     + DFG +  +S     + S    +     
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 223 IGIKGTVGYVAP 234
           I    T  Y  P
Sbjct: 208 ITRNTTPMYRTP 219

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  104 bits (261), Expect = 6e-26
 Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 24/164 (14%)

Query: 54  IGQGSYGSVYKGIL---GEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTK 107
           IG+G +G V++GI        M VA+K    K          F+ E   +R   H ++ K
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +I + +       +   ++ E    G L  +L Q         L L   +  A  +++A+
Sbjct: 456 LIGVIT------ENPVWIIMELCTLGELRSFL-QVRKF----SLDLASLILYAYQLSTAL 504

Query: 168 EYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            YL         VH DI   NVL+ ++    +GDFGLS+++   
Sbjct: 505 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  100 bits (252), Expect = 8e-26
 Identities = 38/160 (23%), Positives = 83/160 (51%), Gaps = 21/160 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRNIRHRNLTKIITI 111
           +G G +G V+ G        VAVK +    +G+    +F+AE   ++ ++H+ L ++  +
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL- 170
            +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++ 
Sbjct: 77  VTQ------EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE 126

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
             N     +H D++ +N+L+ + +   + DFGL++ +  +
Sbjct: 127 ERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  103 bits (258), Expect = 1e-25
 Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 26/193 (13%)

Query: 26  TLPMEKQFPMVSYAELSKATCEFSQS-----NMIGQGSYGSVYKGILGEDEMVVAVKVIN 80
           T       P      L+K   E  +        +GQG +G V+ G        VA+K   
Sbjct: 244 TTVCPTSKPQTQG--LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKT-- 298

Query: 81  LKQKGAFR-SFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL 139
           LK       +F+ E + ++ +RH  L ++  + S       +   +V EYM  GSL D+L
Sbjct: 299 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL 352

Query: 140 HQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHV 198
                      L L Q V++A  +AS + Y+   N     VH D++ +N+L+  ++V  V
Sbjct: 353 KGETGK----YLRLPQLVDMAAQIASGMAYVERMNY----VHRDLRAANILVGENLVCKV 404

Query: 199 GDFGLSKFLSSDH 211
            DFGL++ +  + 
Sbjct: 405 ADFGLARLIEDNE 417

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  100 bits (252), Expect = 1e-25
 Identities = 36/165 (21%), Positives = 74/165 (44%), Gaps = 24/165 (14%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 105
           +GQGS+G VY+G+       E E  VA+K   + +         F+ E   ++     ++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKT--VNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWL----HQTNDHLEVFKLSLIQRVNIAI 161
            +++ + S           ++ E M  G L+ +L        ++  +   SL + + +A 
Sbjct: 91  VRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 162 DVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           ++A  + YL+ +      VH D+   N ++  D    +GDFG+++
Sbjct: 146 EIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTR 186

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  102 bits (256), Expect = 2e-25
 Identities = 34/158 (21%), Positives = 73/158 (46%), Gaps = 17/158 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G +G V+          VAVK +      +  +F+AE   ++ ++H  L K+  + +
Sbjct: 196 LGAGQFGEVWMATY-NKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL-HH 172
                  +   ++ E+M  GSL D+L          K  L + ++ +  +A  + ++   
Sbjct: 254 K------EPIYIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           N     +H D++ +N+L+   +V  + DFGL++ +  +
Sbjct: 304 NY----IHRDLRAANILVSASLVCKIADFGLARVIEDN 337

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  102 bits (255), Expect = 2e-25
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 19/160 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHRNLTKIITIC 112
           +GQG +G V+ G        VA+K   LK       +F+ E + ++ +RH  L ++  + 
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH- 171
           S       +   +V EYM  GSL D+L           L L Q V++A  +AS + Y+  
Sbjct: 249 SE------EPIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVER 298

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
            N     VH D++ +N+L+  ++V  V DFGL++ +  + 
Sbjct: 299 MNY----VHRDLRAANILVGENLVCKVADFGLARLIEDNE 334

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  100 bits (250), Expect = 3e-25
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 24/166 (14%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G++G V+          +D+M+VAVK +    + A + F  E E L  ++H+++ + 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWL---------HQTNDHLEVFKLSLIQRVNI 159
             +C+           +VFEYM +G L  +L             + +    L L Q + +
Sbjct: 109 FGVCTEGRP-----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 160 AIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           A  VA+ + YL   +     VH D+   N L+   +V  +GDFG+S
Sbjct: 164 ASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMS 205

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  102 bits (256), Expect = 3e-25
 Identities = 41/187 (21%), Positives = 73/187 (39%), Gaps = 32/187 (17%)

Query: 53  MIGQGSYGSVYKGILGEDEMV----VAVKVINLKQKGAFRS-FVAECEALRNIRHRNLTK 107
            I  G  G +Y   L  D  V    V +K +        ++  +AE + L  + H ++ +
Sbjct: 87  CIAHGGLGWIY---LALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           I       D  G     +V EY+   SL+    Q        KL + + +   +++  A+
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPAL 195

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
            YLH      +V+ D+KP N++L  + +  + D G    +               +   G
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI----------NSFGYLY--G 239

Query: 228 TVGYVAP 234
           T G+ AP
Sbjct: 240 TPGFQAP 246

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 98.9 bits (247), Expect = 4e-25
 Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 20/183 (10%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           ++G+G+YG VY G    +++ +A+K I  +     +    E    ++++H+N+ + +   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                    F  +  E +  GSL   L      L+  +   I        +   ++YLH 
Sbjct: 88  ----FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIG--FYTKQILEGLKYLHD 140

Query: 173 NCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
           N    +VH DIK  NVL++    V  + DFG SK L+  +  T +          GT+ Y
Sbjct: 141 NQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--------FTGTLQY 189

Query: 232 VAP 234
           +AP
Sbjct: 190 MAP 192

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 99.3 bits (248), Expect = 5e-25
 Identities = 49/224 (21%), Positives = 83/224 (37%), Gaps = 32/224 (14%)

Query: 14  VRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMV 73
           V  RG   + + +   +   P   + +       F + + +G GSYG V+K    ED  +
Sbjct: 31  VSFRGEASETLQSPGYDPSRPESFFQQ------SFQRLSRLGHGSYGEVFKVRSKEDGRL 84

Query: 74  VAVKVINLKQKGAF--RSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYM 130
            AVK      +G       +AE  +   + +H    ++     + +  G  +  L  E  
Sbjct: 85  YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE---QAWEEGGILY--LQTELC 139

Query: 131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
              SL+         L   ++          D   A+ +LH      +VH D+KP+N+ L
Sbjct: 140 G-PSLQQHCEAWGASLPEAQVW-----GYLRDTLLALAHLHSQ---GLVHLDVKPANIFL 190

Query: 191 DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
                  +GDFGL   L          T  +    +G   Y+AP
Sbjct: 191 GPRGRCKLGDFGLLVELG---------TAGAGEVQEGDPRYMAP 225

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  101 bits (253), Expect = 5e-25
 Identities = 44/188 (23%), Positives = 71/188 (37%), Gaps = 22/188 (11%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLTKII-T 110
            +G G +G V + I  +    VA+K    +     R     E + ++ + H N+      
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
                     D   L  EY E G L  +L   N       L       +  D++SA+ YL
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 171 HHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSKFLSSDH-LDTASETPSSSIGIK 226
           H N    ++H D+KP N++L      ++  + D G +K L                    
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----------V 184

Query: 227 GTVGYVAP 234
           GT+ Y+AP
Sbjct: 185 GTLQYLAP 192

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 98.1 bits (245), Expect = 9e-25
 Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 25/173 (14%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G++G V+          +D+M+VAVK +      A + F  E E L N++H ++ K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQTNDHLEVFKLSLIQRVN 158
             +C   D        +VFEYM++G L  +L                    +L L Q ++
Sbjct: 83  YGVCGDGDP-----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 159 IAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
           IA  +AS + YL   +     VH D+   N L+  +++  +GDFG+S+ + S 
Sbjct: 138 IASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  100 bits (250), Expect = 1e-24
 Identities = 47/195 (24%), Positives = 86/195 (44%), Gaps = 31/195 (15%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRN 104
            F   +++G G+ G++    + ++  V AVK I  +    A R    E + LR    H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDV-AVKRILPECFSFADR----EVQLLRESDEHPN 79

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           + +    C+  D     F+ +  E     +L++++ Q +     F    ++ + +     
Sbjct: 80  VIRYF--CTEKDR---QFQYIAIELCA-ATLQEYVEQKD-----FAHLGLEPITLLQQTT 128

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDN-----DMVAHVGDFGLSKFLSSDHLDTASETP 219
           S + +LH      +VH D+KP N+L+        + A + DFGL K L+         + 
Sbjct: 129 SGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG-----RHSF 180

Query: 220 SSSIGIKGTVGYVAP 234
           S   G+ GT G++AP
Sbjct: 181 SRRSGVPGTEGWIAP 195

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 98.3 bits (245), Expect = 2e-24
 Identities = 44/188 (23%), Positives = 71/188 (37%), Gaps = 23/188 (12%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
            +    +G+GS+G V++    +     AVK + L+        V E  A   +    +  
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVP 114

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +         +   +  +  E +E GSL   + Q                         +
Sbjct: 115 LYGAV-----REGPWVNIFMELLEGGSLGQLIKQMG----CLPEDRAL--YYLGQALEGL 163

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDND-MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           EYLH      ++HGD+K  NVLL +D   A + DFG +  L  D L  +  T      I 
Sbjct: 164 EYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY---IP 217

Query: 227 GTVGYVAP 234
           GT  ++AP
Sbjct: 218 GTETHMAP 225

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 97.8 bits (244), Expect = 2e-24
 Identities = 40/170 (23%), Positives = 78/170 (45%), Gaps = 24/170 (14%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +G G++G VY+G +         + VAVK   L +  + +    F+ E   +    H+N+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQT-NDHLEVFKLSLIQRVNIAIDVA 164
            + I +      +      ++ E M  G L+ +L +T     +   L+++  +++A D+A
Sbjct: 96  VRCIGVSLQSLPR-----FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 165 SAIEYL-HHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSD 210
              +YL  ++     +H DI   N LL       VA +GDFG+++ +   
Sbjct: 151 CGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 97.9 bits (244), Expect = 3e-24
 Identities = 37/200 (18%), Positives = 75/200 (37%), Gaps = 38/200 (19%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-----------------ECEA 96
           + QG +  +      +D    A+K          R F                   E + 
Sbjct: 39  LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 97  LRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL--HQTNDHLEVFKLSLI 154
           + +I++        I   I +    +  +++EYMEN S+  +       D      + + 
Sbjct: 97  ITDIKNEYCLTCEGI---ITNYDEVY--IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDT 214
               I   V ++  Y+H+  +  + H D+KPSN+L+D +    + DFG S+++    +  
Sbjct: 152 VIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209

Query: 215 ASETPSSSIGIKGTVGYVAP 234
           +          +GT  ++ P
Sbjct: 210 S----------RGTYEFMPP 219

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 96.6 bits (241), Expect = 6e-24
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 28/171 (16%)

Query: 52  NMIGQGSYGSVYKGIL--GEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNL 105
           ++IG+G++G V K  +      M  A+K   +K+   K   R F  E E L  +  H N+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQTNDHLEVFKLSLIQ 155
             ++  C            L  EY  +G+L D+L               +     LS  Q
Sbjct: 89  INLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 156 RVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
            ++ A DVA  ++YL         +H D+   N+L+  + VA + DFGLS+
Sbjct: 144 LLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR 190

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 95.7 bits (239), Expect = 7e-24
 Identities = 40/170 (23%), Positives = 69/170 (40%), Gaps = 30/170 (17%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 105
           +G+  +G VYKG L     GE    VA+K   LK          F  E      ++H N+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQTNDHLEVFKLSLIQ 155
             ++ + +          +++F Y  +G L ++L             +D      L    
Sbjct: 75  VCLLGVVTKDQPL-----SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 156 RVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
            V++   +A+ +EYL  H+     VH D+   NVL+ + +   + D GL 
Sbjct: 130 FVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLF 175

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 97.0 bits (241), Expect = 7e-24
 Identities = 25/247 (10%), Positives = 54/247 (21%), Gaps = 40/247 (16%)

Query: 13  YVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEM 72
            ++   ++ + +      +       + LS+   +      +  G    V+     E   
Sbjct: 29  ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88

Query: 73  VVAVKVINLKQK---GAFRSFVAECEALRNIRHRNLT---------------------KI 108
             A+KV  +  +              A   +   +                         
Sbjct: 89  DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEV-FKLSLIQRVNIAIDVASAI 167
             +    D        L+        LE      +          ++    +   +    
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
             L       +VHG   P N+ +  D    +GD                 T   +     
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW---------KVGTRGPASS--V 253

Query: 228 TVGYVAP 234
            V Y   
Sbjct: 254 PVTYAPR 260

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 95.8 bits (239), Expect = 9e-24
 Identities = 45/211 (21%), Positives = 87/211 (41%), Gaps = 36/211 (17%)

Query: 25  DTLPMEKQFPMVSYA----ELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVA 75
           D LP+++    + Y     E  +   +  +   +G+G++G V +              VA
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVA 61

Query: 76  VKVINLKQK---GAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYME 131
           VK+  LK+       R+ ++E + L +I  H N+  ++  C+           ++ E+ +
Sbjct: 62  VKM--LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP----LMVIVEFCK 115

Query: 132 NGSLEDWL----------HQTNDHLEVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVH 180
            G+L  +L              + L    L+L   +  +  VA  +E+L    C    +H
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC----IH 171

Query: 181 GDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
            D+   N+LL    V  + DFGL++ +  D 
Sbjct: 172 RDLAARNILLSEKNVVKICDFGLARDIYKDP 202

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 95.9 bits (239), Expect = 2e-23
 Identities = 40/170 (23%), Positives = 78/170 (45%), Gaps = 24/170 (14%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS---FVAECEALRNIRHRNL 105
           +G G++G VY+G +         + VAVK   L +  + +    F+ E   +    H+N+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQT-NDHLEVFKLSLIQRVNIAIDVA 164
            + I +      +      ++ E M  G L+ +L +T     +   L+++  +++A D+A
Sbjct: 137 VRCIGVSLQSLPR-----FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 165 SAIEYL-HHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSD 210
              +YL  ++     +H DI   N LL       VA +GDFG+++ +   
Sbjct: 192 CGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 95.8 bits (238), Expect = 2e-23
 Identities = 40/237 (16%), Positives = 80/237 (33%), Gaps = 36/237 (15%)

Query: 19  SVRKPIDTLPMEKQFP-----MVSYAELSKATCEFSQSNMIGQGSYGSVYKGILG----- 68
            + KP+ + P   ++      +    E    +      +++G+G++  VY+   G     
Sbjct: 33  GLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDA 92

Query: 69  EDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFE 128
           +++    +KV        F       E L+          +   S+   +  +   LV E
Sbjct: 93  KNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM---FMKFYSAHLFQ--NGSVLVGE 147

Query: 129 YMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV 188
               G+L + ++   +  E   +     ++ A+ +   IE +H      ++HGDIKP N 
Sbjct: 148 LYSYGTLLNAINLYKNTPEK-VMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNF 203

Query: 189 LLDNDMVAHVG-----------DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +L N  +               D G S  +      T             T G+   
Sbjct: 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA------KCETSGFQCV 254

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.9 bits (234), Expect = 4e-23
 Identities = 36/166 (21%), Positives = 71/166 (42%), Gaps = 21/166 (12%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           +     +G G++G VYK    E   + A KVI  K +     ++ E E L    H  + K
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 108 IITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           ++         GA +      ++ E+   G+++  + + +  L   ++ ++ R      +
Sbjct: 81  LL---------GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QM 126

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
             A+ +LH      ++H D+K  NVL+  +    + DFG+S     
Sbjct: 127 LEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 93.8 bits (234), Expect = 4e-23
 Identities = 42/180 (23%), Positives = 72/180 (40%), Gaps = 40/180 (22%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGA----FRSFVAECEALRNIRHRN 104
           +G+G +G V K              VAVK+  LK + A     R  ++E   L+ + H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LK-ENASPSELRDLLSEFNVLKQVNHPH 87

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWL------------------HQTNDHL 146
           + K+   CS           L+ EY + GSL  +L                    + DH 
Sbjct: 88  VIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 147 EVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +   L++   ++ A  ++  ++YL         VH D+   N+L+       + DFGLS+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR 198

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 93.5 bits (233), Expect = 6e-23
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 13/175 (7%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA-FRSFVAECEALRNIRHRNLTKIITIC 112
           IG G+   V        +  VA+K INL++        + E +A+    H N+       
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY--YT 80

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI---DVASAIEY 169
           S +     +   LV + +  GS+ D +       E     L +   IA    +V   +EY
Sbjct: 81  SFV--VKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVLEGLEY 136

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
           LH N Q   +H D+K  N+LL  D    + DFG+S FL++    T ++   + +G
Sbjct: 137 LHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 93.2 bits (232), Expect = 7e-23
 Identities = 45/219 (20%), Positives = 84/219 (38%), Gaps = 52/219 (23%)

Query: 42  SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF--RSFVAECEALRN 99
           S+ T EF +   IG G +GSV+K +   D  + A+K       G+   ++ + E  A   
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 100 I-RHRNLTKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLI 154
           + +H ++ +            A  +     +  EY   GSL D + +    +  FK + +
Sbjct: 67  LGQHSHVVRY---------FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117

Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV---------------- 198
           +  ++ + V   + Y+H      +VH DIKPSN+ +    + +                 
Sbjct: 118 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172

Query: 199 ---GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
              GD G    +SS  +             +G   ++A 
Sbjct: 173 FKIGDLGHVTRISSPQV------------EEGDSRFLAN 199

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 94.1 bits (234), Expect = 1e-22
 Identities = 44/202 (21%), Positives = 76/202 (37%), Gaps = 32/202 (15%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALR-NIRHRNLT 106
                ++G GS G+V      +   V AVK +           + E + L  +  H N  
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPV-AVKRML---IDFCDIALMEIKLLTESDDHPN-- 70

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE-VFKLSLIQRVNIAIDVAS 165
            +I    S  +    F  +  E     +L+D +   N   E +        +++   +AS
Sbjct: 71  -VIRYYCSETTD--RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDN-------------DMVAHVGDFGLSKFLSSDHL 212
            + +LH      ++H D+KP N+L+               ++   + DFGL K L S   
Sbjct: 127 GVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ- 182

Query: 213 DTASETPSSSIGIKGTVGYVAP 234
              S   ++     GT G+ AP
Sbjct: 183 ---SSFRTNLNNPSGTSGWRAP 201

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 92.7 bits (231), Expect = 2e-22
 Identities = 38/174 (21%), Positives = 75/174 (43%), Gaps = 33/174 (18%)

Query: 54  IGQGSYGSVYKGIL-------GEDEMVVAVKVINLKQK---GAFRSFVAECEALRNI-RH 102
           +G+G++G V             ++ + VAVK+  LK           V+E E ++ I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQTNDHLEVFKLS 152
           +N+  ++  C+           ++ EY   G+L ++L              + +   +++
Sbjct: 101 KNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 153 LIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
               V+    +A  +EYL    C    +H D+   NVL+  + V  + DFGL++
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.9 bits (229), Expect = 2e-22
 Identities = 36/174 (20%), Positives = 69/174 (39%), Gaps = 35/174 (20%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGA----FRSFVAECEALRNI-RHR 103
           +G G++G V +         +  M VAVK++      A      + ++E + L  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL------------HQTNDHLEVFKL 151
           N+  ++  C+           ++ EY   G L ++L                   +   L
Sbjct: 88  NIVNLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 152 SLIQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
            L   ++ +  VA  + +L   NC    +H D+   N+LL +  +  + DFGL+
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA 192

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.0 bits (229), Expect = 3e-22
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 38/179 (21%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNL 105
           IG+G++G V++         E   +VAVK+  LK+         F  E   +    + N+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDNPNI 112

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWL------------------HQTNDHLE 147
            K++ +C+           L+FEYM  G L ++L                          
Sbjct: 113 VKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 148 VFKLSLIQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
              LS  +++ IA  VA+ + YL         VH D+   N L+  +MV  + DFGLS+
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSR 222

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 92.3 bits (230), Expect = 3e-22
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 15/180 (8%)

Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL-KQKGAF 87
           M KQ+  V      + +  + +   IGQG++G V+K    +    VA+K + +  +K  F
Sbjct: 1   MAKQYDSVECPFCDEVSK-YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59

Query: 88  RSF-VAECEALRNIRHRNLTKIITICSSIDSKGADFKA---LVFEYMENGSLEDWLHQTN 143
               + E + L+ ++H N+  +I IC +  S     K    LVF++ E+  L   L    
Sbjct: 60  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL 118

Query: 144 DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
                F LS I+   +   + + + Y+H N    ++H D+K +NVL+  D V  + DFGL
Sbjct: 119 VK---FTLSEIK--RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 90.8 bits (226), Expect = 4e-22
 Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 23/167 (13%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           +++   IGQG+ G+VY  +       VA++ +NL+Q+      + E   +R  ++ N+  
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 108 IITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            +          +        +V EY+  GSL D + +T        +   Q   +  + 
Sbjct: 82  YL---------DSYLVGDELWVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCREC 125

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
             A+E+LH N    ++H DIK  N+LL  D    + DFG    ++ +
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 90.8 bits (226), Expect = 8e-22
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 31/170 (18%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGA----FRSFVAECEALRNI-RHR 103
           +G G++G V +         +  + VAVK+  LK   A      + ++E + + ++ +H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LK-STAHADEKEALMSELKIMSHLGQHE 110

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF--------KLSLIQ 155
           N+  ++  C+     G     ++ EY   G L ++L + +  LE            S   
Sbjct: 111 NIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 156 RVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
            ++ +  VA  + +L   NC    +H D+   NVLL N  VA +GDFGL+
Sbjct: 166 LLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLA 211

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 91.6 bits (227), Expect = 8e-22
 Identities = 31/245 (12%), Positives = 71/245 (28%), Gaps = 40/245 (16%)

Query: 15  RRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVV 74
             + +    + T       P    +EL +      +  ++GQ    +  +    E     
Sbjct: 42  YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101

Query: 75  AVKVINLKQKGA----------------FRSFVAECEALRNIRHRNLTKIITICSS---- 114
            V V    ++                   R    + +A  ++R      ++         
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161

Query: 115 ---IDSKGADFKALVFEYM-ENGSLEDWLHQTNDHLEV-FKLSLIQRVNIAIDVASAIEY 169
              +D +     +  F Y     +L+ +      H      L    R+ + + V   +  
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
           LHH     +VH  ++P +++LD      +  F       +  + +             + 
Sbjct: 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS------------VSR 266

Query: 230 GYVAP 234
           G+  P
Sbjct: 267 GFEPP 271

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 90.9 bits (226), Expect = 1e-21
 Identities = 39/175 (22%), Positives = 75/175 (42%), Gaps = 35/175 (20%)

Query: 54  IGQGSYGSVYKGIL-------GEDEMVVAVKVINLKQKGA----FRSFVAECEALRNI-R 101
           +G+G +G V             ++ + VAVK+  LK   A        V+E E ++ I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LK-DDATEKDLSDLVSEMEMMKMIGK 145

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQTNDHLEVFKL 151
           H+N+  ++  C+           ++ EY   G+L ++L              + +   ++
Sbjct: 146 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 152 SLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           +    V+    +A  +EYL    C    +H D+   NVL+  + V  + DFGL++
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 251

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 90.5 bits (225), Expect = 1e-21
 Identities = 39/167 (23%), Positives = 70/167 (41%), Gaps = 23/167 (13%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
                 IG+GS G V           VAVK+++L+++        E   +R+ +H N+ +
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 108 IITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           +           +        ++ E+++ G+L D + Q        +L+  Q   +   V
Sbjct: 107 MY---------KSYLVGEELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAV 150

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
             A+ YLH      ++H DIK  ++LL  D    + DFG    +S D
Sbjct: 151 LQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 89.6 bits (223), Expect = 1e-21
 Identities = 52/191 (27%), Positives = 79/191 (41%), Gaps = 33/191 (17%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ---------KGAFRSFVAECEALRNI-RHR 103
           +G+G    V + I        AVK+I++           +    + + E + LR +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N   II +  + ++    F  LVF+ M+ G L D+L       E   LS  +   I   +
Sbjct: 85  N---IIQLKDTYETNTFFF--LVFDLMKKGELFDYL------TEKVTLSEKETRKIMRAL 133

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
              I  LH      +VH D+KP N+LLD+DM   + DFG S  L                
Sbjct: 134 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR--------- 181

Query: 224 GIKGTVGYVAP 234
            + GT  Y+AP
Sbjct: 182 EVCGTPSYLAP 192

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 89.7 bits (223), Expect = 3e-21
 Identities = 42/175 (24%), Positives = 72/175 (41%), Gaps = 35/175 (20%)

Query: 54  IGQGSYGSVYKGIL-------GEDEMVVAVKVINLKQKGA----FRSFVAECEALRNI-R 101
           +G+G++G V                  VAVK++      A        ++E E ++ I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL----------HQTNDHLEVFKL 151
           H+N+  ++  C+           ++ EY   G+L ++L               H    +L
Sbjct: 134 HKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 152 SLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           S    V+ A  VA  +EYL    C    +H D+   NVL+  D V  + DFGL++
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 239

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 88.8 bits (221), Expect = 3e-21
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 27/184 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++  V+         + A+K I         S   E   L+ I+H N   I+T+  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN---IVTLED 73

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             +S    +  LV + +  G L D +      LE    +      +   V SA++YLH N
Sbjct: 74  IYESTTHYY--LVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 174 CQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
               +VH D+KP N+L    + +    + DFGLSK   +  + TA           GT G
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----------GTPG 172

Query: 231 YVAP 234
           YVAP
Sbjct: 173 YVAP 176

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 90.1 bits (223), Expect = 3e-21
 Identities = 30/207 (14%), Positives = 57/207 (27%), Gaps = 35/207 (16%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQK---GAFRSFVAECEALRNIRH------- 102
           ++GQ    +  +    E      V V    ++    A +    E   LR +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 103 ---------RNLTKIITICSSIDSKGADFKALVFEY-----MENGSLEDWLHQTNDHLEV 148
                     +L K       I  +  +    V            +L+ +      H   
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 149 FK-LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
            K L    R+ + + V   +  LHH     +VH  ++P +++LD      +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 208 SSDHLDTASETPSSSIGIKGTVGYVAP 234
            +  +                    A 
Sbjct: 262 GASAVSPIGRGF-------APPETTAE 281

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 88.9 bits (221), Expect = 4e-21
 Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 40/179 (22%)

Query: 54  IGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGA----FRSFVAECEALRNI-RHR 103
           +G G++G V              + VAVK+  LK + A      + ++E + +  +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKM--LK-EKADSSEREALMSELKMMTQLGSHE 109

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWL-----------------HQTNDHL 146
           N+  ++  C+           L+FEY   G L ++L                  +  +  
Sbjct: 110 NIVNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 147 EVFKLSLIQRVNIAIDVASAIEYL-HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
           ++  L+    +  A  VA  +E+L   +C    VH D+   NVL+ +  V  + DFGL+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLA 219

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 88.0 bits (219), Expect = 5e-21
 Identities = 36/187 (19%), Positives = 71/187 (37%), Gaps = 29/187 (15%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKII 109
            +G+G +   ++    + + V A K++    L +         E    R++ H++   ++
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH---VV 78

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
                 +     F  +V E     SL +   +         L+  +       +    +Y
Sbjct: 79  GFHGFFEDNDFVF--VVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQY 130

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH--LDTASETPSSSIGIKG 227
           LH N    ++H D+K  N+ L+ D+   +GDFGL+  +  D         TP+       
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------- 180

Query: 228 TVGYVAP 234
              Y+AP
Sbjct: 181 ---YIAP 184

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 88.2 bits (219), Expect = 5e-21
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           F     +G+GSYGSVYK I  E   +VA+K + ++     +  + E   ++     ++ K
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88

Query: 108 IITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
                      G+ FK     +V EY   GS+ D +   N  L   +++ I +       
Sbjct: 89  YY---------GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ-----ST 134

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
              +EYLH       +H DIK  N+LL+ +  A + DFG++  L+ 
Sbjct: 135 LKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.7 bits (218), Expect = 6e-21
 Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 51/209 (24%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN----LKQKGAFRSFVA----------------- 92
           IG+GSYG V       D    A+KV++    ++Q G  R                     
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 93  -----ECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE 147
                E   L+ + H N+ K++ +   +D    D   +VFE +  G + +          
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLK----- 132

Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
              LS  Q      D+   IEYLH+     ++H DIKPSN+L+  D    + DFG+S   
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 208 SSDH--LDTASETPSSSIGIKGTVGYVAP 234
                 L     TP+          ++AP
Sbjct: 188 KGSDALLSNTVGTPA----------FMAP 206

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.0 bits (219), Expect = 7e-21
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 10/164 (6%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNL 105
           +F Q   +G G+Y +VYKG+     + VA+K + L  + G   + + E   ++ ++H N 
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN- 64

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
             I+ +   I ++      LVFE+M+N  L+ ++           L L         +  
Sbjct: 65  --IVRLYDVIHTENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
            + + H N    ++H D+KP N+L++      +GDFGL++    
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 88.1 bits (219), Expect = 8e-21
 Identities = 36/187 (19%), Positives = 71/187 (37%), Gaps = 29/187 (15%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKII 109
            +G+G +   ++    + + V A K++    L +         E    R++ H++   ++
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH---VV 104

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
                 +     F  +V E     SL +   +         L+  +       +    +Y
Sbjct: 105 GFHGFFEDNDFVF--VVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQY 156

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH--LDTASETPSSSIGIKG 227
           LH N    ++H D+K  N+ L+ D+   +GDFGL+  +  D                + G
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----------LCG 203

Query: 228 TVGYVAP 234
           T  Y+AP
Sbjct: 204 TPNYIAP 210

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 88.2 bits (219), Expect = 8e-21
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 12/165 (7%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLT 106
           F    ++G G+YG VYKG   +   + A+KV+++           E   L+    HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 84

Query: 107 KIITICSSIDSKGADFKA-LVFEYMENGSLEDWLHQTNDH-LEVFKLSLIQRVNIAIDVA 164
                    +  G D +  LV E+   GS+ D +  T  + L+   ++ I R     ++ 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EIL 139

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
             + +LH +    ++H DIK  NVLL  +    + DFG+S  L  
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 88.6 bits (220), Expect = 1e-20
 Identities = 54/195 (27%), Positives = 81/195 (41%), Gaps = 41/195 (21%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA---------ECEALRNIRHRN 104
           +G G+ G V      +    VA+++I+ K+K A  S            E E L+ + H  
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV--NIAID 162
              II I +  D++      +V E ME G L D +        V    L +         
Sbjct: 202 ---IIKIKNFFDAE---DYYIVLELMEGGELFDKV--------VGNKRLKEATCKLYFYQ 247

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETP 219
           +  A++YLH N    ++H D+KP NVLL   + D +  + DFG SK L    L       
Sbjct: 248 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR----- 299

Query: 220 SSSIGIKGTVGYVAP 234
                + GT  Y+AP
Sbjct: 300 ----TLCGTPTYLAP 310

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 87.6 bits (217), Expect = 1e-20
 Identities = 47/245 (19%), Positives = 84/245 (34%), Gaps = 63/245 (25%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEAL-------- 97
           +F     +G+G +G V++     D+   A+K I L  ++ A    + E +AL        
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 98  ---------------RNIRHRNLTKIITICSSIDSKGADFKA------------------ 124
                          +        K  +    + S                         
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 125 -----------LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                      +  +     +L+DW+++     +  +  +     I I +A A+E+LH  
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED-REHGVCLH--IFIQIAEAVEFLHSK 183

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK----GTV 229
               ++H D+KPSN+    D V  VGDFGL   +  D  +    TP  +        GT 
Sbjct: 184 G---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 230 GYVAP 234
            Y++P
Sbjct: 241 LYMSP 245

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 88.0 bits (218), Expect = 1e-20
 Identities = 34/178 (19%), Positives = 63/178 (35%), Gaps = 20/178 (11%)

Query: 54  IGQG--SYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
           IG+G     +V           V V+ INL+            E    +   H N+    
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY- 91

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQT-NDHLEVFKLSLIQRVNIAIDVASAIE 168
              + I     +   +V  +M  GS +D +     D +    ++ I +      V  A++
Sbjct: 92  -RATFI--ADNEL-WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ-----GVLKALD 142

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHL--DTASETPSSSIG 224
           Y+HH      VH  +K S++L+  D   ++     +  + S         + P  S+ 
Sbjct: 143 YIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.3 bits (217), Expect = 2e-20
 Identities = 45/166 (27%), Positives = 86/166 (51%), Gaps = 19/166 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNL 105
            + + + +G+G+Y +VYKG     + +VA+K I L+ + GA  + + E   L++++H N 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN- 61

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF--KLSLIQRVNIAIDV 163
             I+T+   I ++ +    LVFEY++   L+ +L    + + +   KL L Q +      
Sbjct: 62  --IVTLHDIIHTEKSLT--LVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL------ 110

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
              + Y H      ++H D+KP N+L++      + DFGL++  S 
Sbjct: 111 -RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 87.0 bits (216), Expect = 2e-20
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 30/170 (17%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLT 106
           F++   IG+GS+G V+KGI    + VVA+K+I+L++ +        E   L       +T
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 107 KIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI- 161
           K           G+  K     ++ EY+  GS  D          + +   +    IA  
Sbjct: 84  K---------YYGSYLKDTKLWIIMEYLGGGSALD----------LLEPGPLDETQIATI 124

Query: 162 --DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
             ++   ++YLH       +H DIK +NVLL       + DFG++  L+ 
Sbjct: 125 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 87.5 bits (217), Expect = 2e-20
 Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 32/190 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA--------ECEALRNIR-HRN 104
           IG+G    V + +        AVK++ +  +      +         E   LR +  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
              IIT+  S +S    F  LVF+ M  G L D+L       E   LS  +  +I   + 
Sbjct: 162 ---IITLIDSYESSSFMF--LVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLL 210

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            A+ +LH N    +VH D+KP N+LLD++M   + DFG S  L                 
Sbjct: 211 EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---------E 258

Query: 225 IKGTVGYVAP 234
           + GT GY+AP
Sbjct: 259 LCGTPGYLAP 268

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 86.5 bits (215), Expect = 2e-20
 Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 27/186 (14%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKI 108
             +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++RH N   I
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN---I 71

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           + +          +  L+ EY   G++   L + +      K    +      ++A+A+ 
Sbjct: 72  LRLYGYFHDATRVY--LILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALS 123

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           Y H      ++H DIKP N+LL +     + DFG S    S                 GT
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----------GT 170

Query: 229 VGYVAP 234
           + Y+ P
Sbjct: 171 LDYLPP 176

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 86.1 bits (214), Expect = 3e-20
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 30/187 (16%)

Query: 54  IGQGSYGSVYKG---ILGEDEMVVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLTK 107
           +G G   +VY     IL      VA+K I    ++K      F  E      + H+N   
Sbjct: 19  LGGGGMSTVYLAEDTILNIK---VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN--- 72

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           I+++    +     +  LV EY+E  +L +++           LS+   +N    +   I
Sbjct: 73  IVSMIDVDEEDDCYY--LVMEYIEGPTLSEYIESH------GPLSVDTAINFTNQILDGI 124

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           ++ H      +VH DIKP N+L+D++    + DFG++K LS   L     T ++   + G
Sbjct: 125 KHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----TQTNH--VLG 174

Query: 228 TVGYVAP 234
           TV Y +P
Sbjct: 175 TVQYFSP 181

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.6 bits (215), Expect = 3e-20
 Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 21/190 (11%)

Query: 50  QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-ECEALRNIR-HRNLTK 107
           Q +++G+G++  V   I        AVK+I  KQ G  RS V  E E L   + HRN   
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRN--- 72

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           ++ +    + +  D   LVFE M  GS+   +H+     E+ + S++ +     DVASA+
Sbjct: 73  VLELIEFFEEE--DRFYLVFEKMRGGSILSHIHKRRHFNEL-EASVVVQ-----DVASAL 124

Query: 168 EYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
           ++LH+     + H D+KP N+L    +      + DF L   +  +   +   TP     
Sbjct: 125 DFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181

Query: 225 IKGTVGYVAP 234
             G+  Y+AP
Sbjct: 182 C-GSAEYMAP 190

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 86.2 bits (214), Expect = 4e-20
 Identities = 51/194 (26%), Positives = 79/194 (40%), Gaps = 39/194 (20%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN--------LKQKGAFRSFVAECEALRNIRHRNL 105
           +G G+ G V      +    VA+K+I+         ++     +   E E L+ + H   
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC- 76

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV--NIAIDV 163
             II I +  D++      +V E ME G L D +        V    L +         +
Sbjct: 77  --IIKIKNFFDAE---DYYIVLELMEGGELFDKV--------VGNKRLKEATCKLYFYQM 123

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPS 220
             A++YLH N    ++H D+KP NVLL   + D +  + DFG SK L    L        
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR------ 174

Query: 221 SSIGIKGTVGYVAP 234
               + GT  Y+AP
Sbjct: 175 ---TLCGTPTYLAP 185

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 84.9 bits (211), Expect = 5e-20
 Identities = 40/187 (21%), Positives = 78/187 (41%), Gaps = 30/187 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G+GS+  VY+       + VA+K+I+   + + G  +    E +    ++H ++ ++  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASAIEY 169
                +     +  LV E   NG +  +L        E      + ++       + + Y
Sbjct: 79  Y---FEDSNYVY--LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLY 127

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH--LDTASETPSSSIGIKG 227
           LH +    ++H D+  SN+LL  +M   + DFGL+  L   H    T          + G
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT----------LCG 174

Query: 228 TVGYVAP 234
           T  Y++P
Sbjct: 175 TPNYISP 181

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 85.9 bits (213), Expect = 6e-20
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 25/164 (15%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA---FRSFVAECEALRNIRHRN 104
           FS    IG GS+G+VY      +  VVA+K ++   K +   ++  + E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 105 LTKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
             +           G   +     LV EY   GS  D L      L+  +++ +      
Sbjct: 116 TIQYR---------GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTH---- 161

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS 204
                 + YLH +    M+H D+K  N+LL    +  +GDFG +
Sbjct: 162 -GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 84.9 bits (211), Expect = 7e-20
 Identities = 35/165 (21%), Positives = 75/165 (45%), Gaps = 16/165 (9%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRN 104
           ++ +   IG+G+YG+V+K    E   +VA+K + L     G   S + E   L+ ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
              I+ +   + S       LVFE+ +   L+ +              +++  +    + 
Sbjct: 63  ---IVRLHDVLHSDKKLT--LVFEFCDQ-DLKKYFD---SCNGDLDPEIVK--SFLFQLL 111

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
             + + H      ++H D+KP N+L++ +    + +FGL++    
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 84.6 bits (210), Expect = 8e-20
 Identities = 42/184 (22%), Positives = 78/184 (42%), Gaps = 27/184 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G+G +G+VY     +++ ++A+KV+    L+++G       E E   ++RH N   I+ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN---ILR 78

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           + +    +   +  L+ E+   G L   L +        +    +      ++A A+ Y 
Sbjct: 79  MYNYFHDRKRIY--LMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYC 130

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H      ++H DIKP N+L+       + DFG S    S    T            GT+ 
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----------GTLD 177

Query: 231 YVAP 234
           Y+ P
Sbjct: 178 YLPP 181

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 86.3 bits (214), Expect = 8e-20
 Identities = 45/175 (25%), Positives = 80/175 (45%), Gaps = 32/175 (18%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K +   ++   R    E + +R + H N+ +
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111

Query: 108 II-TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDH---------LEVFKLSLIQRV 157
           +     SS + K   +  LV +Y+     E  +++   H         +   KL + Q  
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVP----ET-VYRVARHYSRAKQTLPVIYVKLYMYQ-- 164

Query: 158 NIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFLSSD 210
                +  ++ Y+H       + H DIKP N+LLD D  V  + DFG +K L   
Sbjct: 165 -----LFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 85.4 bits (212), Expect = 9e-20
 Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 35/204 (17%)

Query: 40  ELSKATCEFSQ----SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECE 95
           +L + + +F+        IG GSY    + I     M  AVK+I+  ++        E E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIE 67

Query: 96  AL-RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLI 154
            L R  +H N   IIT+    D     +  +V E M+ G L D + +          S  
Sbjct: 68  ILLRYGQHPN---IITLKDVYDDGKYVY--VVTELMKGGELLDKILRQK------FFSER 116

Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL----DNDMVAHVGDFGLSKFLSSD 210
           +   +   +   +EYLH      +VH D+KPSN+L      N     + DFG +K L ++
Sbjct: 117 EASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 211 HLDTASETPSSSIGIKGTVGYVAP 234
             +    TP        T  +VAP
Sbjct: 174 --NGLLMTPC------YTANFVAP 189

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 85.0 bits (211), Expect = 1e-19
 Identities = 39/188 (20%), Positives = 83/188 (44%), Gaps = 24/188 (12%)

Query: 53  MIGQGSYGSVYKG---ILGEDEMVVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLT 106
           ++G G    V+         D   VAVKV+  +L +  +F   F  E +    + H  + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRD---VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            +     + ++       +V EY++  +L D +H          ++  + + +  D   A
Sbjct: 76  AVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQA 128

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           + + H N    ++H D+KP+N+++       V DFG+++ ++       S T +++  + 
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTAA--VI 180

Query: 227 GTVGYVAP 234
           GT  Y++P
Sbjct: 181 GTAQYLSP 188

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 84.5 bits (210), Expect = 1e-19
 Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 28/186 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           +G+G++  V + +     +  A K+IN K+     F+    E    R ++H N   I+ +
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN---IVRL 70

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             SI  +   +  LVF+ +  G L + +      +     S     +    +  +I Y H
Sbjct: 71  HDSIQEESFHY--LVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCH 122

Query: 172 HNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            N    +VH ++KP N+LL          + DFGL+  ++               G  GT
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---------GFAGT 170

Query: 229 VGYVAP 234
            GY++P
Sbjct: 171 PGYLSP 176

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 85.3 bits (211), Expect = 1e-19
 Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 32/193 (16%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNL 105
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+ +  E + L       +
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93

Query: 106 TKIITICSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
                        GA +      +  E+M+ GSL+  L +     E     ++ +  ++I
Sbjct: 94  VG---------FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGK--VSI 138

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
            V   + YL    +  ++H D+KPSN+L+++     + DFG+S  L     D+ + +   
Sbjct: 139 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS--- 189

Query: 222 SIGIKGTVGYVAP 234
                GT  Y++P
Sbjct: 190 ---FVGTRSYMSP 199

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 84.2 bits (209), Expect = 1e-19
 Identities = 45/191 (23%), Positives = 76/191 (39%), Gaps = 37/191 (19%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G+G+YG V K        ++AVK I                     + R L  +     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRA-------------TVNSQEQKRLLMDLDISMR 61

Query: 114 SIDSK------GADFK----ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           ++D        GA F+     +  E M + SL+ +  Q  D  +     ++ +  IA+ +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSI 118

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+E+LH      ++H D+KPSNVL++      + DFG+S +L                
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDA 170

Query: 224 GIKGTVGYVAP 234
              G   Y+AP
Sbjct: 171 ---GCKPYMAP 178

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.2 bits (209), Expect = 1e-19
 Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 26/163 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLTK 107
           IG+GSYG V+K    +   +VA+K     +      K A R    E   L+ ++H NL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           ++ +      K      LVFEY ++      LH+ + +       L++  +I      A+
Sbjct: 67  LLEV---FRRKRRLH--LVFEYCDH----TVLHELDRYQRGVPEHLVK--SITWQTLQAV 115

Query: 168 EYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
            + H HNC    +H D+KP N+L+    V  + DFG ++ L+ 
Sbjct: 116 NFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTG 154

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 83.8 bits (208), Expect = 2e-19
 Identities = 44/185 (23%), Positives = 73/185 (39%), Gaps = 23/185 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLTKIITIC 112
           +G G++G V+        +   +K IN  + +       AE E L+++ H N   II I 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN---IIKIF 86

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
              +     +  +V E  E G L + +       +    S      +   + +A+ Y H 
Sbjct: 87  EVFEDYHNMY--IVMETCEGGELLERIVSAQARGKAL--SEGYVAELMKQMMNALAYFHS 142

Query: 173 NCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
                +VH D+KP N+L  +        + DFGL++   SD   T            GT 
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST---------NAAGTA 190

Query: 230 GYVAP 234
            Y+AP
Sbjct: 191 LYMAP 195

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.1 bits (209), Expect = 2e-19
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 17/165 (10%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRN 104
           ++ +   +G+G+YG VYK    +   +VA+K I L  +  G   + + E   L+ + H N
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
              I+++   I S+      LVFE+ME   L+  L    ++    + S I+       + 
Sbjct: 81  ---IVSLIDVIHSERCLT--LVFEFMEK-DLKKVLD---ENKTGLQDSQIK--IYLYQLL 129

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
             + + H +    ++H D+KP N+L+++D    + DFGL++    
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 84.2 bits (209), Expect = 2e-19
 Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 27/172 (15%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---------AFRSFVAECEAL 97
            + + + +G+G + +VYK        +VA+K I L  +          A R    E + L
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR----EIKLL 66

Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
           + + H N   II +  +   K      LVF++ME   LE  +   +    V   S I+  
Sbjct: 67  QELSHPN---IIGLLDAFGHKSNIS--LVFDFMET-DLEVIIKDNS---LVLTPSHIK-- 115

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
              +     +EYLH +    ++H D+KP+N+LLD + V  + DFGL+K   S
Sbjct: 116 AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 84.3 bits (209), Expect = 2e-19
 Identities = 46/224 (20%), Positives = 86/224 (38%), Gaps = 35/224 (15%)

Query: 15  RRRGSVRKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVV 74
               S  + +   P  K++ +    +LSK         ++G G  G V +          
Sbjct: 6   HHHSSGLEVLFQGPEPKKYAVTDDYQLSK--------QVLGLGVNGKVLECFHRRTGQKC 57

Query: 75  AVKVINLKQKGAFRSFVAECEAL-RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENG 133
           A+K++      A +    E +   +     ++  I+ +  ++         ++ E ME G
Sbjct: 58  ALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGG 111

Query: 134 SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL--- 190
            L   + +  D       +  +   I  D+ +AI++LH +    + H D+KP N+L    
Sbjct: 112 ELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSK 164

Query: 191 DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + D V  + DFG +K  + + L T             T  YVAP
Sbjct: 165 EKDAVLKLTDFGFAKETTQNALQTPC----------YTPYYVAP 198

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 83.8 bits (208), Expect = 2e-19
 Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 30/174 (17%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG------AFRSFVAECEALRNI 100
            + +   +G+G+YG VYK I       VA+K I L+ +       A R    E   L+ +
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKEL 90

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
           +HRN   II + S I         L+FEY EN    D L +  D      + +I+     
Sbjct: 91  QHRN---IIELKSVIHHNHRLH--LIFEYAEN----D-LKKYMDKNPDVSMRVIKS--FL 138

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG-----DFGLSKFLSS 209
             + + + + H       +H D+KP N+LL     +        DFGL++    
Sbjct: 139 YQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 83.9 bits (208), Expect = 3e-19
 Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 28/186 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           +G+G++  V + +     +  A K+IN K+     F+    E    R ++H N   I+ +
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN---IVRL 93

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             SI  +   +  LVF+ +  G L + +      +     S     +    +  +I Y H
Sbjct: 94  HDSIQEESFHY--LVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYCH 145

Query: 172 HNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            N    +VH ++KP N+LL          + DFGL+  ++               G  GT
Sbjct: 146 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---------GFAGT 193

Query: 229 VGYVAP 234
            GY++P
Sbjct: 194 PGYLSP 199

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 83.5 bits (207), Expect = 3e-19
 Identities = 40/188 (21%), Positives = 75/188 (39%), Gaps = 30/188 (15%)

Query: 53  MIGQGSYGSVYKG---ILGEDEMVVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLT 106
           ++G+G  G VY+    +       VA+K++   L     FR+    E      ++  +  
Sbjct: 41  LVGRGGMGDVYEAEDTVRERI---VALKLMSETLSSDPVFRTRMQREARTAGRLQEPH-- 95

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ I    +  G  +  +    +    L   L +         L+  + V I   + SA
Sbjct: 96  -VVPIHDFGEIDGQLY--VDMRLINGVDLAAMLRRQ------GPLAPPRAVAIVRQIGSA 146

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           ++  H        H D+KP N+L+  D  A++ DFG++   + + L T            
Sbjct: 147 LDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGN------TV 196

Query: 227 GTVGYVAP 234
           GT+ Y+AP
Sbjct: 197 GTLYYMAP 204

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 83.4 bits (207), Expect = 3e-19
 Identities = 39/173 (22%), Positives = 74/173 (42%), Gaps = 20/173 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINL-KQKGAFRSFVAECEALRNI----- 100
            +     IG G+YG+VYK         VA+K + +    G           +R +     
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL--PISTVREVALLRR 67

Query: 101 ----RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
                H N+ +++ +C++  +       LVFE+++   L  +L +            I+ 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP--PGLPAETIK- 123

Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
            ++       +++LH NC   +VH D+KP N+L+ +     + DFGL++  S 
Sbjct: 124 -DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 83.5 bits (207), Expect = 4e-19
 Identities = 44/184 (23%), Positives = 76/184 (41%), Gaps = 27/184 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           IG+G++  V           VA+K+I+  Q      +    E   ++ + H N+ K+  +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
              I+++   +  L+ EY   G + D+L          ++   +  +    + SA++Y H
Sbjct: 83  ---IETEKTLY--LIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCH 131

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH-LDTASETPSSSIGIKGTVG 230
                 +VH D+K  N+LLD DM   + DFG S   +    LD     P           
Sbjct: 132 QKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP---------- 178

Query: 231 YVAP 234
           Y AP
Sbjct: 179 YAAP 182

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 84.4 bits (209), Expect = 4e-19
 Identities = 53/187 (28%), Positives = 78/187 (41%), Gaps = 29/187 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G+GS+G V            AVKVI+   +KQK    S + E + L+ + H N+ K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
                      +  LV E    G L D +       EV    +I++      V S I Y+
Sbjct: 94  FFED-----KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYM 142

Query: 171 HHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           H N    +VH D+KP N+LL++   D    + DFGLS    +                 G
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---------DKIG 190

Query: 228 TVGYVAP 234
           T  Y+AP
Sbjct: 191 TAYYIAP 197

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 83.0 bits (206), Expect = 5e-19
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 26/163 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLTK 107
           +G+GSYG V K    +   +VA+K            K A R    E + L+ +RH NL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENLVN 88

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           ++ +C     K   +  LVFE++++      L             ++Q       + + I
Sbjct: 89  LLEVCKK---KKRWY--LVFEFVDH----TILDDLELFPNGLDYQVVQ--KYLFQIINGI 137

Query: 168 EYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
            + H HN     +H DIKP N+L+    V  + DFG ++ L++
Sbjct: 138 GFCHSHNI----IHRDIKPENILVSQSGVVKLCDFGFARTLAA 176

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.1 bits (206), Expect = 6e-19
 Identities = 45/190 (23%), Positives = 78/190 (41%), Gaps = 28/190 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLTK 107
           IG+G +  V + I  E     AVK+++   K      ++      E      ++H +   
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVD-VAKFTSSPGLSTEDLKREASICHMLKHPH--- 87

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           I+ +  +  S G  +  +VFE+M+   L   + +  D   V+  S     +    +  A+
Sbjct: 88  IVELLETYSSDGMLY--MVFEFMDGADLCFEIVKRADAGFVY--SEAVASHYMRQILEAL 143

Query: 168 EYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            Y H N    ++H D+KP  VLL   +N     +G FG++  L    L           G
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG--------G 192

Query: 225 IKGTVGYVAP 234
             GT  ++AP
Sbjct: 193 RVGTPHFMAP 202

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 82.6 bits (205), Expect = 6e-19
 Identities = 41/165 (24%), Positives = 77/165 (46%), Gaps = 15/165 (9%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRN 104
            F +   IG+G+YG VYK        VVA+K I L  +  G   + + E   L+ + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
              I+ +   I ++   +  LVFE++    L+ ++  +        L LI+  +    + 
Sbjct: 64  ---IVKLLDVIHTENKLY--LVFEFLHQ-DLKKFMDASALTG--IPLPLIK--SYLFQLL 113

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
             + + H +    ++H D+KP N+L++ +    + DFGL++    
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 82.3 bits (204), Expect = 7e-19
 Identities = 49/186 (26%), Positives = 76/186 (40%), Gaps = 28/186 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           +G+GS+G V K      +   AVKVIN          + + E E L+ + H N   I+ +
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN---IMKL 86

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
              ++   + +  +V E    G L D + +        + S      I   V S I Y+H
Sbjct: 87  FEILEDSSSFY--IVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMH 138

Query: 172 HNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            +    +VH D+KP N+LL   + D    + DFGLS     +                GT
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---------DRIGT 186

Query: 229 VGYVAP 234
             Y+AP
Sbjct: 187 AYYIAP 192

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 81.9 bits (203), Expect = 7e-19
 Identities = 44/184 (23%), Positives = 68/184 (36%), Gaps = 26/184 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS+G V   +     +  A K I          F  E E ++++ H N   II +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN---IIRLYE 73

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
           + +     +  LV E    G L + +       E     +++      DV SA+ Y H  
Sbjct: 74  TFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCHKL 125

Query: 174 CQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
               + H D+KP N L      D    + DFGL+       +              GT  
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR---------TKVGTPY 173

Query: 231 YVAP 234
           YV+P
Sbjct: 174 YVSP 177

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 82.6 bits (204), Expect = 9e-19
 Identities = 48/222 (21%), Positives = 73/222 (32%), Gaps = 53/222 (23%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLTKI 108
           IGQGSYG V   I  +   + A+K++N  +              E   ++ + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV----------- 157
             +          +  LV E    G L D L+   D         + +            
Sbjct: 94  YEVYED-----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 158 -----------------------NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM 194
                                  NI   + SA+ YLH+     + H DIKP N L   + 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205

Query: 195 VAHV--GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
              +   DFGLSK     +               GT  +VAP
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMT----TKAGTPYFVAP 243

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 82.7 bits (205), Expect = 1e-18
 Identities = 39/186 (20%), Positives = 74/186 (39%), Gaps = 27/186 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           +G+G++  V + +        A  +IN K+      +    E    R ++H N   I+ +
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN---IVRL 75

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             SI  +G  +  L+F+ +  G L + +      +     S     +    +  A+ + H
Sbjct: 76  HDSISEEGHHY--LIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHCH 127

Query: 172 HNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
                 +VH ++KP N+LL          + DFGL+  +  +             G  GT
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--------GFAGT 176

Query: 229 VGYVAP 234
            GY++P
Sbjct: 177 PGYLSP 182

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 81.5 bits (202), Expect = 1e-18
 Identities = 45/189 (23%), Positives = 82/189 (43%), Gaps = 29/189 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVA-ECEALRNIRHRNLTKII 109
           +G+GSYG V + +  E     AVK++    L++     + V  E + LR +RH+N+ +++
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +  + + K   +  +V EY   G  E  +    D +   +  + Q       +   +EY
Sbjct: 73  DVLYN-EEKQKMY--MVMEYCVCGMQE--ML---DSVPEKRFPVCQAHGYFCQLIDGLEY 124

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS----KFLSSDHLDTASETPSSSIGI 225
           LH      +VH DIKP N+LL       +   G++     F + D   T+  +P+     
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA----- 176

Query: 226 KGTVGYVAP 234
                +  P
Sbjct: 177 -----FQPP 180

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 81.0 bits (201), Expect = 2e-18
 Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 25/169 (14%)

Query: 47  EFSQSNMIGQGSYGSVYKGI--LGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRH 102
           ++     IG+G+YG VYK     GE     A+K I L+++  G   + + E   L+ ++H
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE--VFKLSLIQRVNIA 160
            N   I+ +   I +K      LVFE+++   L+  L      LE    K  L+Q     
Sbjct: 60  SN---IVKLYDVIHTKKRLV--LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ----- 108

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS 209
             + + I Y H      ++H D+KP N+L++ +    + DFGL++    
Sbjct: 109 --LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 80.5 bits (199), Expect = 3e-18
 Identities = 40/191 (20%), Positives = 64/191 (33%), Gaps = 40/191 (20%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G+ G V+K    +   V+AVK +                  +    R L  +  +  
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRR-------------SGNKEENKRILMDLDVVLK 79

Query: 114 SIDSK------GADFKA----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           S D        G         +  E M     E    +    +    L       + + +
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG-----KMTVAI 133

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
             A+ YL       ++H D+KPSN+LLD      + DFG+S  L         +    S 
Sbjct: 134 VKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL------VDDKAKDRSA 185

Query: 224 GIKGTVGYVAP 234
              G   Y+AP
Sbjct: 186 ---GCAAYMAP 193

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 81.7 bits (202), Expect = 3e-18
 Identities = 46/186 (24%), Positives = 72/186 (38%), Gaps = 28/186 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           +G G+YG V         +  A+K+I        +    + E   L+ + H N+ K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
                        LV E  + G L D +       EV    +I+       V S + YLH
Sbjct: 105 FED-----KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------QVLSGVTYLH 153

Query: 172 HNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            +    +VH D+KP N+LL++   D +  + DFGLS    +                 GT
Sbjct: 154 KHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---------ERLGT 201

Query: 229 VGYVAP 234
             Y+AP
Sbjct: 202 AYYIAP 207

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 81.7 bits (202), Expect = 4e-18
 Identities = 51/188 (27%), Positives = 75/188 (39%), Gaps = 28/188 (14%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
            M+G+GS+G V K      +   AVKVIN          + + E E L+ + H N+ K+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            I        +    +V E    G L D + +     E           I   V S I Y
Sbjct: 88  EILED-----SSSFYIVGELYTGGELFDEIIKRKRFSEH------DAARIIKQVFSGITY 136

Query: 170 LHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +H +    +VH D+KP N+LL++   D    + DFGLS     +                
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---------DRI 184

Query: 227 GTVGYVAP 234
           GT  Y+AP
Sbjct: 185 GTAYYIAP 192

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 79.9 bits (198), Expect = 4e-18
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 30/186 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA----ECEALRNIRHRNLTKII 109
           +G G++G V  G        VAVK++N +QK      V     E + L+  RH ++ K+ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I +    F  +V EY+  G L D++ +        ++  ++   +   + SA++Y
Sbjct: 78  QV---ISTPTDFF--MVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDY 126

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH-LDTASETPSSSIGIKGT 228
            H +    +VH D+KP NVLLD  M A + DFGLS  +S    L T+  +P+        
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-------- 175

Query: 229 VGYVAP 234
             Y AP
Sbjct: 176 --YAAP 179

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.5 bits (199), Expect = 4e-18
 Identities = 45/199 (22%), Positives = 77/199 (38%), Gaps = 50/199 (25%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA---------ECEALRNIRHRN 104
           +G G++G V+  +  E    V VK I  K+K     ++          E   L  + H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           + K++ I    +++G     LV E   +G            L++F   + +   +   +A
Sbjct: 91  IIKVLDI---FENQGFFQ--LVMEKHGSG------------LDLFAF-IDRHPRLDEPLA 132

Query: 165 --------SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH-LDTA 215
                   SA+ YL       ++H DIK  N+++  D    + DFG + +L       T 
Sbjct: 133 SYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF 189

Query: 216 SETPSSSIGIKGTVGYVAP 234
                      GT+ Y AP
Sbjct: 190 C----------GTIEYCAP 198

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.0 bits (200), Expect = 5e-18
 Identities = 42/185 (22%), Positives = 78/185 (42%), Gaps = 17/185 (9%)

Query: 28  PMEKQFPMVSYAELSKATCEFSQSNM-IGQGSYGSVYKGI--LGEDEMVVAVKVINLKQK 84
            M+  F +   +E  +    F      +G+G+YG VYK     G+D+   A+K I  +  
Sbjct: 2   KMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGT 59

Query: 85  GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMEN--GSLEDWLHQT 142
           G   S   E   LR ++H N+  +  +     S       L+F+Y E+    +  +   +
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKV---FLSHADRKVWLLFDYAEHDLWHIIKFHRAS 116

Query: 143 NDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH----V 198
             + +  +L      ++   +   I YLH N    ++H D+KP+N+L+  +        +
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173

Query: 199 GDFGL 203
            D G 
Sbjct: 174 ADMGF 178

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 80.9 bits (200), Expect = 5e-18
 Identities = 41/190 (21%), Positives = 77/190 (40%), Gaps = 24/190 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
             S++ ++G G +G V+K       + +A K+I  +          E   +  + H N  
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHAN-- 147

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            +I +  + +SK  +   LV EY++ G L D +       E + L+ +  +     +   
Sbjct: 148 -LIQLYDAFESK--NDIVLVMEYVDGGELFDRIID-----ESYNLTELDTILFMKQICEG 199

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIG 224
           I ++H      ++H D+KP N+L  N     +   DFGL++                   
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--------- 247

Query: 225 IKGTVGYVAP 234
             GT  ++AP
Sbjct: 248 NFGTPEFLAP 257

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.4 bits (199), Expect = 5e-18
 Identities = 42/197 (21%), Positives = 75/197 (38%), Gaps = 30/197 (15%)

Query: 29  MEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR 88
           M       +     K    F    M GQG++G+V  G      M VA+K +    +   R
Sbjct: 6   MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR 65

Query: 89  SFVAECEALRNIRHRNLTKIITICSSIDSKGAD--FKALVFEYMENGSLEDWLHQTNDHL 146
             +   + L  + H N+ ++ +   ++  +     +  +V EY+     +  LH+   + 
Sbjct: 66  E-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-LHRCCRNY 119

Query: 147 EVFKLSL-----------IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDM 194
              +++            + R         +I  LH      + H DIKP NVL++  D 
Sbjct: 120 YRRQVAPPPILIKVFLFQLIR---------SIGCLHLPSV-NVCHRDIKPHNVLVNEADG 169

Query: 195 VAHVGDFGLSKFLSSDH 211
              + DFG +K LS   
Sbjct: 170 TLKLCDFGSAKKLSPSE 186

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 80.5 bits (199), Expect = 6e-18
 Identities = 39/183 (21%), Positives = 74/183 (40%), Gaps = 24/183 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G V++ +      V   K IN        +   E   +  + H     +I +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK---LINLHD 115

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
           + + K      L+ E++  G L D +       E +K+S  + +N        ++++H +
Sbjct: 116 AFEDK--YEMVLILEFLSGGELFDRIAA-----EDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
               +VH DIKP N++ +    + V   DFGL+  L+ D +               T  +
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---------TTATAEF 216

Query: 232 VAP 234
            AP
Sbjct: 217 AAP 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 80.1 bits (198), Expect = 6e-18
 Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 30/188 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA-FRSFVAECE-ALRNIRHRNLTKIITI 111
           IG+G+YGSV K +      ++AVK I         +  + + +  +R+     + +    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85

Query: 112 CSSIDSKGADFKA----LVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASA 166
                  GA F+     +  E M + S + +       L +V    ++ +  I +    A
Sbjct: 86  -----FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKA 137

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           + +L  N +  ++H DIKPSN+LLD      + DFG+S  L        S   +      
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDA--- 186

Query: 227 GTVGYVAP 234
           G   Y+AP
Sbjct: 187 GCRPYMAP 194

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 80.1 bits (198), Expect = 1e-17
 Identities = 52/197 (26%), Positives = 76/197 (38%), Gaps = 39/197 (19%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ-------------KGAFRSFVAECEALRNI 100
           +G G+YG V            A+KVI   Q             +        E   L+++
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
            H N+ K+  +          +  LV E+ E G L + +   +   E          NI 
Sbjct: 104 DHPNIIKLFDVFED-----KKYFYLVTEFYEGGELFEQIINRHKFDEC------DAANIM 152

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGDFGLSKFLSSDHLDTASE 217
             + S I YLH +    +VH DIKP N+LL+N    +   + DFGLS F S D+      
Sbjct: 153 KQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR--- 206

Query: 218 TPSSSIGIKGTVGYVAP 234
                    GT  Y+AP
Sbjct: 207 ------DRLGTAYYIAP 217

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 78.5 bits (194), Expect = 2e-17
 Identities = 41/185 (22%), Positives = 79/185 (42%), Gaps = 29/185 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITIC 112
           +G+GS+    K +  +     AVK+I+ + +   +    E  AL+    H N   I+ + 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPN---IVKLH 72

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
                +   F  LV E +  G L + + +     E     +++       + SA+ ++H 
Sbjct: 73  EVFHDQLHTF--LVMELLNGGELFERIKKKKHFSETEASYIMR------KLVSAVSHMHD 124

Query: 173 NCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
                +VH D+KP N+L    ++++   + DFG ++    D  +   +TP        T+
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPC------FTL 173

Query: 230 GYVAP 234
            Y AP
Sbjct: 174 HYAAP 178

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 78.4 bits (194), Expect = 3e-17
 Identities = 37/176 (21%), Positives = 74/176 (42%), Gaps = 36/176 (20%)

Query: 47  EFSQSNMIGQGSYGSVYKGI-LGEDEMVVAVKVINLKQKGAFRSFVAECE-----ALRNI 100
           ++     IG+G+YG V+K   L      VA+K + ++            E      +R +
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---------GEEGMPLSTIREV 62

Query: 101 ---------RHRNLTKIITICSSIDSKGADFKALVFEYMEN--GSLEDWLHQTNDHLEVF 149
                     H N+ ++  +C+   +       LVFE+++    +  D + +     E  
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 150 KLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
           K  + Q       +   +++LH +    +VH D+KP N+L+ +     + DFGL++
Sbjct: 123 KDMMFQ-------LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 79.1 bits (195), Expect = 3e-17
 Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 30/186 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA----ECEALRNIRHRNLTKII 109
           +G G++G V  G        VAVK++N +QK      V     E + L+  RH ++ K+ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I +    F  +V EY+  G L D++ +        +L   +   +   + S ++Y
Sbjct: 83  QV---ISTPSDIF--MVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDY 131

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH-LDTASETPSSSIGIKGT 228
            H +    +VH D+KP NVLLD  M A + DFGLS  +S    L T+  +P+        
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-------- 180

Query: 229 VGYVAP 234
             Y AP
Sbjct: 181 --YAAP 184

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 77.6 bits (192), Expect = 3e-17
 Identities = 44/190 (23%), Positives = 72/190 (37%), Gaps = 37/190 (19%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+       +  E    + + H N+ K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA-------- 164
                    +  L  EY   G             E+F   +   + +    A        
Sbjct: 74  --RREGNIQY--LFLEYCSGG-------------ELFDR-IEPDIGMPEPDAQRFFHQLM 115

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
           + + YLH      + H DIKP N+LLD      + DFGL+     ++ +           
Sbjct: 116 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---- 168

Query: 225 IKGTVGYVAP 234
             GT+ YVAP
Sbjct: 169 --GTLPYVAP 176

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.1 bits (195), Expect = 3e-17
 Identities = 32/184 (17%), Positives = 70/184 (38%), Gaps = 26/184 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G V++          A K +    +    +   E + +  +RH     ++ +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT---LVNLHD 221

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASAIEYLHH 172
           + +    +   +++E+M  G L + +   ++ + E   +  ++       V   + ++H 
Sbjct: 222 AFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR------QVCKGLCHMHE 273

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           N     VH D+KP N++        +   DFGL+  L                   GT  
Sbjct: 274 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---------TTGTAE 321

Query: 231 YVAP 234
           + AP
Sbjct: 322 FAAP 325

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 78.1 bits (193), Expect = 4e-17
 Identities = 47/184 (25%), Positives = 71/184 (38%), Gaps = 28/184 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G+G+   VY+      +   A+KV+        +    E   L  + H N   II +  
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPN---IIKLKE 115

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             ++       LV E +  G L D +      +E    S     +    +  A+ YLH N
Sbjct: 116 IFETPTEIS--LVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEAVAYLHEN 167

Query: 174 CQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
               +VH D+KP N+L      D    + DFGLSK +    L            + GT G
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---------TVCGTPG 215

Query: 231 YVAP 234
           Y AP
Sbjct: 216 YCAP 219

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.8 bits (192), Expect = 6e-17
 Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 33/175 (18%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++   +IG GS+G V++  L E +  VA+K +   ++   R    E + +R ++H N+  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKHPNVVD 96

Query: 108 II-TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDH---------LEVFKLSLIQRV 157
           +     S+ D K   F  LV EY+     E  +++ + H         + + KL + Q  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP----ET-VYRASRHYAKLKQTMPMLLIKLYMYQ-- 149

Query: 158 NIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSD 210
                +  ++ Y+H       + H DIKP N+LLD    V  + DFG +K L + 
Sbjct: 150 -----LLRSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 76.6 bits (189), Expect = 1e-16
 Identities = 44/190 (23%), Positives = 72/190 (37%), Gaps = 37/190 (19%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-ECEALRNIRHRNLTKIITIC 112
           +G+G+YG V   +    E  VAVK++++K+       +  E    + + H N+ K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA-------- 164
                    +  L  EY   G             E+F   +   + +    A        
Sbjct: 74  --RREGNIQY--LFLEYCSGG-------------ELFDR-IEPDIGMPEPDAQRFFHQLM 115

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
           + + YLH      + H DIKP N+LLD      + DFGL+     ++ +           
Sbjct: 116 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---- 168

Query: 225 IKGTVGYVAP 234
             GT+ YVAP
Sbjct: 169 --GTLPYVAP 176

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 75.9 bits (187), Expect = 1e-16
 Identities = 19/155 (12%), Positives = 44/155 (28%), Gaps = 25/155 (16%)

Query: 54  IGQGSYGSVYKGILGEDEM---VVAVKVI--NLKQKGAFRS-FVAECEALRNIRHRNLTK 107
            G       ++     D      VA+  +              ++    L  I       
Sbjct: 39  HGGVPPLQFWQA---LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG--- 92

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +  +   + ++      +V E++  GSL++    +         S +  +     +A+A 
Sbjct: 93  VARVLDVVHTRAGGL--VVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAA 142

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG 202
           +  H      +      PS V +  D    +    
Sbjct: 143 DAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA 174

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.4 bits (188), Expect = 2e-16
 Identities = 42/186 (22%), Positives = 73/186 (39%), Gaps = 42/186 (22%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLTK 107
           IG GSYG V +     ++ VVA+K I          K   R    E   L  + H ++ K
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116

Query: 108 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ--------TNDHLEVFKLSLIQRV 157
           ++ I    D +   F    +V E  ++    D   +        T  H++    +L+   
Sbjct: 117 VLDIVIPKDVE--KFDELYVVLEIADS----D-FKKLFRTPVYLTELHIKTLLYNLLV-- 167

Query: 158 NIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
                    ++Y+H       ++H D+KP+N L++ D    V DFGL++ +       + 
Sbjct: 168 --------GVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 217 ETPSSS 222
              S  
Sbjct: 216 LPISPR 221

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.1 bits (185), Expect = 4e-16
 Identities = 40/192 (20%), Positives = 69/192 (35%), Gaps = 36/192 (18%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-------ECEALRNIRHR--N 104
           +G G +GSVY GI   D + VA+K +  K + +    +        E   L+ +      
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 105 LTKIITICSSIDSKGADFKALVFEYMEN-GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           + +++      +   +    L+ E  E    L D++ +         L      +    V
Sbjct: 110 VIRLLDW---FERPDSFV--LILERPEPVQDLFDFITERG------ALQEELARSFFWQV 158

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
             A+ + H+     ++H DIK  N+L+D N     + DFG    L               
Sbjct: 159 LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------ 209

Query: 223 IGIKGTVGYVAP 234
               GT  Y  P
Sbjct: 210 ----GTRVYSPP 217

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 75.0 bits (185), Expect = 4e-16
 Identities = 34/184 (18%), Positives = 72/184 (39%), Gaps = 27/184 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G+G +G V++ +    +     K +   +         E   L   RHRN   I+ +  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN---ILHLHE 68

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHL-EVFKLSLIQRVNIAIDVASAIEYLHH 172
           S +S   +   ++FE++    + + ++ +   L E   +S +        V  A+++LH 
Sbjct: 69  SFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVH------QVCEALQFLHS 120

Query: 173 NCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           +    + H DI+P N++      + +   +FG ++ L                 +     
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---------LFTAPE 168

Query: 231 YVAP 234
           Y AP
Sbjct: 169 YYAP 172

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.7 bits (184), Expect = 5e-16
 Identities = 44/201 (21%), Positives = 75/201 (37%), Gaps = 50/201 (24%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA-------ECEALRNIR---- 101
           ++G+G +G+V+ G    D + VA+KVI  + +    S ++       E   L  +     
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGS-LEDWLHQTNDHLE------VFKLSLI 154
           H  + +++      +++      LV E       L D++ +    L        F     
Sbjct: 97  HPGVIRLLDW---FETQEGFM--LVLERPLPAQDLFDYITE-KGPLGEGPSRCFFG---- 146

Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLSKFLSSDHLD 213
           Q       V +AI++ H      +VH DIK  N+L+D     A + DFG    L  +   
Sbjct: 147 Q-------VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT 196

Query: 214 TASETPSSSIGIKGTVGYVAP 234
                        GT  Y  P
Sbjct: 197 DFD----------GTRVYSPP 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 74.6 bits (184), Expect = 5e-16
 Identities = 45/191 (23%), Positives = 72/191 (37%), Gaps = 33/191 (17%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLTK 107
           +G G +  V K       +  A K I  +Q  A R  V+      E   LR + H N   
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN--- 76

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +IT+    +++      L+ E +  G L D+L       +   LS  +  +    +   +
Sbjct: 77  VITLHDVYENR--TDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGV 128

Query: 168 EYLHHNCQPPMVHGDIKPSNVLL----DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
            YLH      + H D+KP N++L           + DFGL+  +                
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--------- 176

Query: 224 GIKGTVGYVAP 234
            I GT  +VAP
Sbjct: 177 NIFGTPEFVAP 187

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 75.1 bits (185), Expect = 5e-16
 Identities = 46/191 (24%), Positives = 73/191 (38%), Gaps = 33/191 (17%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLTK 107
           +G G +  V K       +  A K I  +Q  A R  V       E   LR + H N   
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN--- 76

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           IIT+    +++      L+ E +  G L D+L       +   LS  +  +    +   +
Sbjct: 77  IITLHDVYENR--TDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGV 128

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAH----VGDFGLSKFLSSDHLDTASETPSSSI 223
            YLH      + H D+KP N++L +  +      + DFGL+  +                
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--------- 176

Query: 224 GIKGTVGYVAP 234
            I GT  +VAP
Sbjct: 177 NIFGTPEFVAP 187

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 73.5 bits (181), Expect = 1e-15
 Identities = 47/186 (25%), Positives = 85/186 (45%), Gaps = 31/186 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA----ECEALRNIRHRNLTKII 109
           +G+GS+G V      + +  VA+K I+ +Q             E   L+ +RH ++ K+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +   I +       +V EY   G L D++ +        +++  +       +  AIEY
Sbjct: 76  DV---ITTPTDIV--MVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEY 123

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH-LDTASETPSSSIGIKGT 228
            H +    +VH D+KP N+LLD+++   + DFGLS  ++  + L T+  +P+        
Sbjct: 124 CHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN-------- 172

Query: 229 VGYVAP 234
             Y AP
Sbjct: 173 --YAAP 176

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.4 bits (181), Expect = 1e-15
 Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 42/194 (21%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN-----LKQKGAFRSFVAECEALRNIRHRNLTKI 108
           +G+G+YG V          +VA+K I      L      R    E + L++ +H N+  I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74

Query: 109 ITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------TNDHLEVFKLSLIQRVNI 159
             I      +  +F    ++ E M+     D LH+       ++DH++ F   + Q    
Sbjct: 75  FNIQRPDSFE--NFNEVYIIQELMQ----TD-LHRVISTQMLSDDHIQYF---IYQ---- 120

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
                 A++ LH +    ++H D+KPSN+L++++    V DFGL++ +     D +  T 
Sbjct: 121 ---TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

Query: 220 SSSIGIKGTVGYVA 233
             S      V +VA
Sbjct: 175 QQSG----MVEFVA 184

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 38/168 (22%), Positives = 65/168 (38%), Gaps = 27/168 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--------FRSFVAECEALRNIRHRNL 105
           IG G +G +Y           A  V+ ++ +          F   VA+ + ++    R  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 106 TKIITI-----CSSIDSKGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNI 159
              + I         + KG  ++ +V E +  G  L+    Q               + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG------TFKKSTVLQL 156

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD--NDMVAHVGDFGLSK 205
            I +   +EY+H N     VHGDIK +N+LL   N    ++ D+GLS 
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 73.3 bits (180), Expect = 2e-15
 Identities = 39/170 (22%), Positives = 72/170 (42%), Gaps = 28/170 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMV-----VAVKVIN-----LKQKGAFRSFVAECEALRNIRHR 103
           IGQG +G +Y   +   E V       VKV       L  +  F    A+ E ++     
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 104 NLTKIITICS-----SIDSKGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRV 157
              K + +         D  G  ++ ++ +    G  L+  +++ N      + S    +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANAK----RFSRKTVL 155

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD--NDMVAHVGDFGLSK 205
            +++ +   +EY+H +     VHGDIK SN+LL+  N    ++ D+GL+ 
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.8 bits (179), Expect = 3e-15
 Identities = 42/192 (21%), Positives = 66/192 (34%), Gaps = 44/192 (22%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG G++G          + +VAVK I  +      +   E    R++RH N+ +   +  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEV-- 84

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA--------S 165
            I +      A++ EY   G L + +                    + D A        S
Sbjct: 85  -ILTP--THLAIIMEYASGGELYERI--------------CNAGRFSEDEARFFFQQLLS 127

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH--VGDFGLSKFLSSDH-LDTASETPSSS 222
            + Y H      + H D+K  N LLD        + DFG SK         +   TP+  
Sbjct: 128 GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-- 182

Query: 223 IGIKGTVGYVAP 234
                   Y+AP
Sbjct: 183 --------YIAP 186

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 73.2 bits (180), Expect = 3e-15
 Identities = 40/186 (21%), Positives = 72/186 (38%), Gaps = 28/186 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITIC 112
           +G G  G V +      +   A+K++      A R    E E      +  ++ +I+ + 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
            ++ +       +V E ++ G L   +    D       +  +   I   +  AI+YLH 
Sbjct: 125 ENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHS 179

Query: 173 NCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSKFLSSDH-LDTASETPSSSIGIKGT 228
                + H D+KP N+L      + +  + DFG +K  +S + L T             T
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT----------PCYT 226

Query: 229 VGYVAP 234
             YVAP
Sbjct: 227 PYYVAP 232

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 73.2 bits (180), Expect = 3e-15
 Identities = 42/204 (20%), Positives = 74/204 (36%), Gaps = 48/204 (23%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLTK 107
           IG+GSYG VY       E  VA+K +N      +  K   R    E   L  ++   + +
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89

Query: 108 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ--------TNDHLEVFKLSLIQRV 157
           +  +    D     F    +V E  +     D L +        T +H++     L    
Sbjct: 90  LYDLIIPDDLL--KFDELYIVLEIAD----SD-LKKLFKTPIFLTEEHIKTI---LYN-- 137

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
                +     ++H +    ++H D+KP+N LL+ D    V DFGL++ ++S+       
Sbjct: 138 -----LLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 218 TPSSSIGIKGTV--------GYVA 233
               +                +V 
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVV 213

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 71.9 bits (177), Expect = 5e-15
 Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 33/191 (17%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLTK 107
           +G G +  V K       +  A K I  ++  + R  V+      E   L+ I+H N   
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN--- 75

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +IT+    ++K      L+ E +  G L D+L +     E      ++       + + +
Sbjct: 76  VITLHEVYENK--TDVILILELVAGGELFDFLAEKESLTEEEATEFLK------QILNGV 127

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAH----VGDFGLSKFLSSDHLDTASETPSSSI 223
            YLH      + H D+KP N++L +  V      + DFGL+  +   +            
Sbjct: 128 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--------- 175

Query: 224 GIKGTVGYVAP 234
            I GT  +VAP
Sbjct: 176 NIFGTPEFVAP 186

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 70.7 bits (174), Expect = 9e-15
 Identities = 46/191 (24%), Positives = 76/191 (39%), Gaps = 33/191 (17%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLTK 107
           +G G +  V K          A K I  ++  + R  V+      E   LR IRH N   
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN--- 69

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           IIT+    ++K      L+ E +  G L D+L +     E      ++       +   +
Sbjct: 70  IITLHDIFENK--TDVVLILELVSGGELFDFLAEKESLTEDEATQFLK------QILDGV 121

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAH----VGDFGLSKFLSSDHLDTASETPSSSI 223
            YLH      + H D+KP N++L +  V +    + DFG++  + + +            
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK--------- 169

Query: 224 GIKGTVGYVAP 234
            I GT  +VAP
Sbjct: 170 NIFGTPEFVAP 180

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 71.7 bits (176), Expect = 9e-15
 Identities = 33/202 (16%), Positives = 67/202 (33%), Gaps = 64/202 (31%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G GS+G V +    E     A+K +    +   R    E + ++ + H N+ K++    
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70

Query: 114 SIDSKGADFKA---------------------------------LVFEYMENGSLEDWLH 140
           +   +                                       ++ EY+     +  LH
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP----DT-LH 125

Query: 141 QTNDH---------LEVFKLSLIQRVNIAIDVASAIEYLH-HNCQPPMVHGDIKPSNVLL 190
           +             + +  + + Q       +  A+ ++H       + H DIKP N+L+
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQ-------LFRAVGFIHSLG----ICHRDIKPQNLLV 174

Query: 191 D-NDMVAHVGDFGLSKFLSSDH 211
           +  D    + DFG +K L    
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSE 196

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 38/171 (22%), Positives = 76/171 (44%), Gaps = 29/171 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLTK 107
           IG G+ G V        E  VA+K ++         K A+R    E   ++ + H+N+  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88

Query: 108 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ--TNDHLEVFKLSLIQRVNIAIDV 163
           ++ + +   S   +F+   +V E M+  +L   +     ++ +      L Q       +
Sbjct: 89  LLNVFTPQKSLE-EFQDVYIVMELMDA-NLCQVIQMELDHERMSYL---LYQ-------M 136

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDT 214
              I++LH      ++H D+KPSN+++ +D    + DFGL++   +  + T
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.8 bits (171), Expect = 3e-14
 Identities = 28/173 (16%), Positives = 62/173 (35%), Gaps = 34/173 (19%)

Query: 54  IGQGSYGSVYKGI--------LGEDEMVVAVKV----------INLKQKGAFRSFVAECE 95
             + + G +Y+           G  +   ++K+           N  Q+ A    V + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 96  ALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLI 154
            L +     +   +            ++ LV   +  G SL+  L  +  H  V     +
Sbjct: 110 KLYSTPLLAIPTCM----GFGVHQDKYRFLVLPSL--GRSLQSALDVSPKH--VLSERSV 161

Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL--DNDMVAHVGDFGLSK 205
             + +A  +  A+E+LH N     VHG++   N+ +  ++     +  +G + 
Sbjct: 162 --LQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.2 bits (170), Expect = 4e-14
 Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 49/194 (25%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLTKI 108
           IG+G+YG V       +++ VA+K I+  +     +   R    E + L   RH N+  I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90

Query: 109 ITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------TNDHLEVFKLSLIQRVNI 159
             I  +   +    K   +V + ME     D L++       +NDH+  F   L Q    
Sbjct: 91  NDIIRAPTIE--QMKDVYIVQDLME----TD-LYKLLKTQHLSNDHICYF---LYQ---- 136

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
              +   ++Y+H      ++H D+KPSN+LL+      + DFGL++    DH  T   T 
Sbjct: 137 ---ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT- 189

Query: 220 SSSIGIKGTVGYVA 233
                      YVA
Sbjct: 190 ----------EYVA 193

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 68.7 bits (168), Expect = 1e-13
 Identities = 47/234 (20%), Positives = 92/234 (39%), Gaps = 28/234 (11%)

Query: 8   CLTIVYVRRRGSVRKPIDTLPMEKQFPMVSYAELSKATCE-FSQSNMIGQGSYGSVYKGI 66
            L  V      +  +         +F    + E      + F    ++G+G +G V+   
Sbjct: 146 LLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQ 205

Query: 67  LGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK 123
           +     + A K +N   LK++  ++  + E + L  +  R +    ++  + ++K     
Sbjct: 206 MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV---SLAYAFETKTDLC- 261

Query: 124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVASAIEYLHHNCQPPMVHGD 182
            LV   M  G +   ++  ++    F+     R       + S +E+LH      +++ D
Sbjct: 262 -LVMTIMNGGDIRYHIYNVDEDNPGFQE---PRAIFYTAQIVSGLEHLHQRN---IIYRD 314

Query: 183 IKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +KP NVLLD+D   +V   D GL+  L +                 GT G++AP
Sbjct: 315 LKPENVLLDDD--GNVRISDLGLAVELKAG-----QTKTKGYA---GTPGFMAP 358

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 38/171 (22%), Positives = 77/171 (45%), Gaps = 37/171 (21%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLTK 107
           +G G+YGSV   I       VA+K ++      +  K A+R    E   L++++H N+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87

Query: 108 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ------TNDHLEVFKLSLIQRVNI 159
           ++ + +   S   +F    LV  +M+     D L +      + + ++     + Q    
Sbjct: 88  LLDVFTP-ASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKIQYL---VYQ---- 134

Query: 160 AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
              +   ++Y+H      +VH D+KP N+ ++ D    + DFGL++   ++
Sbjct: 135 ---MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 67.7 bits (166), Expect = 1e-13
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 26/163 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINL-KQKGAFRSFVAECEALRNIR-HRNLTKIITI 111
           +G+G Y  V++ I   +   V VK++   K+K   R    E + L N+R   N+  +  I
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQ-TNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
                S+     ALVFE++ N   +      T+  +  +   +++          A++Y 
Sbjct: 100 VKDPVSRT---PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK----------ALDYC 146

Query: 171 H-HNCQPPMVHGDIKPSNVLLDND-MVAHVGDFGLSKFLSSDH 211
           H       ++H D+KP NV++D++     + D+GL++F     
Sbjct: 147 HSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 67.3 bits (165), Expect = 2e-13
 Identities = 42/201 (20%), Positives = 79/201 (39%), Gaps = 54/201 (26%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLTKII 109
           +G G  G V+  +  + +  VA+K I L      K A R    E + +R + H N+ K+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 110 TI-------CSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------TNDHLEVFKLSL 153
            I        +       +  +  +V EYME     D L           +H  +F   +
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMET----D-LANVLEQGPLLEEHARLF---M 126

Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDHL 212
            Q       +   ++Y+H      ++H D+KP+N+ ++  D+V  +GDFGL++ +   + 
Sbjct: 127 YQ-------LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 213 DTASETPSSSIGIKGTVGYVA 233
                +             + 
Sbjct: 177 HKGHLS-----------EGLV 186

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.6 bits (165), Expect = 2e-13
 Identities = 35/171 (20%), Positives = 75/171 (43%), Gaps = 29/171 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLTK 107
           IG G+ G V        +  VA+K ++         K A+R    E   ++ + H+N+  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIS 125

Query: 108 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ--TNDHLEVFKLSLIQRVNIAIDV 163
           ++ + +   +   +F+   LV E M+  +L   +     ++ +      ++         
Sbjct: 126 LLNVFTPQKTLE-EFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLC-------- 175

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDT 214
              I++LH      ++H D+KPSN+++ +D    + DFGL++   +  + T
Sbjct: 176 --GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 66.9 bits (164), Expect = 2e-13
 Identities = 37/189 (19%), Positives = 68/189 (35%), Gaps = 31/189 (16%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGA--FRSFVAECEALRNIRHRNLTKIITI 111
           +G+G +  V + I        A K +  +++G       + E   L   +     ++I +
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP--RVINL 94

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
               ++       L+ EY   G +               +S    + +   +   + YLH
Sbjct: 95  HEVYENT--SEIILILEYAAGGEIFSLCLPELAE----MVSENDVIRLIKQILEGVYYLH 148

Query: 172 HNCQPPMVHGDIKPSNVLLDND------MVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
            N    +VH D+KP N+LL +        +    DFG+S+ +                 I
Sbjct: 149 QNN---IVHLDLKPQNILLSSIYPLGDIKIV---DFGMSRKIGHACELR---------EI 193

Query: 226 KGTVGYVAP 234
            GT  Y+AP
Sbjct: 194 MGTPEYLAP 202

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 67.1 bits (164), Expect = 3e-13
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 28/192 (14%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRN 104
           F Q  ++G+G +G V    +     + A K +    +K++      + E + L  +  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           +    ++  + ++K A    LV   M  G L+  ++        F  +  + V  A ++ 
Sbjct: 246 VV---SLAYAYETKDALC--LVLTLMNGGDLKFHIYHMGQ--AGFPEA--RAVFYAAEIC 296

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSS 222
             +E LH      +V+ D+KP N+LLD+    H+   D GL+  +      T        
Sbjct: 297 CGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEG--QTIK------ 343

Query: 223 IGIKGTVGYVAP 234
            G  GTVGY+AP
Sbjct: 344 -GRVGTVGYMAP 354

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 66.1 bits (162), Expect = 4e-13
 Identities = 45/209 (21%), Positives = 76/209 (36%), Gaps = 61/209 (29%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKV------INLKQKGAFRSFVAECEALRNIR 101
           F    ++G+GS+ +V            A+K+      I   +         E + +  + 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK---VPYVTRERDVMSRLD 88

Query: 102 HRNLTKIITICSSIDSKGADFKA-----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR 156
           H    K+             F+          Y +NG L               L  I++
Sbjct: 89  HPFFVKL---------YFT-FQDDEKLYFGLSYAKNGEL---------------LKYIRK 123

Query: 157 VNI---------AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSK 205
           +             ++ SA+EYLH      ++H D+KP N+LL+ DM  H+   DFG +K
Sbjct: 124 IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDM--HIQITDFGTAK 178

Query: 206 FLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            LS +     + +        GT  YV+P
Sbjct: 179 VLSPESKQARANS------FVGTAQYVSP 201

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.6 bits (163), Expect = 4e-13
 Identities = 53/203 (26%), Positives = 82/203 (40%), Gaps = 50/203 (24%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-------HRNLT 106
           +G+G+YG V+K I      VVAVK    K   AF++        R I        H N+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK----KIFDAFQNSTDAQRTFREIMILTELSGHENIV 72

Query: 107 KIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------TNDHLEVFKLSLIQRV 157
            ++ +  +      + +   LVF+YME     D LH           H +     + Q +
Sbjct: 73  NLLNVLRA-----DNDRDVYLVFDYME----TD-LHAVIRANILEPVHKQYV---VYQLI 119

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
                    I+YLH      ++H D+KPSN+LL+ +    V DFGLS+   +    T + 
Sbjct: 120 K-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 218 TPSSSIGIKGTV-------GYVA 233
             S +   +           YVA
Sbjct: 170 PLSINENTENFDDDQPILTDYVA 192

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.7 bits (163), Expect = 5e-13
 Identities = 30/175 (17%), Positives = 68/175 (38%), Gaps = 24/175 (13%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR--------HRN 104
            +G G + +V+      +   VA+K++   +     +   E + L+ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 105 LTKIITICSSIDSKGADFK--ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
              I+ +    + KG +     +VFE +   +L   + +         L  +++  I+  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQ--ISKQ 139

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH------VGDFGLSKFLSSDH 211
           +   ++Y+H  C   ++H DIKP NVL++            + D G + +    +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 66.6 bits (163), Expect = 5e-13
 Identities = 41/172 (23%), Positives = 77/172 (44%), Gaps = 38/172 (22%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVA------ECEALRNIRHRNLTK 107
           +G G+YGSV      +  + VAVK    K    F+S +       E   L++++H N+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92

Query: 108 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------TNDHLEVFKLSLIQRVN 158
           ++ + +   S   +F    LV   M      D L+        T+DH++     + Q   
Sbjct: 93  LLDVFTPARSLE-EFNDVYLVTHLMG----AD-LNNIVKCQKLTDDHVQFL---IYQ--- 140

Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               +   ++Y+H      ++H D+KPSN+ ++ D    + DFGL++  + +
Sbjct: 141 ----ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 66.7 bits (163), Expect = 5e-13
 Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 47/202 (23%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRN 104
           F    +IG+G++  V    + +   V A+K++N   + ++G    F  E + L N   R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID-- 162
           +T++     +   +   +  LV EY   G L               L+L+ +    I   
Sbjct: 123 ITQL---HFAFQDENYLY--LVMEYYVGGDL---------------LTLLSKFGERIPAE 162

Query: 163 --------VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHL 212
                   +  AI+ +H       VH DIKP N+LLD     H+   DFG    L +D  
Sbjct: 163 MARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGT 217

Query: 213 DTASETPSSSIGIKGTVGYVAP 234
             +           GT  Y++P
Sbjct: 218 VRSL-VAV------GTPDYLSP 232

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 66.3 bits (162), Expect = 6e-13
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 16/164 (9%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHR---NLTKII 109
           +IG+GS+G V K    +    VA+K++  +++   R    E   L ++R +   N   +I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR-FHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +  +   +      + FE +   +L + + +       F L L+++   A  +   ++ 
Sbjct: 163 HMLENFTFRN--HICMTFELLSM-NLYELIKKNKFQ--GFSLPLVRK--FAHSILQCLDA 215

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAH--VGDFGLSKFLSSDH 211
           LH N    ++H D+KP N+LL     +   V DFG S +     
Sbjct: 216 LHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 65.8 bits (161), Expect = 7e-13
 Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 38/172 (22%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN------LKQKGAFRSFVAECEALRNIRHRNLTK 107
           +G G+YG+V   + G     VA+K +       L  K A+R    E   L+++RH N+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88

Query: 108 IITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ-------TNDHLEVFKLSLIQRVN 158
           ++ + +  D    DF    LV  +M      D L +         D ++     + Q   
Sbjct: 89  LLDVFTP-DETLDDFTDFYLVMPFMG----TD-LGKLMKHEKLGEDRIQFL---VYQ--- 136

Query: 159 IAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               +   + Y+H      ++H D+KP N+ ++ D    + DFGL++   S+
Sbjct: 137 ----MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 66.1 bits (161), Expect = 9e-13
 Identities = 47/193 (24%), Positives = 81/193 (41%), Gaps = 30/193 (15%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRN 104
           FS   +IG+G +G VY     +   + A+K ++   +K K      + E   L  +   +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDV 163
              I+ +  +  +        + + M  G L   L Q      VF       +   A ++
Sbjct: 251 CPFIVCMSYAFHTPDKLS--FILDLMNGGDLHYHLSQH----GVFS---EADMRFYAAEI 301

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSS 221
              +E++H+     +V+ D+KP+N+LLD     HV   D GL+   S          P +
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLACDFSKK-------KPHA 349

Query: 222 SIGIKGTVGYVAP 234
           S+   GT GY+AP
Sbjct: 350 SV---GTHGYMAP 359

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 65.4 bits (160), Expect = 1e-12
 Identities = 39/183 (21%), Positives = 64/183 (34%), Gaps = 43/183 (23%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN--LKQKGAFRSFVAECEALRNIR---------H 102
           I  GSYG+V  G+  E   V A+K +   +                R +R         H
Sbjct: 30  ISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 103 RNLTKIITICSSIDSKGADFKA--LVFEYMENGSLEDWLHQ---------TNDHLEVFKL 151
            N+  +  I    +          LV E M      D L Q         +  H++ F  
Sbjct: 89  PNILGLRDIFVHFEEP--AMHKLYLVTELMRT----D-LAQVIHDQRIVISPQHIQYF-- 139

Query: 152 SLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
            +         +   +  LH      +VH D+ P N+LL ++    + DF L++  ++D 
Sbjct: 140 -MYH-------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 212 LDT 214
             T
Sbjct: 189 NKT 191

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.6 bits (155), Expect = 4e-12
 Identities = 42/159 (26%), Positives = 62/159 (38%), Gaps = 24/159 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG G++G +  G        VA+K+     K        E         + L     I  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFY-----KQLGSGDGIPQ 69

Query: 114 SIDS-KGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
                    + A+V E +  G SLED L    D       SL   + IAI + S +EY+H
Sbjct: 70  VYYFGPCGKYNAMVLELL--GPSLED-LFDLCDR----TFSLKTVLMIAIQLISRMEYVH 122

Query: 172 HNCQPPMVHGDIKPSNVLL-----DNDMVAHVGDFGLSK 205
                 +++ D+KP N L+         V H+ DF L+K
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.2 bits (150), Expect = 1e-11
 Identities = 34/216 (15%), Positives = 60/216 (27%), Gaps = 49/216 (22%)

Query: 25  DTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVI----- 79
             +P     P        K          IG+G +G V++ I       VA+K+I     
Sbjct: 9   GPVPFSHCLPTEKLQRCEK----------IGEGVFGEVFQTIADHTP--VAIKIIAIEGP 56

Query: 80  ---NLKQKGAFRSFVAECEALR---NIRHRNLTKIITICSSIDS---KGADFKALVFEYM 130
              N   +  F   + E    +    +      +             +G+    L+  + 
Sbjct: 57  DLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116

Query: 131 ----ENGSLEDWLHQTNDH--------------LEVF---KLSLIQRVNIAIDVASAIEY 169
                 GS  D      D               LE       SL    +I   + +++  
Sbjct: 117 HYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
              + +    H D+   NVLL    +  +      K
Sbjct: 177 AEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 62.4 bits (152), Expect = 1e-11
 Identities = 42/206 (20%), Positives = 77/206 (37%), Gaps = 57/206 (27%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS----FVAECEALRNIRHR 103
           +    +IG+G++G V          V A+K+++ K +   RS    F  E + +      
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSP 129

Query: 104 NLTKIITICSSIDSKGADFKA-----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVN 158
            + ++           A F+      +V EYM  G L               ++L+   +
Sbjct: 130 WVVQL---------FYA-FQDDRYLYMVMEYMPGGDL---------------VNLMSNYD 164

Query: 159 IAIDVA--------SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLS 208
           +    A         A++ +H       +H D+KP N+LLD     H+   DFG    ++
Sbjct: 165 VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMN 219

Query: 209 SDHLDTASETPSSSIGIKGTVGYVAP 234
            + +     T        GT  Y++P
Sbjct: 220 KEGMVRCD-TAV------GTPDYISP 238

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 58/227 (25%)

Query: 29  MEKQFPMVSYAELSKATCE-FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQK 84
           +E   P  S  +  +   E F    +IG+G++G V    L   + V A+K++N   + ++
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115

Query: 85  GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA-----LVFEYMENGSLEDWL 139
                F  E + L N   + +T +           A F+      LV +Y   G L    
Sbjct: 116 AETACFREERDVLVNGDSKWITTL---------HYA-FQDDNNLYLVMDYYVGGDL---- 161

Query: 140 HQTNDHLEVFKLSLIQRVNIAID----------VASAIEYLHHNCQPPMVHGDIKPSNVL 189
                      L+L+ +    +           +  AI+ +H       VH DIKP N+L
Sbjct: 162 -----------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNIL 207

Query: 190 LDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           +D +   H+   DFG    L  D    +S          GT  Y++P
Sbjct: 208 MDMN--GHIRLADFGSCLKLMEDGTVQSS-VAV------GTPDYISP 245

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 61.2 bits (149), Expect = 2e-11
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 22/157 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG GS+G +Y G        VA+K+  +K K        E +       + +   + I +
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIY-----KMMQGGVGIPT 69

Query: 114 SIDS-KGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
                   D+  +V E +  G SLED L          K SL   + +A  + S IEY+H
Sbjct: 70  IRWCGAEGDYNVMVMELL--GPSLED-LFNFCSR----KFSLKTVLLLADQMISRIEYIH 122

Query: 172 HNCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSK 205
                  +H D+KP N L+       + ++ DFGL+K
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 42/190 (22%), Positives = 83/190 (43%), Gaps = 36/190 (18%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKII 109
            IG+GS+G V      + + + A+K +N     ++   R+   E + ++ + H  L  + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL- 80

Query: 110 TICSSIDSKGADFKA-----LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
                     + F+      +V + +  G L   L Q       FK   + ++ I  ++ 
Sbjct: 81  --------WYS-FQDEEDMFMVVDLLLGGDLRYHLQQN----VHFKEETV-KLFIC-ELV 125

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
            A++YL +     ++H D+KP N+LLD     H+ DF ++  L  +     ++  + +  
Sbjct: 126 MALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-----TQITTMA-- 175

Query: 225 IKGTVGYVAP 234
             GT  Y+AP
Sbjct: 176 --GTKPYMAP 183

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.8 bits (148), Expect = 3e-11
 Identities = 37/159 (23%), Positives = 62/159 (38%), Gaps = 24/159 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS+G +++G    +   VA+K    +          E         + L     I +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTY-----KLLAGCTGIPN 70

Query: 114 SIDS-KGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
                +      LV + +  G SLED L          K S+      A  + + ++ +H
Sbjct: 71  VYYFGQEGLHNVLVIDLL--GPSLED-LLDLCGR----KFSVKTVAMAAKQMLARVQSIH 123

Query: 172 HNCQPPMVHGDIKPSNVLL-----DNDMVAHVGDFGLSK 205
                 +V+ DIKP N L+      N  + +V DFG+ K
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.0 bits (146), Expect = 7e-11
 Identities = 34/156 (21%), Positives = 62/156 (39%), Gaps = 17/156 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEAL-RNIRHRNLTKIITIC 112
           +G G  G V +      +   A+K++      A R    E E   R  +  ++ +I+ + 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
            +    G     +V E ++ G L   +    D       +  +   I   +  AI+YLH 
Sbjct: 81  EN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHS 135

Query: 173 NCQPPMVHGDIKPSNVLL---DNDMVAHVGDFGLSK 205
                + H D+KP N+L      + +  + DFG +K
Sbjct: 136 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 22/157 (14%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG GS+G +Y G   +    VA+K+ N+K K      + E +       R L     I +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIY-----RILQGGTGIPN 67

Query: 114 SIDS-KGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
                   D+  LV + +  G SLED L          KLSL   + +A  + + +E++H
Sbjct: 68  VRWFGVEGDYNVLVMDLL--GPSLED-LFNFCSR----KLSLKTVLMLADQMINRVEFVH 120

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAH---VGDFGLSK 205
                  +H DIKP N L+     A+   + DFGL+K
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 3e-10
 Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 16/166 (9%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHR---NLTK 107
           ++IG+GS+G V K     ++  VA+K+I  K K AF      E   L  +          
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           I+ +      +      LVFE +   +L D L  TN       L+L ++   A  + +A+
Sbjct: 118 IVHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTN--FRGVSLNLTRK--FAQQMCTAL 170

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAH--VGDFGLSKFLSSDH 211
            +L    +  ++H D+KP N+LL N   +   + DFG S  L    
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 58.4 bits (141), Expect = 3e-10
 Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 23/149 (15%)

Query: 53  MIGQGSYGSVYKGILGEDEMV---VAVKVINLKQKGAFRSFVAECEALRNIR-----HRN 104
            +G G + +V+   L  D      VA+KV+   +     + + E   L+++R       N
Sbjct: 44  KLGWGHFSTVW---LSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPN 99

Query: 105 LTKIITICSS--IDSKGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
              ++ +     I         +VFE +  G  L  W+ ++N       L  +++  I  
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQG--LPLPCVKK--IIQ 153

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
            V   ++YLH  C+  ++H DIKP N+LL
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILL 180

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 57.8 bits (140), Expect = 5e-10
 Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 26/186 (13%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           ++G+G++G V            A+K++    +  K      + E   L+N RH  LT + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVASAIE 168
               S  +        V EY   G L   L +      VF      R      ++ SA++
Sbjct: 215 ---YSFQTHDRLC--FVMEYANGGELFFHLSRE----RVFSED---RARFYGAEIVSALD 262

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           YLH      +V+ D+K  N++LD D    + DFGL K    D     +          GT
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--------FCGT 312

Query: 229 VGYVAP 234
             Y+AP
Sbjct: 313 PEYLAP 318

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 54.3 bits (131), Expect = 6e-09
 Identities = 32/147 (21%), Positives = 67/147 (45%), Gaps = 19/147 (12%)

Query: 53  MIGQGSYGSVYKGI-LGEDEMVVAVKVINLKQKGAFR--SFVAECEALRNIRHR---NLT 106
            +G+G++G V + +     +  VA+K+I  +  G +R  + + E   L+ I+ +   N  
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARL-EINVLKKIKEKDKENKF 82

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
             + +    +  G     + FE +   +  ++L + N     + L  ++   +A  +  A
Sbjct: 83  LCVLMSDWFNFHG--HMCIAFELLGK-NTFEFLKENNFQ--PYPLPHVRH--MAYQLCHA 135

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDND 193
           + +LH N    + H D+KP N+L  N 
Sbjct: 136 LRFLHENQ---LTHTDLKPENILFVNS 159

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.3 bits (131), Expect = 7e-09
 Identities = 34/144 (23%), Positives = 63/144 (43%), Gaps = 15/144 (10%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIRHR--NLTKII 109
            +G G++G V      +++   AVKV+  +    +  S   E + L+ I++   N   I+
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
                          L+FE +   SL + + + N +   F +  I+     I++  A+ Y
Sbjct: 100 KYHGKFMYYD--HMCLIFEPLGP-SLYEIITRNNYN--GFHIEDIKL--YCIEILKALNY 152

Query: 170 LHHNCQPPMVHGDIKPSNVLLDND 193
           L       + H D+KP N+LLD+ 
Sbjct: 153 LRKMS---LTHTDLKPENILLDDP 173

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 54.1 bits (131), Expect = 8e-09
 Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 35/191 (18%)

Query: 53  MIGQGSYGSVY---KGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLT 106
           ++GQGS+G V+   K    +   + A+KV+    LK +   R+   E + L  + H  + 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 89

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVAS 165
           K+     +  ++G  +  L+ +++  G L   L +      +F       V     ++A 
Sbjct: 90  KLH---YAFQTEGKLY--LILDFLRGGDLFTRLSKE----VMFTEE---DVKFYLAELAL 137

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSI 223
           A+++LH      +++ D+KP N+LLD +   H+   DFGLSK  S DH   A  +     
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK-ESIDHEKKAY-S----- 185

Query: 224 GIKGTVGYVAP 234
              GTV Y+AP
Sbjct: 186 -FCGTVEYMAP 195

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 53.0 bits (128), Expect = 2e-08
 Identities = 49/188 (26%), Positives = 76/188 (40%), Gaps = 31/188 (16%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLTKII 109
           ++G+G++G V            A+K++    +  K      V E   L+N RH  LT + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVASAIE 168
               +  +        V EY   G L   L +      VF      R      ++ SA+E
Sbjct: 72  ---YAFQTHDRLC--FVMEYANGGELFFHLSRE----RVFTEE---RARFYGAEIVSALE 119

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIGIK 226
           YLH      +V+ DIK  N++LD D   H+   DFGL K    + +   +   +      
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK----EGISDGATMKT----FC 166

Query: 227 GTVGYVAP 234
           GT  Y+AP
Sbjct: 167 GTPEYLAP 174

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 52.3 bits (126), Expect = 3e-08
 Identities = 31/147 (21%), Positives = 64/147 (43%), Gaps = 19/147 (12%)

Query: 53  MIGQGSYGSVYKGI-LGEDEMVVAVKVINLKQKGAFR--SFVAECEALRNIRHR---NLT 106
            +G+G++G V + I        VAVK++  K    +   +   E + L ++      +  
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARS-EIQVLEHLNTTDPNSTF 77

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           + + +    +  G     +VFE +   S  D++ +       F+L  I++  +A  +  +
Sbjct: 78  RCVQMLEWFEHHG--HICIVFELLGL-STYDFIKENGFL--PFRLDHIRK--MAYQICKS 130

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDND 193
           + +LH N    + H D+KP N+L    
Sbjct: 131 VNFLHSNK---LTHTDLKPENILFVQS 154

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 51.9 bits (125), Expect = 4e-08
 Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 55/203 (27%)

Query: 53  MIGQGSYGSVY---KGILGEDEMVVAVKVINLKQKGAFRSFVAEC-EALRNIRHRNLTK- 107
           ++G G+YG V+   K    +   + A+KV+  K     ++   E     R +    L   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-KATIVQKAKTTEHTRTERQV----LEHI 115

Query: 108 -----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI--- 159
                ++T+  +  ++      L+ +Y+  G             E+F  + + +      
Sbjct: 116 RQSPFLVTLHYAFQTETKLH--LILDYINGG-------------ELF--THLSQRERFTE 158

Query: 160 ------AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDH 211
                   ++  A+E+LH      +++ DIK  N+LLD++   HV   DFGLSK   +D 
Sbjct: 159 HEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADE 213

Query: 212 LDTASETPSSSIGIKGTVGYVAP 234
            + A           GT+ Y+AP
Sbjct: 214 TERAY-D------FCGTIEYMAP 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 51.8 bits (125), Expect = 4e-08
 Identities = 45/191 (23%), Positives = 82/191 (42%), Gaps = 33/191 (17%)

Query: 53  MIGQGSYGSVY---KGILGEDEMVVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNL 105
           ++G+G YG V+   K        + A+KV+     ++         AE   L  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
             +I    +  + G  +  L+ EY+  G L   L +      +F         +A +++ 
Sbjct: 84  VDLI---YAFQTGGKLY--LILEYLSGGELFMQLERE----GIFMEDTA-CFYLA-EISM 132

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSI 223
           A+ +LH      +++ D+KP N++L++    HV   DFGL K    D   T +       
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHT------- 180

Query: 224 GIKGTVGYVAP 234
              GT+ Y+AP
Sbjct: 181 -FCGTIEYMAP 190

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.5 bits (123), Expect = 6e-08
 Identities = 25/101 (24%), Positives = 44/101 (43%), Gaps = 6/101 (5%)

Query: 112 CSSIDSKGADFKALVFEYMENGSLED-WLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
              +DS  +   +    ++E  SL D    +  + L    L+L   +  +  VA  +E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 171 -HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
               C    +H D+   N+LL    V  + DFGL++ +  D
Sbjct: 210 ASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKD 246

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.2 bits (117), Expect = 3e-07
 Identities = 29/138 (21%), Positives = 59/138 (42%), Gaps = 23/138 (16%)

Query: 27  LPMEKQFPMVSYAELSKATCEFSQSN-----MIGQGSYGSVYKGIL-----GEDEMVVAV 76
           LP+++    + Y + SK   EF +        +G+G++G V +              VAV
Sbjct: 1   LPLDEHCERLPY-DASK--WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 57

Query: 77  KVINLKQK---GAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMEN 132
           K+  LK+       R+ ++E + L +I  H N+  ++  C+           ++ E+ + 
Sbjct: 58  KM--LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKF 111

Query: 133 GSLEDWLHQTNDHLEVFK 150
           G+L  +L    +    +K
Sbjct: 112 GNLSTYLRSKRNEFVPYK 129

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 50.7 bits (122), Expect = 1e-07
 Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 37/172 (21%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFV----AECEALRNIRH 102
           +F +   +G GS+G V      E     A+K+++ KQK      +     E   L+ +  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI--- 159
             L K+    S  D+       +V EY+  G             E+F  S ++R+     
Sbjct: 101 PFLVKLE--FSFKDN---SNLYMVMEYVAGG-------------EMF--SHLRRIGRFSE 140

Query: 160 ------AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK 205
                 A  +    EYLH      +++ D+KP N+L+D      V DFG +K
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK 189

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 49.8 bits (120), Expect = 2e-07
 Identities = 43/179 (24%), Positives = 73/179 (40%), Gaps = 53/179 (29%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKV------INLKQKGAFRSFV----AECEAL 97
           F     +G GS+G V+      +    A+KV      + LKQ       V     E   L
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-------VEHTNDERLML 60

Query: 98  RNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
             + H  + ++    +  D+       ++ +Y+E G             E+F  SL+++ 
Sbjct: 61  SIVTHPFIIRMW--GTFQDA---QQIFMIMDYIEGG-------------ELF--SLLRKS 100

Query: 158 NI---------AIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSK 205
                      A +V  A+EYLH      +++ D+KP N+LLD +   H+   DFG +K
Sbjct: 101 QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAK 154

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 41/188 (21%), Positives = 77/188 (40%), Gaps = 30/188 (15%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEAL-RNIRHRNLTKI 108
           ++G+GS+G V        + + AVK++    + Q       + E   L    +   LT++
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
               S   +    +   V EY+  G L   + Q        +      V  A ++A  + 
Sbjct: 408 H---SCFQTMDRLY--FVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLF 456

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +L       +++ D+K  NV+LD++   H+   DFG+ K    +++     T +      
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK----ENIWDGVTTKT----FC 503

Query: 227 GTVGYVAP 234
           GT  Y+AP
Sbjct: 504 GTPDYIAP 511

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 48.0 bits (115), Expect = 7e-07
 Identities = 38/159 (23%), Positives = 65/159 (40%), Gaps = 22/159 (13%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEAL-RNIRHRNLTKI 108
           M+G+GS+G V+     +     A+K +    +         + E   L     H  LT +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
                +  +K   F   V EY+  G L   +   +      K  L +    A ++   ++
Sbjct: 84  F---CTFQTKENLF--FVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQ 132

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSK 205
           +LH      +V+ D+K  N+LLD D   H+   DFG+ K
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK 166

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 47.6 bits (114), Expect = 1e-06
 Identities = 35/164 (21%), Positives = 67/164 (40%), Gaps = 32/164 (19%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNI-----RHRN 104
           ++G+GS+G V        + + AVK++    + Q       + E    + +     +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE----KRVLALPGKPPF 82

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDV 163
           LT++    S   +    +   V EY+  G L   + Q       FK          A ++
Sbjct: 83  LTQLH---SCFQTMDRLY--FVMEYVNGGDLMYHIQQV----GRFKEP---HAVFYAAEI 130

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSK 205
           A  + +L       +++ D+K  NV+LD++   H+   DFG+ K
Sbjct: 131 AIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK 169

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 53/189 (28%), Positives = 88/189 (46%), Gaps = 32/189 (16%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEAL-RNIRHRNLTKI 108
           +IG+GS+G V       +E+  AVKV+    + +K   +  ++E   L +N++H  L  +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVASAI 167
                S  +    +   V +Y+  G L   L +       F      R    A ++ASA+
Sbjct: 105 H---FSFQTADKLY--FVLDYINGGELFYHLQRE----RCFLEP---RARFYAAEIASAL 152

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIGI 225
            YLH      +V+ D+KP N+LLD+    H+   DFGL K    ++++  S T +     
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK----ENIEHNSTTST----F 199

Query: 226 KGTVGYVAP 234
            GT  Y+AP
Sbjct: 200 CGTPEYLAP 208

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 39/194 (20%), Positives = 77/194 (39%), Gaps = 42/194 (21%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLTK-- 107
           +IG+GSY  V    L + + + A++V+    +           E    +++      +  
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE----KHV----FEQAS 110

Query: 108 ----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AID 162
               ++ + S   ++   F   V EY+  G L   + +                   + +
Sbjct: 111 NHPFLVGLHSCFQTESRLF--FVIEYVNGGDLMFHMQRQ----RKLPEE---HARFYSAE 161

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPS 220
           ++ A+ YLH      +++ D+K  NVLLD++   H+   D+G+ K    + L     T +
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK----EGLRPGDTTST 212

Query: 221 SSIGIKGTVGYVAP 234
                 GT  Y+AP
Sbjct: 213 ----FCGTPNYIAP 222

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 46.5 bits (111), Expect = 2e-06
 Identities = 40/191 (20%), Positives = 79/191 (41%), Gaps = 36/191 (18%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK----- 107
           +IG+GSY  V    L + + + A+KV+  K+       +   +  +++      +     
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHV----FEQASNHP 70

Query: 108 -IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNI-AIDVAS 165
            ++ + S   ++   F   V EY+  G L   + +                   + +++ 
Sbjct: 71  FLVGLHSCFQTESRLF--FVIEYVNGGDLMFHMQRQ----RKLPEE---HARFYSAEISL 121

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSI 223
           A+ YLH      +++ D+K  NVLLD++   H+   D+G+ K    + L     T +   
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK----EGLRPGDTTST--- 169

Query: 224 GIKGTVGYVAP 234
              GT  Y+AP
Sbjct: 170 -FCGTPNYIAP 179

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 45.7 bits (109), Expect = 4e-06
 Identities = 42/193 (21%), Positives = 78/193 (40%), Gaps = 40/193 (20%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVI---NLKQKGAFRSFVAECEALRNIRHRNLTK-- 107
           ++G+GS+G V    + E   + AVKV+    + Q       + E    + I    L+   
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE----KRI----LSLAR 81

Query: 108 ----IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
               +  +     +    F   V E++  G L   + ++       +    +    A ++
Sbjct: 82  NHPFLTQLFCCFQTPDRLF--FVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEI 133

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSS 221
            SA+ +LH      +++ D+K  NVLLD++   H    DFG+ K    + +     T + 
Sbjct: 134 ISALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK----EGICNGVTTAT- 183

Query: 222 SIGIKGTVGYVAP 234
                GT  Y+AP
Sbjct: 184 ---FCGTPDYIAP 193

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 39.2 bits (92), Expect = 7e-04
 Identities = 33/202 (16%), Positives = 69/202 (34%), Gaps = 47/202 (23%)

Query: 21  RKPIDTLPMEKQFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN 80
               D +        V++ +  K        ++IG+G+   + +    + ++++  +V  
Sbjct: 318 NYRTDMVE-------VNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERV-- 368

Query: 81  LKQKGAFRSFVAECEALRNIRHRNLTKIIT----------ICSSIDSKGADFKALVFEYM 130
              K  +R    + E +R  R     + +               +D    D K ++  Y+
Sbjct: 369 ---KKGYRDERLD-ENIRKSRTAREARYLALVKDFGIPAPYIFDVD---LDNKRIMMSYI 421

Query: 131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL 190
                +D +    D                  +   +  LH N    ++H D+  SN + 
Sbjct: 422 NGKLAKDVIEDNLDIAY--------------KIGEIVGKLHKN---DVIHNDLTTSNFIF 464

Query: 191 DNDMVAHVGDFGLSKFLSSDHL 212
           D D+   + DFGL K   S+  
Sbjct: 465 DKDLY--IIDFGLGKI--SNLD 482

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	234
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.98
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.98
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.98
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.98
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.98
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.98
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.98
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.98
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.98
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.98
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.98
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.98
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.98
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.98
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.98
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.98
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.98
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.97
3niz_A	311	Rhodanese family protein; structural genomics, str	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.96
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.96
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.96
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.96
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.95
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.95
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.95
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.94
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.15
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.86
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.86
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.59
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.35
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.3
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.18
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.86
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.55
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.41
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.39
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.14
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.98
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.88
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.87
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.79
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.53
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	91.3
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	90.61
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	90.49
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	90.14
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.49
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	83.85
3mes_A	424	Choline kinase; malaria, structural genomics, stru	80.55

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-43  Score=288.69  Aligned_cols=169  Identities=24%  Similarity=0.421  Sum_probs=147.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|+++|+.++||||+++++++..     .+.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence            4699999999999999999999999999999999743   33445789999999999999999999999853     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +|+||||+++|+|.+++.+.+      .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence            899999999999999998765      689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+.+........      ...++||+.||||
T Consensus       178 la~~~~~~~~~~~------~~~~~GTp~YmAP  203 (311)
T 4aw0_A          178 TAKVLSPESKQAR------ANSFVGTAQYVSP  203 (311)
T ss_dssp             TCEECCTTTTCCC------BCCCCSCGGGCCH
T ss_pred             CceecCCCCCccc------ccCcccCcccCCH
Confidence            9998754322211      1137899999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.4e-43  Score=289.01  Aligned_cols=166  Identities=26%  Similarity=0.386  Sum_probs=146.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      ..|+..+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|+.++||||+++++++...     +.+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence            4588999999999999999999999999999999866555567789999999999999999999998543     44799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      |||||++|+|.+++...       .+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||+|+
T Consensus       149 vmEy~~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EECCCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence            99999999999998753       588999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+.......        ...+||+.||||
T Consensus       219 ~~~~~~~~~--------~~~~GTp~YmAP  239 (346)
T 4fih_A          219 QVSKEVPRR--------KSLVGTPYWMAP  239 (346)
T ss_dssp             ECCSSSCCB--------CCCCSCGGGCCH
T ss_pred             ecCCCCCcc--------cccccCcCcCCH
Confidence            765432211        127899999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=290.98  Aligned_cols=166  Identities=26%  Similarity=0.386  Sum_probs=146.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      ..|+..+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+.+|+.++||||+++++++...     +.+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence            4689999999999999999999999999999999866555567789999999999999999999998643     45799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      |||||++|+|.+++...       .+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||+|+
T Consensus       226 VmEy~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEECCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence            99999999999998653       588999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+.......        ...+||+.||||
T Consensus       296 ~~~~~~~~~--------~~~~GTp~YmAP  316 (423)
T 4fie_A          296 QVSKEVPRR--------KSLVGTPYWMAP  316 (423)
T ss_dssp             ECCSSCCCB--------CCCEECTTTCCH
T ss_pred             ECCCCCccc--------cccccCcCcCCH
Confidence            765432211        127899999998

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.9e-43  Score=289.26  Aligned_cols=169  Identities=24%  Similarity=0.352  Sum_probs=139.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++.+.||+|+||+||+|+++.+++.||||+++..  .....+.+.+|+.+|+.++||||+++++++..     .+.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEE
Confidence            4799999999999999999999999999999999744  23345789999999999999999999999854     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      |||||||++|+|.+++......    .+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||+
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl  171 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGV----LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI  171 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred             EEEEeCCCCCcHHHHHHHcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence            9999999999999999765422    578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+........        ....+||+.||||
T Consensus       172 a~~~~~~~~~--------~~~~~GT~~YmAP  194 (350)
T 4b9d_A          172 ARVLNSTVEL--------ARACIGTPYYLSP  194 (350)
T ss_dssp             ESCCCHHHHH--------HHHHHSCCTTCCH
T ss_pred             ceeecCCccc--------ccccCCCccccCH
Confidence            9976542111        1126899999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.1e-42  Score=277.56  Aligned_cols=166  Identities=25%  Similarity=0.432  Sum_probs=141.5

Q ss_pred             CCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceee
Q 039258           49 SQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      +..+.||+|+||+||+|.+..++..||+|.+...  .....+.+.+|+++|+.++||||+++++++.... .+...++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence            5567899999999999999999999999999643  2334577999999999999999999999986532 234557999


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeeeC-CCCceEEccCcc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP--MVHGDIKPSNVLLD-NDMVAHVGDFGL  203 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--ivH~dlk~~nil~~-~~~~vki~dfG~  203 (234)
                      ||||++|+|.+++...+      .+++..+..++.||+.||.|||++   +  ||||||||+|||++ .++.+||+|||+
T Consensus       108 mEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGl  178 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence            99999999999998765      688999999999999999999998   6  99999999999997 478999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+.......          ...+||+.||||
T Consensus       179 a~~~~~~~~----------~~~~GTp~YmAP  199 (290)
T 3fpq_A          179 ATLKRASFA----------KAVIGTPEFMAP  199 (290)
T ss_dssp             GGGCCTTSB----------EESCSSCCCCCG
T ss_pred             CEeCCCCcc----------CCcccCccccCH
Confidence            986433211          136899999999

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-41  Score=274.10  Aligned_cols=165  Identities=30%  Similarity=0.477  Sum_probs=131.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++..   .....+++.+|+++|+.++||||+++++++..     .+.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence            5799999999999999999999999999999999643   23344678999999999999999999999753     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +++||||+ +|+|.+++...+      .+++..+..++.||+.||+|+|++   +|+||||||+|||++.++.+||+|||
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             EEEEEeCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecC
Confidence            79999999 679999998765      689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+........         ...+||+.||||
T Consensus       158 la~~~~~~~~~---------~~~~GT~~Y~AP  180 (275)
T 3hyh_A          158 LSNIMTDGNFL---------KTSCGSPNYAAP  180 (275)
T ss_dssp             CC------------------------CTTSCH
T ss_pred             CCeecCCCCcc---------CCeeECcccCCh
Confidence            99875443211         126899999998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-41  Score=276.92  Aligned_cols=184  Identities=24%  Similarity=0.417  Sum_probs=137.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC------
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS------  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~------  117 (234)
                      ..+|++.+.||+|+||+||+|+++.+++.||||.++... ....+.+.+|+.+|+.++||||+++++++...+.      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            346889999999999999999999999999999997543 3344678999999999999999999998865432      


Q ss_pred             -CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCce
Q 039258          118 -KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       118 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~v  196 (234)
                       ....++|+||||+++|+|.+++.......   ..++..++.++.|++.||+|||++   +|+||||||+|||++.++.+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~---~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIE---ERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGG---GSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCC---hhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence             12345789999999999999998654221   345566789999999999999999   99999999999999999999


Q ss_pred             EEccCccccccCCCccCCCC----CCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTAS----ETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|||+|+...........    .......+.+||+.||||
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP  199 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP  199 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCH
Confidence            99999999987654322111    011112236899999998

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-41  Score=276.69  Aligned_cols=175  Identities=26%  Similarity=0.465  Sum_probs=142.3

Q ss_pred             cCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|.+.+.||+|+||+||+|++.     .++..||||.++.......+.|.+|+++|++++||||++++++|..     .
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence            45778899999999999999875     3578999999986665666889999999999999999999999853     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccC-------CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC
Q 039258          121 DFKALVFEYMENGSLEDWLHQTND-------HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~  193 (234)
                      +.++||||||++|+|.+++...+.       ......+++..++.++.||+.||.|||++   +||||||||+|||++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            347999999999999999976431       11223689999999999999999999999   99999999999999999


Q ss_pred             CceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          194 MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       194 ~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.+||+|||+|+...........      ...+||+.||||
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~------~~~~gt~~ymAP  199 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVG------GHTMLPIRWMPP  199 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEET------TTEEECGGGCCH
T ss_pred             CcEEECCcccceecCCCCceeec------CceecChhhcCH
Confidence            99999999999876543221111      114699999998

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-41  Score=280.15  Aligned_cols=168  Identities=26%  Similarity=0.338  Sum_probs=138.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ...|+..+.||+|+||+||+|+++.+++.||||+++....     ..+|+.+|..++||||+++++++..     .+.++
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-----GPWVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            3457778899999999999999999999999999975422     2469999999999999999999854     34579


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC-ceEEccCcc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGL  203 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~-~vki~dfG~  203 (234)
                      |||||+++|+|.+++...+      .+++..+..++.||+.||.|||++   +||||||||+|||++.++ .+||+|||+
T Consensus       127 ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl  197 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH  197 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred             EEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence            9999999999999998765      689999999999999999999999   999999999999999887 699999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+.+..+......   .....++||+.||||
T Consensus       198 a~~~~~~~~~~~~---~~~~~~~GT~~YmAP  225 (336)
T 4g3f_A          198 ALCLQPDGLGKSL---LTGDYIPGTETHMAP  225 (336)
T ss_dssp             CEEC---------------CCCCCCGGGCCH
T ss_pred             CeEccCCCcccce---ecCCccccCccccCH
Confidence            9987654322110   011126899999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.2e-41  Score=276.26  Aligned_cols=175  Identities=26%  Similarity=0.450  Sum_probs=137.3

Q ss_pred             cCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|.+.+.||+|+||+||+|+++     .++..||||+++.......+.|.+|+++|.+++||||++++++|..     .
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            45677789999999999999875     3578999999986666666889999999999999999999999853     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCC---------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDH---------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                      ..++|||||+++|+|.+++......         .....+++.+++.++.||+.||.|||++   +||||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence            3479999999999999999765321         1123588999999999999999999999   999999999999999


Q ss_pred             CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          192 NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       192 ~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .++.+||+|||+|+...........      ...+||+.||||
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~------~~~~gt~~ymAP  229 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVG------GRTMLPIRWMPP  229 (329)
T ss_dssp             TTTEEEECCCC----------------------CCCCGGGCCH
T ss_pred             CCCcEEEcccccceeccCCCcceec------CcccccccccCh
Confidence            9999999999999876543222111      125799999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1e-41  Score=278.12  Aligned_cols=167  Identities=25%  Similarity=0.333  Sum_probs=135.7

Q ss_pred             cCCCCCceeecccceEEEEEEEC---CCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILG---EDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|++.+.||+|+||+||+|++.   .+++.||||+++...  .....++.+|+++|..++||||+++++++..     .
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence            46999999999999999999874   467899999996432  2233568889999999999999999999854     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      +.+++||||+++|+|.+++.+.+      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  169 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD  169 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence            44799999999999999998765      689999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|+.........        ...+||+.||||
T Consensus       170 FGla~~~~~~~~~~--------~~~~GT~~YmAP  195 (304)
T 3ubd_A          170 FGLSKESIDHEKKA--------YSFCGTVEYMAP  195 (304)
T ss_dssp             SEEEEC-----CCC--------CSCCCCGGGCCH
T ss_pred             cccceeccCCCccc--------cccccCcccCCH
Confidence            99998654432211        126899999998

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=272.28  Aligned_cols=167  Identities=32%  Similarity=0.519  Sum_probs=136.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..++++.+.||+|+||+||+|++..   .||||+++..  .....+.|.+|+.+|++++||||+++++++..      +.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence            4567888999999999999998753   4999999743  33445789999999999999999999998732      23


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      ++||||||++|+|.+++.....     .+++..++.++.||+.||.|||++   +||||||||+|||++.++.+||+|||
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             EEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence            6899999999999999976532     688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+...........      ...+||+.||||
T Consensus       178 la~~~~~~~~~~~~------~~~~GT~~ymAP  203 (307)
T 3omv_A          178 LATVKSRWSGSQQV------EQPTGSVLWMAP  203 (307)
T ss_dssp             SCBC------------------CCCCTTSCCH
T ss_pred             CceecccCCcceee------cccccCCCccCH
Confidence            99876543221111      126799999998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.1e-40  Score=269.76  Aligned_cols=174  Identities=22%  Similarity=0.344  Sum_probs=140.1

Q ss_pred             CCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           47 EFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ++++.+.||+|+||+||+|.+.     .+++.||||.++... ....+.|.+|+.++.+++||||++++|+|...     
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-----  101 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-----  101 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-----
Confidence            3556788999999999999864     356899999997442 33457899999999999999999999998532     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCC----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDH----------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL  190 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~  190 (234)
                      ..++||||||++|+|.+++......          .....+++..++.++.||+.||.|||++   +||||||||+|||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            3469999999999999999754321          1123588999999999999999999999   99999999999999


Q ss_pred             CCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          191 DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       191 ~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.++.+||+|||+|+...........      ...+||+.||||
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~------~~~~gt~~ymAP  216 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLL------GNSLLPIRWMAP  216 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSS------SSSCBCGGGCCH
T ss_pred             CCCCCEEECCcccceeccCCCceeEe------cccccCCcccCH
Confidence            99999999999999876543222111      125799999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=272.65  Aligned_cols=175  Identities=24%  Similarity=0.350  Sum_probs=144.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~~  122 (234)
                      .+|++.+.||+|+||+||+|+++.+|+.||||+++...  ....+++.+|+.+|+.++||||+++++++..... .....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            46899999999999999999999999999999996432  2344678899999999999999999998765322 23456


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +||||||++ |+|.+++...+      .+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence            799999996 68999998765      689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+.+........    ......+||+.||||
T Consensus       204 la~~~~~~~~~~~----~~~~~~~GT~~Y~AP  231 (398)
T 4b99_A          204 MARGLCTSPAEHQ----YFMTEYVATRWYRAP  231 (398)
T ss_dssp             TCBCC-------C----CCCCSSCCCCTTCCH
T ss_pred             eeeecccCccccc----cccccceeChHhcCH
Confidence            9987654322111    111237899999998

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.6e-39  Score=268.58  Aligned_cols=183  Identities=21%  Similarity=0.331  Sum_probs=146.5

Q ss_pred             HHHHHHhcCCCCCceeecccceEEEEEEECCC-----CeEEEEEEeeccc-chhhHHHHHHHHHHHhcCC-CCceeEEEE
Q 039258           39 AELSKATCEFSQSNMIGQGSYGSVYKGILGED-----EMVVAVKVINLKQ-KGAFRSFVAECEALRNIRH-RNLTKIITI  111 (234)
Q Consensus        39 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~l~~~  111 (234)
                      .++.....+|++.+.||+|+||+||+|.+..+     ++.||||.++... ....+.+.+|+.+|..+.| |||++++++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            34445567899999999999999999997643     3689999997543 3345779999999999965 899999999


Q ss_pred             eeecCCCCCCcceeeEeecCCCCHHHHhhhccCC----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 039258          112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDH----------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHG  181 (234)
Q Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~  181 (234)
                      |...    ...++||||||++|+|.+++......          .....+++..++.++.||+.||.|||++   +||||
T Consensus       137 ~~~~----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR  209 (353)
T 4ase_A          137 CTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  209 (353)
T ss_dssp             ECCT----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEec----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence            8532    33478999999999999999764321          0122478899999999999999999999   99999


Q ss_pred             CCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          182 DIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       182 dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||||+|||++.++.+||+|||+|+.+..+.....      ....+||+.||||
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~------~~~~~gt~~ymAP  256 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMAP  256 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEE------ETTEEECGGGCCH
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCcee------eccccccccccCH
Confidence            9999999999999999999999997654322111      1126799999998

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.4e-39  Score=261.61  Aligned_cols=172  Identities=27%  Similarity=0.402  Sum_probs=133.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHH--HHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFV--AECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++....   +.+.  .|+..+..++||||++++++|...+. ....+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEE
Confidence            3577788999999999999998  578999999964432   2333  45555567899999999999875432 23346


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCCeeeCCCCceEE
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC-----QPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-----~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                      +|||||+++|+|.+++...       .+++..+..++.|++.||.|+|+++     ..+||||||||+|||++.++++||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             EEEecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence            8999999999999999754       5788899999999999999999752     348999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+|+..........    ......+||+.||||
T Consensus       150 ~DFGla~~~~~~~~~~~----~~~~~~~GT~~ymAP  181 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTID----IAPNHRVGTKRYMAP  181 (303)
T ss_dssp             CCCTTCEEEETTTTEES----CC-----CCGGGCCH
T ss_pred             EeCCCCccccCCCCcee----eecccccccccccCH
Confidence            99999987654322111    111125799999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-38  Score=280.78  Aligned_cols=165  Identities=24%  Similarity=0.327  Sum_probs=140.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHH---HHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSF---VAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~---~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++..   ........   ..++.++..++||||+++++++..     
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-----  263 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----  263 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-----
Confidence            5799999999999999999999999999999999632   11222233   334666777899999999999853     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      .+.+|+||||++||+|.+++...+      .+++..+..++.||+.||.|||++   +||||||||+|||++.+|.+||+
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~  334 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS  334 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEec
Confidence            455899999999999999998765      689999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+|+........          +.+||+.||||
T Consensus       335 DFGlA~~~~~~~~~----------t~~GTp~YmAP  359 (689)
T 3v5w_A          335 DLGLACDFSKKKPH----------ASVGTHGYMAP  359 (689)
T ss_dssp             CCTTCEECSSCCCC----------SCCSCGGGCCH
T ss_pred             ccceeeecCCCCCC----------CccCCcCccCH
Confidence            99999876543221          27899999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.5e-37  Score=272.78  Aligned_cols=167  Identities=21%  Similarity=0.335  Sum_probs=145.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|++.+.||+|+||+||+|.++.+|+.||+|++........+.+.+|+.+|..++||||+++++++..     ...+++
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEE
Confidence            578999999999999999999999999999999976655556788999999999999999999999853     445899


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC--CCceEEccCcc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN--DMVAHVGDFGL  203 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~--~~~vki~dfG~  203 (234)
                      |||||++|+|.+++.....     .+++..+..++.||+.||.|||++   +|+||||||+|||++.  .+.+||+|||+
T Consensus       232 v~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~  303 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL  303 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred             EEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccc
Confidence            9999999999999875432     688899999999999999999999   9999999999999974  48999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+.+......         ...+||+.||||
T Consensus       304 a~~~~~~~~~---------~~~~GT~~y~AP  325 (573)
T 3uto_A          304 TAHLDPKQSV---------KVTTGTAEFAAP  325 (573)
T ss_dssp             CEECCTTSEE---------EEECSSGGGCCH
T ss_pred             eeEccCCCce---------eeeEECccccCH
Confidence            9986543211         126899999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.3e-37  Score=256.66  Aligned_cols=151  Identities=24%  Similarity=0.333  Sum_probs=130.1

Q ss_pred             HHHHHhcCCCCCceeecccceEEEEEEEC---CCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeec
Q 039258           40 ELSKATCEFSQSNMIGQGSYGSVYKGILG---EDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSI  115 (234)
Q Consensus        40 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~  115 (234)
                      ..+...+.|++.+.||+|+||+||+|+++   .+++.||+|.+....  ...++.+|+++|..+ +||||+++++++.. 
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-   91 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK-   91 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-
Confidence            34556678999999999999999999874   467899999986433  235678999999988 69999999998754 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC-C
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND-M  194 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~-~  194 (234)
                          .+++++||||+++++|.+++.         .+++..+..++.|++.||.|||++   +|+||||||+|||++.+ +
T Consensus        92 ----~~~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~  155 (361)
T 4f9c_A           92 ----NDHVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLK  155 (361)
T ss_dssp             ----TTEEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred             ----CCEEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCC
Confidence                345799999999999999984         478889999999999999999999   99999999999999865 7


Q ss_pred             ceEEccCccccccCC
Q 039258          195 VAHVGDFGLSKFLSS  209 (234)
Q Consensus       195 ~vki~dfG~a~~~~~  209 (234)
                      .+||+|||+|+...+
T Consensus       156 ~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          156 KYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEECCCTTCEECTT
T ss_pred             eEEECcCCCCcccCC
Confidence            999999999987654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-34  Score=238.63  Aligned_cols=169  Identities=24%  Similarity=0.385  Sum_probs=146.3

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ....+|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++..++||||+++++++..     .
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~   86 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----E   86 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----C
Confidence            3456899999999999999999999999999999999644  23345678899999999999999999999753     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++...+      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~D  157 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIAD  157 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             CEEEEEEECCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEee
Confidence            44799999999999999998765      688899999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++.........         ...+||+.|+||
T Consensus       158 FG~a~~~~~~~~~---------~~~~gt~~y~aP  182 (328)
T 3fe3_A          158 FGFSNEFTVGGKL---------DAFCGAPPYAAP  182 (328)
T ss_dssp             TTCCGGGSSSCGG---------GTTSSSGGGCCH
T ss_pred             ccCceecCCCCcc---------ccccCCcceeCc
Confidence            9999865543211         126799999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-33  Score=229.72  Aligned_cols=167  Identities=27%  Similarity=0.407  Sum_probs=145.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|+..+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.++..++||||+++++++...     +..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence            45799999999999999999999999999999999766555567889999999999999999999988543     3479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++...       .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        94 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            999999999999998764       477889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ...+||+.|+||
T Consensus       164 ~~~~~~~~~~--------~~~~gt~~y~aP  185 (297)
T 3fxz_A          164 AQITPEQSKR--------STMVGTPYWMAP  185 (297)
T ss_dssp             EECCSTTCCB--------CCCCSCGGGCCH
T ss_pred             eecCCccccc--------CCccCCcCccCh
Confidence            8765433211        125799999998

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5e-35  Score=250.56  Aligned_cols=177  Identities=25%  Similarity=0.334  Sum_probs=147.7

Q ss_pred             hHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeee
Q 039258           38 YAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSS  114 (234)
Q Consensus        38 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~  114 (234)
                      ..++.....+|++.+.||+|+||+||+|+++.+++.||+|+++..   .......+.+|..++..++||||+++++++..
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            334445567899999999999999999999999999999999642   22233458899999999999999999998853


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                           ...+++||||+++|+|.+++.....     .+++..+..++.|++.||.|||++   +|+||||||+|||++.++
T Consensus       146 -----~~~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g  212 (437)
T 4aw2_A          146 -----DNNLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNG  212 (437)
T ss_dssp             -----SSEEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             -----CCEEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCC
Confidence                 3457999999999999999986432     688999999999999999999999   999999999999999999


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||+++..........       ...+||+.|+||
T Consensus       213 ~vkL~DFGla~~~~~~~~~~~-------~~~~GT~~Y~AP  245 (437)
T 4aw2_A          213 HIRLADFGSCLKLMEDGTVQS-------SVAVGTPDYISP  245 (437)
T ss_dssp             CEEECCCTTCEECCTTSCEEC-------CSCCSCGGGCCH
T ss_pred             CEEEcchhhhhhcccCCCccc-------ccccCCcCeeCh
Confidence            999999999986654322111       125799999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.5e-34  Score=235.86  Aligned_cols=168  Identities=29%  Similarity=0.373  Sum_probs=144.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|+..+.||+|+||.||+|++..+++.||+|+++..   .......+.+|+.++..++||||+++++++..     .+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence            35788999999999999999999999999999999643   23345678899999999999999999998753     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+++||||+++++|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence            5799999999999999998755      688899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++.........        ...+||+.|+||
T Consensus       150 G~a~~~~~~~~~~--------~~~~gt~~y~aP  174 (337)
T 1o6l_A          150 GLCKEGISDGATM--------KTFCGTPEYLAP  174 (337)
T ss_dssp             TTCBCSCCTTCCB--------CCCEECGGGCCG
T ss_pred             cchhhcccCCCcc--------cccccChhhCCh
Confidence            9998643322111        126899999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.8e-34  Score=236.86  Aligned_cols=168  Identities=26%  Similarity=0.382  Sum_probs=140.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|+++.+++.||+|+++..   .....+.+..|..++..+ +||||+++++++..     .
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-----P   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----C
Confidence            46799999999999999999999999999999999743   233446788999999988 79999999998743     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ..+++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~D  167 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLAD  167 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcc
Confidence            45799999999999999998765      688999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++........        ....+||+.|+||
T Consensus       168 FG~a~~~~~~~~~--------~~~~~gt~~y~aP  193 (353)
T 3txo_A          168 FGMCKEGICNGVT--------TATFCGTPDYIAP  193 (353)
T ss_dssp             CTTCBCSCC-----------------CCGGGCCH
T ss_pred             ccceeecccCCcc--------ccccCCCcCeECh
Confidence            9999854332211        1126899999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.6e-33  Score=238.34  Aligned_cols=168  Identities=23%  Similarity=0.332  Sum_probs=141.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||+||+|+++.+++.||+|+++..   .....+.+..|..++..+ +||||+++++++..     .
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence            45789999999999999999999999999999999743   223345678899999877 89999999998743     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ..+++||||+++++|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D  196 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD  196 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence            45799999999999999998765      688999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++........        ....+||+.|+||
T Consensus       197 FGla~~~~~~~~~--------~~~~~gt~~Y~aP  222 (396)
T 4dc2_A          197 YGMCKEGLRPGDT--------TSTFCGTPNYIAP  222 (396)
T ss_dssp             CTTCBCCCCTTCC--------BCCCCBCGGGCCH
T ss_pred             cceeeecccCCCc--------cccccCCcccCCc
Confidence            9999853322111        1127899999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.9e-34  Score=242.12  Aligned_cols=172  Identities=20%  Similarity=0.318  Sum_probs=144.9

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      +.....+|++.+.||+|+||.||+|+++.++..||+|+++..   .....+.+.+|..++..++||||+++++++..   
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~---  140 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD---  140 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE---
Confidence            334456899999999999999999999999999999999642   22233567899999999999999999999853   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                        ...+++||||+++++|.+++...       .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|
T Consensus       141 --~~~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ik  208 (410)
T 3v8s_A          141 --DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK  208 (410)
T ss_dssp             --SSEEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEE
Confidence              34579999999999999998653       578889999999999999999999   999999999999999999999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||+++..........       ...+||+.|+||
T Consensus       209 L~DFG~a~~~~~~~~~~~-------~~~~gt~~Y~AP  238 (410)
T 3v8s_A          209 LADFGTCMKMNKEGMVRC-------DTAVGTPDYISP  238 (410)
T ss_dssp             ECCCTTCEECCTTSEEEC-------CSCCSCGGGCCH
T ss_pred             EeccceeEeeccCCcccc-------cCCcCCccccCH
Confidence            999999987654321111       126799999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=240.64  Aligned_cols=175  Identities=27%  Similarity=0.371  Sum_probs=147.0

Q ss_pred             HHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecC
Q 039258           40 ELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSID  116 (234)
Q Consensus        40 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~  116 (234)
                      +......+|++.+.||+|+||.||+|+++.+++.||+|+++..   .....+.+.+|..++..++||||+++++++..  
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--  132 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--  132 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--
Confidence            3344557899999999999999999999999999999999642   22233567889999999999999999998743  


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCce
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~v  196 (234)
                         ...+++||||+++++|.+++...+.     .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+
T Consensus       133 ---~~~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~v  201 (412)
T 2vd5_A          133 ---ENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHI  201 (412)
T ss_dssp             ---SSEEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             ---CCEEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCE
Confidence               3457999999999999999986542     588889999999999999999999   99999999999999999999


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|||+++.........       ....+||+.|+||
T Consensus       202 kL~DFGla~~~~~~~~~~-------~~~~~Gt~~Y~AP  232 (412)
T 2vd5_A          202 RLADFGSCLKLRADGTVR-------SLVAVGTPDYLSP  232 (412)
T ss_dssp             EECCCTTCEECCTTSCEE-------CSSCCSCGGGCCH
T ss_pred             EEeechhheeccCCCccc-------cceeccccCcCCH
Confidence            999999998765432211       1126799999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-33  Score=233.17  Aligned_cols=170  Identities=24%  Similarity=0.385  Sum_probs=143.3

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSK  118 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~  118 (234)
                      ....+|++.+.||+|+||.||+|+++.+++.||+|+++...   ....+.+..|..++..+ +||||+++++++..    
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----   89 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----   89 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----
Confidence            34568999999999999999999999999999999997431   23446678899999876 89999999998753    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                       ....++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||
T Consensus        90 -~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL  159 (345)
T 1xjd_A           90 -KENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI  159 (345)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEE
Confidence             345799999999999999998765      688899999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++........        ....+||+.|+||
T Consensus       160 ~DFG~a~~~~~~~~~--------~~~~~gt~~y~aP  187 (345)
T 1xjd_A          160 ADFGMCKENMLGDAK--------TNTFCGTPDYIAP  187 (345)
T ss_dssp             CCCTTCBCCCCTTCC--------BCCCCSCGGGCCH
T ss_pred             eEChhhhhcccCCCc--------ccCCCCCcccCCh
Confidence            999999864322111        1126899999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.5e-33  Score=236.38  Aligned_cols=166  Identities=23%  Similarity=0.395  Sum_probs=144.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||.||+|.+..++..||+|++...   .....+.+.+|+.++..++||||+++++++..     ...
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~   89 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EED   89 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CCE
Confidence            5688899999999999999999999999999999643   23345778899999999999999999998853     344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG  160 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFN  160 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccc
Confidence            799999999999999998754      688899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++........         ...+||+.|+||
T Consensus       161 ~a~~~~~~~~~---------~~~~gt~~Y~aP  183 (384)
T 4fr4_A          161 IAAMLPRETQI---------TTMAGTKPYMAP  183 (384)
T ss_dssp             TCEECCTTCCB---------CCCCSCGGGCCG
T ss_pred             eeeeccCCCce---------eccCCCccccCC
Confidence            99876543211         126799999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.5e-33  Score=232.68  Aligned_cols=167  Identities=25%  Similarity=0.344  Sum_probs=143.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc------hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      ...|++.+.||+|+||.||+|.+..++..||+|+++....      ...+.+.+|+.++..++||||+++++++..    
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----   86 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN----   86 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence            4568999999999999999999999999999999974322      134678999999999999999999999753    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC----
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM----  194 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~----  194 (234)
                       ....++||||+++++|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+||+++.++    
T Consensus        87 -~~~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           87 -RTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence             345799999999999999997654      688899999999999999999999   999999999999998766    


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||++..........         ..+||+.|+||
T Consensus       157 ~vkl~DFG~a~~~~~~~~~~---------~~~gt~~y~aP  187 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGVEFK---------NIFGTPEFVAP  187 (361)
T ss_dssp             CEEECCCSSCEECCTTCCCC---------CCCSCGGGCCH
T ss_pred             CEEEEecCCceEcCCCCccc---------cCCCCccEECc
Confidence            79999999998765432111         25799999998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.5e-33  Score=228.61  Aligned_cols=185  Identities=24%  Similarity=0.407  Sum_probs=144.2

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-----
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-----  117 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-----  117 (234)
                      ...+|++.+.||+|+||.||+|++..++..||||+++... ....+.+.+|+.++..++||||+++++++.....     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3457889999999999999999999999999999997543 3345789999999999999999999998755332     


Q ss_pred             -----------------------------------------------CCCCcceeeEeecCCCCHHHHhhhccCCccccc
Q 039258          118 -----------------------------------------------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFK  150 (234)
Q Consensus       118 -----------------------------------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  150 (234)
                                                                     ....+.++||||+++++|.+++.......   .
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---~  160 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE---D  160 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG---G
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc---c
Confidence                                                           12234789999999999999998754321   4


Q ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCC----CCCcccccc
Q 039258          151 LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE----TPSSSIGIK  226 (234)
Q Consensus       151 ~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~----~~~~~~~~~  226 (234)
                      .++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++............    ........+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            46667889999999999999999   99999999999999999999999999999776543211100    001112357


Q ss_pred             ccccccCC
Q 039258          227 GTVGYVAP  234 (234)
Q Consensus       227 gt~~y~aP  234 (234)
                      ||+.|+||
T Consensus       238 gt~~y~aP  245 (332)
T 3qd2_B          238 GTKLYMSP  245 (332)
T ss_dssp             -CGGGSCH
T ss_pred             CCcCccCh
Confidence            99999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.1e-33  Score=231.57  Aligned_cols=167  Identities=24%  Similarity=0.338  Sum_probs=142.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|++.+.||+|+||.||+|+++.+++.||+|+++..   .....+.+.+|..++..+ +||||+++++++..     ..
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~~   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ES   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----CC
Confidence            4688899999999999999999999999999999743   223446688899999887 89999999998743     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF  154 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY  154 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCG
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEec
Confidence            5799999999999999998754      688899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++........        ....+||+.|+||
T Consensus       155 G~a~~~~~~~~~--------~~~~~gt~~y~aP  179 (345)
T 3a8x_A          155 GMCKEGLRPGDT--------TSTFCGTPNYIAP  179 (345)
T ss_dssp             GGCBCSCCTTCC--------BCCCCSCGGGCCH
T ss_pred             cccccccCCCCc--------ccccCCCccccCc
Confidence            999854322111        1126899999998

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.7e-33  Score=227.15  Aligned_cols=177  Identities=23%  Similarity=0.429  Sum_probs=145.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|...+.||+|+||.||+|.+..++..||+|.+........+.+.+|++++..++||||+++++++...     ...+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence            35688899999999999999999999999999998655555667899999999999999999999998643     3468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence            99999999999999987432     688899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCC------CCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTAS------ETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........      .........+||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP  191 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCH
T ss_pred             eecccccccccccccccccccccccccCCCcceeCH
Confidence            876543322110      000111136799999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-33  Score=229.86  Aligned_cols=165  Identities=25%  Similarity=0.383  Sum_probs=143.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|..++..++||||+++++++..     ..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence            35688999999999999999999999999999999743   22344678899999999999999999998743     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence            5799999999999999998755      678889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++......           ...+||+.|+||
T Consensus       151 g~a~~~~~~~-----------~~~~gt~~y~aP  172 (318)
T 1fot_A          151 GFAKYVPDVT-----------YTLCGTPDYIAP  172 (318)
T ss_dssp             SSCEECSSCB-----------CCCCSCTTTCCH
T ss_pred             CcceecCCcc-----------ccccCCccccCH
Confidence            9998654321           126799999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.5e-33  Score=232.53  Aligned_cols=169  Identities=24%  Similarity=0.347  Sum_probs=143.6

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~  119 (234)
                      ...+|++.+.||+|+||.||+|++..+++.||+|+++..   .....+.+..|..++..+ +||||+++++++..     
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----
Confidence            346799999999999999999999999999999999743   233456788899999887 79999999998743     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      ....++||||+++++|.+++...+      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence            345799999999999999998765      688899999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++........        ....+||+.|+||
T Consensus       164 DFG~a~~~~~~~~~--------~~~~~gt~~y~aP  190 (353)
T 2i0e_A          164 DFGMCKENIWDGVT--------TKTFCGTPDYIAP  190 (353)
T ss_dssp             CCTTCBCCCCTTCC--------BCCCCSCGGGCCH
T ss_pred             eCCcccccccCCcc--------cccccCCccccCh
Confidence            99999864332211        1126899999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.2e-33  Score=226.49  Aligned_cols=169  Identities=27%  Similarity=0.459  Sum_probs=139.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|.+...   .....+.+.+|+.++..++||||+++++++..     .+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-----DD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----SS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----CC
Confidence            45799999999999999999999999999999998643   23345678999999999999999999998743     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++...+      .+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+||+||
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  155 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF  155 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence            5799999999999999998765      688899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++...........       ...+||+.|+||
T Consensus       156 g~~~~~~~~~~~~~-------~~~~gt~~y~aP  181 (294)
T 4eqm_A          156 GIAKALSETSLTQT-------NHVLGTVQYFSP  181 (294)
T ss_dssp             SSSTTC--------------------CCSSCCH
T ss_pred             CCcccccccccccc-------CccccCccccCH
Confidence            99987654322111       125699999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.8e-33  Score=231.65  Aligned_cols=164  Identities=24%  Similarity=0.339  Sum_probs=143.4

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|+..+.||+|+||.||+|++..++..||+|+++..   .....+.+.+|+.++..++||||+++++++..     ...
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~  115 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CCE
Confidence            5788999999999999999999999999999999643   22345678899999999999999999998753     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++...+      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg  186 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccc
Confidence            799999999999999998765      688899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++......           ...+||+.|+||
T Consensus       187 ~a~~~~~~~-----------~~~~gt~~y~aP  207 (350)
T 1rdq_E          187 FAKRVKGRT-----------WTLCGTPEALAP  207 (350)
T ss_dssp             TCEECSSCB-----------CCCEECGGGCCH
T ss_pred             cceeccCCc-----------ccccCCccccCH
Confidence            998654321           126799999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-32  Score=226.13  Aligned_cols=179  Identities=25%  Similarity=0.343  Sum_probs=149.5

Q ss_pred             CCCcChHHHHHHhcC----------CCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCC
Q 039258           33 FPMVSYAELSKATCE----------FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH  102 (234)
Q Consensus        33 ~~~~~~~~~~~~~~~----------~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h  102 (234)
                      .+.++.+++..+...          |+..+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++..++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            355677777665543          5667799999999999999998999999999986655566788999999999999


Q ss_pred             CCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039258          103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD  182 (234)
Q Consensus       103 ~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~d  182 (234)
                      |||+++++++...     ...++||||+++++|.+++...       .+++..+..++.|++.||.|||++   +++|||
T Consensus       102 ~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  166 (321)
T 2c30_A          102 FNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRD  166 (321)
T ss_dssp             TTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             CCcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence            9999999988643     3469999999999999998643       578899999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+||+++.++.+||+|||++..........        ....||+.|+||
T Consensus       167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~gt~~y~aP  210 (321)
T 2c30_A          167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--------KSLVGTPYWMAP  210 (321)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCSSSCCB--------CCCCSCGGGCCH
T ss_pred             CCHHHEEECCCCcEEEeeeeeeeecccCcccc--------ccccCCccccCH
Confidence            99999999999999999999998765432211        125799999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.3e-33  Score=238.69  Aligned_cols=154  Identities=23%  Similarity=0.389  Sum_probs=127.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++.+.||+|+||+||+|.+..+++.||||.+...  .....+++.+|+.+|..++||||+++++++..........+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            5799999999999999999999999999999998643  23345778999999999999999999999866554555668


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+ +++|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecc-ccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence            9999998 569999987654      688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCC
Q 039258          204 SKFLSS  209 (234)
Q Consensus       204 a~~~~~  209 (234)
                      ++....
T Consensus       203 a~~~~~  208 (458)
T 3rp9_A          203 ARTVDY  208 (458)
T ss_dssp             CBCTTS
T ss_pred             chhccC
Confidence            997654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-32  Score=228.51  Aligned_cols=166  Identities=26%  Similarity=0.450  Sum_probs=142.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .++|.+.+.||+|+||.||+|.+..++..||+|++...   .......+.+|+.++..++||||+++++++...     .
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence            46799999999999999999999999999999999633   222346788999999999999999999998543     3


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+ +++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+||
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF  152 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF  152 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred             EEEEEEECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence            479999999 679999987765      688899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........         ..+||+.|+||
T Consensus       153 G~s~~~~~~~~~~---------~~~gt~~y~aP  176 (336)
T 3h4j_B          153 GLSNIMTDGNFLK---------TSCGSPNYAAP  176 (336)
T ss_dssp             SCTBTTTTSBTTC---------CCTTSTTTSCG
T ss_pred             ccceeccCCcccc---------cccCCcCcCCH
Confidence            9998755432211         25799999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.7e-32  Score=235.50  Aligned_cols=170  Identities=22%  Similarity=0.354  Sum_probs=142.6

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ....+|++.+.||+|+||.||+|.+..++..+|+|++....  ....+.+.+|+.++..++||||+++++++..     .
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~   82 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----E   82 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----S
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----C
Confidence            34567999999999999999999999999999999997543  2334678999999999999999999998753     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC---CCCceE
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAH  197 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~---~~~~vk  197 (234)
                      +..++||||+++++|.+.+....      .+++..+..++.|++.||.|||++   +|+||||||+||+++   .++.+|
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk  153 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK  153 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred             CEEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence            45799999999999999998765      688999999999999999999999   999999999999997   467899


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||++..........        ...+||+.|+||
T Consensus       154 L~DFG~a~~~~~~~~~~--------~~~~gt~~Y~AP  182 (444)
T 3soa_A          154 LADFGLAIEVEGEQQAW--------FGFAGTPGYLSP  182 (444)
T ss_dssp             ECCCSSCBCCCTTCCBC--------CCSCSCGGGCCH
T ss_pred             EccCceeEEecCCCcee--------ecccCCcccCCH
Confidence            99999998655432111        126799999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.6e-33  Score=228.87  Aligned_cols=170  Identities=25%  Similarity=0.396  Sum_probs=141.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++..++||||+++++++..     ....
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CCeE
Confidence            4679999999999999999999999999999999964432 233568899999999999999999998753     3446


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence            89999999999999987654      688899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++...........      ...+||+.|+||
T Consensus       152 a~~~~~~~~~~~~------~~~~gt~~y~aP  176 (323)
T 3tki_A          152 ATVFRYNNRERLL------NKMCGTLPYVAP  176 (323)
T ss_dssp             CEECEETTEECCB------CSCCSCGGGSCH
T ss_pred             cceeccCCccccc------CCCccCcCccCc
Confidence            9865432211111      125799999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-32  Score=226.33  Aligned_cols=167  Identities=19%  Similarity=0.295  Sum_probs=143.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+..++..+|+|.+.... .....+.+|+.++..++||||+++++++...     +..+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-----EELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEE
Confidence            467899999999999999999999999999999997443 3346688999999999999999999998543     3479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC--CCceEEccCc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN--DMVAHVGDFG  202 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~--~~~vki~dfG  202 (234)
                      +||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.  ++.+||+|||
T Consensus        78 lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            99999999999999976432     588899999999999999999999   9999999999999986  7899999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.........         ....||+.|+||
T Consensus       150 ~a~~~~~~~~~---------~~~~gt~~y~aP  172 (321)
T 1tki_A          150 QARQLKPGDNF---------RLLFTAPEYYAP  172 (321)
T ss_dssp             TCEECCTTCEE---------EEEESCGGGSCH
T ss_pred             CCeECCCCCcc---------ccccCChhhcCc
Confidence            99876543211         125699999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2e-32  Score=229.34  Aligned_cols=169  Identities=25%  Similarity=0.437  Sum_probs=143.2

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ....+|++.+.||+|+||.||+|.+..++..||+|++....  ....+.+.+|+.++..++||||+++++++..     .
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~  100 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----E  100 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----C
Confidence            34567999999999999999999999999999999997542  2344678899999999999999999998753     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC---CceE
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND---MVAH  197 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~---~~vk  197 (234)
                      ...++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.+   +.+|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~k  171 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVK  171 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEE
T ss_pred             CEEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEE
Confidence            44799999999999999987654      578899999999999999999999   99999999999999754   4599


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||++.........         ...+||+.|+||
T Consensus       172 l~DfG~a~~~~~~~~~---------~~~~gt~~y~aP  199 (362)
T 2bdw_A          172 LADFGLAIEVNDSEAW---------HGFAGTPGYLSP  199 (362)
T ss_dssp             ECCCTTCBCCTTCCSC---------CCSCSCTTTCCH
T ss_pred             EeecCcceEecCCccc---------ccCCCCccccCH
Confidence            9999999876543211         125799999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-32  Score=224.83  Aligned_cols=166  Identities=23%  Similarity=0.342  Sum_probs=141.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc------hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ..|++.+.||+|+||.||+|.+..++..||+|+++....      ...+.+.+|+.++..++||||+++++++..     
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   85 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-----   85 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence            458889999999999999999999999999999974321      134678999999999999999999999753     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC----c
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM----V  195 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~----~  195 (234)
                      ....++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++    .
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~  156 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR  156 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCC
Confidence            344799999999999999997654      688899999999999999999999   999999999999998776    8


Q ss_pred             eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+|||+++.........         ..+||+.|+||
T Consensus       157 ~kl~Dfg~a~~~~~~~~~~---------~~~gt~~y~aP  186 (326)
T 2y0a_A          157 IKIIDFGLAHKIDFGNEFK---------NIFGTPEFVAP  186 (326)
T ss_dssp             EEECCCTTCEECCTTSCCC---------CCCSCTTTCCH
T ss_pred             EEEEECCCCeECCCCCccc---------cccCCcCcCCc
Confidence            9999999998765432111         15699999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.7e-32  Score=223.72  Aligned_cols=173  Identities=24%  Similarity=0.449  Sum_probs=130.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|+.++..++||||+++++++..     .+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCeE
Confidence            457999999999999999999999999999999997543 3344778899999999999999999999743     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||++ ++|.+++...........+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            99999997 59999987654322233588889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++..........        ...||+.|+||
T Consensus       155 ~~~~~~~~~~~~--------~~~~t~~y~aP  177 (317)
T 2pmi_A          155 ARAFGIPVNTFS--------SEVVTLWYRAP  177 (317)
T ss_dssp             CEETTSCCCCCC--------CCCSCCTTCCH
T ss_pred             ceecCCCcccCC--------CCcccccccCc
Confidence            987653321111        14689999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-32  Score=228.01  Aligned_cols=172  Identities=24%  Similarity=0.376  Sum_probs=141.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-----KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ...|++.+.||+|+||.||+|.+..+++.||||+++...     ....+.+.+|+.++..++||||+++++++..     
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence            456899999999999999999999999999999996321     1234778999999999999999999998854     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc---e
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV---A  196 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~---v  196 (234)
                      ....++||||+++++|.+++......  ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.   +
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v  172 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV  172 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence            34479999999999999888654311  11478889999999999999999999   9999999999999976544   9


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|||++..........        ...+||+.|+||
T Consensus       173 kl~Dfg~a~~~~~~~~~~--------~~~~gt~~y~aP  202 (351)
T 3c0i_A          173 KLGGFGVAIQLGESGLVA--------GGRVGTPHFMAP  202 (351)
T ss_dssp             EECCCTTCEECCTTSCBC--------CCCCSCGGGCCH
T ss_pred             EEecCcceeEecCCCeee--------cCCcCCcCccCH
Confidence            999999998765432211        125799999998

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-32  Score=222.74  Aligned_cols=169  Identities=29%  Similarity=0.433  Sum_probs=138.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc--------------------------hhhHHHHHHHHHHH
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--------------------------GAFRSFVAECEALR   98 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~   98 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.....                          ...+.+.+|++++.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3579999999999999999999999999999999964321                          12356889999999


Q ss_pred             hcCCCCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039258           99 NIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPM  178 (234)
Q Consensus        99 ~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~i  178 (234)
                      .++||||+++++++...   .....++||||+++++|.+++...       .+++..+..++.|++.||.|||++   ++
T Consensus        92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i  158 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTLK-------PLSEDQARFYFQDLIKGIEYLHYQ---KI  158 (298)
T ss_dssp             TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCSS-------CCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            99999999999998542   235579999999999988765322       578899999999999999999999   99


Q ss_pred             eecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          179 VHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       179 vH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||||||+||+++.++.+||+|||+++.........        ....||+.|+||
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~gt~~y~aP  206 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--------SNTVGTPAFMAP  206 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEE--------CCCCSCGGGCCG
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCccccccccccc--------cCCcCCccccCh
Confidence            999999999999999999999999998765432111        125699999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.2e-33  Score=232.54  Aligned_cols=168  Identities=30%  Similarity=0.415  Sum_probs=133.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHH-HHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEA-LRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|+++.++..||+|+++...   ......+..|..+ +..++||||+++++++..     .
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-----~  111 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----A  111 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----S
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----C
Confidence            457999999999999999999999999999999997432   2233456667766 467899999999998753     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      +.+++||||+++++|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D  182 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD  182 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence            45799999999999999998755      678889999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++........        ....+||+.|+||
T Consensus       183 FG~a~~~~~~~~~--------~~~~~gt~~y~aP  208 (373)
T 2r5t_A          183 FGLCKENIEHNST--------TSTFCGTPEYLAP  208 (373)
T ss_dssp             CCBCGGGBCCCCC--------CCSBSCCCCCCCH
T ss_pred             CccccccccCCCc--------cccccCCccccCH
Confidence            9999864332211        1126899999998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-32  Score=239.65  Aligned_cols=169  Identities=25%  Similarity=0.386  Sum_probs=144.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|+..+.||+|+||.||+|.+..++..||+|++...   .......+.+|+.+|..++||||+++++++..     .+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----CC
Confidence            35688899999999999999999999999999999643   22334678899999999999999999998743     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+++||||+++++|.+++...+..    .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~----~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQA----GFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence            579999999999999999765422    488999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++........         ...+||+.|+||
T Consensus       331 Gla~~~~~~~~~---------~~~~GT~~Y~AP  354 (576)
T 2acx_A          331 GLAVHVPEGQTI---------KGRVGTVGYMAP  354 (576)
T ss_dssp             TTCEECCTTCCE---------ECCCSCGGGCCH
T ss_pred             ccceecccCccc---------cccCCCccccCH
Confidence            999876543211         125799999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-32  Score=222.18  Aligned_cols=172  Identities=27%  Similarity=0.427  Sum_probs=144.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++..++||||+++++++...   +....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence            456899999999999999999999999999999997432 23456788999999999999999999987532   23356


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee----CCCCceEEc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL----DNDMVAHVG  199 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~----~~~~~vki~  199 (234)
                      ++||||+++++|.+++......   ..+++..+..++.|++.||.|||++   +++||||||+||++    +.++.+||+
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             EEEEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEc
Confidence            8999999999999999865421   1388899999999999999999999   99999999999999    777889999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++.........         ...||+.|+||
T Consensus       159 Dfg~a~~~~~~~~~~---------~~~gt~~y~aP  184 (319)
T 4euu_A          159 DFGAARELEDDEQFV---------SLYGTEEYLHP  184 (319)
T ss_dssp             CCTTCEECCTTCCBC---------CCCSCGGGCCH
T ss_pred             cCCCceecCCCCcee---------ecccCCCccCH
Confidence            999998765432211         25699999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.7e-32  Score=219.86  Aligned_cols=167  Identities=23%  Similarity=0.426  Sum_probs=140.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.++..++||||+++++++..     ....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence            46888999999999999999999999999999997442  3344678899999999999999999999854     3347


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++ ++.+.+.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus        77 ~lv~e~~~~-~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999975 77776665432     688899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++..........        ...||+.|+||
T Consensus       148 ~~~~~~~~~~~~--------~~~~t~~y~aP  170 (292)
T 3o0g_A          148 ARAFGIPVRCYS--------AEVVTLWYRPP  170 (292)
T ss_dssp             CEECCSCCSCCC--------SCCSCGGGCCH
T ss_pred             ceecCCcccccc--------CCccccCCcCh
Confidence            987653322111        25689999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9e-33  Score=237.46  Aligned_cols=168  Identities=28%  Similarity=0.353  Sum_probs=133.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++..   .......+.+|+.++..++||||+++++++...     +
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----D  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----T
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----C
Confidence            35689999999999999999999999999999999743   233446678899999999999999999998543     3


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ..++||||+++++|.+++....      .+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence            4799999999999999997765      68889999999999999999998 8   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++.........        ...+||+.|+||
T Consensus       293 FG~a~~~~~~~~~~--------~~~~gt~~y~aP  318 (446)
T 4ejn_A          293 FGLCKEGIKDGATM--------KTFCGTPEYLAP  318 (446)
T ss_dssp             CCCCCTTCC-------------CCSSSCGGGCCH
T ss_pred             CCCceeccCCCccc--------ccccCCccccCH
Confidence            99998643322111        126799999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-32  Score=229.27  Aligned_cols=168  Identities=21%  Similarity=0.323  Sum_probs=143.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+..++..+|+|++..........+.+|+.++..++||||+++++++..     ....+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEEE
Confidence            4578999999999999999999999999999999976544455678999999999999999999999853     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC--CCCceEEccCc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD--NDMVAHVGDFG  202 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~--~~~~vki~dfG  202 (234)
                      +||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +|+||||||+||+++  ..+.+||+|||
T Consensus       125 lv~E~~~gg~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence            99999999999999876432     588899999999999999999999   999999999999997  45779999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++........         ...+||+.|+||
T Consensus       197 ~a~~~~~~~~~---------~~~~gt~~y~aP  219 (387)
T 1kob_A          197 LATKLNPDEIV---------KVTTATAEFAAP  219 (387)
T ss_dssp             TCEECCTTSCE---------EEECSSGGGCCH
T ss_pred             cceecCCCcce---------eeeccCCCccCc
Confidence            99876543211         125699999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.98  E-value=4.6e-32  Score=232.17  Aligned_cols=180  Identities=23%  Similarity=0.312  Sum_probs=143.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||||.+...  .....+++.+|+.+|..++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            45799999999999999999999999999999999643  3334578899999999999999999999986544333456


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||++ ++|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence            799999996 59999997654      688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCC--------------CCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTAS--------------ETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~--------------~~~~~~~~~~gt~~y~aP  234 (234)
                      +++...........              .........+||+.|+||
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  220 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP  220 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCH
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCH
Confidence            99976543221000              000011236799999998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.98  E-value=4.2e-32  Score=224.40  Aligned_cols=168  Identities=24%  Similarity=0.334  Sum_probs=132.5

Q ss_pred             hcCCCCCceeecccceEEEEEEEC---CCCeEEEEEEeeccc----chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG---EDEMVVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      ..+|++.+.||+|+||.||+|++.   .++..||+|+++...    ......+.+|+.++..++||||+++++++..   
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT---   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence            457899999999999999999985   678999999996431    2234567889999999999999999998853   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                        .+..++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+|
T Consensus        93 --~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k  161 (327)
T 3a62_A           93 --GGKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK  161 (327)
T ss_dssp             --SSCEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence              344799999999999999998755      578888999999999999999999   999999999999999999999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||+++.........        ...+||+.|+||
T Consensus       162 l~Dfg~~~~~~~~~~~~--------~~~~gt~~y~aP  190 (327)
T 3a62_A          162 LTDFGLCKESIHDGTVT--------HTFCGTIEYMAP  190 (327)
T ss_dssp             ECCCSCC------------------CTTSSCCTTSCH
T ss_pred             EEeCCcccccccCCccc--------cccCCCcCccCH
Confidence            99999988543322111        125799999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.98  E-value=3.3e-32  Score=235.35  Aligned_cols=167  Identities=29%  Similarity=0.468  Sum_probs=144.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++....   ......+.+|+.++..++||||+++++++...     .
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence            357899999999999999999999999999999996432   23346789999999999999999999998543     3


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++...+      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence            4799999999999999997654      688899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++.........         ...+||+.|+||
T Consensus       161 G~a~~~~~~~~~---------~~~~gt~~y~aP  184 (476)
T 2y94_A          161 GLSNMMSDGEFL---------RTSCGSPNYAAP  184 (476)
T ss_dssp             SSCEECCTTCCB---------CCCCSCSTTCCH
T ss_pred             cchhhccccccc---------cccCCCcCeECh
Confidence            999876543211         125799999998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.98  E-value=3.7e-32  Score=227.67  Aligned_cols=166  Identities=24%  Similarity=0.314  Sum_probs=134.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++..     ....+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEE
Confidence            457999999999999999999999999999999996432 233678899999999999999999999853     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc--eEEccCc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV--AHVGDFG  202 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~--vki~dfG  202 (234)
                      +||||+++++|.+++...+      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.  +||+|||
T Consensus        93 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             EEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence            9999999999999997765      688899999999999999999999   9999999999999986665  9999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++........         ...+||+.|+||
T Consensus       164 ~a~~~~~~~~~---------~~~~gt~~y~aP  186 (361)
T 3uc3_A          164 YSKSSVLHSQP---------KSTVGTPAYIAP  186 (361)
T ss_dssp             CC------------------------CTTSCH
T ss_pred             ccccccccCCC---------CCCcCCCCcCCh
Confidence            98743322111         125699999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.98  E-value=2.4e-32  Score=222.32  Aligned_cols=174  Identities=27%  Similarity=0.456  Sum_probs=140.4

Q ss_pred             hcCCCCCceeecccceEEEEEE----ECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGI----LGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|+    +..++..||+|.+........+.+.+|+.++..++||||+++++++...+   .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence            4578899999999999999998    45678999999997665556678999999999999999999999875422   2


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D  157 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD  157 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence            346899999999999999987542     588889999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++............     .....||..|+||
T Consensus       158 fg~~~~~~~~~~~~~~-----~~~~~~~~~y~aP  186 (295)
T 3ugc_A          158 FGLTKVLPQDKEFFKV-----KEPGESPIFWYAP  186 (295)
T ss_dssp             CCSCC------------------CTTCGGGGCCH
T ss_pred             CcccccccCCcceeee-----ccCCCCccceeCc
Confidence            9999876543221111     1114577889998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.98  E-value=3.4e-32  Score=227.09  Aligned_cols=188  Identities=20%  Similarity=0.323  Sum_probs=149.1

Q ss_pred             CCcChHHHHHHhcCCCCCceeecccceEEEEEE-----ECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCce
Q 039258           34 PMVSYAELSKATCEFSQSNMIGQGSYGSVYKGI-----LGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLT  106 (234)
Q Consensus        34 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~  106 (234)
                      ..+....+.....+|++.+.||+|+||.||+|.     +..+++.||||+++... ....+.+.+|++++..+ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            334455666677889999999999999999998     45677999999997542 33446789999999999 789999


Q ss_pred             eEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCcc---------------------------------------
Q 039258          107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE---------------------------------------  147 (234)
Q Consensus       107 ~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~---------------------------------------  147 (234)
                      ++++++...    ....++||||+++++|.+++........                                       
T Consensus        90 ~~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (359)
T 3vhe_A           90 NLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS  165 (359)
T ss_dssp             CEEEEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------
T ss_pred             eeeeeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccc
Confidence            999998532    3346899999999999999976542100                                       


Q ss_pred             ---------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          148 ---------------------VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       148 ---------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                                           ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  242 (359)
T 3vhe_A          166 GFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD  242 (359)
T ss_dssp             ------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred             ccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceee
Confidence                                 11278889999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCccCCCCCCCCccccccccccccCC
Q 039258          207 LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........      .....||+.|+||
T Consensus       243 ~~~~~~~~~------~~~~~~t~~y~aP  264 (359)
T 3vhe_A          243 IYKDPDYVR------KGDARLPLKWMAP  264 (359)
T ss_dssp             TTSCTTCEE------C--CEECGGGCCH
T ss_pred             ecccccchh------ccccCCCceeECh
Confidence            544321111      1125689999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.98  E-value=7.2e-32  Score=236.12  Aligned_cols=171  Identities=23%  Similarity=0.391  Sum_probs=144.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|...+.||+|+||.||+|+++.+++.||+|++...   .......+..|+.++..++||||+++++++..     ...
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~~  259 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KTD  259 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CCE
Confidence            5688889999999999999999999999999999643   22334678899999999999999999998743     344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +++||||+++++|.+++......  ...+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecc
Confidence            79999999999999998764321  11588899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++.........        ...+||+.|+||
T Consensus       335 la~~~~~~~~~~--------~~~~GT~~Y~AP  358 (543)
T 3c4z_A          335 LAVELKAGQTKT--------KGYAGTPGFMAP  358 (543)
T ss_dssp             TCEECCTTCCCB--------CCCCSCTTTSCH
T ss_pred             eeeeccCCCccc--------ccccCCccccCh
Confidence            998765432211        125799999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.98  E-value=1.3e-32  Score=225.70  Aligned_cols=175  Identities=20%  Similarity=0.397  Sum_probs=138.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.++..++||||+++++++..... ...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CCc
Confidence            46799999999999999999999999999999999743   22334678899999999999999999998765432 223


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++....      .+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+||+||
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred             ccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence            4489999999999999998765      688899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++...........     ......||+.|+||
T Consensus       161 g~a~~~~~~~~~~~-----~~~~~~gt~~y~aP  188 (311)
T 3ork_A          161 GIARAIADSGNSVT-----QTAAVIGTAQYLSP  188 (311)
T ss_dssp             SCC-----------------------CCTTCCH
T ss_pred             cCcccccccccccc-----cccccCcCcccCCH
Confidence            99987654322111     11125699999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.98  E-value=1.1e-31  Score=216.32  Aligned_cols=167  Identities=26%  Similarity=0.345  Sum_probs=144.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .++|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|++++..++||||+++++++..     ....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeEE
Confidence            4568999999999999999999999999999999976555556789999999999999999999999853     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee---CCCCceEEccC
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDF  201 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~---~~~~~vki~df  201 (234)
                      +||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||++   +.++.+||+||
T Consensus        83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Df  153 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDF  153 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEec
Confidence            9999999999999987755      578899999999999999999999   99999999999999   77889999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........         ...||+.|+||
T Consensus       154 g~~~~~~~~~~~~---------~~~~t~~y~aP  177 (277)
T 3f3z_A          154 GLAARFKPGKMMR---------TKVGTPYYVSP  177 (277)
T ss_dssp             TTCEECCTTSCBC---------CCCSCTTTCCH
T ss_pred             ccceeccCccchh---------ccCCCCCccCh
Confidence            9998765432211         15699999998

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.98  E-value=4.7e-32  Score=223.24  Aligned_cols=182  Identities=35%  Similarity=0.597  Sum_probs=148.7

Q ss_pred             cChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeec
Q 039258           36 VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSI  115 (234)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~  115 (234)
                      ++..++.....+|+..+.||+|+||.||+|.+. ++..||+|.+........+.+.+|+.++..++||||+++++++.. 
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-  106 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-  106 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            344455667789999999999999999999974 678999999876655566789999999999999999999999743 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV  195 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~  195 (234)
                          .+..++||||+++++|.+++......  ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.
T Consensus       107 ----~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~  177 (321)
T 2qkw_B          107 ----RNEMILIYKYMENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV  177 (321)
T ss_dssp             ----TTCCEEEEECCTTCBTGGGSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCC
T ss_pred             ----CCeEEEEEEcCCCCcHHHHHhccCCC--ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCC
Confidence                34468999999999999998754321  12578899999999999999999999   9999999999999999999


Q ss_pred             eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+|||+++..........      .....||+.|+||
T Consensus       178 ~kl~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aP  210 (321)
T 2qkw_B          178 PKITDFGISKKGTELDQTHL------STVVKGTLGYIDP  210 (321)
T ss_dssp             EEECCCTTCEECSSSSCCCC------BCCCEEETTTCCH
T ss_pred             EEEeeccccccccccccccc------ccccCCCccccCH
Confidence            99999999986543221111      1125699999998

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.98  E-value=7.4e-32  Score=222.75  Aligned_cols=172  Identities=29%  Similarity=0.504  Sum_probs=138.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCC---eEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDE---MVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|.+..++   ..||||.++.. .....+.+.+|+.++..++||||+++++++..     .
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-----G  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-----G
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence            346788899999999999999997544   46999999754 33345678999999999999999999999743     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  194 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD  194 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence            346899999999999999976532     588899999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++...........     .....||+.|+||
T Consensus       195 fg~a~~~~~~~~~~~~-----~~~~~~t~~y~aP  223 (325)
T 3kul_A          195 FGLSRVLEDDPDAAYT-----TTGGKIPIRWTAP  223 (325)
T ss_dssp             CSSCEECC----CCEE-----CC---CCGGGSCH
T ss_pred             CCcccccccCccceee-----ccCCCCcccccCH
Confidence            9999876553221111     0113467889998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.98  E-value=4.1e-32  Score=228.59  Aligned_cols=172  Identities=24%  Similarity=0.423  Sum_probs=142.0

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ...+|++.+.||+|+||.||+|.+..++..||||.++... ....+.+.+|+.+|..++||||+++++++..     ...
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence            3456888999999999999999999899999999987432 2334568899999999999999999999843     234


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++...+.     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             cEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence            6999999999999999986542     578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++............      ...+|+.|+||
T Consensus       259 ~s~~~~~~~~~~~~~------~~~~~~~y~aP  284 (377)
T 3cbl_A          259 MSREEADGVYAASGG------LRQVPVKWTAP  284 (377)
T ss_dssp             GCEECTTSEEECCSS------CCEEEGGGSCH
T ss_pred             CceecCCCceeecCC------CCCCCcCcCCH
Confidence            998654432211100      12367789998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.98  E-value=1.4e-31  Score=224.81  Aligned_cols=176  Identities=22%  Similarity=0.410  Sum_probs=141.6

Q ss_pred             hcCCCCCceeecccceEEEEEEEC-------CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeec
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG-------EDEMVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSI  115 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~  115 (234)
                      ..+|++.+.||+|+||.||+|.+.       .++..||+|+++.. .....+.+.+|+.++..+ +||||+++++++.. 
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence            356888899999999999999864       34578999999754 233457799999999999 89999999999743 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCCc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDHL----------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP  185 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~  185 (234)
                          .+.+++||||+++++|.+++.......          ....+++..++.++.|++.||.|||++   +|+||||||
T Consensus       159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  231 (370)
T 2psq_A          159 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  231 (370)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             ----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence                334799999999999999998754210          112478889999999999999999999   999999999


Q ss_pred             CCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          186 SNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       186 ~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+++.++.+||+|||+++...........      ....||+.|+||
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~------~~~~~t~~y~aP  274 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYKKT------TNGRLPVKWMAP  274 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTCTT------TTTTSCGGGCCH
T ss_pred             hhEEECCCCCEEEccccCCcccCcccceecc------cCCCcccceECH
Confidence            9999999999999999999876543221111      114578899998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.98  E-value=1.4e-31  Score=219.19  Aligned_cols=174  Identities=28%  Similarity=0.440  Sum_probs=141.2

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-----chhhHHHHHHHHHHHhc---CCCCceeEEEEeeec
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-----KGAFRSFVAECEALRNI---RHRNLTKIITICSSI  115 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~i~~l~~~~~~~  115 (234)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++....     ......+.+|+.++..+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3568999999999999999999999999999999996432     12234566777777766   499999999998765


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV  195 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~  195 (234)
                      ........++|||++. ++|.+++......    .+++..+..++.|++.||.|||++   +++||||||+||+++.++.
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            5444446789999996 5999999876432    488999999999999999999999   9999999999999999999


Q ss_pred             eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+|||+++........         ...+||+.|+||
T Consensus       159 ~kl~Dfg~a~~~~~~~~~---------~~~~gt~~y~aP  188 (308)
T 3g33_A          159 VKLADFGLARIYSYQMAL---------TPVVVTLWYRAP  188 (308)
T ss_dssp             EEECSCSCTTTSTTCCCS---------GGGGCCCSSCCH
T ss_pred             EEEeeCccccccCCCccc---------CCccccccccCc
Confidence            999999999865433211         125799999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.98  E-value=1.1e-31  Score=221.28  Aligned_cols=188  Identities=36%  Similarity=0.639  Sum_probs=153.3

Q ss_pred             cCCCcChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEE
Q 039258           32 QFPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIIT  110 (234)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~  110 (234)
                      +...++..++.....+|+..+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.++..++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            3456788899999999999999999999999999854 57899999996442 222346889999999999999999999


Q ss_pred             EeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee
Q 039258          111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL  190 (234)
Q Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~  190 (234)
                      ++...     ...++||||+++++|.+++.......  ..+++..+..++.|++.||.|||+++..+++||||||+||++
T Consensus        95 ~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A           95 FCMTP-----TERLLVYPYMANGSVASCLRERPESQ--PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             EECCS-----SCCEEEEECCTTCBHHHHHHCCSTTC--CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred             EEecC-----CceEEEEEeccCCCHHHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence            98533     33689999999999999998754321  147888999999999999999998755689999999999999


Q ss_pred             CCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          191 DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       191 ~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.++.+||+|||+++..........       ....||+.|+||
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~gt~~y~aP  204 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYKDTHVT-------TAVRGTIGHIAP  204 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSSSSCEE-------CCCCSCGGGCCH
T ss_pred             CCCCCEEeccCccccccCccccccc-------ccccCCcCccCH
Confidence            9999999999999987654322111       125699999998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.98  E-value=8.8e-32  Score=241.73  Aligned_cols=168  Identities=25%  Similarity=0.346  Sum_probs=143.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||||+++..   .....+.+..|..++..+ +||+|+.+++++.     +.
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-----~~  414 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TM  414 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-----CS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-----eC
Confidence            45788999999999999999999999999999999743   234456788899999887 7999999999874     34


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      +.+++||||+++++|.+++...+      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~D  485 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIAD  485 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEee
Confidence            45799999999999999998765      688999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++.........        ...+||+.|+||
T Consensus       486 FGla~~~~~~~~~~--------~~~~GT~~Y~AP  511 (674)
T 3pfq_A          486 FGMCKENIWDGVTT--------KTFCGTPDYIAP  511 (674)
T ss_dssp             CTTCEECCCTTCCB--------CCCCSCSSSCCH
T ss_pred             cceeeccccCCccc--------ccccCCCcccCH
Confidence            99998643322111        126899999998

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.98  E-value=9.1e-32  Score=226.26  Aligned_cols=162  Identities=23%  Similarity=0.355  Sum_probs=134.0

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      .+.||+|+||.||+|.+..++..||+|+++.......+.+.+|++++..++||||+++++++..     ....++||||+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~E~~  168 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLVMEYV  168 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEEECC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEEeCC
Confidence            5679999999999999999999999999986554556789999999999999999999999854     33479999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee--CCCCceEEccCccccccC
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL--DNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~--~~~~~vki~dfG~a~~~~  208 (234)
                      ++++|.+++.....     .+++..+..++.|++.||.|||++   +|+||||||+||++  +.++.+||+|||+++...
T Consensus       169 ~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          169 DGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             TTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            99999998875432     578889999999999999999999   99999999999999  567899999999998765


Q ss_pred             CCccCCCCCCCCccccccccccccCC
Q 039258          209 SDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......         ..+||+.|+||
T Consensus       241 ~~~~~~---------~~~gt~~y~aP  257 (373)
T 2x4f_A          241 PREKLK---------VNFGTPEFLAP  257 (373)
T ss_dssp             TTCBCC---------CCCSSCTTCCH
T ss_pred             Cccccc---------cccCCCcEeCh
Confidence            432211         14699999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=2e-31  Score=225.14  Aligned_cols=179  Identities=17%  Similarity=0.168  Sum_probs=145.7

Q ss_pred             HHhcCCCCCceeecc--cceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           43 KATCEFSQSNMIGQG--SYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G--~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      ....+|++.+.||+|  +||.||+|.+..+++.||||+++...  ....+.+.+|+.++..++||||+++++++...   
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---   98 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD---   98 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC---
Confidence            345679999999999  99999999999999999999997542  33446788899999999999999999998543   


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                        ...++||||+++++|.+++......    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||
T Consensus        99 --~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl  169 (389)
T 3gni_B           99 --NELWVVTSFMAYGSAKDLICTHFMD----GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYL  169 (389)
T ss_dssp             --TEEEEEEECCTTCBHHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred             --CEEEEEEEccCCCCHHHHHhhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence              3479999999999999999875322    588899999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||++............. .......+||+.|+||
T Consensus       170 ~dfg~~~~~~~~~~~~~~~-~~~~~~~~gt~~y~aP  204 (389)
T 3gni_B          170 SGLRSNLSMISHGQRQRVV-HDFPKYSVKVLPWLSP  204 (389)
T ss_dssp             CCGGGCEECEETTEECSCB-CCCCTTCTTTGGGSCH
T ss_pred             cccccceeecccccccccc-ccccccccccccccCH
Confidence            9999987543322111100 0111124699999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.97  E-value=1.4e-31  Score=219.70  Aligned_cols=172  Identities=30%  Similarity=0.510  Sum_probs=133.6

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      .....+|++.+.||+|+||.||+|.+  ++..||+|++....  ....+.+.+|+.++..++||||+++++++..     
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----  105 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----  105 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----
Confidence            34456788999999999999999987  57789999986442  3344678999999999999999999999743     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeeeCCCCceE
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP--MVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--ivH~dlk~~nil~~~~~~vk  197 (234)
                      ....++||||+++++|.+++.....   ...+++..++.++.|++.||.|||++   +  ++||||||+||+++.++.+|
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~k  179 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVK  179 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEE
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEE
Confidence            3346899999999999999976431   11488889999999999999999998   8  99999999999999999999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||+++.........        ....||+.|+||
T Consensus       180 L~Dfg~a~~~~~~~~~~--------~~~~gt~~y~aP  208 (309)
T 3p86_A          180 VCDFGLSRLKASTFLSS--------KSAAGTPEWMAP  208 (309)
T ss_dssp             ECCCC-------------------------CCTTSCH
T ss_pred             ECCCCCCcccccccccc--------ccCCCCccccCh
Confidence            99999998644332111        125699999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.97  E-value=2.3e-31  Score=218.46  Aligned_cols=167  Identities=27%  Similarity=0.430  Sum_probs=137.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|.+...  .......+.+|++++..++||||+++++++..     ...
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----ERC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----SSC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----CCE
Confidence            467999999999999999999985 5889999999643  22334678899999999999999999999743     344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++ +|.+++.....     .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEcCCCC-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence            7999999975 88888876542     588899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++..........        ...||+.|+||
T Consensus       165 ~a~~~~~~~~~~~--------~~~~t~~y~aP  188 (311)
T 3niz_A          165 LARAFGIPVRSYT--------HEVVTLWYRAP  188 (311)
T ss_dssp             TCEETTSCCC-----------CCCCCCTTCCH
T ss_pred             CceecCCCccccc--------CCcccCCcCCH
Confidence            9987653321111        14689999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=1.2e-31  Score=231.39  Aligned_cols=169  Identities=21%  Similarity=0.298  Sum_probs=135.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++..++||||+++++++..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            45789999999999999999999999999999999643  33345778899999999999999999999854332 2234


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++ ++.+.+..        .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence            56999999975 67776643        477888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++........         ...+||+.|+||
T Consensus       209 G~a~~~~~~~~~---------~~~~gt~~y~aP  232 (464)
T 3ttj_A          209 GLARTAGTSFMM---------TPYVVTRYYRAP  232 (464)
T ss_dssp             CCC-----CCCC-------------CCCTTCCH
T ss_pred             EeeeecCCCccc---------CCCcccccccCH
Confidence            999875543211         126799999998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=1.8e-31  Score=232.58  Aligned_cols=169  Identities=31%  Similarity=0.447  Sum_probs=141.4

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-------------hhhHHHHHHHHHHHhcCCCCceeEE
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-------------GAFRSFVAECEALRNIRHRNLTKII  109 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~l~  109 (234)
                      ....+|.+.+.||+|+||.||+|.+..++..||+|++.....             ...+.+.+|+.++..++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            345679999999999999999999999999999999964321             2346789999999999999999999


Q ss_pred             EEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCee
Q 039258          110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVL  189 (234)
Q Consensus       110 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil  189 (234)
                      +++..     ....++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+
T Consensus       113 ~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil  178 (504)
T 3q5i_A          113 DVFED-----KKYFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENIL  178 (504)
T ss_dssp             EEEEC-----SSEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             EEEEc-----CCEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEE
Confidence            99853     345799999999999999997765      688999999999999999999999   9999999999999


Q ss_pred             eCCCC---ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          190 LDNDM---VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       190 ~~~~~---~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.++   .+||+|||++..........         ..+||+.|+||
T Consensus       179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~gt~~y~aP  217 (504)
T 3q5i_A          179 LENKNSLLNIKIVDFGLSSFFSKDYKLR---------DRLGTAYYIAP  217 (504)
T ss_dssp             ESSTTCCSSEEECCCTTCEECCTTSCBC---------CCCSCTTTCCH
T ss_pred             EecCCCCccEEEEECCCCEEcCCCCccc---------cccCCcCCCCH
Confidence            98665   69999999998765432111         25699999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=2e-31  Score=220.35  Aligned_cols=173  Identities=23%  Similarity=0.344  Sum_probs=141.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++.....  .+.+.+|+.++..+ +||||+++++++..     ....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCcc
Confidence            3578999999999999999999999999999999874432  24678999999999 89999999998754     3347


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc-----eEE
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV-----AHV  198 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~-----vki  198 (234)
                      ++||||+ +++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.     +||
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence            9999999 8999999986532     688999999999999999999999   9999999999999998877     999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++............ .......+||+.|+||
T Consensus       152 ~DFg~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aP  186 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHIP-YREHKSLTGTARYMSI  186 (330)
T ss_dssp             CCCTTCEESBCTTTCCBCC-CCCCCCCCSCTTTCCH
T ss_pred             EEcccceeeecCCCCcccc-ccccCCcCCCccccCh
Confidence            9999999765443221110 0111236799999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=5.4e-31  Score=212.96  Aligned_cols=168  Identities=24%  Similarity=0.433  Sum_probs=142.6

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ...+|++.+.||+|+||.||+|.+..++..||+|++....  ....+.+.+|+.++..++||||+++++++..     ..
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   78 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ES   78 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CC
Confidence            4568999999999999999999999999999999997442  3344678899999999999999999999743     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc---eEE
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV---AHV  198 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~---vki  198 (234)
                      ..++||||+++++|.+.+....      .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.   +||
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl  149 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL  149 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEE
Confidence            4689999999999999887764      688899999999999999999999   9999999999999976554   999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||++..........         ...||+.|+||
T Consensus       150 ~Dfg~~~~~~~~~~~~---------~~~~~~~y~aP  176 (284)
T 3kk8_A          150 ADFGLAIEVNDSEAWH---------GFAGTPGYLSP  176 (284)
T ss_dssp             CCCTTCEECCSSCBCC---------CSCSCGGGCCH
T ss_pred             eeceeeEEcccCcccc---------CCCCCcCCcCc
Confidence            9999998655432211         25699999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=7.4e-32  Score=223.49  Aligned_cols=165  Identities=18%  Similarity=0.231  Sum_probs=133.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhcC---------CCCcee
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--------KGAFRSFVAECEALRNIR---------HRNLTK  107 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~  107 (234)
                      ..+|++.+.||+|+||+||+|++  +++.||||++....        ....+.+.+|+.+++.++         |||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35688899999999999999998  67999999997442        223477889999998885         888888


Q ss_pred             EEEEeeecC-------------------------CCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHH
Q 039258          108 IITICSSID-------------------------SKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID  162 (234)
Q Consensus       108 l~~~~~~~~-------------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~q  162 (234)
                      +.+++....                         ..+....++||||+++|++.+.+...       .+++..+..++.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-------~~~~~~~~~i~~q  169 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQ  169 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-------CCCHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-------CCCHHHHHHHHHH
Confidence            777643211                         01245679999999999777766432       5788999999999


Q ss_pred             HHHHHHHHH-hCCCCCeeecCCCCCCeeeCCCC--------------------ceEEccCccccccCCCccCCCCCCCCc
Q 039258          163 VASAIEYLH-HNCQPPMVHGDIKPSNVLLDNDM--------------------VAHVGDFGLSKFLSSDHLDTASETPSS  221 (234)
Q Consensus       163 i~~~l~~lh-~~~~~~ivH~dlk~~nil~~~~~--------------------~vki~dfG~a~~~~~~~~~~~~~~~~~  221 (234)
                      ++.||.||| ++   +|+||||||+|||++.++                    .+||+|||+|+.....           
T Consensus       170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----------  235 (336)
T 2vuw_A          170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----------  235 (336)
T ss_dssp             HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----------
T ss_pred             HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----------
Confidence            999999999 88   999999999999998776                    8999999999875532           


Q ss_pred             cccccccccccCC
Q 039258          222 SIGIKGTVGYVAP  234 (234)
Q Consensus       222 ~~~~~gt~~y~aP  234 (234)
                        ..+||+.||||
T Consensus       236 --~~~gt~~y~aP  246 (336)
T 2vuw_A          236 --IVVFCDVSMDE  246 (336)
T ss_dssp             --EEECCCCTTCS
T ss_pred             --cEEEeecccCh
Confidence              14699999998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.1e-31  Score=225.70  Aligned_cols=172  Identities=27%  Similarity=0.427  Sum_probs=144.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++..++||||+++++++...   +....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence            456899999999999999999999999999999997432 23346788999999999999999999987543   23356


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee----CCCCceEEc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL----DNDMVAHVG  199 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~----~~~~~vki~  199 (234)
                      ++||||+++++|.+++......   ..+++..+..++.|++.||.|||++   +|+||||||+||++    +.++.+||+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             EEEEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEe
Confidence            8999999999999999765421   1388899999999999999999999   99999999999999    777889999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++.........         ...||+.|+||
T Consensus       159 DFG~a~~~~~~~~~~---------~~~gt~~y~aP  184 (396)
T 4eut_A          159 DFGAARELEDDEQFV---------SLYGTEEYLHP  184 (396)
T ss_dssp             CGGGCEECCCGGGSS---------CSSSCCTTCCH
T ss_pred             cCCCceEccCCCccc---------cccCCccccCH
Confidence            999998765533211         15699999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=3.4e-31  Score=217.35  Aligned_cols=175  Identities=25%  Similarity=0.354  Sum_probs=137.5

Q ss_pred             hcCCCCC-ceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQS-NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ...|++. +.||+|+||.||+|.+..+++.||||++........+.+.+|++++..+ +||||+++++++...     +.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CE
Confidence            3467764 7899999999999999999999999999765555567889999999885 799999999998543     34


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc---eEEc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV---AHVG  199 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~---vki~  199 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++.   +||+
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~  156 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKIC  156 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred             EEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEE
Confidence            799999999999999998764      678889999999999999999999   9999999999999987665   9999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++............. .......+||+.|+||
T Consensus       157 Dfg~~~~~~~~~~~~~~~-~~~~~~~~gt~~y~aP  190 (316)
T 2ac3_A          157 DFDLGSGIKLNGDCSPIS-TPELLTPCGSAEYMAP  190 (316)
T ss_dssp             CTTCCC--------------------CCSGGGCCH
T ss_pred             EccCccccccCCcccccc-ccccccccCCcCccCh
Confidence            999998654322111100 0111125699999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=1.2e-31  Score=228.80  Aligned_cols=168  Identities=29%  Similarity=0.412  Sum_probs=134.5

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhcCCCCceeEEEEeee
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--------KGAFRSFVAECEALRNIRHRNLTKIITICSS  114 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~  114 (234)
                      ....+|.+.+.||+|+||.||+|.+..++..||+|++....        ......+.+|+.+|..++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            44678999999999999999999999999999999996432        1122357899999999999999999998732


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                            ...++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++
T Consensus       212 ------~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~  276 (419)
T 3i6u_A          212 ------EDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE  276 (419)
T ss_dssp             ------SEEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred             ------CceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence                  12589999999999999887654      688899999999999999999999   999999999999996544


Q ss_pred             ---ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 ---VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ---~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                         .+||+|||+++.........         ..+||+.|+||
T Consensus       277 ~~~~~kl~DFG~a~~~~~~~~~~---------~~~gt~~y~aP  310 (419)
T 3i6u_A          277 EDCLIKITDFGHSKILGETSLMR---------TLCGTPTYLAP  310 (419)
T ss_dssp             SSCCEEECCSSTTTSCC--------------------CTTCCT
T ss_pred             CcceEEEeecccceecCCCcccc---------ccCCCCCccCc
Confidence               59999999998765432111         26799999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=2.4e-31  Score=230.84  Aligned_cols=167  Identities=31%  Similarity=0.429  Sum_probs=141.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||||++...  .......+.+|++++..++||||+++++++..     ...
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~   95 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS   95 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CCE
Confidence            45699999999999999999999999999999999633  23345778999999999999999999999853     344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC---CCCceEEc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVG  199 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~---~~~~vki~  199 (234)
                      .++||||+++++|.+.+....      .+++..+..++.|++.||.|||++   +|+||||||+||+++   .++.+||+
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  166 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII  166 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEE
Confidence            799999999999999987765      688899999999999999999999   999999999999995   45679999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++.........         ..+||+.|+||
T Consensus       167 Dfg~a~~~~~~~~~~---------~~~gt~~y~aP  192 (486)
T 3mwu_A          167 DFGLSTCFQQNTKMK---------DRIGTAYYIAP  192 (486)
T ss_dssp             SCSCTTTBCCC-------------CCTTGGGGCCG
T ss_pred             ECCcCeECCCCCccC---------CCcCCCCCCCH
Confidence            999998654432111         25699999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=2.7e-31  Score=216.37  Aligned_cols=170  Identities=27%  Similarity=0.430  Sum_probs=137.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHh--cCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .++|++.+.||+|+||.||+|.+  ++..||||++....   ...+.+|.+++..  ++||||+++++++.... .....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCce
Confidence            46799999999999999999988  67899999986432   3556667777776  78999999999875432 23445


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCCeeeCCCC
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH--------HNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--------~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                      .++||||+++++|.+++...       .+++..+..++.|++.||.|||        ++   +++||||||+||+++.++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred             eEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence            68999999999999999543       5788899999999999999999        77   999999999999999999


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||+++...........    ......||+.|+||
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~----~~~~~~gt~~y~aP  186 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDV----GNNPRVGTKRYMAP  186 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEEC----CCCCCCCCGGGCCH
T ss_pred             CEEEeeCCCeeecccccccccc----cccccccccceeCh
Confidence            9999999999865543221110    01124799999998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=1.7e-31  Score=222.72  Aligned_cols=167  Identities=28%  Similarity=0.405  Sum_probs=128.0

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|+++...  ..+.+.+|++++..++||||+++++++..     ...
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~  122 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTE  122 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCe
Confidence            34567899999999999999999999999999999997432  23567889999999999999999999853     334


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC---CCceEEc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVG  199 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~---~~~vki~  199 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.   ++.+||+
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~  193 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIA  193 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEc
Confidence            799999999999999997654      578899999999999999999999   9999999999999975   7899999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++.........         ..+||+.|+||
T Consensus       194 Dfg~a~~~~~~~~~~---------~~~gt~~y~aP  219 (349)
T 2w4o_A          194 DFGLSKIVEHQVLMK---------TVCGTPGYCAP  219 (349)
T ss_dssp             CCC-------------------------CGGGSCH
T ss_pred             cCccccccCcccccc---------cccCCCCccCH
Confidence            999998654322111         25699999998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=4.3e-31  Score=217.58  Aligned_cols=167  Identities=25%  Similarity=0.346  Sum_probs=142.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc------hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++.....      ...+.+.+|+.++..++||||+++++++..    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----   86 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN----   86 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence            3468899999999999999999999999999999974321      134678999999999999999999999753    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC----
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM----  194 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~----  194 (234)
                       ....++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||+++.++    
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           87 -RTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence             344799999999999999997654      578889999999999999999999   999999999999998777    


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||++..........         ...||+.|+||
T Consensus       157 ~~kl~Dfg~~~~~~~~~~~~---------~~~gt~~y~aP  187 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDGVEFK---------NIFGTPEFVAP  187 (321)
T ss_dssp             CEEECCCTTCEECCTTCCCC---------CCCSCGGGCCH
T ss_pred             CEEEccCccceecCcccccc---------ccCCCCCccCc
Confidence            79999999998765432111         15699999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=7.5e-32  Score=223.63  Aligned_cols=169  Identities=26%  Similarity=0.430  Sum_probs=143.1

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhcCCCCceeEEEEeee
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--------KGAFRSFVAECEALRNIRHRNLTKIITICSS  114 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~  114 (234)
                      ....+|++.+.||+|+||.||+|.+..++..||||+++...        ......+.+|+.++..++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            34567999999999999999999999999999999997432        1133457789999999999999999999843


Q ss_pred             cCCCCCCcceeeEeecCCC-CHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC
Q 039258          115 IDSKGADFKALVFEYMENG-SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~  193 (234)
                           ....++||||+.++ +|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.+
T Consensus       101 -----~~~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  166 (335)
T 3dls_A          101 -----QGFFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED  166 (335)
T ss_dssp             -----SSEEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             -----CCEEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence                 34578999998766 9999998765      688899999999999999999999   99999999999999999


Q ss_pred             CceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          194 MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       194 ~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.+||+|||++..........         ..+||+.|+||
T Consensus       167 ~~~kL~Dfg~a~~~~~~~~~~---------~~~gt~~y~aP  198 (335)
T 3dls_A          167 FTIKLIDFGSAAYLERGKLFY---------TFCGTIEYCAP  198 (335)
T ss_dssp             SCEEECCCTTCEECCTTCCBC---------EECSCGGGCCH
T ss_pred             CcEEEeecccceECCCCCcee---------ccCCCccccCh
Confidence            999999999998765432111         25799999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=2.6e-31  Score=219.47  Aligned_cols=159  Identities=25%  Similarity=0.363  Sum_probs=124.1

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcceeeEee
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKALVFEY  129 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~lv~e~  129 (234)
                      .+.||+|+||.||+|.+..+++.||||++...   ....+.+|+.++..+. ||||+++++++..     ....++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~~~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-----QLHTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSEEEEEECC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----CCEEEEEEEc
Confidence            47899999999999999999999999999643   2356778999999997 9999999999853     3447999999


Q ss_pred             cCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC---ceEEccCccccc
Q 039258          130 MENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM---VAHVGDFGLSKF  206 (234)
Q Consensus       130 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~---~vki~dfG~a~~  206 (234)
                      +++++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||+++.++   .+||+|||+++.
T Consensus        88 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           88 LNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             CCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999998764      688999999999999999999999   999999999999997655   899999999986


Q ss_pred             cCCCccCCCCCCCCccccccccccccCC
Q 039258          207 LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........        ..+||+.|+||
T Consensus       159 ~~~~~~~~~--------~~~~t~~y~aP  178 (325)
T 3kn6_A          159 KPPDNQPLK--------TPCFTLHYAAP  178 (325)
T ss_dssp             CCC-------------------------
T ss_pred             cCCCCCccc--------ccCCCcCccCH
Confidence            554322111        25689999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=2.6e-31  Score=231.10  Aligned_cols=167  Identities=27%  Similarity=0.415  Sum_probs=138.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ...|++.+.||+|+||.||+|.+..++..+|+|++....  ......+.+|+.++..++||||+++++++..     ...
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence            446899999999999999999999999999999997432  3345778999999999999999999999853     344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC---CCceEEc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVG  199 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~---~~~vki~  199 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.   ++.+||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence            799999999999999887765      688899999999999999999999   9999999999999975   4459999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++..........         ..+||+.|+||
T Consensus       182 DfG~a~~~~~~~~~~---------~~~gt~~y~aP  207 (494)
T 3lij_A          182 DFGLSAVFENQKKMK---------ERLGTAYYIAP  207 (494)
T ss_dssp             CCTTCEECBTTBCBC---------CCCSCTTTCCH
T ss_pred             ECCCCeECCCCcccc---------ccCCCcCeeCH
Confidence            999998765432111         25799999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=2.1e-31  Score=223.98  Aligned_cols=172  Identities=28%  Similarity=0.538  Sum_probs=130.8

Q ss_pred             hcCCCCCceeecccceEEEEEEEC---CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG---EDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|++.   .++..||||.++.. .....+.+.+|+.++..++||||+++++++..     .
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----S  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----C
Confidence            357899999999999999999876   45678999999754 33345679999999999999999999999843     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....     .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  190 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD  190 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECc
Confidence            346899999999999999976542     578889999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++...........     .....+|+.|+||
T Consensus       191 fg~a~~~~~~~~~~~~-----~~~~~~~~~y~aP  219 (373)
T 2qol_A          191 FGLGRVLEDDPEAAYT-----TRGGKIPIRWTSP  219 (373)
T ss_dssp             C---------------------------CTTSCH
T ss_pred             CccccccccCCcccee-----ccCCCcCCCccCh
Confidence            9999876543221110     0113457789987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=1.8e-31  Score=232.12  Aligned_cols=171  Identities=27%  Similarity=0.558  Sum_probs=143.6

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ...+|++.+.||+|+||.||+|.+..++..||||.++... ...+.+.+|+.+|..++||||++++++|..     ....
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~  291 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF  291 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcE
Confidence            3456888899999999999999999889999999997443 235789999999999999999999999843     2346


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++......    .+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTT----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             EEEEEccCCCCHHHHHHhcCcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccc
Confidence            9999999999999999865422    578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++..........       ....+|+.|+||
T Consensus       365 a~~~~~~~~~~~-------~~~~~~~~y~aP  388 (495)
T 1opk_A          365 SRLMTGDTYTAH-------AGAKFPIKWTAP  388 (495)
T ss_dssp             EECCTTCCEECC-------TTCCCCGGGCCH
T ss_pred             ceeccCCceeec-------CCCcCCcceeCH
Confidence            987654322111       114577889998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=2.7e-31  Score=221.90  Aligned_cols=177  Identities=27%  Similarity=0.347  Sum_probs=147.4

Q ss_pred             CCCcChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-----CCCcee
Q 039258           33 FPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-----HRNLTK  107 (234)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~  107 (234)
                      ...+++.+.....++|++.+.||+|+||.||+|.+..+++.||||+++.. ....+.+..|+.++..+.     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34455566666678999999999999999999999999999999999632 233456778999999986     999999


Q ss_pred             EEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039258          108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSN  187 (234)
Q Consensus       108 l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~n  187 (234)
                      +++++...     +..++||||+ +++|.+++......    .+++..+..++.|++.||.|||++   +|+||||||+|
T Consensus       101 ~~~~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N  167 (360)
T 3llt_A          101 YHGKFMYY-----DHMCLIFEPL-GPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPEN  167 (360)
T ss_dssp             EEEEEEET-----TEEEEEECCC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccceeeEC-----CeeEEEEcCC-CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCccc
Confidence            99988543     3479999999 88999999875432    578889999999999999999999   99999999999


Q ss_pred             eeeCC-------------------------CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          188 VLLDN-------------------------DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       188 il~~~-------------------------~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++.                         ++.+||+|||++........           ...||+.|+||
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~-----------~~~gt~~y~aP  228 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG-----------SIINTRQYRAP  228 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC-----------SCCSCGGGCCH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCc-----------CccCcccccCc
Confidence            99975                         78899999999986443211           15699999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=2.2e-31  Score=221.47  Aligned_cols=165  Identities=27%  Similarity=0.392  Sum_probs=137.3

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ...+|++.+.||+|+||.||+|.++.+++.||+|+++....    ...+|++++..+ +||||+++++++..     ...
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD-----GKY   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC-----SSE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc-----CCE
Confidence            45579999999999999999999999999999999975432    234688888887 79999999999743     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-C---CceEE
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-D---MVAHV  198 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-~---~~vki  198 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||++.. +   +.+||
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence            799999999999999997654      688899999999999999999999   9999999999999843 2   35999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++.........        ...+||+.|+||
T Consensus       162 ~Dfg~a~~~~~~~~~~--------~~~~gt~~y~aP  189 (342)
T 2qr7_A          162 CDFGFAKQLRAENGLL--------MTPCYTANFVAP  189 (342)
T ss_dssp             CCCTTCEECBCTTCCB--------CCSSCCSSCCCH
T ss_pred             EECCCcccCcCCCCce--------eccCCCccccCH
Confidence            9999998765432211        125799999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=3.7e-31  Score=217.19  Aligned_cols=167  Identities=26%  Similarity=0.284  Sum_probs=135.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .++|+..+.||+|+||+||+|.+..+++.||||++....  .........|+..+..+ +||||+++++++..     ..
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~  130 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GG  130 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CC
Confidence            357999999999999999999999999999999985432  22334556666666555 89999999999853     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+ +++|.+++...+.     .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred             EEEEEEecc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence            479999999 6799998876543     588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........         ...||+.|+||
T Consensus       202 G~a~~~~~~~~~~---------~~~gt~~y~aP  225 (311)
T 3p1a_A          202 GLLVELGTAGAGE---------VQEGDPRYMAP  225 (311)
T ss_dssp             TTCEECC---------------CCCCCGGGCCG
T ss_pred             eeeeecccCCCCc---------ccCCCccccCH
Confidence            9988765432211         14699999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=225.09  Aligned_cols=174  Identities=18%  Similarity=0.202  Sum_probs=136.9

Q ss_pred             HHhcCCCCCceeecccceEEEEEE-----ECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC---CCCceeEEEEeee
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGI-----LGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR---HRNLTKIITICSS  114 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~l~~~~~~  114 (234)
                      ....+|.+.+.||+|+||.||+|.     +..+++.||+|+++...   ...+..|++++..++   |+|++.+++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345668889999999999999994     56678899999996443   356677888888886   8999999998754


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC--
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN--  192 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~--  192 (234)
                      .     +..++||||+++++|.+++....... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.  
T Consensus       139 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          139 Q-----NGSVLVGELYSYGTLLNAINLYKNTP-EKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             S-----SCEEEEECCCCSCBHHHHHHHHHTST-TCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGG
T ss_pred             C-----CCcEEEEeccCCCcHHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccc
Confidence            3     33689999999999999997532111 11688999999999999999999999   9999999999999988  


Q ss_pred             ---------CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 ---------DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ---------~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                               ++.+||+|||+|+.........      .....+||+.|+||
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~------~~~~~~gt~~y~aP  254 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGT------IFTAKCETSGFQCV  254 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTE------EECCSSCTTSCCCH
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCc------eeeeecCCCCCCCh
Confidence                     8999999999997654221111      11125799999998

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=1.7e-31  Score=216.38  Aligned_cols=165  Identities=22%  Similarity=0.447  Sum_probs=140.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCC-------eEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDE-------MVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      ..+|++.+.||+|+||.||+|.+..++       ..||+|++........+.+.+|+.++..++||||+++++++...  
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG--   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence            456888999999999999999987665       57999999766556668899999999999999999999998542  


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc--
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV--  195 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~--  195 (234)
                         +..++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.  
T Consensus        85 ---~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~  153 (289)
T 4fvq_A           85 ---DENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK  153 (289)
T ss_dssp             ---TCCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred             ---CCCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence               346899999999999999987542     478889999999999999999999   9999999999999987776  


Q ss_pred             ------eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 ------AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 ------vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                            +||+|||++.......            ...||+.|+||
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~y~aP  186 (289)
T 4fvq_A          154 TGNPPFIKLSDPGISITVLPKD------------ILQERIPWVPP  186 (289)
T ss_dssp             GTBCCEEEECCCCSCTTTSCHH------------HHHHTTTTSCH
T ss_pred             ccccceeeeccCcccccccCcc------------ccCCcCcccCH
Confidence                  9999999987543321            14588889987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=2.2e-31  Score=219.19  Aligned_cols=183  Identities=26%  Similarity=0.463  Sum_probs=129.9

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCe---EEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEM---VVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      ....+|++.+.||+|+||.||+|.+..++.   .||+|+++..  .....+.+.+|+.++..++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            445679999999999999999999877664   8999999743  33455789999999999999999999998865433


Q ss_pred             CC-CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCce
Q 039258          118 KG-ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       118 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~v  196 (234)
                      .+ ....++||||+++++|.+++...........+++..+..++.|++.||.|||++   +++||||||+||+++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            21 122389999999999999997654333333588899999999999999999999   99999999999999999999


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|||+++...........      ....||+.|+||
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~------~~~~~~~~y~aP  208 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQG------CASKLPVKWLAL  208 (323)
T ss_dssp             EECCCCC-----------------------CCGGGCCH
T ss_pred             EEeecccccccccccccccc------ccccCcccccCc
Confidence            99999999876543221111      113477889987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=9.6e-31  Score=209.90  Aligned_cols=168  Identities=27%  Similarity=0.483  Sum_probs=140.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|++++..++||||+++++++..     ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYPIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCceE
Confidence            457888999999999999999886 466799999974432 33678999999999999999999999743     34468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++...+.     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence            99999999999999977542     588899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........       ....||+.|+||
T Consensus       152 ~~~~~~~~~~~-------~~~~~~~~y~aP  174 (268)
T 3sxs_A          152 RYVLDDQYVSS-------VGTKFPVKWSAP  174 (268)
T ss_dssp             EECCTTCEEEC-------CSCCCCGGGCCH
T ss_pred             eecchhhhhcc-------cCCCcCcccCCH
Confidence            87654332211       124577889998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=6.8e-31  Score=220.07  Aligned_cols=174  Identities=26%  Similarity=0.341  Sum_probs=145.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.++..++||||+++++++...........
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            45799999999999999999999999999999999643 23344778999999999999999999999866544444567


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++|||+++ ++|.+++...       .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEcccC-cCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence            99999996 5999988653       578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +............     ....+||+.|+||
T Consensus       175 a~~~~~~~~~~~~-----~~~~~gt~~y~aP  200 (364)
T 3qyz_A          175 ARVADPDHDHTGF-----LTEYVATRWYRAP  200 (364)
T ss_dssp             CEECCGGGCBCCT-----TCCCCSCGGGCCH
T ss_pred             eEecCCCCCcccc-----ccccccccCCCCC
Confidence            9876543222110     1125799999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=5e-31  Score=211.79  Aligned_cols=168  Identities=27%  Similarity=0.511  Sum_probs=139.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|+..+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|++++..++||||+++++++..     ....+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceE
Confidence            356888999999999999999986 466799999974432 33678999999999999999999999743     33469


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        82 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             EEEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence            99999999999999976542     578889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ............       ...||+.|+||
T Consensus       154 ~~~~~~~~~~~~-------~~~~~~~y~aP  176 (269)
T 4hcu_A          154 RFVLDDQYTSST-------GTKFPVKWASP  176 (269)
T ss_dssp             GGBCCHHHHSTT-------STTCCGGGCCH
T ss_pred             cccccccccccc-------CcccccccCCH
Confidence            876543322111       14578889998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=7.7e-31  Score=213.28  Aligned_cols=168  Identities=21%  Similarity=0.364  Sum_probs=143.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|.+.+.||+|+||.||+|.+..++..+|+|++...   .....+.+.+|+.++..++||||+++++++..     .+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----CC
Confidence            45688999999999999999999999999999999643   22345678899999999999999999999753     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++....      .+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.+||+||
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence            5799999999999999987654      678899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........        ....||+.|+||
T Consensus       160 g~~~~~~~~~~~~--------~~~~~~~~y~aP  184 (294)
T 2rku_A          160 GLATKVEYDGERK--------KVLCGTPNYIAP  184 (294)
T ss_dssp             TTCEECCSTTCCB--------CCCCSCCSSCCH
T ss_pred             cCceecccCcccc--------ccccCCCCcCCc
Confidence            9998764332111        125689999997

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=7.2e-31  Score=217.56  Aligned_cols=169  Identities=21%  Similarity=0.364  Sum_probs=144.4

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ...+|.+.+.||+|+||.||+|.+..++..+|+|++...   .....+.+.+|+.++..++|+||+++++++..     .
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----N  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----C
Confidence            346799999999999999999999999999999999643   23345678899999999999999999999853     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      +..++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D  184 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGD  184 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             CeEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEee
Confidence            45799999999999999987654      688899999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++..........        ....||+.|+||
T Consensus       185 fg~~~~~~~~~~~~--------~~~~gt~~y~aP  210 (335)
T 2owb_A          185 FGLATKVEYDGERK--------KVLCGTPNYIAP  210 (335)
T ss_dssp             CTTCEECCSTTCCB--------CCCCSCCSSCCH
T ss_pred             ccCceecccCcccc--------cccCCCccccCH
Confidence            99998765332111        125699999997

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=4.6e-31  Score=216.11  Aligned_cols=167  Identities=23%  Similarity=0.365  Sum_probs=136.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+....  ....+.+.+|+.++..++||||+++++++...     ...
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeE
Confidence            57889999999999999999999999999999885432  22346788999999999999999999998543     346


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            89999999988888876554      578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........        ...||+.|+||
T Consensus       149 ~~~~~~~~~~~~--------~~~~~~~y~aP  171 (311)
T 4agu_A          149 ARLLTGPSDYYD--------DEVATRWYRSP  171 (311)
T ss_dssp             CEECC--------------------GGGCCH
T ss_pred             chhccCcccccC--------CCcCCccccCh
Confidence            987653321111        14689999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=2.8e-31  Score=215.49  Aligned_cols=166  Identities=25%  Similarity=0.428  Sum_probs=136.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++.+.||+|+||.||+|.+ .++..||+|.+....  ....+.+.+|++++..++||||+++++++..     .+..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence            4688899999999999999998 678899999996432  2334678899999999999999999999853     3347


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++ +|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             EEEEEecCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence            999999975 99998876532     578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.........        ....||+.|+||
T Consensus       147 ~~~~~~~~~~~--------~~~~~t~~y~aP  169 (288)
T 1ob3_A          147 ARAFGIPVRKY--------THEIVTLWYRAP  169 (288)
T ss_dssp             HHHHCC-----------------CCCTTCCH
T ss_pred             ccccCcccccc--------ccccccccccCc
Confidence            98654322111        114689999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=8.4e-31  Score=212.67  Aligned_cols=169  Identities=25%  Similarity=0.421  Sum_probs=142.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..|.+.+.||+|+||.||+|.+..++..||+|.+...  .....+.+.+|+.++..++||||+++++++.... .+....
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence            3477788999999999999999999999999999743  2334577899999999999999999999876543 234557


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeeeC-CCCceEEcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP--MVHGDIKPSNVLLD-NDMVAHVGD  200 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--ivH~dlk~~nil~~-~~~~vki~d  200 (234)
                      ++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +  ++|+||||+||+++ .++.+||+|
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence            99999999999999998754      678889999999999999999998   7  99999999999997 789999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++.........          ...||+.|+||
T Consensus       176 fg~~~~~~~~~~~----------~~~~t~~y~aP  199 (290)
T 1t4h_A          176 LGLATLKRASFAK----------AVIGTPEFMAP  199 (290)
T ss_dssp             TTGGGGCCTTSBE----------ESCSSCCCCCG
T ss_pred             CCCcccccccccc----------cccCCcCcCCH
Confidence            9999754432211          25689999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=3.3e-31  Score=213.94  Aligned_cols=166  Identities=26%  Similarity=0.440  Sum_probs=139.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++...   .......+.+|+.++..++||||+++++++..     ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-----CC
Confidence            45788999999999999999999999999999999643   22234678899999999999999999999853     33


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+||
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Df  153 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF  153 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSC
T ss_pred             EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEec
Confidence            4799999999999999998765      678889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++.........          ...||+.|+||
T Consensus       154 g~~~~~~~~~~~----------~~~~~~~y~aP  176 (279)
T 3fdn_A          154 GWSVHAPSSRRT----------DLCGTLDYLPP  176 (279)
T ss_dssp             CEESCC------------------CCCCTTCCH
T ss_pred             cccccCCccccc----------ccCCCCCccCH
Confidence            998654332211          15689999987

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=4e-31  Score=224.25  Aligned_cols=167  Identities=22%  Similarity=0.335  Sum_probs=131.0

Q ss_pred             cCCCCC-ceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHH-hcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQS-NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALR-NIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|.+. +.||+|+||+||+|.+..+++.||||+++..     ..+.+|++++. ..+||||+++++++.... .+...+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEE
Confidence            345554 6899999999999999999999999998632     45667888874 458999999999876422 234557


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC---CCceEEcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGD  200 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~---~~~vki~d  200 (234)
                      ++||||+++++|.+++......    .+++..+..++.|++.||.|||++   +|+||||||+|||++.   ++.+||+|
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence            9999999999999999865422    588899999999999999999999   9999999999999986   78899999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++........         ...+||+.|+||
T Consensus       208 FG~a~~~~~~~~~---------~~~~gt~~y~aP  232 (400)
T 1nxk_A          208 FGFAKETTSHNSL---------TTPCYTPYYVAP  232 (400)
T ss_dssp             CTTCEECC--------------------CTTCCG
T ss_pred             cccccccCCCCcc---------ccCCCCCCccCH
Confidence            9999865432211         125799999998

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=4e-31  Score=219.22  Aligned_cols=179  Identities=26%  Similarity=0.434  Sum_probs=143.8

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeec
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSI  115 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~  115 (234)
                      .....+|++.+.||+|+||.||+|.+.     .++..||+|+++... ....+.+.+|+.++..++||||+++++++.. 
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-
Confidence            345578999999999999999999986     345899999997542 3345678999999999999999999999843 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCCc------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDHL------------------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPP  177 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------------------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~  177 (234)
                          ....++||||+++++|.+++.......                  ....+++..++.++.|++.||.|||++   +
T Consensus       122 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~  194 (343)
T 1luf_A          122 ----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K  194 (343)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             ----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence                344799999999999999998643110                  012688899999999999999999999   9


Q ss_pred             eeecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          178 MVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       178 ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++||||||+||+++.++.+||+|||+++...........      ....||+.|+||
T Consensus       195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~------~~~~~t~~y~aP  245 (343)
T 1luf_A          195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD------GNDAIPIRWMPP  245 (343)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCH
T ss_pred             eecCCCCcceEEECCCCeEEEeecCCCcccccCcccccc------CCCcccceecCh
Confidence            999999999999999999999999999876443221111      124588999998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=4.6e-31  Score=220.01  Aligned_cols=163  Identities=28%  Similarity=0.436  Sum_probs=139.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..|+..+.||+|+||.||+|.+..++..||||.+....   ....+.+.+|++++..++||||+++++++...     ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence            44888899999999999999999999999999997432   23346789999999999999999999998543     34


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||++ |+|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EEEEEecCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence            789999997 588888865432     678899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++......            ..+||+.|+||
T Consensus       200 ~a~~~~~~~------------~~~gt~~y~aP  219 (348)
T 1u5q_A          200 SASIMAPAN------------SFVGTPYWMAP  219 (348)
T ss_dssp             TCBSSSSBC------------CCCSCGGGCCH
T ss_pred             CceecCCCC------------cccCCcceeCH
Confidence            998654321            15699999998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=1e-30  Score=219.25  Aligned_cols=171  Identities=29%  Similarity=0.471  Sum_probs=144.7

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc--------hhhHHHHHHHHHHHhc-CCCCceeEEEE
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--------GAFRSFVAECEALRNI-RHRNLTKIITI  111 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~i~~l~~~  111 (234)
                      ......+|++.+.||+|+||.||+|.+..+|..||||++.....        ...+.+.+|+.++..+ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            34455679999999999999999999998999999999974321        1245678999999999 79999999998


Q ss_pred             eeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                      +..     ....++||||+++++|.+++....      .+++..+..++.|++.||.|||+.   +++|+||||+||+++
T Consensus       169 ~~~-----~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~  234 (365)
T 2y7j_A          169 YES-----SSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLD  234 (365)
T ss_dssp             EEB-----SSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             Eee-----CCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            753     344799999999999999998654      688899999999999999999999   999999999999999


Q ss_pred             CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          192 NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       192 ~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .++.+||+|||++..........         ..+||+.|+||
T Consensus       235 ~~~~ikl~DfG~~~~~~~~~~~~---------~~~gt~~y~aP  268 (365)
T 2y7j_A          235 DNMQIRLSDFGFSCHLEPGEKLR---------ELCGTPGYLAP  268 (365)
T ss_dssp             TTCCEEECCCTTCEECCTTCCBC---------CCCSCGGGCCH
T ss_pred             CCCCEEEEecCcccccCCCcccc---------cCCCCCCccCh
Confidence            99999999999998765432111         25799999998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=5.9e-31  Score=222.22  Aligned_cols=177  Identities=27%  Similarity=0.397  Sum_probs=134.1

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~  120 (234)
                      ...+|++.+.||+|+||.||+|.+..+++.||||.+...  .......+.+|+.++..+. ||||+++++++...   +.
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---ND   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TS
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CC
Confidence            456899999999999999999999999999999998532  3344567889999999997 99999999998542   23


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ..+++||||++ ++|.+++...       .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D  152 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVAD  152 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             CEEEEEecccC-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecC
Confidence            45799999997 5999988753       578888999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCC-------------CCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTA-------------SETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~-------------~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++..........             ..........+||+.|+||
T Consensus       153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  199 (388)
T 3oz6_A          153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP  199 (388)
T ss_dssp             CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCH
T ss_pred             CcccccccccccccccccccccccccccccccccccCCcccCCcCCH
Confidence            999987643211000             0001111236799999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=7.6e-31  Score=218.55  Aligned_cols=177  Identities=26%  Similarity=0.420  Sum_probs=142.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC---CC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDS---KG  119 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~---~~  119 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.++..++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            357999999999999999999999999999999986432  2334678899999999999999999999865432   11


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      ....++||||+++ +|.+.+.....     .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence            3457899999975 88887765432     588899999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++...........    ......||+.|+||
T Consensus       167 Dfg~a~~~~~~~~~~~~----~~~~~~gt~~y~aP  197 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPN----RYTNRVVTLWYRPP  197 (351)
T ss_dssp             CCTTCEECCCCSSSSCC----CCCSSCSCGGGCCH
T ss_pred             cchhccccccccccccc----ccCCcccccCccCc
Confidence            99999876543222111    11125689999998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=6e-31  Score=212.20  Aligned_cols=169  Identities=25%  Similarity=0.460  Sum_probs=133.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.++..++||||+++++++..     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence            356899999999999999999999999999999996432   2334678999999999999999999999753     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+||+||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df  156 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVK-----PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF  156 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEee
Confidence            57999999999999999986532     578899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........        ....||+.|+||
T Consensus       157 g~~~~~~~~~~~~--------~~~~~~~~y~aP  181 (278)
T 3cok_A          157 GLATQLKMPHEKH--------YTLCGTPNYISP  181 (278)
T ss_dssp             TTCEECC--------------------------
T ss_pred             cceeeccCCCCcc--------eeccCCCCcCCc
Confidence            9998765332111        125689999998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=6.6e-31  Score=216.91  Aligned_cols=174  Identities=24%  Similarity=0.361  Sum_probs=144.9

Q ss_pred             hcCCCCCceeecccceEEEEEE----ECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGI----LGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|.    +..++..||+|++........+.+.+|++++..++||||+++++++...   +.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CC
Confidence            3568889999999999999999    4567899999999766555567799999999999999999999987532   34


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....     .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~D  170 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIAD  170 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred             ceEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcc
Confidence            557899999999999999986432     588899999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++.............     ....||+.|+||
T Consensus       171 fg~~~~~~~~~~~~~~~-----~~~~~~~~y~aP  199 (327)
T 3lxl_A          171 FGLAKLLPLDKDYYVVR-----EPGQSPIFWYAP  199 (327)
T ss_dssp             GGGCEECCTTCSEEECS-----SCCCSCGGGSCH
T ss_pred             cccceecccCCccceee-----ccCCccccccCH
Confidence            99998765432211110     114588889998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.8e-31  Score=223.90  Aligned_cols=176  Identities=24%  Similarity=0.402  Sum_probs=139.1

Q ss_pred             hcCCCCCceeecccceEEEEEEE-----CCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      ..+|++.+.||+|+||.||+|.+     ..++..||||.++.. .......+.+|+.++..++||||+++++++..    
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            35688899999999999999994     456789999999643 33344678899999999999999999999743    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCC-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC---
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDH-LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM---  194 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~---  194 (234)
                       ....++||||+++++|.+++...... .....+++..++.++.|++.||.|||++   +|+||||||+|||++.++   
T Consensus       146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence             33468999999999999999875421 1123588899999999999999999999   999999999999998554   


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||+++...........      ....||+.|+||
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~------~~~~~t~~y~aP  255 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKG------GCAMLPVKWMPP  255 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTC------CGGGSCGGGCCH
T ss_pred             eEEECCCccccccccccccccC------CCcCCcccEECH
Confidence            5999999999865332211110      114688999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=7e-31  Score=212.87  Aligned_cols=170  Identities=26%  Similarity=0.380  Sum_probs=138.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+|.+.+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|++++..++||||+++++++..     ....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHNMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCeEE
Confidence            46888999999999999999999999999999997543 3345788999999999999999999999853     33479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee---CCCCceEEccC
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDF  201 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~---~~~~~vki~df  201 (234)
                      +||||+++++|.+++......  ...+++..+..++.|++.||.|||++   +++|+||||+||++   +.++.+||+||
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            999999999999988653211  11688899999999999999999999   99999999999999   45678999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........         ...||+.|+||
T Consensus       172 g~a~~~~~~~~~~---------~~~~t~~y~aP  195 (285)
T 3is5_A          172 GLAELFKSDEHST---------NAAGTALYMAP  195 (285)
T ss_dssp             CCCCC-------------------CTTGGGCCH
T ss_pred             ecceecCCcccCc---------CcccccCcCCh
Confidence            9998655432111         25699999998

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=4.9e-31  Score=215.00  Aligned_cols=174  Identities=27%  Similarity=0.447  Sum_probs=140.7

Q ss_pred             hcCCCCCceeecccceEEEEEE----ECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGI----LGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ..+|+..+.||+|+||.||+|.    +..+++.||+|++... .....+.+.+|+.++..++||||+++++++...   +
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence            3458889999999999999999    4568899999999743 233457789999999999999999999988643   2


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      ....++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~  168 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIG  168 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEEC
Confidence            2446899999999999999966542     588899999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++............     .....||..|+||
T Consensus       169 Dfg~~~~~~~~~~~~~~-----~~~~~~~~~y~aP  198 (302)
T 4e5w_A          169 DFGLTKAIETDKEYYTV-----KDDRDSPVFWYAP  198 (302)
T ss_dssp             CCTTCEECCTTCCEEEC-----CCCTTCCGGGCCH
T ss_pred             cccccccccCCCcceec-----cCCCCCCccccCC
Confidence            99999876554321110     1114588889998

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=3e-31  Score=220.27  Aligned_cols=182  Identities=27%  Similarity=0.378  Sum_probs=141.3

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-----cchhhHHHHHHHHHHHhcCCCCceeEEEEeeec
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLTKIITICSSI  115 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~  115 (234)
                      +.....+|++.+.||+|+||.||+|.+..++..||+|++...     .....+.+.+|+.++..++||||+++++++.. 
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-   99 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-   99 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-
Confidence            345566799999999999999999999999999999999643     23445789999999999999999999999853 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCC----------------------------------ccccccCHHHHHHHHH
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDH----------------------------------LEVFKLSLIQRVNIAI  161 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------------------------~~~~~~~~~~~~~~~~  161 (234)
                          ....++||||+++++|.+++......                                  .....+++..+..++.
T Consensus       100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A          100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence                34579999999999999998531100                                  0011345677888999


Q ss_pred             HHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC--ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM--VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       162 qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~--~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++.||.|||++   +++||||||+||+++.++  .+||+|||+++..........    .......||+.|+||
T Consensus       176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aP  243 (345)
T 3hko_A          176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY----YGMTTKAGTPYFVAP  243 (345)
T ss_dssp             HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCH
T ss_pred             HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCcccc----ccccccCCCccccCc
Confidence            999999999999   999999999999998666  899999999986543221111    011125699999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.2e-31  Score=219.33  Aligned_cols=170  Identities=28%  Similarity=0.442  Sum_probs=135.1

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-----hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-----GAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++.....     ...+.+.+|+.++..++||||+++++++..   
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   83 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH---   83 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence            345689999999999999999999999999999999964321     123578899999999999999999999743   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                        ....++||||+++ +|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+|
T Consensus        84 --~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  152 (346)
T 1ua2_A           84 --KSNISLVFDFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLK  152 (346)
T ss_dssp             --TTCCEEEEECCSE-EHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             --CCceEEEEEcCCC-CHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEE
Confidence              3347899999976 89888876532     467778899999999999999999   999999999999999999999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||+++.........        ...+||+.|+||
T Consensus       153 l~Dfg~a~~~~~~~~~~--------~~~~~t~~y~aP  181 (346)
T 1ua2_A          153 LADFGLAKSFGSPNRAY--------THQVVTRWYRAP  181 (346)
T ss_dssp             ECCCGGGSTTTSCCCCC--------CCSCCCCTTCCH
T ss_pred             EEecccceeccCCcccC--------CcccccccccCc
Confidence            99999998764432111        125689999998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=4.8e-30  Score=209.71  Aligned_cols=183  Identities=35%  Similarity=0.539  Sum_probs=149.6

Q ss_pred             CCCcChHHHHHHhcCCCCC------ceeecccceEEEEEEECCCCeEEEEEEeecc----cchhhHHHHHHHHHHHhcCC
Q 039258           33 FPMVSYAELSKATCEFSQS------NMIGQGSYGSVYKGILGEDEMVVAVKVINLK----QKGAFRSFVAECEALRNIRH  102 (234)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~------~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h  102 (234)
                      ...++..++...+.+|...      +.||+|+||.||+|.+  ++..||+|.+...    .....+.+.+|+.++..++|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            3567888888888888776      8999999999999987  5678999998632    23345778999999999999


Q ss_pred             CCceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 039258          103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGD  182 (234)
Q Consensus       103 ~~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~d  182 (234)
                      |||+++++++..     .+..++||||+++++|.+++......   ..+++..+..++.|++.||.|||++   +++|+|
T Consensus        90 ~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  158 (307)
T 2nru_A           90 ENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHEN---HHIHRD  158 (307)
T ss_dssp             TTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTGGGC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             CCeEEEEEEEec-----CCceEEEEEecCCCcHHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhcC---CeecCC
Confidence            999999998743     33469999999999999998754321   1578889999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          183 IKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       183 lk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+||+++.++.+||+|||++...........      .....||+.|+||
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~g~~~y~aP  204 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQTVM------TSRIVGTTAYMAP  204 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSSCEE------CSSCCSCGGGCCH
T ss_pred             CCHHHEEEcCCCcEEEeeccccccccccccccc------ccccCCCcCcCCh
Confidence            999999999999999999999987554321111      1125699999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=6.1e-31  Score=220.75  Aligned_cols=168  Identities=23%  Similarity=0.366  Sum_probs=135.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~  121 (234)
                      ..+|+..+.||+|+||.||+|.+..+++.||||.+...  .....+++.+|+.++..++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            45789999999999999999999999999999998533  23345678999999999999999999999854322 1123


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+ +++|.+++...       .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence            458999999 78999998763       578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++.......           ..+||+.|+||
T Consensus       173 g~a~~~~~~~~-----------~~~~t~~y~aP  194 (367)
T 1cm8_A          173 GLARQADSEMT-----------GYVVTRWYRAP  194 (367)
T ss_dssp             TTCEECCSSCC-----------SSCSCGGGCCT
T ss_pred             ecccccccccC-----------cCcCCCCcCCH
Confidence            99987543211           25799999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=9.4e-31  Score=214.35  Aligned_cols=177  Identities=22%  Similarity=0.369  Sum_probs=142.5

Q ss_pred             HhcCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      ...+|.+.+.||+|+||.||+|.+.     .++..||+|++... .....+.+.+|+.++..++||||+++++++..   
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ---   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence            3567888999999999999999873     45689999999744 23445778999999999999999999998743   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCc------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHL------------------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMV  179 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~------------------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~iv  179 (234)
                        .+..++||||+++++|.+++.......                  ....+++..+..++.|++.||.|||++   +++
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iv  172 (314)
T 2ivs_A           98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV  172 (314)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence              334699999999999999998654210                  112478889999999999999999999   999


Q ss_pred             ecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          180 HGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       180 H~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+||||+||+++.++.+||+|||+++...........      ....||+.|+||
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~------~~~~~~~~y~aP  221 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR------SQGRIPVKWMAI  221 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECS------SCCCSCGGGCCH
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceec------cCCCCcccccCh
Confidence            9999999999999999999999999876543221111      114578889998

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=5.7e-31  Score=217.07  Aligned_cols=173  Identities=29%  Similarity=0.417  Sum_probs=139.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|++.  ++.||||++..... .......|+.++..++||||+++++++..... ....++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEE
Confidence            457899999999999999999885  68999999964432 23445668888999999999999999865432 233468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC-------CCCeeecCCCCCCeeeCCCCceE
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC-------QPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-------~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                      +||||+++++|.+++...       .+++..+..++.|++.||.|||+.+       ..+++||||||+||+++.++.+|
T Consensus        99 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             EEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            999999999999999764       4788899999999999999999641       12799999999999999999999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||+++..........      ....+||+.|+||
T Consensus       172 L~DFg~a~~~~~~~~~~~------~~~~~gt~~y~aP  202 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGD------THGQVGTRRYMAP  202 (322)
T ss_dssp             ECCCTTCEEECTTSCCCC------CTTCCCCGGGCCH
T ss_pred             EccCCcccccccccCccc------cccCccCccccCH
Confidence            999999987655432211      1125699999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=2.4e-31  Score=230.71  Aligned_cols=167  Identities=31%  Similarity=0.438  Sum_probs=143.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||||++...   .....+.+.+|+.++..++||||+++++++..     ..
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence            45688999999999999999999999999999999643   23345788999999999999999999999853     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee---CCCCceEE
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHV  198 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~---~~~~~vki  198 (234)
                      ..++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||++   +.++.+||
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  170 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI  170 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence            5799999999999999987765      688899999999999999999999   99999999999999   46789999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++.......         ....+||+.|+||
T Consensus       171 ~Dfg~a~~~~~~~~---------~~~~~gt~~y~aP  197 (484)
T 3nyv_A          171 IDFGLSTHFEASKK---------MKDKIGTAYYIAP  197 (484)
T ss_dssp             CCTTHHHHBCCCCS---------HHHHTTGGGTCCH
T ss_pred             EeeeeeEEcccccc---------cccCCCCccccCc
Confidence            99999986654321         1125699999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=8.6e-31  Score=219.02  Aligned_cols=178  Identities=24%  Similarity=0.310  Sum_probs=141.0

Q ss_pred             hHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-----------hhhHHHHHHHHHHHhcCCCCce
Q 039258           38 YAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-----------GAFRSFVAECEALRNIRHRNLT  106 (234)
Q Consensus        38 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~  106 (234)
                      ..++.....+|++.+.||+|+||.||+|.+.. +..||||.+.....           ...+.+.+|+.++..++||||+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            45667778899999999999999999999865 88999999853211           1236789999999999999999


Q ss_pred             eEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 039258          107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPS  186 (234)
Q Consensus       107 ~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~  186 (234)
                      ++++++...+.......++||||++ ++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  163 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI-----VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG  163 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence            9999987765555667899999997 588888875432     578899999999999999999999   9999999999


Q ss_pred             CeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          187 NVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       187 nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++.++.+||+|||++..........         ...||+.|+||
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~---------~~~~t~~y~aP  202 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTADANKT---------HYVTHRWYRAP  202 (362)
T ss_dssp             GEEECTTCCEEECCTTC------------------------CGGGCCH
T ss_pred             HEEEcCCCCEEEEecCcccccccccccc---------eecccceecCc
Confidence            9999999999999999998544322111         25689999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=3e-31  Score=217.56  Aligned_cols=188  Identities=24%  Similarity=0.450  Sum_probs=137.2

Q ss_pred             hHHHHHHhcCCCCCceeecccceEEEEEEECC---CCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEe
Q 039258           38 YAELSKATCEFSQSNMIGQGSYGSVYKGILGE---DEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITIC  112 (234)
Q Consensus        38 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~  112 (234)
                      ..+......+|.+.+.||+|+||.||+|.+..   ++..||+|.++..  .....+.+.+|+.++..++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            34444556678999999999999999998754   5678999999744  233456789999999999999999999998


Q ss_pred             eecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC
Q 039258          113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN  192 (234)
Q Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~  192 (234)
                      ......+....++||||+++++|.+++...........+++..++.++.|++.||.|||++   +++||||||+||+++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence            7655444445689999999999999986433222223688999999999999999999999   9999999999999999


Q ss_pred             CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.+||+|||++............      ....|++.|+||
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~------~~~~~~~~y~aP  218 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQG------RIAKMPVKWIAI  218 (313)
T ss_dssp             TSCEEECSCSCC----------------------CCGGGSCH
T ss_pred             CCcEEEeecCcceecccccccCcc------cccCCCccccCc
Confidence            999999999999876543221110      114578889987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.97  E-value=4.9e-31  Score=212.97  Aligned_cols=171  Identities=25%  Similarity=0.498  Sum_probs=142.5

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC------
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS------  117 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~------  117 (234)
                      ...+|+..+.||+|+||.||+|.+..+++.||+|.+....    +.+.+|++++..++||||+++++++...+.      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3456899999999999999999999899999999997543    345689999999999999999998754221      


Q ss_pred             -----CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC
Q 039258          118 -----KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN  192 (234)
Q Consensus       118 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~  192 (234)
                           ......++||||+++++|.+++......    .+++..+..++.|++.||.|||++   +++|+||||+||+++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----KLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                 1234468999999999999999765321    678889999999999999999999   9999999999999999


Q ss_pred             CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.+||+|||++..........         ...||+.|+||
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~y~aP  190 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGKRT---------RSKGTLRYMSP  190 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSCCC---------CCCSCCTTSCH
T ss_pred             CCCEEECcchhheecccccccc---------ccCCcccccCh
Confidence            9999999999998765432211         14689999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=2e-30  Score=211.01  Aligned_cols=169  Identities=29%  Similarity=0.420  Sum_probs=143.2

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---------chhhHHHHHHHHHHHhcC-CCCceeEEEEe
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---------KGAFRSFVAECEALRNIR-HRNLTKIITIC  112 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~  112 (234)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|+++...         ....+.+.+|+.++.++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34568999999999999999999999999999999997432         122456889999999995 99999999987


Q ss_pred             eecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC
Q 039258          113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN  192 (234)
Q Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~  192 (234)
                      ..     ....++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||+|+||+++.
T Consensus        94 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~  159 (298)
T 1phk_A           94 ET-----NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD  159 (298)
T ss_dssp             EC-----SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred             cc-----CCeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcC
Confidence            43     345799999999999999998754      678899999999999999999999   9999999999999999


Q ss_pred             CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.+||+|||++..........         ...||+.|+||
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~---------~~~~~~~y~aP  192 (298)
T 1phk_A          160 DMNIKLTDFGFSCQLDPGEKLR---------EVCGTPSYLAP  192 (298)
T ss_dssp             TCCEEECCCTTCEECCTTCCBC---------CCCSCGGGCCH
T ss_pred             CCcEEEecccchhhcCCCcccc---------cccCCccccCH
Confidence            9999999999998765432111         15689999997

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=1.8e-30  Score=214.72  Aligned_cols=178  Identities=33%  Similarity=0.548  Sum_probs=136.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHH--HhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEAL--RNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l--~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|++.+.||+|+||.||+|.+  ++..||||++.....   ..+..|.+++  ..++||||+++++.+......+...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            46789999999999999999987  678999999974432   3344455544  4589999999998776555555566


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC------CCCeeecCCCCCCeeeCCCCce
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC------QPPMVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~------~~~ivH~dlk~~nil~~~~~~v  196 (234)
                      .++||||+++++|.+++...       ..++..+..++.|++.||.|||+.+      ..+|+||||||+||+++.++.+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             EEEEEecCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            78999999999999999765       3477888999999999999999752      2289999999999999999999


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|||+++....................+||+.|+||
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP  197 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCH
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCc
Confidence            99999999876654322211111112235799999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=1.3e-30  Score=211.02  Aligned_cols=166  Identities=24%  Similarity=0.426  Sum_probs=142.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++...   .......+.+|++++..++||||+++++++..     ..
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CC
Confidence            35688999999999999999999999999999999643   22334678899999999999999999999753     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+||+||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df  158 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF  158 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence            5799999999999999998765      578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++.........          ...||+.|+||
T Consensus       159 g~~~~~~~~~~~----------~~~~~~~y~aP  181 (284)
T 2vgo_A          159 GWSVHAPSLRRR----------TMCGTLDYLPP  181 (284)
T ss_dssp             TTCEECSSSCBC----------CCCSCGGGCCH
T ss_pred             cccccCcccccc----------cccCCCCcCCH
Confidence            998764432111          25689999997

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=1.9e-31  Score=215.99  Aligned_cols=172  Identities=27%  Similarity=0.558  Sum_probs=144.5

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ....+|++.+.||+|+||.||+|.+..++..||+|.+... ....+.+.+|+.++..++||||+++++++..     ...
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~   83 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP   83 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCC
Confidence            3456788899999999999999999999999999999643 3345778999999999999999999998743     334


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++......    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTT----TSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcccC----CccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence            69999999999999999875432    578889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++..........       .....||+.|+||
T Consensus       157 ~~~~~~~~~~~~-------~~~~~~~~~y~aP  181 (288)
T 3kfa_A          157 LSRLMTGDTYTA-------HAGAKFPIKWTAP  181 (288)
T ss_dssp             GGGTSCSSSSEE-------ETTEEECGGGCCH
T ss_pred             cceeccCCcccc-------ccCCccccCcCCh
Confidence            998765432211       1124578889998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=7e-31  Score=214.59  Aligned_cols=166  Identities=28%  Similarity=0.395  Sum_probs=139.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|+++.......+.+.+|+.++..++||||+++++++..     ....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEEE
Confidence            4568899999999999999999999999999999975544444678899999999999999999998753     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee---CCCCceEEccC
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDF  201 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~---~~~~~vki~df  201 (234)
                      +||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||++   +.++.+||+||
T Consensus        83 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df  153 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF  153 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred             EEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence            9999999999999987654      578889999999999999999999   99999999999999   67889999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++.......          .....||+.|+||
T Consensus       154 g~~~~~~~~~----------~~~~~~~~~y~aP  176 (304)
T 2jam_A          154 GLSKMEQNGI----------MSTACGTPGYVAP  176 (304)
T ss_dssp             STTCCCCCBT----------THHHHSCCCBCCT
T ss_pred             CcceecCCCc----------cccccCCCCccCh
Confidence            9987543221          1124689999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=1.9e-30  Score=209.58  Aligned_cols=169  Identities=24%  Similarity=0.381  Sum_probs=140.4

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ...+|++.+.||+|+||.||+|.+..++..||+|++...  .......+.+|+..+..+ +||||+++++++...     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----
Confidence            456789999999999999999999999999999999743  233446788999999999 899999999998543     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC--------
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN--------  192 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~--------  192 (234)
                      +..++||||+++++|.+++......  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.        
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence            3479999999999999999765211  01578899999999999999999999   9999999999999984        


Q ss_pred             -----------CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 -----------DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 -----------~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                                 ...+||+|||++........            ..||+.|+||
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------------~~gt~~y~aP  199 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQV------------EEGDSRFLAN  199 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCSCC------------CCCCGGGCCH
T ss_pred             cccccccccCCceEEEEcccccccccCCccc------------cCCCccccCh
Confidence                       34799999999987544221            3589999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=2e-30  Score=218.66  Aligned_cols=176  Identities=24%  Similarity=0.388  Sum_probs=142.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECC-------CCeEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeec
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGE-------DEMVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSI  115 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~  115 (234)
                      ..+|.+.+.||+|+||.||+|.+..       .+..||+|+++.. .....+.+.+|++++..+ +||||+++++++.. 
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  146 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-  146 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-
Confidence            4578889999999999999999743       3468999999754 333457789999999999 89999999999843 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCCc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDHL----------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP  185 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~  185 (234)
                          ....++||||+++++|.+++.......          ....+++..++.++.|++.||.|||++   +|+||||||
T Consensus       147 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  219 (382)
T 3tt0_A          147 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  219 (382)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             ----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence                334699999999999999998754211          112588999999999999999999999   999999999


Q ss_pred             CCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          186 SNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       186 ~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+++.++.+||+|||+++...........      ....||+.|+||
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~------~~~~~t~~y~aP  262 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKT------TNGRLPVKWMAP  262 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCC------TTCCCGGGGSCH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccc------cCCCCCcceeCH
Confidence            9999999999999999999876543221111      114578899998

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=5.3e-31  Score=213.01  Aligned_cols=170  Identities=26%  Similarity=0.486  Sum_probs=137.9

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ....+|+..+.||+|+||.||+|.+. ++..||+|+++.... ..+.+.+|++++..++||||+++++++..     ...
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~   93 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRP   93 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSS
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCC
Confidence            33557888999999999999999886 567899999974432 23678999999999999999999999743     344


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             eEEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccc
Confidence            7999999999999999976432     588899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++............       ...||+.|+||
T Consensus       166 ~~~~~~~~~~~~~~-------~~~~~~~y~aP  190 (283)
T 3gen_A          166 LSRYVLDDEYTSSV-------GSKFPVRWSPP  190 (283)
T ss_dssp             GGGGBCCHHHHSTT-------STTSCGGGCCH
T ss_pred             cccccccccccccc-------CCccCcccCCH
Confidence            99876543222111       14477889987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=4.8e-31  Score=217.96  Aligned_cols=169  Identities=24%  Similarity=0.460  Sum_probs=133.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeE----EEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMV----VAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|+..+.||+|+||.||+|.+..++..    ||+|.+... .....+.+.+|+.++..++||||+++++++...     
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   89 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   89 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence            4688899999999999999998877654    577777533 234457899999999999999999999998532     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                       ..++|+|++++++|.+++.....     .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|
T Consensus        90 -~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D  160 (327)
T 3poz_A           90 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD  160 (327)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred             -CeEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEcc
Confidence             15799999999999999987543     578889999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++...........      ....||+.|+||
T Consensus       161 fg~a~~~~~~~~~~~~------~~~~~t~~y~aP  188 (327)
T 3poz_A          161 FGLAKLLGAEEKEYHA------EGGKVPIKWMAL  188 (327)
T ss_dssp             TTHHHHHTTTCC-------------CCCGGGSCH
T ss_pred             CcceeEccCCcccccc------cCCCccccccCh
Confidence            9999876543322111      124578899998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=6.1e-31  Score=216.77  Aligned_cols=182  Identities=26%  Similarity=0.373  Sum_probs=143.9

Q ss_pred             ChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeec
Q 039258           37 SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSI  115 (234)
Q Consensus        37 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~  115 (234)
                      ...++....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ +||||+++++++...
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            34444556778999999999999999999999999999999997443 2346788999999998 799999999998654


Q ss_pred             CCC-CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          116 DSK-GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       116 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                      ... .....++||||+++++|.+++......    .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~  166 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA  166 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence            321 135579999999999999999865321    678888999999999999999999   999999999999999999


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||++..........        ....||+.|+||
T Consensus       167 ~~kl~Dfg~~~~~~~~~~~~--------~~~~~~~~y~aP  198 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDRTVGRR--------NTFIGTPYWMAP  198 (326)
T ss_dssp             CEEECCCTTTC---------------------CCGGGCCH
T ss_pred             CEEEeeCcCceecCcCcccc--------ccccCCccccCh
Confidence            99999999988654322111        125689999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3e-31  Score=221.67  Aligned_cols=168  Identities=26%  Similarity=0.353  Sum_probs=140.6

Q ss_pred             cCCCCCceeecccceEEEEEEEC---CCCeEEEEEEeecc----cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILG---EDEMVVAVKVINLK----QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDS  117 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~  117 (234)
                      .+|++.+.||+|+||.||+|++.   .+++.||||+++..    .....+.+.+|++++..+ +||||+++++++...  
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  131 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE--  131 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC--
Confidence            57899999999999999999984   57899999998632    122345677899999999 699999999987543  


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                         ...++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+|
T Consensus       132 ---~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  199 (355)
T 1vzo_A          132 ---TKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV  199 (355)
T ss_dssp             ---TEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             ---ceEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEE
Confidence               34789999999999999998764      678899999999999999999999   999999999999999999999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||+++..........       ...+||+.|+||
T Consensus       200 l~DfG~a~~~~~~~~~~~-------~~~~gt~~y~aP  229 (355)
T 1vzo_A          200 LTDFGLSKEFVADETERA-------YDFCGTIEYMAP  229 (355)
T ss_dssp             ESCSSEEEECCGGGGGGG-------CGGGSCCTTCCH
T ss_pred             EeeCCCCeecccCCCCcc-------cCcccCcCccCh
Confidence            999999986544322111       125799999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=1.5e-30  Score=210.77  Aligned_cols=164  Identities=29%  Similarity=0.494  Sum_probs=137.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccch-------hhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG-------AFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      ..+|+..+.||+|+||.||+|.+..++..||+|++......       ..+.+.+|+.++..++||||+++++++...  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   95 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--   95 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence            35788899999999999999999999999999998643211       126789999999999999999999987321  


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeeeCCCCc
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP--MVHGDIKPSNVLLDNDMV  195 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--ivH~dlk~~nil~~~~~~  195 (234)
                           .++||||+++++|.+++.....     .+++..+..++.|++.|+.|||++   +  ++|+||||+||+++.++.
T Consensus        96 -----~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~  162 (287)
T 4f0f_A           96 -----PRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDE  162 (287)
T ss_dssp             -----TEEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCT
T ss_pred             -----CeEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCC
Confidence                 2699999999999998876543     688899999999999999999998   8  999999999999987776


Q ss_pred             -----eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 -----AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 -----vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                           +||+|||+++......           ....||+.|+||
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~~~-----------~~~~g~~~y~aP  195 (287)
T 4f0f_A          163 NAPVCAKVADFGLSQQSVHSV-----------SGLLGNFQWMAP  195 (287)
T ss_dssp             TCSCCEEECCCTTCBCCSSCE-----------ECCCCCCTTSCG
T ss_pred             CCceeEEeCCCCccccccccc-----------cccCCCccccCc
Confidence                 9999999987543321           125689999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=1.8e-30  Score=209.13  Aligned_cols=167  Identities=29%  Similarity=0.477  Sum_probs=136.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.++..++||||+++++++..     ..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence            45789999999999999999999989999999999643   22345678899999999999999999998753     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+||+||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence            4799999999999999998765      578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........         ...||+.|+||
T Consensus       156 g~~~~~~~~~~~~---------~~~~~~~y~aP  179 (276)
T 2h6d_A          156 GLSNMMSDGEFLR---------TSCGSPNYAAP  179 (276)
T ss_dssp             CGGGCCCC----------------------CCT
T ss_pred             ccccccCCCccee---------cccCCccccCH
Confidence            9998755432111         14688999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=1.2e-30  Score=209.95  Aligned_cols=171  Identities=25%  Similarity=0.387  Sum_probs=143.5

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ...+|++.+.||+|+||.||+|.+..++..||+|+++... ....+.+.+|+.++..++||||+++++++..     ...
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   79 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI   79 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCE
Confidence            3457899999999999999999999999999999997443 3344778899999999999999999998753     334


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+||+|||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEEEecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence            689999999999999987543      578899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++............      ....||+.|+||
T Consensus       151 ~~~~~~~~~~~~~~------~~~~~~~~y~aP  176 (276)
T 2yex_A          151 LATVFRYNNRERLL------NKMCGTLPYVAP  176 (276)
T ss_dssp             TCEECEETTEECCB------CCCCSCGGGCCG
T ss_pred             CccccCCCcchhcc------cCCccccCccCh
Confidence            99865432211110      125689999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=4.2e-31  Score=218.06  Aligned_cols=169  Identities=26%  Similarity=0.452  Sum_probs=136.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeE----EEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMV----VAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|++.+.||+|+||.||+|.+..++..    ||+|.+... .......+.+|+.++..++||||+++++++..      
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence            4688899999999999999999877654    777777533 23334567889999999999999999998732      


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D  158 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD  158 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECS
T ss_pred             CccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECC
Confidence            236899999999999999976532     577788899999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++...........      ....||..|+||
T Consensus       159 fg~a~~~~~~~~~~~~------~~~~~~~~y~aP  186 (325)
T 3kex_A          159 FGVADLLPPDDKQLLY------SEAKTPIKWMAL  186 (325)
T ss_dssp             CSGGGGSCCCTTCCC-----------CCTTTSCH
T ss_pred             CCcccccCcccccccc------cCCCCcccccCh
Confidence            9999976544322111      124578899997

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=6.2e-31  Score=220.29  Aligned_cols=180  Identities=20%  Similarity=0.326  Sum_probs=139.9

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCC-----CeEEEEEEeecccch-----------hhHHHHHHHHHHHhcCCCCcee
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGED-----EMVVAVKVINLKQKG-----------AFRSFVAECEALRNIRHRNLTK  107 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~  107 (234)
                      ...+|++.+.||+|+||.||+|.+..+     ++.||+|++......           .......|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345799999999999999999998764     578999998644311           1123445666777888999999


Q ss_pred             EEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039258          108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSN  187 (234)
Q Consensus       108 l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~n  187 (234)
                      +++++.... .+..+.++||||+ +++|.+++.....     .+++..++.++.|++.||.|||++   +|+||||||+|
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N  182 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN  182 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence            999986543 2345579999999 9999999987532     688999999999999999999999   99999999999


Q ss_pred             eeeC--CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          188 VLLD--NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       188 il~~--~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++  .++.+||+|||+++.+.......... .......+||+.|+||
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aP  230 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA-ADPKRCHDGTIEFTSI  230 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSS-CCSSCCCCCCTTTCCH
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccc-cCcccccCCCCCccCH
Confidence            9998  88999999999998766543222111 1111235699999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=2e-30  Score=223.11  Aligned_cols=164  Identities=35%  Similarity=0.466  Sum_probs=136.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+.  +..||||+++...  ..+.+.+|+.+|..++||||+++++++...    ....+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence            456888999999999999999984  6789999997433  457899999999999999999999987542    23478


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++...+..    .+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||++
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            999999999999999876432    367888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.......           ...+|+.|+||
T Consensus       337 ~~~~~~~~-----------~~~~~~~y~aP  355 (450)
T 1k9a_A          337 KEASSTQD-----------TGKLPVKWTAP  355 (450)
T ss_dssp             EECC-----------------CCCTTTSCH
T ss_pred             cccccccc-----------CCCCCcceeCH
Confidence            85432110           13477889988

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=1.1e-30  Score=220.19  Aligned_cols=173  Identities=20%  Similarity=0.283  Sum_probs=136.5

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-----
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-----  117 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-----  117 (234)
                      ....+|++.+.||+|+||.||+|.+..++..||||.+......    ..+|+++++.++||||+++++++.....     
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            3456899999999999999999999999999999998643222    2379999999999999999998865432     


Q ss_pred             ----------------------------CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHH
Q 039258          118 ----------------------------KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY  169 (234)
Q Consensus       118 ----------------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  169 (234)
                                                  ....+.++||||++ ++|.+.+......  ...+++..+..++.|++.||.|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHH
Confidence                                        33455789999997 4888877642111  0168889999999999999999


Q ss_pred             HHhCCCCCeeecCCCCCCeeeC-CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          170 LHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       170 lh~~~~~~ivH~dlk~~nil~~-~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++   +|+||||||+||+++ .++.+||+|||+++.........         ...||+.|+||
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~t~~y~aP  210 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---------AYICSRFYRAP  210 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---------CCCCCSSCCCH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---------CcccCCCccCH
Confidence            9999   999999999999997 68899999999998765432211         25689999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=2.5e-30  Score=208.92  Aligned_cols=166  Identities=24%  Similarity=0.361  Sum_probs=139.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc------hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK------GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      .+|++.+.||+|+||.||+|.+..++..||+|+++....      ...+.+.+|+.++..++||||+++++++..     
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-----   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence            458889999999999999999999999999999964321      135778999999999999999999999853     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC----c
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM----V  195 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~----~  195 (234)
                      ....++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++    .
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence            334799999999999999997654      688899999999999999999999   999999999999998766    8


Q ss_pred             eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+|||++..........         ...||+.|+||
T Consensus       151 ~kl~dfg~~~~~~~~~~~~---------~~~~~~~y~aP  180 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGNEFK---------NIFGTPEFVAP  180 (283)
T ss_dssp             EEECCCTTCEECC-----------------CCCGGGCCH
T ss_pred             eEEEecccceeccCCCccc---------ccCCCcCccCc
Confidence            9999999998654432111         14689999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=4.4e-31  Score=215.30  Aligned_cols=170  Identities=22%  Similarity=0.341  Sum_probs=139.5

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ...+|++.+.||+|+||.||+|.+..++..+|+|++........+.+.+|+.++..++||||+++++++...     ...
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   91 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKL   91 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeE
Confidence            346789999999999999999999999999999999766555668899999999999999999999988542     347


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  163 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGV  163 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred             EEEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCC
Confidence            999999999999999876432     588899999999999999999999   999999999999999999999999998


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........        ....||+.|+||
T Consensus       164 ~~~~~~~~~~~--------~~~~~~~~y~aP  186 (302)
T 2j7t_A          164 SAKNLKTLQKR--------DSFIGTPYWMAP  186 (302)
T ss_dssp             HHHHHHHHHC-------------CCGGGCCH
T ss_pred             Ccccccccccc--------ccccCChhhcCC
Confidence            76432211111        014689999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=3.3e-31  Score=218.65  Aligned_cols=167  Identities=25%  Similarity=0.450  Sum_probs=132.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.++..++||||+++++++..     ....+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            468889999999999999999999999999999964322 222345679999999999999999999853     33479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||++ ++|.+++...+.     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        77 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             EEecccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence            9999997 599999887543     578889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........        ...||+.|+||
T Consensus       148 ~~~~~~~~~~~--------~~~~t~~y~aP  169 (324)
T 3mtl_A          148 RAKSIPTKTYD--------NEVVTLWYRPP  169 (324)
T ss_dssp             ECC--------------------CGGGCCH
T ss_pred             ccccCCccccc--------cccCcccccCh
Confidence            86543221111        14689999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.6e-30  Score=215.79  Aligned_cols=178  Identities=24%  Similarity=0.413  Sum_probs=140.3

Q ss_pred             HHhcCCCCCceeecccceEEEEEEE-----CCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeec
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSI  115 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~  115 (234)
                      ....+|++.+.||+|+||.||+|.+     ..++..||+|++... .....+.+.+|+.++..+ +||||+++++++.. 
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  120 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-  120 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence            3456788999999999999999997     346679999999743 233457889999999999 89999999999753 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCCc-----------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDHL-----------------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPM  178 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~i  178 (234)
                          .+..++||||+++++|.+++.......                 ....+++..++.++.|++.||.|||++   ++
T Consensus       121 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  193 (344)
T 1rjb_A          121 ----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC  193 (344)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             ----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                334799999999999999997653210                 011378889999999999999999999   99


Q ss_pred             eecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          179 VHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       179 vH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||||||+||+++.++.+||+|||++..........      ......||+.|+||
T Consensus       194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~t~~y~aP  243 (344)
T 1rjb_A          194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV------VRGNARLPVKWMAP  243 (344)
T ss_dssp             EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE------EETTEEECGGGCCH
T ss_pred             ccCCCChhhEEEcCCCcEEeCCCccCcccccCccce------eccCccCccCccCH
Confidence            999999999999999999999999998665432211      11124578899998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=1.8e-30  Score=211.25  Aligned_cols=182  Identities=24%  Similarity=0.375  Sum_probs=140.1

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC------
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS------  117 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~------  117 (234)
                      ...+|++.+.||+|+||.||+|.+..++..||+|.+... ....+.+.+|+.++..++||||+++++++.....      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            345789999999999999999999999999999999643 3344778999999999999999999998754321      


Q ss_pred             --CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc
Q 039258          118 --KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV  195 (234)
Q Consensus       118 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~  195 (234)
                        .+....++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence              234567899999999999999986432     567788899999999999999999   9999999999999999999


Q ss_pred             eEEccCccccccCCCccCCC------CCCCCccccccccccccCC
Q 039258          196 AHVGDFGLSKFLSSDHLDTA------SETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 vki~dfG~a~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+|||++...........      ...........||+.|+||
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT  199 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCc
Confidence            99999999987643211000      0000111125689999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=2.1e-30  Score=210.95  Aligned_cols=176  Identities=24%  Similarity=0.480  Sum_probs=140.2

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCC---CeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGED---EMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      ....+|++.+.||+|+||.||+|.+..+   ...+|+|.+... .....+.+.+|+.++..++||||+++++++...   
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   98 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---   98 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC---
Confidence            3345688899999999999999997543   356899998643 334457789999999999999999999986432   


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                       ....++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||
T Consensus        99 -~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl  169 (298)
T 3f66_A           99 -EGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKV  169 (298)
T ss_dssp             -SSCCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEE
T ss_pred             -CCceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEE
Confidence             3346899999999999999976432     578889999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++...........    ......||+.|+||
T Consensus       170 ~Dfg~a~~~~~~~~~~~~----~~~~~~~~~~y~aP  201 (298)
T 3f66_A          170 ADFGLARDMYDKEYYSVH----NKTGAKLPVKWMAL  201 (298)
T ss_dssp             CSCGGGCCCSCGGGCBC---------CCBCGGGSCH
T ss_pred             Ccccccccccccchhccc----cccCCCCCccccCh
Confidence            999999876554322211    11125688899997

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=1.9e-30  Score=212.66  Aligned_cols=171  Identities=21%  Similarity=0.297  Sum_probs=136.9

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.++..++||||+++++++..     
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----  105 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----  105 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----
Confidence            44578999999999999999999999999999999996432   2234678899999999999999999999854     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      .+..++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~  176 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLV  176 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             CCeEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEe
Confidence            234799999999999999998754      578899999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++...........       ....||+.|+||
T Consensus       177 Dfg~~~~~~~~~~~~~-------~~~~~~~~y~aP  204 (309)
T 2h34_A          177 DFGIASATTDEKLTQL-------GNTVGTLYYMAP  204 (309)
T ss_dssp             SCCC-----------------------CCGGGCCG
T ss_pred             cCccCccccccccccc-------cccCCCcCccCH
Confidence            9999986554321111       124689999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=5.5e-31  Score=217.77  Aligned_cols=170  Identities=26%  Similarity=0.458  Sum_probs=133.5

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      .....+|++.+.||+|+||.||+|.+..+++.||+|+++...  ....+.+.+|+.++..++||||+++++++...    
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----  105 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN----  105 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET----
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC----
Confidence            344567999999999999999999999999999999996442  22345678999999999999999999998543    


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC-----CCC
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-----NDM  194 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~-----~~~  194 (234)
                       ...++||||+++ +|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+||+++     ..+
T Consensus       106 -~~~~lv~e~~~~-~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  174 (329)
T 3gbz_A          106 -HRLHLIFEYAEN-DLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETP  174 (329)
T ss_dssp             -TEEEEEEECCSE-EHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CC
T ss_pred             -CEEEEEEecCCC-CHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccc
Confidence             347999999975 9999998765      578889999999999999999999   999999999999994     455


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||++..........        ....||+.|+||
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~--------~~~~~t~~y~aP  206 (329)
T 3gbz_A          175 VLKIGDFGLARAFGIPIRQF--------THEIITLWYRPP  206 (329)
T ss_dssp             EEEECCTTHHHHHC-------------------CCTTCCH
T ss_pred             eEEECcCCCccccCCccccc--------CCCcCCccccCH
Confidence            69999999998765332111        114689999998

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=5.8e-31  Score=220.00  Aligned_cols=166  Identities=24%  Similarity=0.384  Sum_probs=141.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++..++||||+++++++...     ...
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEE
Confidence            34688999999999999999999999999999999754 333457789999999999999999999988543     347


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      ++||||+++++|.+++....      .+++..+..++.|++.||.|||+ .   +++|+||||+||+++.++.+||+|||
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEEECCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECC
Confidence            99999999999999998765      57888999999999999999998 4   79999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.........          ...||+.|+||
T Consensus       178 ~~~~~~~~~~~----------~~~gt~~y~aP  199 (360)
T 3eqc_A          178 VSGQLIDSMAN----------SFVGTRSYMSP  199 (360)
T ss_dssp             CCHHHHHHC--------------CCCCTTCCH
T ss_pred             CCccccccccc----------CCCCCCCeECH
Confidence            98765332111          15689999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=3.2e-30  Score=214.65  Aligned_cols=179  Identities=23%  Similarity=0.342  Sum_probs=143.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||||.+.... ......+.+|+.++..++||||+++++++...........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467899999999999999999999999999999996432 3344678899999999999999999998765443444667


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||++ ++|.+++...       .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccC-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            99999996 5999988753       578889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCC--CCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTAS--ETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aP  234 (234)
                      +............  .........+||+.|+||
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAP  191 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCH
T ss_pred             ccccccccccccCccccccchhhccccccccCC
Confidence            9876543221110  001111235799999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=5.2e-30  Score=209.22  Aligned_cols=166  Identities=29%  Similarity=0.439  Sum_probs=142.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..|+..+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++..++||||+++++++...     ...+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence            45888999999999999999999999999999997543 34457889999999999999999999988543     3479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++...       .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+||+|||++
T Consensus        97 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             EEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccc
Confidence            999999999999998642       578889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....||+.|+||
T Consensus       167 ~~~~~~~~~~--------~~~~~~~~y~aP  188 (303)
T 3a7i_A          167 GQLTDTQIKR--------NTFVGTPFWMAP  188 (303)
T ss_dssp             EECBTTBCCB--------CCCCSCGGGCCH
T ss_pred             eecCcccccc--------CccCCCcCccCH
Confidence            8765432211        125689999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.97  E-value=1e-30  Score=211.30  Aligned_cols=170  Identities=25%  Similarity=0.428  Sum_probs=130.2

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCC---CeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGED---EMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ...+|++.+.||+|+||.||+|.+..+   +..||+|.++.. .....+.+.+|+.++..++||||+++++++..     
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----   87 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence            345788899999999999999998653   467999998643 33345678999999999999999999998631     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                       +..++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+
T Consensus        88 -~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  158 (281)
T 1mp8_A           88 -NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG  158 (281)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             -CccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEEC
Confidence             236899999999999999976532     578889999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++..........       ....||+.|+||
T Consensus       159 Dfg~~~~~~~~~~~~~-------~~~~~~~~y~aP  186 (281)
T 1mp8_A          159 DFGLSRYMEDSTYYKA-------SKGKLPIKWMAP  186 (281)
T ss_dssp             C--------------------------CCGGGCCH
T ss_pred             ccccccccCccccccc-------ccCCCcccccCh
Confidence            9999987654322111       113477889998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=6.5e-30  Score=207.58  Aligned_cols=170  Identities=28%  Similarity=0.394  Sum_probs=138.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++..++||||+++++++...     +..++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEE
Confidence            3455666999999999999999999999999999766555567899999999999999999999998542     34789


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-CCceEEccCccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DMVAHVGDFGLS  204 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-~~~vki~dfG~a  204 (234)
                      ||||+++++|.+++.....   ...+++..+..++.|++.||.|||++   +++|+||+|+||+++. ++.+||+|||++
T Consensus        97 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~  170 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTS  170 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred             EEEeCCCCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccc
Confidence            9999999999999976532   12456788889999999999999999   9999999999999986 899999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........        ....||+.|+||
T Consensus       171 ~~~~~~~~~~--------~~~~~~~~y~aP  192 (295)
T 2clq_A          171 KRLAGINPCT--------ETFTGTLQYMAP  192 (295)
T ss_dssp             EESCC-------------CCCCCCGGGCCH
T ss_pred             cccCCCCCcc--------cccCCCccccCh
Confidence            8754422111        125689999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=1.6e-30  Score=214.87  Aligned_cols=182  Identities=19%  Similarity=0.284  Sum_probs=145.3

Q ss_pred             cCCCcChHHHHHHhcCCCCC-ceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcC-CCCcee
Q 039258           32 QFPMVSYAELSKATCEFSQS-NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIR-HRNLTK  107 (234)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~  107 (234)
                      ..+...++......+.|.+. +.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.++..+. ||||++
T Consensus        14 ~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~   93 (327)
T 3lm5_A           14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN   93 (327)
T ss_dssp             --CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             cchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence            34555556666667778777 89999999999999999999999999997432  233567899999999994 699999


Q ss_pred             EEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCC
Q 039258          108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSN  187 (234)
Q Consensus       108 l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~n  187 (234)
                      +++++..     ....++||||+++++|.+++......    .+++..+..++.|++.||.|||++   +++||||||+|
T Consensus        94 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~N  161 (327)
T 3lm5_A           94 LHEVYEN-----TSEIILILEYAAGGEIFSLCLPELAE----MVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQN  161 (327)
T ss_dssp             EEEEEEC-----SSEEEEEEECCTTEEGGGGGSSCC-C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred             EEEEEEe-----CCeEEEEEEecCCCcHHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHH
Confidence            9999743     34479999999999999998654222    688899999999999999999999   99999999999


Q ss_pred             eeeCC---CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          188 VLLDN---DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       188 il~~~---~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++.   ++.+||+|||+++.........         ...||+.|+||
T Consensus       162 Il~~~~~~~~~~kL~Dfg~a~~~~~~~~~~---------~~~gt~~y~aP  202 (327)
T 3lm5_A          162 ILLSSIYPLGDIKIVDFGMSRKIGHACELR---------EIMGTPEYLAP  202 (327)
T ss_dssp             EEESCBTTBCCEEECCGGGCEEC------------------CCCGGGCCH
T ss_pred             EEEecCCCCCcEEEeeCccccccCCccccc---------cccCCcCccCC
Confidence            99987   7899999999998765432111         15699999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=1.5e-30  Score=224.16  Aligned_cols=172  Identities=22%  Similarity=0.471  Sum_probs=141.0

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ......+|++.+.||+|+||.||+|.+. ++..||||.++... ...+.+.+|+.+|..++||||+++++++.      .
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~  254 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------K  254 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------C
Confidence            3344567888999999999999999985 45789999997543 34578999999999999999999999874      2


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....    ..+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECS
T ss_pred             CccEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEee
Confidence            236899999999999999975431    1567788899999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++...........       ...+|..|+||
T Consensus       328 FG~a~~~~~~~~~~~~-------~~~~~~~y~aP  354 (454)
T 1qcf_A          328 FGLARVIEDNEYTARE-------GAKFPIKWTAP  354 (454)
T ss_dssp             TTGGGGBCCHHHHTTC-------SSSSCGGGSCH
T ss_pred             CCCceEcCCCceeccC-------CCcccccccCH
Confidence            9999876543221110       13477889998

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=2.5e-30  Score=211.75  Aligned_cols=177  Identities=22%  Similarity=0.409  Sum_probs=142.8

Q ss_pred             HhcCCCCCceeecccceEEEEEEE-----CCCCeEEEEEEeecccc-hhhHHHHHHHHHHHhc-CCCCceeEEEEeeecC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQK-GAFRSFVAECEALRNI-RHRNLTKIITICSSID  116 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~  116 (234)
                      ...+|++.+.||+|+||.||+|.+     ..++..||+|++..... ...+.+.+|+.++..+ +||||+++++++..  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence            345788999999999999999985     45778999999975432 3457789999999999 89999999999843  


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCC------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDH------------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIK  184 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk  184 (234)
                         .+..++||||+++++|.+++......            .....+++..+..++.|++.||.|||++   +++|+|||
T Consensus        99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk  172 (313)
T 1t46_A           99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA  172 (313)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             ---CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence               33468999999999999999865421            1112478899999999999999999999   99999999


Q ss_pred             CCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          185 PSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       185 ~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+||+++.++.+||+|||++...........      .....||+.|+||
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aP  216 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVV------KGNARLPVKWMAP  216 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEE------CSSSEECGGGCCH
T ss_pred             cceEEEcCCCCEEEcccccccccccccccee------ccCCCCcceeeCh
Confidence            9999999999999999999987654322111      1114578889998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=7.1e-30  Score=207.64  Aligned_cols=173  Identities=21%  Similarity=0.315  Sum_probs=141.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++....  ..+.+.+|+..+..+ +|+|++.+++++..     ....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----Ccee
Confidence            457999999999999999999999999999999986432  235578899999999 79999999998743     3446


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc-----eEE
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV-----AHV  198 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~-----vki  198 (234)
                      ++||||+ +++|.+++...+.     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.     +||
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EEEEEec-CCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence            8999999 8999999986542     588899999999999999999999   9999999999999987665     999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++............ ........||+.|+||
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~-~~~~~~~~gt~~y~aP  187 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIP-YREKKNLSGTARYMSI  187 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCC-CCCCCCCCSCTTTCCH
T ss_pred             EECcccccccccccccccc-ccCccCCCCCcccCCc
Confidence            9999998766543221111 0111236799999998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=5e-30  Score=212.33  Aligned_cols=177  Identities=21%  Similarity=0.410  Sum_probs=140.5

Q ss_pred             HhcCCCCCceeecccceEEEEEEEC-------CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeee
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILG-------EDEMVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSS  114 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~  114 (234)
                      ...+|++.+.||+|+||.||+|.+.       .++..||+|+++.. .....+.+.+|+.++..+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3467899999999999999999975       35678999999744 233456789999999999 89999999999743


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHL----------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIK  184 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk  184 (234)
                           .+..++||||+++++|.+++.......          ....+++..++.++.|++.||.|||++   +++|+|||
T Consensus       113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk  184 (334)
T 2pvf_A          113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA  184 (334)
T ss_dssp             -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCc
Confidence                 334799999999999999998654210          112478889999999999999999999   99999999


Q ss_pred             CCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          185 PSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       185 ~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+||+++.++.+||+|||+++...........      ....||+.|+||
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~------~~~~~~~~y~aP  228 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYYKKT------TNGRLPVKWMAP  228 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSEECC------SCCCCCGGGCCH
T ss_pred             cceEEEcCCCCEEEcccccccccccccccccc------CCCCcccceeCh
Confidence            99999999999999999999876543221111      114578889998

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=1.5e-30  Score=213.27  Aligned_cols=186  Identities=20%  Similarity=0.337  Sum_probs=147.2

Q ss_pred             cChHHHHHHhcCCCCCceeecccceEEEEEEE-----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeE
Q 039258           36 VSYAELSKATCEFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKI  108 (234)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l  108 (234)
                      +..........+|++.+.||+|+||.||+|.+     ..+++.||+|++.... ....+.+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34455556677899999999999999999985     3567899999997543 23446789999999999 79999999


Q ss_pred             EEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCcc----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039258          109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----------VFKLSLIQRVNIAIDVASAIEYLHHNCQPPM  178 (234)
Q Consensus       109 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~i  178 (234)
                      ++++...    ....++||||+++++|.+++........          ...+++..+..++.|++.||.|||++   ++
T Consensus        97 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i  169 (316)
T 2xir_A           97 LGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC  169 (316)
T ss_dssp             EEEECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             EEEEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            9987532    3346899999999999999987543110          01277889999999999999999999   99


Q ss_pred             eecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          179 VHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       179 vH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+||||+||+++.++.+||+|||+++.........      ......||+.|+||
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~t~~y~aP  219 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV------RKGDARLPLKWMAP  219 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSE------EETTEEECGGGCCH
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCccce------eccCCCcceeecCc
Confidence            999999999999999999999999998665432111      11124588899998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=1.6e-30  Score=214.96  Aligned_cols=168  Identities=26%  Similarity=0.407  Sum_probs=136.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+....  ....+.+.+|+.++..++||||+++++++..     ...
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----KKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----CCE
Confidence            346888999999999999999999999999999986432  2234567899999999999999999999854     334


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.++.....      .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  169 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  169 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence            799999999888888766544      578899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++...........        ...||+.|+||
T Consensus       170 ~~~~~~~~~~~~~--------~~~~t~~y~aP  193 (331)
T 4aaa_A          170 FARTLAAPGEVYD--------DEVATRWYRAP  193 (331)
T ss_dssp             TC--------------------CCCCCTTCCH
T ss_pred             CceeecCCccccC--------CCcCCccccCc
Confidence            9986544321111        14689999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=4.1e-30  Score=212.12  Aligned_cols=174  Identities=28%  Similarity=0.478  Sum_probs=142.7

Q ss_pred             hcCCCCCceeecccceEEEEEEE----CCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGIL----GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|.+    ..++..||+|.+........+.+.+|++++..++||||+++++++...   +.
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CC
Confidence            45688899999999999999984    567899999999766556667899999999999999999999987532   22


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D  188 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD  188 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred             CceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence            346899999999999999987542     578889999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++.............     ....||..|+||
T Consensus       189 fg~~~~~~~~~~~~~~~-----~~~~~~~~y~aP  217 (326)
T 2w1i_A          189 FGLTKVLPQDKEYYKVK-----EPGESPIFWYAP  217 (326)
T ss_dssp             CTTCEECCSSCSEEECS-----SCCSCCGGGCCH
T ss_pred             Ccchhhccccccccccc-----cCCCCceeEECc
Confidence            99998765432211100     013477789987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=7.7e-30  Score=210.49  Aligned_cols=162  Identities=22%  Similarity=0.359  Sum_probs=137.6

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+|++.+.||+|+||.||+|.+..+++.||+|+++..   ..+.+.+|+.++..++ ||||+++++++...   .....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceE
Confidence            5688999999999999999999999999999998633   2367889999999997 99999999988542   234568


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC-ceEEccCcc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGL  203 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~-~vki~dfG~  203 (234)
                      +||||+++++|.+++.         .+++..+..++.|++.||.|||++   +++||||||+||+++.++ .+||+|||+
T Consensus       110 lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             EEEECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence            9999999999999875         467788999999999999999999   999999999999998666 899999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.........         ...||+.|+||
T Consensus       178 a~~~~~~~~~~---------~~~~~~~y~aP  199 (330)
T 3nsz_A          178 AEFYHPGQEYN---------VRVASRYFKGP  199 (330)
T ss_dssp             CEECCTTCCCC---------SCCSCGGGCCH
T ss_pred             ceEcCCCCccc---------cccccccccCh
Confidence            98765432211         14688999987

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=4e-30  Score=215.99  Aligned_cols=169  Identities=21%  Similarity=0.295  Sum_probs=132.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||||++...  .....+.+.+|+.++..++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            45799999999999999999999999999999999743  23344678899999999999999999999854331 1233


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++ +|.+.+..        .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+||
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence            57999999975 78888752        477888899999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++........         ...+||+.|+||
T Consensus       172 g~a~~~~~~~~~---------~~~~gt~~y~aP  195 (371)
T 2xrw_A          172 GLARTAGTSFMM---------TPYVVTRYYRAP  195 (371)
T ss_dssp             CC-------------------------CTTCCH
T ss_pred             eccccccccccc---------CCceecCCccCH
Confidence            999865432211         125799999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=5.9e-30  Score=209.81  Aligned_cols=169  Identities=27%  Similarity=0.403  Sum_probs=137.7

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ....+|++.+.||+|+||.||+|.+..++..||+|.+....  ..+.+.+|+.++..++||||+++++++...     ..
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   98 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TD   98 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CE
Confidence            34567999999999999999999999999999999997442  346788999999999999999999988542     34


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++.....     .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  170 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG  170 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEeecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecc
Confidence            6999999999999999875432     678899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++..........        ....||+.|+||
T Consensus       171 ~~~~~~~~~~~~--------~~~~~~~~y~aP  194 (314)
T 3com_A          171 VAGQLTDTMAKR--------NTVIGTPFWMAP  194 (314)
T ss_dssp             TCEECBTTBSCB--------CCCCSCGGGCCH
T ss_pred             cchhhhhhcccc--------CccCCCCCccCh
Confidence            998765432211        125689999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=8.8e-30  Score=207.84  Aligned_cols=174  Identities=24%  Similarity=0.408  Sum_probs=140.5

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc----chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ..++|++.+.||+|+||.||+|.+..++..+|+|++....    ......+.+|+.++..++||||+++++++...   .
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   79 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---E   79 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---C
Confidence            3468999999999999999999999999999999996432    23457789999999999999999999987432   2


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      ....++||||++++ |.+++......    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+
T Consensus        80 ~~~~~lv~e~~~~~-l~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~  151 (305)
T 2wtk_C           80 KQKMYMVMEYCVCG-MQEMLDSVPEK----RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKIS  151 (305)
T ss_dssp             --CEEEEEECCSEE-HHHHHHHSTTC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             CCeEEEEehhccCC-HHHHHHhCccc----ccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEee
Confidence            34569999999765 77777654322    678889999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++...........      .....||+.|+||
T Consensus       152 dfg~~~~~~~~~~~~~------~~~~~~~~~y~aP  180 (305)
T 2wtk_C          152 ALGVAEALHPFAADDT------CRTSQGSPAFQPP  180 (305)
T ss_dssp             CCTTCEECCTTCSSCE------ECCCCSCGGGCCH
T ss_pred             ccccccccCccccccc------cccCCCCCCCcCh
Confidence            9999987654322111      1124689999997

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.2e-30  Score=208.46  Aligned_cols=173  Identities=22%  Similarity=0.404  Sum_probs=138.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCC---eEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDE---MVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..|...+.||+|+||.||+|.+..++   ..+|+|.+.... ....+.+.+|+.++..++||||+++++++...+    .
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~   96 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----G   96 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----S
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----C
Confidence            34666789999999999999975443   489999986433 334578899999999999999999999985322    2


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+.+++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+||
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Df  168 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADF  168 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCT
T ss_pred             CcEEEEecccCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcC
Confidence            34899999999999999976432     577888999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++...........    ......||+.|+||
T Consensus       169 g~~~~~~~~~~~~~~----~~~~~~~~~~y~aP  197 (298)
T 3pls_A          169 GLARDILDREYYSVQ----QHRHARLPVKWTAL  197 (298)
T ss_dssp             TSSCTTTTGGGGCSC----CSSCTTCGGGGSCH
T ss_pred             CCcccccCCcccccc----cCcCCCCCccccCh
Confidence            999866543322111    11124688899987

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=3.2e-30  Score=217.99  Aligned_cols=166  Identities=22%  Similarity=0.413  Sum_probs=134.3

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcC--CCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIR--HRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|++.+.||+|+||.||+|.+.. +..||||++...  .....+.+.+|+.++..++  ||||+++++++..     .+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence            459999999999999999999865 889999999744  2334577899999999996  5999999998753     33


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+++|||+ .+++|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+|||++ ++.+||+||
T Consensus       130 ~~~lv~E~-~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          130 YIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             EEEEEEEC-CSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred             EEEEEEec-CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence            47999994 5789999998765      577888999999999999999999   999999999999995 578999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++...........      ...+||+.|+||
T Consensus       199 G~a~~~~~~~~~~~~------~~~~gt~~y~aP  225 (390)
T 2zmd_A          199 GIANQMQPDTTSVVK------DSQVGAVNYMPP  225 (390)
T ss_dssp             SSSCCC---------------CCSCCCGGGCCH
T ss_pred             CccccccCCCccccC------CCCCcCCCccCh
Confidence            999876543221111      125799999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=1.5e-30  Score=213.98  Aligned_cols=185  Identities=23%  Similarity=0.393  Sum_probs=145.2

Q ss_pred             cChHHHHHHhcCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEE
Q 039258           36 VSYAELSKATCEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKII  109 (234)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~  109 (234)
                      +..++......+|++.+.||+|+||.||+|.+.     .++..||+|.+.... ......+.+|+.++..++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            334445555678999999999999999999876     356889999997432 23345788999999999999999999


Q ss_pred             EEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCC----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 039258          110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDH----LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP  185 (234)
Q Consensus       110 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~  185 (234)
                      +++..     ....++||||+++++|.+++......    .....+++..+..++.|++.||.|||++   +++||||||
T Consensus        95 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp  166 (322)
T 1p4o_A           95 GVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA  166 (322)
T ss_dssp             EEECS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSG
T ss_pred             EEEcc-----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCcc
Confidence            99743     33468999999999999998764210    0011467889999999999999999999   999999999


Q ss_pred             CCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          186 SNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       186 ~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+++.++.+||+|||+++..........      .....||+.|+||
T Consensus       167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aP  209 (322)
T 1p4o_A          167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRK------GGKGLLPVRWMSP  209 (322)
T ss_dssp             GGEEECTTCCEEECCTTCCCGGGGGGCEEG------GGSSEECGGGCCH
T ss_pred             ceEEEcCCCeEEECcCcccccccccccccc------ccCCCCCCCccCh
Confidence            999999999999999999986543321111      0113578889998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=4.9e-30  Score=211.78  Aligned_cols=184  Identities=20%  Similarity=0.252  Sum_probs=135.6

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCC---CC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDS---KG  119 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~---~~  119 (234)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.++..+. ||||+++++++.....   ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3457899999999999999999999999999999986555555678899999999996 9999999998853222   33


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeeeCCCCceE
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP--MVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--ivH~dlk~~nil~~~~~~vk  197 (234)
                      ....++||||+. ++|.+++.......   .+++..++.++.|++.||.|||++   +  ++|+||||+||+++.++.+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRG---PLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTC---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence            455789999995 69999887532111   588899999999999999999998   8  99999999999999999999


Q ss_pred             EccCccccccCCCccCCCCC----CCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASE----TPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~----~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||++.............    .........||+.|+||
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP  219 (337)
T ss_dssp             BCCCTTCBCCSSCC---------------------------
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCCh
Confidence            99999998765432211000    00011125699999998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=2.5e-30  Score=214.97  Aligned_cols=167  Identities=23%  Similarity=0.413  Sum_probs=134.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCC--CCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRH--RNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|.+. ++..||||++...  .....+.+.+|+.++..++|  +||+++++++..     .
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----C
Confidence            456899999999999999999884 5789999999744  23344678999999999976  999999998753     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++|||+ .+++|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+|||++ ++.+||+|
T Consensus        82 ~~~~lv~e~-~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           82 QYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             SEEEEEECC-CSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred             CEEEEEEeC-CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence            457999995 4779999998765      678889999999999999999999   999999999999997 57899999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++..........      ....+||+.|+||
T Consensus       151 FG~a~~~~~~~~~~~------~~~~~gt~~y~aP  178 (343)
T 3dbq_A          151 FGIANQMQPDTTSVV------KDSQVGTVNYMPP  178 (343)
T ss_dssp             CSSSCCC------------------CCCCSSCCH
T ss_pred             cccccccCccccccc------CCCCcCCcCcCCH
Confidence            999987654322211      1125799999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=1.4e-30  Score=214.45  Aligned_cols=166  Identities=30%  Similarity=0.417  Sum_probs=136.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhcCCCCceeEEEEeeecC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--------KGAFRSFVAECEALRNIRHRNLTKIITICSSID  116 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~  116 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||||++....        ......+.+|++++..++||||+++++++... 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence            456899999999999999999999999999999986331        11224578999999999999999999987421 


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc-
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV-  195 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~-  195 (234)
                          . .++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||+++.++. 
T Consensus        88 ----~-~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  153 (322)
T 2ycf_A           88 ----D-YYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED  153 (322)
T ss_dssp             ----S-EEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSS
T ss_pred             ----c-eEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCC
Confidence                2 589999999999999987654      678889999999999999999999   9999999999999986554 


Q ss_pred             --eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 --AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 --vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                        +||+|||+++........         ....||+.|+||
T Consensus       154 ~~~kl~Dfg~~~~~~~~~~~---------~~~~gt~~y~aP  185 (322)
T 2ycf_A          154 CLIKITDFGHSKILGETSLM---------RTLCGTPTYLAP  185 (322)
T ss_dssp             CCEEECCCTTCEECCCCHHH---------HHHHSCCTTCCH
T ss_pred             CeEEEccCccceeccccccc---------ccccCCcCccCc
Confidence              999999999875432111         125689999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=3.1e-30  Score=213.21  Aligned_cols=180  Identities=22%  Similarity=0.364  Sum_probs=143.0

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEECCCC-----eEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEee
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILGEDE-----MVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICS  113 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~  113 (234)
                      ......+|+..+.||+|+||.||+|.+..++     ..||+|.+.... ....+.+.+|+.++..+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3444577899999999999999999987655     489999997442 23456789999999999 8999999999984


Q ss_pred             ecCCCCCCcceeeEeecCCCCHHHHhhhccCCc--------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 039258          114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHL--------EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP  185 (234)
Q Consensus       114 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~  185 (234)
                      .     .+..++||||+++++|.+++.......        ....+++..++.++.|++.||.|||++   +++|+||||
T Consensus       121 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  192 (333)
T 2i1m_A          121 H-----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA  192 (333)
T ss_dssp             S-----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             c-----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence            3     334799999999999999997642100        011468889999999999999999999   999999999


Q ss_pred             CCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          186 SNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       186 ~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+++.++.+||+|||++...........      .....||+.|+||
T Consensus       193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aP  235 (333)
T 2i1m_A          193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIV------KGNARLPVKWMAP  235 (333)
T ss_dssp             GGCEEEGGGEEEBCCCGGGCCGGGCTTSEE------CSSCEECGGGSCH
T ss_pred             ceEEECCCCeEEECccccccccccccceee------cCCCCCCccccCH
Confidence            999999999999999999986544322111      0114578889998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.6e-30  Score=218.69  Aligned_cols=172  Identities=25%  Similarity=0.503  Sum_probs=128.7

Q ss_pred             CCCCCceeecccceEEEEEEECCC---CeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGED---EMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .|+..+.||+|+||.||+|.+..+   +..||+|.++.. .....+.+.+|+.++..++||||+++++++...    .+.
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SSC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CCC
Confidence            456678999999999999987532   357899998643 334557899999999999999999999987432    234


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG  237 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  237 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence            6899999999999999976542     467788899999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++...........    ......||+.|+||
T Consensus       238 ~a~~~~~~~~~~~~----~~~~~~~~~~y~aP  265 (373)
T 3c1x_A          238 LARDMYDKEFDSVH----NKTGAKLPVKWMAL  265 (373)
T ss_dssp             ------------------------CCGGGSCH
T ss_pred             cccccccccccccc----ccCCCCCcccccCh
Confidence            99876543221110    11124578889998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=7.1e-30  Score=204.51  Aligned_cols=168  Identities=27%  Similarity=0.493  Sum_probs=139.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|+..+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|++++..++||||+++++++..     .+..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeE
Confidence            356888999999999999999986 567899999975432 23678999999999999999999998743     33468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence            99999999999999976532     578889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ............       ...||+.|+||
T Consensus       152 ~~~~~~~~~~~~-------~~~~~~~y~aP  174 (267)
T 3t9t_A          152 RFVLDDQYTSST-------GTKFPVKWASP  174 (267)
T ss_dssp             GGBCCHHHHSTT-------STTCCGGGCCH
T ss_pred             cccccccccccc-------cccccccccCh
Confidence            876443211110       14577889987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=1.8e-30  Score=221.60  Aligned_cols=170  Identities=25%  Similarity=0.390  Sum_probs=135.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~~~~  124 (234)
                      .+|+..+.||+|+||.||+|.+..+++.||||.+.....    ...+|+++|..++||||+++++++..... .+..+++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            368889999999999999999999999999999864322    22469999999999999999998765332 2344567


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC-CceEEccCcc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND-MVAHVGDFGL  203 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~-~~vki~dfG~  203 (234)
                      +||||+++ ++.+.+......  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.+ +.+||+|||+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eehhcccc-cHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence            99999975 777766532111  11678889999999999999999999   99999999999999854 6789999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.........         ..+||+.|+||
T Consensus       204 a~~~~~~~~~~---------~~~~t~~y~aP  225 (420)
T 1j1b_A          204 AKQLVRGEPNV---------SYICSRYYRAP  225 (420)
T ss_dssp             CEECCTTCCCC---------SCCSCTTSCCH
T ss_pred             hhhcccCCCce---------eeeeCCCcCCH
Confidence            98764432111         25689999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=8.7e-31  Score=211.24  Aligned_cols=175  Identities=25%  Similarity=0.372  Sum_probs=142.1

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+...  .....+.+.+|+.++..++||||+++++++...   ...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence            346789999999999999999999999999999999744  233456789999999999999999999987532   234


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC-----eeecCCCCCCeeeCCCCce
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP-----MVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~-----ivH~dlk~~nil~~~~~~v  196 (234)
                      ..++||||+++++|.+++......  ...+++..+..++.|++.||.|||++   +     ++|+||+|+||+++.++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~  155 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNV  155 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCE
T ss_pred             eEEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCE
Confidence            578999999999999999764321  11478899999999999999999998   7     9999999999999999999


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|||++.........        .....||+.|+||
T Consensus       156 kl~dfg~~~~~~~~~~~--------~~~~~~~~~y~aP  185 (279)
T 2w5a_A          156 KLGDFGLARILNHDTSF--------AKTFVGTPYYMSP  185 (279)
T ss_dssp             EECCCCHHHHC---CHH--------HHHHHSCCTTCCH
T ss_pred             EEecCchheeecccccc--------ccccCCCccccCh
Confidence            99999999875432211        1124688999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=4.8e-30  Score=210.10  Aligned_cols=172  Identities=25%  Similarity=0.397  Sum_probs=131.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||+|.+...   .......+.+|+.++..++||||+++++++...     +
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----N  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence            45689999999999999999999999999999999742   233456789999999999999999999998643     3


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++......  ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+||+||
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cEEEEEecCCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEec
Confidence            468999999999999998753211  11578889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++..........        ....||+.|+||
T Consensus       181 g~~~~~~~~~~~~--------~~~~~~~~y~aP  205 (310)
T 2wqm_A          181 GLGRFFSSKTTAA--------HSLVGTPYYMSP  205 (310)
T ss_dssp             --------------------------CCSSCCH
T ss_pred             cceeeecCCCccc--------cccCCCeeEeCh
Confidence            9988654432111        114688999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=7e-30  Score=209.43  Aligned_cols=174  Identities=24%  Similarity=0.390  Sum_probs=135.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-------
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-------  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-------  117 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.++..++||||+++++++.....       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4578999999999999999999999999999999976665666789999999999999999999998743211       


Q ss_pred             --CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC-CCC
Q 039258          118 --KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDM  194 (234)
Q Consensus       118 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~-~~~  194 (234)
                        ......++||||++ ++|.+++...       .+++..+..++.|++.||.|||++   +++|+||||+||+++ .++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence              23356789999997 5999998643       577888999999999999999999   999999999999997 567


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||+++..........     ......||+.|+||
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aP  193 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKG-----HLSEGLVTKWYRSP  193 (320)
T ss_dssp             EEEECCCTTCBCC-------------CCCGGGSCCTTCCH
T ss_pred             eEEEccCccccccCCCccccc-----ccccccccccccCc
Confidence            999999999987654321111     01124578889987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=5.9e-30  Score=206.75  Aligned_cols=169  Identities=24%  Similarity=0.476  Sum_probs=136.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECC---CCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGE---DEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||.||+|.+..   ++..||+|.+... .....+.+.+|+.++..++||||+++++++..      
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------   84 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE------   84 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS------
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC------
Confidence            4578889999999999999998643   4567999999754 23345778999999999999999999998742      


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  156 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGD  156 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECC
T ss_pred             CCCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCc
Confidence            124899999999999999976542     578889999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++...........       ....||+.|+||
T Consensus       157 fg~~~~~~~~~~~~~-------~~~~~~~~y~aP  183 (281)
T 3cc6_A          157 FGLSRYIEDEDYYKA-------SVTRLPIKWMSP  183 (281)
T ss_dssp             CCGGGCC----------------CCCCCGGGCCH
T ss_pred             cCCCccccccccccc-------ccCCCCcceeCc
Confidence            999987654322111       114578889998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=8e-30  Score=204.75  Aligned_cols=163  Identities=25%  Similarity=0.447  Sum_probs=127.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc----chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ----KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|+..+.||+|+||.||+|.+.  +..+|+|++....    ....+.+.+|++++..++||||+++++++..     .
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence            457888999999999999999984  7889999986432    2234678899999999999999999999853     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC---eeecCCCCCCeeeCC-----
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP---MVHGDIKPSNVLLDN-----  192 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~---ivH~dlk~~nil~~~-----  192 (234)
                      ...++||||+++++|.+++...       .+++..+..++.|++.|+.|||++   +   ++|+||||+||+++.     
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~  148 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENG  148 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSS
T ss_pred             CceEEEEEcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccc
Confidence            3469999999999999998643       578889999999999999999998   7   999999999999975     


Q ss_pred             ---CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 ---DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ---~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                         ++.+||+|||++.........          ...||+.|+||
T Consensus       149 ~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~y~aP  183 (271)
T 3dtc_A          149 DLSNKILKITDFGLAREWHRTTKM----------SAAGAYAWMAP  183 (271)
T ss_dssp             CCSSCCEEECCCCC-----------------------CCGGGSCH
T ss_pred             cccCcceEEccCCccccccccccc----------CCCCccceeCH
Confidence               678999999999865443211          14689999998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=3.5e-30  Score=211.44  Aligned_cols=159  Identities=18%  Similarity=0.227  Sum_probs=134.8

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|++++..++||||+++++++.... ......
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCcee
Confidence            3567999999999999999999999999999999997655556678899999999999999999999886432 233456


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|.+++.......  ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKG--NFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            89999999999999987632111  1678899999999999999999999   999999999999999999999999999


Q ss_pred             ccccC
Q 039258          204 SKFLS  208 (234)
Q Consensus       204 a~~~~  208 (234)
                      +....
T Consensus       181 ~~~~~  185 (317)
T 2buj_A          181 MNQAC  185 (317)
T ss_dssp             CEESC
T ss_pred             chhcc
Confidence            87644

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=9.9e-30  Score=212.24  Aligned_cols=181  Identities=23%  Similarity=0.293  Sum_probs=133.0

Q ss_pred             hHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           38 YAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        38 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      .........+|++.+.||+|+||.||+|.+..++..||||.+... ......+.+++..+..++||||+++++++.....
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            345566678899999999999999999999999999999988543 2233567788888999999999999999866443


Q ss_pred             --CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHH--hCCCCCeeecCCCCCCeeeCC-
Q 039258          118 --KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH--HNCQPPMVHGDIKPSNVLLDN-  192 (234)
Q Consensus       118 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~~~~ivH~dlk~~nil~~~-  192 (234)
                        ....+.++||||+++ +|.+.+......  ...+++..+..++.|++.|+.|+|  ++   +|+||||||+||+++. 
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRR--QVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence              223346899999975 666655432111  115778888999999999999999  88   9999999999999986 


Q ss_pred             CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++.+||+|||+++.........         ...||+.|+||
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~---------~~~gt~~y~aP  200 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSEPNV---------AYICSRYYRAP  200 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTSCCC---------STTSCGGGCCH
T ss_pred             CCcEEEeeCCCceecCCCCCcc---------cccCCcceeCH
Confidence            8999999999998765432211         25689999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=3.8e-30  Score=221.48  Aligned_cols=170  Identities=28%  Similarity=0.506  Sum_probs=135.0

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ....+|++.+.||+|+||.||+|.+..+ ..||||+++... ...+.+.+|+.+|..++||||+++++++..      ..
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~  252 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP  252 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence            3456688899999999999999999654 679999997543 234678999999999999999999998742      23


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++......    .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             eEEEehhhcCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCc
Confidence            68999999999999999754211    478889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++..........       ....+|..|+||
T Consensus       326 ~a~~~~~~~~~~~-------~~~~~~~~y~aP  350 (452)
T 1fmk_A          326 LARLIEDNEYTAR-------QGAKFPIKWTAP  350 (452)
T ss_dssp             TTC---------------------CCGGGSCH
T ss_pred             cceecCCCceecc-------cCCcccccccCH
Confidence            9987654322111       124577889998

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.6e-30  Score=212.80  Aligned_cols=170  Identities=24%  Similarity=0.462  Sum_probs=132.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeE----EEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMV----VAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ..+|++.+.||+|+||.||+|.+..++..    ||+|.+... .....+.+.+|+.++..++||||+++++++....   
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST---   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS---
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC---
Confidence            35789999999999999999999877754    466666432 3344578899999999999999999999985321   


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                         .++++|++++++|.+++.....     .+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+
T Consensus        91 ---~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~  159 (327)
T 3lzb_A           91 ---VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             ---EEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEEC
T ss_pred             ---ceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEc
Confidence               5799999999999999987543     578889999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++...........      ....||+.|+||
T Consensus       160 DfG~a~~~~~~~~~~~~------~~~~~t~~y~aP  188 (327)
T 3lzb_A          160 DFGLAKLLGAEEKEYHA------EGGKVPIKWMAL  188 (327)
T ss_dssp             CTTC----------------------CCCGGGSCH
T ss_pred             cCcceeEccCccccccc------cCCCccccccCH
Confidence            99999876543222111      124578889998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=4.7e-30  Score=208.31  Aligned_cols=170  Identities=30%  Similarity=0.490  Sum_probs=130.0

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      .....+|++.+.||+|+||.||+|.+..   .+|+|+++..  .....+.+.+|+.++..++||||+++++++.      
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------   90 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------   90 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------
Confidence            3345679999999999999999998643   4999999744  2334577899999999999999999999752      


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      ....++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~  162 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIG  162 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred             CCccEEEEEecCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEc
Confidence            2236899999999999999965432     688889999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++............      ....||+.|+||
T Consensus       163 Dfg~~~~~~~~~~~~~~------~~~~gt~~y~aP  191 (289)
T 3og7_A          163 DFGLATEKSRWSGSHQF------EQLSGSILWMAP  191 (289)
T ss_dssp             CCC------------------------CCCTTCCH
T ss_pred             cceeccccccccccccc------cccCCCccccCc
Confidence            99999865432211111      125689999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=2e-30  Score=217.58  Aligned_cols=168  Identities=23%  Similarity=0.363  Sum_probs=124.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~  121 (234)
                      ..+|+..+.||+|+||.||+|.+..+++.||||.+...  .....+.+.+|+.++..++||||+++++++..... ....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36799999999999999999999999999999998643  23345678899999999999999999998754321 1224


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++|||++ +++|.+++...       .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCEEEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             eEEEEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence            468999999 67998888652       588899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++.......           ...||+.|+||
T Consensus       177 G~a~~~~~~~~-----------~~~~t~~y~aP  198 (367)
T 2fst_X          177 GLARHTADEMT-----------GYVATRWYRAP  198 (367)
T ss_dssp             -------------------------CCCTTCCH
T ss_pred             cccccccccCC-----------CcCcCcCccCh
Confidence            99986443211           25689999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=7.6e-30  Score=211.31  Aligned_cols=171  Identities=30%  Similarity=0.542  Sum_probs=132.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCC----CeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGED----EMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|+..+.||+|+||.||+|.+..+    +..||+|.++... ......+.+|+.++..++||||+++++++..     .
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  118 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y  118 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-----C
Confidence            4567789999999999999987644    3569999997442 3344678999999999999999999999743     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||+++++|.+++.....     .+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  190 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD  190 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence            447999999999999999976532     578899999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++...........     .....||+.|+||
T Consensus       191 fg~~~~~~~~~~~~~~-----~~~~~~~~~y~aP  219 (333)
T 1mqb_A          191 FGLSRVLEDDPEATYT-----TSGGKIPIRWTAP  219 (333)
T ss_dssp             CCC----------------------CCCGGGSCH
T ss_pred             CCcchhhccccccccc-----cCCCCccccccCc
Confidence            9999876543221110     0113467889987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.97  E-value=1.6e-29  Score=205.29  Aligned_cols=175  Identities=26%  Similarity=0.392  Sum_probs=137.6

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+|+.++..++|++++..+..+..    .....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC----CCCce
Confidence            45679999999999999999999999999999998764322  2457889999999999888777776643    23456


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee---CCCCceEEcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGD  200 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~---~~~~~vki~d  200 (234)
                      ++||||+ +++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||++   +.++.+||+|
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D  151 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred             EEEEEcc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence            8999999 8899999975432     588899999999999999999999   99999999999999   7888999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++............ ........||+.|+||
T Consensus       152 fg~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aP  184 (296)
T 4hgt_A          152 FGLAKKYRDARTHQHIP-YRENKNLTGTARYASI  184 (296)
T ss_dssp             CTTCEECBCTTTCCBCC-CCCSCCCCSCGGGCCH
T ss_pred             CccceeccCcccCccCC-CCcccccCCCccccch
Confidence            99998766543321110 0111125799999998

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.97  E-value=9.4e-30  Score=207.11  Aligned_cols=168  Identities=25%  Similarity=0.424  Sum_probs=138.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|+..+.||+|+||.||+|.+..+++.||+|.+....  ....+.+.+|+.++..++||||+++++++...     +..
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   77 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL   77 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecC-----Cce
Confidence            46888999999999999999999999999999986432  23346788999999999999999999998543     347


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||++ ++|.+++......    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+
T Consensus        78 ~lv~e~~~-~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~  149 (299)
T 2r3i_A           78 YLVFEFLH-QDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL  149 (299)
T ss_dssp             EEEEECCS-EEHHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTTH
T ss_pred             EEEEEccc-CCHHHHHHhhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcchh
Confidence            99999997 5999998765322    577888999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........        ...||+.|+||
T Consensus       150 ~~~~~~~~~~~~--------~~~~~~~y~aP  172 (299)
T 2r3i_A          150 ARAFGVPVRTYT--------HEVVTLWYRAP  172 (299)
T ss_dssp             HHHHCCCSBCTT--------SCBCCCTTCCH
T ss_pred             hhhccCCccccC--------cccccccccCc
Confidence            987543221111        14588999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=5.1e-30  Score=213.29  Aligned_cols=178  Identities=20%  Similarity=0.301  Sum_probs=137.1

Q ss_pred             hcCCCCCceeecccceEEEEEEECC---CCeEEEEEEeecccch-----------hhHHHHHHHHHHHhcCCCCceeEEE
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGE---DEMVVAVKVINLKQKG-----------AFRSFVAECEALRNIRHRNLTKIIT  110 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~l~~  110 (234)
                      ..+|++.+.||+|+||.||+|.+..   ++..+|+|+.......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4579999999999999999999987   7789999998644221           1234678888999999999999999


Q ss_pred             EeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee
Q 039258          111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL  190 (234)
Q Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~  190 (234)
                      ++.... .+....++||||+ +++|.+++....      .+++..++.++.|++.||.|||++   +++||||||+||++
T Consensus       116 ~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  184 (345)
T 2v62_A          116 SGLTEF-KGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL  184 (345)
T ss_dssp             EEEEES-SSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             cccccc-CCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence            986532 2345679999999 899999998755      688899999999999999999999   99999999999999


Q ss_pred             CCCC--ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          191 DNDM--VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       191 ~~~~--~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.++  .+||+|||+++.+......... .........||+.|+||
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aP  229 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQY-QENPRKGHNGTIEFTSL  229 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCC-CCCGGGCSCSCTTTCCH
T ss_pred             ccCCCCcEEEEeCCCceecccccccccc-hhccccccCCCccccCH
Confidence            8776  9999999999877544322111 11111235799999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=6.9e-31  Score=221.07  Aligned_cols=174  Identities=16%  Similarity=0.216  Sum_probs=131.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHH---HHHhcCCCCceeEE-------EE
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECE---ALRNIRHRNLTKII-------TI  111 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~l~-------~~  111 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...   .....+.+.+|+.   .+..++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688889999999999999999889999999999732   3344577889994   55556799999988       55


Q ss_pred             eeecCC---------CCC---CcceeeEeecCCCCHHHHhhhccCCcc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039258          112 CSSIDS---------KGA---DFKALVFEYMENGSLEDWLHQTNDHLE-VFKLSLIQRVNIAIDVASAIEYLHHNCQPPM  178 (234)
Q Consensus       112 ~~~~~~---------~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~i  178 (234)
                      +.....         .+.   ...++||||+ +|+|.+++........ ...+++..+..++.|++.||.|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            432211         000   0268999999 6799999986531110 11334577788999999999999999   99


Q ss_pred             eecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          179 VHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       179 vH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||||||+|||++.++.+||+|||+++......           ...+| +.|+||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----------~~~~g-~~y~aP  271 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV-----------VSSVS-RGFEPP  271 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTCEE-----------ECCCC-TTCCCH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCCcc-----------cCCCC-cCccCh
Confidence            999999999999999999999999998533211           12567 899998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=1.7e-29  Score=203.82  Aligned_cols=168  Identities=24%  Similarity=0.527  Sum_probs=138.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++..++||||+++++++..      +..+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~   83 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCcE
Confidence            457888999999999999999985 56789999986443 234778999999999999999999998742      2368


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++.....    ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence            99999999999999975421    1578889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ............       ...||+.|+||
T Consensus       157 ~~~~~~~~~~~~-------~~~~~~~y~aP  179 (279)
T 1qpc_A          157 RLIEDNEYTARE-------GAKFPIKWTAP  179 (279)
T ss_dssp             EECSSSCEECCT-------TCCCCTTTSCH
T ss_pred             ccccCccccccc-------CCCCccCccCh
Confidence            876543321111       13477889987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=1.3e-29  Score=208.63  Aligned_cols=175  Identities=25%  Similarity=0.445  Sum_probs=140.8

Q ss_pred             HHhcCCCCCceeecccceEEEEEEEC-CCCeEEEEEEeeccc--chhhHHHHHHHHHHHhc---CCCCceeEEEEeeecC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILG-EDEMVVAVKVINLKQ--KGAFRSFVAECEALRNI---RHRNLTKIITICSSID  116 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~l~~~~~~~~  116 (234)
                      ....+|++.+.||+|+||.||+|.+. .+++.||+|++....  ......+.+|+.++..+   +||||+++++++....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34578999999999999999999995 678999999996432  22234566777777665   8999999999986433


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCce
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVA  196 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~v  196 (234)
                      .......++||||++ ++|.+++......    .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCE
Confidence            334556799999997 5999999875432    478889999999999999999999   99999999999999999999


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|||+++.........         ...||+.|+||
T Consensus       160 kl~Dfg~~~~~~~~~~~~---------~~~~~~~y~aP  188 (326)
T 1blx_A          160 KLADFGLARIYSFQMALT---------SVVVTLWYRAP  188 (326)
T ss_dssp             EECSCCSCCCCCGGGGGC---------CCCCCCTTCCH
T ss_pred             EEecCcccccccCCCCcc---------ccccccceeCH
Confidence            999999998654322111         25689999997

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.97  E-value=1.1e-29  Score=203.65  Aligned_cols=165  Identities=25%  Similarity=0.393  Sum_probs=138.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|++.+.||+|+||.||+|.+.  +..+|+|++....  ....+.+.+|+.++..++||||+++++++...   ....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence            356888999999999999999984  7889999997542  33446789999999999999999999997543   2245


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeeeCCCCceEEcc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP--MVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      .++||||+++++|.+++......    .+++..+..++.|++.||.|||++   +  ++|+||||+||+++.++.++++|
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSC----CCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             eEeeecccCCCcHHHHHhhcccC----CCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence            68999999999999999875432    578899999999999999999998   7  99999999999999999999998


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++......             ...||+.|+||
T Consensus       157 ~~~~~~~~~~-------------~~~~t~~y~aP  177 (271)
T 3kmu_A          157 ADVKFSFQSP-------------GRMYAPAWVAP  177 (271)
T ss_dssp             GGSCCTTSCT-------------TCBSCGGGSCH
T ss_pred             ccceeeeccc-------------CccCCccccCh
Confidence            8886542221             14589999998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.96  E-value=2.9e-29  Score=207.94  Aligned_cols=180  Identities=26%  Similarity=0.367  Sum_probs=143.4

Q ss_pred             CcChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHh--cCCCCceeEEEEe
Q 039258           35 MVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRN--IRHRNLTKIITIC  112 (234)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~l~~~~  112 (234)
                      ..+.........+|++.+.||+|+||.||+|.+  +++.||+|++...   ....+.+|.+++..  ++||||+++++++
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            344444455567899999999999999999998  5789999998633   23567788998887  7899999999997


Q ss_pred             eecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCC
Q 039258          113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH--------HNCQPPMVHGDIK  184 (234)
Q Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--------~~~~~~ivH~dlk  184 (234)
                      ..... .....++||||+++++|.+++...       .+++..++.++.|++.||.|||        +.   +++|+|||
T Consensus       106 ~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlk  174 (342)
T 1b6c_B          106 NKDNG-TWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLK  174 (342)
T ss_dssp             ECCCS-SCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCS
T ss_pred             cccCC-ccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCC
Confidence            65432 223578999999999999999753       5788899999999999999999        77   99999999


Q ss_pred             CCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          185 PSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       185 ~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+||+++.++.+||+|||++............    ......||+.|+||
T Consensus       175 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~----~~~~~~gt~~y~aP  220 (342)
T 1b6c_B          175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDI----APNHRVGTKRYMAP  220 (342)
T ss_dssp             GGGEEECTTSCEEECCCTTCEEEETTTTEEEE----CCCSCCCCGGGCCH
T ss_pred             HHHEEECCCCCEEEEECCCceecccccccccc----ccccCCcCcccCCH
Confidence            99999999999999999999876543211100    01125699999998

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.96  E-value=2.5e-29  Score=215.03  Aligned_cols=165  Identities=24%  Similarity=0.329  Sum_probs=137.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc------CCCCceeEEEEeeecCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI------RHRNLTKIITICSSIDSK  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~l~~~~~~~~~~  118 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.++..+      +|+||+++++++...   
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~---  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR---  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET---
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC---
Confidence            45799999999999999999999999999999999643 23345677888888776      577999999987543   


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc--e
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV--A  196 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~--v  196 (234)
                        ...++||||+. ++|.+++......    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.  +
T Consensus       172 --~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          172 --NHICMTFELLS-MNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             --TEEEEEECCCC-CBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred             --CeEEEEEeccC-CCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence              44799999995 6999998875432    478889999999999999999999   9999999999999998876  9


Q ss_pred             EEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          197 HVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       197 ki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|||++........           ..+||+.|+||
T Consensus       242 kL~DFG~a~~~~~~~~-----------~~~gt~~y~aP  268 (429)
T 3kvw_A          242 KVIDFGSSCYEHQRVY-----------TYIQSRFYRAP  268 (429)
T ss_dssp             EECCCTTCEETTCCCC-----------SSCSCGGGCCH
T ss_pred             EEeecccceecCCccc-----------ccCCCCCccCh
Confidence            9999999976443211           15799999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=1.4e-29  Score=208.30  Aligned_cols=169  Identities=30%  Similarity=0.452  Sum_probs=137.8

Q ss_pred             CCCCceeecccceEEEEEEE----CCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           48 FSQSNMIGQGSYGSVYKGIL----GEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      |++.+.||+|+||.||++.+    ..+++.||+|+++... ....+.+.+|++++..++||||+++++++...   +...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence            48899999999999988764    3578899999997543 33456789999999999999999999998643   2345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++...       .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcc
Confidence            78999999999999999754       478889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++............     .....||+.|+||
T Consensus       180 ~a~~~~~~~~~~~~-----~~~~~~~~~y~aP  206 (318)
T 3lxp_A          180 LAKAVPEGHEYYRV-----REDGDSPVFWYAP  206 (318)
T ss_dssp             GCEECCTTCSEEEC--------CCCCGGGCCH
T ss_pred             cccccccccccccc-----ccCCCCCceeeCh
Confidence            99876543211100     0114588889997

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.4e-29  Score=207.86  Aligned_cols=182  Identities=27%  Similarity=0.369  Sum_probs=138.3

Q ss_pred             cChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc--CCCCceeEEEEee
Q 039258           36 VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI--RHRNLTKIITICS  113 (234)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~l~~~~~  113 (234)
                      .+........++|++.+.||+|+||.||+|.+.  +..||||++....   ......|.+++...  +||||+++++++.
T Consensus        27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             CCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            334444455678999999999999999999984  7899999986432   23445566666554  8999999999886


Q ss_pred             ecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCCe
Q 039258          114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC-----QPPMVHGDIKPSNV  188 (234)
Q Consensus       114 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-----~~~ivH~dlk~~ni  188 (234)
                      .... .....++||||+++++|.+++...       .+++..+..++.|++.||.|||+++     ..+++||||||+||
T Consensus       102 ~~~~-~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Ni  173 (337)
T 3mdy_A          102 KGTG-SWTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI  173 (337)
T ss_dssp             ESCG-GGCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGE
T ss_pred             cCCC-CCCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHE
Confidence            5432 224578999999999999999654       5788899999999999999999641     22799999999999


Q ss_pred             eeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          189 LLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       189 l~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++.++.+||+|||++.............    .....||+.|+||
T Consensus       174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~----~~~~~gt~~y~aP  215 (337)
T 3mdy_A          174 LVKKNGTCCIADLGLAVKFISDTNEVDIP----PNTRVGTKRYMPP  215 (337)
T ss_dssp             EECTTSCEEECCCTTCEECC-------------CCSSCSCGGGCCH
T ss_pred             EECCCCCEEEEeCCCceeeccccccccCC----CCCCccCcceeCh
Confidence            99999999999999998765433221110    1125799999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=4.8e-30  Score=210.26  Aligned_cols=171  Identities=25%  Similarity=0.357  Sum_probs=135.2

Q ss_pred             HHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc------hhhHHHHHHHHHHHhc----CCCCceeEE
Q 039258           40 ELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK------GAFRSFVAECEALRNI----RHRNLTKII  109 (234)
Q Consensus        40 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~i~~l~  109 (234)
                      +......+|++.+.||+|+||.||+|.+..+++.||+|++.....      .....+.+|+.++..+    +|+||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            344556789999999999999999999999999999999964321      1223456789999888    899999999


Q ss_pred             EEeeecCCCCCCcceeeEee-cCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCe
Q 039258          110 TICSSIDSKGADFKALVFEY-MENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNV  188 (234)
Q Consensus       110 ~~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~ni  188 (234)
                      +++...     +..++|||+ +.+++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||
T Consensus       105 ~~~~~~-----~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  170 (312)
T 2iwi_A          105 DWFETQ-----EGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI  170 (312)
T ss_dssp             EEC----------CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred             EEEecC-----CeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence            987432     346899999 78899999998754      578899999999999999999999   999999999999


Q ss_pred             eeC-CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          189 LLD-NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       189 l~~-~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++ .++.+||+|||++.........          ...||+.|+||
T Consensus       171 l~~~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~y~aP  207 (312)
T 2iwi_A          171 LIDLRRGCAKLIDFGSGALLHDEPYT----------DFDGTRVYSPP  207 (312)
T ss_dssp             EEETTTTEEEECCCSSCEECCSSCBC----------CCCSCTTTSCH
T ss_pred             EEeCCCCeEEEEEcchhhhcccCccc----------ccCCcccccCc
Confidence            998 8899999999999876543221          15689999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=3.6e-29  Score=203.29  Aligned_cols=174  Identities=26%  Similarity=0.394  Sum_probs=140.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.....  .+.+.+|+.++..++|++++..+..+..    .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence            4679999999999999999999999999999999864432  2568899999999999887776666543    234568


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee---CCCCceEEccC
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDF  201 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~---~~~~~vki~df  201 (234)
                      +||||+ +++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+||++   +.++.+||+||
T Consensus        82 lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  152 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEec-CCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence            999999 8899999975432     588899999999999999999999   99999999999999   47889999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++............. ........||+.|+||
T Consensus       153 g~~~~~~~~~~~~~~~-~~~~~~~~gt~~y~aP  184 (296)
T 3uzp_A          153 GLAKKYRDARTHQHIP-YRENKNLTGTARYASI  184 (296)
T ss_dssp             TTCEECBCTTTCCBCC-CCCSCCCCSCTTTCCH
T ss_pred             CCcccccccccccccc-cccccccccccccCCh
Confidence            9998766543221110 0111225799999998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=2.3e-30  Score=210.90  Aligned_cols=182  Identities=26%  Similarity=0.354  Sum_probs=124.6

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .....+|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++..++||||+++++++...     
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----   85 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----   85 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----
Confidence            344578999999999999999999998889999999986432 33446788999999999999999999988543     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccC--CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          121 DFKALVFEYMENGSLEDWLHQTND--HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                      +..++||||+++++|.+++.....  ......+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.+||
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEE
Confidence            336899999999999999875211  00112578899999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||++...........   ........||+.|+||
T Consensus       163 ~dfg~~~~~~~~~~~~~---~~~~~~~~~~~~y~aP  195 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITR---NKVRKTFVGTPCWMAP  195 (303)
T ss_dssp             CCCHHHHHCC------------------CCCTTCCH
T ss_pred             EeccchheeccCCCccc---hhhhcccCCCccccCH
Confidence            99999987654321110   0111125699999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=1.4e-29  Score=214.33  Aligned_cols=170  Identities=25%  Similarity=0.365  Sum_probs=133.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~~~  123 (234)
                      ..+|+..+.||+|+||+||+|.+..++. +|+|.+......    ..+|+++++.++||||+++++++..... .+..+.
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            4469999999999999999999987766 788877533211    2369999999999999999999866443 344557


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC-CCCceEEccCc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFG  202 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~-~~~~vki~dfG  202 (234)
                      ++||||+++ ++.+.+......  ...+++..+..++.|++.||.|||++   +|+||||||+||+++ .++.+||+|||
T Consensus       114 ~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          114 NLVLEYVPE-TVYRASRHYAKL--KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEeeccCc-cHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            899999976 555544321100  11678889999999999999999999   999999999999998 78999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++.........         ...||+.|+||
T Consensus       188 ~a~~~~~~~~~~---------~~~~t~~y~aP  210 (394)
T 4e7w_A          188 SAKILIAGEPNV---------SYICSRYYRAP  210 (394)
T ss_dssp             TCEECCTTCCCC---------SSCSCGGGCCH
T ss_pred             CcccccCCCCCc---------ccccCcCccCH
Confidence            998764432211         25689999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=3e-29  Score=203.32  Aligned_cols=169  Identities=30%  Similarity=0.409  Sum_probs=141.7

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|++++..++||||+++++++..     .
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   93 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----S   93 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----C
Confidence            34467999999999999999999999899999999996432  3345788999999999999999999998753     3


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC---CceE
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND---MVAH  197 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~---~~vk  197 (234)
                      ...++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||+|+||+++.+   +.+|
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CeEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence            44799999999999999887654      578899999999999999999999   99999999999999653   4799


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||++..........         ...||+.|+||
T Consensus       165 L~Dfg~~~~~~~~~~~~---------~~~~~~~y~aP  192 (287)
T 2wei_A          165 IIDFGLSTCFQQNTKMK---------DRIGTAYYIAP  192 (287)
T ss_dssp             ECSTTGGGTBCCCSSCS---------CHHHHHTTCCH
T ss_pred             EeccCcceeecCCCccc---------cccCcccccCh
Confidence            99999998654432111         14588999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.96  E-value=7.7e-30  Score=211.98  Aligned_cols=166  Identities=22%  Similarity=0.408  Sum_probs=139.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccch---h--------------hHHHHHHHHHHHhcCCCCcee
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKG---A--------------FRSFVAECEALRNIRHRNLTK  107 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~---~--------------~~~~~~e~~~l~~l~h~~i~~  107 (234)
                      ..+|++.+.||+|+||.||+|.+  ++..||+|++......   .              .+.+.+|+.++..++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999999  8899999999643211   1              178899999999999999999


Q ss_pred             EEEEeeecCCCCCCcceeeEeecCCCCHHHH------hhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeee
Q 039258          108 IITICSSIDSKGADFKALVFEYMENGSLEDW------LHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVH  180 (234)
Q Consensus       108 l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH  180 (234)
                      +++++..     .+..++||||+++++|.++      +.....    ..+++..+..++.|++.||.|||+ +   +++|
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H  175 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYT----CFIPIQVIKCIIKSVLNSFSYIHNEK---NICH  175 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSC----CCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccc----cCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence            9999754     3457999999999999998      443211    268889999999999999999998 8   9999


Q ss_pred             cCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          181 GDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       181 ~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+|+||+++.++.+||+|||++.........          ...||+.|+||
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~y~aP  219 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK----------GSRGTYEFMPP  219 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTTEEC----------SSCSCGGGCCG
T ss_pred             cCCChHhEEEcCCCcEEEecccccccccccccc----------CCCCCcCccCc
Confidence            999999999999999999999999876443211          14689999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=1.4e-29  Score=208.89  Aligned_cols=172  Identities=28%  Similarity=0.454  Sum_probs=135.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEE--EEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVV--AVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|++.+.||+|+||.||+|.+..++..+  |+|.+... .....+.+.+|++++..+ +||||+++++++...     +
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----C
Confidence            46888999999999999999998888755  99988643 333456789999999999 899999999998543     3


Q ss_pred             cceeeEeecCCCCHHHHhhhccCC----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDH----------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                      ..++||||+++++|.+++......          .....+++..++.++.|++.||.|||++   +++||||||+||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence            479999999999999999764310          0112578899999999999999999999   999999999999999


Q ss_pred             CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          192 NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       192 ~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .++.+||+|||+++.........         ...+|+.|+||
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~~~~---------~~~~~~~y~aP  210 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYVKKT---------MGRLPVRWMAI  210 (327)
T ss_dssp             GGGCEEECCTTCEESSCEECCC-------------CCTTTCCH
T ss_pred             CCCeEEEcccCcCcccccccccc---------CCCCCccccCh
Confidence            99999999999987433211111         13477889887

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=1.2e-29  Score=226.44  Aligned_cols=163  Identities=28%  Similarity=0.446  Sum_probs=131.1

Q ss_pred             ceeecccceEEEEEEE--CCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGIL--GEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~--~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||.||+|.+  ..++..||||+++..  .....+.+.+|+++|..++||||+++++++..      ...++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            4799999999999965  456789999999743  23345789999999999999999999998742      1258999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++++|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       449 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             EccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            9999999999997654      678899999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........     .....||+.|+||
T Consensus       520 ~~~~~~~~~-----~~~~~~t~~y~AP  541 (635)
T 4fl3_A          520 RADENYYKA-----QTHGKWPVKWYAP  541 (635)
T ss_dssp             TC------------------CGGGSCH
T ss_pred             ccCcccccc-----ccCCCCceeeeCh
Confidence            554321111     1113578889998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=2.2e-29  Score=204.45  Aligned_cols=170  Identities=27%  Similarity=0.421  Sum_probs=136.9

Q ss_pred             hcCCCCCc-eeecccceEEEEEEE--CCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           45 TCEFSQSN-MIGQGSYGSVYKGIL--GEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        45 ~~~~~~~~-~lG~G~fg~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ..+|++.+ .||+|+||.||+|.+  ..++..||+|+++...  ....+.+.+|+.++..++||||+++++++..     
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-----
Confidence            34677777 999999999999954  5667899999997432  3335778999999999999999999998721     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                       ...++||||+++++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+
T Consensus        90 -~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           90 -ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             -CCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEc
Confidence             23689999999999999998754      578889999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++............     .....||+.|+||
T Consensus       160 Dfg~~~~~~~~~~~~~~-----~~~~~~~~~y~aP  189 (291)
T 1xbb_A          160 DFGLSKALRADENYYKA-----QTHGKWPVKWYAP  189 (291)
T ss_dssp             CCTTCEECCTTCSEEEC---------CCCGGGCCH
T ss_pred             cCCcceeeccCCCcccc-----cccCCCCceeeCh
Confidence            99999876543221110     0113467889987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=9.2e-30  Score=229.20  Aligned_cols=166  Identities=24%  Similarity=0.374  Sum_probs=137.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECC-CCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGE-DEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|++.+.||+|+||.||+|.+.. +++.||||++... .......+.+|+.++..++||||+++++++...+..+...
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4689999999999999999999976 7899999998643 2334467889999999999999999999987654433333


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++..        .+++..++.++.|++.||.|+|++   +|+||||||+||+++.+ .+||+|||
T Consensus       159 ~~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             EEEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             eEEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence            5899999999999887643        478899999999999999999999   99999999999999875 89999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++......            ...||+.|+||
T Consensus       227 ~a~~~~~~~------------~~~gt~~y~aP  246 (681)
T 2pzi_A          227 AVSRINSFG------------YLYGTPGFQAP  246 (681)
T ss_dssp             TCEETTCCS------------CCCCCTTTSCT
T ss_pred             cchhcccCC------------ccCCCccccCH
Confidence            998754431            15699999998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.96  E-value=1.9e-29  Score=211.90  Aligned_cols=167  Identities=23%  Similarity=0.344  Sum_probs=135.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC-CCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK-GAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~-~~~  121 (234)
                      ..+|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++..++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            45789999999999999999999999999999999643  233457788999999999999999999998543321 111


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||++ ++|.+++..        .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+||
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred             eEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence            2389999996 588887742        478889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++.......           ...||+.|+||
T Consensus       189 g~a~~~~~~~~-----------~~~~t~~y~aP  210 (371)
T 4exu_A          189 GLARHADAEMT-----------GYVVTRWYRAP  210 (371)
T ss_dssp             TCC-------------------CTTCCCTTSCH
T ss_pred             CcccccccCcC-----------CcccCccccCH
Confidence            99986543211           25689999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.96  E-value=8e-30  Score=223.73  Aligned_cols=170  Identities=28%  Similarity=0.510  Sum_probs=139.4

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ....+|++.+.||+|+||.||+|.+..+ ..||||+++... ...+.+.+|+++|..++|+||+++++++..      ..
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~  335 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP  335 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence            3455688889999999999999999654 679999997543 234679999999999999999999998742      23


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++++|.+++......    .+++..++.++.||+.||.|||++   +++||||||+|||++.++.+||+|||
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             ceEeeehhcCCcHHHHHhhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccc
Confidence            68999999999999999754211    478889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++...........       ...+|..|+||
T Consensus       409 ~a~~~~~~~~~~~~-------~~~~~~~y~aP  433 (535)
T 2h8h_A          409 LARLIEDNEYTARQ-------GAKFPIKWTAP  433 (535)
T ss_dssp             STTTCCCHHHHTTC-------STTSCGGGSCH
T ss_pred             cceecCCCceeccc-------CCcCcccccCH
Confidence            99876543211110       13477889987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=1.5e-29  Score=208.86  Aligned_cols=176  Identities=24%  Similarity=0.400  Sum_probs=135.1

Q ss_pred             hcCCCCCceeecccceEEEEEE-----ECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGI-----LGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      ..+|++.+.||+|+||.||+|.     +..++..||+|.+... .......+.+|+.++..++||||+++++++..    
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence            4679999999999999999999     4456789999999643 33445678999999999999999999999753    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCC-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC---CC
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDH-LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DM  194 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~---~~  194 (234)
                       ....++||||+++++|.+++...... .....+++..++.++.|++.||.|||++   +++|+||||+||+++.   +.
T Consensus       105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence             33468999999999999999875421 1123578889999999999999999999   9999999999999984   45


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||++............      ....||+.|+||
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~------~~~~~~~~y~aP  214 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKG------GCAMLPVKWMPP  214 (327)
T ss_dssp             CEEECCCHHHHHHHC------C------CGGGSCGGGCCH
T ss_pred             eEEECccccccccccccccccC------CCcCCCcceeCH
Confidence            6999999999865433211110      114588899998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=4e-29  Score=202.57  Aligned_cols=170  Identities=25%  Similarity=0.448  Sum_probs=137.6

Q ss_pred             cCCCCCc-eeecccceEEEEEEEC--CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSN-MIGQGSYGSVYKGILG--EDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~-~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|.+.+ .||+|+||.||+|.+.  .++..||+|+++.. .....+.+.+|++++..++||||+++++++..      +
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence            3455555 8999999999999864  46788999999754 33445778999999999999999999998732      2


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence            26899999999999999975432     588899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |++............     .....||+.|+||
T Consensus       155 g~~~~~~~~~~~~~~-----~~~~~~~~~y~aP  182 (287)
T 1u59_A          155 GLSKALGADDSYYTA-----RSAGKWPLKWYAP  182 (287)
T ss_dssp             TTCEECTTCSCEECC-----CCSSCCCGGGCCH
T ss_pred             cceeeeccCcceeec-----cccccccccccCH
Confidence            999876543221110     1113578899998

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=4.3e-30  Score=215.74  Aligned_cols=170  Identities=12%  Similarity=0.065  Sum_probs=121.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc---hhhHHHHHHHHHHHhc--CCCCceeEE-------EEe
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK---GAFRSFVAECEALRNI--RHRNLTKII-------TIC  112 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~i~~l~-------~~~  112 (234)
                      ..+|+..+.||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.++..+  +|||+++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3458889999999999999999999999999999975432   3345677785545444  699988755       333


Q ss_pred             eecCCC------------CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHH------HHHHHHHHHHHHHHHhCC
Q 039258          113 SSIDSK------------GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQR------VNIAIDVASAIEYLHHNC  174 (234)
Q Consensus       113 ~~~~~~------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~------~~~~~qi~~~l~~lh~~~  174 (234)
                      ......            .....++||||++ ++|.+++...+.     .++....      ..++.|++.||.|||++ 
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSK-  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence            221110            0134699999998 799999987532     2233333      56779999999999999 


Q ss_pred             CCCeeecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          175 QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       175 ~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                        +|+||||||+|||++.++.+||+|||+++.......           ...||+.|+||
T Consensus       214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----------~~~~t~~y~aP  260 (371)
T 3q60_A          214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----------ASSVPVTYAPR  260 (371)
T ss_dssp             --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----------GGGSCGGGCCH
T ss_pred             --CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----------CccCCcCCcCh
Confidence              999999999999999999999999999986543221           14577999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=2.5e-29  Score=205.87  Aligned_cols=164  Identities=27%  Similarity=0.452  Sum_probs=128.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|++.+.||+|+||.||+|.+.  +..||+|.+...  ...+.+.+|+.++..++||||+++++++.       +..++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l   76 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL   76 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence            46888999999999999999984  678999998633  34477899999999999999999999863       12589


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc-eEEccCccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV-AHVGDFGLS  204 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~-vki~dfG~a  204 (234)
                      ||||+++++|.+++......   ..+++..++.++.|++.||.|||+....+++||||||+||+++.++. +||+|||++
T Consensus        77 v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPL---PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSE---ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             EEEcCCCCCHHHHHhccCCC---CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence            99999999999999765421   14678888999999999999999921128999999999999987776 799999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ........           ...||+.|+||
T Consensus       154 ~~~~~~~~-----------~~~gt~~y~aP  172 (307)
T 2eva_A          154 CDIQTHMT-----------NNKGSAAWMAP  172 (307)
T ss_dssp             ----------------------CCTTSSCH
T ss_pred             cccccccc-----------cCCCCCceECh
Confidence            75443211           14589999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=2.5e-30  Score=228.01  Aligned_cols=157  Identities=15%  Similarity=0.052  Sum_probs=119.1

Q ss_pred             eeecccceEEEEEEECCCCeEEEEEEeeccc----------chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCC
Q 039258           53 MIGQGSYGSVYKGILGEDEMVVAVKVINLKQ----------KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ..+.|+.|.+..++..-.|+.+|+|++....          +...+.+.+|+++|+++ .|+||++++++++.     ..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-----~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-----AQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-----SS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-----CC
Confidence            3556777766666666677889999996321          22346799999999999 69999999999743     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..||||||++|++|.+++...+      .+++.   .++.||+.||.|+|++   |||||||||+|||++.++.+||+||
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence            4799999999999999998765      45543   4789999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|+........        ..+.+||+.||||
T Consensus       384 GlAr~~~~~~~~--------~~t~vGTp~YmAP  408 (569)
T 4azs_A          384 GSIVTTPQDCSW--------PTNLVQSFFVFVN  408 (569)
T ss_dssp             TTEESCC---CC--------SHHHHHHHHHHHH
T ss_pred             ccCeeCCCCCcc--------ccCceechhhccH
Confidence            999876543221        1236899999997

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.96  E-value=2.3e-29  Score=223.98  Aligned_cols=163  Identities=26%  Similarity=0.464  Sum_probs=130.6

Q ss_pred             eeecccceEEEEEEEC--CCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeEee
Q 039258           53 MIGQGSYGSVYKGILG--EDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEY  129 (234)
Q Consensus        53 ~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~e~  129 (234)
                      .||+|+||.||+|.++  .++..||||+++.. .....+.+.+|+.+|..++||||+++++++..      +..++||||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~  416 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM  416 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence            7999999999999875  45678999999754 33455789999999999999999999999853      226899999


Q ss_pred             cCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCC
Q 039258          130 MENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       130 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      +++++|.+++.....     .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       417 ~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          417 AGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             CTTCBHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             CCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999976432     588899999999999999999999   999999999999999999999999999987654


Q ss_pred             CccCCCCCCCCccccccccccccCC
Q 039258          210 DHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       210 ~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ......     ......+|+.|+||
T Consensus       489 ~~~~~~-----~~~~~~~~~~y~AP  508 (613)
T 2ozo_A          489 DDSYYT-----ARSAGKWPLKWYAP  508 (613)
T ss_dssp             ------------------CCTTSCH
T ss_pred             CCceee-----eccCCCCccceeCH
Confidence            321111     01113466889998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=2.9e-29  Score=203.25  Aligned_cols=171  Identities=25%  Similarity=0.284  Sum_probs=126.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc--hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.++...+..++||||+++++++...     ..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CC
Confidence            4578899999999999999999999999999999964322  2223344555567788999999999998532     34


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++ +|.+++......  ...+++..+..++.|++.||.|||+++  +++|+||||+||+++.++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           81 VWICMELMDT-SLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             EEEEEehhcc-chHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence            6999999974 888877652111  016888999999999999999999842  89999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++..........         ...||+.|+||
T Consensus       156 ~~~~~~~~~~~~---------~~~~t~~y~aP  178 (290)
T 3fme_A          156 ISGYLVDDVAKD---------IDAGCKPYMAP  178 (290)
T ss_dssp             -----------------------CCCCCCSCH
T ss_pred             Cccccccccccc---------ccCCCccccCh
Confidence            998765432221         14589999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=1.8e-29  Score=203.68  Aligned_cols=164  Identities=35%  Similarity=0.463  Sum_probs=130.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+  ++..||+|+++..  ...+.+.+|+.++..++|||++++++++...    ....+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceE
Confidence            45788999999999999999988  4789999998643  2447789999999999999999999986432    23468


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++++|.+++.....    ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEecCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence            99999999999999976532    1378888999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ........           ...+|+.|+||
T Consensus       165 ~~~~~~~~-----------~~~~~~~y~aP  183 (278)
T 1byg_A          165 KEASSTQD-----------TGKLPVKWTAP  183 (278)
T ss_dssp             ----------------------CCTTTSCH
T ss_pred             cccccccc-----------CCCccccccCH
Confidence            75443211           13477889887

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=1.6e-29  Score=208.18  Aligned_cols=171  Identities=24%  Similarity=0.344  Sum_probs=141.0

Q ss_pred             HHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc------hhhHHHHHHHHHHHhcC--CCCceeEEEE
Q 039258           40 ELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK------GAFRSFVAECEALRNIR--HRNLTKIITI  111 (234)
Q Consensus        40 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~l~~~  111 (234)
                      +......+|++.+.||+|+||.||+|.+..+++.||||++.....      ...+.+.+|+.++..++  |+|+++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            344456789999999999999999999999999999999974321      12245678999999996  5999999999


Q ss_pred             eeecCCCCCCcceeeEeecCC-CCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee
Q 039258          112 CSSIDSKGADFKALVFEYMEN-GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL  190 (234)
Q Consensus       112 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~  190 (234)
                      +...     +..++|||++.+ ++|.+++....      .+++..+..++.|++.||.|||++   +++||||||+||++
T Consensus       117 ~~~~-----~~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  182 (320)
T 3a99_A          117 FERP-----DSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILI  182 (320)
T ss_dssp             EECS-----SEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             EecC-----CcEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEE
Confidence            8533     346899999975 89999998754      678889999999999999999999   99999999999999


Q ss_pred             C-CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          191 D-NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       191 ~-~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      + .++.+||+|||+++........          ...||+.|+||
T Consensus       183 ~~~~~~~kL~Dfg~~~~~~~~~~~----------~~~gt~~y~aP  217 (320)
T 3a99_A          183 DLNRGELKLIDFGSGALLKDTVYT----------DFDGTRVYSPP  217 (320)
T ss_dssp             ETTTTEEEECCCTTCEECCSSCBC----------CCCSCGGGSCH
T ss_pred             eCCCCCEEEeeCcccccccccccc----------CCCCCccCCCh
Confidence            8 7889999999999876543211          15699999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=7.4e-29  Score=214.73  Aligned_cols=174  Identities=26%  Similarity=0.385  Sum_probs=137.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.+..++..||||++.....  ...+..|++++..++|++.+..+..+..    .....+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence            4679999999999999999999999999999999864432  2457889999999987554444443322    234568


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee---CCCCceEEccC
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL---DNDMVAHVGDF  201 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~---~~~~~vki~df  201 (234)
                      +||||+ +++|.+++.....     .+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++.+||+||
T Consensus        80 lvme~~-g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEECC-CCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence            999999 8899999976433     688999999999999999999999   99999999999999   57889999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++............ ........||+.|+||
T Consensus       151 Gla~~~~~~~~~~~~~-~~~~~~~~gt~~Y~aP  182 (483)
T 3sv0_A          151 GLAKKYRDTSTHQHIP-YRENKNLTGTARYASV  182 (483)
T ss_dssp             TTCEECBCTTTCCBCC-CCCCCCCCSCTTTCCH
T ss_pred             CcceeccCCccccccc-cccccccCCCccccCH
Confidence            9998766543221110 0111136799999997

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=4.8e-29  Score=210.35  Aligned_cols=170  Identities=21%  Similarity=0.347  Sum_probs=138.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC--------CCCceeEEEEeeecC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR--------HRNLTKIITICSSID  116 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~l~~~~~~~~  116 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.++..++        |+||+++++++....
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            46799999999999999999999999999999999643 334467889999999885        788999999876432


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC--
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM--  194 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~--  194 (234)
                       ......++||||+ ++++.+++......    .+++..+..++.|++.||.|||+++  +|+||||||+|||++.++  
T Consensus       115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          115 -VNGTHICMVFEVL-GHHLLKWIIKSNYQ----GLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             -TTEEEEEEEECCC-CCBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred             -CCCceEEEEEecc-CccHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence             1344579999999 66777777654322    5888999999999999999999853  899999999999998765  


Q ss_pred             -----------------------------------------------ceEEccCccccccCCCccCCCCCCCCccccccc
Q 039258          195 -----------------------------------------------VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG  227 (234)
Q Consensus       195 -----------------------------------------------~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~g  227 (234)
                                                                     .+||+|||++........           ..+|
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~-----------~~~g  255 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-----------EDIQ  255 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC-----------SCCS
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc-----------cCCC
Confidence                                                           799999999987543211           1469


Q ss_pred             cccccCC
Q 039258          228 TVGYVAP  234 (234)
Q Consensus       228 t~~y~aP  234 (234)
                      |+.|+||
T Consensus       256 t~~y~aP  262 (397)
T 1wak_A          256 TRQYRSL  262 (397)
T ss_dssp             CGGGCCH
T ss_pred             CCcccCC
Confidence            9999998

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=1.4e-29  Score=211.14  Aligned_cols=172  Identities=16%  Similarity=0.245  Sum_probs=136.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCC--------CeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCcee---------
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGED--------EMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK---------  107 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------  107 (234)
                      ..+|++.+.||+|+||.||+|.+..+        +..||+|++...     +.+.+|++++..++|||+++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            46799999999999999999999874        789999998643     45778999999999999887         


Q ss_pred             ------EEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 039258          108 ------IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHG  181 (234)
Q Consensus       108 ------l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~  181 (234)
                            +++++..    .....++||||+ +++|.+++......    .+++..+..++.|++.||.|||++   +++||
T Consensus       116 ~~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~  183 (352)
T 2jii_A          116 LLAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVSPKH----VLSERSVLQVACRLLDALEFLHEN---EYVHG  183 (352)
T ss_dssp             TCSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCS
T ss_pred             ccCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhCCcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCC
Confidence                  4555432    234579999999 89999999875211    688999999999999999999999   99999


Q ss_pred             CCCCCCeeeCCCC--ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          182 DIKPSNVLLDNDM--VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       182 dlk~~nil~~~~~--~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||||+||+++.++  .+||+|||+++............ ........||+.|+||
T Consensus       184 Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aP  237 (352)
T 2jii_A          184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV-EGSRSPHEGDLEFISM  237 (352)
T ss_dssp             CCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCC-TTSSCTTCSCTTTCCH
T ss_pred             CCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccc-ccccccccCCccccCH
Confidence            9999999999888  89999999998766543221111 1111225799999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.96  E-value=7e-29  Score=205.77  Aligned_cols=168  Identities=24%  Similarity=0.376  Sum_probs=122.3

Q ss_pred             hcCCCCC-ceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQS-NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|.+. +.||+|+||.||+|.+..+++.||+|++....    ....+....+..+.|||++++++++.... .+....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceE
Confidence            4568775 46999999999999999999999999986432    11122233456679999999999886533 224456


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC---CCceEEcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGD  200 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~---~~~vki~d  200 (234)
                      ++||||+++++|.+++......    .+++..+..++.|++.||.|||++   +++||||||+||+++.   ++.+||+|
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~----~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeccCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence            8999999999999999875432    588899999999999999999999   9999999999999975   45599999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++.........          ...||+.|+||
T Consensus       175 fg~~~~~~~~~~~----------~~~~t~~y~aP  198 (336)
T 3fhr_A          175 FGFAKETTQNALQ----------TPCYTPYYVAP  198 (336)
T ss_dssp             CTTCEEC---------------------------
T ss_pred             cccceeccccccc----------cCCCCcCccCh
Confidence            9999865432211          14689999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=4.8e-29  Score=207.91  Aligned_cols=167  Identities=23%  Similarity=0.347  Sum_probs=135.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC-CCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK-GAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~-~~~  121 (234)
                      ..+|...+.||+|+||.||+|.+..+++.||||.+...  .....+.+.+|+.++..++||||+++++++...... ...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            35788899999999999999999999999999999643  233346788999999999999999999987543221 112


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||++ ++|.+++..        .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+||
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  170 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  170 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred             eEEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence            3489999996 588777642        478889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++.......           ...||+.|+||
T Consensus       171 g~~~~~~~~~~-----------~~~~t~~y~aP  192 (353)
T 3coi_A          171 GLARHADAEMT-----------GYVVTRWYRAP  192 (353)
T ss_dssp             TCTTC-------------------CCSBCCSCH
T ss_pred             ccccCCCCCcc-----------ccccCcCcCCH
Confidence            99986443211           15689999997

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.96  E-value=6.3e-29  Score=222.59  Aligned_cols=171  Identities=26%  Similarity=0.421  Sum_probs=137.7

Q ss_pred             HHhcCCCCCceeecccceEEEEEEECCC---CeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           43 KATCEFSQSNMIGQGSYGSVYKGILGED---EMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        43 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      ....+|++.+.||+|+||.||+|.+..+   +..||+|.++.. .....+.+.+|+.++..++||||+++++++..    
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----  462 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----  462 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            3345678889999999999999998643   468999998643 33345778999999999999999999998731    


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                        +..++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||
T Consensus       463 --~~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL  532 (656)
T 2j0j_A          463 --NPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL  532 (656)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred             --CceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEE
Confidence              236899999999999999976532     578889999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++..........       ....||+.|+||
T Consensus       533 ~DFG~a~~~~~~~~~~~-------~~~~~t~~y~aP  561 (656)
T 2j0j_A          533 GDFGLSRYMEDSTYYKA-------SKGKLPIKWMAP  561 (656)
T ss_dssp             CCCCCCCSCCC-----------------CCGGGCCH
T ss_pred             EecCCCeecCCCcceec-------cCCCCCcceeCH
Confidence            99999987654322111       113578899998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=1.1e-28  Score=203.60  Aligned_cols=165  Identities=22%  Similarity=0.370  Sum_probs=136.3

Q ss_pred             hcCCCCCceeecccceEEEEEEE-CCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCC------ceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGIL-GEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRN------LTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~l~~~~~~~~~  117 (234)
                      ..+|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+.+|+.++..++|++      ++++++++..   
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~---   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH---   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE---
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc---
Confidence            45799999999999999999998 567899999999643 233467888999998887654      8999998754   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-----
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-----  192 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-----  192 (234)
                        .+..++||||+ +++|.+++......    .+++..+..++.|++.||.|||++   +++||||||+||+++.     
T Consensus        89 --~~~~~lv~e~~-~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           89 --HGHICIVFELL-GLSTYDFIKENGFL----PFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             --TTEEEEEEECC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred             --CCcEEEEEcCC-CCCHHHHHHhcCCC----CCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence              33579999999 88999999775432    578889999999999999999999   9999999999999986     


Q ss_pred             --------------CCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 --------------DMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 --------------~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                                    ++.+||+|||++........           ...||+.|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----------~~~gt~~y~aP  203 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEHHS-----------TLVSTRHYRAP  203 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTSCCC-----------SSCSCGGGCCH
T ss_pred             ccCCccccccccccCCCceEeeCcccccCccccc-----------cccCCccccCh
Confidence                          66899999999986443211           15699999998

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.96  E-value=6.5e-29  Score=210.85  Aligned_cols=173  Identities=25%  Similarity=0.342  Sum_probs=123.6

Q ss_pred             CCC-CceeecccceEEEEEEEC--CCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           48 FSQ-SNMIGQGSYGSVYKGILG--EDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        48 ~~~-~~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      |.. .++||+|+||.||+|.++  .++..||+|++....  ....+.+|+.+|..++||||+++++++...   .....+
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~   96 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVW   96 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEE
Confidence            544 568999999999999976  467899999986432  235788999999999999999999988542   234579


Q ss_pred             eeEeecCCCCHHHHhhhccC---CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee----CCCCceE
Q 039258          125 LVFEYMENGSLEDWLHQTND---HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL----DNDMVAH  197 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~----~~~~~vk  197 (234)
                      +||||++ ++|.+++.....   ......+++..+..++.|++.||.|||++   +|+||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence            9999996 488888764321   11122488899999999999999999999   99999999999999    6778999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||+++..........     .....+||+.|+||
T Consensus       173 l~Dfg~a~~~~~~~~~~~-----~~~~~~gt~~y~aP  204 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLA-----DLDPVVVTFWYRAP  204 (405)
T ss_dssp             ECCTTCCC---------------------CCCTTCCH
T ss_pred             EEECCCceecCCCCcccc-----cCCCceecCcccCc
Confidence            999999987654321111     11125799999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=1.3e-28  Score=207.47  Aligned_cols=173  Identities=26%  Similarity=0.313  Sum_probs=138.1

Q ss_pred             HHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CC-----CceeEEEEe
Q 039258           39 AELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HR-----NLTKIITIC  112 (234)
Q Consensus        39 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~l~~~~  112 (234)
                      ........+|++.+.||+|+||.||+|.+..+++.||||+++.. ......+..|+.++..++ |+     +++.+.+++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            33344567899999999999999999999999999999999633 233466778888888875 55     488999887


Q ss_pred             eecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC-
Q 039258          113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD-  191 (234)
Q Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~-  191 (234)
                      ...     +..++||||++ ++|.+++......    .+++..+..++.|++.||.|+|.. ..+|+||||||+|||++ 
T Consensus       126 ~~~-----~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~  194 (382)
T 2vx3_A          126 MFR-----NHLCLVFEMLS-YNLYDLLRNTNFR----GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCN  194 (382)
T ss_dssp             EET-----TEEEEEEECCC-CBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESS
T ss_pred             ccC-----CceEEEEecCC-CCHHHHHhhcCcC----CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEec
Confidence            543     44799999996 5999999875422    578889999999999999999942 12899999999999994 


Q ss_pred             -CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          192 -NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       192 -~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                       .++.+||+|||+++.......           ...||+.|+||
T Consensus       195 ~~~~~~kL~DFG~a~~~~~~~~-----------~~~~t~~y~aP  227 (382)
T 2vx3_A          195 PKRSAIKIVDFGSSCQLGQRIY-----------QYIQSRFYRSP  227 (382)
T ss_dssp             TTSCCEEECCCTTCEETTCCCC-----------SSCSCGGGCCH
T ss_pred             CCCCcEEEEeccCceecccccc-----------cccCCccccCh
Confidence             577899999999987643211           15699999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=5.7e-29  Score=201.65  Aligned_cols=171  Identities=27%  Similarity=0.410  Sum_probs=130.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECC-CC--eEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGE-DE--MVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSK  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~  118 (234)
                      ..+|++.+.||+|+||.||+|.+.. ++  ..||+|+++..   .....+.+.+|+.++..++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            3568899999999999999998643 33  47999998643   334557889999999999999999999987532   


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                         ..++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||
T Consensus        94 ---~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl  162 (291)
T 1u46_A           94 ---PMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI  162 (291)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred             ---CceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEE
Confidence               15899999999999999976532     578889999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||++............     .....||+.|+||
T Consensus       163 ~Dfg~~~~~~~~~~~~~~-----~~~~~~~~~y~aP  193 (291)
T 1u46_A          163 GDFGLMRALPQNDDHYVM-----QEHRKVPFAWCAP  193 (291)
T ss_dssp             CCCTTCEECCC-CCEEEC----------CCGGGCCH
T ss_pred             ccccccccccccccchhh-----hccCCCCceeeCc
Confidence            999999876543221100     0013578889987

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.96  E-value=6.8e-29  Score=220.72  Aligned_cols=175  Identities=26%  Similarity=0.421  Sum_probs=141.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~~  122 (234)
                      .++|++.+.||+|+||.||+|.+..++..||||++... .....+.+.+|++++..++||||+++++++..... ...+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36799999999999999999999999999999998643 33445778999999999999999999998754221 22456


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCc---eEEc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMV---AHVG  199 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~---vki~  199 (234)
                      .++||||+++++|.+++......   ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.   +||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence            78999999999999999865421   1466778899999999999999999   9999999999999986654   9999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||++..........         ...||+.|+||
T Consensus       167 DFG~a~~~~~~~~~~---------~~~gt~~Y~AP  192 (676)
T 3qa8_A          167 DLGYAKELDQGELCT---------EFVGTLQYLAP  192 (676)
T ss_dssp             SCCCCCBTTSCCCCC---------CCCSCCTTCSS
T ss_pred             ccccccccccccccc---------cccCCcccCCh
Confidence            999998765432211         25699999998

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.96  E-value=5.8e-29  Score=204.00  Aligned_cols=176  Identities=22%  Similarity=0.400  Sum_probs=136.0

Q ss_pred             cChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcC--CCCceeEEEE
Q 039258           36 VSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIR--HRNLTKIITI  111 (234)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~l~~~  111 (234)
                      +..+.+.....+|++.+.||+|+||.||+|.+. ++..||+|++...  .....+.+.+|+.++..++  |+||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            334444455667999999999999999999985 4788999999743  2334577899999999997  5999999998


Q ss_pred             eeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                      +..     ....++|||+ .+++|.+++....      .+++..+..++.|++.||.|||++   +++|+||||+||+++
T Consensus        97 ~~~-----~~~~~lv~e~-~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~  161 (313)
T 3cek_A           97 EIT-----DQYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV  161 (313)
T ss_dssp             EEC-----SSEEEEEECC-CSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE
T ss_pred             eec-----CCEEEEEEec-CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE
Confidence            753     3457999995 5789999998754      578889999999999999999999   999999999999996


Q ss_pred             CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          192 NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       192 ~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      . +.+||+|||++............      ....||+.|+||
T Consensus       162 ~-~~~kL~Dfg~~~~~~~~~~~~~~------~~~~gt~~y~aP  197 (313)
T 3cek_A          162 D-GMLKLIDFGIANQMQPDTTSVVK------DSQVGTVNYMPP  197 (313)
T ss_dssp             T-TEEEECCCSSSCC--------------------CCGGGCCH
T ss_pred             C-CeEEEeeccccccccCccccccc------cCCCCCCCcCCH
Confidence            4 89999999999876543321111      125699999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.95  E-value=4.2e-28  Score=200.03  Aligned_cols=172  Identities=23%  Similarity=0.286  Sum_probs=123.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHH-HHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECE-ALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|+..+.||+|+||.||+|.+..+++.||||++.... ......+..|+. ++..++||||+++++++...     +.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----Cc
Confidence            467888999999999999999999999999999997542 223345566666 66778999999999998542     34


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++ +|.+++...... ....+++..+..++.|++.|+.|||++.  +++|+||||+||+++.++.+||+|||
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             eEEEEeecCC-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence            6899999975 888877642110 0116788899999999999999999842  79999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++.........         ...||+.|+||
T Consensus       172 ~~~~~~~~~~~~---------~~~gt~~y~aP  194 (327)
T 3aln_A          172 ISGQLVDSIAKT---------RDAGCRPYMAP  194 (327)
T ss_dssp             SSCC----------------------------
T ss_pred             Cceecccccccc---------cCCCCccccCc
Confidence            998654432111         13689999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.95  E-value=2.9e-29  Score=205.99  Aligned_cols=178  Identities=23%  Similarity=0.365  Sum_probs=135.8

Q ss_pred             ChHHHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeee
Q 039258           37 SYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSS  114 (234)
Q Consensus        37 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~  114 (234)
                      ...+......+|++.+.||+|+||.||+|.+..   .+|+|+++..  .....+.+.+|+.++..++||||+++++++..
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            344445556789999999999999999999864   3899998643  22334567789999999999999999999854


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                      .     ...++||||+++++|.+++.....     .+++..+..++.|++.||.|||++   +++|+||||+||+++ ++
T Consensus       101 ~-----~~~~iv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~  166 (319)
T 2y4i_B          101 P-----PHLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NG  166 (319)
T ss_dssp             S-----SCEEEECBCCCSEEHHHHTTSSCC-----CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---
T ss_pred             C-----CceEEEeecccCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CC
Confidence            3     347899999999999999976532     577788999999999999999999   999999999999998 67


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||++...........   ........||+.|+||
T Consensus       167 ~~~l~Dfg~~~~~~~~~~~~~---~~~~~~~~g~~~y~aP  203 (319)
T 2y4i_B          167 KVVITDFGLFSISGVLQAGRR---EDKLRIQNGWLCHLAP  203 (319)
T ss_dssp             CCEECCCSCCC-------------CCSCBCCSGGGGTSCH
T ss_pred             CEEEeecCCcccccccccccc---ccccccCCCcccccCh
Confidence            999999999876543221111   0111124589999998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.95  E-value=5.8e-28  Score=200.69  Aligned_cols=166  Identities=22%  Similarity=0.355  Sum_probs=134.8

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCC-eEEEEEEeecccchhhHHHHHHHHHHHhcCCCC------ceeEEEEeeecC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDE-MVVAVKVINLKQKGAFRSFVAECEALRNIRHRN------LTKIITICSSID  116 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~l~~~~~~~~  116 (234)
                      ...+|++.+.||+|+||.||+|.+..++ ..||+|+++.. ....+.+.+|+.++..++|++      ++.+.+++..  
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--   93 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--   93 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--
Confidence            3568999999999999999999998766 79999999643 233467788999999887655      8888887643  


Q ss_pred             CCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee------
Q 039258          117 SKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL------  190 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~------  190 (234)
                         .+..++||||+ ++++.+++......    .+++..+..++.|++.||.|||++   +|+||||||+||++      
T Consensus        94 ---~~~~~lv~e~~-~~~l~~~l~~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~  162 (355)
T 2eu9_A           94 ---HGHMCIAFELL-GKNTFEFLKENNFQ----PYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFE  162 (355)
T ss_dssp             ---TTEEEEEEECC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEE
T ss_pred             ---CCeEEEEEecc-CCChHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccc
Confidence               33479999999 66888887665322    578899999999999999999999   99999999999999      


Q ss_pred             -------------CCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          191 -------------DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       191 -------------~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                                   +.++.+||+|||+++.......           ...||+.|+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----------~~~gt~~y~aP  208 (355)
T 2eu9_A          163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT-----------TIVATRHYRPP  208 (355)
T ss_dssp             EEECCC-CCCEEEESCCCEEECCCTTCEETTSCCC-----------SSCSCGGGCCH
T ss_pred             ccccccccccccccCCCcEEEeecCcccccccccc-----------CCcCCCcccCC
Confidence                         4578899999999986433211           15699999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=4.5e-28  Score=203.02  Aligned_cols=170  Identities=20%  Similarity=0.339  Sum_probs=138.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-----------CCCceeEEEEee
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-----------HRNLTKIITICS  113 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~l~~~~~  113 (234)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.++..++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            45799999999999999999999999999999999633 233466788999998876           789999999876


Q ss_pred             ecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC--
Q 039258          114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD--  191 (234)
Q Consensus       114 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~--  191 (234)
                      .... +....++|||++ +++|.+++......    .+++..+..++.|++.||.|||+++  +|+||||||+||+++  
T Consensus        97 ~~~~-~~~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           97 HKGP-NGVHVVMVFEVL-GENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEET-TEEEEEEEECCC-CEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred             ccCC-CCceEEEEEecC-CCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence            5431 233578999999 88999999875422    5788899999999999999999842  899999999999994  


Q ss_pred             ----CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          192 ----NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       192 ----~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                          ..+.+||+|||++........           ...||+.|+||
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~t~~y~aP  204 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHYT-----------NSIQTREYRSP  204 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCCC-----------SCCSCGGGCCH
T ss_pred             CCCcCcceEEEcccccccccCCCCC-----------CCCCCccccCc
Confidence                445899999999987543211           14689999998

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.95  E-value=1.5e-27  Score=193.63  Aligned_cols=145  Identities=12%  Similarity=0.118  Sum_probs=125.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+..+..++||||+++++++...     +
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----A  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----C
Confidence            357999999999999999999999999999999997442   23347789999999999999999999998543     3


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++...        ....++..++.|++.||.|||++   +|+||||||+||+++.++.+||+++
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC
T ss_pred             cEEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec
Confidence            479999999999999998542        24456788999999999999999   9999999999999999999999987


Q ss_pred             cccc
Q 039258          202 GLSK  205 (234)
Q Consensus       202 G~a~  205 (234)
                      |...
T Consensus       174 ~~~~  177 (286)
T 3uqc_A          174 ATMP  177 (286)
T ss_dssp             CCCT
T ss_pred             cccC
Confidence            7543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.95  E-value=7.8e-28  Score=197.28  Aligned_cols=168  Identities=21%  Similarity=0.310  Sum_probs=120.7

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc-hh-hHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-GA-FRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      ...+|+..+.||+|+||.||+|.+..+++.||||++..... .. .+.+.++..++..++||||+++++++..     .+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~   97 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NT   97 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CC
Confidence            34578889999999999999999999999999999975432 22 2334445556788899999999999853     33


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ..++||||+ ++.+..+......     .+++..+..++.|++.||.|||+ .   +++|+||||+||+++.++.+||+|
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~d  168 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCD  168 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECC
T ss_pred             cEEEEEecc-CCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEE
Confidence            479999999 5456555544322     67888999999999999999998 5   899999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||++..........         ...||+.|+||
T Consensus       169 fg~~~~~~~~~~~~---------~~~~~~~y~aP  193 (318)
T 2dyl_A          169 FGISGRLVDDKAKD---------RSAGCAAYMAP  193 (318)
T ss_dssp             CTTC-----------------------CCTTCCH
T ss_pred             CCCchhccCCcccc---------ccCCCccccCh
Confidence            99997654432111         14689999987

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.95  E-value=2.8e-27  Score=192.87  Aligned_cols=152  Identities=21%  Similarity=0.371  Sum_probs=128.3

Q ss_pred             hcCCCCC-ceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHH-HhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQS-NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEAL-RNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|.+. +.||+|+||.||+|.+..+++.||+|+++..     ..+.+|++++ ...+||||+++++++.... .+...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCce
Confidence            3456666 7899999999999999999999999998632     4567888888 5568999999999886532 22445


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC---CCceEEc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVG  199 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~---~~~vki~  199 (234)
                      .++||||+++++|.+++......    .+++..+..++.|++.||.|||++   +++||||||+||+++.   ++.+||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEeecCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence            79999999999999999875432    578899999999999999999999   9999999999999987   7889999


Q ss_pred             cCccccccCC
Q 039258          200 DFGLSKFLSS  209 (234)
Q Consensus       200 dfG~a~~~~~  209 (234)
                      |||++.....
T Consensus       163 Dfg~a~~~~~  172 (299)
T 3m2w_A          163 DFGFAKETTG  172 (299)
T ss_dssp             CCTTCEECTT
T ss_pred             cccccccccc
Confidence            9999986543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=6.6e-28  Score=206.53  Aligned_cols=171  Identities=25%  Similarity=0.313  Sum_probs=121.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .|...+.||+|+||+||.+. ..+++.||||.+....   .+.+.+|+.++..+ +||||+++++++..     ....++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~~~l   86 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETT-----DRFLYI   86 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCeEEE
Confidence            34556889999999997654 3578899999986432   35678899999876 89999999998743     345799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccc-cCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC-----------
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFK-LSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND-----------  193 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~-----------  193 (234)
                      ||||++ ++|.+++........... .++..++.++.|++.||.|||++   +|+||||||+||+++.+           
T Consensus        87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence            999996 599999986543211111 12334567999999999999999   99999999999999653           


Q ss_pred             --CceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          194 --MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       194 --~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                        +.+||+|||+++...........    .....+||+.|+||
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~~~----~~~~~~gt~~y~aP  201 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSFRT----NLNNPSGTSGWRAP  201 (434)
T ss_dssp             CSCEEEECCCTTCEECCC------------------CCTTSCH
T ss_pred             CceEEEEcccccceecCCCCcccee----eecCCCCCCCccCH
Confidence              48999999999976553321110    01125699999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=204.27  Aligned_cols=167  Identities=25%  Similarity=0.377  Sum_probs=123.8

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|...+.||+|+||.|+.. ...+++.||||.+.....   ..+.+|+.++..+ +||||+++++++..     ....
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~~   93 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKD-----RQFQ   93 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEec-----CCEE
Confidence            446888999999999986532 334678999999864322   2346799999999 79999999998743     3447


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-----CCceEE
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-----DMVAHV  198 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-----~~~vki  198 (234)
                      ++||||++ ++|.+++.....     ...+..+..++.|++.||.|||++   +|+||||||+||+++.     ...+||
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL  164 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMI  164 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred             EEEEECCC-CCHHHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEE
Confidence            99999996 599999976542     233335578999999999999999   9999999999999943     235889


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++..........     .....+||+.|+||
T Consensus       165 ~DFG~a~~~~~~~~~~~-----~~~~~~gt~~y~AP  195 (432)
T 3p23_A          165 SDFGLCKKLAVGRHSFS-----RRSGVPGTEGWIAP  195 (432)
T ss_dssp             CCTTEEECC-----------------CCSCTTSCCG
T ss_pred             ecccceeeccCCCccee-----eccccCCCcCccCh
Confidence            99999987654321111     11125799999998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.94  E-value=9.5e-27  Score=198.14  Aligned_cols=173  Identities=16%  Similarity=0.187  Sum_probs=123.4

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCC-CCc---------eeEEEEe
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRH-RNL---------TKIITIC  112 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i---------~~l~~~~  112 (234)
                      ..|...+.||+|+||+||+|.+..+++.||||++....   ....+.+.+|+.++..++| .|.         +...+.+
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34677889999999999999999999999999987332   2235788999999999976 221         1111111


Q ss_pred             ------------eecCCCCCCcceeeEeecCCCCHHHHhhhccC-CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 039258          113 ------------SSIDSKGADFKALVFEYMENGSLEDWLHQTND-HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMV  179 (234)
Q Consensus       113 ------------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~iv  179 (234)
                                  ...........+++|+++ +++|.+++..... ......+++..++.++.|++.||.|||++   +|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                        100000122246677766 6799998853210 00111567778889999999999999999   999


Q ss_pred             ecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          180 HGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       180 H~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||||||+|||++.++.+||+|||+++.......           ..+| +.|+||
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~-----------~~~g-~~y~aP  276 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV-----------SPIG-RGFAPP  276 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEEEC-----------CCCC-TTTCCH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCccc-----------cCCC-CceeCc
Confidence            999999999999999999999999886544311           1468 999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=9e-27  Score=204.30  Aligned_cols=159  Identities=18%  Similarity=0.217  Sum_probs=113.0

Q ss_pred             CCCceeecccceEEEEEEECCCCeEEEEEEeeccc--------chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           49 SQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--------KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ...+.||+|+||.||+|..  .+..+++|......        ....+++.+|++++..++||||+.+..++..     .
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-----L  411 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----T
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----C
Confidence            4467899999999999954  55678898864321        1123568999999999999999944333322     1


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      +..++||||+++++|.+++..              +..++.|++.||.|||++   +|+||||||+|||++.  .+||+|
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECC
T ss_pred             CccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEE
Confidence            235899999999999999875              357889999999999999   9999999999999998  999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++........... .......++||+.||||
T Consensus       473 FGla~~~~~~~~~~~~-~~~~~~~~~GT~~y~AP  505 (540)
T 3en9_A          473 FGLGKISNLDEDKAVD-LIVFKKAVLSTHHEKFD  505 (540)
T ss_dssp             CTTCEECCCHHHHHHH-HHHHHHHHHHHCGGGHH
T ss_pred             CccCEECCCccccccc-hhhhhhhhcCCCCcCCH
Confidence            9999976543211000 00001136899999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.1e-25  Score=180.66  Aligned_cols=141  Identities=18%  Similarity=0.213  Sum_probs=111.1

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc------------------hhhHHHHHHHHHHHhcCCC
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK------------------GAFRSFVAECEALRNIRHR  103 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~  103 (234)
                      ......|.+.+.||+|+||.||+|.+ .++..||+|+++....                  .....+.+|+.++..++| 
T Consensus        86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-  163 (282)
T 1zar_A           86 VRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-  163 (282)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred             HhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence            34445667779999999999999999 8899999999963221                  124568899999999984 


Q ss_pred             CceeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 039258          104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDI  183 (234)
Q Consensus       104 ~i~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dl  183 (234)
                        +.+.+++..      +..++||||+++++|.+ +...            ....++.|++.||.|+|++   +++||||
T Consensus       164 --~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~~------------~~~~i~~qi~~~l~~lH~~---giiHrDl  219 (282)
T 1zar_A          164 --LAVPKVYAW------EGNAVLMELIDAKELYR-VRVE------------NPDEVLDMILEEVAKFYHR---GIVHGDL  219 (282)
T ss_dssp             --SSSCCEEEE------ETTEEEEECCCCEEGGG-CCCS------------CHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             --CCcCeEEec------cceEEEEEecCCCcHHH-cchh------------hHHHHHHHHHHHHHHHHHC---CCEeCCC
Confidence              444444321      22589999999999988 4211            1246899999999999999   9999999


Q ss_pred             CCCCeeeCCCCceEEccCccccccCC
Q 039258          184 KPSNVLLDNDMVAHVGDFGLSKFLSS  209 (234)
Q Consensus       184 k~~nil~~~~~~vki~dfG~a~~~~~  209 (234)
                      ||+|||++ ++.+||+|||+|+....
T Consensus       220 kp~NILl~-~~~vkl~DFG~a~~~~~  244 (282)
T 1zar_A          220 SQYNVLVS-EEGIWIIDFPQSVEVGE  244 (282)
T ss_dssp             STTSEEEE-TTEEEECCCTTCEETTS
T ss_pred             CHHHEEEE-CCcEEEEECCCCeECCC
Confidence            99999999 99999999999986543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=1e-22  Score=162.78  Aligned_cols=139  Identities=19%  Similarity=0.201  Sum_probs=105.9

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeE--EEEEEeecccch------------------------hhHHHHHHHHHHHhc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMV--VAVKVINLKQKG------------------------AFRSFVAECEALRNI  100 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  100 (234)
                      -|.+.+.||+|+||.||+|.+..+|..  ||||+++.....                        ....+.+|+..|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            357788999999999999998777888  999997532110                        013578899999999


Q ss_pred             CCCCc--eeEEEEeeecCCCCCCcceeeEeecCC-C----CHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHH-h
Q 039258          101 RHRNL--TKIITICSSIDSKGADFKALVFEYMEN-G----SLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH-H  172 (234)
Q Consensus       101 ~h~~i--~~l~~~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~  172 (234)
                      .|+++  +.++..         ...++||||+.+ |    +|.++...         .++..+..++.|++.++.|+| +
T Consensus       128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~  189 (258)
T 1zth_A          128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQE  189 (258)
T ss_dssp             HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred             HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHH
Confidence            87754  344432         124899999942 3    66665432         112345788999999999999 8


Q ss_pred             CCCCCeeecCCCCCCeeeCCCCceEEccCccccccC
Q 039258          173 NCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       173 ~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~  208 (234)
                      .   +++||||||+|||++.  .++|+|||+|....
T Consensus       190 ~---givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          190 A---ELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             S---CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             C---CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            8   9999999999999988  89999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=2.9e-18  Score=143.36  Aligned_cols=141  Identities=13%  Similarity=0.152  Sum_probs=100.2

Q ss_pred             HHHHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc--------------hhhH--------HHHHHHHHH
Q 039258           40 ELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK--------------GAFR--------SFVAECEAL   97 (234)
Q Consensus        40 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l   97 (234)
                      .+.....-|.+...||+|+||.||+|.+. +|+.||||+++....              ....        ...+|...|
T Consensus        89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           89 THAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            44444456899999999999999999984 688999999752100              0000        123567777


Q ss_pred             HhcCCCCc--eeEEEEeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 039258           98 RNIRHRNL--TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQ  175 (234)
Q Consensus        98 ~~l~h~~i--~~l~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~  175 (234)
                      .++.++++  ...++..         ..+|||||+++.+|.++...            .....++.|++.+|.++|.+  
T Consensus       168 ~rL~~~gv~vp~p~~~~---------~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~--  224 (397)
T 4gyi_A          168 KALYEEGFPVPEPIAQS---------RHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKH--  224 (397)
T ss_dssp             HHHHHTTCSCCCEEEEE---------TTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHhcCCCCCeeeecc---------CceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHC--
Confidence            77754443  2333321         13799999998877654321            12346788999999999999  


Q ss_pred             CCeeecCCCCCCeeeCCCC----------ceEEccCcccc
Q 039258          176 PPMVHGDIKPSNVLLDNDM----------VAHVGDFGLSK  205 (234)
Q Consensus       176 ~~ivH~dlk~~nil~~~~~----------~vki~dfG~a~  205 (234)
                       ++|||||||.|||++.++          .+.|+||+=+-
T Consensus       225 -gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          225 -GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             -TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred             -CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence             999999999999997665          38899999554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=1.2e-12  Score=104.14  Aligned_cols=145  Identities=16%  Similarity=0.133  Sum_probs=106.0

Q ss_pred             HhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCc
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ....|+....++.|+.+.||++...  +..+++|+...........+.+|+.++..+. +..+.++++++..     .+.
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~   84 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGW   84 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCc
Confidence            3456877778888888999998753  5789999986432223346788999999884 6677788887643     234


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC----------------------------  174 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~----------------------------  174 (234)
                      .++|||+++|.+|.+.+...           .....++.+++.++..||+..                            
T Consensus        85 ~~lv~e~i~G~~l~~~~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYEDE-----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             EEEEEECCSSEEHHHHCCTT-----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             eEEEEEecCCeehhhccCCc-----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence            68999999998887763211           112356778888999999810                            


Q ss_pred             ----------------------------CCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          175 ----------------------------QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       175 ----------------------------~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                                                  +..++|+|+++.||+++..+.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                        02589999999999998765567999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=2.7e-11  Score=95.76  Aligned_cols=138  Identities=17%  Similarity=0.137  Sum_probs=90.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCC--ceeEEEEeeecCCCCCCcce
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRN--LTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+......+.|..+.||++.. .++..+++|+....   ....+.+|+.++..+.+.+  +.+++.+...     .+..+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~   91 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDW   91 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCE
Confidence            344333333556689999865 45667999997533   2245678999998885434  4567776532     23368


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC------------------------------  174 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~------------------------------  174 (234)
                      +|||+++|.++.  ...         ..   ...++.+++..+..+|+..                              
T Consensus        92 ~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD  157 (264)
T ss_dssp             EEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred             EEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence            999999987773  111         11   1134455666666666531                              


Q ss_pred             -------------------------CCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          175 -------------------------QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       175 -------------------------~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                                               +..++|+|++|.||+++.++.+.++|||.+...
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                     112999999999999987666679999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.15  E-value=2.6e-10  Score=94.74  Aligned_cols=145  Identities=15%  Similarity=0.194  Sum_probs=100.5

Q ss_pred             CCceeecccceEEEEEEECCCCeEEEEEEee--cccc-hhhHHHHHHHHHHHhcC--CCCceeEEEEeeecCCCCCCcce
Q 039258           50 QSNMIGQGSYGSVYKGILGEDEMVVAVKVIN--LKQK-GAFRSFVAECEALRNIR--HRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        50 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~e~~~l~~l~--h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+.++.|.++.||+....  +..+++|...  .... .....+.+|..++..+.  +..+++++.++....  ..+..+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence            3567899999999998764  3578888775  3221 12346778999999887  445778888764321  123458


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC------------------------------  174 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~------------------------------  174 (234)
                      +|||+++|..+.+....        .++......++.+++..|..+|+..                              
T Consensus       118 ~vme~v~G~~l~~~~~~--------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQSLP--------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             EEEECCCCBCCCCTTCT--------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCeecCCCccc--------cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            99999998766431110        3456667778889999999999720                              


Q ss_pred             -------------------------CCCeeecCCCCCCeeeCCCCc--eEEccCccccc
Q 039258          175 -------------------------QPPMVHGDIKPSNVLLDNDMV--AHVGDFGLSKF  206 (234)
Q Consensus       175 -------------------------~~~ivH~dlk~~nil~~~~~~--vki~dfG~a~~  206 (234)
                                               ...++|+|+++.||+++.++.  +.++||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     236999999999999987653  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.86  E-value=1.7e-08  Score=81.85  Aligned_cols=140  Identities=18%  Similarity=0.231  Sum_probs=91.1

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCC--ceeEEEEeeecCCCCCCcceeeE
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRN--LTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      .+.++.|.+..||+..     ..+++|+....  .....+.+|+++|..+ .+..  +.+.+.....  .......|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence            4568999999999863     34888886422  3346788999999887 3333  3445444321  11123457899


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN----------------------------------  173 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~----------------------------------  173 (234)
                      ++++|.++......        .++..+...++.+++..+..+|+.                                  
T Consensus        96 ~~i~G~~l~~~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             ECCCCEECCHHHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cccCCeECCccccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            99998776543221        234444455555666666555541                                  


Q ss_pred             ---------------------CCCCeeecCCCCCCeeeCC--CCceEEccCcccccc
Q 039258          174 ---------------------CQPPMVHGDIKPSNVLLDN--DMVAHVGDFGLSKFL  207 (234)
Q Consensus       174 ---------------------~~~~ivH~dlk~~nil~~~--~~~vki~dfG~a~~~  207 (234)
                                           ....++|+|+++.||+++.  ...+.++||+.+..-
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                                 1235799999999999987  456789999988754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=7.4e-07  Score=72.34  Aligned_cols=76  Identities=9%  Similarity=0.043  Sum_probs=51.8

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCC---CceeEEEEeeecCCCCCCcceeeE
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHR---NLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      ...++.|....||+.     +..+++|+..  .......+.+|..+|..+.+.   .+.+.+.+...    ..+..++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEE
Confidence            456788888899987     3457888853  223346788999999998642   34566665431    123357999


Q ss_pred             eecCCCCHHH
Q 039258          128 EYMENGSLED  137 (234)
Q Consensus       128 e~~~~~~L~~  137 (234)
                      |+++|.++.+
T Consensus        93 e~i~G~~l~~  102 (306)
T 3tdw_A           93 RKVQGQILGE  102 (306)
T ss_dssp             ECCCSEECHH
T ss_pred             eccCCeECch
Confidence            9999877654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.59  E-value=1.1e-06  Score=69.79  Aligned_cols=137  Identities=18%  Similarity=0.123  Sum_probs=86.7

Q ss_pred             eeecccce-EEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           53 MIGQGSYG-SVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        53 ~lG~G~fg-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      .+..|..| .||+......+..+.+|+-...   ....+.+|...|+.+. +--+.+++.++...     +..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEee
Confidence            34556555 5898877667778899986532   2356778999888774 33356777776432     3358999999


Q ss_pred             CCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 039258          131 ENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH--------------------------------------  172 (234)
Q Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~--------------------------------------  172 (234)
                      +|.++.+.......          ....+..++...+.-||.                                      
T Consensus       103 ~G~~~~~~~~~~~~----------~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A          103 PGKTAFQVLEEYPD----------SGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             CSEEHHHHHHHCGG----------GHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             CCccccccccCCHH----------HHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            98776654322110          011222233333333332                                      


Q ss_pred             -------------CC----CCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          173 -------------NC----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       173 -------------~~----~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                                   ..    ...++|+|+.+.|++++..+.+-|+||+.+..-
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                         10    112789999999999987766779999988753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.30  E-value=4.7e-06  Score=69.91  Aligned_cols=76  Identities=16%  Similarity=0.110  Sum_probs=48.1

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccc-------hhhHHHHHHHHHHHhcCC--C-CceeEEEEeeecCCCCC
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-------GAFRSFVAECEALRNIRH--R-NLTKIITICSSIDSKGA  120 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-~i~~l~~~~~~~~~~~~  120 (234)
                      .+.+|.|.++.||++....++..+++|.......       ....++..|.+++..+..  + .+.+++.+.  .     
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~-----  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T-----  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C-----
Confidence            4578999999999997665667899998643211       123566789998887742  3 344555432  1     


Q ss_pred             CcceeeEeecCCC
Q 039258          121 DFKALVFEYMENG  133 (234)
Q Consensus       121 ~~~~lv~e~~~~~  133 (234)
                      ...++|||++++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            1247999999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.18  E-value=7.4e-06  Score=67.62  Aligned_cols=83  Identities=10%  Similarity=0.019  Sum_probs=51.3

Q ss_pred             cee-ecccceEEEEEEEC---C---CCeEEEEEEeeccc---chhhHHHHHHHHHHHhcC-C--CCceeEEEEeeecCCC
Q 039258           52 NMI-GQGSYGSVYKGILG---E---DEMVVAVKVINLKQ---KGAFRSFVAECEALRNIR-H--RNLTKIITICSSIDSK  118 (234)
Q Consensus        52 ~~l-G~G~fg~V~~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~l~~~~~~~~~~  118 (234)
                      +.| +.|....+|+....   .   ++..+++|+.....   ......+.+|+.++..+. +  ..+.+++.++....  
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~--  103 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD--  103 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST--
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC--
Confidence            456 77888899987653   1   15678899865322   101245678888888774 2  34667777653221  


Q ss_pred             CCCcceeeEeecCCCCHH
Q 039258          119 GADFKALVFEYMENGSLE  136 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~  136 (234)
                      ..+..++|||+++|..+.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence            113347999999875543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.86  E-value=4.4e-05  Score=62.25  Aligned_cols=31  Identities=29%  Similarity=0.413  Sum_probs=27.8

Q ss_pred             CCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          176 PPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       176 ~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      ..++|+|+.+.|++++.++.+.++||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            4899999999999998778899999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.71  E-value=0.00064  Score=54.23  Aligned_cols=77  Identities=16%  Similarity=0.160  Sum_probs=53.8

Q ss_pred             CCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCC---CCceeEEEEeeecCCCCCCcce
Q 039258           48 FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH---RNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        48 ~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ......+|.|..+.||+... .+|+.+.+|+...........+..|+..|+.+.-   --+.+.+.+.    .     -+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~-----~~   86 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D-----RT   86 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T-----TE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----C-----ce
Confidence            44467789999999999986 4567899998764443344567889999988742   2345555542    1     27


Q ss_pred             eeEeecCCCC
Q 039258          125 LVFEYMENGS  134 (234)
Q Consensus       125 lv~e~~~~~~  134 (234)
                      +|||++++..
T Consensus        87 lv~e~l~~~~   96 (288)
T 3f7w_A           87 LAMEWVDERP   96 (288)
T ss_dssp             EEEECCCCCC
T ss_pred             EEEEeecccC
Confidence            8999987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.55  E-value=0.00078  Score=56.83  Aligned_cols=31  Identities=26%  Similarity=0.458  Sum_probs=27.0

Q ss_pred             CCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          176 PPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       176 ~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ..++|+|+.+.||+++.++ +.++||+.+..-
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            3799999999999998766 999999988753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.41  E-value=0.0012  Score=52.93  Aligned_cols=69  Identities=10%  Similarity=0.088  Sum_probs=40.9

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCc-eeEEEEeeecCCCCCCcceeeEee
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-TKIITICSSIDSKGADFKALVFEY  129 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~l~~~~~~~~~~~~~~~~lv~e~  129 (234)
                      .+.|+.|....+|++      ..+++|+........ -...+|+.++..+...++ .+++....  +     .-++++||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~--~-----~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP--A-----TGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT--T-----TCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC--C-----CCEEEEee
Confidence            677888999999998      347888875332211 122457777776642222 45665421  1     12689999


Q ss_pred             c-CCC
Q 039258          130 M-ENG  133 (234)
Q Consensus       130 ~-~~~  133 (234)
                      + ++.
T Consensus        89 i~~g~   93 (301)
T 3dxq_A           89 IAGAQ   93 (301)
T ss_dssp             CTTCE
T ss_pred             cCCCc
Confidence            9 553

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.39  E-value=0.0028  Score=51.33  Aligned_cols=75  Identities=17%  Similarity=0.144  Sum_probs=53.7

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC---CCCceeEEEEeeecCCCCCCcceeeE
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR---HRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      .+.|+.|.+..+|+...  ++..+++|+....   ....+..|...|..+.   ...+++.+.+...     .+..++||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvm  110 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLL  110 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEE
Confidence            45788999999999875  4567889987532   2466788988888774   2456777776532     23468999


Q ss_pred             eecCCCCH
Q 039258          128 EYMENGSL  135 (234)
Q Consensus       128 e~~~~~~L  135 (234)
                      |++++..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99987643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.14  E-value=0.0055  Score=52.34  Aligned_cols=73  Identities=14%  Similarity=0.103  Sum_probs=45.4

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCc-eeEEEEeeecCCCCCCcceeeEee
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNL-TKIITICSSIDSKGADFKALVFEY  129 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~l~~~~~~~~~~~~~~~~lv~e~  129 (234)
                      .+.|+.|-...+|++.....+..+++|+......... ....|..++..+...++ .++++.+.    .     .+||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~----~-----G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT----N-----GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET----T-----EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC----C-----eEEEEe
Confidence            3467778888999998755457888998743222111 12478888888864444 56676641    1     359999


Q ss_pred             cCCC
Q 039258          130 MENG  133 (234)
Q Consensus       130 ~~~~  133 (234)
                      ++|.
T Consensus       183 I~G~  186 (458)
T 2qg7_A          183 MDGY  186 (458)
T ss_dssp             CCSE
T ss_pred             eCCc
Confidence            9863

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.98  E-value=0.014  Score=46.91  Aligned_cols=167  Identities=13%  Similarity=0.106  Sum_probs=80.8

Q ss_pred             cChHHHHHHhcCCCC-----CceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCC--ceeE
Q 039258           36 VSYAELSKATCEFSQ-----SNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRN--LTKI  108 (234)
Q Consensus        36 ~~~~~~~~~~~~~~~-----~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~l  108 (234)
                      ++.+++......|..     .+.|+.|....+|+..... + .+++|+....  .....+..|..++..+...+  +.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            444555555555544     2345667778899987532 3 5789988642  11234556777776663212  2333


Q ss_pred             EEEeeecC-CCCCCcceeeEeecCCCCHH-----------HHh---hhcc-CCcccc--ccC---HHHHHH---------
Q 039258          109 ITICSSID-SKGADFKALVFEYMENGSLE-----------DWL---HQTN-DHLEVF--KLS---LIQRVN---------  158 (234)
Q Consensus       109 ~~~~~~~~-~~~~~~~~lv~e~~~~~~L~-----------~~l---~~~~-~~~~~~--~~~---~~~~~~---------  158 (234)
                      +....... ....+..+++|++++|..+.           ..+   .... ....+.  ...   +.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            32100000 00012357899999875421           111   1110 000000  000   110000         


Q ss_pred             ---HHHHHHHHHHHHHhC----CCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          159 ---IAIDVASAIEYLHHN----CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       159 ---~~~qi~~~l~~lh~~----~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                         +...+...+..+...    .+..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               001133344444421    234799999999999998765567999987764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.88  E-value=0.0041  Score=51.83  Aligned_cols=145  Identities=13%  Similarity=0.130  Sum_probs=77.7

Q ss_pred             ceeecccceEEEEEEECC-------CCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcc
Q 039258           52 NMIGQGSYGSVYKGILGE-------DEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      +.+..|....+|++....       .+..+.+|+..... .......+|..++..+. +.-..++++.+.    .     
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~----~-----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFP----E-----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET----T-----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcC----C-----
Confidence            456668888899988642       34678899863221 22355668998888774 322356666542    1     


Q ss_pred             eeeEeecCCCCHH--------------HHhhh-ccC-Ccccccc--CHHHHHHHHHHHH-------------------HH
Q 039258          124 ALVFEYMENGSLE--------------DWLHQ-TND-HLEVFKL--SLIQRVNIAIDVA-------------------SA  166 (234)
Q Consensus       124 ~lv~e~~~~~~L~--------------~~l~~-~~~-~~~~~~~--~~~~~~~~~~qi~-------------------~~  166 (234)
                      .+||||++|..+.              +.+.. +.- .......  .+.++..+..++.                   ..
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            2899999864332              11111 110 0000011  1223333333221                   11


Q ss_pred             HHH----HHhC-CCCCeeecCCCCCCeeeCCC----CceEEccCccccc
Q 039258          167 IEY----LHHN-CQPPMVHGDIKPSNVLLDND----MVAHVGDFGLSKF  206 (234)
Q Consensus       167 l~~----lh~~-~~~~ivH~dlk~~nil~~~~----~~vki~dfG~a~~  206 (234)
                      +..    +... .+..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            222    2221 23358999999999999765    6899999998874

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.87  E-value=0.0064  Score=51.46  Aligned_cols=71  Identities=21%  Similarity=0.179  Sum_probs=46.0

Q ss_pred             CceeecccceEEEEEEECC-------CCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCC-ceeEEEEeeecCCCCCCc
Q 039258           51 SNMIGQGSYGSVYKGILGE-------DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRN-LTKIITICSSIDSKGADF  122 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~l~~~~~~~~~~~~~~  122 (234)
                      .+.|+.|....+|++....       .+..+++|+....  .....+..|..++..+...+ ..++++.+.    .    
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~----~----  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS----G----  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----T----
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC----C----
Confidence            3467778889999998643       2467889987421  11145567888888774223 356666541    1    


Q ss_pred             ceeeEeecCC
Q 039258          123 KALVFEYMEN  132 (234)
Q Consensus       123 ~~lv~e~~~~  132 (234)
                       .+|+||++|
T Consensus       148 -g~v~e~l~G  156 (429)
T 1nw1_A          148 -GRLEEYIPS  156 (429)
T ss_dssp             -EEEECCCCE
T ss_pred             -CEEEEEeCC
Confidence             378999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.79  E-value=0.038  Score=44.69  Aligned_cols=32  Identities=28%  Similarity=0.239  Sum_probs=27.4

Q ss_pred             CCeeecCCCCCCeeeCCC----CceEEccCcccccc
Q 039258          176 PPMVHGDIKPSNVLLDND----MVAHVGDFGLSKFL  207 (234)
Q Consensus       176 ~~ivH~dlk~~nil~~~~----~~vki~dfG~a~~~  207 (234)
                      ..++|+|+.+.||+++.+    +.+.++||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            479999999999999864    67899999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=91.30  E-value=0.09  Score=42.25  Aligned_cols=78  Identities=13%  Similarity=0.079  Sum_probs=43.4

Q ss_pred             ceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCC--CceeEEEEeeecC-CCCCCcceeeEe
Q 039258           52 NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHR--NLTKIITICSSID-SKGADFKALVFE  128 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~l~~~~~~~~-~~~~~~~~lv~e  128 (234)
                      ..++ |....||+... .+|..+++|+..... .....+..|..++..+...  .+++++.. .... ....+..+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEE
Confidence            4566 77788998754 345568999986321 1234566788777776421  23333322 0000 001233478999


Q ss_pred             ecCCC
Q 039258          129 YMENG  133 (234)
Q Consensus       129 ~~~~~  133 (234)
                      +++|.
T Consensus       108 ~i~G~  112 (328)
T 1zyl_A          108 SVGGR  112 (328)
T ss_dssp             CCCCE
T ss_pred             ecCCC
Confidence            99764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=90.61  E-value=0.018  Score=49.20  Aligned_cols=62  Identities=15%  Similarity=0.116  Sum_probs=17.4

Q ss_pred             CCCceeecccceEEEEEEECCCCeEEEE------EEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEee
Q 039258           49 SQSNMIGQGSYGSVYKGILGEDEMVVAV------KVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICS  113 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~  113 (234)
                      ...+.||   ||.||+|....+..+||+      |..+..  .+.....+.+|..++...+|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3345666   999999998765567888      655422  2233456788999999999999998877654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=90.49  E-value=0.098  Score=42.57  Aligned_cols=32  Identities=25%  Similarity=0.334  Sum_probs=27.8

Q ss_pred             CCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          176 PPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       176 ~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ..++|+|+.+.|++++.++.+.++||+.+..-
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            36899999999999988788999999877653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=90.14  E-value=0.15  Score=41.82  Aligned_cols=73  Identities=11%  Similarity=0.150  Sum_probs=41.4

Q ss_pred             CceeecccceEEEEEEECC--------CCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCC-ceeEEEEeeecCCCCCC
Q 039258           51 SNMIGQGSYGSVYKGILGE--------DEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRN-LTKIITICSSIDSKGAD  121 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~l~~~~~~~~~~~~~  121 (234)
                      ...++.|....+|++....        .+..+++|+....... ......|..++..+...+ ..++++..    .    
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~----  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----N----  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----T----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----C----
Confidence            3456778888999987643        1257888887533221 112356777777774223 44666543    1    


Q ss_pred             cceeeEeecCCC
Q 039258          122 FKALVFEYMENG  133 (234)
Q Consensus       122 ~~~lv~e~~~~~  133 (234)
                       -++||||++|.
T Consensus       109 -~~~v~e~i~G~  119 (369)
T 3c5i_A          109 -GGRIEEWLYGD  119 (369)
T ss_dssp             -TEEEEECCCSE
T ss_pred             -CcEEEEEecCC
Confidence             26899999864

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.49  E-value=2  Score=32.59  Aligned_cols=56  Identities=20%  Similarity=0.298  Sum_probs=44.2

Q ss_pred             ccCHHHHHHHHHHHHHHHH-HHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccccCCC
Q 039258          150 KLSLIQRVNIAIDVASAIE-YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD  210 (234)
Q Consensus       150 ~~~~~~~~~~~~qi~~~l~-~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~  210 (234)
                      .++....+.++.+++.... +++     .-+|--+.|+|++++.++.+++.-.|+-..+.+.
T Consensus        81 ~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~lpP~  137 (219)
T 4ano_A           81 KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKESLPPD  137 (219)
T ss_dssp             TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTTBSSC
T ss_pred             hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCcccCCCC
Confidence            4667788888888877666 554     4467789999999999999999999986665443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=83.85  E-value=0.59  Score=38.88  Aligned_cols=29  Identities=28%  Similarity=0.463  Sum_probs=24.5

Q ss_pred             eeecCCCCCCeee------CCCCceEEccCccccc
Q 039258          178 MVHGDIKPSNVLL------DNDMVAHVGDFGLSKF  206 (234)
Q Consensus       178 ivH~dlk~~nil~------~~~~~vki~dfG~a~~  206 (234)
                      ++|+|+.+.||++      +.++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      3456799999998875

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=80.55  E-value=0.77  Score=38.65  Aligned_cols=74  Identities=9%  Similarity=0.089  Sum_probs=45.0

Q ss_pred             CceeecccceEEEEEEECCC-------CeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCc
Q 039258           51 SNMIGQGSYGSVYKGILGED-------EMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+.+..|-...+|++.....       +..+++++........ -...+|..++..+. +.-..++++.+    .     
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~----~-----  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF----P-----  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE----T-----
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc----C-----
Confidence            34566677888999887521       4678899864332211 12346777777774 22235566543    1     


Q ss_pred             ceeeEeecCCCC
Q 039258          123 KALVFEYMENGS  134 (234)
Q Consensus       123 ~~lv~e~~~~~~  134 (234)
                      -+.||||++|..
T Consensus       145 ~~~I~efI~G~~  156 (424)
T 3mes_A          145 EGRIEEFIDGEP  156 (424)
T ss_dssp             TEEEEECCCSEE
T ss_pred             CCEEEEEeCCcc
Confidence            268999998754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	234
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-43
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-41
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-40
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-40
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-39
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-37
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-37
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-35
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-35
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-34
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-33
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-33
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-32
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-31
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-30
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-30
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-29
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-27
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-24
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-22
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 3e-46
 Identities = 53/190 (27%), Positives = 88/190 (46%), Gaps = 25/190 (13%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRN 104
           + +    IG GS+G+VYKG    D   VAVK++N+        ++F  E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           +   +   ++         A+V ++ E  SL   LH         K  +I+ ++IA   A
Sbjct: 66  ILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTA 114

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
             ++YLH      ++H D+K +N+ L  D+   +GDFGL+   S        E       
Sbjct: 115 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ------ 165

Query: 225 IKGTVGYVAP 234
           + G++ ++AP
Sbjct: 166 LSGSILWMAP 175

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  147 bits (373), Expect = 4e-44
 Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 29/211 (13%)

Query: 37  SYAELSKATCEFSQS---------NMIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQ- 83
           ++ + ++A  EF++           +IG G +G V  G L   G+ E+ VA+K +     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 84  KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTN 143
           +   R F++E   +    H N+  +  + +      +    ++ E+MENGSL+ +L Q +
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122

Query: 144 DHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL 203
                   ++IQ V +   +A+ ++YL        VH D+   N+L+++++V  V DFGL
Sbjct: 123 GQF-----TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           S+FL     DT+  T +S++G K  + + AP
Sbjct: 175 SRFLED---DTSDPTYTSALGGKIPIRWTAP 202

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 1e-43
 Identities = 43/189 (22%), Positives = 82/189 (43%), Gaps = 24/189 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRNL 105
           +F + + +G G+ G V+K       +V+A K+I+L+ K A R+  + E + L       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
                   S         ++  E+M+ GSL+  L +        ++       ++I V  
Sbjct: 67  VGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIK 115

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
            + YL       ++H D+KPSN+L+++     + DFG+S  L     ++           
Sbjct: 116 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----------F 163

Query: 226 KGTVGYVAP 234
            GT  Y++P
Sbjct: 164 VGTRSYMSP 172

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 6e-41
 Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 21/184 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+GS+ +VYKG+  E  + VA   +  ++  K   + F  E E L+ ++H N+ +    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             S   KG     LV E M +G+L+ +L +         + +    +    +   +++LH
Sbjct: 77  WES-TVKGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLH 129

Query: 172 HNCQPPMVHGDIKPSNVLL-DNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
               PP++H D+K  N+ +        +GD GL+    +               + GT  
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----------VIGTPE 178

Query: 231 YVAP 234
           ++AP
Sbjct: 179 FMAP 182

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-40
 Identities = 43/184 (23%), Positives = 79/184 (42%), Gaps = 22/184 (11%)

Query: 54  IGQGSYGSVYKGIL--GEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G G++GSV +G+    + ++ VA+KV+    +K      + E + +  + +  + ++I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           +C +          LV E    G L  +L    + +      +     +   V+  ++YL
Sbjct: 77  VCQAEA------LMLVMEMAGGGPLHKFLVGKREEI-----PVSNVAELLHQVSMGMKYL 125

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
                   VH D+   NVLL N   A + DFGLSK L +D         ++    K  + 
Sbjct: 126 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-----DSYYTARSAGKWPLK 177

Query: 231 YVAP 234
           + AP
Sbjct: 178 WYAP 181

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 3e-40
 Identities = 40/188 (21%), Positives = 87/188 (46%), Gaps = 22/188 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
                  +G G +G V+ G        VAVK +  +   +  +F+AE   ++ ++H+ L 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           ++  + +       +   ++ EYMENGSL D+L   +      KL++ + +++A  +A  
Sbjct: 72  RLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEG 121

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           + ++        +H D++ +N+L+ + +   + DFGL++ +  +             G K
Sbjct: 122 MAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-------GAK 171

Query: 227 GTVGYVAP 234
             + + AP
Sbjct: 172 FPIKWTAP 179

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 6e-40
 Identities = 45/186 (24%), Positives = 84/186 (45%), Gaps = 20/186 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+G +G V++G        VAVK+ + +++ ++    AE      +RH N+   I   +
Sbjct: 11  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
             +        LV +Y E+GSL D+L++       + +++   + +A+  AS + +LH  
Sbjct: 68  KDNGTWTQL-WLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHME 119

Query: 174 C-----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
                 +P + H D+K  N+L+  +    + D GL+    S           +     GT
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT----DTIDIAPNHRVGT 175

Query: 229 VGYVAP 234
             Y+AP
Sbjct: 176 KRYMAP 181

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (343), Expect = 1e-39
 Identities = 42/190 (22%), Positives = 72/190 (37%), Gaps = 29/190 (15%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK---GAFRSFVAECEALRNIRHRN 104
           FS    IG GS+G+VY      +  VVA+K ++   K     ++  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
             +                 LV EY    + +              L  ++   +     
Sbjct: 77  TIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGAL 125

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIG 224
             + YLH +    M+H D+K  N+LL    +  +GDFG +  ++  +             
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------------S 170

Query: 225 IKGTVGYVAP 234
             GT  ++AP
Sbjct: 171 FVGTPYWMAP 180

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-39
 Identities = 44/192 (22%), Positives = 79/192 (41%), Gaps = 17/192 (8%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRN 104
           ++     IG GSYG   K     D  ++  K ++     +   +  V+E   LR ++H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           + +          +      +V EY E G L   + +     +      + R  +   + 
Sbjct: 65  IVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR--VMTQLT 119

Query: 165 SAIEYLH--HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
            A++  H   +    ++H D+KP+NV LD      +GDFGL++ L+ D         S +
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--------TSFA 171

Query: 223 IGIKGTVGYVAP 234
               GT  Y++P
Sbjct: 172 KAFVGTPYYMSP 183

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-39
 Identities = 41/181 (22%), Positives = 76/181 (41%), Gaps = 21/181 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G VYK    E  ++ A KVI+ K +     ++ E + L +  H N+ K++    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   ++ E+   G+++  + +         L+  Q   +      A+ YLH N
Sbjct: 80  Y-----ENNLWILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN 129

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVA 233
               ++H D+K  N+L   D    + DFG+S   +       S          GT  ++A
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--------FIGTPYWMA 178

Query: 234 P 234
           P
Sbjct: 179 P 179

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (336), Expect = 8e-39
 Identities = 48/188 (25%), Positives = 93/188 (49%), Gaps = 20/188 (10%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           + +  + +G G YG VY+G+  +  + VAVK +  +       F+ E   ++ I+H NL 
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +C+           ++ E+M  G+L D+L + N      ++S +  + +A  ++SA
Sbjct: 77  QLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSA 127

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +EYL        +H D+   N L+  + +  V DFGLS+ ++ D       T ++  G K
Sbjct: 128 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-------TYTAHAGAK 177

Query: 227 GTVGYVAP 234
             + + AP
Sbjct: 178 FPIKWTAP 185

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 5e-38
 Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 22/188 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
                  +GQG +G V+ G        VA+K +      +  +F+ E + ++ +RH  L 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           ++  + S       +   +V EYM  GSL D+L               Q V++A  +AS 
Sbjct: 76  QLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASG 125

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           + Y+        VH D++ +N+L+  ++V  V DFGL++ +  +         ++  G K
Sbjct: 126 MAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAK 175

Query: 227 GTVGYVAP 234
             + + AP
Sbjct: 176 FPIKWTAP 183

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 7e-38
 Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 27/191 (14%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 103
           +F     +G+G +G+VY     + + ++A+KV+    L++ G       E E   ++RH 
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
           N+ ++           A    L+ EY   G++   L + +      K    +      ++
Sbjct: 67  NILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITEL 115

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
           A+A+ Y H      ++H DIKP N+LL +     + DFG S    S    T         
Sbjct: 116 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT--------- 163

Query: 224 GIKGTVGYVAP 234
            + GT+ Y+ P
Sbjct: 164 -LCGTLDYLPP 173

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-37
 Identities = 46/189 (24%), Positives = 78/189 (41%), Gaps = 24/189 (12%)

Query: 50  QSNMIGQGSYGSVYKGIL--GEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNL 105
           +   +G G++G+V KG     +    VAVK++  +          +AE   ++ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            ++I IC +      +   LV E  E G L  +L Q         +     + +   V+ 
Sbjct: 71  VRMIGICEA------ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSM 118

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
            ++YL  +     VH D+   NVLL     A + DFGLSK L +D          +    
Sbjct: 119 GMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHG 170

Query: 226 KGTVGYVAP 234
           K  V + AP
Sbjct: 171 KWPVKWYAP 179

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 3e-37
 Identities = 43/189 (22%), Positives = 75/189 (39%), Gaps = 21/189 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNL 105
           ++     +G+G+YG V   +    E  VAVK++++K+      +   E    + + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            K          +  + + L  EY   G L D +           +           + +
Sbjct: 66  VKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMA 114

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGI 225
            + YLH      + H DIKP N+LLD      + DFGL+     ++ +           +
Sbjct: 115 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------M 165

Query: 226 KGTVGYVAP 234
            GT+ YVAP
Sbjct: 166 CGTLPYVAP 174

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 1e-36
 Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 22/188 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           + +    +G G +G V  G     +  VA+K+I  +   +   F+ E + + N+ H  L 
Sbjct: 5   DLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           ++  +C+           ++ EYM NG L ++L +        +    Q + +  DV  A
Sbjct: 63  QLYGVCTK-----QRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEA 112

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +EYL        +H D+   N L+++  V  V DFGLS+++  D         +SS+G K
Sbjct: 113 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSK 162

Query: 227 GTVGYVAP 234
             V +  P
Sbjct: 163 FPVRWSPP 170

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-36
 Identities = 43/212 (20%), Positives = 82/212 (38%), Gaps = 38/212 (17%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFR-SFVAECEALRNI 100
                 ++G G++G V              + VAVK++  K   + R + ++E + +  +
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 101 -RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL------------- 146
             H N+  ++  C+      +    L+FEY   G L ++L    +               
Sbjct: 98  GSHENIVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 147 ----EVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG 202
               ++  L+    +  A  VA  +E+L        VH D+   NVL+ +  V  + DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFG 209

Query: 203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           L++ + SD               +  V ++AP
Sbjct: 210 LARDIMSD------SNYVVRGNARLPVKWMAP 235

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 5e-36
 Identities = 60/188 (31%), Positives = 85/188 (45%), Gaps = 26/188 (13%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           E      IG+G +G V  G        VAVK I  K     ++F+AE   +  +RH NL 
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +++ +   ++ KG  +  +V EYM  GSL D+L      +    L     +  ++DV  A
Sbjct: 64  QLLGVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEA 115

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +EYL  N     VH D+   NVL+  D VA V DFGL+K  SS                K
Sbjct: 116 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----------K 161

Query: 227 GTVGYVAP 234
             V + AP
Sbjct: 162 LPVKWTAP 169

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 7e-36
 Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 23/193 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL----GEDEMVVAVKVINLKQKGAFR-SFVAECEALRNIR 101
             ++  +IG G +G VYKG+L    G+ E+ VA+K +        R  F+ E   +    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           H N+ ++  + S           ++ EYMENG+L+ +L + +        S++Q V +  
Sbjct: 68  HHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKDGEF-----SVLQLVGMLR 117

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
            +A+ +    +      VH D+   N+L+++++V  V DFGLS+ L  D      E   +
Sbjct: 118 GIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEATYT 169

Query: 222 SIGIKGTVGYVAP 234
           + G K  + + AP
Sbjct: 170 TSGGKIPIRWTAP 182

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  125 bits (314), Expect = 2e-35
 Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 43/217 (19%)

Query: 47  EFSQSN-----MIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFRS-FVAECE 95
           E+ ++N      IG+G++G V++         E   +VAVK++  +     ++ F  E  
Sbjct: 9   EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68

Query: 96  ALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVF------ 149
            +    + N+ K++ +C+           L+FEYM  G L ++L   + H          
Sbjct: 69  LMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 150 ------------KLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH 197
                        LS  +++ IA  VA+ + YL        VH D+   N L+  +MV  
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180

Query: 198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
           + DFGLS+ + S     A             + ++ P
Sbjct: 181 IADFGLSRNIYSADYYKADGN------DAIPIRWMPP 211

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-35
 Identities = 50/201 (24%), Positives = 77/201 (38%), Gaps = 30/201 (14%)

Query: 45  TC-----EFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVIN---LKQKGAFRSFVAE 93
           TC     +      +G GS+G V +G         + VAVK +    L Q  A   F+ E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSL 153
             A+ ++ HRNL ++  +  +          +V E    GSL D L +   H       L
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGHF-----LL 110

Query: 154 IQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
                 A+ VA  + YL        +H D+   N+LL    +  +GDFGL + L  +   
Sbjct: 111 GTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167

Query: 214 TASETPSSSIGIKGTVGYVAP 234
              +        K    + AP
Sbjct: 168 YVMQE-----HRKVPFAWCAP 183

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 6e-35
 Identities = 42/193 (21%), Positives = 88/193 (45%), Gaps = 25/193 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGED----EMVVAVKVINL-KQKGAFRSFVAECEALRNIR 101
           EF +  ++G G++G+VYKG+   +    ++ VA+K +       A +  + E   + ++ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
           + ++ +++ IC +          L+ + M  G L D++ +  D++          +N  +
Sbjct: 70  NPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNI-----GSQYLLNWCV 118

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSS 221
            +A  + YL       +VH D+   NVL+       + DFGL+K L ++      E    
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYH 169

Query: 222 SIGIKGTVGYVAP 234
           + G K  + ++A 
Sbjct: 170 AEGGKVPIKWMAL 182

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 6e-35
 Identities = 46/188 (24%), Positives = 83/188 (44%), Gaps = 22/188 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLT 106
           E +    IG G +G V+ G    ++  VA+K I  +   +   F+ E E +  + H  L 
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           ++  +C            LVFE+ME+G L D+L       +    +    + + +DV   
Sbjct: 64  QLYGVCLE-----QAPICLVFEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCEG 113

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
              + +  +  ++H D+   N L+  + V  V DFG+++F+  D         +SS G K
Sbjct: 114 ---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTK 163

Query: 227 GTVGYVAP 234
             V + +P
Sbjct: 164 FPVKWASP 171

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-34
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 20/188 (10%)

Query: 51  SNMIGQGSYGSVYKGILGED---EMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLT 106
           + +IG+G +G VY G L ++   ++  AVK +N +   G    F+ E   +++  H N+ 
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++ IC  + S+G+    +V  YM++G L +++       E    ++   +   + VA  
Sbjct: 92  SLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 142

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
              +        VH D+   N +LD      V DFGL++ +     D    +  +  G K
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD----SVHNKTGAK 195

Query: 227 GTVGYVAP 234
             V ++A 
Sbjct: 196 LPVKWMAL 203

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 2e-34
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 23/183 (12%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITI 111
             IGQG+ G+VY  +       VA++ +NL+Q+      + E   +R  ++ N+   +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
                    D   +V EY+  GSL D + +T            Q   +  +   A+E+LH
Sbjct: 86  YLV-----GDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLH 133

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
            N    ++H DIK  N+LL  D    + DFG    ++ +    ++        + GT  +
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--------MVGTPYW 182

Query: 232 VAP 234
           +AP
Sbjct: 183 MAP 185

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 3e-34
 Identities = 40/207 (19%), Positives = 80/207 (38%), Gaps = 33/207 (15%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFR-SFVAECEALRNI 100
             S    +G G++G V +         +  M VAVK++        R + ++E + L  +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 101 -RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHL------------E 147
             H N+  ++  C+           ++ EY   G L ++L +  D              +
Sbjct: 84  GNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
              L L   ++ +  VA  + +L        +H D+   N+LL +  +  + DFGL++ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 208 SSDHLDTASETPSSSIGIKGTVGYVAP 234
            +D               +  V ++AP
Sbjct: 196 KND------SNYVVKGNARLPVKWMAP 216

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 3e-34
 Identities = 40/191 (20%), Positives = 75/191 (39%), Gaps = 23/191 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 103
           +F    ++G+GS+ +V            A+K++    + ++        E + +  + H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
              K+            +       Y +NG L  ++ +                    ++
Sbjct: 69  FFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEI 117

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
            SA+EYLH      ++H D+KP N+LL+ DM   + DFG +K LS +     + +     
Sbjct: 118 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS----- 169

Query: 224 GIKGTVGYVAP 234
              GT  YV+P
Sbjct: 170 -FVGTAQYVSP 179

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  122 bits (306), Expect = 9e-34
 Identities = 36/183 (19%), Positives = 68/183 (37%), Gaps = 24/183 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G V++          A K +    +    +   E + +  +RH  L  +     
Sbjct: 34  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                  +   +++E+M  G L + +   ++     K+S  + V     V   + ++H N
Sbjct: 94  D-----DNEMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
                VH D+KP N++        +   DFGL+  L             S     GT  +
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---------SVKVTTGTAEF 191

Query: 232 VAP 234
            AP
Sbjct: 192 AAP 194

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-33
 Identities = 47/216 (21%), Positives = 89/216 (41%), Gaps = 38/216 (17%)

Query: 33  FPMVSYAELSKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRS 89
           +P++ + +           ++IG+G++G V K  + +D + +   +  +K+   K   R 
Sbjct: 4   YPVLDWND-------IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 90  FVAECEALRNI-RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ------- 141
           F  E E L  +  H N+  ++  C     +   +  L  EY  +G+L D+L +       
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111

Query: 142 ---TNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV 198
                 +     LS  Q ++ A DVA     + +  Q   +H D+   N+L+  + VA +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKI 168

Query: 199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP 234
            DFGLS+           E        +  V ++A 
Sbjct: 169 ADFGLSRG---------QEVYVKKTMGRLPVRWMAI 195

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  119 bits (298), Expect = 3e-33
 Identities = 35/185 (18%), Positives = 76/185 (41%), Gaps = 18/185 (9%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKII 109
           ++G G    V+          VAVKV+     +    +  F  E +    + H  +  + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
               +    G     +V EY++  +L D +H          ++  + + +  D   A+ +
Sbjct: 74  DTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNF 126

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
            H N    ++H D+KP+N+++       V DFG+++ ++         + + +  + GT 
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG-----NSVTQTAAVIGTA 178

Query: 230 GYVAP 234
            Y++P
Sbjct: 179 QYLSP 183

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  120 bits (302), Expect = 4e-33
 Identities = 37/183 (20%), Positives = 70/183 (38%), Gaps = 24/183 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G++G V++ +      V   K IN        +   E   +  + H  L  +     
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                      L+ E++  G L D +   +     +K+S  + +N        ++++H +
Sbjct: 97  D-----KYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 146

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGY 231
               +VH DIKP N++ +    + V   DFGL+  L+ D +               T  +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---------VKVTTATAEF 194

Query: 232 VAP 234
            AP
Sbjct: 195 AAP 197

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  120 bits (302), Expect = 5e-33
 Identities = 34/179 (18%), Positives = 66/179 (36%), Gaps = 20/179 (11%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK------QKGAFRSFVAECEALRNI 100
           +FS   +IG+G +G VY     +   + A+K ++ K       +    +       +   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIA 160
               +  +     +      D  + + + M  G L   L Q     E            A
Sbjct: 65  DCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQHGVFSE------ADMRFYA 113

Query: 161 IDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETP 219
            ++   +E++H+     +V+ D+KP+N+LLD      + D GL+   S      +  T 
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 169

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 3e-32
 Identities = 42/198 (21%), Positives = 83/198 (41%), Gaps = 24/198 (12%)

Query: 47  EFSQSNMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQKGAFR-SFVAECEALRNI 100
           + + S  +GQGS+G VY+G+       E E  VA+K +N       R  F+ E   ++  
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 101 RHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE----VFKLSLIQR 156
              ++ +++ + S           ++ E M  G L+ +L      +     +   SL + 
Sbjct: 81  NCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 157 VNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTAS 216
           + +A ++A  + YL+ N     VH D+   N ++  D    +GDFG+++ +         
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 217 ETPSSSIGIKGTVGYVAP 234
                       V +++P
Sbjct: 193 GK------GLLPVRWMSP 204

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 5e-32
 Identities = 44/185 (23%), Positives = 78/185 (42%), Gaps = 25/185 (13%)

Query: 53  MIGQGSYGSVYKGIL---GEDEMVVAVKVINLKQKGAFRS-FVAECEALRNIRHRNLTKI 108
            IG+G +G V++GI        + VA+K        + R  F+ E   +R   H ++ K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 109 ITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           I + +       +   ++ E    G L  +L         + L L   +  A  +++A+ 
Sbjct: 74  IGVITE------NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALA 122

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
           YL        VH DI   NVL+ ++    +GDFGLS+++       AS         K  
Sbjct: 123 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-------KGKLP 172

Query: 229 VGYVA 233
           + ++A
Sbjct: 173 IKWMA 177

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 5e-32
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 12/166 (7%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTK 107
           ++ + +IG GS+G VY+  L +   +VA+K +   ++   R    E + +R + H N+ +
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77

Query: 108 IITIC-SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
           +     SS + K   +  LV +Y+         H +        L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDND-MVAHVGDFGLSKFLSSDH 211
           + Y+H      + H DIKP N+LLD D  V  + DFG +K L    
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  113 bits (283), Expect = 6e-31
 Identities = 51/197 (25%), Positives = 81/197 (41%), Gaps = 33/197 (16%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAF---------RSFVAECEALR 98
           +    ++G+G    V + I        AVK+I++   G+F          + + E + LR
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 99  NIR-HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRV 157
            +  H N+ ++     +       F  LVF+ M+ G L D+L +         LS  +  
Sbjct: 65  KVSGHPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETR 113

Query: 158 NIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASE 217
            I   +   I  LH      +VH D+KP N+LLD+DM   + DFG S  L          
Sbjct: 114 KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR--- 167

Query: 218 TPSSSIGIKGTVGYVAP 234
                  + GT  Y+AP
Sbjct: 168 ------EVCGTPSYLAP 178

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (284), Expect = 7e-31
 Identities = 42/184 (22%), Positives = 66/184 (35%), Gaps = 21/184 (11%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIIT 110
           +++G G++  V        + +VA+K I  K  +G   S   E   L  I+H N+  +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           I  S          L+ + +  G L D + +          +      +   V  A++YL
Sbjct: 75  IYES-----GGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYL 123

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H                  LD D    + DFGLSK      + +            GT G
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---------TACGTPG 174

Query: 231 YVAP 234
           YVAP
Sbjct: 175 YVAP 178

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 3e-30
 Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 17/184 (9%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVIN-LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           + IG+G+YG V       +++ VA+K I+  + +   +  + E + L   RH N+  I  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
           I  +   +      LV   M    L   L           LS          +   ++Y+
Sbjct: 74  IIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYI 125

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H      ++H D+KPSN+LL+      + DFGL++    DH     +          T  
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-----DHTGFLTEYVATRW 177

Query: 231 YVAP 234
           Y AP
Sbjct: 178 YRAP 181

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 4e-30
 Identities = 38/199 (19%), Positives = 78/199 (39%), Gaps = 28/199 (14%)

Query: 52  NMIGQGSYGSVYKGIL-----GEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNL 105
             +G+G++G V +              VAVK++         R+ ++E + L +I H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFK----------LSLIQ 155
             ++ +  +    G     ++ E+ + G+L  +L    +    +K          L+L  
Sbjct: 79  --VVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 156 RVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTA 215
            +  +  VA  +E+L        +H D+   N+LL    V  + DFGL++ +  D     
Sbjct: 136 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----- 187

Query: 216 SETPSSSIGIKGTVGYVAP 234
                     +  + ++AP
Sbjct: 188 -PDYVRKGDARLPLKWMAP 205

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 4e-30
 Identities = 32/169 (18%), Positives = 71/169 (42%), Gaps = 17/169 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G+G +G V++ +    +     K + +K          E   L   RHRN+  +     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESFE 71

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
           S      +   ++FE++    + + ++ +      F+L+  + V+    V  A+++LH +
Sbjct: 72  S-----MEELVMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH 121

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHV--GDFGLSKFLS-SDHLDTASETP 219
               + H DI+P N++      + +   +FG ++ L   D+       P
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-29
 Identities = 39/186 (20%), Positives = 72/186 (38%), Gaps = 26/186 (13%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEAL-RNIRHRNLTKIITI 111
           ++G G  G V +      +   A+K++    K        E E   R  +  ++ +I+ +
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             ++ +       +V E ++ G L   +    D       +  +   I   +  AI+YLH
Sbjct: 74  YENLYAGRKCL-LIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLH 128

Query: 172 HNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
                 + H D+KP N+L      + +  + DFG +K  +S +         S      T
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYT 176

Query: 229 VGYVAP 234
             YVAP
Sbjct: 177 PYYVAP 182

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 4e-29
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 18/186 (9%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITI 111
           IGQG++G V+K    +    VA+K + ++  ++G   + + E + L+ ++H N+  +I I
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 112 CSSIDSKGADFKA---LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           C +  S     K    LVF++ E+       +     L  F LS I+RV   +     + 
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQML-----LN 128

Query: 169 YLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGT 228
            L++  +  ++H D+K +NVL+  D V  + DFGL++  S       +   +       T
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN----RVVT 184

Query: 229 VGYVAP 234
           + Y  P
Sbjct: 185 LWYRPP 190

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 8e-29
 Identities = 41/192 (21%), Positives = 72/192 (37%), Gaps = 26/192 (13%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEAL-RNIRH 102
           +F    M+G+GS+G V+     +     A+K +    +         + E   L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 103 RNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAID 162
             LT +     +      +    V EY+  G L   +   +      K  L +    A +
Sbjct: 63  PFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAE 111

Query: 163 VASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSS 222
           +   +++LH      +V+ D+K  N+LLD D    + DFG+ K              + +
Sbjct: 112 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--------AKT 160

Query: 223 IGIKGTVGYVAP 234
               GT  Y+AP
Sbjct: 161 NTFCGTPDYIAP 172

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-28
 Identities = 44/188 (23%), Positives = 77/188 (40%), Gaps = 27/188 (14%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLK-----QKGAFRSFVAECEALRNIRHRNLT 106
           + +G+G + +VYK        +VA+K I L      + G  R+ + E + L+ + H N+ 
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++              +LVF++ME          +                  +     
Sbjct: 64  GLLDAFGH-----KSNISLVFDFMETDLEVIIKDNSLVLTPS------HIKAYMLMTLQG 112

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIK 226
           +EYLH +    ++H D+KP+N+LLD + V  + DFGL+K   S +         +     
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--------RAYTHQV 161

Query: 227 GTVGYVAP 234
            T  Y AP
Sbjct: 162 VTRWYRAP 169

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 7e-28
 Identities = 43/200 (21%), Positives = 79/200 (39%), Gaps = 33/200 (16%)

Query: 54  IGQGSYGSVYKGIL-------GEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRN 104
           +G+G++G V                  VAVK++     +      ++E E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQ----------TNDHLEVFKLSLI 154
           +  ++  C+           ++ EY   G+L ++L               H    +LS  
Sbjct: 81  IINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135

Query: 155 QRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDT 214
             V+ A  VA  +EYL        +H D+   NVL+  D V  + DFGL++ +       
Sbjct: 136 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID--- 189

Query: 215 ASETPSSSIGIKGTVGYVAP 234
                  +   +  V ++AP
Sbjct: 190 ---YYKKTTNGRLPVKWMAP 206

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  104 bits (259), Expect = 2e-27
 Identities = 41/185 (22%), Positives = 70/185 (37%), Gaps = 19/185 (10%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITIC 112
            IG GS+G +Y G        VA+K+  +K K        E +  + ++       I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
            +      D+  +V E +     + +   +       K SL   + +A  + S IEY+H 
Sbjct: 72  GAEG----DYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHS 121

Query: 173 NCQPPMVHGDIKPSNVL---LDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTV 229
                 +H D+KP N L        + ++ DFGL+K               +   + GT 
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK-NLTGTA 177

Query: 230 GYVAP 234
            Y + 
Sbjct: 178 RYASI 182

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (260), Expect = 2e-27
 Identities = 35/184 (19%), Positives = 66/184 (35%), Gaps = 28/184 (15%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G GS+G V+      +    A+KV+    + +         E   L  + H  + ++  
Sbjct: 12  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
                    A    ++ +Y+E G L   L ++              V            L
Sbjct: 72  TFQD-----AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV---------CLAL 117

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
            +     +++ D+KP N+LLD +    + DFG +K++                 + GT  
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----------LCGTPD 166

Query: 231 YVAP 234
           Y+AP
Sbjct: 167 YIAP 170

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 2e-26
 Identities = 46/191 (24%), Positives = 73/191 (38%), Gaps = 25/191 (13%)

Query: 47  EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHR 103
           +F    ++G+G++G V            A+K++    +  K      V E   L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 104 NLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDV 163
            LT +     +      D    V EY   G L   L +          +  +      ++
Sbjct: 66  FLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEI 114

Query: 164 ASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
            SA   L +     +V+ DIK  N++LD D    + DFGL K   SD         ++  
Sbjct: 115 VSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMK 163

Query: 224 GIKGTVGYVAP 234
              GT  Y+AP
Sbjct: 164 TFCGTPEYLAP 174

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 6e-26
 Identities = 42/187 (22%), Positives = 81/187 (43%), Gaps = 23/187 (12%)

Query: 54  IGQGSYGSVYKGI-LGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNI---RHRNLTK 107
           IG+G+YG V+K   L      VA+K + ++  ++G   S + E   LR++    H N+ +
Sbjct: 15  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +  +C+   +       LVFE+++                   +      ++   +   +
Sbjct: 75  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGL 129

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           ++LH +    +VH D+KP N+L+ +     + DFGL++  S     T          +  
Sbjct: 130 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---------SVVV 177

Query: 228 TVGYVAP 234
           T+ Y AP
Sbjct: 178 TLWYRAP 184

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 9e-26
 Identities = 36/179 (20%), Positives = 75/179 (41%), Gaps = 18/179 (10%)

Query: 40  ELSKATCEFSQS----NMIGQGSYGSVYKGILGEDEMVVAVKVIN--LKQKGAFRSFVAE 93
           E++K   E          +G G+YG+V   + G     VA+K +    + +   +    E
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 94  CEALRNIRHRNLTKIITICSSIDSKGADFK-ALVFEYMENGSLEDWLHQTNDHLEVFKLS 152
              L+++RH N+  ++ + +  ++        LV  +M     +   H+        KL 
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--------KLG 119

Query: 153 LIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
             +   +   +   + Y+H      ++H D+KP N+ ++ D    + DFGL++   S+ 
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 175

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 2e-25
 Identities = 38/191 (19%), Positives = 62/191 (32%), Gaps = 32/191 (16%)

Query: 53  MIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS------FVAECEALRNIR--HRN 104
           ++G G +GSVY GI   D + VA+K +   +   +           E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 105 LTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVA 164
           + +++           D   L+ E  E                   L      +    V 
Sbjct: 71  VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVL 120

Query: 165 SAIEYLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDHLDTASETPSSSI 223
            A+ + H+     ++H DIK  N+L+D N     + DFG    L                
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD--------- 168

Query: 224 GIKGTVGYVAP 234
              GT  Y  P
Sbjct: 169 -FDGTRVYSPP 178

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 99.1 bits (246), Expect = 3e-25
 Identities = 38/163 (23%), Positives = 71/163 (43%), Gaps = 20/163 (12%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITIC 112
           +G+G Y  V++ I   +   V VK++   +K   +    E + L N+R   N   IIT+ 
Sbjct: 43  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN---IITLA 96

Query: 113 SSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH 172
             +    +   ALVFE++ N   +              L+         ++  A++Y H 
Sbjct: 97  DIVKDPVSRTPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS 147

Query: 173 NCQPPMVHGDIKPSNVLLDND-MVAHVGDFGLSKFLSSDHLDT 214
                ++H D+KP NV++D++     + D+GL++F        
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.6 bits (239), Expect = 1e-24
 Identities = 35/160 (21%), Positives = 72/160 (45%), Gaps = 16/160 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG+G+YG+V+K    E   +VA+K + L    +G   S + E   L+ ++H+N+ ++  +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLH 171
             S          LVFE+ +    + +     D       S + ++         ++ L 
Sbjct: 70  LHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL---------LKGLG 115

Query: 172 HNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
                 ++H D+KP N+L++ +    + +FGL++      
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (238), Expect = 2e-24
 Identities = 37/191 (19%), Positives = 71/191 (37%), Gaps = 33/191 (17%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRS------FVAECEALRNIRHRNLTK 107
           +G G +  V K       +  A K I  ++  + R          E   L+ I+H N+  
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 108 IITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAI 167
           +  +  +          L+ E +  G L D+L +     E      ++++         +
Sbjct: 78  LHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---------L 123

Query: 168 EYLHHNCQPPMVHGDIKPSNVLLDNDMVA----HVGDFGLSKFLSSDHLDTASETPSSSI 223
             +++     + H D+KP N++L +  V      + DFGL+  +            +   
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---------NEFK 174

Query: 224 GIKGTVGYVAP 234
            I GT  +VAP
Sbjct: 175 NIFGTPEFVAP 185

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 3e-24
 Identities = 37/166 (22%), Positives = 71/166 (42%), Gaps = 15/166 (9%)

Query: 48  FSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNL 105
           F +   IG+G+YG VYK        VVA+K I L    +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 106 TKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVAS 165
            K++ +  +      +   LVFE++     +              + L    +    +  
Sbjct: 64  VKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALT-----GIPLPLIKSYLFQLLQ 113

Query: 166 AIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
            + + H +    ++H D+KP N+L++ +    + DFGL++      
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 96.0 bits (238), Expect = 4e-24
 Identities = 34/161 (21%), Positives = 60/161 (37%), Gaps = 17/161 (10%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN---LKQKGAFRSFVAECEALRNIRHRNLTKIIT 110
           +G GS+G V      E     A+K+++   + +       + E   L+ +    L K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
                         +V EY+  G +   L +        + S       A  +    EYL
Sbjct: 109 SFKDNS-----NLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYL 157

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
           H      +++ D+KP N+L+D      V DFG +K +    
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 95.3 bits (236), Expect = 5e-24
 Identities = 31/186 (16%), Positives = 59/186 (31%), Gaps = 21/186 (11%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           IG+GS+G +++G    +   VA+K    +          E    + +        +    
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 114 SIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHN 173
                      LV + +     +             K S+      A  + + ++ +H  
Sbjct: 71  QEG----LHNVLVIDLLGPSLEDLLDLCGR------KFSVKTVAMAAKQMLARVQSIHEK 120

Query: 174 CQPPMVHGDIKPSNVLLDNDMVAHVG-----DFGLSKFLSSDHLDTASETPSSSIGIKGT 228
               +V+ DIKP N L+      +       DFG+ KF                  + GT
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK-NLSGT 176

Query: 229 VGYVAP 234
             Y++ 
Sbjct: 177 ARYMSI 182

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 92.6 bits (229), Expect = 3e-23
 Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 17/161 (10%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKII 109
             IG+G+YG VYK      E   A+K I L++  +G   + + E   L+ ++H N+ K+ 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 110 TICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEY 169
            +  +          LVFE+++    +              L  +   +  + + + I Y
Sbjct: 67  DVIHT-----KKRLVLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAY 115

Query: 170 LHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSD 210
            H      ++H D+KP N+L++ +    + DFGL++     
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 8e-23
 Identities = 36/184 (19%), Positives = 77/184 (41%), Gaps = 16/184 (8%)

Query: 34  PMVSYAELSKATCEFSQS----NMIGQGSYGSVYKGILGEDEMVVAVKVIN--LKQKGAF 87
           P     EL+K   E  +     + +G G+YGSV      +  + VAVK ++   +     
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 88  RSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLE 147
           +    E   L++++H N+  ++ + +   S        +  ++    L + +        
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----- 116

Query: 148 VFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL 207
             KL+      +   +   ++Y+H      ++H D+KPSN+ ++ D    + DFGL++  
Sbjct: 117 --KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171

Query: 208 SSDH 211
             + 
Sbjct: 172 DDEM 175

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.5 bits (226), Expect = 2e-22
 Identities = 34/184 (18%), Positives = 73/184 (39%), Gaps = 24/184 (13%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVIN--LKQKGAFRSFVAECEALRNIRHRNLTKIITI 111
           IG G+ G V        +  VA+K ++   + +   +    E   ++ + H+N+  ++ +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 112 CSSIDSKGADFK-ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYL 170
            +   +        LV E M+    +    + +           +   +   +   I++L
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQMLCGIKHL 135

Query: 171 HHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVG 230
           H      ++H D+KPSN+++ +D    + DFGL++   +  + T             T  
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVTRY 183

Query: 231 YVAP 234
           Y AP
Sbjct: 184 YRAP 187

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 6e-21
 Identities = 38/167 (22%), Positives = 70/167 (41%), Gaps = 20/167 (11%)

Query: 54  IGQGSYGSVYKGILGEDE---MVVAVKVIN----LKQKGAFRSFVAECEALRNIRHRNLT 106
           +G G+YG V+            + A+KV+     +++         E + L +IR     
Sbjct: 32  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF- 90

Query: 107 KIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASA 166
            ++T+  +  ++      L+ +Y+  G L   L Q     E           + I V   
Sbjct: 91  -LVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEH---------EVQIYVGEI 138

Query: 167 IEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLD 213
           +  L H  +  +++ DIK  N+LLD++    + DFGLSK   +D  +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 86.2 bits (212), Expect = 2e-20
 Identities = 37/187 (19%), Positives = 71/187 (37%), Gaps = 15/187 (8%)

Query: 54  IGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICS 113
           +G G + +V+      +   VA+K++    K    +   E + L+ +   + TK  ++ +
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 114 S-----IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIE 168
           +     +D         V   M    L + L       E   + LI    I+  +   ++
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 169 YLHHNCQPPMVHGDIKPSNVLLD-NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKG 227
           Y+H  C   ++H DIKP NVL++  D   ++    ++       L  A            
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIA------DLGNACWYDEHYTNSIQ 191

Query: 228 TVGYVAP 234
           T  Y +P
Sbjct: 192 TREYRSP 198

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 71.4 bits (174), Expect = 6e-16
 Identities = 25/170 (14%), Positives = 53/170 (31%), Gaps = 29/170 (17%)

Query: 52  NMIGQGSYGSVYKGILGEDEMVVAVKVINL----------KQKGAFRSFVAECEALRNIR 101
            ++G+G   +V+     +      VK   +          K+      F           
Sbjct: 6   KLMGEGKESAVFNCYSEKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 102 HRNLTKIITICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAI 161
            R L K+  +         +  A++ E ++   L     +  D              +  
Sbjct: 65  FRALQKLQGLAV-PKVYAWEGNAVLMELIDAKELYRVRVENPDE-------------VLD 110

Query: 162 DVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDH 211
            +   +   +H     +VHGD+   NVL+  + +  + DF  S  +  + 
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	234
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.47
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.01
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.77
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.68
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.5
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.58

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-42  Score=273.62  Aligned_cols=170  Identities=25%  Similarity=0.384  Sum_probs=143.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ..+|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|+++|++++||||+++++++...     +..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----cee
Confidence            457999999999999999999999999999999997543 23346789999999999999999999998543     447


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++|+|.+++....      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence            99999999999999997654      688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+...........      ...+||+.||||
T Consensus       150 a~~~~~~~~~~~~------~~~~GT~~Y~AP  174 (271)
T d1nvra_         150 ATVFRYNNRERLL------NKMCGTLPYVAP  174 (271)
T ss_dssp             CEECEETTEECCB------CCCCSCGGGSCT
T ss_pred             heeeccCCccccc------cceeeCcCccCH
Confidence            9976543221111      126799999999

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-41  Score=270.60  Aligned_cols=166  Identities=27%  Similarity=0.415  Sum_probs=145.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|++.+.||+|+||+||+|.++.+++.||||+++.......+.+.+|+++|+.++||||+++++++...     +.+++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEE
Confidence            4699999999999999999999999999999999866555567899999999999999999999998643     34799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++++|.+++...       .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        95 vmEy~~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence            99999999999987653       588899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+........        ..+||+.||||
T Consensus       165 ~~~~~~~~~~--------~~~gt~~Y~aP  185 (293)
T d1yhwa1         165 QITPEQSKRS--------TMVGTPYWMAP  185 (293)
T ss_dssp             ECCSTTCCBC--------CCCSCGGGCCH
T ss_pred             eecccccccc--------ccccCCCccCh
Confidence            7654322111        25799999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=265.29  Aligned_cols=165  Identities=26%  Similarity=0.441  Sum_probs=144.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||+||+|+++.+++.||+|++...   .....+.+.+|++++..++||||+++++++..     .+.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----ATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CCE
Confidence            3688899999999999999999999999999999632   23345678999999999999999999999853     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+++|+|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EEEEEeecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence            799999999999999998765      688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+.......          ...+||+.||||
T Consensus       152 ~a~~~~~~~~----------~~~~Gt~~Y~AP  173 (263)
T d2j4za1         152 WSVHAPSSRR----------TTLCGTLDYLPP  173 (263)
T ss_dssp             SCSCCCCCCC----------EETTEEGGGCCH
T ss_pred             eeeecCCCcc----------cccCCCCcccCH
Confidence            9986543221          126799999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-41  Score=269.47  Aligned_cols=167  Identities=24%  Similarity=0.384  Sum_probs=145.4

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      .|++.+.||+|+||+||+|+++.++..||||+++.......+.+.+|+++|+.++||||+++++++...     +..++|
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~lv   87 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWIL   87 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEEE
Confidence            588899999999999999999999999999999866666668899999999999999999999998543     347999


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      |||+++|+|.+++.+...     .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        88 mEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~  159 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK  159 (288)
T ss_dssp             EECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhc
Confidence            999999999999876542     588999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCccCCCCCCCCccccccccccccCC
Q 039258          207 LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ........        ...+||+.||||
T Consensus       160 ~~~~~~~~--------~~~~Gt~~y~AP  179 (288)
T d2jfla1         160 NTRTIQRR--------DSFIGTPYWMAP  179 (288)
T ss_dssp             CHHHHHHH--------TCCCSCCTTCCH
T ss_pred             cCCCcccc--------cccccccccCCH
Confidence            54322111        125799999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-40  Score=265.52  Aligned_cols=169  Identities=24%  Similarity=0.421  Sum_probs=143.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|+++|++++||||+++++++..     .+.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence            4689999999999999999999999999999999643   23345778999999999999999999999753     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +++||||+++|+|.+++...+      .+++..+..++.|++.||.|+|++   +|+||||||+|||++.++.+||+|||
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence            799999999999999988766      688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+.+........      ....+||+.||||
T Consensus       154 ~a~~~~~~~~~~~------~~~~~GT~~Y~AP  179 (288)
T d1uu3a_         154 TAKVLSPESKQAR------ANSFVGTAQYVSP  179 (288)
T ss_dssp             TCEECC----------------CCCCGGGCCH
T ss_pred             cceecccCCcccc------cccccCCccccCc
Confidence            9997654322211      1126799999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=273.47  Aligned_cols=166  Identities=24%  Similarity=0.391  Sum_probs=144.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++.. .....+.+.+|+.+|+.++||||++++++|..     .+.+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence            45799999999999999999999999999999999754 33445678999999999999999999999854     3447


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      ++||||+++++|.+++.+.+      .+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence            99999999999999998765      68899999999999999999996 5   89999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+...+....          ..+||+.||||
T Consensus       151 la~~~~~~~~~----------~~~GT~~Y~AP  172 (322)
T d1s9ja_         151 VSGQLIDSMAN----------SFVGTRSYMSP  172 (322)
T ss_dssp             CCHHHHHHTC-------------CCSSCCCCH
T ss_pred             CccccCCCccc----------cccCCccccCc
Confidence            99876443211          26899999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=260.36  Aligned_cols=166  Identities=25%  Similarity=0.432  Sum_probs=141.4

Q ss_pred             CCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceee
Q 039258           49 SQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      +..+.||+|+||+||+|.+..++..||+|.+...  .....+.+.+|+++|..++||||+++++++.... .+...+++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEE
Confidence            5566899999999999999999999999999744  3344567899999999999999999999986543 234557899


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCCeeeC-CCCceEEccCcc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPP--MVHGDIKPSNVLLD-NDMVAHVGDFGL  203 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~--ivH~dlk~~nil~~-~~~~vki~dfG~  203 (234)
                      |||+++++|.+++.+..      .+++..+..++.||+.||+|||++   +  |+||||||+|||++ .++.+||+|||+
T Consensus        91 mE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EeCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            99999999999998765      688899999999999999999998   6  99999999999996 578999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+.......          ...+||+.||||
T Consensus       162 a~~~~~~~~----------~~~~GT~~Y~aP  182 (270)
T d1t4ha_         162 ATLKRASFA----------KAVIGTPEFMAP  182 (270)
T ss_dssp             GGGCCTTSB----------EESCSSCCCCCG
T ss_pred             ceeccCCcc----------CCcccCccccCH
Confidence            986443221          126799999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-39  Score=267.06  Aligned_cols=167  Identities=29%  Similarity=0.376  Sum_probs=145.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|+.+|+.++||||+++++++..     .+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-----ccc
Confidence            4689999999999999999999999999999999743   23345778999999999999999999999853     445


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +++||||+++|+|.+++...+      .+++..+..++.|++.||+|+|++   +|+||||||+|||++.++.+||+|||
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG  150 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cccceeccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecc
Confidence            799999999999999998766      688899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+.........        ...+||+.||||
T Consensus       151 ~a~~~~~~~~~~--------~~~~GT~~Y~aP  174 (337)
T d1o6la_         151 LCKEGISDGATM--------KTFCGTPEYLAP  174 (337)
T ss_dssp             TCBCSCCTTCCB--------CCCEECGGGCCG
T ss_pred             cccccccCCccc--------ccceeCHHHhhh
Confidence            998654432211        126899999998

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-40  Score=265.60  Aligned_cols=170  Identities=28%  Similarity=0.566  Sum_probs=144.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||+||+|.++.+++.||||+++... ...+++.+|+++|..++||||++++++|..     .+..+
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~   89 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY   89 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEee-----CCeeE
Confidence            456888999999999999999999999999999986443 345789999999999999999999999853     34478


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++|+|.+++......    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~----~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTT----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             EEeecccCcchHHHhhhcccc----chHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence            999999999999999765432    688899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........       ....||+.||||
T Consensus       163 ~~~~~~~~~~~-------~~~~g~~~y~aP  185 (287)
T d1opja_         163 RLMTGDTYTAH-------AGAKFPIKWTAP  185 (287)
T ss_dssp             TTCCSSSSEEE-------TTEEECGGGCCH
T ss_pred             eecCCCCceee-------ccccccccccCh
Confidence            87654322211       124588999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-40  Score=263.92  Aligned_cols=176  Identities=24%  Similarity=0.377  Sum_probs=134.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++.+.||+|+||+||+|+++.+++.||+|.++...  +...+.+.+|+++|..++||||+++++++..   .....+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence            46899999999999999999999999999999997542  3345678999999999999999999998753   223447


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC--QPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ++||||+++|+|.+++......  ...+++..++.++.|++.||.|||+++  ..+|+||||||+|||++.++.+||+||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EEEEecCCCCcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            8999999999999998753211  116889999999999999999999861  113999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|+.........        ...+||+.||||
T Consensus       159 G~a~~~~~~~~~~--------~~~~gt~~Y~AP  183 (269)
T d2java1         159 GLARILNHDTSFA--------KAFVGTPYYMSP  183 (269)
T ss_dssp             HHHHHC-------------------CCCSCCCH
T ss_pred             cceeecccCCCcc--------ccCCCCcccCCH
Confidence            9999765432211        126799999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-39  Score=263.63  Aligned_cols=162  Identities=25%  Similarity=0.403  Sum_probs=141.0

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .|+..+.||+|+||+||+|++..+++.||||+++...   ....+.+.+|+.+|..++||||+++++++...     +..
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEE
Confidence            4888999999999999999999999999999997443   23446789999999999999999999998543     347


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+++++|..++....      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             EEEEEecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccc
Confidence            99999999988877766554      689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+......            ..+||+.||||
T Consensus       162 a~~~~~~~------------~~~GT~~Y~AP  180 (309)
T d1u5ra_         162 ASIMAPAN------------SFVGTPYWMAP  180 (309)
T ss_dssp             CBSSSSBC------------CCCSCGGGCCH
T ss_pred             ccccCCCC------------ccccCccccCH
Confidence            98654321            15799999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.6e-39  Score=266.14  Aligned_cols=167  Identities=21%  Similarity=0.334  Sum_probs=145.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|..++||||+++++++..     .+.+++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            479999999999999999999999999999999976655556788999999999999999999999854     344799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC--CCCceEEccCcc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD--NDMVAHVGDFGL  203 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~--~~~~vki~dfG~  203 (234)
                      ||||+++|+|.+++.....     .+++..+..++.||+.||.|||++   +||||||||+|||++  .++.+||+|||+
T Consensus       101 vmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             EECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecch
Confidence            9999999999999865432     689999999999999999999999   999999999999995  467899999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+........         ...+||+.||||
T Consensus       173 a~~~~~~~~~---------~~~~gT~~Y~aP  194 (350)
T d1koaa2         173 TAHLDPKQSV---------KVTTGTAEFAAP  194 (350)
T ss_dssp             CEECCTTSCE---------EEECSCTTTCCH
T ss_pred             heeccccccc---------ceecCcccccCH
Confidence            9876543221         126799999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.4e-39  Score=265.92  Aligned_cols=167  Identities=22%  Similarity=0.334  Sum_probs=145.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|++.+.||+|+||+||+|.+..+++.||||+++.......+.+.+|+.+|..++||||+++++++..     .+.+++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            469999999999999999999999999999999976554455678899999999999999999999853     345799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC--CCCceEEccCcc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD--NDMVAHVGDFGL  203 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~--~~~~vki~dfG~  203 (234)
                      ||||+++|+|.+++.....     .+++..+..++.||+.||.|||++   +|+||||||+|||++  .++.+||+|||+
T Consensus       104 vmE~~~gg~L~~~~~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEcCCCChHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccc
Confidence            9999999999998776542     689999999999999999999999   999999999999997  578999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+.........         ...||+.||||
T Consensus       176 a~~~~~~~~~~---------~~~gt~~y~aP  197 (352)
T d1koba_         176 ATKLNPDEIVK---------VTTATAEFAAP  197 (352)
T ss_dssp             CEECCTTSCEE---------EECSSGGGCCH
T ss_pred             ceecCCCCcee---------eccCcccccCH
Confidence            99876542211         25799999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.8e-39  Score=262.22  Aligned_cols=164  Identities=25%  Similarity=0.389  Sum_probs=144.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.+|+.++||||+++++++..     .+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence            4688999999999999999999999999999999632   23345788999999999999999999999853     345


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +++||||+++++|.+++....      .+++..+..++.||+.||.|+|++   +|+||||||+|||++.++.+||+|||
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eeeEeeecCCccccccccccc------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence            799999999999999988766      577888889999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+.......           ..+||+.||||
T Consensus       150 ~a~~~~~~~~-----------~~~Gt~~Y~AP  170 (316)
T d1fota_         150 FAKYVPDVTY-----------TLCGTPDYIAP  170 (316)
T ss_dssp             SCEECSSCBC-----------CCCSCTTTCCH
T ss_pred             cceEeccccc-----------cccCcccccCH
Confidence            9987654321           26799999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-39  Score=259.49  Aligned_cols=167  Identities=31%  Similarity=0.523  Sum_probs=136.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|++.+.||+|+||+||+|++..   .||||+++..  .....+.+.+|+++|.+++||||+++++++..      +.
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            4678999999999999999998643   5999999643  34456789999999999999999999998632      23


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +++||||+++|+|.+++.....     .+++..++.++.||+.||.|||++   +||||||||+|||++.++.+||+|||
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             EEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence            6899999999999999976542     588899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+...........      ....||+.||||
T Consensus       150 la~~~~~~~~~~~~------~~~~gt~~y~AP  175 (276)
T d1uwha_         150 LATVKSRWSGSHQF------EQLSGSILWMAP  175 (276)
T ss_dssp             CSCC------------------CCCCGGGCCH
T ss_pred             ceeeccccCCcccc------cccccCcccCCH
Confidence            99876543221111      125799999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-39  Score=262.98  Aligned_cols=167  Identities=28%  Similarity=0.419  Sum_probs=128.6

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ...|++.+.||+|+||+||+|+++.+++.||||++.... ......+.+|+.+|..++||||+++++++..     .+.+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-----GGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence            456899999999999999999999999999999997442 2233567899999999999999999999753     3457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC---CCCceEEcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGD  200 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~---~~~~vki~d  200 (234)
                      ++||||+++++|.+++...+      .+++..+..++.||+.||.|||++   +|+||||||+||++.   .++.+||+|
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence            99999999999999998755      689999999999999999999999   999999999999994   578999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|+.........         ..+||+.||||
T Consensus       154 FG~a~~~~~~~~~~---------~~~GT~~y~AP  178 (307)
T d1a06a_         154 FGLSKMEDPGSVLS---------TACGTPGYVAP  178 (307)
T ss_dssp             C---------------------------CTTSCH
T ss_pred             cceeEEccCCCeee---------eeeeCccccCc
Confidence            99998655432211         26799999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.4e-38  Score=252.48  Aligned_cols=167  Identities=29%  Similarity=0.426  Sum_probs=144.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc---------hhhHHHHHHHHHHHhcC-CCCceeEEEEeee
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK---------GAFRSFVAECEALRNIR-HRNLTKIITICSS  114 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~  114 (234)
                      ..+|++.+.||+|+||+||+|++..+++.||||+++....         ...+++.+|+.++.+++ ||||+++++++..
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            3578999999999999999999999999999999964321         12346889999999997 9999999999853


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM  194 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~  194 (234)
                           ++.+++||||+++++|.+++...+      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        82 -----~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~  147 (277)
T d1phka_          82 -----NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM  147 (277)
T ss_dssp             -----SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             -----CcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCC
Confidence                 455899999999999999998765      689999999999999999999999   999999999999999999


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||+++.........         ..+||+.|+||
T Consensus       148 ~~kl~DFG~a~~~~~~~~~~---------~~~gt~~y~~P  178 (277)
T d1phka_         148 NIKLTDFGFSCQLDPGEKLR---------EVCGTPSYLAP  178 (277)
T ss_dssp             CEEECCCTTCEECCTTCCBC---------CCCSCGGGCCH
T ss_pred             CeEEccchheeEccCCCcee---------eeeccCCCCCH
Confidence            99999999999765532211         15699999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-38  Score=255.24  Aligned_cols=168  Identities=24%  Similarity=0.522  Sum_probs=140.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||.||+|.++ ++..||||+++... ...+.+.+|++++.+++||||+++++++..      +..+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence            456888999999999999999985 56789999997433 334679999999999999999999998732      2258


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++|+|.+++.....    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence            99999999999998765432    1588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........       ....||+.||||
T Consensus       157 ~~~~~~~~~~~-------~~~~gt~~y~AP  179 (272)
T d1qpca_         157 RLIEDNEYTAR-------EGAKFPIKWTAP  179 (272)
T ss_dssp             EECSSSCEECC-------TTCCCCTTTSCH
T ss_pred             EEccCCccccc-------cccCCcccccCh
Confidence            98765332211       125699999998

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-38  Score=253.58  Aligned_cols=166  Identities=23%  Similarity=0.339  Sum_probs=143.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc------chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ------KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      .+|++.+.||+|+||+||+|+++.+|+.||||+++...      ....+.+.+|+.+|..++||||+++++++..     
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-----   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence            46999999999999999999999999999999996321      1234678999999999999999999999853     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC----c
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM----V  195 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~----~  195 (234)
                      .+.+++||||+++|+|.+++...+      .+++..+..++.|++.||.|||++   +|+||||||+||+++.++    .
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~  155 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR  155 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred             CCEEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence            345799999999999999998765      688999999999999999999999   999999999999998665    5


Q ss_pred             eEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          196 AHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       196 vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|++|||+|..........         ...||+.||||
T Consensus       156 vkl~DfG~a~~~~~~~~~~---------~~~~t~~y~AP  185 (293)
T d1jksa_         156 IKIIDFGLAHKIDFGNEFK---------NIFGTPEFVAP  185 (293)
T ss_dssp             EEECCCTTCEECTTSCBCS---------CCCCCGGGCCH
T ss_pred             eEecchhhhhhcCCCcccc---------ccCCCCcccCH
Confidence            9999999998765432211         25699999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-38  Score=252.12  Aligned_cols=167  Identities=28%  Similarity=0.502  Sum_probs=131.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|+..+.||+|+||.||+|.+. ++..||||.++... ...+.+.+|++++.+++||||++++++|...     +..++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEE
Confidence            46888999999999999999986 45789999997433 3347799999999999999999999998543     34699


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++|+|.+++.....     .+++..++.++.|++.||.|+|++   +|+||||||+|||++.++.+||+|||+++
T Consensus        78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence            9999999999999876542     578888999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........       ....||+.||||
T Consensus       150 ~~~~~~~~~~-------~~~~gt~~y~aP  171 (263)
T d1sm2a_         150 FVLDDQYTSS-------TGTKFPVKWASP  171 (263)
T ss_dssp             ----------------------CTTSCCH
T ss_pred             eccCCCceee-------cceecCcccCCh
Confidence            7654332211       124689999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-38  Score=257.09  Aligned_cols=173  Identities=29%  Similarity=0.526  Sum_probs=129.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCC---eEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDE---MVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|++.+.||+|+||+||+|.++.++   ..||||.+... .....+.+.+|+++|++++||||+++++++...     +
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence            35677889999999999999987655   36899988643 334457899999999999999999999998432     3


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++|+|.+++.....     .+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence            47999999999999998876543     588899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|+..........   .....+..||+.||||
T Consensus       173 Gla~~~~~~~~~~~---~~~~~~~~~t~~y~aP  202 (299)
T d1jpaa_         173 GLSRFLEDDTSDPT---YTSALGGKIPIRWTAP  202 (299)
T ss_dssp             --------------------------CGGGSCH
T ss_pred             ccceEccCCCCcce---eeecccccCCccccCH
Confidence            99997665432221   1111224689999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.1e-38  Score=259.94  Aligned_cols=164  Identities=24%  Similarity=0.341  Sum_probs=144.3

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+|++++.||+|+||.||+|+++.+++.||||+++..   .....+.+.+|+.+|..++||||+++++++..     ...
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----ccc
Confidence            4689999999999999999999999999999999632   23345778999999999999999999999754     334


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .++||||+.+++|.+++...+      .+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cccccccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence            789999999999999998765      688999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+.......           ..+||+.||||
T Consensus       187 ~a~~~~~~~~-----------~~~Gt~~Y~AP  207 (350)
T d1rdqe_         187 FAKRVKGRTW-----------TLCGTPEALAP  207 (350)
T ss_dssp             TCEECSSCBC-----------CCEECGGGCCH
T ss_pred             eeeecccccc-----------cccCccccCCH
Confidence            9997654321           26799999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.9e-38  Score=259.74  Aligned_cols=165  Identities=24%  Similarity=0.340  Sum_probs=138.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc---chhhHHHH---HHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ---KGAFRSFV---AECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....   ......+.   .|+.++..++||||+++++++..     
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-----   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-----
Confidence            57999999999999999999999999999999996321   11223333   44667777789999999999854     


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      .+.+++||||+++++|.+++....      .+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~  149 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS  149 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred             CCEEEEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEe
Confidence            344799999999999999998765      678889999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+|+........          ..+||+.||||
T Consensus       150 DFGla~~~~~~~~~----------~~~GT~~y~AP  174 (364)
T d1omwa3         150 DLGLACDFSKKKPH----------ASVGTHGYMAP  174 (364)
T ss_dssp             CCTTCEECSSSCCC----------SCCSCGGGCCH
T ss_pred             eeceeeecCCCccc----------ccccccccchh
Confidence            99999876543221          25799999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=250.80  Aligned_cols=169  Identities=25%  Similarity=0.440  Sum_probs=138.6

Q ss_pred             CCCCCc-eeecccceEEEEEEECC--CCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           47 EFSQSN-MIGQGSYGSVYKGILGE--DEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        47 ~~~~~~-~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      +|.+.+ +||+|+||+||+|.++.  ++..||||+++.. .....+++.+|+++|.+++||||+++++++...      .
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~   82 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------A   82 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------S
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------e
Confidence            455566 49999999999998764  4568999999744 334557899999999999999999999987431      2


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +++||||+++|+|.+++.....     .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFG  154 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG  154 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccch
Confidence            6899999999999999865432     688899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+...........     .....||+.||||
T Consensus       155 la~~~~~~~~~~~~-----~~~~~gt~~y~aP  181 (285)
T d1u59a_         155 LSKALGADDSYYTA-----RSAGKWPLKWYAP  181 (285)
T ss_dssp             TCEECTTCSCEECC-----CCSSCCCGGGCCH
T ss_pred             hhhccccccccccc-----ccccccCccccCh
Confidence            99977553322111     1125699999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-37  Score=244.00  Aligned_cols=167  Identities=27%  Similarity=0.499  Sum_probs=142.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      ++|+..+.||+|+||+||+|+++ ++..||||.++.... ..+.+++|+.++..++||||++++++|..     .+.+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~i   76 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceEE
Confidence            57999999999999999999985 678899999975433 34789999999999999999999999853     234799


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++|+|.+++.....     .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        77 v~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             EEEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence            9999999999999766543     577888999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ...........       ...||+.|+||
T Consensus       149 ~~~~~~~~~~~-------~~~~t~~y~aP  170 (258)
T d1k2pa_         149 YVLDDEYTSSV-------GSKFPVRWSPP  170 (258)
T ss_dssp             BCSSSSCCCCC-------CSCCCGGGCCH
T ss_pred             eccCCCceeec-------ccCCCCCcCCc
Confidence            76554322211       25699999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-37  Score=249.04  Aligned_cols=163  Identities=28%  Similarity=0.435  Sum_probs=134.0

Q ss_pred             ceeecccceEEEEEEEC--CCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceeeE
Q 039258           52 NMIGQGSYGSVYKGILG--EDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALVF  127 (234)
Q Consensus        52 ~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv~  127 (234)
                      +.||+|+||+||+|.++  .+++.||||+++..  ++...+.+.+|+++|.+++||||++++++|...      ..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence            47999999999999864  45678999999643  334457899999999999999999999998421      258999


Q ss_pred             eecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccccc
Q 039258          128 EYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKFL  207 (234)
Q Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~~  207 (234)
                      ||+++|+|.+++....      .+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+|++|||+++..
T Consensus        87 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          87 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence            9999999999998765      688999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCccCCCCCCCCccccccccccccCC
Q 039258          208 SSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .........     .....||+.||||
T Consensus       158 ~~~~~~~~~-----~~~~~gt~~y~AP  179 (277)
T d1xbba_         158 RADENYYKA-----QTHGKWPVKWYAP  179 (277)
T ss_dssp             CTTCSEEEC---------CCCGGGCCH
T ss_pred             ccccccccc-----ccccCCCceecCc
Confidence            543322111     1125699999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-37  Score=250.96  Aligned_cols=167  Identities=25%  Similarity=0.409  Sum_probs=141.7

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHH-hcCCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALR-NIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|++.+.||+|+||+||+|.++.+++.||||+++..   .....+.+..|..++. .++||||+++++++..     .+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence            4688999999999999999999999999999999632   2334456677777665 6899999999999854     34


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+++||||+++|+|.+++....      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|++||
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ceeEEEeecCCCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence            5799999999999999998765      688899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+++..........        ..+||+.|+||
T Consensus       148 G~a~~~~~~~~~~~--------~~~gt~~y~aP  172 (320)
T d1xjda_         148 GMCKENMLGDAKTN--------TFCGTPDYIAP  172 (320)
T ss_dssp             TTCBCCCCTTCCBC--------CCCSCGGGCCH
T ss_pred             chhhhccccccccc--------ccCCCCCcCCH
Confidence            99986544322211        25799999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-37  Score=251.93  Aligned_cols=167  Identities=19%  Similarity=0.291  Sum_probs=141.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||+||+|.++.+++.||||+++.... ....+.+|+++|..++||||+++++++..     .+.++
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFES-----MEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence            3568999999999999999999999999999999975432 23568899999999999999999999854     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC--CCceEEccCc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN--DMVAHVGDFG  202 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~--~~~vki~dfG  202 (234)
                      +||||+++++|.+++...+.     .+++.++..++.||+.||.|||++   +|+||||||+|||++.  ...+||+|||
T Consensus        78 lvmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence            99999999999999976542     588999999999999999999999   9999999999999974  4589999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++........         ...+||+.|+||
T Consensus       150 ~~~~~~~~~~~---------~~~~~t~~y~ap  172 (321)
T d1tkia_         150 QARQLKPGDNF---------RLLFTAPEYYAP  172 (321)
T ss_dssp             TCEECCTTCEE---------EEEESCGGGSCH
T ss_pred             hhhccccCCcc---------cccccccccccc
Confidence            99875443211         125689999997

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-37  Score=248.18  Aligned_cols=171  Identities=29%  Similarity=0.542  Sum_probs=133.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCC----eEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDE----MVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..|+..++||+|+||.||+|.++.++    ..||||.++.. .......+.+|+.++..++||||+++++++...     
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----
Confidence            35778899999999999999986544    57999999643 333446789999999999999999999998533     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      ...++||||++++++.+++.....     .+++..++.++.|++.|+.|||++   +|+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D  153 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD  153 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             CceEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcc
Confidence            346899999999999998876543     688899999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+++...........     .....||+.||||
T Consensus       154 FGla~~~~~~~~~~~~-----~~~~~gt~~Y~AP  182 (283)
T d1mqba_         154 FGLSRVLEDDPEATYT-----TSGGKIPIRWTAP  182 (283)
T ss_dssp             CCC----------------------CCCGGGSCH
T ss_pred             cchhhcccCCCccceE-----eccCCCCccccCH
Confidence            9999976554322111     1124689999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.8e-37  Score=247.24  Aligned_cols=175  Identities=19%  Similarity=0.380  Sum_probs=140.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..   +......+.+|++++..++||||+++++++...+. ...
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~-~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS-SSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC-CCc
Confidence            45699999999999999999999999999999999643   23345678999999999999999999999876442 334


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      ..++||||+++++|.+++...+      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++++||
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred             eEEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence            5689999999999999987765      688999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |.+...........     .....+||+.||||
T Consensus       156 ~~~~~~~~~~~~~~-----~~~~~~Gt~~Y~aP  183 (277)
T d1o6ya_         156 GIARAIADSGNSVT-----QTAAVIGTAQYLSP  183 (277)
T ss_dssp             TTCEECC---------------------TTCCH
T ss_pred             hhhhhhcccccccc-----ccccccCcccccCH
Confidence            99876544322111     11236799999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-37  Score=251.98  Aligned_cols=176  Identities=24%  Similarity=0.409  Sum_probs=138.9

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCC-----eEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDE-----MVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~  117 (234)
                      ..+|++.+.||+|+||+||+|++..++     ..||+|.+... .......+.+|+.+|.++ +||||+++++++..   
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~---  112 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---  112 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee---
Confidence            356888999999999999999986543     47999998643 334457789999999998 89999999999854   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCC-----------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDH-----------------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVH  180 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH  180 (234)
                        .+.+++||||+++|+|.+++......                 .....+++..++.++.|++.||.|||++   +|||
T Consensus       113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH  187 (325)
T d1rjba_         113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  187 (325)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             --CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence              33479999999999999999764321                 0112478889999999999999999999   9999


Q ss_pred             cCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          181 GDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       181 ~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||||+||+++.++.+||+|||+|+..........      .....||+.||||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~------~~~~~gt~~y~aP  235 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV------RGNARLPVKWMAP  235 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEE------ETTEEECGGGCCH
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceee------eccccCCCccCCh
Confidence            99999999999999999999999987554332111      1125689999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-37  Score=249.58  Aligned_cols=163  Identities=28%  Similarity=0.417  Sum_probs=132.9

Q ss_pred             CCceeecccceEEEEEEECCCCeEEEEEEeecccc-----hhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           50 QSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK-----GAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        50 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+++||+|+||+||+|+++.+++.||||+++....     ...+.+.+|+.+|..++||||+++++++..     .+.++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence            35789999999999999999999999999964321     123578899999999999999999999853     34479


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||++++++..+.....      .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        77 ivmE~~~~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a  147 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  147 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ehhhhhcchHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccc
Confidence            9999998876665554333      577788899999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........        ..+||+.||||
T Consensus       148 ~~~~~~~~~~~--------~~~gt~~y~aP  169 (299)
T d1ua2a_         148 KSFGSPNRAYT--------HQVVTRWYRAP  169 (299)
T ss_dssp             STTTSCCCCCC--------CSCCCCTTCCH
T ss_pred             cccCCCccccc--------ceecChhhccH
Confidence            87554322211        25799999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-37  Score=251.31  Aligned_cols=167  Identities=23%  Similarity=0.344  Sum_probs=138.9

Q ss_pred             cCCCCC-ceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQS-NMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|.+. +.||+|+||+||+|++..+++.||||+++..     ..+.+|++++.++ +||||+++++++.... ....++
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEE
Confidence            468776 4699999999999999999999999998632     4567899987654 8999999999886532 234557


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC---CCceEEcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN---DMVAHVGD  200 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~---~~~vki~d  200 (234)
                      ++|||||++|+|.+++...+..    .+++.++..++.|++.||.|||++   +|+||||||+|||++.   .+.+||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCC----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEECCCCCcHHHHHHhcCCC----CcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence            9999999999999999865432    688999999999999999999999   9999999999999974   56799999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|+.........         ..+||+.||||
T Consensus       158 FG~a~~~~~~~~~~---------~~~gt~~y~aP  182 (335)
T d2ozaa1         158 FGFAKETTSHNSLT---------TPCYTPYYVAP  182 (335)
T ss_dssp             CTTCEECCCCCCCC---------CCSCCCSSCCC
T ss_pred             cceeeeccCCCccc---------cccCCcccCCc
Confidence            99998765543221         25799999999

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-37  Score=248.03  Aligned_cols=168  Identities=28%  Similarity=0.516  Sum_probs=135.3

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ..+|++.+.||+|+||+||+|+++.+ ..||||+++... ...+.+.+|+.++.+++||||+++++++..      +..+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~   87 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   87 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence            35789999999999999999999766 569999996443 334789999999999999999999998732      1258


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      +||||+++|+|.+++......    .+++.+++.++.||+.||.|||++   +++||||||+|||++.++++||+|||+|
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~----~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEEEecCCCchhhhhhhcccc----cchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence            999999999999988764321    588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +..........       ....||+.|+||
T Consensus       161 ~~~~~~~~~~~-------~~~~gt~~y~aP  183 (285)
T d1fmka3         161 RLIEDNEYTAR-------QGAKFPIKWTAP  183 (285)
T ss_dssp             C---------------------CCGGGSCH
T ss_pred             hhccCCCceee-------ccccccccccCh
Confidence            87654332211       124699999998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-36  Score=246.05  Aligned_cols=168  Identities=25%  Similarity=0.428  Sum_probs=138.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++.+.||+|+||+||+|.+..+++.||||+++...  +...+++.+|+++|+.++||||+++++++...     +.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence            47889999999999999999999999999999996432  23457889999999999999999999998643     347


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++||||+.+ ++.+++......    .+++..+..++.|++.||.|||++   +||||||||+|||++.++.+|++|||+
T Consensus        77 ~iv~e~~~~-~~~~~~~~~~~~----~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          77 YLVFEFLHQ-DLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             EEEEECCSE-EHHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             eEEEeecCC-chhhhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence            999999965 566655443322    689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+..........        ...||+.|+||
T Consensus       149 a~~~~~~~~~~~--------~~~gt~~y~ap  171 (298)
T d1gz8a_         149 ARAFGVPVRTYT--------HEVVTLWYRAP  171 (298)
T ss_dssp             HHHHCCCSBCTT--------CCBCCCTTCCH
T ss_pred             ceeccCCcccce--------eecccceeeeh
Confidence            987654322211        15699999997

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-36  Score=247.31  Aligned_cols=169  Identities=24%  Similarity=0.460  Sum_probs=136.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCe----EEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEM----VVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      .+|++.+.||+|+||+||+|.+..+++    .||+|.++.. .....+.+.+|+.++.+++||||++++++|...     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            468999999999999999999987764    6888887533 334557899999999999999999999998532     


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                       ..+++||++.+++|.+++.....     .+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D  154 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD  154 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred             -CeeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence             14789999999999998876543     688899999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|+...........      ....||+.||||
T Consensus       155 FGla~~~~~~~~~~~~------~~~~gt~~y~AP  182 (317)
T d1xkka_         155 FGLAKLLGAEEKEYHA------EGGKVPIKWMAL  182 (317)
T ss_dssp             CSHHHHTTTTCC--------------CCTTTSCH
T ss_pred             cccceecccccccccc------cccccCccccCh
Confidence            9999976553322211      124689999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-36  Score=243.59  Aligned_cols=183  Identities=21%  Similarity=0.341  Sum_probs=135.9

Q ss_pred             HHHHHHhcCCCCCceeecccceEEEEEEECC-----CCeEEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEE
Q 039258           39 AELSKATCEFSQSNMIGQGSYGSVYKGILGE-----DEMVVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITI  111 (234)
Q Consensus        39 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~  111 (234)
                      .+++....+|++.+.||+|+||.||+|.+..     +++.||||.++.. .....+.+.+|...+.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            3444445679999999999999999999753     4578999999643 233446788888888777 68999999998


Q ss_pred             eeecCCCCCCcceeeEeecCCCCHHHHhhhccCC----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 039258          112 CSSIDSKGADFKALVFEYMENGSLEDWLHQTNDH----------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHG  181 (234)
Q Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~  181 (234)
                      +...    ...+++||||+++|+|.+++......          .....+++..++.++.||+.||.|||++   +|+||
T Consensus        86 ~~~~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr  158 (299)
T d1ywna1          86 CTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  158 (299)
T ss_dssp             ECST----TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             eccC----CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCC
Confidence            7432    34478999999999999999764321          0112478899999999999999999999   99999


Q ss_pred             CCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          182 DIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       182 dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||||+|||++.++.+||+|||+|+..........      .....||+.||||
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~------~~~~~gt~~y~AP  205 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVR------KGDARLPLKWMAP  205 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTTSCC------TTSCCCGGGGCCH
T ss_pred             cCCccceeECCCCcEEEccCcchhhccccccccc------cCceeeCccccch
Confidence            9999999999999999999999987654332211      1125799999998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-36  Score=244.38  Aligned_cols=180  Identities=27%  Similarity=0.428  Sum_probs=143.8

Q ss_pred             HHHHhcCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhcCCCCceeEEEEeee
Q 039258           41 LSKATCEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNIRHRNLTKIITICSS  114 (234)
Q Consensus        41 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~  114 (234)
                      +....++|++.+.||+|+||+||+|+++     .++..||||.++... ....+++.+|+++|+.++|||+++++++|..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3344667999999999999999999975     356899999997543 3345779999999999999999999999854


Q ss_pred             cCCCCCCcceeeEeecCCCCHHHHhhhccCC------------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCC
Q 039258          115 IDSKGADFKALVFEYMENGSLEDWLHQTNDH------------------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQP  176 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~  176 (234)
                      .     ...+++|||+++++|.+++......                  .....+++..++.++.|++.||+|+|++   
T Consensus        88 ~-----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---  159 (301)
T d1lufa_          88 G-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---  159 (301)
T ss_dssp             S-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             C-----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---
Confidence            3     3368999999999999998653211                  1122478889999999999999999999   


Q ss_pred             CeeecCCCCCCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          177 PMVHGDIKPSNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       177 ~ivH~dlk~~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++|||||||+|||++.++.+||+|||+|+...........      ....||+.||||
T Consensus       160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~------~~~~~~~~y~aP  211 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD------GNDAIPIRWMPP  211 (301)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCH
T ss_pred             CeEeeEEcccceEECCCCcEEEccchhheeccCCcccccc------CCCCcCcCcCCH
Confidence            9999999999999999999999999999876543322211      125689999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-36  Score=242.10  Aligned_cols=166  Identities=23%  Similarity=0.341  Sum_probs=138.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccc------hhhHHHHHHHHHHHhcC--CCCceeEEEEeeecC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK------GAFRSFVAECEALRNIR--HRNLTKIITICSSID  116 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~l~~~~~~~~  116 (234)
                      .++|++.+.||+|+||+||+|++..+++.||||+++....      ....++.+|+.+|.+++  ||||+++++++... 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence            4579999999999999999999999999999999964311      12234678999999986  89999999998543 


Q ss_pred             CCCCCcceeeEeecCC-CCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-CC
Q 039258          117 SKGADFKALVFEYMEN-GSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-DM  194 (234)
Q Consensus       117 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-~~  194 (234)
                          +..++||||+.+ +++.+++....      .+++..+..++.|++.||.|||++   +|+||||||+|||++. ++
T Consensus        82 ----~~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~  148 (273)
T d1xwsa_          82 ----DSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG  148 (273)
T ss_dssp             ----SEEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred             ----CeEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCC
Confidence                447999999975 57888887665      688999999999999999999999   9999999999999984 57


Q ss_pred             ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          195 VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       195 ~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .+||+|||+|+........          ..+||+.||||
T Consensus       149 ~vkl~DFG~a~~~~~~~~~----------~~~GT~~y~aP  178 (273)
T d1xwsa_         149 ELKLIDFGSGALLKDTVYT----------DFDGTRVYSPP  178 (273)
T ss_dssp             EEEECCCTTCEECCSSCBC----------CCCSCGGGSCH
T ss_pred             eEEECccccceeccccccc----------ccccCCCcCCH
Confidence            9999999999865443211          26799999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-36  Score=239.32  Aligned_cols=169  Identities=25%  Similarity=0.431  Sum_probs=130.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCC---CeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGED---EMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~  120 (234)
                      ..+|++.+.||+|+||+||+|.+..+   +..||||.++.. .....+.+.+|+++|++++||||+++++++..      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            35688899999999999999998654   467899988643 33445779999999999999999999998732      


Q ss_pred             CcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEcc
Q 039258          121 DFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGD  200 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~d  200 (234)
                      +..++||||+++|+|.+++.....     .+++..++.++.||+.||.|+|++   +++||||||+||+++.++.+||+|
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D  151 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  151 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence            236899999999999998766542     678899999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          201 FGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       201 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ||+|+..........       ....||+.|+||
T Consensus       152 fG~a~~~~~~~~~~~-------~~~~gt~~y~ap  178 (273)
T d1mp8a_         152 FGLSRYMEDSTYYKA-------SKGKLPIKWMAP  178 (273)
T ss_dssp             --------------------------CCGGGCCH
T ss_pred             chhheeccCCcceec-------cceecCcccchh
Confidence            999987654322211       114689999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-35  Score=244.46  Aligned_cols=173  Identities=25%  Similarity=0.335  Sum_probs=139.9

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      .+|++.+.||+|+||+||+|.+..+++.||||+++.. .....+++.+|+++|..++|||++++++++..........++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4689999999999999999999999999999999643 334456889999999999999999999998655443344445


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLS  204 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a  204 (234)
                      ++ +++.+++|.+++...       .+++..+..++.|++.||.|||++   +||||||||+|||++.++.+||+|||+|
T Consensus        88 l~-~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          88 LV-THLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             EE-EECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EE-EeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence            55 556688999999754       588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........     ....+||+.|+||
T Consensus       157 ~~~~~~~~~~~~-----~~~~~gt~~y~aP  181 (345)
T d1pmea_         157 RVADPDHDHTGF-----LTEYVATRWYRAP  181 (345)
T ss_dssp             EECCGGGCBCCT-----TCCCCSCGGGCCG
T ss_pred             eeccCCCcccee-----eccccccceechH
Confidence            876554322211     1125799999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-35  Score=239.36  Aligned_cols=173  Identities=24%  Similarity=0.401  Sum_probs=138.2

Q ss_pred             hcCCCCCceeecccceEEEEEEECCC-CeEEEEEEeecc--cchhhHHHHHHHHHHHhc---CCCCceeEEEEeeecCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGED-EMVVAVKVINLK--QKGAFRSFVAECEALRNI---RHRNLTKIITICSSIDSK  118 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~~i~~l~~~~~~~~~~  118 (234)
                      ..+|++++.||+|+||+||+|++..+ ++.||||+++..  .......+.+|+.+|+.+   +||||+++++++......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999999755 678999999643  222234566777777655   799999999998765555


Q ss_pred             CCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEE
Q 039258          119 GADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                      ...+.+++||+++++++.........     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCceEEEEEEeccCCchhhhhhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence            56678999999987655544433322     678889999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++.........         ..+||+.||||
T Consensus       158 ~dfg~~~~~~~~~~~~---------~~~gT~~Y~AP  184 (305)
T d1blxa_         158 ADFGLARIYSFQMALT---------SVVVTLWYRAP  184 (305)
T ss_dssp             CSCCSCCCCCGGGGGC---------CCCCCCTTCCH
T ss_pred             cchhhhhhhcccccCC---------CcccChhhcCc
Confidence            9999988654432211         26799999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=236.36  Aligned_cols=168  Identities=26%  Similarity=0.535  Sum_probs=137.8

Q ss_pred             CceeecccceEEEEEEECCC---CeEEEEEEeec-ccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcceee
Q 039258           51 SNMIGQGSYGSVYKGILGED---EMVVAVKVINL-KQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKALV  126 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~lv  126 (234)
                      .++||+|+||+||+|.+..+   ...||||.++. ......+++.+|+++|.+++||||+++++++...+    ...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEEE
Confidence            46899999999999998654   34799999863 34555688999999999999999999999886433    236899


Q ss_pred             EeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          127 FEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      |||+++++|.+++.....     ..++..++.++.|++.||.|+|+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       108 ~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~  179 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  179 (311)
T ss_dssp             EECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred             EEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence            999999999999876543     466778899999999999999999   999999999999999999999999999997


Q ss_pred             cCCCccCCCCCCCCccccccccccccCC
Q 039258          207 LSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ..........    ......||+.|+||
T Consensus       180 ~~~~~~~~~~----~~~~~~gt~~y~aP  203 (311)
T d1r0pa_         180 MYDKEFDSVH----NKTGAKLPVKWMAL  203 (311)
T ss_dssp             TTTTTCCCTT----CTTCSSCCGGGSCH
T ss_pred             ccccccccce----ecccccccccccCh
Confidence            7654332211    11125689999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-35  Score=239.00  Aligned_cols=172  Identities=27%  Similarity=0.409  Sum_probs=134.3

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHH--HHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECE--ALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~--~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      ++|.+.+.||+|+||.||+|++  +|+.||||+++....   +.+.+|.+  .+..++||||+++++++...+ .+...+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence            4577788999999999999987  578999999864432   33444544  445679999999999987644 233457


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeecCCCCCCeeeCCCCceEE
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNC-----QPPMVHGDIKPSNVLLDNDMVAHV  198 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-----~~~ivH~dlk~~nil~~~~~~vki  198 (234)
                      ++||||+++|+|.+++.+.       .+++..++.++.|++.||.|+|+..     ..+|+||||||+|||++.++.+||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             EEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            8999999999999999764       5788899999999999999999620     128999999999999999999999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+++...........    ......||+.||||
T Consensus       150 ~DFGl~~~~~~~~~~~~~----~~~~~~gt~~y~aP  181 (303)
T d1vjya_         150 ADLGLAVRHDSATDTIDI----APNHRVGTKRYMAP  181 (303)
T ss_dssp             CCCTTCEEEETTTTEECC--------CCSCGGGCCH
T ss_pred             EecCccccccCCCcceec----cccceecccCcCCh
Confidence            999999876543211110    11125799999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.5e-35  Score=239.44  Aligned_cols=162  Identities=22%  Similarity=0.358  Sum_probs=137.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCcce
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADFKA  124 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~~~  124 (234)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..   ..+++.+|+++|..++ ||||+++++++...   ....++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence            4699999999999999999999999999999998643   2367889999999995 99999999987542   234578


Q ss_pred             eeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC-CceEEccCcc
Q 039258          125 LVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND-MVAHVGDFGL  203 (234)
Q Consensus       125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~-~~vki~dfG~  203 (234)
                      +||||+++++|..+..         .+++..+..++.||+.||.|||++   +|+||||||+|||++.+ +.+|++|||+
T Consensus       109 ~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             EEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             EEEeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence            9999999999876642         588899999999999999999999   99999999999999865 4699999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+.........         ..+||+.|+||
T Consensus       177 a~~~~~~~~~~---------~~~~t~~y~aP  198 (328)
T d3bqca1         177 AEFYHPGQEYN---------VRVASRYFKGP  198 (328)
T ss_dssp             CEECCTTCCCC---------SCCSCGGGCCH
T ss_pred             ceeccCCCccc---------ccccCccccCc
Confidence            98765532211         25699999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-35  Score=238.77  Aligned_cols=177  Identities=25%  Similarity=0.390  Sum_probs=138.0

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC---CC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS---KG  119 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~---~~  119 (234)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++...  .+....++.+|+.+|..++|||++++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            46799999999999999999999999999999998643  33345788999999999999999999998755322   22


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                      .+.+++||||++++.+........      .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCCCccchhhhccc------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence            455789999997765554443333      678888999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++............    ....+||+.|+||
T Consensus       160 dfg~~~~~~~~~~~~~~~----~~~~~gT~~Y~aP  190 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNR----YTNRVVTLWYRPP  190 (318)
T ss_dssp             CCTTCEECCC-----CCC----CCSCCSCGGGCCH
T ss_pred             ecceeeeccccccccccc----ccceecCHHHhhH
Confidence            999998766443222111    1125799999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-35  Score=241.35  Aligned_cols=169  Identities=25%  Similarity=0.388  Sum_probs=134.3

Q ss_pred             CCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCCccee
Q 039258           47 EFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGADFKAL  125 (234)
Q Consensus        47 ~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~~~~l  125 (234)
                      +|+..++||+|+||+||+|++..+++.||||++......    ..+|+++|+.++||||+++++++..... .+..++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            588889999999999999999999999999999644322    2379999999999999999999865432 34566789


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCC-ceEEccCccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDM-VAHVGDFGLS  204 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~-~vki~dfG~a  204 (234)
                      ||||+++ ++.+.+......  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||++
T Consensus        97 v~Ey~~~-~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          97 VLDYVPE-TVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEECCSE-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEeccCC-ccHHHHHhhhhc--cCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            9999976 444444321100  11688999999999999999999999   999999999999998764 8999999999


Q ss_pred             cccCCCccCCCCCCCCccccccccccccCC
Q 039258          205 KFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +.........         ..+||+.|+||
T Consensus       171 ~~~~~~~~~~---------~~~gt~~y~aP  191 (350)
T d1q5ka_         171 KQLVRGEPNV---------SYICSRYYRAP  191 (350)
T ss_dssp             EECCTTSCCC---------SCCSCTTSCCH
T ss_pred             hhccCCcccc---------cccccccccCh
Confidence            8765432211         25799999997

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-35  Score=238.56  Aligned_cols=172  Identities=28%  Similarity=0.455  Sum_probs=137.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCe--EEEEEEeecc-cchhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCCCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEM--VVAVKVINLK-QKGAFRSFVAECEALRNI-RHRNLTKIITICSSIDSKGAD  121 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~~~~~  121 (234)
                      .+|++.+.||+|+||+||+|.++.++.  .||||.++.. .....+.+.+|+++|..+ +||||++++++|...     +
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence            468888999999999999999987775  4777877532 334456899999999998 799999999998643     3


Q ss_pred             cceeeEeecCCCCHHHHhhhccC----------CccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC
Q 039258          122 FKALVFEYMENGSLEDWLHQTND----------HLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD  191 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~  191 (234)
                      .+++||||+++|+|.+++.....          ......+++..+..++.||+.||.|+|++   +++||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence            47999999999999999865421          01112688999999999999999999999   999999999999999


Q ss_pred             CCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          192 NDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       192 ~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .++.+||+|||+++.........         ...||..|+||
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~~~---------~~~gt~~y~aP  195 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVKKT---------MGRLPVRWMAI  195 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECCC-------------CCTTTCCH
T ss_pred             CCCceEEcccccccccccccccc---------ceecCCcccch
Confidence            99999999999998654432221         15689999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-35  Score=240.71  Aligned_cols=168  Identities=23%  Similarity=0.366  Sum_probs=136.5

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGAD  121 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~  121 (234)
                      ..+|++.+.||+|+||+||+|.++.+++.||||+++..  .....+.+.+|+++|+.++|||+++++++|...+. ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            45799999999999999999999999999999999643  23345678999999999999999999999865432 1334


Q ss_pred             cceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccC
Q 039258          122 FKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDF  201 (234)
Q Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~df  201 (234)
                      .+++||||+ +.+|..++...       .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|++||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecc-cccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence            568999999 56787776543       588999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          202 GLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       202 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|+.......           ...||+.|+||
T Consensus       166 g~a~~~~~~~~-----------~~~~t~~y~aP  187 (346)
T d1cm8a_         166 GLARQADSEMT-----------GYVVTRWYRAP  187 (346)
T ss_dssp             TTCEECCSSCC-----------SSCSCGGGCCT
T ss_pred             cceeccCCccc-----------cccccccccCH
Confidence            99987654321           15699999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-35  Score=235.01  Aligned_cols=170  Identities=27%  Similarity=0.413  Sum_probs=131.2

Q ss_pred             cCCCCCceeecccceEEEEEEEC-CC--CeEEEEEEeecc---cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILG-ED--EMVVAVKVINLK---QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKG  119 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~-~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~  119 (234)
                      .+|++.+.||+|+||.||+|++. .+  ...||||+++..   .+...+.+.+|+.+|.+++||||+++++++...    
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~----   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence            56888999999999999999864 23  357999998643   344457899999999999999999999998432    


Q ss_pred             CCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEc
Q 039258          120 ADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVG  199 (234)
Q Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~  199 (234)
                        ..++||||++++++.+.+.....     .+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+|++
T Consensus        84 --~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~  153 (273)
T d1u46a_          84 --PMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG  153 (273)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             --chheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence              25899999999999998876543     688999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          200 DFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       200 dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |||+++...........     .....||..|+||
T Consensus       154 DfGl~~~~~~~~~~~~~-----~~~~~~~~~~~aP  183 (273)
T d1u46a_         154 DFGLMRALPQNDDHYVM-----QEHRKVPFAWCAP  183 (273)
T ss_dssp             CCTTCEECCC-CCEEEC----------CCGGGCCH
T ss_pred             cchhhhhcccCCCccee-----cCccccCcccCCH
Confidence            99999976554322111     1114578899998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.5e-35  Score=236.07  Aligned_cols=166  Identities=24%  Similarity=0.375  Sum_probs=135.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++.+.||+|+||+||+|+++ +++.||||+++..  .....+++.+|+.+|+.++||||+++++++...     ...
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence            46889999999999999999985 6789999999643  233457899999999999999999999998543     336


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      +++||++.++.+..+....+      .+++..+..++.||+.||+|||++   +||||||||+|||++.++.+|++|||+
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             eEEEEeehhhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence            89999997755555554443      689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCccCCCCCCCCccccccccccccCC
Q 039258          204 SKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       204 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +...........        ...||+.|+||
T Consensus       147 a~~~~~~~~~~~--------~~~~~~~y~~p  169 (286)
T d1ob3a_         147 ARAFGIPVRKYT--------HEIVTLWYRAP  169 (286)
T ss_dssp             HHHHCC-----------------CCCTTCCH
T ss_pred             ceecccCccccc--------eecccchhhhH
Confidence            987654322211        14588889887

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-35  Score=233.36  Aligned_cols=163  Identities=35%  Similarity=0.473  Sum_probs=130.8

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      .+|+..+.||+|+||.||+|.+  ++..||||.++..  ...+.+.+|+++++.++||||++++++|...    .+.+++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEEE
Confidence            4677889999999999999998  4678999999643  3447899999999999999999999987432    233689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcccc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSK  205 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~  205 (234)
                      ||||+++|+|.+++......    .+++..++.++.||+.||.|||++   +++||||||+||+++.++.+|++|||+++
T Consensus        79 v~ey~~~g~L~~~l~~~~~~----~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHH----HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             EEeccCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccce
Confidence            99999999999999764321    578899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCccCCCCCCCCccccccccccccCC
Q 039258          206 FLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      .......           ...+|+.|+||
T Consensus       152 ~~~~~~~-----------~~~~~~~y~aP  169 (262)
T d1byga_         152 EASSTQD-----------TGKLPVKWTAP  169 (262)
T ss_dssp             ---------------------CCTTTSCH
T ss_pred             ecCCCCc-----------cccccccCCCh
Confidence            6543211           14588899998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-35  Score=239.01  Aligned_cols=177  Identities=23%  Similarity=0.401  Sum_probs=141.7

Q ss_pred             HhcCCCCCceeecccceEEEEEEECC-----CCeEEEEEEeecc-cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC
Q 039258           44 ATCEFSQSNMIGQGSYGSVYKGILGE-----DEMVVAVKVINLK-QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS  117 (234)
Q Consensus        44 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~  117 (234)
                      ...+|++.+.||+|+||.||+|.+..     ++..||||.++.. .......+.+|++++..++||||+++++++...  
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--   95 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--   95 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC--
Confidence            34678889999999999999998752     3578999999643 333446789999999999999999999998533  


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCC----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCC
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDH----LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDND  193 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~  193 (234)
                         ...++||||+++|+|.+++......    .....+++..+..++.|++.||.|||++   +|+||||||+|||++.+
T Consensus        96 ---~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          96 ---QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  169 (308)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ---CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence               3369999999999999998653211    1112467888999999999999999999   99999999999999999


Q ss_pred             CceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          194 MVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       194 ~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++||+|||+|+..........      .....||+.|+||
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~------~~~~~~t~~y~aP  204 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRK------GGKGLLPVRWMSP  204 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEG------GGSSEECGGGCCH
T ss_pred             ceEEEeecccceeccCCcceee------ccceecccccCCH
Confidence            9999999999987654332111      1124689999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-34  Score=234.14  Aligned_cols=176  Identities=22%  Similarity=0.397  Sum_probs=142.5

Q ss_pred             hcCCCCCceeecccceEEEEEEEC-----CCCeEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeecCC
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILG-----EDEMVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSIDS  117 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~~~  117 (234)
                      ..+|++.+.||+|+||.||+|++.     .++..||||+++... ......+.+|+.++.++ +||||++++++|..   
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~---   98 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence            357888999999999999999863     466899999997543 33456789999999999 69999999999853   


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCC------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDH------------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP  185 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~  185 (234)
                        .+..++||||+++++|.+++......            .....+++..+..++.||+.|+.|||++   +++||||||
T Consensus        99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp  173 (311)
T d1t46a_          99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (311)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence              33469999999999999998764321            1122578899999999999999999999   999999999


Q ss_pred             CCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          186 SNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       186 ~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +||+++.++.+|++|||+++...........      ...+||+.|+||
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~------~~~~gt~~y~aP  216 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVK------GNARLPVKWMAP  216 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEEC------SSSEECGGGCCH
T ss_pred             ccccccccCcccccccchheeccCCCcceEe------eecccChHHcCH
Confidence            9999999999999999999876543322111      125799999998

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9e-34  Score=229.14  Aligned_cols=173  Identities=21%  Similarity=0.321  Sum_probs=139.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCC-CCceeEEEEeeecCCCCCCcc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH-RNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...  ....+.+|++.+..+.| +|++.+++++..     ....
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCcc
Confidence            357999999999999999999999999999999986432  22456788999999965 899899888643     3446


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCC-----CCceEE
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDN-----DMVAHV  198 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~-----~~~vki  198 (234)
                      ++||||+ +++|.+++...+.     .+++..+..++.|++.||.|+|++   +|+||||||+||+++.     ++.+||
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EEEEEec-CCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEE
Confidence            8999999 6899999876543     578889999999999999999999   9999999999999963     578999


Q ss_pred             ccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          199 GDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       199 ~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||+|+.+.......... .......+||+.||||
T Consensus       148 ~DFG~a~~~~~~~~~~~~~-~~~~~~~~GT~~y~aP  182 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIP-YREKKNLSGTARYMSI  182 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCC-CCCCCCCCSCTTTCCH
T ss_pred             cccceeEEcccCcccccee-ecccCceEEchhhcCH
Confidence            9999999876543322211 1112236899999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-34  Score=229.14  Aligned_cols=151  Identities=23%  Similarity=0.414  Sum_probs=133.2

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCcc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFK  123 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~  123 (234)
                      .+|++.+.||+|+||+||+|++..+++.||||+++..  ......++.+|+.+|+.++||||+++++++...     ...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence            4689999999999999999999999999999999644  234457889999999999999999999998543     346


Q ss_pred             eeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCcc
Q 039258          124 ALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFGL  203 (234)
Q Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG~  203 (234)
                      ++|+|++.++++..++...+      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||.
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEeeecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence            89999999888888776654      678889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCC
Q 039258          204 SKFLSSD  210 (234)
Q Consensus       204 a~~~~~~  210 (234)
                      |+.....
T Consensus       148 a~~~~~~  154 (292)
T d1unla_         148 ARAFGIP  154 (292)
T ss_dssp             CEECCSC
T ss_pred             hhcccCC
Confidence            9876554

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-34  Score=230.61  Aligned_cols=176  Identities=24%  Similarity=0.392  Sum_probs=137.4

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCC-------eEEEEEEeeccc-chhhHHHHHHHHHHHhc-CCCCceeEEEEeeec
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDE-------MVVAVKVINLKQ-KGAFRSFVAECEALRNI-RHRNLTKIITICSSI  115 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~l~~~~~~~  115 (234)
                      ..+|++.+.||+|+||.||+|++..++       ..||||.++... ......+.+|...+.++ +||||++++++|.. 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            457888999999999999999875443       579999997543 23446788899999888 79999999999853 


Q ss_pred             CCCCCCcceeeEeecCCCCHHHHhhhccCC----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 039258          116 DSKGADFKALVFEYMENGSLEDWLHQTNDH----------LEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKP  185 (234)
Q Consensus       116 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~  185 (234)
                          .+..++||||+++|+|.+++......          .....+++..++.++.|++.||.|+|++   +||||||||
T Consensus        91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp  163 (299)
T d1fgka_          91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  163 (299)
T ss_dssp             ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence                34479999999999999999765321          1122578999999999999999999999   999999999


Q ss_pred             CCeeeCCCCceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          186 SNVLLDNDMVAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       186 ~nil~~~~~~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|||++.++.+||+|||+++...........      ....||+.|+||
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~------~~~~~~~~y~aP  206 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKT------TNGRLPVKWMAP  206 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTCCC------TTSCCGGGGSCH
T ss_pred             cceeecCCCCeEeccchhhcccccccccccc------ccCCCChhhhhh
Confidence            9999999999999999999977654433211      125699999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-33  Score=229.26  Aligned_cols=173  Identities=26%  Similarity=0.398  Sum_probs=136.5

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCccee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADFKAL  125 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~~~l  125 (234)
                      ++|++.+.||+|+||+||+|++..+++.||||++.....  ...+..|+++++.++|+|++..+..+..    ..+..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEE
Confidence            469999999999999999999999999999999875432  2457889999999988877666655533    2345689


Q ss_pred             eEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeC---CCCceEEccCc
Q 039258          126 VFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLD---NDMVAHVGDFG  202 (234)
Q Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~---~~~~vki~dfG  202 (234)
                      ||||+ ++++.+.+.....     .+++..+..++.|++.||+|+|++   +|+||||||+|||++   .+..+|++|||
T Consensus        81 vme~~-~~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             EEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             EEEEc-CCchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence            99999 5677777655432     688899999999999999999999   999999999999985   45579999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +|+............ .......+||+.||||
T Consensus       152 ~a~~~~~~~~~~~~~-~~~~~~~~gt~~y~aP  182 (299)
T d1ckia_         152 LAKKYRDARTHQHIP-YRENKNLTGTARYASI  182 (299)
T ss_dssp             SCEECBCTTTCCBCC-CCBCCSCCCCSSSCCH
T ss_pred             cceecccccccccee-ccccCCcCCCccccCH
Confidence            999876544332211 1112236799999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-34  Score=236.41  Aligned_cols=169  Identities=21%  Similarity=0.332  Sum_probs=137.7

Q ss_pred             hcCCCCCceeecccceEEEEEEECCCCeEEEEEEeeccc--chhhHHHHHHHHHHHhcCCCCceeEEEEeeecCCCCCCc
Q 039258           45 TCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQ--KGAFRSFVAECEALRNIRHRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        45 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      ..+|++.+.||+|+||+||+|++..+++.||||+++...  ....+++.+|+++|..++|||++++++++..........
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            346999999999999999999999999999999997432  234467889999999999999999999886544323333


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      .+++|+++.+++|.+++...       .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|++|||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence            45667778899999998543       588999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++........           +..||+.|+||
T Consensus       167 ~a~~~~~~~~-----------~~~g~~~y~ap  187 (348)
T d2gfsa1         167 LARHTDDEMT-----------GYVATRWYRAP  187 (348)
T ss_dssp             ---CCTGGGS-----------SSCHHHHTSCH
T ss_pred             hhcccCcccc-----------cccccccccCc
Confidence            9886543221           25699999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-34  Score=233.03  Aligned_cols=168  Identities=26%  Similarity=0.368  Sum_probs=140.6

Q ss_pred             cCCCCCceeecccceEEEEEEE---CCCCeEEEEEEeecc----cchhhHHHHHHHHHHHhcCC-CCceeEEEEeeecCC
Q 039258           46 CEFSQSNMIGQGSYGSVYKGIL---GEDEMVVAVKVINLK----QKGAFRSFVAECEALRNIRH-RNLTKIITICSSIDS  117 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~l~~~~~~~~~  117 (234)
                      .+|++.+.||+|+||+||+|++   +.+++.||||+++..    .....+.+.+|++++.+++| |||+++++++...  
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~--  101 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE--  101 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence            4599999999999999999987   357899999998632    22334678899999999976 8999999987543  


Q ss_pred             CCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceE
Q 039258          118 KGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAH  197 (234)
Q Consensus       118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vk  197 (234)
                         ...+++|||+++++|.+++....      .+++..+..++.|++.||.|+|++   +++||||||+||+++.++.+|
T Consensus       102 ---~~~~~v~e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk  169 (322)
T d1vzoa_         102 ---TKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV  169 (322)
T ss_dssp             ---TEEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             ---CceeeeeecccccHHHHHHHhcc------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence               34799999999999999998776      577888999999999999999999   999999999999999999999


Q ss_pred             EccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          198 VGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       198 i~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      |+|||+++.+........       ....||+.|+||
T Consensus       170 L~DFG~a~~~~~~~~~~~-------~~~~g~~~~~~p  199 (322)
T d1vzoa_         170 LTDFGLSKEFVADETERA-------YDFCGTIEYMAP  199 (322)
T ss_dssp             ESCSSEEEECCGGGGGGG-------CGGGSCCTTCCH
T ss_pred             Eeeccchhhhcccccccc-------cccccccccchh
Confidence            999999987654332221       125688999887

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-33  Score=232.93  Aligned_cols=168  Identities=21%  Similarity=0.309  Sum_probs=131.0

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecc--cchhhHHHHHHHHHHHhcCCCCceeEEEEeeecCC-CCCCc
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLK--QKGAFRSFVAECEALRNIRHRNLTKIITICSSIDS-KGADF  122 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~l~~~~~~~~~-~~~~~  122 (234)
                      .+|++.+.||+|+||+||+|+++.+|+.||||+++..  ......++.+|+.+++.++||||+++++++..... +...+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5699999999999999999999999999999999743  23344678899999999999999999999865432 24567


Q ss_pred             ceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeeeCCCCceEEccCc
Q 039258          123 KALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLLDNDMVAHVGDFG  202 (234)
Q Consensus       123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~~~~~~vki~dfG  202 (234)
                      +|+||||+.+ ++.+.+..        .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|++|||
T Consensus        97 ~~iv~Ey~~~-~l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEeccch-HHHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            8999999965 55555532        578899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCccCCCCCCCCccccccccccccCC
Q 039258          203 LSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       203 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      +++.........         ..+||+.|+||
T Consensus       165 ~~~~~~~~~~~~---------~~~~t~~y~aP  187 (355)
T d2b1pa1         165 LARTAGTSFMMT---------PYVVTRYYRAP  187 (355)
T ss_dssp             C------------------------CCTTCCH
T ss_pred             hhhccccccccc---------cccccccccCh
Confidence            988655432211         25799999998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=7.1e-28  Score=199.53  Aligned_cols=167  Identities=19%  Similarity=0.284  Sum_probs=127.1

Q ss_pred             cCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-----------CCCceeEEEEeee
Q 039258           46 CEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-----------HRNLTKIITICSS  114 (234)
Q Consensus        46 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~l~~~~~~  114 (234)
                      .+|++.+.||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.++..++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999999999999999997432 23466778888888775           5788888887754


Q ss_pred             cCCCCCCcceeeEeecCCCC-HHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCCeeeCC
Q 039258          115 IDSKGADFKALVFEYMENGS-LEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHH-NCQPPMVHGDIKPSNVLLDN  192 (234)
Q Consensus       115 ~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~~~~ivH~dlk~~nil~~~  192 (234)
                      .   +....+++|+++.... ...........    .+++..+..++.|++.|++|+|+ .   +|+||||||+|||++.
T Consensus        92 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          92 K---GPNGVHVVMVFEVLGENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI  161 (362)
T ss_dssp             E---ETTEEEEEEEECCCCEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred             c---cccceeeeeeeccccccccccccccccc----CCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence            2   2334566777665443 33333222211    67888999999999999999997 6   9999999999999975


Q ss_pred             CC------ceEEccCccccccCCCccCCCCCCCCccccccccccccCC
Q 039258          193 DM------VAHVGDFGLSKFLSSDHLDTASETPSSSIGIKGTVGYVAP  234 (234)
Q Consensus       193 ~~------~vki~dfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  234 (234)
                      ++      .++++|||.+........           ..+||+.|+||
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~~~~-----------~~~gt~~y~aP  198 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDEHYT-----------NSIQTREYRSP  198 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBCCC-----------SCCSCGGGCCH
T ss_pred             cCcccccceeeEeecccccccccccc-----------cccccccccCh
Confidence            44      489999999886543221           15799999998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.5e-24  Score=164.00  Aligned_cols=133  Identities=20%  Similarity=0.251  Sum_probs=102.8

Q ss_pred             CCCceeecccceEEEEEEECCCCeEEEEEEeecccc------------------hhhHHHHHHHHHHHhcCCCCceeEEE
Q 039258           49 SQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQK------------------GAFRSFVAECEALRNIRHRNLTKIIT  110 (234)
Q Consensus        49 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~l~~  110 (234)
                      .+.+.||+|+||+||+|.+. +|+.||||+++....                  .......+|...+..+.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45789999999999999984 678999998752110                  01123456888999999999988876


Q ss_pred             EeeecCCCCCCcceeeEeecCCCCHHHHhhhccCCccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCCeee
Q 039258          111 ICSSIDSKGADFKALVFEYMENGSLEDWLHQTNDHLEVFKLSLIQRVNIAIDVASAIEYLHHNCQPPMVHGDIKPSNVLL  190 (234)
Q Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~~~~ivH~dlk~~nil~  190 (234)
                      +.    .     .+++||++++..+.+             ++......++.|++.++.|||++   +|+||||||+|||+
T Consensus        82 ~~----~-----~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv  136 (191)
T d1zara2          82 WE----G-----NAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV  136 (191)
T ss_dssp             EE----T-----TEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             ec----C-----CEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheee
Confidence            53    1     279999998754322             22234467889999999999999   99999999999999


Q ss_pred             CCCCceEEccCccccccC
Q 039258          191 DNDMVAHVGDFGLSKFLS  208 (234)
Q Consensus       191 ~~~~~vki~dfG~a~~~~  208 (234)
                      +.+ .++++|||+|....
T Consensus       137 ~~~-~~~liDFG~a~~~~  153 (191)
T d1zara2         137 SEE-GIWIIDFPQSVEVG  153 (191)
T ss_dssp             ETT-EEEECCCTTCEETT
T ss_pred             eCC-CEEEEECCCcccCC
Confidence            865 58999999987654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.47  E-value=1.3e-06  Score=67.02  Aligned_cols=90  Identities=12%  Similarity=0.088  Sum_probs=53.7

Q ss_pred             HHHhcCCCCCceeecccceEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCC
Q 039258           42 SKATCEFSQSNMIGQGSYGSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGA  120 (234)
Q Consensus        42 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~  120 (234)
                      ......|+..+..+-++.+.||+...  ++..+.+|............+.+|...+..+. +--+.+++.+...     .
T Consensus        10 ~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-----~   82 (263)
T d1j7la_          10 KKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----D   82 (263)
T ss_dssp             HHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----T
T ss_pred             HHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-----C
Confidence            33344555444433344468998753  44567788876443333345677888877664 3335666665432     2


Q ss_pred             CcceeeEeecCCCCHHHH
Q 039258          121 DFKALVFEYMENGSLEDW  138 (234)
Q Consensus       121 ~~~~lv~e~~~~~~L~~~  138 (234)
                      +..++||++++|.++.+.
T Consensus        83 ~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             TEEEEEEECCSSEEHHHH
T ss_pred             CceEEEEEeccccccccc
Confidence            345899999988766543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.01  E-value=2.9e-05  Score=63.17  Aligned_cols=76  Identities=16%  Similarity=0.121  Sum_probs=47.8

Q ss_pred             CceeecccceEEEEEEECCCCeEEEEEEeecc----c---chhhHHHHHHHHHHHhcC-C--CCceeEEEEeeecCCCCC
Q 039258           51 SNMIGQGSYGSVYKGILGEDEMVVAVKVINLK----Q---KGAFRSFVAECEALRNIR-H--RNLTKIITICSSIDSKGA  120 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~-h--~~i~~l~~~~~~~~~~~~  120 (234)
                      .+.+|.|....||++....+++.+++|.....    .   +....+...|.+.|..+. +  ..+++++.+.  .     
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~-----  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T-----  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C-----
Confidence            45789999999999988777888999976421    1   112345667888887663 3  3456666542  1     


Q ss_pred             CcceeeEeecCCC
Q 039258          121 DFKALVFEYMENG  133 (234)
Q Consensus       121 ~~~~lv~e~~~~~  133 (234)
                      ...++|||++++.
T Consensus       104 ~~~~lvmE~L~~~  116 (392)
T d2pula1         104 EMAVTVMEDLSHL  116 (392)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CCCEEEEeccCCc
Confidence            1237899999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.77  E-value=0.00013  Score=55.08  Aligned_cols=144  Identities=15%  Similarity=0.122  Sum_probs=76.5

Q ss_pred             eecccc-eEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCC--CCceeEEEEeeecCCCCCCcceeeEeec
Q 039258           54 IGQGSY-GSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRH--RNLTKIITICSSIDSKGADFKALVFEYM  130 (234)
Q Consensus        54 lG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~l~~~~~~~~~~~~~~~~lv~e~~  130 (234)
                      +..|.. +.||+... .++..+.+|......   ...+..|...++.+..  -.+.+++.+...     .+..++||+++
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~i   88 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGEV   88 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEECC
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEee
Confidence            344544 57898765 345567888765332   2345677777776642  235667766432     23458999999


Q ss_pred             CCCCHHH--------------Hhhh-ccC--CccccccCHHHHHHHHH--------------------HHHHHHHHHHhC
Q 039258          131 ENGSLED--------------WLHQ-TND--HLEVFKLSLIQRVNIAI--------------------DVASAIEYLHHN  173 (234)
Q Consensus       131 ~~~~L~~--------------~l~~-~~~--~~~~~~~~~~~~~~~~~--------------------qi~~~l~~lh~~  173 (234)
                      +|.++.+              .+.. +..  ...+..........-..                    .....+..+...
T Consensus        89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  168 (255)
T d1nd4a_          89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR  168 (255)
T ss_dssp             SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred             eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence            8754322              1111 000  00000111110000000                    011123333322


Q ss_pred             C----CCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          174 C----QPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       174 ~----~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      .    +..++|+|+.|.||+++.+..+-|+||+.+..
T Consensus       169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            1    12379999999999998776677999998764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.68  E-value=0.0015  Score=51.12  Aligned_cols=71  Identities=14%  Similarity=0.094  Sum_probs=39.7

Q ss_pred             eEEEEEEECCCCeEEEEEEeecccchhhHHHHHHHHHHHhcCCCCc--eeEEEEeeecCCCCCCcceeeEeecCC
Q 039258           60 GSVYKGILGEDEMVVAVKVINLKQKGAFRSFVAECEALRNIRHRNL--TKIITICSSIDSKGADFKALVFEYMEN  132 (234)
Q Consensus        60 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~l~~~~~~~~~~~~~~~~lv~e~~~~  132 (234)
                      -.||++.. .+|..+++|+.... ....+++..|...+..+....+  +..+............+.+.++++++|
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            47999876 45678999998643 2234667788888877642222  111111000001123445778888765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.50  E-value=0.01  Score=47.59  Aligned_cols=72  Identities=19%  Similarity=0.129  Sum_probs=45.9

Q ss_pred             CceeecccceEEEEEEECCC-------CeEEEEEEeecccchhhHHHHHHHHHHHhcC-CCCceeEEEEeeecCCCCCCc
Q 039258           51 SNMIGQGSYGSVYKGILGED-------EMVVAVKVINLKQKGAFRSFVAECEALRNIR-HRNLTKIITICSSIDSKGADF  122 (234)
Q Consensus        51 ~~~lG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~l~~~~~~~~~~~~~~  122 (234)
                      .+.|+.|-.-.+|++.....       ...|.+++.. .... .....+|..+++.+. +.-..++++++.         
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~---------  115 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFS---------  115 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET---------
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC---------
Confidence            34677788889999986532       3567777764 2222 234557888888774 333357777652         


Q ss_pred             ceeeEeecCCC
Q 039258          123 KALVFEYMENG  133 (234)
Q Consensus       123 ~~lv~e~~~~~  133 (234)
                      -.+|+||++|.
T Consensus       116 ~g~I~efi~g~  126 (395)
T d1nw1a_         116 GGRLEEYIPSR  126 (395)
T ss_dssp             TEEEECCCCEE
T ss_pred             CceEEEEeccc
Confidence            15899998763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.58  E-value=0.0049  Score=47.70  Aligned_cols=33  Identities=21%  Similarity=0.271  Sum_probs=28.2

Q ss_pred             CCCCeeecCCCCCCeeeCCCCceEEccCccccc
Q 039258          174 CQPPMVHGDIKPSNVLLDNDMVAHVGDFGLSKF  206 (234)
Q Consensus       174 ~~~~ivH~dlk~~nil~~~~~~vki~dfG~a~~  206 (234)
                      .+.++||+|+.+.|++++.+...-++||+.+..
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCcchhhhhcccccceeEeccccccc
Confidence            355799999999999999887778999998763